Citrus Sinensis ID: 018244
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 359 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FHD7 | 487 | Probable serine/threonine | yes | no | 0.891 | 0.657 | 0.8 | 1e-156 | |
| Q944A7 | 512 | Probable serine/threonine | no | no | 0.799 | 0.560 | 0.679 | 1e-118 | |
| Q7XJT7 | 465 | Probable inactive recepto | no | no | 0.835 | 0.645 | 0.450 | 4e-75 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.860 | 0.753 | 0.319 | 9e-39 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.774 | 0.671 | 0.347 | 1e-36 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.777 | 0.677 | 0.322 | 1e-36 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.746 | 0.688 | 0.323 | 3e-36 | |
| P43298 | 942 | Probable receptor protein | no | no | 0.743 | 0.283 | 0.322 | 7e-35 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.766 | 0.670 | 0.330 | 1e-34 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.796 | 0.724 | 0.314 | 1e-34 |
| >sp|Q9FHD7|Y5126_ARATH Probable serine/threonine-protein kinase At5g41260 OS=Arabidopsis thaliana GN=At5g41260 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 550 bits (1418), Expect = e-156, Method: Compositional matrix adjust.
Identities = 256/320 (80%), Positives = 289/320 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVS 320
PNP+SLV+A++ LQKD E++
Sbjct: 301 PNPKSLVSAMIPLQKDLEIA 320
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q944A7|Y4523_ARATH Probable serine/threonine-protein kinase At4g35230 OS=Arabidopsis thaliana GN=At4g35230 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 195/287 (67%), Positives = 240/287 (83%)
Query: 38 VPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA 97
+P F E+S L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+ IAVK+F + AWP+
Sbjct: 55 IPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPEP 114
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
+QF EEA VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++WAMR
Sbjct: 115 KQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAMR 174
Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217
LRV +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYSTNLA
Sbjct: 175 LRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNLA 234
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI L DS LEG+F
Sbjct: 235 YTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGKF 294
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLF 324
S++E T +V LAS+CLQYEPRERPN + LV L LQ ++V ++
Sbjct: 295 STEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVM 341
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XJT7|SSP_ARATH Probable inactive receptor-like kinase SSP OS=Arabidopsis thaliana GN=SSP PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 4e-75, Method: Compositional matrix adjust.
Identities = 145/322 (45%), Positives = 208/322 (64%), Gaps = 22/322 (6%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC C LS+ + D +E + G P ++S L+TAT+ F+ EN
Sbjct: 1 MGC-CYSLSSTVDPVQ-----DHTTDASSEPRNGGGEDPPLTKFSFSALKTATNHFSPEN 54
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVS+ + +VV+KG+L+N +A+KRFN AW D + FLEEA+ VG+LR++RL NL+G
Sbjct: 55 IVSD---QTSDVVFKGRLQNGGFVAIKRFNNMAWSDPKLFLEEAQRVGKLRHKRLVNLIG 111
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC+GD+R LVA++M NDTLAK LF + Q M W++RLRVA +AEAL+YC + A Y+
Sbjct: 112 YCCDGDKRFLVADFMANDTLAKRLFQRKYQTMDWSIRLRVAYFVAEALDYCNTAGFASYN 171
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
+L+AY+++FD+D + LSCFGLMK + + + TG V PE+V+Y FGT
Sbjct: 172 NLSAYKVLFDEDGDACLSCFGLMKEINNDQ-------------ITTGSVNPENVIYRFGT 218
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++LLSGK IPPSHA ++I +N+ L D L+G+FS DE + +LAS+CL+YE +E
Sbjct: 219 VLVNLLSGKQIPPSHAPEMIHRKNVFKLMDPYLKGKFSIDEANVVYKLASQCLKYEGQES 278
Query: 301 PNPRSLVTALVTLQKDTEVSCF 322
PN + +V L TLQ TE +
Sbjct: 279 PNTKEIVATLETLQTRTEAPSY 300
|
Probable inactive protein kinase that activates the YODA MAP kinase cascade, regulating the asymmetric first division, and thus embryo polarity. Acts as an adapter at the plasma membrane, possibly recruiting an activator. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 9e-39, Method: Compositional matrix adjust.
Identities = 111/347 (31%), Positives = 168/347 (48%), Gaps = 38/347 (10%)
Query: 3 CECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN----VPVFCEYSIETLRTATSGFAM 58
E S S + G +A V P + P +S L++AT F
Sbjct: 11 AESSGASTKYDAKDIGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSFAELKSATRNFRP 70
Query: 59 ENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKRFNRSAWPDARQFLEEARAVG 108
++++ GE V+KG ++ + IAVK+ N+ W +++L E +G
Sbjct: 71 DSVL---GEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLG 127
Query: 109 QLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAE 166
Q +R L L+G C E + RLLV E+MP +L HLF QP+ W +RL+VAL A+
Sbjct: 128 QFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAK 187
Query: 167 ALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNS--RDGRSYSTNL----AFT 219
L + S E R +Y D I+ D + N +LS FGL K+ D ST + +
Sbjct: 188 GLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYA 247
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHALD--------LIRDRNIQT 267
PEYL TG +T +S +YSFG +LL+LLSG+ PS + L+ R I
Sbjct: 248 APEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFR 307
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
+ D+ L+ Q+S +E ++ L+ RCL E + RPN +V+ L +Q
Sbjct: 308 VIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 109/314 (34%), Positives = 156/314 (49%), Gaps = 36/314 (11%)
Query: 25 QDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI 84
Q+ N+E V N +S L TAT F E ++ GE VYKGKLE I
Sbjct: 48 QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLI---GEGGFGRVYKGKLEKTGMI 104
Query: 85 -AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
AVK+ +R+ ++F+ E + L ++ L NL+G C +GD+RLLV EYM +L H
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 144 LFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSC 199
L + P+ W R+R+AL A LEY K +Y DL A I+ D + N +LS
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 200 FGLMKNS--RDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
FGL K D + S+ + + PEY RTG++T +S +YSFG +LL+L++G+ +
Sbjct: 225 FGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRV-- 282
Query: 254 SHALDLIRDRNIQTLT-----------------DSCLEGQFSSDEGTELVRLASRCLQYE 296
+D R ++ Q L D LEG F + V +A+ CLQ E
Sbjct: 283 ---IDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEE 339
Query: 297 PRERPNPRSLVTAL 310
RP +VTAL
Sbjct: 340 ATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 101/313 (32%), Positives = 160/313 (51%), Gaps = 34/313 (10%)
Query: 39 PVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKR 88
P ++ L+ AT F ++++ E G + V+KG ++ Q IAVK+
Sbjct: 52 PNLKSFTFAELKAATRNFRPDSVLGEGGFGS---VFKGWIDEQTLTASKPGTGVVIAVKK 108
Query: 89 FNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE 148
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168
Query: 149 T--QPMKWAMRLRVALHIAEALEYCTSKERA-LYHDLNAYRIVFDDDVNPRLSCFGLMKN 205
+ QP+ W +RL+VAL A+ L + + E + +Y D I+ D + N +LS FGL K+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228
Query: 206 --SRDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPS 254
+ D ST + + PEYL TG +T +S +YS+G +LL++LSG K+ PP
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288
Query: 255 HAL-------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
L R + + D+ L+ Q+S +E ++ LA RCL +E + RPN +V
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348
Query: 308 TALVTLQKDTEVS 320
+ L +Q E
Sbjct: 349 SHLEHIQTLNEAG 361
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 98/303 (32%), Positives = 155/303 (51%), Gaps = 35/303 (11%)
Query: 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLE----------NQFRIAVKRFNRSA 93
+S L+ AT F +++V GE V++G L+ + IAVKR N
Sbjct: 49 FSFNELKLATRNFRSDSVV---GEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDG 105
Query: 94 WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF---HWETQ 150
+ R++L E +GQL + L L+G C E ++RLLV E+M +L HLF + + +
Sbjct: 106 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFK 165
Query: 151 PMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209
P+ W +R++VAL A+ L + S + +Y D+ A I+ D D N +LS FGL ++ G
Sbjct: 166 PLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMG 225
Query: 210 -RSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDL 259
+SY + + PEY+ TG + S +YSFG +LL+LL G+ H P+ +L
Sbjct: 226 EQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNL 285
Query: 260 I--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
+ R + + D+ L Q+ + L +A +CL +EP+ RP +V ALV
Sbjct: 286 VDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALV 345
Query: 312 TLQ 314
LQ
Sbjct: 346 QLQ 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 148 bits (373), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 99/307 (32%), Positives = 166/307 (54%), Gaps = 40/307 (13%)
Query: 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRS--AWPDARQFLE 102
SI+ LR+ T+ F+ +NI+ G VVYKG+L + +IAVKR A +F
Sbjct: 577 SIQVLRSVTNNFSSDNIL---GSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKS 633
Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ---PMKWAMRLR 159
E + ++R+R L LLG C +G+E+LLV EYMP TL++HLF W + P+ W RL
Sbjct: 634 EIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLT 693
Query: 160 VALHIAEALEYC--TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNL 216
+AL +A +EY + + ++ DL I+ DD+ +++ FGL++ + +G+ S T +
Sbjct: 694 LALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 753
Query: 217 AFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI-------- 260
A T PEY TGRVT + +YSFG +L++L++G+ P ++ L+
Sbjct: 754 AGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHLVSWFKRMYI 813
Query: 261 -RDRNIQTLTDSCLEGQFSSDEGT-----ELVRLASRCLQYEPRERPN---PRSLVTALV 311
++ + + D+ ++ DE T + LA C EP +RP+ +++++LV
Sbjct: 814 NKEASFKKAIDTTID----LDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNILSSLV 869
Query: 312 TLQKDTE 318
L K ++
Sbjct: 870 ELWKPSD 876
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 101/306 (33%), Positives = 147/306 (48%), Gaps = 31/306 (10%)
Query: 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI-------AVKRFNRSAWPD 96
+++ L T T F + I+ E G VYKG +++ R+ AVK N+
Sbjct: 57 FTLFELETITKSFRPDYILGEGGF---GTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQG 113
Query: 97 ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAM 156
R++L E +GQLR+ L L+G CCE D RLLV E+M +L HLF T P+ W+
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173
Query: 157 RLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
R+ +AL A+ L + + ER +Y D I+ D D +LS FGL K G S
Sbjct: 174 RMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 214 TNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI----- 260
T + + PEY+ TG +T S +YSFG +LL++L+G+ PS +L+
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 261 ---RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ--K 315
R + + D LE Q+S + LA CL P+ RP +V L LQ
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTG 353
Query: 316 DTEVSC 321
D + C
Sbjct: 354 DALIPC 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (370), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 102/324 (31%), Positives = 161/324 (49%), Gaps = 38/324 (11%)
Query: 24 AQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ-- 81
AQ E E + + PV ++ L+ AT F ++++ GE V+KG L+
Sbjct: 39 AQKTEGEI---LSSTPV-KSFTFNELKLATRNFRPDSVI---GEGGFGCVFKGWLDESTL 91
Query: 82 --------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
IAVK+ N+ + R++L E +GQL + L L+G C E + RLLV E
Sbjct: 92 TPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYE 151
Query: 134 YMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFD 190
+M +L HLF +P+ W +R+ VAL A+ L + S + +Y D+ A I+ D
Sbjct: 152 FMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211
Query: 191 DDVNPRLSCFGLMKNSRDGR-SYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
D N +LS FGL ++ G SY + + PEY+ +G + S +YSFG LLL+
Sbjct: 212 ADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLE 271
Query: 245 LLSGK----HIPPSHALDLI--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
+LSGK H P+ +L+ R + + D+ L+ Q+ +E + +A +C
Sbjct: 272 ILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQC 331
Query: 293 LQYEPRERPNPRSLVTALVTLQKD 316
L +EP+ RP +V AL LQ +
Sbjct: 332 LSFEPKSRPTMDQVVRALQQLQDN 355
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 359 | ||||||
| 224071868 | 487 | predicted protein [Populus trichocarpa] | 0.888 | 0.655 | 0.849 | 1e-161 | |
| 224058519 | 488 | predicted protein [Populus trichocarpa] | 0.888 | 0.653 | 0.830 | 1e-160 | |
| 225426412 | 488 | PREDICTED: probable serine/threonine-pro | 0.888 | 0.653 | 0.846 | 1e-159 | |
| 225454188 | 491 | PREDICTED: probable serine/threonine-pro | 0.888 | 0.649 | 0.833 | 1e-158 | |
| 297805526 | 487 | kinase family protein [Arabidopsis lyrat | 0.891 | 0.657 | 0.803 | 1e-155 | |
| 356520418 | 491 | PREDICTED: probable serine/threonine-pro | 0.888 | 0.649 | 0.811 | 1e-154 | |
| 15237604 | 487 | putative serine/threonine-protein kinase | 0.891 | 0.657 | 0.8 | 1e-154 | |
| 357520451 | 495 | Protein kinase-like protein [Medicago tr | 0.888 | 0.644 | 0.822 | 1e-154 | |
| 449452322 | 486 | PREDICTED: probable serine/threonine-pro | 0.883 | 0.652 | 0.830 | 1e-153 | |
| 356504529 | 491 | PREDICTED: probable serine/threonine-pro | 0.888 | 0.649 | 0.802 | 1e-153 |
| >gi|224071868|ref|XP_002303586.1| predicted protein [Populus trichocarpa] gi|222841018|gb|EEE78565.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1483), Expect = e-161, Method: Compositional matrix adjust.
Identities = 271/319 (84%), Positives = 294/319 (92%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSKLS CC S+Y + PE ++ NEEK +D++P F EY+IETLR ATSGF++EN
Sbjct: 1 MGCECSKLSKCCWSSDYNGSVPEDRNEVNEEKSELDDLPAFREYNIETLRMATSGFSVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ R+AVKRFNRSAWPDARQFLEEARAVGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRVAVKRFNRSAWPDARQFLEEARAVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EGDERLLVAE+MPNDTLAKHLFHWET+PMKWAMRLRVALH+A+ALEYCTSK RALYH
Sbjct: 121 CCGEGDERLLVAEFMPNDTLAKHLFHWETKPMKWAMRLRVALHLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDD+ NPRLSCFGLMKN RDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct: 181 DLNAYRIVFDDEGNPRLSCFGLMKNRRDGKSYSTNLAFTPPEYLRTGRVIPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PN +SLV AL+ LQKDTEV
Sbjct: 301 PNSKSLVAALIPLQKDTEV 319
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058519|ref|XP_002299534.1| predicted protein [Populus trichocarpa] gi|222846792|gb|EEE84339.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1469), Expect = e-160, Method: Compositional matrix adjust.
Identities = 265/319 (83%), Positives = 292/319 (91%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSKL+ CC S+Y + PE + + EE+ +D++P F EY+IETLR ATSGF++EN
Sbjct: 1 MGCECSKLTKCCWSSDYNGSVPEDHNEDKEERSELDDLPAFREYNIETLRMATSGFSVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RI VKRFNRS+WPDARQFLEEAR VGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIVVKRFNRSSWPDARQFLEEARTVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEGDERLLV+E+MPNDTLAKHLFHWETQPMKWAMRLRVALH+A+ALEYC SK RALYH
Sbjct: 121 CCCEGDERLLVSEFMPNDTLAKHLFHWETQPMKWAMRLRVALHLAQALEYCASKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR+VFDD+ NPRLSCFGLMKNS DG+SYSTNLAFTPPEYLRTGRVT ESV+YSFGT
Sbjct: 181 DLNAYRVVFDDEGNPRLSCFGLMKNSIDGKSYSTNLAFTPPEYLRTGRVTAESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L+DSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLSDSCLEGQFANDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PNP+SLV AL+ LQKDTEV
Sbjct: 301 PNPKSLVAALIPLQKDTEV 319
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426412|ref|XP_002270065.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297742525|emb|CBI34674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 270/319 (84%), Positives = 288/319 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC+CSK CC SE E VENEE D++P F EY+I+ LR ATSGFA EN
Sbjct: 1 MGCQCSKFWVCCWDSEQKGLVVEPPSVENEENSEADDLPAFHEYTIDQLRMATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFN+SAWPDARQFLEEAR+VGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNKSAWPDARQFLEEARSVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EGDERLLVAE+MPNDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RALYH
Sbjct: 121 CCSEGDERLLVAEFMPNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDDD +PRLSCFG+MKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYSFGT
Sbjct: 181 DLNAYRIVFDDDGDPRLSCFGMMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFSSD+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSSDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PNP+SLV AL+ LQK+TEV
Sbjct: 301 PNPKSLVAALIPLQKETEV 319
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225454188|ref|XP_002272416.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297745267|emb|CBI40347.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-158, Method: Compositional matrix adjust.
Identities = 266/319 (83%), Positives = 291/319 (91%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC+CSKL+ CC S++ + EA DV+N EK VD +PVFCEY+ E L+ ATSGFA+EN
Sbjct: 1 MGCQCSKLAPCCWDSQFKGSVLEAPDVDNGEKSEVDYLPVFCEYTFEQLKNATSGFAVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPDARQF EEARAVGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRVAWPDARQFSEEARAVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCE +ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCT + RALYH
Sbjct: 121 CCCEDNERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTGRGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRI+FD+D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRILFDEDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRN+Q LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PNP+SLV AL LQK+TEV
Sbjct: 301 PNPKSLVAALTPLQKETEV 319
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297805526|ref|XP_002870647.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316483|gb|EFH46906.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 257/320 (80%), Positives = 290/320 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EG+ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEGEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVS 320
PNP+SLV+A++ LQKD E++
Sbjct: 301 PNPKSLVSAMIPLQKDLEIA 320
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520418|ref|XP_003528859.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 259/319 (81%), Positives = 285/319 (89%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG +CS+L CC S+ + E D E E+ V N P F EY++E L+ ATSGFA+EN
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPDAEIEDSSEVSNWPTFREYTLEQLKNATSGFAVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR+AWPDARQFLEEAR+VGQLRN+RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEEARSVGQLRNQRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEG+ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCTSK RALYH
Sbjct: 121 CCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD+D NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALD+IR RN+Q LTDSCLEGQFS D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PNP+SLV AL LQK+TEV
Sbjct: 301 PNPKSLVVALAPLQKETEV 319
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237604|ref|NP_198942.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|75333858|sp|Q9FHD7.1|Y5126_ARATH RecName: Full=Probable serine/threonine-protein kinase At5g41260 gi|10177770|dbj|BAB11102.1| protein kinase-like [Arabidopsis thaliana] gi|115311489|gb|ABI93925.1| At5g41260 [Arabidopsis thaliana] gi|332007275|gb|AED94658.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 256/320 (80%), Positives = 289/320 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVS 320
PNP+SLV+A++ LQKD E++
Sbjct: 301 PNPKSLVSAMIPLQKDLEIA 320
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520451|ref|XP_003630514.1| Protein kinase-like protein [Medicago truncatula] gi|355524536|gb|AET04990.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 264/321 (82%), Positives = 286/321 (89%), Gaps = 2/321 (0%)
Query: 1 MGCECSKLSACCSGSEYGEA-APEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAM 58
MGC SK S CC +E G PEA ENE+ N + F EY+I+ LR ATSGFA+
Sbjct: 7 MGCNFSKYSTCCCSTEQGGVQVPEANIEENEDNNVEGNGLASFREYTIDQLRKATSGFAI 66
Query: 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118
ENIVSEHGEKAPNVVYKGKLENQ RIAVKRFN+S WPDA QFLEEARAVGQLR++RLANL
Sbjct: 67 ENIVSEHGEKAPNVVYKGKLENQVRIAVKRFNKSNWPDAHQFLEEARAVGQLRSQRLANL 126
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
LGCCCEGDERLLV+EYM NDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RAL
Sbjct: 127 LGCCCEGDERLLVSEYMSNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRAL 186
Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
YHDLNAYR++FDDD NP+LSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV YSF
Sbjct: 187 YHDLNAYRVLFDDDFNPKLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVTYSF 246
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
GTLLLDLLSGKHIPPSHALDLIRDRN+Q+LTDSCLEGQFS DEGTELVRLASRCLQ EPR
Sbjct: 247 GTLLLDLLSGKHIPPSHALDLIRDRNLQSLTDSCLEGQFSDDEGTELVRLASRCLQSEPR 306
Query: 299 ERPNPRSLVTALVTLQKDTEV 319
ERPNP+SLVTAL+ LQKD+EV
Sbjct: 307 ERPNPKSLVTALIPLQKDSEV 327
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452322|ref|XP_004143908.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus] gi|449495800|ref|XP_004159948.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 265/319 (83%), Positives = 287/319 (89%), Gaps = 2/319 (0%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSK S C GSE + D E+ K D +P F E++I+ LRTATSGFA+EN
Sbjct: 1 MGCECSKFSDCF-GSEETKPVARVPDNESIGKSEFD-LPAFREFTIDQLRTATSGFAVEN 58
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKL+NQ RIAVKRFNRSAWPDARQFL+EARAVGQLRN+RLANLLG
Sbjct: 59 IVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRSAWPDARQFLDEARAVGQLRNQRLANLLG 118
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EG+ERLLVAE+MPN+TLAKHLFHWE QPMKW+MRLRVALH+A+ALEYCTSK RALYH
Sbjct: 119 CCFEGEERLLVAEFMPNETLAKHLFHWENQPMKWSMRLRVALHLAQALEYCTSKGRALYH 178
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDD+ NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG +TPESV+YSFGT
Sbjct: 179 DLNAYRIVFDDEGNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGGITPESVIYSFGT 238
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFS+DEGTELVRLASRCLQYEPRER
Sbjct: 239 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSNDEGTELVRLASRCLQYEPRER 298
Query: 301 PNPRSLVTALVTLQKDTEV 319
PN +SLVTAL+ LQKD EV
Sbjct: 299 PNTKSLVTALIPLQKDLEV 317
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504529|ref|XP_003521048.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 256/319 (80%), Positives = 284/319 (89%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG +CS+L CC S+ + E D E E+ N P F E+++E L+ ATSGFA+EN
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPDAEIEDSSEASNWPTFREFTLEQLKNATSGFAVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR+AWPDARQFLEE+R+VGQLRN+RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEESRSVGQLRNQRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEG+ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCTSK RALYH
Sbjct: 121 CCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD+D NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALD+IR RN+Q LTDSCLEGQFS D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEV 319
PNP+SLV AL LQK+TEV
Sbjct: 301 PNPKSLVAALAPLQKETEV 319
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 359 | ||||||
| TAIR|locus:2155115 | 487 | BSK8 "brassinosteroid-signalin | 0.891 | 0.657 | 0.8 | 2.4e-140 | |
| TAIR|locus:2031279 | 487 | BSK7 "brassinosteroid-signalin | 0.883 | 0.650 | 0.815 | 5.6e-139 | |
| TAIR|locus:2127118 | 489 | BSK3 "brassinosteroid-signalin | 0.885 | 0.650 | 0.783 | 2.5e-136 | |
| TAIR|locus:2198160 | 483 | BSK4 "brassinosteroid-signalin | 0.880 | 0.654 | 0.746 | 1.7e-128 | |
| TAIR|locus:2154538 | 489 | BSK5 "brassinosteroid-signalin | 0.877 | 0.644 | 0.730 | 2.6e-125 | |
| TAIR|locus:2084475 | 490 | BSK6 "brassinosteroid-signalin | 0.888 | 0.651 | 0.697 | 7.4e-121 | |
| TAIR|locus:2122058 | 512 | BSK1 "brassinosteroid-signalin | 0.807 | 0.566 | 0.675 | 1.3e-107 | |
| TAIR|locus:2142315 | 489 | BSK2 "brassinosteroid-signalin | 0.880 | 0.646 | 0.604 | 3.7e-103 | |
| TAIR|locus:2083499 | 477 | BSK9 "brassinosteroid-signalin | 0.813 | 0.612 | 0.640 | 1.7e-100 | |
| TAIR|locus:2150074 | 499 | BSK10 "brassinosteroid-signali | 0.874 | 0.629 | 0.593 | 4.1e-97 |
| TAIR|locus:2155115 BSK8 "brassinosteroid-signaling kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 256/320 (80%), Positives = 289/320 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVS 320
PNP+SLV+A++ LQKD E++
Sbjct: 301 PNPKSLVSAMIPLQKDLEIA 320
|
|
| TAIR|locus:2031279 BSK7 "brassinosteroid-signaling kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 260/319 (81%), Positives = 285/319 (89%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
MGCE SKL A C S+ E + +E++ G N +P F E+SIETLR ATSGFA E
Sbjct: 1 MGCEVSKLCAFCCVSD-PEGSNHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFATE 59
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
NIVSEHGEKAPNVVYKGKL+NQ RIAVKRFNR AWPD+RQFLEEA+AVGQLRN R+ANLL
Sbjct: 60 NIVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMANLL 119
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EG+ERLLVAE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCT K RALY
Sbjct: 120 GCCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRALY 179
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYS+G
Sbjct: 180 HDLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSYG 239
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
TLLLDLLSGKHIPPSHALDLIRDRNIQ L DSCLEGQFSSD+GTEL+RLASRCLQYEPRE
Sbjct: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEPRE 299
Query: 300 RPNPRSLVTALVTLQKDTE 318
RPNP+SLVTA++ LQKD E
Sbjct: 300 RPNPKSLVTAMIPLQKDLE 318
|
|
| TAIR|locus:2127118 BSK3 "brassinosteroid-signaling kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 2.5e-136, P = 2.5e-136
Identities = 250/319 (78%), Positives = 282/319 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG +CS LS CC + + A EA DV+N E + +VP F EY++E L+ ATSGFA+E
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVDNGESSEITDVPNFREYTLEQLKAATSGFAVEY 59
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ +IAVKRF R AWPD+RQFLEEAR+VGQLR+ R+ANLLG
Sbjct: 60 IVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMANLLG 119
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEGDERLLVAE+MPN+TLAKHLFHWETQPMKW MRLRV L++A+ALEYCTSK R LYH
Sbjct: 120 CCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRTLYH 179
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+TPESV+YSFGT
Sbjct: 180 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYSFGT 239
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRN+QTLTDSCL+GQFS +GTELVRLASRCLQYE RER
Sbjct: 240 LLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEARER 299
Query: 301 PNPRSLVTALVTLQKDTEV 319
PN +SLVTAL LQK+TEV
Sbjct: 300 PNTKSLVTALTPLQKETEV 318
|
|
| TAIR|locus:2198160 BSK4 "brassinosteroid-signaling kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
Identities = 238/319 (74%), Positives = 276/319 (86%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG + SK+ CCS + A EA DVEN+E V+ V F EYS+E L+ ATS FA+EN
Sbjct: 1 MGGQSSKIGTCCS---HKTTALEAPDVENKENGEVNGVHSFREYSLEQLKIATSCFALEN 57
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
+VSEHGE APNVVY+GKLEN +IA+KRF+ +AWPD RQFLEEAR VGQLR++R+ANLLG
Sbjct: 58 VVSEHGETAPNVVYQGKLENHMKIAIKRFSGTAWPDPRQFLEEARLVGQLRSKRMANLLG 117
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCEG ERLLVAE+MPN+TLAKHLFHW+T+PMKWAMRLRVAL+I+EALEYC++ LYH
Sbjct: 118 YCCEGGERLLVAEFMPNETLAKHLFHWDTEPMKWAMRLRVALYISEALEYCSNNGHTLYH 177
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+T ESV+YSFGT
Sbjct: 178 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITAESVIYSFGT 237
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLL+GKHIPPSHALDLIRDRN+QTLTDSCLEGQFS +GTELVRL S CLQYE RER
Sbjct: 238 LLLDLLTGKHIPPSHALDLIRDRNLQTLTDSCLEGQFSDSDGTELVRLTSCCLQYEARER 297
Query: 301 PNPRSLVTALVTLQKDTEV 319
PN +SLVTAL++LQKDTEV
Sbjct: 298 PNIKSLVTALISLQKDTEV 316
|
|
| TAIR|locus:2154538 BSK5 "brassinosteroid-signaling kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1231 (438.4 bits), Expect = 2.6e-125, P = 2.6e-125
Identities = 233/319 (73%), Positives = 271/319 (84%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG CSKLS C + EA D++N G D++P F E+S + LR AT GF+ ++
Sbjct: 1 MGPRCSKLSLCWWPTHLKSTHNEASDLDN----GTDDLPSFTEFSFDQLRAATCGFSTDS 56
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHG KAPNVVYKG+LE+ IAVKRFNRSAWPD RQFLEEA+AVGQLRN RLANL+G
Sbjct: 57 IVSEHGVKAPNVVYKGRLEDDRWIAVKRFNRSAWPDTRQFLEEAKAVGQLRNERLANLIG 116
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCEGDERLLVAE+MP +TL+KHLFHW++QPMKW+MRLRVAL++A+ALEYC+SK RALYH
Sbjct: 117 FCCEGDERLLVAEFMPFETLSKHLFHWDSQPMKWSMRLRVALYLAQALEYCSSKGRALYH 176
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRI+FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct: 177 DLNAYRILFDQDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVIPESVVYSFGT 236
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIR +N L DSCL+G FS+D+GT+LVRLASRCLQYE RER
Sbjct: 237 LLLDLLSGKHIPPSHALDLIRGKNFLMLMDSCLDGHFSNDDGTDLVRLASRCLQYEARER 296
Query: 301 PNPRSLVTALVTLQKDTEV 319
PN +SLV++L LQK+T++
Sbjct: 297 PNVKSLVSSLAPLQKETDI 315
|
|
| TAIR|locus:2084475 BSK6 "brassinosteroid-signaling kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 226/324 (69%), Positives = 272/324 (83%)
Query: 1 MGCECSKLSACCSGSEYGEAAP-EAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAME 59
MG CSK S C S + A+ E+ D+EN K P F E+ +E L++AT GF+ +
Sbjct: 1 MGARCSKFSFCLFPSHFKSASVLESPDIENGGKVW----PTFKEFKLEQLKSATGGFSSD 56
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
NIVSEHGEKAPNVVY+G+L++ IAVKRFNR AW D RQFL+EA+AVG LR+ RLANL+
Sbjct: 57 NIVSEHGEKAPNVVYRGRLDDGRLIAVKRFNRLAWADHRQFLDEAKAVGSLRSDRLANLI 116
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EG+ERLLVAE+MP++TLAKHLFHWE PMKWAMRLRVAL +A+ALEYC++K RALY
Sbjct: 117 GCCFEGEERLLVAEFMPHETLAKHLFHWENNPMKWAMRLRVALCLAQALEYCSNKGRALY 176
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYR++FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV++SFG
Sbjct: 177 HDLNAYRVLFDKDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVVFSFG 236
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
T+LLDL+SGKHIPPSHALDLIR +N L DS LEG FS+++GTELVRLA+RCLQYE RE
Sbjct: 237 TVLLDLMSGKHIPPSHALDLIRGKNCAMLMDSALEGHFSNEDGTELVRLATRCLQYEARE 296
Query: 300 RPNPRSLVTALVTLQKDTEVSCFL 323
RPN +SLVT+LVTLQK+++V+ ++
Sbjct: 297 RPNVKSLVTSLVTLQKESDVASYV 320
|
|
| TAIR|locus:2122058 BSK1 "brassinosteroid-signaling kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 196/290 (67%), Positives = 241/290 (83%)
Query: 34 GVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA 93
G +P F E+S L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+ IAVK+F + A
Sbjct: 51 GGGGIPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMA 110
Query: 94 WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMK 153
WP+ +QF EEA VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++
Sbjct: 111 WPEPKQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIE 170
Query: 154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
WAMRLRV +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYS
Sbjct: 171 WAMRLRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYS 230
Query: 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273
TNLA+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI L DS L
Sbjct: 231 TNLAYTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHL 290
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFL 323
EG+FS++E T +V LAS+CLQYEPRERPN + LV L LQ ++V ++
Sbjct: 291 EGKFSTEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYV 340
|
|
| TAIR|locus:2142315 BSK2 "brassinosteroid-signaling kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
Identities = 194/321 (60%), Positives = 252/321 (78%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
MGC SK + S + +AP + N ++ VD + F E+ + LR AT+GF+
Sbjct: 1 MGCLHSKTANLPSSDD--PSAPNKPESVNGDQ--VDQEIQNFKEFELNELRKATNGFSPS 56
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
IVSE GEKAPNVVY+GKLE +A+KRF+R +WPDA+QF+ EA VG+LRN+R+ +L+
Sbjct: 57 CIVSEGGEKAPNVVYRGKLEGNHLVAIKRFSRQSWPDAQQFVVEATGVGKLRNKRIVSLI 116
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EGDERLLVAEYMPNDTL+KHLFHWE QP+ W MR+R+A +IAEAL+YC + R +Y
Sbjct: 117 GCCAEGDERLLVAEYMPNDTLSKHLFHWEKQPLPWDMRVRIADYIAEALDYCNIENRKIY 176
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYRI+FD++ +PRLS FGLMKNSRDG+SYSTNLA+TPPE+LRTGRV PESV++S+G
Sbjct: 177 HDLNAYRILFDEEGDPRLSTFGLMKNSRDGKSYSTNLAYTPPEFLRTGRVIPESVIFSYG 236
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
T+LLDLLSGKHIPPSHALD+IR +N L DS LEGQ+++D+ T+LV LAS+CLQ E ++
Sbjct: 237 TILLDLLSGKHIPPSHALDIIRGKNALLLMDSSLEGQYANDDATKLVDLASKCLQSEAKD 296
Query: 300 RPNPRSLVTALVTLQKDTEVS 320
RP+ + L++A+ LQK EV+
Sbjct: 297 RPDTKFLLSAVAPLQKQEEVA 317
|
|
| TAIR|locus:2083499 BSK9 "brassinosteroid-signaling kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
Identities = 187/292 (64%), Positives = 229/292 (78%)
Query: 28 ENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVK 87
+N+E+ P F E+S+E LR AT GF+ +NIVSEH E+ PN+VYKG+L + +IAVK
Sbjct: 13 DNKEEDEGSTCPNFLEFSLEQLRVATDGFSADNIVSEHNERVPNIVYKGQLNDGRKIAVK 72
Query: 88 RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW 147
RF R +WPD+ +F+EEA+AVG+ R+ +ANL+GCC EG ERLLVAEYMPN+TLAKHLFHW
Sbjct: 73 RFQRLSWPDSLEFIEEAQAVGRCRSEHMANLIGCCSEGHERLLVAEYMPNETLAKHLFHW 132
Query: 148 ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207
E +PMKW MRLRVALH A ALEYC LYHDLN YRI+FD NPRLSCFGLMK SR
Sbjct: 133 EKRPMKWEMRLRVALHTATALEYCNDWGIDLYHDLNTYRILFDKVGNPRLSCFGLMKCSR 192
Query: 208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
+G+SYSTNLAF PPEYLR G V PESV +SFGTLLLDL+SG+HIPP+HALDL R +N
Sbjct: 193 EGKSYSTNLAFAPPEYLRLGTVIPESVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNYLV 252
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
L DS L+GQFS ++ TEL+ LASRCL+ EP ERP+ + L++AL L+K E+
Sbjct: 253 LMDSALDGQFSDEDRTELIHLASRCLRPEPDERPSIKFLMSALSRLEKRAEL 304
|
|
| TAIR|locus:2150074 BSK10 "brassinosteroid-signaling kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
Identities = 190/320 (59%), Positives = 230/320 (71%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN----VP-VFCEYSIETLRTATSG 55
MGC C K S S S + D+EN + D+ P +F E+S+E LR AT G
Sbjct: 1 MGCICFK-SWRRSSSSPSITSTVIDDLENVREYDADDDGGHYPLIFREFSLEQLRIATDG 59
Query: 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL 115
F+ NIVSEH + PN+VYKGKL + RIAVKRF R +WPD +F+ EA+AVG+LR+ +
Sbjct: 60 FSAGNIVSEHNDSVPNIVYKGKLGDGRRIAVKRFQRLSWPDPFEFINEAQAVGRLRSEHM 119
Query: 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
ANL+GCCC+ +ERLLVAEYMPN TLAKHLFHWE +PMKW MRL+VALH A ALEYC K
Sbjct: 120 ANLIGCCCDDNERLLVAEYMPNGTLAKHLFHWEKRPMKWEMRLKVALHTARALEYCNDKG 179
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVM 235
LYHDLN YRI+FD P+LSCFGLMKNS +G+ YSTNLAF PPEYLR G V ESV
Sbjct: 180 IDLYHDLNPYRIMFDKTGIPKLSCFGLMKNSHEGKIYSTNLAFAPPEYLRLGTVIAESVT 239
Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+SFGTLLLDL+SG+HIPP+HALDL R +N L DS L+GQFS ++ TEL+ +ASRC +
Sbjct: 240 FSFGTLLLDLMSGRHIPPNHALDLFRGKNYLVLMDSALDGQFSDEDRTELIHVASRCFKT 299
Query: 296 EPRERPNPRSLVTALVTLQK 315
EP ERP+ + L L LQK
Sbjct: 300 EPEERPSIKFLKATLSRLQK 319
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9FHD7 | Y5126_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8 | 0.8913 | 0.6570 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 359 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-09 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.001 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 55/245 (22%), Positives = 91/245 (37%), Gaps = 49/245 (20%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY + + ++A+K + + L E + +L + + L G + +
Sbjct: 8 TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI- 187
LV EY +L L E + LR+ L I E LEY S + H DL I
Sbjct: 68 LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENIL 124
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLR-TGRVTPESVMYSFGTLL 242
+ D+ +L+ FGL K +S A+ PE L G + +S ++S G +L
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+L DLIR + LQ +P +RP+
Sbjct: 185 YEL--------PELKDLIR-----------------------------KMLQKDPEKRPS 207
Query: 303 PRSLV 307
+ ++
Sbjct: 208 AKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 71/260 (27%), Positives = 114/260 (43%), Gaps = 36/260 (13%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73
Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
+ ++V EYMP D L K+ + + + L AL IA +EY SK H
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKN----RPKELSLSDLLSFALQIARGMEYLESKN--FIHR 127
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
DL A + +++ ++S FGL ++ D Y + PE L+ G+ T +S +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+SFG LL ++ + G+ + + L+ ++ +C EL +L
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP---------ELYKLML 238
Query: 291 RCLQYEPRERPNPRSLVTAL 310
+C +P +RP LV L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-22
Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 37/260 (14%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKGKL+ + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73
Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
+ +V EYM L K+ + + L AL IA +EY SK H
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRKN-----RPKLSLSDLLSFALQIARGMEYLESKN--FIHR 126
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
DL A + +++ ++S FGL ++ D Y + PE L+ G+ T +S +
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+SFG LL ++ + G+ + L+ +++ +C EL L
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP---------ELYDLML 237
Query: 291 RCLQYEPRERPNPRSLVTAL 310
+C +P +RP LV L
Sbjct: 238 QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-21
Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 33/262 (12%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKGKL +AVK A + R FL+EAR + +L + + LLG C E +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69
Query: 127 ERLLVAEYMPNDTLAKHL-------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
LV EYM L +L E + L A+ IA+ +EY SK + ++
Sbjct: 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVH 128
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
DL A + +D+ ++S FGL ++ D Y + + PE L+ G T +S
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188
Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG LL ++ + G + L+ +R + C + EL L
Sbjct: 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD---------ELYEL 239
Query: 289 ASRCLQYEPRERPNPRSLVTAL 310
C Q +P +RP LV L
Sbjct: 240 MLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 5e-21
Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 30/257 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L + ++AVK A + R+ FLEEA + +L + + LLG C +G
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
+ +V EYMP L L + + L++AL IA+ +EY SK H DL A
Sbjct: 74 EPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAA 130
Query: 185 YRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSF 238
+ +++ ++S FGL ++ D P PE L+ G+ T +S ++SF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 239 GTLLLDLLSG-----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G LL ++ + + L+L+ D ++C + EL L +C
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD---------ELYELMLQCW 241
Query: 294 QYEPRERPNPRSLVTAL 310
Y+P +RP LV L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-19
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 4/181 (2%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V G Q ++AVK + A+ FL EA + LR+ L LLG +G+ +V
Sbjct: 22 VMLGDYRGQ-KVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L +L + A +L AL + E +EY K ++ DL A ++ +D
Sbjct: 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSED 138
Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
+ ++S FGL K + G+ + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 252 P 252
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 16/247 (6%)
Query: 72 VVYKGKLEN-QFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VYK K + +AVK + + E R + +L + + L+ + D
Sbjct: 14 TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHL 73
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
LV EY L +L P+ ++AL I LEY S + H DL I
Sbjct: 74 YLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHS--NGIIHRDLKPENI 129
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGR-VTPESVMYSFGTLL 242
+ D++ +++ FGL K S T TP PE L G P+ ++S G +L
Sbjct: 130 LLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVIL 189
Query: 243 LDLLSGKHIPPSHALD--LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+LL+GK + L R I + S E L +CL +P +R
Sbjct: 190 YELLTGKPPFSGENILDQLQLIRRILG-PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 301 PNPRSLV 307
P ++
Sbjct: 249 PTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 19/239 (7%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VYKG L+ +AVK + PD ++ FL+EA + Q + + L+G C + +V
Sbjct: 11 VYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E +P +L L + + + L+++L A +EY SK ++ DL A + +
Sbjct: 71 MELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGE 128
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ ++S FG M +G Y+ + + +T PE L GR T ES ++S+G LL +
Sbjct: 129 NNVLKISDFG-MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRERP 301
S P N QT + + + E+ RL +C Y+P RP
Sbjct: 188 TFSLGDTPYPGM------SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 8e-16
Identities = 51/252 (20%), Positives = 84/252 (33%), Gaps = 34/252 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY + + +A+K + D + L E + + +L++ + L + D+
Sbjct: 14 KVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR-- 186
LV EY L L A I ALEY H +R
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYL--------HSKGIVHRDL 123
Query: 187 ----IVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
I+ D+D + +L+ FGL + G +T + PE L ++S G
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG 183
Query: 240 TLLLDLLSGK-----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
+L +LL+GK I S E +L+R + L
Sbjct: 184 VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD----ISPEAKDLIR---KLLV 236
Query: 295 YEPRERPNPRSL 306
+P +R
Sbjct: 237 KDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 20/251 (7%)
Query: 66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
GE V +G+ Q ++AVK N A+ FLEE + +L ++ L LLG
Sbjct: 15 GEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
+ +V E M L L + L+ +L +AE +EY SK + ++ DL A
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129
Query: 186 RIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
I+ +D ++S FGL + S + + +T PE L+ + + +S ++S+G LL +
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 245 LLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRE 299
+ S G+ P +L +++ C+E + + EG ++ L + C + EP++
Sbjct: 190 VFSYGRAPYPKMSLKEVKE---------CVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 300 RPNPRSLVTAL 310
RP+ L L
Sbjct: 241 RPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARA 106
T+ S EN++S + A YKGK ++N + VK N + + +
Sbjct: 684 TINDILSSLKEENVISRGKKGAS---YKGKSIKNGMQFVVKEINDVNSIPSSEIAD---- 736
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
+G+L++ + L+G C L+ EY+ L++ L + + W R ++A+ IA+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAK 791
Query: 167 ALEY--CTSKERALYHDLNAYRIVFDDDVNPRLSCFGL-----MKNSRDGRSYSTNLAFT 219
AL + C + +L+ +I+ D P L L S A+
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYV 845
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--------LDLIR----DRNIQT 267
PE T +T +S +Y FG +L++LL+GK P+ A ++ R D ++
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 268 LTDSCLEGQFSSD--EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE--VSCFL 323
D + G S + E E++ LA C +P RP ++ L + + + V+
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGLK 963
Query: 324 FSSQF 328
FSS F
Sbjct: 964 FSSLF 968
|
Length = 968 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 14/236 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+KG L+++ +AVK + + +FL EAR + Q + + L+G C + +V
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E +P L + +K ++ AL A + Y SK ++ DL A + +
Sbjct: 71 MELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGE 128
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ ++S FG+ + DG S+ L +T PE L GR + ES ++S+G LL +
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188
Query: 247 SGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
S P P R++ + SC Q D ++ ++ RC Y+P RP
Sbjct: 189 SLGVCPYPGMTNQQAREQVEKGYRMSC--PQKCPD---DVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 18/250 (7%)
Query: 73 VYKGKLE-NQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ G+L + +AVK + PD + +FL+EAR + Q + + L+G C + +
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V E + L E +K +++ + A +EY SK ++ DL A +
Sbjct: 71 VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVT 128
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ ++S FG+ + DG ST + +T PE L GR + ES ++SFG LL +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRERPN 302
S +P ++ N QT + E + RL RC +Y+P +RP+
Sbjct: 189 AFSLGAVPYANL------SNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
Query: 303 PRSLVTALVT 312
++ L +
Sbjct: 243 FSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 61 IVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNR 113
+ E GE A V+ G+ + + +AVK +A DAR+ F EA + ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHL------------FHWETQPMKWAMRLRVA 161
+ G C EGD ++V EYM + L K L + + L++A
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 162 LHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------ 215
+ IA + Y S + ++ DL + D+ ++ FG+ SRD Y+T+
Sbjct: 129 VQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGM---SRD--VYTTDYYRVGG 182
Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK 249
+ + PPE + + T ES ++SFG +L ++ + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 56/243 (23%), Positives = 110/243 (45%), Gaps = 19/243 (7%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V++G +N+ R+A+K + F +E +A+ +LR++ L +L C G+ ++
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
E M +L L E Q + A + +A +AE + Y + +++ DL A I+ +D
Sbjct: 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGED 140
Query: 193 VNPRLSCFGLMKNSRDG--RSYSTNLAF--TPPEYLRTGRVTPESVMYSFGTLLLDLLSG 248
+ +++ FGL + ++ S + + T PE G + +S ++SFG LL ++ +
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 249 KHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+P D I C + E+ ++ C EP +RP+
Sbjct: 201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ---------EIYKIMLECWAAEPEDRPSF 251
Query: 304 RSL 306
++L
Sbjct: 252 KAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 74 YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVA 132
Y+G ++AVK A A+ FL EA + QLR+ L LLG E L +V
Sbjct: 27 YRGN-----KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L +L + L+ +L + EA+EY + ++ DL A ++ +D
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSED 138
Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
++S FGL K + + + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 252 P 252
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 60 NIVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRN 112
++ E G+ + +VY+G K E + R+AVK N SA R +FL EA +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLR----VALHI 164
+ LLG +G L+V E M + L +L E P + L+ +A I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAF 218
A+ + Y +K + ++ DL A + D ++ FG+ ++ R G + +
Sbjct: 129 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCL 273
PE L+ G T S M+SFG +L ++ S P L + D D+C
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
E + L C Q+ P+ RP +V L
Sbjct: 248 E---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 28/242 (11%)
Query: 73 VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++A+K + S P+A FL EA + QL++ RL L + + ++
Sbjct: 22 VWMGYYNGHTKVAIKSLKQGSMSPEA--FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N +L L E + + +A IAE + + K ++ DL A I+ +
Sbjct: 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSE 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ +++ FGL + +R+G + + +T PE + G T +S ++SFG LL +
Sbjct: 138 TLCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIPPSHALDLIRDRNIQTL-----TDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+++ IP + +N++ D+C E EL L C + +P E
Sbjct: 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE---------ELYELMRLCWKEKPEE 246
Query: 300 RP 301
RP
Sbjct: 247 RP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 54/297 (18%)
Query: 56 FAMENI--VSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARA 106
+ + + E GE A VYKG+L + +A+K +A P +Q F +EA
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------------HWETQPMK 153
+ L++ + LLG C + ++ EY+ + L + L +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 154 WAMR-LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
L +A+ IA +EY +S ++ DL A + + + ++S FGL SRD Y
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISDFGL---SRDI--Y 175
Query: 213 STN-----------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHA 256
S + + + PPE + G+ T ES ++SFG +L ++ S P
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 257 LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
+++IR R + + C + L C P RP + + T L +
Sbjct: 236 IEMIRSRQLLPCPEDC---------PARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.9 bits (159), Expect = 7e-12
Identities = 66/309 (21%), Positives = 106/309 (34%), Gaps = 30/309 (9%)
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRL 115
I+ + GE + VY + ++ +A+K + +FL E + + L +
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSK 174
L + LV EY+ +L L P+ + L + I ALEY SK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 175 ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN----------LAFTPPEY 223
++ D+ I+ D D +L FGL K D S S+ + PE
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 224 LR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNIQTLTDSCLEGQF 277
L + S ++S G L +LL+G + I L L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 278 SSDEG----TELVRLASRCLQYEPRERPNPRSLVT-ALVTLQKDTEVSCFLFSSQFTYAL 332
S L + L +P+ R + S ++ L+ K E A
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299
Query: 333 LRLHIWSSS 341
LRL + S
Sbjct: 300 LRLSLPPSL 308
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 24/260 (9%)
Query: 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
+ E G VV+ GK + +A+K A + F+EEA+ + +L + L L G
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
C + +V EYM N L +L + K L + + EA+EY S ++
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG-FIH 123
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
DL A + +D ++S FGL + D + S+ + + PPE R + +S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE----GTELVRLAS 290
++SFG L+ ++ S +P R N + + +S G + TE+ +
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE------RFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 291 RCLQYEPRERPNPRSLVTAL 310
C +P +RP + L++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 33/269 (12%)
Query: 73 VYKGKLENQF-----RIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE 124
V + + ++AVK N S R E R + LR + G C +
Sbjct: 20 VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIVKYKGVCEK 77
Query: 125 GDER--LLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
R L+ EY+P+ +L +L H + +K L + I + ++Y S+ R ++ D
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ-RYIHRD 134
Query: 182 LNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP-----PEYLRTGRVTPESV 234
L A I+ + + ++S FGL K Y +P PE LRT + + S
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194
Query: 235 MYSFGTLLLDLLS-GKH--IPPSHALDLI---RDRNIQT-LTDSCLEGQ-FSSDEG--TE 284
++SFG L +L + G PP+ L +I + + I T L + EG+ E
Sbjct: 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE 254
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313
+ L C + EP++RP+ L+ + L
Sbjct: 255 VYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64 EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
E G+ + +VY+G K E + R+A+K N +A R +FL EA + + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQ------PMKWAMRLRVALHIAEAL 168
LLG +G L++ E M L +L E + P +++A IA+ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
Y + + ++ DL A + +D ++ FG+ ++ R G + + PE
Sbjct: 133 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
L+ G T S ++SFG +L ++ + P L + + + D+C + F
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF 251
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL+R+ C QY P+ RP+ +++++
Sbjct: 252 ------ELMRM---CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 58/256 (22%), Positives = 115/256 (44%), Gaps = 34/256 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + + +F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77
Query: 132 AEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
EYM N + L +H ++ + L + + E + Y SK+ ++ DL A
Sbjct: 78 TEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQ-FIHRDLAARNC 131
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLL 242
+ DD ++S FGL + D S+ + ++PPE L + + +S +++FG L+
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191
Query: 243 LDLLSGKHIPPSHALDLIRDR-NIQTLTDSCLEG------QFSSDEGTELVRLASRCLQY 295
++ S +P +R N + +G +S+ ++ + C
Sbjct: 192 WEVYSLGKMP--------YERFNNSETVEKVSQGLRLYRPHLASE---KVYAIMYSCWHE 240
Query: 296 EPRERPNPRSLVTALV 311
+ ERP + L++++
Sbjct: 241 KAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 50/187 (26%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G ++AVK + FL+EA+ + +LR+ +L L C E + +V
Sbjct: 22 VWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L L E + ++ + +A IAE + Y S+ ++ DL A I+ ++
Sbjct: 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGEN 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ +++ FGL + +R+G + + +T PE GR T +S ++SFG LL ++
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
Query: 246 LSGKHIP 252
++ +P
Sbjct: 198 VTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 24/250 (9%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
+AVK R + +E + L + + GCC E + L+ EY+P +L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
+L + A L A I E + Y S+ ++ DL A ++ D+D ++ F
Sbjct: 96 RDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
GL K +G Y + + + E L+ + + S ++SFG L +LL+ K
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 251 IPPSHALDLIRDRNIQT----LTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNP 303
PP ++I + Q L + G + E+ L C + E + RP
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 304 RSLVTALVTL 313
RSL+ L +
Sbjct: 272 RSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRL 158
F E A + QL ++ L G C GDE ++V EY+ +L +L + + W +L
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 159 RVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--- 214
VA +A AL + +++ L H ++ A ++ + + + +K S G S +
Sbjct: 104 EVAKQLAWALHFL--EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161
Query: 215 -----NLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
+ + PPE + + ++ + +SFGT L ++ SG P S ALD + +Q
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-ALD--SQKKLQFY 218
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
D Q + + TEL L ++C+ YEP RP+ R+++ L
Sbjct: 219 ED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 61/254 (24%), Positives = 109/254 (42%), Gaps = 32/254 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV+ GK Q ++A+K N A + F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M N L +L + + K M L + + E +EY + ++ DL A +
Sbjct: 78 TEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEY-LERNSFIHRDLAARNCLVSS 135
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FG+ + D S++ A ++PPE + + +S ++SFG L+ ++
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR--LAS--------RCLQYE 296
+ +P + N + + G L R LAS C +
Sbjct: 196 TEGKMP------FEKKSNYEVVE--------MISRGFRLYRPKLASMTVYEVMYSCWHEK 241
Query: 297 PRERPNPRSLVTAL 310
P RP L+ A+
Sbjct: 242 PEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 20/238 (8%)
Query: 73 VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++AVK P++ FLEEA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L E + +K + +A +A + Y + ++ DL + I+ D
Sbjct: 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IERMNYIHRDLRSANILVGD 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 GLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L++ +P P + +R + + D L L +C + +P ERP
Sbjct: 196 LVTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 37/272 (13%)
Query: 66 GEKAPNVVYKGKLE----NQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
GE V +G+L +Q ++AVK + + + + +FL EA + + + L+
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67
Query: 120 GCCCEGDER------LLVAEYMPNDTLAKHLFH--WETQPMKWA--MRLRVALHIAEALE 169
G C E +++ +M + L L + P K L+ + IA +E
Sbjct: 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EY 223
Y +++ ++ DL A + +D+ ++ FGL K G Y P E
Sbjct: 128 YLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFS 278
L T +S +++FG + ++ + P D +R N + CL+
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD---- 242
Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL L C + +P++RP L L
Sbjct: 243 -----ELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 20/238 (8%)
Query: 73 VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++A+K + P+A FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M +L L + + +K + +A IA+ + Y + ++ DL A I+ D
Sbjct: 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYIHRDLRAANILVGD 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 NLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L++ +P P + ++ + C +G S L L C + +P ERP
Sbjct: 196 LVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES-----LHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G N ++AVK + + FLEEA + L++ +L L + + ++
Sbjct: 22 VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L L E + + + IAE + Y ++ ++ DL A ++ +
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY-IERKNYIHRDLRAANVLVSES 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ +++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
Query: 246 LSGKHIP 252
++ IP
Sbjct: 198 VTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 73 VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G R+A+K P+A FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y + ++ DL A I+ +
Sbjct: 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L + +P + +R + + + L L +C + EP ERP
Sbjct: 196 LTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
V E G +V+ G + ++A+K A + F+EEA+ + +L + +L L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
C E LV E+M + L+ +L Q K++ L + L + E + Y S ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN-VIH 123
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
DL A + ++ ++S FG+ + D + S+ + ++ PE + + +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 235 MYSFGTLLLDLLSGKHIP 252
++SFG L+ ++ S P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 57/240 (23%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
+AVK +FL+EA + ++++ L LLG C ++ E+M L +
Sbjct: 34 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
L Q + + L +A I+ A+EY K ++ DL A + ++ +++ FGL
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLS 151
Query: 204 KNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257
+ G +Y+ + + +T PE L + + +S +++FG LL ++ + + P +
Sbjct: 152 RLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 209
Query: 258 DLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
DL + L LE + + EG ++ L C Q+ P +RP+ + A T+
Sbjct: 210 DL---SQVYEL----LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 42/268 (15%)
Query: 79 ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
+++ +AVK ++ + F EA + L++ + G C EGD ++V EYM +
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 139 TLAKHL--------FHWETQP---MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
L K L E + + L +A IA + Y S + ++ DL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNC 151
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVMY 236
+ +++ ++ FG+ SRD YST+ + + PPE + + T ES ++
Sbjct: 152 LVGENLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206
Query: 237 SFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
S G +L ++ + GK + + ++ I + +C + E+ L
Sbjct: 207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK---------EVYDLMLG 257
Query: 292 CLQYEPRERPNPRSLVTALVTLQKDTEV 319
C Q EP R N + + + L L K + V
Sbjct: 258 CWQREPHMRLNIKEIHSLLQNLAKASPV 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 55/182 (30%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 126 DERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+E+L LV EY P L HL + A R A I ALEY S +Y DL
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERA-RFYAA-EIVLALEYLHSL-GIIYRDLKP 121
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D D + +L+ FGL K S + TP PE L +S G
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVRLASRCLQYEPR 298
LL ++L+GK PP +A + + + + L+ F E L S LQ +P
Sbjct: 182 LLYEMLTGK--PPFYA------EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
Query: 299 ER 300
+R
Sbjct: 234 KR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 40/267 (14%)
Query: 64 EHGEKAPNVVYKGKLENQFR----IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANL 118
E GE V +G+L+ + +A+K + R FL EA +GQ + + L
Sbjct: 16 EFGE-----VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
G + +++ EYM N +L K L + + + + IA ++Y + E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLS--EMNY 127
Query: 179 YH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTN-----LAFTPPEYLRTGRVTP 231
H DL A I+ + ++ ++S FGL + D + Y+T + +T PE + + T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--------SCLEGQFSSDEGT 283
S ++SFG ++ +++S P D+ I+ + D C
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIKAVEDGYRLPPPMDCPSA-------- 236
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
L +L C Q + ERP +V+ L
Sbjct: 237 -LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 45/271 (16%)
Query: 79 ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
+++ +AVK + F EA + L++ + G C +GD ++V EYM +
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 139 TLAKHL--------FHWETQPMK------WAMRLRVALHIAEALEYCTSKERALYHDLNA 184
L K L + QP + + L +A IA + Y S + ++ DL
Sbjct: 93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLAT 151
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPES 233
+ ++ ++ FG+ SRD YST+ + + PPE + + T ES
Sbjct: 152 RNCLVGANLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 234 VMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG +L ++ + GK + + ++ I + C + E+ +
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK---------EVYDI 257
Query: 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
C Q EP++R N + + L L K T +
Sbjct: 258 MLGCWQREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 48/279 (17%)
Query: 56 FAMENIV--SEHGEKAPNVVYKGKLEN------QFRIAVKRFN-RSAWPDARQFLEEARA 106
E I E G+ + +VY+G + + R+A+K N ++ + +FL EA
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRL 158
+ + + LLG G L+V E M L +L + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--- 215
++A IA+ + Y +K + ++ DL A + +D+ ++ FG+ +RD Y T+
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGM---TRD--IYETDYYR 176
Query: 216 --------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP---PSH--ALDLIRD 262
+ + PE L+ G T +S ++SFG +L ++ + P S+ L + D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236
Query: 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L ++C + +L+ L C QY P+ RP
Sbjct: 237 GGHLDLPENCPD---------KLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 44/187 (23%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V++G N +AVK + D + FL EA+ + +LR+ +L L C + +V
Sbjct: 22 VWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
E M +L ++L + +K + +A +A + Y + + ++ DL A ++ ++
Sbjct: 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGEN 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+++ FGL + +R+G + + +T PE R + +S ++SFG LL ++
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
Query: 246 LSGKHIP 252
++ +P
Sbjct: 198 VTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 53/241 (21%), Positives = 93/241 (38%), Gaps = 23/241 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VYK + +A+K + + + E + + + ++ + G + DE +
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V E+ +L K L Q + + V + + LEY S ++ D+ A I+
Sbjct: 75 VMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLT 132
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
D +L FGL D ++ + TP PE + ++ ++S G ++L
Sbjct: 133 SDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191
Query: 247 SGKHIPPSH------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
GK PP AL I L + SDE + + +CLQ P +R
Sbjct: 192 EGK--PPYSELPPMKALFKIATNGPPGL----RNPEKWSDEFKDFL---KKCLQKNPEKR 242
Query: 301 P 301
P
Sbjct: 243 P 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 42/265 (15%)
Query: 66 GEKAPNVVYKGKL---ENQFRIAVKRF-----NRSAWPDARQFLEEARAVGQLRNRRLAN 117
GE V +G+L ++ ++AVK RS D FL EA + + + +
Sbjct: 8 GEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED---FLSEAVCMKEFDHPNVMR 64
Query: 118 LLGCCCEGDER------LLVAEYMPNDTLAKHLFHWE--TQP--MKWAMRLRVALHIAEA 167
L+G C + E +++ +M + L L + P + M ++ IA
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPP 221
+EY +SK ++ DL A + ++++N ++ FGL K R GR + +
Sbjct: 125 MEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG + ++ + P S D +R N CL+G
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243
Query: 277 FSSDEGTELVRLASRCLQYEPRERP 301
+S L S C P++RP
Sbjct: 244 YS---------LMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 19/252 (7%)
Query: 66 GEKAPNVVYKGKLENQFRI-AVKRFNRSAWPDARQ--FLEEARAVGQLRNRRLANLLGCC 122
G+ + VV+K + R+ A+K+ + S + ++EAR + +L + +
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68
Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
+ + +V EY N L K L +P+ R + I L + SK + L+ D+
Sbjct: 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDI 127
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSF 238
+ + D N ++ G+ K D +++ + TP PE +S +++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQY 295
G +L + +GKH P A N L + G F S +L +L +CL
Sbjct: 188 GVVLYECCTGKH--PFDA------NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 296 EPRERPNPRSLV 307
+ R+RP+ L+
Sbjct: 240 DYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 158 LRVALHIAEALEYC----TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
R+ + AL C L+ DL I D + N +L FGL K S++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQ 266
TP PE L +S ++S G L+ +L + PP A L L I+
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTARNQLQLA--SKIK 223
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+ ++SS EL + L +P +RP+
Sbjct: 224 EGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 54/253 (21%), Positives = 100/253 (39%), Gaps = 46/253 (18%)
Query: 84 IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
+AVK +A + R L E + Q+ + + L G C + LL+ EY +L
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
+ +L + + + + + A I+ ++Y E L H
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVH 150
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
DL A ++ + ++S FGL ++ + SY + + E L T +S
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210
Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG LL ++++ G + I P +L++ ++C E E+ L
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---------EMYNL 261
Query: 289 ASRCLQYEPRERP 301
C + EP +RP
Sbjct: 262 MLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 96 DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWA 155
D+ F E A + QL ++ L L G C DE ++V EY+ L L H E +
Sbjct: 44 DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLH 101
Query: 156 MRLRVALHIAEALEYCTSKE--------RALY---HDLNAYRIVFDDDVNPRLSCFGLMK 204
+L VA +A AL Y K+ + + + LN + F +P + L +
Sbjct: 102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 205 NSRDGRSYSTNLAFTPPEYLRTGRVTPESVM--YSFGTLLLDLLSGKHIP-----PSHAL 257
R R + PE +R G+ + +SFGT LL++ S P S
Sbjct: 162 EERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
+D++ + D EL L ++C Y+P +RP+ R+++ L
Sbjct: 217 RFYQDQHRLPMPDC-----------AELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
R FL EA +GQ + + L G G+ ++V EYM N L L E Q + A +
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQ 108
Query: 158 LRVALH-IAEALEYCTSKERALYHD-LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
L L +A ++Y + E H L A++++ + D+ ++S F ++ + Y+T
Sbjct: 109 LMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM 166
Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ + PE ++ + S ++SFG ++ +++S
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 44/261 (16%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK AR FL+E + + +L+N + LLG C D ++ EYM N L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 143 HLFHWETQP----------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
L E + + A L +A+ IA ++Y S ++ DL + +
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165
Query: 193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLL 246
+++ FG+ +N G Y P E + G+ T S +++FG L ++
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------LVRLASR 291
+ L +++ L+D + G+F ++G + + +L R
Sbjct: 226 T-----------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274
Query: 292 CLQYEPRERPNPRSLVTALVT 312
C + ++RP + L
Sbjct: 275 CWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 52/268 (19%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK A +AR FL+E + + +L++ + LLG C + D ++ EYM N L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 143 HLFHWETQ-----------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L + ++ L VAL IA ++Y +S ++ DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFG 239
+ +++ +++ FG+ +N G Y P E + G+ T S +++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------ 284
L ++L L +++ LTD + G+F D+G +
Sbjct: 228 VTLWEILM-----------LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG 276
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVT 312
L L +C + RERP S + A +T
Sbjct: 277 LYELMLQCWSRDCRERP-SFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
FL EA + L++ +L L + + ++ E+M +L L E +
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-------NSRDGRSY 212
+ IAE + + + ++ DL A I+ + +++ FGL + +R+G +
Sbjct: 107 FSAQIAEGMAF-IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQ 266
+ +T PE + G T +S ++SFG LL+++++ IP P L R +
Sbjct: 166 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
++C E EL + RC + P ERP
Sbjct: 224 R-PENCPE---------ELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 72 VVYKGKL--ENQFRI--AVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
VY G L + +I AVK NR + + QFL+E + + + +LLG C +
Sbjct: 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V YM + L ++ ET + L +A+ +EY SK + ++ DL A
Sbjct: 70 GSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAAR 127
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D YS + + + E L+T + T +S ++S
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG------QFSSDEGTELVRLASR 291
FG LL +L++ + PP D + +T L+G ++ D L +
Sbjct: 188 FGVLLWELMT-RGAPP------YPDVDSFDITVYLLQGRRLLQPEYCPD---PLYEVMLS 237
Query: 292 CLQYEPRERPNPRSLVT 308
C +P RP LV+
Sbjct: 238 CWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 49/268 (18%)
Query: 68 KAPNVVYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
+AP ++ E +AVK A D + F EA + + + + LLG C G
Sbjct: 25 RAPGLL---PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81
Query: 127 ERLLVAEYMPNDTLAKHLFH----WETQ----------------PMKWAMRLRVALHIAE 166
L+ EYM L + L H + P+ +L +A +A
Sbjct: 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141
Query: 167 ALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN--SRDGRSYSTNLA----FT 219
+ Y + ER H DL + +++ +++ FGL +N S D S N A +
Sbjct: 142 GMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD------LIRDRNIQTLTDSCL 273
PPE + R T ES ++++G +L ++ S + P + + +RD N+ + D+C
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC- 257
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERP 301
EL L C P +RP
Sbjct: 258 --------PLELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 63/284 (22%), Positives = 118/284 (41%), Gaps = 48/284 (16%)
Query: 62 VSEHGEKAPNVVYKGKL-----ENQFRIAVKRF----NRSAWPDARQFLEEARAVGQLRN 112
+ E GE A +YKG L ++ +A+K N W + F +EA + +L +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHH 66
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-----------ETQPMKWAMR---- 157
+ LLG + ++ EY+ L + L E +K ++
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-- 215
L +A+ IA +EY +S ++ DL A I+ + ++ ++S GL + Y
Sbjct: 127 LHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 216 ----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQ 266
+ + PPE + G+ + +S ++SFG +L ++ S P ++++R R +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
++ C +S L + C Q P RP + + T L
Sbjct: 246 PCSEDCPPRMYS---------LMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANL 118
E GE V++G L+ + +A+K RQ FL EA +GQ + + L
Sbjct: 17 EFGE-----VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
G + +++ EYM N L K+L E + LR IA ++Y S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY-LSDMN 127
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN-----LAFTPPEYLRTGRV 229
++ DL A I+ + ++ ++S FGL + D +Y+T+ + +T PE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 230 TPESVMYSFGTLLLDLLS 247
T S ++SFG ++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 56/256 (21%), Positives = 102/256 (39%), Gaps = 35/256 (13%)
Query: 73 VYKGKL-------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
VY+G R+AVK + A + +FL+EA + + + LLG C
Sbjct: 11 VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAM-----RLRVALHIAEALEYCTSKERALY 179
+ + ++ E M L +L + + L + L +A+ Y + ++
Sbjct: 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY-LEQMHFIH 129
Query: 180 HDLNAYRIV-----FDDDVNPRLSCFGLMKNSRDGRSYST------NLAFTPPEYLRTGR 228
DL A + +D D ++ FGL ++ Y + + PE L G+
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189
Query: 229 VTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--EL 285
T +S ++SFG L+ ++L+ P P+ N + L G+ E ++
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAGGRLQKPENCPDKI 242
Query: 286 VRLASRCLQYEPRERP 301
+L + C +P ERP
Sbjct: 243 YQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 24/244 (9%)
Query: 76 GKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135
E + ++ +K + S + F E A + Q+ ++ + L G C E ++V E++
Sbjct: 27 YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86
Query: 136 PNDTLAKHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIV 188
L LF H ++ + + +VA +A AL Y K+ L H ++ R
Sbjct: 87 EFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREG 142
Query: 189 FDDDVNP--RLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDL 245
D + P +LS G+ + + + PE + + + + +SFGT L ++
Sbjct: 143 IDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF--SSDEGTELVRLASRCLQYEPRERPNP 303
IP ++D+ + + EGQ + EL L + C+ Y+P +RP
Sbjct: 203 CYNGEIP-------LKDKTLAE-KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFF 254
Query: 304 RSLV 307
R+++
Sbjct: 255 RAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 12/183 (6%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY K + +AVK + ++FL EA + QL + + L+G C+G+ +LV
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCKGEPLMLV 73
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E P L K+L + + + + +A +A + Y SK ++ DL A ++ +
Sbjct: 74 MELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVN 130
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++S FG+ + G Y L + PE + G+ + +S ++S+G L +
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190
Query: 245 LLS 247
S
Sbjct: 191 AFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 34/247 (13%)
Query: 81 QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140
+ R+ +K + S A F E A + Q+ + LA + G C G E ++V E++ + L
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 141 AKHLFHWETQ-PMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIVFDDDV 193
L + + P+ W ++ VA +A AL Y K L H ++ R+ +
Sbjct: 104 DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGT 159
Query: 194 NP--RLS--CFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSG 248
+P +LS SR+ R + + PE + G ++ + +SFGT LL++
Sbjct: 160 SPFIKLSDPGVSFTALSREERV--ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217
Query: 249 KHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+P PS + ++ + SC EL L S+CL YEP +RP+
Sbjct: 218 GEVPLKERTPSEK-ERFYEKKHRLPEPSC----------KELATLISQCLTYEPTQRPSF 266
Query: 304 RSLVTAL 310
R+++ L
Sbjct: 267 RTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 26/226 (11%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
FL+EA + L + L L G ++V E P +L L +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---- 215
A+ IA + Y SK R ++ DL A I+ D ++ FGLM+ +
Sbjct: 102 YAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-----GKHIPPSHALDLIRDRNIQT 267
A+ PE LRT + S ++ FG L ++ + + S L I D+ +
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGER 219
Query: 268 LT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
L ++C + ++ + +C + P +RP +L L
Sbjct: 220 LERPEACPQ---------DIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 52/273 (19%)
Query: 64 EHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
E GE A V+ + N + +AVK + A ARQ F EA + L+++ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIV 70
Query: 117 NLLGCCCEGDERLLVAEYMPNDTL----------AKHLFHWETQP---MKWAMRLRVALH 163
G C EG L+V EYM + L AK L E + L +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 164 IAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------- 215
IA + Y S ++ DL + + ++ FG+ SRD YST+
Sbjct: 131 IASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGM---SRD--IYSTDYYRVGGRT 184
Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQT 267
+ + PPE + + T ES ++SFG +L ++ + GK + + A++ I
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+C E+ + C Q EP++R
Sbjct: 245 RPRTC---------PPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 27/266 (10%)
Query: 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLAN 117
++ G A VVY L N ++A+KR + + +E +A+ Q + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 118 LLGCCCEGDERLLVAEYMPNDTLA---KHLFHWETQPMKW-AMRLRVALHIAEALEYCTS 173
GDE LV Y+ +L K + A L+ L + LEY S
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHS 120
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFG----LMKNSRDGRSYSTNLAFTP----PEYLR 225
+ ++ D+ A I+ +D + +++ FG L R TP PE +
Sbjct: 121 NGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 226 TGRVTPESV-MYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
++SFG ++L +G PP L L + +L ++S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK- 238
Query: 281 EGTELVRLASRCLQYEPRERPNPRSL 306
++ S CLQ +P +RP L
Sbjct: 239 ---SFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--- 157
+E + +G+ +N + NLLG C + ++ EY L ++L M ++
Sbjct: 68 MEMMKMIGKHKN--IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 158 -----------LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ A +A +EY S+ + ++ DL A ++ +D +++ FGL ++
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSH 255
+ Y +TN + + PE L T +S ++SFG LL ++ + IP
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L+++ + +C EL + C P +RP + LV L
Sbjct: 245 LFKLLKEGHRMDKPANCTH---------ELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 42/250 (16%)
Query: 84 IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK S D FL EA + + ++ + L+G E R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 143 HLFHWE---TQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
L +P M+ L A +A+ +Y ++ D+ A + L
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCL--------L 149
Query: 198 SC-----------FGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGT 240
+C FG+ ++ Y + + PPE G T ++ ++SFG
Sbjct: 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209
Query: 241 LLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEP 297
LL ++ S ++P P N + + G+ +G + R+ + C Q+ P
Sbjct: 210 LLWEIFSLGYMPYPGR-------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTP 262
Query: 298 RERPNPRSLV 307
+RPN +++
Sbjct: 263 EDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 23/249 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY + +AVK P R+ FL+EA + Q + + L+G E + +V
Sbjct: 26 VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E P L +L + A + + ++ AL Y SK R ++ D+ A ++
Sbjct: 85 MELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSS 142
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLL 246
+L FGL + D Y + P PE + R T S ++ FG + ++L
Sbjct: 143 PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
G + + + I + + +C L L ++C Y+P +RP
Sbjct: 203 MLGVKPFQGVKNNDVIGRIENGERLPMPPNC---------PPTLYSLMTKCWAYDPSKRP 253
Query: 302 NPRSLVTAL 310
L L
Sbjct: 254 RFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 16/223 (7%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------HWETQPM 152
F E +L ++ + LLG C E + ++ EY L + L + P+
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
++ + IA +++ S R ++ DL A + ++S L K+ + Y
Sbjct: 115 STKQKVALCTQIALGMDH-LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 213 STN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
L + PE ++ + +S ++SFG L+ ++ + +P L + +
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---GLSDEEVLNR 230
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L LE + L +L +RC P++RP+ LV+AL
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 53/243 (21%), Positives = 104/243 (42%), Gaps = 19/243 (7%)
Query: 73 VYKGKLENQFR--IAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VYKG ++N+ + +A+K + A + +E + Q + + G +G +
Sbjct: 20 VYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
++ EY+ + L + P++ + I + L+Y S ER ++ D+ A ++
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLL 134
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
+ + +L+ FG+ D + TP PE ++ ++ ++S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 246 LSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
G+ PP+ L +R I + LEGQ+S CL +PR RP +
Sbjct: 195 AKGE--PPNSDLHPMRVLFLIPKNSPPTLEGQYSK----PFKEFVEACLNKDPRFRPTAK 248
Query: 305 SLV 307
L+
Sbjct: 249 ELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 27/201 (13%)
Query: 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
E GE V +G+L+ + +A+K +S + + R FL EA +GQ + + +
Sbjct: 16 EFGE-----VCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKE 175
L G + +++ E+M N L L + Q ++ LR IA ++Y S+
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKY-LSEM 125
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---YSTNLA------FTPPEYLRT 226
++ DL A I+ + ++ ++S FGL + D S Y+++L +T PE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 227 GRVTPESVMYSFGTLLLDLLS 247
+ T S ++S+G ++ +++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 10/174 (5%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
+A+K+ N P + E + +L+N + N L GDE +V EY+ +L
Sbjct: 47 VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106
Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
+ + A R L +ALE+ + + ++ D+ + ++ D + +L+ FG
Sbjct: 107 VTETCMDEAQIAAVCRECL---QALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFC 162
Query: 204 KNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
+S + + TP PE + P+ ++S G + ++++ G+ PP
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 40/246 (16%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL---------FHWET-- 149
+E + +G+ +N + NLLG C + ++ EY L ++L + ++
Sbjct: 71 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 150 ---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-- 204
+ M + + +A +EY S ++ ++ DL A ++ ++ +++ FGL +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 205 NSRDGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
N+ D +TN + + PE L T +S ++SFG L+ ++ L G IP
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL---VT 312
L+++ + +C EL + C P RP + LV L +T
Sbjct: 248 LFKLLKEGHRMDKPANCT---------NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
Query: 313 LQKDTE 318
L + E
Sbjct: 299 LTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FH 146
+E + +G+ +N + NLLG C + ++ EY L ++L
Sbjct: 74 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ + + + A +A +EY SK + ++ DL A ++ +D +++ FGL ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 207 R--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
D +TN + + PE L T +S ++SFG LL ++ L G +P
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L+++ + +C EL + C P +RP + LV L
Sbjct: 251 LFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK A +AR FL+E + + +L++ + LL C D ++ EYM N L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 143 HLFHWETQP---------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
L E Q + ++ + +A IA ++Y +S ++ DL + +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVGKNY 167
Query: 194 NPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLLS 247
+++ FG+ +N G Y P E + G+ T S +++FG L ++L+
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 248 -GKHIPPSHALD---------LIRDRNIQT 267
K P S D RD+ Q
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQV 257
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 16/228 (7%)
Query: 77 KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYM 135
KLE + RI KR S + +Q LE+ N R L E + L LV M
Sbjct: 32 KLEKK-RIK-KRKGESMALNEKQILEKV-------NSRFVVSLAYAYETKDALCLVLTLM 82
Query: 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
L H++H + + A I LE +ER +Y DL I+ DD +
Sbjct: 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED-LHQERIVYRDLKPENILLDDHGHI 141
Query: 196 RLSCFGLMKNSRDGRSYS---TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
R+S GL + +G++ + + PE ++ R T ++ G LL ++++G+ P
Sbjct: 142 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-P 200
Query: 253 PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
I+ ++ L E ++S + L L +P+ER
Sbjct: 201 FQQRKKKIKREEVERLVKEVQE-EYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 44/200 (22%), Positives = 82/200 (41%), Gaps = 41/200 (20%)
Query: 73 VYKG-----KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKG + + +A+K P A + L+EA + + + + LLG C
Sbjct: 23 VYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SS 81
Query: 127 ERLLVAEYMP-----------NDTL-AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK 174
+ L+ + MP D + +++L +W Q IA+ + Y +
Sbjct: 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------------IAKGMSYL--E 126
Query: 175 ERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTG 227
E+ L H DL A ++ + +++ FGL K D + Y P E +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 228 RVTPESVMYSFGTLLLDLLS 247
T +S ++S+G + +L++
Sbjct: 187 IYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 66 GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLL 119
G A VYKG + +A+K N + P A +F++EA + + + L LL
Sbjct: 16 GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
G C + LV + MP+ L ++ H + + L + IA+ + Y +ER L
Sbjct: 76 GVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYL--EERRLV 131
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYL-----RTGRVTPE 232
H DL A ++ + +++ FGL + D + Y+ + P +++ + T +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 233 SVMYSFGTLLLDLLS 247
S ++S+G + +L++
Sbjct: 192 SDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT----LAKHLFHWETQPMK 153
R FL EA +GQ + + +L G + ++V EYM N + L KH + +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211
+R IA ++Y S ++ DL A I+ + ++ ++S FGL + D +
Sbjct: 110 GMLR-----GIASGMKY-LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 212 YSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
Y+T + +T PE + + T S ++S+G ++ +++S
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 30/247 (12%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMP----N 137
+AVK+ S R F E + L++ + G C R LV EY+P
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
D L KH + + + L A I + +EY SK R ++ DL I+ + + ++
Sbjct: 96 DYLQKHRERLDHRKL-----LLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKI 149
Query: 198 SCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH 250
FGL K + Y + + PE L + + S ++SFG +L +L +
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD 209
Query: 251 I---PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRE 299
PP+ + ++ D+ Q + +E G+ + G E+ + C +P +
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQ 269
Query: 300 RPNPRSL 306
RP+ L
Sbjct: 270 RPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTN 215
++A+ + E L Y + R ++ D+ I+ + +L FG+ + NS T+
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166
Query: 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK------------HIPPSHALDLIRDR 263
+ PE ++ G+ T +S ++S G +++L GK P LDL++ +
Sbjct: 167 -TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-Q 224
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
+Q F D L CL +P ERP P+ L
Sbjct: 225 IVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + + A R L +ALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 205 MAIEMIEGE--PP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+K+ N P + E + + +N + N L
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + + A R L +AL++ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQ-VIHRDIKS 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 204 MAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 23/146 (15%)
Query: 130 LVAEYMPND---TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+V EYM +D L + +K M+ + E L+Y S L+ D+
Sbjct: 77 MVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYLHSN-GILHRDIKGSN 130
Query: 187 IVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFT----PPEYLRTG--RVTPESVMYSF 238
I+ ++D +L+ FGL + R+ Y TN T PPE L G R PE M+S
Sbjct: 131 ILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL-LGATRYGPEVDMWSV 188
Query: 239 GTLLLDLLSGKHIPP----SHALDLI 260
G +L +L GK I L+ I
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 35/225 (15%)
Query: 111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAM 156
+++ + NLLG C + ++ EY L + L + + +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--ST 214
+ A +A +EY S+ R ++ DL A ++ +D +++ FGL + D Y ++
Sbjct: 136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 215 N----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKH---IPPSHALDLIRDRNI 265
N + + PE L T +S ++SFG L+ ++ L G IP L+R+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+C EL L C P +RP + LV AL
Sbjct: 255 MDKPSNCTH---------ELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 50/231 (21%), Positives = 101/231 (43%), Gaps = 34/231 (14%)
Query: 110 LRNRRLANLL---GCCCEGDER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHI 164
LRN N++ G C E L+ E++P+ +L ++L + +L+ A+ I
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQI 118
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-------NLA 217
+ ++Y S++ ++ DL A ++ + + ++ FGL K + Y T +
Sbjct: 119 CKGMDYLGSRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSG------------KHIPPSHALDLIRDRNI 265
+ PE L + S ++SFG L +LL+ K I P+H + R +
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-QMTVTRLV 236
Query: 266 QTLTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
+ L EG+ + E+ +L +C +++P +R ++L+ +
Sbjct: 237 RVLE----EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 26/202 (12%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
+VY + L Q RIA+K + EE L++R + LG E +
Sbjct: 23 IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82
Query: 131 VAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIV 188
E +P +L+ L W + I E L+Y HD +R +
Sbjct: 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY--------LHDNQIVHRDI 134
Query: 189 FDDDV--NP-----RLSCFGLMKN----SRDGRSYSTNLAFTPPEYLRTGR--VTPESVM 235
D+V N ++S FG K + +++ L + PE + G + +
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 236 YSFGTLLLDLLSGKHIPPSHAL 257
+S G ++++ +GK PP L
Sbjct: 195 WSLGCTIVEMATGK--PPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 26/182 (14%)
Query: 126 DERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
D LV ++ L H+ + E +WA + VAL +AL +E + D
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL---DALH----REGIVCRD 110
Query: 182 LNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
LN I+ DD + +L+ F +++S DG + + PE T +S
Sbjct: 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN--MYCAPEVGGISEETEACDWWSL 168
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
G +L +LL+GK + H I T T + ++ S+E L+ + LQ+ P
Sbjct: 169 GAILFELLTGKTLVECHP------SGINTHTTLNIP-EWVSEEARSLL---QQLLQFNPT 218
Query: 299 ER 300
ER
Sbjct: 219 ER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 76 GKLENQFRIAVKRFNRSAWPDARQFL-EEARAVGQLRNR-RLANLLGCCCEGDERLLVAE 133
K + ++AVK +A R+ L E + + L N + NLLG C G L++ E
Sbjct: 60 SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119
Query: 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
Y L L + L + +A+ + + SK ++ DL A ++
Sbjct: 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGK 178
Query: 194 NPRLSCFGLMKNSRDGRSY-STNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
++ FGL ++ + +Y A P PE + T ES ++S+G LL ++ S
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 248 -GKHIPPSHALDLIRDRNIQTLTDS---CLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
G + P + D L + + + E ++++ C +P +RP
Sbjct: 239 LGSNPYP----GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK---TCWDADPLKRPTF 291
Query: 304 RSLVTAL 310
+ +V +
Sbjct: 292 KQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 6/174 (3%)
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
LV M L H+++ A + A I LE+ + R +Y DL ++
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH-LHQRRIVYRDLKPENVLL 128
Query: 190 DDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
DD N R+S GL +K + + + + PE L+ ++ G L +++
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+G P + + ++ T + ++ E L LQ +P +R
Sbjct: 189 AG-RSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 40/181 (22%), Positives = 71/181 (39%), Gaps = 18/181 (9%)
Query: 148 ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207
E P+ + I + L+Y S E+ ++ D+ A ++ + +L+ FG+
Sbjct: 94 EPGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152
Query: 208 DGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDL 259
D + TP PE ++ ++ ++S G ++L G+ + P L L
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212
Query: 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
I N TL EG +S L CL EP RP + L+ ++ +
Sbjct: 213 IPKNNPPTL-----EGNYSK----PLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263
Query: 320 S 320
S
Sbjct: 264 S 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 30/210 (14%)
Query: 83 RIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
R+ VK SA PD + FL+E + +L + + LG C E LLV E+ P L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 142 KHL------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
+L Q + R+A +A L + + ++ DL D++
Sbjct: 84 NYLRSNRGMVAQMAQKD---VLQRMACEVASGLLW-LHQADFIHSDLALRNCQLTADLSV 139
Query: 196 RLSCFGLMKNSRDGRSYSTN------LAFTPPEY-------LRTGRVTPESVMYSFGTLL 242
++ +GL Y T L + PE L T +S ++S G +
Sbjct: 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199
Query: 243 LDLLSGKHIPPSHALDL------IRDRNIQ 266
+L + P D +R+++I+
Sbjct: 200 WELFTAADQPYPDLSDEQVLKQVVREQDIK 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 43/193 (22%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+K+ N P + E + + ++ + N L
Sbjct: 28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + ET M V +ALE+ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVT--ETC-MDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKS 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 204 MAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 37/235 (15%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM--------------PNDTLAKHLFH 146
+E + +G+ +N + NLLG C + +V EY P + +
Sbjct: 66 MEMMKMIGKHKN--IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ + + A +A +E+ SK + ++ DL A ++ +D +++ FGL ++
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKHIP--PSHA 256
Y +TN + + PE L T +S ++SFG LL ++ L G P P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 257 L-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L L+++ +C + EL L C P +RP + LV L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQ---------ELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 50/243 (20%), Positives = 100/243 (41%), Gaps = 33/243 (13%)
Query: 62 VSEHGEKAPNVVYKGKL------ENQFRIAVKRF-NRSAWPDARQFLEEARAVGQLRNRR 114
+ E GE VYKG L E +A+K +++ P +F EA +L++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLF----HWET------QPMKWAMR----LRV 160
+ LLG + ++ Y + L + L H + + +K + + +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST------ 214
IA +E+ +S ++ DL ++ D +N ++S GL + Y
Sbjct: 130 VTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT 269
+ + PE + G+ + +S ++S+G +L ++ S P +++IR+R +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
Query: 270 DSC 272
D C
Sbjct: 249 DDC 251
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 19/263 (7%)
Query: 66 GEKAPNVVYKGKL----EN-QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
G A VYKG EN + +A+K + P A ++ L+EA + + + + LL
Sbjct: 16 GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
G C +L V + MP L ++ + + + L + IA+ + Y + R ++
Sbjct: 76 GICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSY-LEEVRLVH 132
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTG-----RVTPES 233
DL A ++ + +++ FGL + D Y + P +++ R T +S
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
++S+G + +L++ P D I R I L + ++ + +C
Sbjct: 193 DVWSYGVTVWELMTFGAKP----YDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCW 248
Query: 294 QYEPRERPNPRSLVTALVTLQKD 316
+ RP R LV + +D
Sbjct: 249 MIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 34/186 (18%)
Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLL--VAEYMPNDTLAKHLFHWETQPMKWAMRLRV 160
E R + ++ + + L E D+R L + EY+P L +L + + L
Sbjct: 51 EKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFY 106
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP 220
A I ALEY SKE +Y DL I+ D + + +L+ FG K RD R+++ L T
Sbjct: 107 ASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT--LCGT- 161
Query: 221 PEYLRTGRVTPESVM----------YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD 270
PEYL PE + ++ G L+ ++L G PP D N + +
Sbjct: 162 PEYL-----APEVIQSKGHNKAVDWWALGILIYEMLVG--YPP------FFDDNPFGIYE 208
Query: 271 SCLEGQ 276
L G+
Sbjct: 209 KILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY 223
LEY S + ++ D+ A I+ +++ +L+ FG+ D + + TP PE
Sbjct: 112 LEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
++ ++ ++S G +++ GK I P A+ +I ++ TL+D ++S
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP---EKWS- 226
Query: 280 DEGTELVRLASRCLQYEPRERPNPRSL 306
E +CL +P ERP+ L
Sbjct: 227 ---PEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 23/199 (11%)
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
+V + G +Y K+ + I K RQ LE R R L L
Sbjct: 18 LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLH- 71
Query: 121 CCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSKER 176
+ D +L L+ +Y+ L HL+ E V ++IAE AL+ +
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALD-HLHQLG 125
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMK-----NSRDGRSYSTNLAFTPPEYLRTGRVTP 231
+Y D+ I+ D + + L+ FGL K S+ + + PE +R G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 232 ESVM--YSFGTLLLDLLSG 248
+ + +S G L +LL+G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 13/164 (7%)
Query: 96 DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL-VAEYMPNDTLAKHLFHWETQPMKW 154
D + E R + RN L CC + +RL V E++ L +FH +
Sbjct: 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD 94
Query: 155 AMRLRV-ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RDGRSY 212
R R A I AL + K +Y DL ++ D + + +L+ FG+ K +G++
Sbjct: 95 EARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153
Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
ST TP PE L+ P ++ G LL ++L G H P
Sbjct: 154 ST-FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 359 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.37 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.6 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.03 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.85 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.21 | |
| PLN02236 | 344 | choline kinase | 97.19 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.06 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.94 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.88 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.79 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.61 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.51 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.22 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.08 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.37 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.78 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=382.49 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=211.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCc-ceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 133 (359)
++.+.++.||+|+.|+|||+.+ .+++.+|+|++...... ..+++.+|+++++..+||+||+++|.|..... ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3566788899999999999995 57899999999655433 35789999999999999999999999999985 999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~ 211 (359)
||++|||.+++. ..+.+++....+++.+|++||.|||+..+||||||||+|||++..|.|||||||.++..... ++
T Consensus 159 YMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 159 YMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred hcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhccc
Confidence 999999999997 44779999999999999999999996349999999999999999999999999999876544 57
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh-hhhhhccccccCCCChH-HHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR-NIQTLTDSCLEGQFSSD-EGTELVRLA 289 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~l~~li 289 (359)
++||..|||||.+.+..|+.++||||||++++|+.+|+.|++.........- .+..+.+ ...+..|.. +++++++++
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCHHHHHHH
Confidence 7899999999999999999999999999999999999988876411000000 1111222 123344554 899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
..||++||.+|||+.+++++
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999976
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=391.89 Aligned_cols=274 Identities=35% Similarity=0.618 Sum_probs=234.7
Q ss_pred cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccccc
Q 018244 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119 (359)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 119 (359)
....|+++++..+|++|+..+++ |+|+||.||+|.++++..||||++.........+|.+|+.+|.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 56779999999999999998888 999999999999999899999988876543145599999999999999999999
Q ss_pred ceeeeCC-cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CcccccCCCCCeeeCCCCCeE
Q 018244 120 GCCCEGD-ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 120 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~ivH~Dikp~NIll~~~~~~k 196 (359)
|||.+.+ ..+||+||+++|+|.+++.......++|.++.+|+.++|.||+|||... .|+||||||+|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999998 4999999999999999997633328999999999999999999999963 499999999999999999999
Q ss_pred EeccCCcccCCC-CCCc----CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch-----------hHHH
Q 018244 197 LSCFGLMKNSRD-GRSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-----------LDLI 260 (359)
Q Consensus 197 l~DFg~a~~~~~-~~~~----~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~-----------~~~~ 260 (359)
|+|||+|+.... .... .||.+|+|||++..+..+.++|||||||+|+||+||+.+..... ...+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977664 3322 78999999999999999999999999999999999997654321 1223
Q ss_pred hhhhhhhhcccccc-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 261 RDRNIQTLTDSCLE-GQFSS-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 261 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.......++++.+. ..++. .....+..+...|++.+|.+||+|.+|++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 33456777777765 44443 5677799999999999999999999999999766543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-54 Score=376.88 Aligned_cols=249 Identities=17% Similarity=0.233 Sum_probs=208.9
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch-------HHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
++.|.+.+.||+|+||.|-+|. .++|+.||||++++..... ...+.+|+++|++|+|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456677889999999999998 6789999999998653221 2236799999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcc
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK 204 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~ 204 (359)
.|+||||+.||.|.+.+. ....+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999997 556788888899999999999999999 99999999999999765 779999999999
Q ss_pred cCCCC---CCcCCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCC
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 277 (359)
..... ++.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.++..+. +.++....-.. ..+..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--f~p~~ 405 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--FGPLQ 405 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--ccChh
Confidence 98755 4678999999999998765 3347899999999999999999998775544 33333221111 11122
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+++..+||.+||..||++|||+.|+|++
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 35688999999999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=381.19 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=216.0
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCC-cceEEEecCCC
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAEYMPN 137 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 137 (359)
+.+.+|.|+||+||+|.+.....||||.+....... .+.|.+|+.+|.+++|||||+++|+|..+. .++|||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 344479999999999999766559999998754333 458999999999999999999999999887 79999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-cccccCCCCCeeeCCCC-CeEEeccCCcccCCC----CCC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD----GRS 211 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~----~~~ 211 (359)
|+|.+++.......+++..+..|+.||+.||.|||++ + ||||||||+|||++.++ ++||+|||+++.... ...
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~ 203 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTS 203 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccC
Confidence 9999999754467899999999999999999999999 8 99999999999999997 999999999986553 233
Q ss_pred cCCCccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 212 ~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
..||+.|||||++. ...|+.++||||||+++|||+||+.||......... ..+.....++.++..+++.+..|+
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----~~v~~~~~Rp~~p~~~~~~l~~l~ 279 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA----SAVVVGGLRPPIPKECPPHLSSLM 279 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCCCCCCCccCCHHHHHHH
Confidence 67899999999999 568999999999999999999999988766432222 222233344555666888999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
..||+.||++||++.+++..|+.+.....
T Consensus 280 ~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 280 ERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 99999999999999999999998876443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-53 Score=386.76 Aligned_cols=244 Identities=17% Similarity=0.213 Sum_probs=216.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|..-+.||+|||+.||.++. ..|..||+|++.+.. ....+++.+||++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5677777789999999999995 889999999998742 234677999999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
|+|.+++|..+++ ....+++..++.+++||+.||.|||++ +|+|||||..|++++++.+|||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 567899999999999999999999999 9999999999999999999999999999887643
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
.+.+||+.|+|||++....++..+||||+||+||-||.|++||.............. .....|...+.++.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMPSHLSAEAKDL 248 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccccccCHHHHHH
Confidence 467899999999999999999999999999999999999999988755544333322 1223466788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
|.++|+.||.+|||+++|+++
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=368.13 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=211.3
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..+|...++||.|+||+||+|+ ..++..||||.+... .....+-+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4577888889999999999999 456899999999877 3444666889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC------CCeEEeccCCcccC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD------VNPRLSCFGLMKNS 206 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~------~~~kl~DFg~a~~~ 206 (359)
|||+||+|.+|++ ..+.+++..+..++.|++.||++||++ +||||||||.||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999997 455899999999999999999999999 99999999999999754 56999999999998
Q ss_pred CCCC---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 207 RDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 207 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
.++. +.+|++-|||||++....|+.|+|+||+|+|+|++++|+.||......++...... ........+...+.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k---~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK---GNEIVPVLPAELSN 242 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---cccccCchhhhccC
Confidence 8664 56899999999999999999999999999999999999999987765554432211 11122233445566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.+|+...++.+|.+|.+..+....
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhh
Confidence 67799999999999999888876543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=355.25 Aligned_cols=250 Identities=18% Similarity=0.231 Sum_probs=212.8
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccc-eeeeCCc-ceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLG-CCCEGDE-RLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 131 (359)
.+|+++++||.|+||+||++. ..+|..||.|.++..... .......|+.+|++|+|||||++++ .+.+... ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999998 778999999999855433 3456889999999999999999998 4555544 8999
Q ss_pred EecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhc--C-CCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTS--K-ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~--~-~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
||||.+|+|.+.++.. .++.+++..+|+++.|++.||.++|+ . .-|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999753 46679999999999999999999999 3 13999999999999999999999999999998
Q ss_pred CCCC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC-hHH
Q 018244 207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDE 281 (359)
Q Consensus 207 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 281 (359)
.... +.+||+.||+||.+.+.+|+.++||||+||++|||+.-++||.+.....+...+.+. ..++.| ...
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-----d~~~~p~~~Y 253 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-----DYPPLPDEHY 253 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-----CCCCCcHHHh
Confidence 7664 568999999999999999999999999999999999999999988665554444332 222234 678
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
+.++..|+..|+..||++||+.-.++..+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999999998655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=359.43 Aligned_cols=239 Identities=21% Similarity=0.250 Sum_probs=209.8
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
+..++++++.||+|+||+||.++ .++++.+|+|++++... ...+....|..+|..++||+||+++..|++++.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45677889999999999999998 55689999999987543 235668899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC---
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~--- 207 (359)
|+||+.||.|...|. +.+.+++..+..++.+|+.||.|||++ |||||||||+|||+|.+|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999997 567899999999999999999999999 99999999999999999999999999998532
Q ss_pred -CCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 208 -DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 208 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
.....+||+.|||||++.+..|+.++|+||||+++|||++|.+||.......+.+.....- ....+...+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----LPLPPGYLSEEAR 254 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----CCCCCccCCHHHH
Confidence 3346789999999999999999999999999999999999999999887666555544432 1122344778999
Q ss_pred HHHHHhcccCCCCCC
Q 018244 287 RLASRCLQYEPRERP 301 (359)
Q Consensus 287 ~li~~cl~~dp~~Rp 301 (359)
+++.++|+.||++|.
T Consensus 255 dll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHhccCHHHhc
Confidence 999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=347.00 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=202.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-h-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-D-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|+.++++|+|+||+||+|+. .+|+.||||++..+... . .+-.++|+++|++++|+|+|.++++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 578899999999999999994 56999999999865432 2 33478999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC-CC---C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-DG---R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~-~~---~ 210 (359)
|+. ++.+.+.+ ....++...+..+++|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+... ++ +
T Consensus 83 ~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 988 55555544 556789999999999999999999999 99999999999999999999999999999876 33 3
Q ss_pred CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcch-hHHHhh-------------------hhhhhhc
Q 018244 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRD-------------------RNIQTLT 269 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~-~~~~~~-------------------~~~~~~~ 269 (359)
.++.|.+|+|||.+.+ ..|..++||||+||++.||++|.+.+++.. .+.... ..+..+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 4567999999999998 569999999999999999999999887652 111110 0000111
Q ss_pred cccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
-+..... -.+..+.-+.+|+..||+.||++|++.++++.+
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0100000 012356688999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=366.30 Aligned_cols=250 Identities=17% Similarity=0.238 Sum_probs=207.1
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHH-HHHHHHHHHhcCC-CcccccccceeeeCC-cceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLR-NRRLANLLGCCCEGD-ERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~ 132 (359)
..|.++++||.|+||.||+|+ ...+..||||+++.....-.+ .-+||++.|++|. |||||++++++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 468899999999999999999 667889999999876433221 2478999999998 999999999999988 999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC---C
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---G 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---~ 209 (359)
|||+. +|.++++++ ...+++..+..|++||++||+|+|.+ |++|||+||+|||+..+..+||+|||+|+.... .
T Consensus 90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCCc
Confidence 99987 899999875 78999999999999999999999999 999999999999999999999999999998654 3
Q ss_pred CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc----------------
Q 018244 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC---------------- 272 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------------- 272 (359)
+.++.|.+|+|||++.. +.|+.+.||||+|||++|+.+-++.|++...-.........+-.+.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 56788999999998764 5699999999999999999999999987522111111111111110
Q ss_pred -cc---C----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 -LE---G----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 -~~---~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+. + ..-+.++.++.+||.+|++.||++||||.+++++
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 0 0112378899999999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=367.15 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=216.2
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
..++++||+|-||.||.|.++....||+|.++... -..+.|.+|+++|++|+|+|||+++++|..+..++|||||++.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 46788899999999999999888799999998754 33567889999999999999999999999988999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc--CC--
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--ST-- 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~-- 214 (359)
+|.++|+...+..+...+.+.++.|||+|++||+++ ++|||||-+.||||+++..+||+|||+|+...++.-. .+
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 999999876778899999999999999999999999 9999999999999999999999999999965544321 11
Q ss_pred -CccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 215 -NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 215 -t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
...|+|||.+..+.++.++|||||||+||||+|-.. |++..... .....+....+-..|..++.++.++|..|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 357999999999999999999999999999999554 44443332 23334444455566788999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhhc
Q 018244 293 LQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
|+.+|++|||++.+...|+.+...
T Consensus 441 W~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999988887553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=329.45 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=206.1
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|..++.+|+|.||.||+|+ ..+|+.||||++......+ .....+||+.|+.++|+||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357788889999999999999 6789999999998765443 3457899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|++. +|...+++ +...++...+..|+.+++.||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9987 89999876 667899999999999999999999999 99999999999999999999999999999876543
Q ss_pred -CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh---------------------
Q 018244 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT--------------------- 267 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--------------------- 267 (359)
..+.|.+|+|||.+.|.+ |+..+||||.|||+.||+-|.+.|++..--......+..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 235689999999998764 999999999999999999999877765211111111111
Q ss_pred --hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 --LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+.... .-..++.++.+|+.+||..||.+|+|+.+++++
T Consensus 239 ~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111 123456778999999999999999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=351.93 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=206.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC--cceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 133 (359)
..+...+.||+|+||+||++.. ++|...|||.+...+....+.+.+|+.+|..++|||||+++|...... .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 3456677789999999999995 458899999998765444677899999999999999999999855555 5899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~---- 208 (359)
|+++|+|.+++.+... .+++..+..++.||+.||.|||++ |++||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999986444 799999999999999999999999 9999999999999999 79999999999886652
Q ss_pred ---CCCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
.....||+.|||||++..+. ...++|||||||++.||+||..|+... .............. ..+.++...+.+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~-~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED-SLPEIPDSLSDE 251 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC-CCCCCCcccCHH
Confidence 23567999999999999643 345999999999999999998877653 00111111111111 223567778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+++++.+|+..||++||||.++|++.--.
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 99999999999999999999999875443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=356.11 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=204.5
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeC--CcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 131 (359)
+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+... ...-..+||.+|++|.||||+++.+..... ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457889999999999999999 678999999999876532 344568999999999999999999998876 689999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
+|||+. +|..++.. ..-.+++.++..++.|++.||+|+|++ ||+|||||.+|||||++|.+||+|||+|++.....
T Consensus 197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999998 79888853 456899999999999999999999999 99999999999999999999999999999765443
Q ss_pred ----CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc-------------
Q 018244 211 ----SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC------------- 272 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------- 272 (359)
..+.|++|+|||.+.+.. |+.++|+||.||||.||++|++++++...-.....++...-.+.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 345689999999999864 99999999999999999999998886532221111111000000
Q ss_pred -ccC--CC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 -LEG--QF-------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 -~~~--~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... .+ -...+....+|+..+|..||++|.|+.++|+.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000 00 12346788999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=359.78 Aligned_cols=248 Identities=18% Similarity=0.269 Sum_probs=214.8
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.-..|....++|+|+.|.||.|. ..++..||||++........+-+.+|+.+|+..+|+|||++++.|...+.+|.|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34456667788999999999998 66788999999998877777789999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|++||+|.+.+ ....+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++......
T Consensus 351 ym~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999999999 556799999999999999999999999 9999999999999999999999999998776543
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+||+.|||||++....|++++||||||++.+||+-|++||..+.--.. ..............+...+..+++|+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---lyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---HHHHhhcCCCCcCCccccCHHHHHHH
Confidence 467899999999999999999999999999999999999998875422111 11111122223344567889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||..|+++|+++.++|++
T Consensus 504 ~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=332.79 Aligned_cols=236 Identities=18% Similarity=0.215 Sum_probs=209.9
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..++++++.||.|+||.|.+++ ..+|..+|+|++.+..... .+...+|..+|+.+.||+++++.+.|.+.+++++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4567889999999999999999 4568899999998765443 44578899999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-C
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~ 210 (359)
|||++||.|.++++ +.+.+++..++.++.||+.||+|||++ +|++||+||+|||+|.+|.+||+|||+|+..... -
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999997 667899999999999999999999999 9999999999999999999999999999987654 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
+.+||+.|+|||+++..+|+.++|.|||||++|||+.|.+||.......+.+.+... .-.+|...+.++++|+.
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------KVKFPSYFSSDAKDLLK 273 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------cccCCcccCHHHHHHHH
Confidence 668999999999999999999999999999999999999999887654444443332 12467788899999999
Q ss_pred HhcccCCCCC
Q 018244 291 RCLQYEPRER 300 (359)
Q Consensus 291 ~cl~~dp~~R 300 (359)
.+|+.|-.+|
T Consensus 274 ~LL~vD~t~R 283 (355)
T KOG0616|consen 274 KLLQVDLTKR 283 (355)
T ss_pred HHHhhhhHhh
Confidence 9999999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=356.80 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=213.0
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcc
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 128 (359)
....+|.+.+.||.|+|++|++|+ ...++.+|||++.+.-. ...+.+.+|-.+|..| .||.|++++-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345567778888999999999999 56789999999976422 2245678899999999 799999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|+|+||+++|.|.++|. +-+.+++...+.++.||+.||+|||++ |||||||||+|||||.+++++|+|||.|+...+
T Consensus 150 YFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999997 557899999999999999999999999 999999999999999999999999999986542
Q ss_pred C-----------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc
Q 018244 209 G-----------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 209 ~-----------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 271 (359)
. ..++||..|.+||++.....+..+|+|+||||||+|+.|.+||-....-...+.+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~----- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA----- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-----
Confidence 1 246799999999999999999999999999999999999999987654443333322
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.-.++...++.+.+|+.+.|..||.+|+|+++|-++
T Consensus 302 -l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2334667778899999999999999999999888764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=351.66 Aligned_cols=244 Identities=20% Similarity=0.232 Sum_probs=208.9
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCC----CC-chHHHHHHHHHHHhcCC-CcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 128 (359)
...|.+.+.||+|+||+|+.|. ..++..||+|++.+. .. ...+.+.+|+.+++.++ ||||+++++++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4578888899999999999998 556899999987764 11 22445678999999998 99999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~ 207 (359)
++||||+.||.|.+++.+ .+.+.+..+..+++|++.|++|+|++ ||+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999974 67899999999999999999999999 99999999999999999 999999999999772
Q ss_pred -C---CCCcCCCccccCcccccCCC-CC-CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 208 -D---GRSYSTNLAFTPPEYLRTGR-VT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 208 -~---~~~~~~t~~y~aPE~~~~~~-~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
. .....||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.......+...... . ...++...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~----~--~~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK----G--EFKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----C--CccCCCCc
Confidence 2 35678999999999999877 86 589999999999999999999987544433333111 1 12234445
Q ss_pred -HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 282 -GTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 282 -~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
+.++..|+.+||..||.+|+|+.+++.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 899999999999999999999999993
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=338.62 Aligned_cols=255 Identities=16% Similarity=0.216 Sum_probs=211.9
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+-++|++...||.|.-++||+|. .+.+..||||++....... .+.+.+|++.|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 355789999999999999999998 6778999999999765443 57899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|.||.+||+.+.++..-...+++..+..|.++++.||.|||++ |.||||||+.||||+++|.|||+|||.+-.....
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999999876677799999999999999999999999 9999999999999999999999999975432211
Q ss_pred ------CCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC----
Q 018244 210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---- 277 (359)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 277 (359)
+...||++|||||++.. ..|+.|+||||||++..||.+|..||.......+.-..++.-.........
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 45678999999999553 359999999999999999999999987654333222222221111111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+..+++++..||.+||.+|||+.+++..
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 22356789999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=351.14 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=212.4
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|.+.+.+|+|+||.||||+ ..+.+.||+|.+.+.... +.+.+.+|+++++.++|||||.++++|+...++++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 45566667999999999998 556889999999876533 356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+.| +|..++. ....++++.+..++.+++.||.|||++ +|+|||+||.|||++..|.+|++|||+|+.....+
T Consensus 83 a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 83 AVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 977 9999997 667899999999999999999999999 99999999999999999999999999999877654
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+-|||||.+.+..|+..+|+||+|||+||+++|++||...........+..+. ..++...+..+.+++.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~------v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP------VKPPSTASSSFVNFLQ 232 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC------CCCcccccHHHHHHHH
Confidence 4579999999999999999999999999999999999999998765544433333321 2345678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
..|.+||.+|.|..+++.+
T Consensus 233 gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHhhcChhhcccHHHHhcC
Confidence 9999999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=347.35 Aligned_cols=248 Identities=16% Similarity=0.154 Sum_probs=207.8
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...++.++..||+||||.||.|+ ..+|..+|+|+++++.. ...+.++.|-.+|....+|.||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56788899999999999999999 55799999999997643 335568889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~-- 208 (359)
||||++||++..+|. ....|++..+..++.+++.|+.-||+. |+|||||||+|+|||..|++||+|||++.....
T Consensus 219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999997 677899999999999999999999999 999999999999999999999999999742110
Q ss_pred -----------------------C--------------------------CCcCCCccccCcccccCCCCCCccchhhHH
Q 018244 209 -----------------------G--------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239 (359)
Q Consensus 209 -----------------------~--------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 239 (359)
. ...+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 024689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 018244 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (359)
Q Consensus 240 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~ 308 (359)
||+||||.|.+||..+...........- ...+........+.++.+||.+|+. ||++|.. ++||-+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999999887655443322211 1111112223466899999999999 9999975 555544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.10 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=202.5
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCC-cc
Q 018244 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD-ER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~~ 128 (359)
+|++.+.||.|+||.||+|.. .++..||||++..... .....+.+|+.++..+ +||||+++++++...+ .+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 577888899999999999973 2356799999975432 2345688999999999 8999999999887644 58
Q ss_pred eEEEecCCCCCHhhhhhcCC------------------------------------------------------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (359)
++||||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999986421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------CcCCCccccCcc
Q 018244 149 TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPE 222 (359)
Q Consensus 149 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE 222 (359)
...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...... ...++..|+|||
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 13478889999999999999999999 99999999999999999999999999997643221 223457899999
Q ss_pred cccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 018244 223 YLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (359)
Q Consensus 223 ~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 301 (359)
++.+..++.++||||||+++|||++ |..||............ .........+...+.++.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----LKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9998889999999999999999997 88887654322111111 111111223445677899999999999999999
Q ss_pred CHHHHHHHHHHhhh
Q 018244 302 NPRSLVTALVTLQK 315 (359)
Q Consensus 302 s~~~il~~L~~~~~ 315 (359)
|+.++++.|+.+..
T Consensus 323 s~~el~~~l~~~~~ 336 (338)
T cd05102 323 TFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=325.70 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=207.7
Q ss_pred HHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeee--C
Q 018244 51 TATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCE--G 125 (359)
Q Consensus 51 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~--~ 125 (359)
...+..++|+++.+|++|+||.||+|+ .++++.||+|+++...... --..++||.+|.+++|||||.+..+... -
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 345566788999999999999999999 5578999999998765322 2246899999999999999999887754 3
Q ss_pred CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
+.+|||||||+. +|.+++.. ..+.+...++.-++.|++.|++|||.+ .|+||||||+|+|+.+.|.+||+|||+|+.
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhh
Confidence 579999999988 79998865 457899999999999999999999999 999999999999999999999999999998
Q ss_pred CCCC----CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc---------
Q 018244 206 SRDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--------- 271 (359)
Q Consensus 206 ~~~~----~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 271 (359)
.... +..+.|.+|+|||.+.+.+ |+.++|+||+|||+.||+++++.|++...-...+.++..+-.+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7655 3456799999999999865 9999999999999999999999888653222211111111110
Q ss_pred ----------------cccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ----------------CLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ----------------~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++..+... .++...+|+..+|.+||.+|.|+.+.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111112221 45788999999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=349.93 Aligned_cols=239 Identities=19% Similarity=0.289 Sum_probs=210.0
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
+..++++++.||+|+||+|+++. ..+++.+|||.+++... .+.+..+.|.+++... +||.+++++..|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 45677899999999999999999 45688999999997643 3466778888888887 4999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC---
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS--- 206 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~--- 206 (359)
+||||+.||++.... ....+++..+..++..|+.||.|||++ ||||||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999844333 557899999999999999999999999 9999999999999999999999999999853
Q ss_pred -CCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 207 -RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
....+..||+.|+|||++.+..|+.++|+|||||+||||+.|+.||+++..+.+.+.+..+ ...+|...+.++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ea 595 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSKEA 595 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccHHH
Confidence 3445778999999999999999999999999999999999999999988877776665542 234677789999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 018244 286 VRLASRCLQYEPRERPNP 303 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~ 303 (359)
.+++.++|.++|++|..+
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 999999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=332.63 Aligned_cols=245 Identities=16% Similarity=0.235 Sum_probs=203.3
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeee----CCcceEEEecCC
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMP 136 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 136 (359)
.+|+|++|.||+|.. +|..||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||++
T Consensus 27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred EEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 459999999999998 57799999998654333 4567899999999999999999999877 346899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCcCCC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTN 215 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~~~t 215 (359)
+|+|.+++. ....+++.....++.|++.||.|||+..+++||||||+||++++++.+||+|||+++..... ....++
T Consensus 106 ~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 106 RGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 999999996 34578999999999999999999998448899999999999999999999999998865433 344678
Q ss_pred ccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 216 LAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 216 ~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
..|+|||++.+ ..++.++||||||+++|||++|..||............ .........+...+..+.+++.+||
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI----INKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 89999999976 67999999999999999999999998765433322221 1111222334456788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 018244 294 QYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+.||++|||+.++++.|+.++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999988753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=334.03 Aligned_cols=253 Identities=16% Similarity=0.165 Sum_probs=207.4
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--------------hHHHHHHHHHHHhcCCCccccccc
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--------------DARQFLEEARAVGQLRNRRLANLL 119 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~~ 119 (359)
....|.++++||+|.||.|-+|. ..+++.||||++.+.... ..++..+||.+|+++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35678899999999999999998 557899999999753211 245789999999999999999999
Q ss_pred ceeeeC--CcceEEEecCCCCCHhhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeE
Q 018244 120 GCCCEG--DERLLVAEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 120 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~k 196 (359)
++..++ +.+|||+|||..|.+...- .... +++.+++.|+++++.||.|||.+ |||||||||+|+||+++|.+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEE
Confidence 999876 5799999999988765432 3334 99999999999999999999999 999999999999999999999
Q ss_pred EeccCCcccCCCC---------CCcCCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh
Q 018244 197 LSCFGLMKNSRDG---------RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263 (359)
Q Consensus 197 l~DFg~a~~~~~~---------~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~ 263 (359)
|+|||.+..+..+ ....||+.|+|||.+.++. .+.+.||||+||+||.|+.|+-||.++..-...+.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998765222 2467999999999998743 35689999999999999999999988765555444
Q ss_pred hhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+....+ ......+..+++++||.+||.+||++|.+..+|..+.-..+.
T Consensus 331 Ivn~pL----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVNDPL----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcCcc----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 443222 222223578899999999999999999999998876554443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=338.63 Aligned_cols=244 Identities=15% Similarity=0.254 Sum_probs=209.7
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|..+..||+|+||.||+|. ...++.||+|++...... ..+.+.+|+.+|..++++||.++++.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 45566778999999999998 456889999999976544 3678899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~ 211 (359)
.||++.+.++ .+..+.+..+.-++++++.||.|||.. +.+|||||+.|||+..+|.+||+|||.+-.... ...
T Consensus 94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999995 444558999999999999999999999 999999999999999999999999999876543 357
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
++||+-|||||++.+..|+.++||||||++.+||.+|.+|+..... .....++....++.....+++.+++|+..
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 7899999999999988999999999999999999999987754322 12222333333444455788899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||++||+.||||.+++.+
T Consensus 246 CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HhhcCcccCcCHHHHhhh
Confidence 999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=341.58 Aligned_cols=247 Identities=19% Similarity=0.200 Sum_probs=221.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCc-ceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 132 (359)
+.|..++.+|.|+||.++.++ ..+++.+++|.+....... .....+|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 467888999999999999998 4467899999998654333 3467899999999999999999999999888 99999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
+||+||+|.+.+.+.++..++++.+..|+.|++.|+.|||++ +|+|||||+.||+++.++.|+|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999999999887778899999999999999999999988 9999999999999999999999999999987665
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
.+..||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|.......+...+...... ..+...+.+++.+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-----Plp~~ys~el~~l 237 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-----PLPSMYSSELRSL 237 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-----CCCccccHHHHHH
Confidence 3578999999999999999999999999999999999999999888777776666555433 3466788899999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+..||+++|+.||++.++|.+
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=337.22 Aligned_cols=243 Identities=18% Similarity=0.187 Sum_probs=204.2
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|++++.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778888999999999999954 688999999975322 234568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~ 212 (359)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999996 445789999999999999999999999 9999999999999999999999999998865443 245
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...++...+..+.+|+.+|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------KLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CcCCCccCCHHHHHHHHHH
Confidence 6899999999999888999999999999999999999998765433222221111 1123445577899999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 018244 293 LQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 293 l~~dp~~Rps-----~~~il~~ 309 (359)
|+.||.+||+ +.+++++
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcC
Confidence 9999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=328.31 Aligned_cols=255 Identities=19% Similarity=0.265 Sum_probs=204.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeC--CCCCchHHHHHHHHHHHhcCCCcccccccceeee-----CCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFN--RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE-----GDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~ 129 (359)
.|..++.||.|+||.|.+|. ..+|..||||++. .......++..+|+++|+.++|+||+.+.+.+.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 34447888999999999998 5678999999998 4455567889999999999999999999998866 34689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+|+|+|+. +|...++ .++.++...+..+++|++.||.|+|+. +++|||+||+|+|++.+..+||+|||+|+.....
T Consensus 103 iV~elMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99999954 8999885 445599999999999999999999999 9999999999999999999999999999987531
Q ss_pred ------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-------------------h
Q 018244 210 ------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------R 263 (359)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-------------------~ 263 (359)
+.++.|.+|.|||++.. ..|+.+.||||.|||+.||++|++.|++...-.... .
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 35667999999998875 459999999999999999999999988652111100 0
Q ss_pred hhhhhccccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhhc
Q 018244 264 NIQTLTDSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQKD 316 (359)
Q Consensus 264 ~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~~ 316 (359)
.....+.... .+. .-+..++.+.+|+.+||..||.+|+|++|+|++ |....+.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 0111111000 000 113567899999999999999999999999986 5555443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=341.89 Aligned_cols=246 Identities=15% Similarity=0.174 Sum_probs=206.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+.+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 356788999999999999999995 468899999997542 1234568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+.+|+|.+++. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999986 445689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.............. . ...++...+..+.+|+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----G--RLKFPNWFDGRARDLV 246 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----C--CcCCCCCCCHHHHHHH
Confidence 345689999999999988899999999999999999999999876533222211111 1 1123344567899999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 018244 290 SRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps-----~~~il~~ 309 (359)
.+||+.||.+||+ +++++.+
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999997 6777754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=341.25 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=206.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+..+...||+|.||+||+|.|.. .||||+++..... ..+.|.+|+..+++-+|.||+-+.|+|..+.. .||+.+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 34566778999999999999854 4999999876543 36679999999999999999999999988876 9999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC------C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------G 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~------~ 209 (359)
+|.+|..+++. ....++..+...|++||++|+.|||.+ +|||+|||..||++.+++.|||+|||++..... .
T Consensus 470 eGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 470 EGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred cCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 99999999975 446799999999999999999999999 999999999999999999999999999865322 1
Q ss_pred CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc---CCCChHHHH
Q 018244 210 RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE---GQFSSDEGT 283 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 283 (359)
....|...|||||+++. .+|++.+||||||+++|||+||.-|+.....+.+ +..+-...+. ......++.
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEEecccccCccchhhhccCHH
Confidence 23345678999999873 4699999999999999999999988875433322 2222111111 112356778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
++++|+..||.+++++||.+.+|+..|+.+..
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 99999999999999999999999998888766
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=333.52 Aligned_cols=248 Identities=17% Similarity=0.220 Sum_probs=202.6
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|+.++.||+|+||.||+|. ..+++.||+|.+..... .....+.+|++++..++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 4566778999999999998 45789999999875432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~ 211 (359)
+++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+|||+++++.++|+|||++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999888654455789999999999999999999999 9999999999999999999999999999875433 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..||..|+|||++.+..++.++|||||||++|+|++|+.||.................. ....++...+.++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 46789999999999889999999999999999999999998754321111111111111 1122345567889999999
Q ss_pred hcccCCCCCCC-----HHHHHHH
Q 018244 292 CLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~ 309 (359)
||+.||++||+ +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 7777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=327.05 Aligned_cols=243 Identities=19% Similarity=0.195 Sum_probs=207.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
++..+++++.||.|.-|+||++... .+..+|+|++.+..... ..+...|.++|+.++||.++.++..|+.....|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 5677889999999999999999965 46899999999765443 3356779999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC---
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~--- 207 (359)
+||||+||+|..+.++..+..+++..++.++.+|+.||+|||-. |||+|||||+||||-++|++.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999888888999999999999999999999999 99999999999999999999999999853110
Q ss_pred ---------------------------------C------------------------CCCcCCCccccCcccccCCCCC
Q 018244 208 ---------------------------------D------------------------GRSYSTNLAFTPPEYLRTGRVT 230 (359)
Q Consensus 208 ---------------------------------~------------------------~~~~~~t~~y~aPE~~~~~~~~ 230 (359)
. ....+||..|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0124678899999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 018244 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (359)
Q Consensus 231 ~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 302 (359)
.++|+|+||+++|||+.|..||.+...+....+.+. ..+.-......+..+++||+++|.+||.+|..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----CCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999988765544333322 22222223367789999999999999999987
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=340.42 Aligned_cols=237 Identities=18% Similarity=0.225 Sum_probs=200.1
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+.+|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 479999999999984 578899999997542 2234567889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCCC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYSTN 215 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~t 215 (359)
|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .....||
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999886 445789999999999999999999999 999999999999999999999999999875322 1234689
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (359)
+.|+|||++.+..++.++|||||||++|||++|..||............... ...++...+.++.+|+.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999889999999999999999999999998765443332222111 1234456678899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018244 296 EPRERP-----NPRSLVTA 309 (359)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (359)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=343.36 Aligned_cols=244 Identities=18% Similarity=0.234 Sum_probs=214.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++-+.||.|+-|.|-.|+ ..+|+.+|||++.+.. ......+.+|+-+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457778889999999999999 5689999999998652 122345789999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||+++|.|++++. .++.+++..+.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....++.
T Consensus 92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 9999999999997 677899999999999999999999999 99999999999999999999999999998877664
Q ss_pred -CcCCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
+.+|.+.|.|||++.+.+|. .++||||.|||||.||||+-||.++....+........ ...|...+.++.+|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------FEMPSNISSEAQDL 242 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------ccCCCcCCHHHHHH
Confidence 67899999999999999986 58999999999999999999999776554433322211 12457788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+|+..||++|.|+++|+.+
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHhccCccccccHHHHhhC
Confidence 999999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=335.29 Aligned_cols=251 Identities=18% Similarity=0.226 Sum_probs=204.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+|++++.||+|+||.||++.. .++..+|+|.+...... ..+.+.+|+++|+.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5678899999999999999995 46889999999765322 245689999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCc
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~ 212 (359)
+++|+|.+++. ....+++..+..++.|++.||.|||+..+++|+||||+|||++.++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 99999999986 34568999999999999999999998636999999999999999999999999998765432 345
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh--------------------------
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------------------- 266 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-------------------------- 266 (359)
.+|..|+|||++.+..++.++||||||+++|+|++|+.||..............
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 688999999999988899999999999999999999999864332221110000
Q ss_pred ----------------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 ----------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.............+.++.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000112356789999999999999999999999976
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=326.53 Aligned_cols=243 Identities=17% Similarity=0.236 Sum_probs=212.7
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++.+.||+|.||.|-+|. ...|..||||.+.++...+ .-.+.+||++|..|+||||+.++++|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468899999999999999998 5789999999998875544 345789999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||..+|.|.+|+. +.+.+++....++++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+...+
T Consensus 133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999998 567899999999999999999999999 99999999999999999999999999998877664
Q ss_pred -CcCCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
+++|++-|.+||++.+.+|. +.+|-||||++||-|+.|..||.+.....+..++..... ..+..+.++.-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-------rEP~~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-------REPETPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-------cCCCCCchHHHH
Confidence 67899999999999999875 579999999999999999999988765544333222111 123344578899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
|.+||..||++|.|+.+|..+
T Consensus 283 IRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHhcCcccchhHHHHhhh
Confidence 999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=355.88 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=214.0
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
+....++||+|+||.||+|... +...||||.++..... ...+|++|+++|..++|||||+++|+|..++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3456788999999999999842 3568999999987665 56789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcC--------CCCC----CCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEe
Q 018244 131 VAEYMPNDTLAKHLFHW--------ETQP----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~--------~~~~----l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~ 198 (359)
|+|||..|+|.++|+.+ .+.. ++..+.+.|+.|||.|+.||-++ .+|||||-..|+||.++..|||+
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEec
Confidence 99999999999999753 1223 88999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCCCCCCc------CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccc
Q 018244 199 CFGLMKNSRDGRSY------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 199 DFg~a~~~~~~~~~------~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (359)
|||+++......-+ .-..+|||||.+..++|+.++|||||||+|||++| |+.|+.+...+...+.... .
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~----g 721 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA----G 721 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc----C
Confidence 99999876543322 22468999999999999999999999999999998 5556555444333322222 1
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.+ -..|..++.++.+||..||+.+|.+||+++||-..|+..-...+
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 12 34577889999999999999999999999999999998765443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=304.63 Aligned_cols=245 Identities=21% Similarity=0.255 Sum_probs=213.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
++++-+.||.|-||.||.|+ .+++..||+|++.+++.. -..++.+|+++-..|+||||++++++|.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 44566777999999999999 667889999999865422 24578999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC--CCCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRS 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~--~~~~ 211 (359)
|..+|+|...|.......+++...+.++.|+|.||.|+|.+ +++||||||+|+|++..+.+|++|||.+-... ....
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~t 181 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKT 181 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCcee
Confidence 99999999999876677899999999999999999999999 99999999999999999999999999876654 3356
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.+||..|.|||...+..++..+|+|++|++.||++.|.+||.....+........ ....+|...+.++.++|.+
T Consensus 182 lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 182 LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------VDLKFPSTISGGAADLISR 255 (281)
T ss_pred eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------ccccCCcccChhHHHHHHH
Confidence 7899999999999999999999999999999999999999987664443333222 1233557788899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
|+.++|.+|.+..+++++
T Consensus 256 ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDH 273 (281)
T ss_pred HhccCccccccHHHHhhh
Confidence 999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=338.26 Aligned_cols=246 Identities=17% Similarity=0.199 Sum_probs=205.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-C-CcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-N-QFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
.+.+|.+++.||+|+||.||+|... . +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4557888999999999999999843 3 3689999986432 223456888999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+.+|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999996 345689999999999999999999999 9999999999999999999999999999875433
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....||+.|+|||++.+..++.++|||||||++|+|++|..||................ ..++...+..+.++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------IYFPKFLDNNCKHL 258 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHH
Confidence 34568999999999998889999999999999999999999987654332222221111 12345566789999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHH
Q 018244 289 ASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
+.+||+.||++|+ |+++++++
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999995 88888765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=333.98 Aligned_cols=236 Identities=18% Similarity=0.203 Sum_probs=197.2
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 59999999999995 468899999987532 23345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCCc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t~ 216 (359)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++..... ....||+
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99986 345689999999999999999999999 9999999999999999999999999998754222 2346899
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
.|+|||++.+..++.++|||||||++|+|++|..||............... ...++...+.++.+++.+||+.|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------CCCCCCcCCHHHHHHHHHHcCCC
Confidence 999999999888999999999999999999999998765443332222111 12234556788999999999999
Q ss_pred CCCCCC---HHHHHHH
Q 018244 297 PRERPN---PRSLVTA 309 (359)
Q Consensus 297 p~~Rps---~~~il~~ 309 (359)
|++||+ +.+++.+
T Consensus 232 p~~R~~~~~~~e~l~h 247 (312)
T cd05585 232 PTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCCCHHHHHcC
Confidence 999985 5565543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=328.17 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=199.3
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-----------------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~ 118 (359)
.+|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ....+.+|++++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 367788889999999999997532 346999999865333 34568999999999999999999
Q ss_pred cceeeeCCcceEEEecCCCCCHhhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 018244 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE-----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (359)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~D 181 (359)
++++...+..++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||+. +++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~d 163 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRD 163 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccC
Confidence 999999999999999999999999885421 12468889999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhC--CCCCC
Q 018244 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG--KHIPP 253 (359)
Q Consensus 182 ikp~NIll~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg--~~p~~ 253 (359)
|||+|||++.++.+||+|||+++...... ...++..|+|||++.++.++.++||||||+++|+|+++ ..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999987653322 22346789999999888899999999999999999875 34444
Q ss_pred cchhHHHhhhhhhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 254 SHALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 254 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
................. .......+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 32222211111110000 01111123455678999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.99 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=205.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...|++.+.||+|+||.||+|.+. .+..||+|.++..... ....+.+|+..++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346778888999999999999743 3668999999865332 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 84 VTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999864 345789999999999999999999999 99999999999999999999999999876543221
Q ss_pred -----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
...++..|+|||.+.+..++.++||||||+++||+++ |..||............. .......+...+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 236 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-----DGFRLPAPRNCPNL 236 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----CCCCCCCCCCCCHH
Confidence 1234568999999998899999999999999999775 888876543322221111 11112234556778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+.+++.+||+.+|++|||+.++++.|.++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=335.88 Aligned_cols=249 Identities=17% Similarity=0.159 Sum_probs=205.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|.+++.||+|+||.||+|... ++..||+|++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778889999999999999954 58899999997542 2234568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-CCCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~-~~~~ 212 (359)
|+++|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999996 445789999999999999999999999 999999999999999999999999999886544 2345
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh--hhccccccCCCChHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--TLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ...............+.++.+++.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 689999999999988999999999999999999999999876543332211111 000000000001245778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||..+|++|||+.+++++
T Consensus 239 ~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhhChhhhcCCHHHHHhC
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.79 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=211.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+|.+++.||.|+||.||+|...++..+|+|.+..........+.+|+++++.++|+||+++++++......++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 57788889999999999999877889999999877655567889999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----CcC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYS 213 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~~~ 213 (359)
++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||.+....... ...
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 165 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence 9999999765566789999999999999999999999 99999999999999999999999999987654332 223
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
++..|+|||.+.+..++.++||||||+++|+|++ |..|+............. .......+...+..+.+++.+|
T Consensus 166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHHHHHH
Confidence 4568999999988889999999999999999998 777775543222221111 1112223455678899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHh
Q 018244 293 LQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~ 313 (359)
|+.||++|||+.++++.|+.+
T Consensus 241 l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 241 WAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=334.53 Aligned_cols=237 Identities=18% Similarity=0.233 Sum_probs=199.2
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||++.. .++..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 469999999999984 568899999997542 2234567889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t 215 (359)
|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....||
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 998886 445789999999999999999999999 9999999999999999999999999998753221 234689
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (359)
+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ....++...+.++.+|+.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CCccCCCCCCHHHHHHHHHHcCC
Confidence 999999999988899999999999999999999999876543332221111 11123455678899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018244 296 EPRERP-----NPRSLVTA 309 (359)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (359)
||++|+ ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.53 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=209.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..+|+++++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678999999999999999998778889999987543 23567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 999999999765556789999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...++..|+|||.+.+..++.++||||||+++|+|+| |..||............... .........+.++.+++
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 237 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENCPDELYDIM 237 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHH
Confidence 2234567999999998889999999999999999998 88777654332222221111 11112234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+||..+|++|||++++++.|+.+
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=337.77 Aligned_cols=245 Identities=21% Similarity=0.325 Sum_probs=209.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|....-++-||.|+-|.||.|++.+. .||||+++.-. ..+|+-|++|+|+||+.+.|+|.....+|||||||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HHHhhhhhhhccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 33334456679999999999998654 69999886422 34789999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCc
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~ 212 (359)
..|.|...|+ .++.++......|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++...+. -.+
T Consensus 195 a~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 9999999997 677899999999999999999999999 9999999999999999999999999998876544 356
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.||..|||||++...+.++|+|||||||||||||||..|+.+-... .++..+-...+....|..+++.++-|+++|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqc 347 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQC 347 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHH
Confidence 8999999999999999999999999999999999999887644322 223333333344455678889999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhh
Q 018244 293 LQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~~~ 315 (359)
|+..|..||++.+|+.+|.-...
T Consensus 348 w~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 348 WNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HhcCCCCCccHHHHHHHHhhcCH
Confidence 99999999999999999886543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.88 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=201.2
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
+|++.+.||+|+||.||+|++ .++..||||++.... ....+.+.+|+++|..+ +||||+++++++...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 567788899999999999973 235689999997543 23345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC-------------------------------------------------------------
Q 018244 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (359)
+||||+++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999986421
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-----
Q 018244 149 ------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----- 211 (359)
Q Consensus 149 ------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~----- 211 (359)
...+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++.......
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 12478899999999999999999999 999999999999999999999999999876543321
Q ss_pred -cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ...........+...+.++.+|+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY----KMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH----HHHHhCccCCCCCCCCHHHHHHH
Confidence 223467999999998899999999999999999998 776665432221111 11111111112233457899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+||+.||++|||+.++++.|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=333.72 Aligned_cols=237 Identities=18% Similarity=0.239 Sum_probs=198.2
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||++.. .+|..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 479999999999984 568899999997542 2234567789999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t 215 (359)
|..++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...... ....||
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 998886 445789999999999999999999999 9999999999999999999999999998753221 234688
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (359)
+.|+|||++.+..++.++|||||||++|+|++|+.||.............. . ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~----~--~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----E--EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc----C--CCCCCCCCCHHHHHHHHHHccC
Confidence 999999999988999999999999999999999998865543322222111 1 1123455678899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018244 296 EPRERP-----NPRSLVTA 309 (359)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (359)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=302.08 Aligned_cols=255 Identities=19% Similarity=0.196 Sum_probs=210.1
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cc
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ER 128 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 128 (359)
|-++|++.+.||.|||+.||.++ ..++..+|+|++..+...+.+..++|++..++++|||+++++++..... ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 44689999999999999999999 7788999999999888788889999999999999999999999886554 48
Q ss_pred eEEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
||++.|...|||.+.+... ++..+++.+++.|+.+|++||.+||.. . ..||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999754 456899999999999999999999998 6 9999999999999999999999999987
Q ss_pred cCCCC---C----------CcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-h
Q 018244 205 NSRDG---R----------SYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-T 267 (359)
Q Consensus 205 ~~~~~---~----------~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-~ 267 (359)
...-. + ...-|..|+|||.+.- ...++++|||||||+||.|+.|..||..... ..+.+. .
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLA 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALA 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEe
Confidence 54321 1 1234789999999873 4578999999999999999999998853311 111111 1
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+......-......++.+.+++++|++.||.+||++.+++..+..+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111111234788999999999999999999999999988765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.85 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=198.9
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+|.+++.||+|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5778888999999999999964 678899999875432 2245678999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----- 209 (359)
++++.+..+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99876665443 345689999999999999999999999 9999999999999999999999999998865432
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh--------------------hhc
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLT 269 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--------------------~~~ 269 (359)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||+............. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 234578999999999988899999999999999999999998875432111000000 000
Q ss_pred ccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+... .......+.++.+|+.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 00112256789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=323.02 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=205.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCC------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
.++++++.||+|+||.||+|.... ...||+|.+...... ....+.+|++++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998532 257999998755432 2456889999999999999999999999888999
Q ss_pred EEEecCCCCCHhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~ 195 (359)
++|||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcE
Confidence 99999999999999864311 4578999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhh
Q 018244 196 RLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (359)
Q Consensus 196 kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 268 (359)
+|+|||++...... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.............
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~--- 240 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR--- 240 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence 99999998764322 22345678999999988889999999999999999998 888876544332222111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
.......+...+.++.+|+.+||+.||++|||+.++++.|+.
T Consensus 241 --~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 --SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111122345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=317.42 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=203.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+++.+++.||+|+||.||++.+.++..+|+|.+.... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35677888999999999999998888889999987543 23467889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 82 ENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999864 234689999999999999999999999 99999999999999999999999999987643322
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...++..|+|||.+.+..++.++||||||+++|+|++ |+.||............... .....+...+..+.+++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li 234 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVM 234 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHH
Confidence 1233567999999998889999999999999999999 78777554322222111111 11112333456899999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L 310 (359)
.+||+.||++|||+.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=338.06 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=202.7
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
+|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.+ +|+||+++++++......+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 5678888999999999999731 2457999999765332 345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC-------------------------------------------------------------
Q 018244 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (359)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999885321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------CcCCC
Q 018244 149 -------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTN 215 (359)
Q Consensus 149 -------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------~~~~t 215 (359)
...+++..+.+++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...... ...++
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 12478889999999999999999999 99999999999999999999999999987654322 12234
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
..|+|||++.+..++.++||||||+++|+|++ |..||+....... .............+...+.++.+++.+||+
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 67999999988889999999999999999997 8888765432211 111111111222233456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 018244 295 YEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 295 ~dp~~Rps~~~il~~L~~~ 313 (359)
.||++|||+.++++.|+++
T Consensus 354 ~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 354 LEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CChhhCcCHHHHHHHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=318.60 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=208.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.++.+.+.||.|+||.||+|.. +.+..||+|.+.... .....+.+|+++++.++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4567778889999999999985 458899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---- 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~---- 211 (359)
++++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 999999999765556789999999999999999999999 999999999999999999999999999876544321
Q ss_pred -cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+..|+|||.+.+..++.++||||||+++|+|++ |..|++............ .......+...+.++.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----KGYRMERPEGCPPKVYELM 238 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----CCCCCCCCCCCCHHHHHHH
Confidence 123567999999998889999999999999999998 888876654333222211 1112233445678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+||+.||++|||+.++++.|+.+
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.93 Aligned_cols=252 Identities=17% Similarity=0.236 Sum_probs=200.3
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
...+|.+++.||.|+||.||+|.. .++..||+|.+...... ....+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 346788999999999999999985 46889999999754322 2446788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++ +|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 89988864 344678999999999999999999999 9999999999999999999999999998764322
Q ss_pred -CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-------------------
Q 018244 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL------------------- 268 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~------------------- 268 (359)
....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||................
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 23456889999999875 458999999999999999999999887653322211111000
Q ss_pred -ccccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 -TDSCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 -~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..+.... ......+.++.+|+.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0012245788999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=329.67 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=201.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+|++++.||.|+||.||+|... ++..+|+|.+...... ....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 46788899999999999999954 6888999988765322 245688999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCc
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~ 212 (359)
+++|+|.+++. ....+++..+..++.|++.||.|||+..+++|+||||+|||++.++.+||+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 99999999986 34568999999999999999999997537999999999999999999999999998754332 345
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh----------------------------
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---------------------------- 264 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~---------------------------- 264 (359)
.++..|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 6889999999999888999999999999999999999988654322111000
Q ss_pred -----------hhhhccccccCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 -----------IQTLTDSCLEGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 -----------~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
............. ....+.++.+|+.+||+.||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000000 11245679999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.64 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=203.0
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcc-cccccceeeeCC-----
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRR-LANLLGCCCEGD----- 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 126 (359)
...|..+++||+|+||+||+|+ ..+|+.||+|++...... ......+|+.+|+.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456778888999999999999 567899999999876542 2345689999999999999 999999998877
Q ss_pred -cceEEEecCCCCCHhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 127 -ERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
.+++|+||++. +|..++..... ..++...+..+++||+.||+|||++ +|+||||||.||||+++|.+||+|||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchH
Confidence 78999999976 89999975432 4678899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC----CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc----
Q 018244 204 KNSRDG----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE---- 274 (359)
Q Consensus 204 ~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 274 (359)
+...-. ....+|.+|+|||++.+. .|+...||||+|||+.||++++..|++...-.........+-.+...
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 976522 345679999999999987 59999999999999999999999888764322221111111111000
Q ss_pred --------CCC-----C-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 --------GQF-----S-------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 --------~~~-----~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..+ + +....+..+++.+||+.+|.+|.|++.++.+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 0 1122488999999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.15 Aligned_cols=246 Identities=17% Similarity=0.172 Sum_probs=197.5
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+.+|..++.||.|+||.||+|.. .+++.||||++...... ....+.+|+++++.++|+||+++++++...+.+++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 466788889999999999999985 46889999999754332 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++|+|.+.. ..++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999999886533 356788899999999999999999 9999999999999999999999999998765432
Q ss_pred -CCcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
....||..|+|||++.. ...+.++|||||||++|||++|+.||.......+...... . ........+...+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~ 302 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA-I-CMSQPPEAPATASR 302 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-H-hccCCCCCCCccCH
Confidence 34568999999998753 2245689999999999999999998863321111110000 0 00111223345677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+|+.+||+.||++|||+.+++++
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.41 Aligned_cols=247 Identities=18% Similarity=0.198 Sum_probs=205.6
Q ss_pred CcccccccCCCCCCcEEEEEEeC-C-CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-N-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 45888899999999999999843 3 678999987665544456678899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999987542 345689999999999999999999999 9999999999999999999999999999865432
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ....+...+.++.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~ 300 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-----YDPFPCPVSSGMK 300 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCCccCCHHHH
Confidence 23458999999999998889999999999999999999999987654332222221111 1122345667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+||..||++|||+.+++..
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhC
Confidence 99999999999999999998753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=309.51 Aligned_cols=247 Identities=20% Similarity=0.231 Sum_probs=212.0
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|.+-+.||+|+|+.||++. ..+|+.+|+|.++.. ...+.+++.+|+.+-+.|+||||+++.+.+......|||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 35666778999999999998 557888999988743 223577899999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCCCC-
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~~~- 210 (359)
+.|+.|..-+-. ...+++..+..+++||+.||.|+|.+ +|||||+||+|+++.. ..-+||+|||+|.....+.
T Consensus 92 m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 92 VTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 999999877753 35678999999999999999999999 9999999999999953 3459999999999887554
Q ss_pred --CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...||++|||||++...+|+..+|||+.|||||-|+.|..||.++....+.+++.....+ ..+...+..++++++|
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd--~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD--YPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC--CCCcccCcCCHHHHHH
Confidence 356899999999999999999999999999999999999999987766666665554333 2233446778999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||..||.+|.|+.|+|++
T Consensus 247 vrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHhccChhhhccHHHHhCC
Confidence 999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=325.85 Aligned_cols=250 Identities=18% Similarity=0.197 Sum_probs=195.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+|.+++.||.|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 56888999999999999999954 6889999999754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+. ++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 96 578887754 345689999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHH-Hhhhhhhhhc-----------------cc
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLT-----------------DS 271 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-----------------~~ 271 (359)
...+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... .......... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 34568899999998754 57889999999999999999999987531110 0000000000 00
Q ss_pred cccCCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+ ...+.++.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000 0123578899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=337.82 Aligned_cols=246 Identities=15% Similarity=0.133 Sum_probs=200.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||.|+||+||+|.. .+++.||||++.... ......+.+|+.+|..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 577888899999999999995 468899999997532 1234557889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+.+|+|.+++. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999986 345689999999999999999999999 99999999999999999999999999986532110
Q ss_pred ---------------------------------------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 018244 211 ---------------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251 (359)
Q Consensus 211 ---------------------------------------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p 251 (359)
...||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 23589999999999988899999999999999999999999
Q ss_pred CCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 018244 252 PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (359)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (359)
|.............. .. ...........++++.+|+.+|+. +|.+|++ +.+++++
T Consensus 239 f~~~~~~~~~~~i~~-~~-~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIIN-WK-ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHc-CC-CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 876543222211111 00 001111112356789999999996 9999997 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=335.44 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=212.8
Q ss_pred ccccCCCCCCcEEEEEEeCC--C---cEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 61 IVSEHGEKAPNVVYKGKLEN--Q---FRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+.++||+|+||.||+|++.. + ..||||...... .....++.+|.++|+.++|||||+++|++.....++|||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 44788999999999998532 2 238999998532 344678999999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~- 211 (359)
|+|.||+|.++|+. ....++..++..++.+.|.||+|||++ +++||||-..|+|++.++.+||+|||+++.......
T Consensus 241 El~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred EecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence 99999999999975 333799999999999999999999999 999999999999999999999999999887652221
Q ss_pred ---cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 212 ---~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
..-...|+|||.+..+.|+.++|||||||++||+++ |..|+++........... ....+...+...+.++..
T Consensus 319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~----~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV----KNGYRMPIPSKTPKELAK 394 (474)
T ss_pred cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH----hcCccCCCCCCCHHHHHH
Confidence 123468999999999999999999999999999999 777777765544433331 222333445677889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 288 LASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
++.+||..||++||||.++.+.|+.+.......
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999998766643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.32 Aligned_cols=246 Identities=20% Similarity=0.202 Sum_probs=204.1
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||+|+||+||+|... ++..||+|++.... ......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5778889999999999999954 68899999997542 1334568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999974 36799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ------------------------------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH
Q 018244 211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (359)
Q Consensus 211 ------------------------------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~ 260 (359)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 34578999999999999999999999999999999999999876543322
Q ss_pred hhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 018244 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN-PRSLVTA 309 (359)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~il~~ 309 (359)
...... .. ...........++++.+|+.+||. ||.+||+ +.+++++
T Consensus 239 ~~~i~~-~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIIN-WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhc-cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 221111 00 111111112257889999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=329.41 Aligned_cols=241 Identities=19% Similarity=0.286 Sum_probs=197.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHH---hcCCCcccccccceeeeCCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAV---GQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
|++++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788899999999999984 468899999997532 12234566666554 566899999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC---
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--- 208 (359)
|||+++++|..++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998873 45799999999999999999999999 999999999999999999999999999875322
Q ss_pred -CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 209 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ 230 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSREAIS 230 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence 22456889999999999888999999999999999999999998765433322221111 11234456788999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 018244 288 LASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
++.+||+.||++|| ++.+++++
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.23 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=193.8
Q ss_pred cccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cceEEEe
Q 018244 60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLLVAE 133 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e 133 (359)
.-.+.+|.|+||.||+|.. .+++.||||++..+.. .-.+|+++|+.++|||||++.-+|.... ...+|||
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 3445569999999999994 4578999999976542 2346999999999999999988886432 4568999
Q ss_pred cCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCCCCC
Q 018244 134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~~~~ 210 (359)
|++. +|.++++.. .+..++.-.+.-+++||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 9987 899998642 356788888999999999999999998 99999999999999965 999999999999876655
Q ss_pred ---CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh------------------
Q 018244 211 ---SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL------------------ 268 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~------------------ 268 (359)
++.-|.-|+|||.+.+.. |+.+.||||.||++.||+-|++.|+++............+
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 445588999999999865 9999999999999999999999998763322211111110
Q ss_pred -----ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 -----TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 -----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+...+....++++.+|+.++|.++|.+|.++.+++.+
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00000011334567899999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=319.04 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=205.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.+++.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++|+.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 35778888999999999999853 2478999999865544 3567899999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEE
Q 018244 130 LVAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl 197 (359)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEE
Confidence 9999999999999996431 24578999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcc
Q 018244 198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 198 ~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 270 (359)
+|||++...... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||..............
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~---- 239 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ---- 239 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----
Confidence 999998754321 22334678999999998899999999999999999998 8888765433322222111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
......+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 -GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111223446678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=328.33 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=197.3
Q ss_pred ccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCC----CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+.||+|+||.||++.. .++..||+|++.... ......+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5679999999999984 357889999987532 12234577899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+++++|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999986 345688899999999999999999999 9999999999999999999999999998753222 2
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .. ....+...+.++.+++.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL----KG--KLNLPPYLTPEARDLLK 232 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH----cC--CCCCCCCCCHHHHHHHH
Confidence 3468899999999998889999999999999999999999987654332222111 11 11234456778999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 018244 291 RCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~il~~ 309 (359)
+||+.||++|| ++.+++++
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcC
Confidence 99999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=315.29 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=203.7
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.+|.+++.||+|+||+||+|...++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999998777779999987544 234678999999999999999999999998889999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++...... .
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 99999998642 33689999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .....+...+..+.+++.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPHLASEKVYAIMY 235 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCCCCCHHHHHHHH
Confidence 224567999999998889999999999999999998 88776544332222222111 111123335678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~ 311 (359)
+||+.||++|||+.+++..|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=323.12 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=204.4
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCc----EEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||.||+|.+. ++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46788888999999999999853 333 489999875432 3356788999999999999999999998764 6789
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 86 v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 86 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999974 345688999999999999999999999 99999999999999999999999999998765332
Q ss_pred C------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
. ..++..|+|||.+.+..++.++||||||+++|||++ |..|+.......... ..........+..++.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTI 238 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhCCCCCCCCCCCCH
Confidence 1 123567999999998899999999999999999998 887776543322211 1111111122344567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
++.+++.+||..||++|||+.+++..|..+.++.
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 8999999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=323.31 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=195.3
Q ss_pred ccccCCCCCCcEEEEEEeC-----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 61 IVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+.+.||.|+||.||+|.+. .+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567899999999999965 3678999999764333 367899999999999999999999999988889999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----- 209 (359)
+++|+|.+++.......+++..+..|+.|++.||.|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999875567899999999999999999999999 9999999999999999999999999998876322
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
........|+|||.+.+..++.++||||||+++|||++ |+.|+............ ........+..++..+.+
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-----KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-----HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccceeccchhHHHHH
Confidence 22335678999999998889999999999999999999 56666544322222111 111222334556778999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~L 310 (359)
++.+||+.||++|||+.++++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.66 Aligned_cols=237 Identities=19% Similarity=0.244 Sum_probs=198.0
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||++.. .++..||+|.+.... ......+.+|++++..++||||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 479999999999984 578899999997532 2234567889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~ 214 (359)
|..++. ....+++..+..++.||+.||.|||+ . +++||||||+|||++.++.+||+|||+++..... ....|
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999886 44578999999999999999999997 6 9999999999999999999999999998753221 23468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----E--EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----C--CCCCCCCCCHHHHHHHHHHhh
Confidence 9999999999988899999999999999999999999876543332222111 1 112344567789999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 018244 295 YEPRERP-----NPRSLVTA 309 (359)
Q Consensus 295 ~dp~~Rp-----s~~~il~~ 309 (359)
.||++|+ ++.+++++
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=334.47 Aligned_cols=246 Identities=13% Similarity=0.082 Sum_probs=197.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|++++.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++..++|+||+++++.+.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 567888899999999999984 468899999997532 1223567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999996 446799999999999999999999999 9999999999999999999999999998753211
Q ss_pred -----------------------------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 018244 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (359)
Q Consensus 210 -----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~ 254 (359)
....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 124689999999999988999999999999999999999999876
Q ss_pred chhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 018244 255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR---ERPNPRSLVTA 309 (359)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~---~Rps~~~il~~ 309 (359)
................ .........+.++.+++.+++. +|. .||++++++++
T Consensus 239 ~~~~~~~~~i~~~~~~--~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKET--LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCc--ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 5433322221110000 0000112356788899988664 444 45899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.54 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=206.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..+++.+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3567888899999999999997777889999997654 235678899999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--CcCC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--SYST 214 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--~~~~ 214 (359)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||+++...... ...+
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 99999999754445789999999999999999999999 99999999999999999999999999988654322 1122
Q ss_pred ---CccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 215 ---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 215 ---t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
+..|+|||.+.+..++.++||||||+++|+|++ |+.||.............. ......+...+..+.+++.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-----GYRMPCPPGCPKELYDIML 238 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCCcCCHHHHHHHH
Confidence 357999999998889999999999999999999 8877765433222211111 1111223456678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+||+.+|++||++.+++..|+.
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=336.61 Aligned_cols=247 Identities=17% Similarity=0.160 Sum_probs=198.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|.+++.||+|+||+||+|. ..++..||+|++.... ......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 56788899999999999998 4568899999997543 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----- 208 (359)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999986 345689999999999999999999999 999999999999999999999999998753210
Q ss_pred ----------------------------------------------CCCcCCCccccCcccccCCCCCCccchhhHHHHH
Q 018244 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (359)
Q Consensus 209 ----------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 242 (359)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0124688999999999988899999999999999
Q ss_pred HHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh--cccCCCCCCCHHHHHHH
Q 018244 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC--LQYEPRERPNPRSLVTA 309 (359)
Q Consensus 243 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dp~~Rps~~~il~~ 309 (359)
|||++|..||.............. . ............+.++.+|+.+| +..++..||++.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN-W-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc-c-ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999876433222111111 0 00011111123567899999884 45566669999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=319.42 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=207.4
Q ss_pred CcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
..|.+.+.+|.|+||.||++.. .++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3567778889999999999974 2356799999986654556678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEec
Q 018244 131 VAEYMPNDTLAKHLFHWE-----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~D 199 (359)
||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEecc
Confidence 999999999999986321 23589999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccc
Q 018244 200 FGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (359)
Q Consensus 200 Fg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (359)
||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~---- 239 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR---- 239 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 99987653321 2234668999999998889999999999999999998 777765543322222211111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
....+...+.++.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 240 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 -VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1112234567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=321.73 Aligned_cols=248 Identities=17% Similarity=0.212 Sum_probs=203.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|++++.||+|+||+||++.. .++..||+|.+...... ....+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 56777889999999999985 46889999999754322 234567899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---~ 211 (359)
+.+|+|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999999888654445789999999999999999999999 99999999999999999999999999988754332 3
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..|+..|+|||++.+..++.++||||+|+++|+|++|..||...............+.. ....++...+..+.+|+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHH
Confidence 46789999999999888999999999999999999999998764332211111111111 1122344567789999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 018244 292 CLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rp-----s~~~il~~ 309 (359)
||+.||++|| ++++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=320.89 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=194.0
Q ss_pred cccccccCCCCCCcEEEEEEe-C-CCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcC---CCcccccccceeee-----C
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-E-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----G 125 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 125 (359)
.|++++.||+|+||.||+|.. . ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577888999999999999985 3 4678999998754322 233556777777665 69999999998852 4
Q ss_pred CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
...++||||++ ++|.+++.......+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 56899999996 5899998765556789999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc-------------
Q 018244 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------- 269 (359)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------- 269 (359)
.... ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 5433 234578999999999888899999999999999999999988865432211111110000
Q ss_pred -ccccc--C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 270 -DSCLE--G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 270 -~~~~~--~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..... . ......+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0 011234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.38 Aligned_cols=247 Identities=19% Similarity=0.173 Sum_probs=212.0
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP---DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+.+.||.|.||.||+++.+ +|..+|+|.+.+.... ..+.+.+|+++|+.+. |||||.+++.|.+...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 35677788999999999999954 5999999999876443 3467899999999998 99999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC----CCeEEeccCCcccCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSR 207 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~----~~~kl~DFg~a~~~~ 207 (359)
||++.||.|.+.+... .+++..+..++.|++.|++|||+. |++||||||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999764 499999999999999999999999 99999999999999633 579999999999877
Q ss_pred CC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
.+ ....||+.|+|||++....|+..+||||+|+++|.|++|.+||...............-. ..........+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence 63 356899999999999999999999999999999999999999988765444332222111 1222334567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++..|+..||.+|+|+.++|++
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=328.19 Aligned_cols=237 Identities=19% Similarity=0.230 Sum_probs=196.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCC-cccccccceeeeCCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 132 (359)
+|.+++.||+|+||.||+|.. .+++.||+|++.... ....+.+..|.+++..+.| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467888999999999999985 457889999997532 2334567889999999976 46888999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---- 208 (359)
||+++|+|.+++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999886 345689999999999999999999999 999999999999999999999999999874321
Q ss_pred CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
.....||+.|+|||++.+..++.++||||||+++|+|+||+.||.............. ....++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l 231 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSLSKEAVSI 231 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCCCHHHHHH
Confidence 1234689999999999988899999999999999999999999876543332222211 1122345567789999
Q ss_pred HHHhcccCCCCCCCH
Q 018244 289 ASRCLQYEPRERPNP 303 (359)
Q Consensus 289 i~~cl~~dp~~Rps~ 303 (359)
+.+||..||.+|++.
T Consensus 232 i~~~l~~~P~~R~~~ 246 (324)
T cd05587 232 CKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHhhcCHHHcCCC
Confidence 999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=327.27 Aligned_cols=231 Identities=20% Similarity=0.257 Sum_probs=193.0
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.. .++..||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 479999999999995 468899999987532 22345677888888877 6999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999886 445789999999999999999999999 999999999999999999999999999875322 123468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999888999999999999999999999998765443332222211 112334467789999999999
Q ss_pred cCCCCCCCH
Q 018244 295 YEPRERPNP 303 (359)
Q Consensus 295 ~dp~~Rps~ 303 (359)
.||++||++
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=318.52 Aligned_cols=245 Identities=16% Similarity=0.202 Sum_probs=196.8
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||+|+||.||++.. .+|..+|+|.+..... .....+..|+++++.++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 59999999999984 4688999999975321 1233456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---CcCCCcc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYSTNLA 217 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---~~~~t~~ 217 (359)
.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....... ...++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 9988655556789999999999999999999999 99999999999999999999999999987654432 3457889
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (359)
|+|||++.+..++.++|||||||++|+|++|..||...................... ......+.++.+|+.+||+.||
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence 999999998889999999999999999999999886532211111111111111111 1112456789999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 018244 298 RERPNPRSLVTALV 311 (359)
Q Consensus 298 ~~Rps~~~il~~L~ 311 (359)
++||++.++++.+.
T Consensus 239 ~~R~~~~~~~~~~~ 252 (277)
T cd05607 239 EDRLGSREKNDDPR 252 (277)
T ss_pred hhCCCCccchhhhh
Confidence 99999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=317.46 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=203.6
Q ss_pred CCcccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
++++++.+.||+|+||.||+|.. ..+..+|+|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45678889999999999999984 24678999999754332 3456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWE---------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~ 194 (359)
++|||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCc
Confidence 9999999999999985321 23578999999999999999999999 9999999999999999999
Q ss_pred eEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhh
Q 018244 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 267 (359)
+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK- 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999998765332 22334567999999988889999999999999999998 7777755432222111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
......+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 242 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 ----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112334556789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=304.46 Aligned_cols=252 Identities=19% Similarity=0.202 Sum_probs=206.9
Q ss_pred hcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC----ch----HHHHHHHHHHHhcCC-Cccccccccee
Q 018244 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW----PD----ARQFLEEARAVGQLR-NRRLANLLGCC 122 (359)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~----~~~~~~e~~~l~~l~-h~niv~~~~~~ 122 (359)
...|..|.-.+.+|.|..++|-++. ..+|..+|+|++..... +. .+.-.+|+.+|+++. ||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445566666667999999999987 55788899999874321 11 234567999999995 99999999999
Q ss_pred eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
..+..+++|+|.|+.|.|.+++. ..-.+++....+|++|+..|+.|||.+ +||||||||+|||+|++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999996 667899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC---CcCCCccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc
Q 018244 203 MKNSRDGR---SYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 203 a~~~~~~~---~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
++...++. ..+||++|.|||.+.. ..|+..+|+||+|||+|-|+.|.+||.....-.+........ -..
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk--yqF 247 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK--YQF 247 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc--ccc
Confidence 99988775 5689999999998763 358889999999999999999998876543222221111111 111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+.+.+.++||.+||+.||.+|.|++|+|.+
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222335678899999999999999999999999975
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=318.26 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=207.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45677788999999999999742 355799999886665556678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeE
Q 018244 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~k 196 (359)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||++++++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEE
Confidence 999999999999986422 23489999999999999999999999 999999999999999999999
Q ss_pred EeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhc
Q 018244 197 LSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLT 269 (359)
Q Consensus 197 l~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 269 (359)
|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|+| |..|+.........+....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--- 240 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC---
Confidence 9999998754332 22345678999999998889999999999999999999 8887655433222221111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
......+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 241 --~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 241 --GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11112233456789999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=333.22 Aligned_cols=248 Identities=16% Similarity=0.139 Sum_probs=203.6
Q ss_pred cCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
....+|.+++.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4556788999999999999999985 468899999996432 123345778999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999884 34588999999999999999999999 9999999999999999999999999998765432
Q ss_pred -----CCcCCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC--
Q 018244 210 -----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-- 278 (359)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 278 (359)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||............. .......++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~ 271 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----DHKNSLTFPDD 271 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH----cCCCcCCCCCc
Confidence 234689999999998753 37889999999999999999999987654432222211 111111122
Q ss_pred hHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
...+.++.+|+.+||+.+|++ |+|+.+++++
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 245788999999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=319.08 Aligned_cols=242 Identities=19% Similarity=0.247 Sum_probs=195.7
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||+|+||+||++.. .+++.+|+|.+...... ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 59999999999984 46889999998754322 234567899999999999999999999999999999999999999
Q ss_pred hhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----CcCC
Q 018244 141 AKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST 214 (359)
Q Consensus 141 ~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~~~~ 214 (359)
.+++... ....+++..+..++.||+.||.|||++ +++||||||+||++++++.++|+|||++....... ...|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 8877432 345689999999999999999999999 99999999999999999999999999987654332 3467
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||.+.+..++.++||||||+++|+|++|+.||................... ....+...+.++.+++.+||+
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999886542211111111111111 112344567889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 018244 295 YEPRERP-----NPRSLVTA 309 (359)
Q Consensus 295 ~dp~~Rp-----s~~~il~~ 309 (359)
.||++|| ++++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcC
Confidence 9999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=335.06 Aligned_cols=246 Identities=16% Similarity=0.112 Sum_probs=198.0
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||.|+||+||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 56788889999999999998 4578899999986532 1224567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999986 345689999999999999999999999 9999999999999999999999999998632110
Q ss_pred -----------------------------------------------CCcCCCccccCcccccCCCCCCccchhhHHHHH
Q 018244 210 -----------------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (359)
Q Consensus 210 -----------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 242 (359)
....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 023588999999999988899999999999999
Q ss_pred HHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 018244 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER---PNPRSLVTA 309 (359)
Q Consensus 243 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~il~~ 309 (359)
|||++|..||.............. ... ..........+.++.+|+.+||. +|.+| +|+.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~-~~~-~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIIN-WRE-TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHc-cCC-ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999865433222111111 000 01101112356789999999997 77765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.52 Aligned_cols=246 Identities=17% Similarity=0.157 Sum_probs=197.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|.+++.||+|+||+||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467888999999999999984 5688999999975421 224568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----- 208 (359)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999863 45689999999999999999999999 999999999999999999999999999753210
Q ss_pred ----------------------------------------------CCCcCCCccccCcccccCCCCCCccchhhHHHHH
Q 018244 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (359)
Q Consensus 209 ----------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 242 (359)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0123578999999999988999999999999999
Q ss_pred HHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 018244 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (359)
Q Consensus 243 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (359)
|||++|+.||............... ............++++.+++.+|+ .+|++|++ +.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999998765332221111110 011111112345678899998876 59999987 8877754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=341.54 Aligned_cols=252 Identities=17% Similarity=0.152 Sum_probs=210.1
Q ss_pred CcccccccCCCCCCcEEEEEEeCCC-cEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccce-eeeC------Cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGC-CCEG------DE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~------~~ 127 (359)
....+.+.|.+|||+.||.|....+ ..+|+|++...+....+.+.+||++|+.|+ |+|||.+++. .... -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3556778889999999999996554 899999999888788888999999999997 9999999993 3221 25
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
++|.||||.||+|-+++..+....|++.++++|++|+++|+++||.. ..|||||||-+||||..+|..||||||.|...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 78999999999999999877677799999999999999999999987 34999999999999999999999999998643
Q ss_pred CCC--C-----------CcCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc
Q 018244 207 RDG--R-----------SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 207 ~~~--~-----------~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 270 (359)
-.. . ...+|+.|+|||++. +...++|+|||||||+||-|+....||.....-.+.....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y----- 271 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY----- 271 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc-----
Confidence 211 1 124689999999875 5679999999999999999999999997663322222222
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.-...+..+..+.+||..||+.||++||++-+++..+-.+...
T Consensus 272 ---~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 272 ---SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1122357889999999999999999999999999998887653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=311.58 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=203.7
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|.+.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+++++.++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 35788999999999999999976666799999985432 3457899999999999999999999874 456899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+|+|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 99999999754445689999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||++.+..++.++||||||+++|+|+| |..||.............. ......+...+..+.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMC 237 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----CCCCCCccccCHHHHHHHH
Confidence 234567999999988889999999999999999999 6666654433222211111 1111223456778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHh
Q 018244 291 RCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+||+.||++|||+.++++.|+..
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=326.10 Aligned_cols=237 Identities=17% Similarity=0.236 Sum_probs=196.3
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|++.... ......+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 579999999999985 457899999997542 22344577888888876 7999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~ 214 (359)
+|..++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999886 445789999999999999999999999 9999999999999999999999999998753222 23457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------DVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHhc
Confidence 89999999999888999999999999999999999998765443332222111 112234456789999999999
Q ss_pred cCCCCCC-------CHHHHHHH
Q 018244 295 YEPRERP-------NPRSLVTA 309 (359)
Q Consensus 295 ~dp~~Rp-------s~~~il~~ 309 (359)
.||++|| ++.+++++
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=325.62 Aligned_cols=235 Identities=19% Similarity=0.224 Sum_probs=194.0
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|.+.... .........|..++..+ +||||+++++++.+.+..++||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 579999999999995 468899999997542 12344567788888754 8999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||+++.... .....|
T Consensus 82 ~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 82 DLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9999886 345689999999999999999999999 999999999999999999999999999875321 234568
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------TPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999889999999999999999999999998765443332221111 122334467789999999999
Q ss_pred cCCCCCCCHH-HHH
Q 018244 295 YEPRERPNPR-SLV 307 (359)
Q Consensus 295 ~dp~~Rps~~-~il 307 (359)
.||++||++. +++
T Consensus 233 ~dP~~R~~~~~~~~ 246 (316)
T cd05620 233 RDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHcCCChHHHH
Confidence 9999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.79 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=204.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
++.+|++++.||.|+||.||+|... .+..||+|++....... .+.+.+|+.++..++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 3456788999999999999999853 24789999998654332 4568899999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
.++++||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCC
Confidence 99999999999999998521 123578889999999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhh
Q 018244 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 266 (359)
.+||+|||+++...... ...+++.|+|||.+.++.++.++||||||+++|||++ |..|+.............
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR- 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987653322 2234678999999988889999999999999999998 666665443222221111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
. ......+..++..+.+|+.+||+.+|++||++++|+..|+.
T Consensus 241 ---~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 ---N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11122345577889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=311.99 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=204.6
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.+|++++.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35788889999999999999987878899999976543 3467899999999999999999999875 456899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 99999999754455689999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...+..+.+|+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-----RGYRMPCPQDCPISLHELML 237 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHH
Confidence 223567999999988889999999999999999999 777776543222221111 11122234456778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+||..+|++|||+.++++.|+.
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=312.94 Aligned_cols=255 Identities=16% Similarity=0.189 Sum_probs=207.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+|.+.+.||.|+||.||+|+. .++..||||.+.... ......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4677888899999999999994 578899999886432 222446788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888532 234588999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.....+... ....+.............+..+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--LCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--HHHHHhcCCCCCCChhhcCHHHH
Confidence 345778999999998888999999999999999999999988654322111 00111111111112234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
+++.+||+.+|++|||+.++++.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=328.80 Aligned_cols=247 Identities=18% Similarity=0.209 Sum_probs=198.3
Q ss_pred cccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCC----CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcc
Q 018244 58 MENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 128 (359)
+|++++.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367888899999999999874 357899999987532 12245678899999999 499999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999986 445689999999999999999999999 999999999999999999999999999876432
Q ss_pred C-----CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 209 G-----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 209 ~-----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
. ....||..|+|||++.+. .++.++||||||+++|+|++|..||...............+.. .....+...+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCC
Confidence 2 234689999999999865 4788999999999999999999988543211111111111111 1122344567
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
..+.+++.+||+.||++|| ++++++++
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 7899999999999999999 67787764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.78 Aligned_cols=247 Identities=17% Similarity=0.164 Sum_probs=199.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
++|.+++.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++|+.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3678899999999999999984 568899999987532 122456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---- 208 (359)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999996 445689999999999999999999999 999999999999999999999999999743210
Q ss_pred -------------------------------------------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHH
Q 018244 209 -------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245 (359)
Q Consensus 209 -------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 245 (359)
.....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0123588999999999988899999999999999999
Q ss_pred HhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 018244 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVTA 309 (359)
Q Consensus 246 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~il~~ 309 (359)
++|+.||.............. . ............+.++.+++.+|+ .+|.+|+ |+.+++++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN-W-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc-c-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999876543222111110 0 001111112345678899999977 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=330.91 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=204.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCC-CcccccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 128 (359)
..|.+.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+++|+.+. ||||+++++++...+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 35677888999999999999842 1346999999764332 2456899999999996 99999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCC------------------------------------------------------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (359)
+|||||+++|+|.+++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999999875421
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC
Q 018244 149 ----------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 149 ----------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~ 194 (359)
...+++..+..++.|++.||.|||++ +++|+||||+|||+++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCE
Confidence 12478888999999999999999999 9999999999999999999
Q ss_pred eEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhh
Q 018244 195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 267 (359)
+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|++....+......
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~--- 352 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK--- 352 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH---
Confidence 9999999987653322 2234578999999998889999999999999999997 88777654322111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.........+...+.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus 353 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 -IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111122334567789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=311.78 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=205.3
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|+++++||+|+||.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 35788899999999999999988888999999986543 3567899999999999999999999874 567899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99999998755556789999999999999999999999 99999999999999999999999999987655221 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+...+.++.+++.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-----RGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence 234568999999998889999999999999999999 888876543322221111 11111223445678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+||+.+|++|||+++++..|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=329.01 Aligned_cols=245 Identities=17% Similarity=0.175 Sum_probs=195.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.-..|.+++.||.|+||.||+|.. .++..||+|.... ..+.+|+++|+.++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 345689999999999999999984 5688999997542 346789999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----- 208 (359)
++. ++|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 164 ~~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 995 58888886 345689999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh--------HHHh---h--------------h
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--------DLIR---D--------------R 263 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~--------~~~~---~--------------~ 263 (359)
.....||+.|+|||++.+..++.++|||||||++|+|++|..|+..... .... . .
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 1234689999999999988899999999999999999999977643210 0000 0 0
Q ss_pred hhh----hhccc--cccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 264 NIQ----TLTDS--CLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 264 ~~~----~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ..... ...... ....+.++.+|+.+||+.||++|||+.+++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00000 000000 01245689999999999999999999999964
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=311.58 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=203.8
Q ss_pred cccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+|.+.+.||+|+||+||+|.+. +...||+|.+...... ....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 4667778899999999999864 2457999998754322 3456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 85 EYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999864 334789999999999999999999999 99999999999999999999999999998764211
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .....+...+..+
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l 237 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YRLPPPMDCPSAL 237 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHH
Confidence 1223567999999998889999999999999999998 88777544322222211111 1112234556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+++.+||+.+|++||++.++++.|..+
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.73 Aligned_cols=236 Identities=19% Similarity=0.253 Sum_probs=193.0
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999995 457899999997532 12234456677777654 7999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999886 345689999999999999999999999 999999999999999999999999999875432 223468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++|||||||++|+|++|..||.............. ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999988899999999999999999999999876543332222111 1122344567789999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 018244 295 YEPRERPNPR-SLVT 308 (359)
Q Consensus 295 ~dp~~Rps~~-~il~ 308 (359)
.||++||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999875 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=326.11 Aligned_cols=237 Identities=18% Similarity=0.229 Sum_probs=196.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+|++++.||+|+||.||+|.. .++..||+|.+..... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 467788899999999999985 4578999999875421 2234567788888877 5899999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---- 208 (359)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999999886 345689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. . ...++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~~l 231 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----H--NVAYPKSMSKEAVAI 231 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCcCCHHHHHH
Confidence 2245689999999999999999999999999999999999999876544333222211 1 122345567889999
Q ss_pred HHHhcccCCCCCCCH
Q 018244 289 ASRCLQYEPRERPNP 303 (359)
Q Consensus 289 i~~cl~~dp~~Rps~ 303 (359)
+.+||+.||++|++.
T Consensus 232 i~~~l~~~p~~R~~~ 246 (323)
T cd05616 232 CKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHcccCHHhcCCC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=316.40 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=203.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
+.++.+.++||+|+||.||++.. .++..+|+|.+..........+.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 45677888999999999999963 235689999988766555678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeE
Q 018244 130 LVAEYMPNDTLAKHLFHWET-------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~k 196 (359)
++|||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEE
Confidence 99999999999999864321 3588999999999999999999999 999999999999999999999
Q ss_pred EeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhc
Q 018244 197 LSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLT 269 (359)
Q Consensus 197 l~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 269 (359)
|+|||++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---- 238 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT---- 238 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH----
Confidence 9999998754322 12234578999999998889999999999999999998 777765432221111111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
. ......+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 239 ~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 Q-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 1111223445678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.65 Aligned_cols=248 Identities=19% Similarity=0.275 Sum_probs=194.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 129 (359)
.|++.+.||+|+||.||+|.. .++..||||.+.... ......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367888899999999999994 568899999987432 223456889999999999999999999885432 479
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 58998886 345689999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------CCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh------------------
Q 018244 210 -------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------------------ 262 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~------------------ 262 (359)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 23467899999999875 568999999999999999999998886543211100
Q ss_pred -hhhhhhcc---ccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 263 -RNIQTLTD---SCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 263 -~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
........ ...... .....+.++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 000000 001245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.63 Aligned_cols=236 Identities=19% Similarity=0.229 Sum_probs=193.6
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.. .++..||+|.+.... .........|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 579999999999995 457899999997542 12344566788888764 8999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 82 DLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999986 345689999999999999999999999 999999999999999999999999999875322 223468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|..|+|||++.+..++.++|||||||++|+|++|..||.............. ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM------DNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCccCCHHHHHHHHHHhc
Confidence 8999999999988899999999999999999999999876543322221111 0112334466789999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 018244 295 YEPRERPNPR-SLVT 308 (359)
Q Consensus 295 ~dp~~Rps~~-~il~ 308 (359)
.||++||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05619 233 REPERRLGVKGDIRQ 247 (316)
T ss_pred cCHhhcCCChHHHHc
Confidence 9999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=311.87 Aligned_cols=255 Identities=17% Similarity=0.215 Sum_probs=208.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|.+.+.||.|++|.||+|. ..++..+|||.+..... .....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467788889999999999999 45788999998875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||+++++|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988632 245689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+.... ...+.............+..+.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence 3457789999999998889999999999999999999999886543221111 0111111111112234677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
+++.+||+.||++|||+.+|++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.37 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=201.9
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeC-Ccc
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~ 128 (359)
.|++++.||.|+||.||+|... +++.||+|++...... ..+.+.+|++++..+ +|+||+++++++... ..+
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 6788899999999999999632 2468999998754322 245678899999999 799999999988654 568
Q ss_pred eEEEecCCCCCHhhhhhcCC-----------------------------------------------------------C
Q 018244 129 LLVAEYMPNDTLAKHLFHWE-----------------------------------------------------------T 149 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------~ 149 (359)
+++|||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999885321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC------CCcCCCccccCccc
Q 018244 150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEY 223 (359)
Q Consensus 150 ~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~ 223 (359)
..+++..+..++.||+.||.|||++ +|+||||||+||++++++.++|+|||++...... ....++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 2689999999999999999999999 9999999999999999999999999999865332 12334678999999
Q ss_pred ccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 018244 224 LRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (359)
Q Consensus 224 ~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 302 (359)
+.+..++.++|||||||++|+|++ |..||............ .........+...+.++.+++.+||+.+|++|||
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR----LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH----HhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999999998 88877543221111111 1111111223445678999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q 018244 303 PRSLVTALVTLQK 315 (359)
Q Consensus 303 ~~~il~~L~~~~~ 315 (359)
+.++++.|+++..
T Consensus 323 ~~ell~~l~~~~~ 335 (337)
T cd05054 323 FSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=310.75 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=201.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.++.+.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45678888999999999999987777899999875432 34568889999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-----
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----- 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~----- 211 (359)
+++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 83 NGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 99999998642 34789999999999999999999999 999999999999999999999999999876543221
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...+.++.+++.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-----AGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-----cCCcCCCCCCCCHHHHHHHH
Confidence 122357999999998889999999999999999999 676665432222211111 11112233446778999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L 310 (359)
+||..+|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.06 Aligned_cols=251 Identities=16% Similarity=0.154 Sum_probs=202.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
...+|.+++.||+|+||.||+|+. .++..||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 345788999999999999999994 5788999999976654556678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 87 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 999999999886 345689999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCcCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh-hhhhccccccCCCChHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 285 (359)
....++..|+|||.+. ...++.++||||||+++|+|++|+.|+............ ......+. .......+..+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 241 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK--LKDKTKWSSTF 241 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC--CccccccCHHH
Confidence 2345778999999885 344788999999999999999999887543211110000 00000010 01122356789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
.+++.+||+.+|++|||++++++.|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.89 Aligned_cols=237 Identities=19% Similarity=0.261 Sum_probs=196.6
Q ss_pred cCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||.|+||+||+|... ++..||+|.+.... ......+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999854 57899999998542 22345677889999888 6999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~ 214 (359)
+|..++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++..... ....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999886 345799999999999999999999999 9999999999999999999999999998653221 23457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|..|+|||++.+..++.++|||||||++|+|++|..||.............. . ...++...+..+.+|+.+||+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE----D--EVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcc
Confidence 8999999999998999999999999999999999999876543332222111 1 112344567789999999999
Q ss_pred cCCCCCCCH-----HHHHHH
Q 018244 295 YEPRERPNP-----RSLVTA 309 (359)
Q Consensus 295 ~dp~~Rps~-----~~il~~ 309 (359)
.||++|||+ .+++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcC
Confidence 999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=308.50 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=196.1
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHh
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (359)
.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 579999999999985 4788999998865432 23456899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC------cCCC
Q 018244 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN 215 (359)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~------~~~t 215 (359)
+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........ ...+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99864 344689999999999999999999999 999999999999999999999999999876443211 1123
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
..|+|||.+.++.++.++||||||+++|+|++ |..|+............ ........+...+..+.+++.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-----EQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-----HcCCCCCCcccCCHHHHHHHHHHcC
Confidence 56999999998889999999999999999998 66655433222111111 1111222344556789999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 018244 295 YEPRERPNPRSLVTALV 311 (359)
Q Consensus 295 ~dp~~Rps~~~il~~L~ 311 (359)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=328.93 Aligned_cols=247 Identities=16% Similarity=0.127 Sum_probs=201.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||+|+||+||+|.. .++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 577888899999999999984 4688999999985432 234567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999964 335799999999999999999999999 99999999999999999999999999997654332
Q ss_pred --CcCCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 211 --SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
...+|+.|+|||++. ...++.++||||||+++|+|++|..||............... ............+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 237 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKVS 237 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCC
Confidence 235789999999987 455789999999999999999999998765433222211111 0001111112456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+|+..||+ +|.+|||+.+++.+
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 789999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=339.88 Aligned_cols=247 Identities=17% Similarity=0.211 Sum_probs=204.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCC-------
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------- 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 126 (359)
..|.+.+.||+|+||+||+|. ..++..||||.+..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 477888889999999999998 45789999999976532 23456788999999999999999988775432
Q ss_pred -cceEEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 127 -ERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
.+++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 368999999999999998642 235689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 204 KNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 204 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
+.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||................ ....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~ 265 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----YDPL 265 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----CCCC
Confidence 76432 234568999999999999899999999999999999999999987654433322222111 1123
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+...++++.+++.+||+.||++|||+.+++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 45567889999999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=312.34 Aligned_cols=253 Identities=18% Similarity=0.246 Sum_probs=201.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCc----EEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||.|+||+||+|.+ .++. .+|+|.+..... ....++..|+..+..+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3567788899999999999985 3343 478888764432 22456778888999999999999999875 456789
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
++||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999964 345789999999999999999999999 99999999999999999999999999997653321
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...++..|+|||.+.++.++.++||||||+++|||++ |..|+.........+. .........+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 238 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-----LEKGERLAQPQICTI 238 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHCCCcCCCCCCCCH
Confidence 2235678999999998889999999999999999998 8887765433222111 111111112233456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
++.+++.+||..||++|||+.++++.|..+.++.
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 7899999999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=327.85 Aligned_cols=244 Identities=20% Similarity=0.233 Sum_probs=207.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|.-+..||.|+||.||-|. ..+...||||++.-+.... ...+..|+..|++++|||++.+.|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4446677999999999998 5678899999998765444 45688999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~ 214 (359)
|-| |-.|++.- ...++.+..+..|+.+.++||+|||+. +.||||||+.|||+++.|.|||+|||.|....+.++++|
T Consensus 108 ClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvG 184 (948)
T KOG0577|consen 108 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVG 184 (948)
T ss_pred Hhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchhcccC
Confidence 965 78887743 456799999999999999999999999 999999999999999999999999999999999999999
Q ss_pred CccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
|+.|||||++. .+.|+-++||||||++..||.-.++|.+..........+ ...-.+. ....+++..+++++..
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-AQNesPt---Lqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNESPT---LQSNEWSDYFRNFVDS 260 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-HhcCCCC---CCCchhHHHHHHHHHH
Confidence 99999999886 567999999999999999999999776654332221111 1111111 2256789999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||++-|.+|||.++++.+
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999999999999998863
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=327.12 Aligned_cols=234 Identities=17% Similarity=0.193 Sum_probs=194.9
Q ss_pred ccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
+.||+|+||.||++.. .+|..+|+|++...... ....+.+|+++|+.++||||+++++++...+..++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5679999999999874 35789999999754322 23456789999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCc
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~ 212 (359)
+|+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999986 445689999999999999999999999 9999999999999999999999999998765433 234
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. . ....+...+.++.+|+.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----A--KLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHH
Confidence 678999999999988899999999999999999999998876543322221111 1 1123445677899999999
Q ss_pred cccCCCCCCCHHH
Q 018244 293 LQYEPRERPNPRS 305 (359)
Q Consensus 293 l~~dp~~Rps~~~ 305 (359)
|+.||++|||+.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.60 Aligned_cols=249 Identities=16% Similarity=0.142 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
......|++++.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 33446788999999999999999995 468899999986421 12344578899999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999984 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred C-----CCcCCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC-
Q 018244 209 G-----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS- 278 (359)
Q Consensus 209 ~-----~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 278 (359)
. ....||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ........++
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i----~~~~~~~~~p~ 270 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI----MDHKNSLNFPE 270 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCcccCCCC
Confidence 2 244689999999998754 3788999999999999999999998765433222221 1111111122
Q ss_pred -hHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 279 -SDEGTELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 279 -~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
...+..+.+++..||..++.+ |+|+.+++++
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 245778999999999865544 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=324.78 Aligned_cols=241 Identities=16% Similarity=0.224 Sum_probs=194.6
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|++.... ......+.+|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999985 468899999998542 22345578899999998 6999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9998886 446799999999999999999999999 999999999999999999999999999875221 224568
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----HhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........+... ....+...+.++.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 999999999998889999999999999999999999885321100 000011111111 1123455677899999
Q ss_pred HHhcccCCCCCCC------HHHHHHH
Q 018244 290 SRCLQYEPRERPN------PRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps------~~~il~~ 309 (359)
.+||+.||.+||| +.+++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999998 5666643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=315.43 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=205.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CC--cEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQ--FRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 130 (359)
+++|.+.+.||.|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++.++ +||||+++++++......++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 356788889999999999999854 33 347888887432 23345688999999999 79999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeE
Q 018244 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~k 196 (359)
++||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEE
Confidence 999999999999986421 13588999999999999999999999 999999999999999999999
Q ss_pred EeccCCcccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccc
Q 018244 197 LSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (359)
Q Consensus 197 l~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (359)
|+|||++...... .....+..|+|||++.+..++.++||||||+++|+|++ |..||.............. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-----~ 234 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----G 234 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----C
Confidence 9999998643321 11222457999999988889999999999999999997 8888765543332222111 1
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
.....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+....
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111223446678999999999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=324.11 Aligned_cols=232 Identities=20% Similarity=0.230 Sum_probs=190.6
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHH-HHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.. .++..||+|++..... .....+.+|.. +++.++||||+++++++...+..++||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 479999999999995 4688999999975321 22334555554 567899999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~ 214 (359)
+|..++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999886 445789999999999999999999999 9999999999999999999999999998753221 23458
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|..||................ ...+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence 899999999998889999999999999999999999987654433322222111 11233457789999999999
Q ss_pred cCCCCCCCHH
Q 018244 295 YEPRERPNPR 304 (359)
Q Consensus 295 ~dp~~Rps~~ 304 (359)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=314.20 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=201.6
Q ss_pred cccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee--CCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 130 (359)
.+++++.||+|+||.||+|.. .++..||+|.+........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 577888999999999999974 2578899999987665556678999999999999999999998754 346899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 85 VMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999864 334689999999999999999999999 99999999999999999999999999988654332
Q ss_pred C-------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh---h--------hhhhhcccc
Q 018244 211 S-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---R--------NIQTLTDSC 272 (359)
Q Consensus 211 ~-------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~---~--------~~~~~~~~~ 272 (359)
. ..++..|+|||++.+..++.++||||||+++|||++|..++.......... . .........
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1 122345999999998889999999999999999999876543222111100 0 000111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.....+...+.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=314.43 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=199.8
Q ss_pred cccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeC--CcceEE
Q 018244 60 NIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV 131 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 131 (359)
.+++.||+|+||+||++.. .++..||+|.+..... .....+.+|+++|+.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6788899999999988652 3577899999976532 2355688999999999999999999987653 357899
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+.+++|.+++. ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999985 34699999999999999999999999 99999999999999999999999999988654322
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH--Hhh--------hhhhhhcccccc
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL--IRD--------RNIQTLTDSCLE 274 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~--~~~--------~~~~~~~~~~~~ 274 (359)
...++..|+|||.+.+..++.++||||||+++|+|+||..|+....... ... ............
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 1234567999999988889999999999999999999998764322110 000 001111111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
...+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2234456688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=324.70 Aligned_cols=241 Identities=17% Similarity=0.223 Sum_probs=193.9
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 469999999999995 467899999998642 22345577889888777 7999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|..++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9998886 445799999999999999999999999 999999999999999999999999999875322 223468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhH-----HHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
|..|+|||++.+..++.++||||||+++|+|++|..||...... .........+... ....+...+..+.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 99999999999889999999999999999999999988521100 0000011111111 1234556678899999
Q ss_pred HHhcccCCCCCCCH------HHHHHH
Q 018244 290 SRCLQYEPRERPNP------RSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~------~~il~~ 309 (359)
.+||+.||++|||+ .+++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=307.96 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=205.2
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||+|++|.||+|.. .++..|++|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 56677889999999999995 468899999987542 234567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 999999999765456799999999999999999999999 99999999999999999999999999988654432 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||++.+..++.++|+||||+++|+|++|..||............... .....+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-----VFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----CCCCCccccCHHHHHHHHH
Confidence 35678999999999888999999999999999999999988655432222211111 1122233566789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HccCCcccCcCHHHHhhC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=308.85 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=204.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceee-eCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 134 (359)
..+|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++. ..+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 456788889999999999999864 6679999987543 2456889999999999999999999764 45678999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-CcC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYS 213 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-~~~ 213 (359)
+++++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 9999999999765555689999999999999999999999 99999999999999999999999999987654332 333
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.+..|+|||++.+..++.++||||||+++|+|++ |+.|+.............. ......+...+..+.+++.+|
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCCHHHHHHHHHH
Confidence 4568999999988889999999999999999998 8877765443332221111 111223345677899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHh
Q 018244 293 LQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~ 313 (359)
|+.+|++|||+.++++.|+.+
T Consensus 236 l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 236 WHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.19 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=207.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.+|++.+.+|.|+||.||+|... +..||+|.+..... ..+++.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45677888899999999999875 67899999986653 46678999999999999999999999998899999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-cCCC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTN 215 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-~~~t 215 (359)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+........ ...+
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 99999999755545799999999999999999999999 999999999999999999999999999887643322 2335
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
..|+|||.+.++.++.++||||||+++|++++ |..|+.............. ......+...++.+.+++.+||.
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-----GYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----CCCCCCccCCCHHHHHHHHHHhc
Confidence 67999999988889999999999999999997 8877765543332221111 11122234456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 018244 295 YEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 295 ~dp~~Rps~~~il~~L~~~ 313 (359)
.+|++|||+.++++.|+.+
T Consensus 238 ~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 238 LDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cChhhCcCHHHHHHHHhcC
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=316.58 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=204.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCc--EEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
.+.+|.+.+.||+|+||.||+|... ++. .+|+|.+..... .....+.+|+.++.++ +|+||+++++++...+..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3567788888999999999999853 443 468887765332 2345688899999999 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~ 195 (359)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcE
Confidence 9999999999999986421 23578999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccc
Q 018244 196 RLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 196 kl~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (359)
||+|||++...... .....+..|+|||.+.+..++.++||||||+++|+|+| |..||............ ..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQ 238 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hc
Confidence 99999998643221 11223567999999988889999999999999999998 88877644332222111 11
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
......+...+.++.+|+.+||+.+|++|||+.+++..|..+....
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111223345678999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=312.71 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=194.4
Q ss_pred cCCCCCCcEEEEEEeCC--------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 64 EHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.||.|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 57999999999998532 2358888887655445567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC--------eEEeccCCcccCC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCFGLMKNSR 207 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~--------~kl~DFg~a~~~~ 207 (359)
++|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||+++.++. ++++|||++....
T Consensus 82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999864 344689999999999999999999999 9999999999999987765 6999999988776
Q ss_pred CCCCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 208 DGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 208 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
......++..|+|||++.+. .++.++||||||+++|+|++|..++........... .... ....+...+.++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~ 233 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYED--RHQLPAPKWTELA 233 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHc--cccCCCCCcHHHH
Confidence 66666788999999999864 478999999999999999999644433211111110 1111 1123344557899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L 310 (359)
+++.+||+.||++|||++++++.|
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.29 Aligned_cols=238 Identities=19% Similarity=0.343 Sum_probs=192.2
Q ss_pred cCCCCCCcEEEEEEeCC-------------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 64 EHGEKAPNVVYKGKLEN-------------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 57999999999998432 23689999876554445578889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC-------eEEeccCCc
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-------PRLSCFGLM 203 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~-------~kl~DFg~a 203 (359)
||||+++|+|..++.. ....+++..+..++.||+.||+|||++ +++||||||+|||++.++. ++++|||++
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999888753 345689999999999999999999999 9999999999999987654 899999998
Q ss_pred ccCCCCCCcCCCccccCccccc-CCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 204 KNSRDGRSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 204 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
..........++..|+|||.+. +..++.++||||||+++|+|++ |..|+.......... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~--~~~~~~ 232 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-----FYEGQC--MLVTPS 232 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----HHhcCc--cCCCCC
Confidence 8766656667888999999887 4568899999999999999984 666554432211111 001100 112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
+.++.+|+.+||+.||++||++.+|++.|
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 56799999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=307.85 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=202.6
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
.|.+...||.|++|.||+|....+..+|+|.+.... ...+.+.+|+++++.++|+|++++++++. .+..+++|||+.+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 467778899999999999997776679999887543 23456889999999999999999998875 4578999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----Cc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~~ 212 (359)
++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 9999999754455689999999999999999999999 99999999999999999999999999997654322 22
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.++..|+|||.+.+..++.++||||||+++|+|+| |..|+.............. ......+...+..+.+++.+
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-----GYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCcccCHHHHHHHHH
Confidence 34567999999988889999999999999999999 7777765433222211111 11122334567789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~ 312 (359)
||..||++||+++++++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.07 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=207.2
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.+|.+.+.||.|+||.||+|...++..+|||.+..... ..+.+.+|+.+++.++|+||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 45678888999999999999987778899999986543 35678999999999999999999999998889999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... .
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 99999999765556789999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...+..|+|||.+.+..++.++||||||+++|+|++ |+.||............... .....+...+.++.+++.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-----YRMPRPPNCPEELYDLML 238 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHHH
Confidence 223468999999998889999999999999999998 88877654332222211111 111223344678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+||+.+|++||+++++++.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.01 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=197.0
Q ss_pred cCCCCCCcEEEEEEe---CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
+||+|+||.||+|.+ .++..+|+|++...... ..+.+.+|+.+++.+.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 579999999999964 35788999998754322 3457889999999999999999999875 45779999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-------C
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-------~ 211 (359)
+|.+++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999986 345689999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+....++.++||||||+++|||++ |..||........... +........+...+.++.+++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-----i~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-----IESGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCCCCCCCCCCCHHHHHHHH
Confidence 123468999999988889999999999999999998 8887765432222111 1111222344556788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHh
Q 018244 291 RCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+||+.||++||++.+|...|++.
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=315.81 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=207.9
Q ss_pred hcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+....|.+++.||.|++|.||+|.. .++..||+|.+........+.+.+|+.+++.+.|+|++++++.+......++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 34456788899999999999999984 56889999999876666667789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++++|.+++. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999999984 34689999999999999999999999 9999999999999999999999999998764332
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||............ ..........+...+..+.+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHH
Confidence 2346788999999999888999999999999999999999988654321111111 11111111123456678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||..||++|||+.++++.
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=328.80 Aligned_cols=195 Identities=18% Similarity=0.194 Sum_probs=174.6
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Cc-----ccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NR-----RLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~l 130 (359)
.|.+++.||+|+||.|.+|. .++++.||||+++... .-..+...|+.+|..|+ |. |+|+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 56889999999999999998 5679999999998653 33556778999999997 53 89999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC--CCCeEEeccCCcccCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~~~~ 208 (359)
|+|.+.. +|.++++.++...++...++.++.||+.||.+||.. +|||+||||+||||.+ ...+||+|||.+.....
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999965 899999988888999999999999999999999999 9999999999999974 45799999999988765
Q ss_pred CC-CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 018244 209 GR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (359)
Q Consensus 209 ~~-~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~ 255 (359)
.- .+.-+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|+++
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 43 556678899999999999999999999999999999999888765
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.64 Aligned_cols=246 Identities=16% Similarity=0.198 Sum_probs=205.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|.+.+.||.|+||.||++.. .++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 367788899999999999984 468899999986532 234567888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999988654556789999999999999999999999 99999999999999999999999999987654332 3
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||++.+..++.++|+||||+++|+|++|..||............... .....+...+..+.+++.+
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-----SYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-----CCCCCCcccCHHHHHHHHH
Confidence 45788899999999888999999999999999999999998765433222111111 1112234466789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.||++|||+.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=310.45 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=203.1
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCc----EEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.++++++.||.|+||+||+|.+ .++. .||+|.+...... ....+.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 3567788889999999999984 3444 4899998754332 34568899999999999999999999865 45789
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
++||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+|||+++++.+||+|||+++......
T Consensus 86 ~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 86 VTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999999864 345689999999999999999999999 99999999999999999999999999988654322
Q ss_pred C------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
. ..++..|+|||.+.+..++.++||||||+++|||++ |..|+.......... ..........+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----LLEKGERLPQPPICTI 238 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCCCcCCCCccCCH
Confidence 1 223567999999998889999999999999999998 777765433222211 1111111222345667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 8999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.23 Aligned_cols=246 Identities=12% Similarity=0.096 Sum_probs=198.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|++++.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 567888899999999999985 468899999997432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999986 445789999999999999999999999 9999999999999999999999999998643211
Q ss_pred -----------------------------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 018244 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (359)
Q Consensus 210 -----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~ 254 (359)
....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123588999999999988999999999999999999999999876
Q ss_pred chhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 018244 255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (359)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (359)
............. . ...........+.++.+|+.+++. ||.+|++ +.+++++
T Consensus 239 ~~~~~~~~~i~~~-~-~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNW-K-ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcC-C-CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 5433322221110 0 000000112356789999999874 9999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=334.45 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=192.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC--------Cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------DE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~ 127 (359)
..|.+.+.||+|+||.||+|.. .++..||||++.... ....+|+.+|+.++|+||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4688889999999999999985 568899999886532 2345799999999999999998877432 24
Q ss_pred ceEEEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcc
Q 018244 128 RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMK 204 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~ 204 (359)
+++||||+++ +|.+++.. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 6799999976 67776643 2456789999999999999999999999 999999999999999654 79999999998
Q ss_pred cCCCC---CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc-----------
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----------- 269 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------- 269 (359)
..... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...............+.
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65433 245678999999998764 689999999999999999999998876432211111111000
Q ss_pred ------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 ------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+...++...+.++.+|+.+||..||.+|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0001111223356789999999999999999999999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.83 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=199.2
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
+|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4677788899999999999743 256799999865332 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCC
Confidence 999999999999986421 23467889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 203 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
+....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. . ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~-~~~ 240 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----G-GLL 240 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C-CcC
Confidence 87543221 2234678999999998889999999999999999999 5666655433222211111 1 111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=323.99 Aligned_cols=235 Identities=17% Similarity=0.193 Sum_probs=191.8
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHH-HHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.. .+|..+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+.+|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 579999999999984 568899999997532 122334555554 567789999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|..++. ....+++..+..++.||+.||.|||++ |++||||||+|||+++++.+||+|||+++.... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9998886 456789999999999999999999999 999999999999999999999999999875322 223468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++|||||||++|+|++|..||................ .......+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELLE 232 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHhc
Confidence 899999999999899999999999999999999999987654433322222111 11223456789999999999
Q ss_pred cCCCCCCCHHHHH
Q 018244 295 YEPRERPNPRSLV 307 (359)
Q Consensus 295 ~dp~~Rps~~~il 307 (359)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05604 233 KDRQRRLGAKEDF 245 (325)
T ss_pred cCHHhcCCCCCCH
Confidence 9999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=322.61 Aligned_cols=235 Identities=20% Similarity=0.211 Sum_probs=190.9
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHH-HHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEA-RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.. .++..||+|++..... .....+.+|. .+++.++|+||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 579999999999995 4678899999975321 1223344444 4567889999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|.+++. ....+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999986 345688899999999999999999999 999999999999999999999999999875322 223468
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CcCCCCCCCHHHHHHHHHHcc
Confidence 99999999999888999999999999999999999998765433322222111 112234567789999999999
Q ss_pred cCCCCCCCHHHHH
Q 018244 295 YEPRERPNPRSLV 307 (359)
Q Consensus 295 ~dp~~Rps~~~il 307 (359)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=297.42 Aligned_cols=289 Identities=18% Similarity=0.232 Sum_probs=226.9
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 133 (359)
.+.+.++.||.|+.|.|++++ ...|...|||.+.+... +..++++..+.++..-. +|.||+.+|||..+..++|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445678889999999999999 45689999999987643 34566788888777664 8999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---C
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~ 210 (359)
.|.. .+..++++ -.+++++..+-++...++.||.||..+++|+|||+||+|||+|+.|++||||||++...-+. .
T Consensus 172 lMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 172 LMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 9844 56666654 56679999999999999999999999889999999999999999999999999999876543 3
Q ss_pred CcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...|-+.|||||.+.- ..|+..+||||||++++||.||+.|+.....+...-.++..-..+.++. ...+++++++
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~--~~gFSp~F~~ 327 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG--HMGFSPDFQS 327 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc--ccCcCHHHHH
Confidence 4567889999999874 3589999999999999999999999988655543333332222233332 2337899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCccccchhHHHHHHhhcccccccccccccccc
Q 018244 288 LASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQFTYALLRLHIWSSSQIQQPARLCF 351 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (359)
++..||++|+.+||...+++++ .+...-+........++.......+....++.....++++
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h--~Fi~~ye~a~~dVa~WF~dV~~~~~~~~~~~~~s~~~~p~ 389 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEH--PFIKRYETAEVDVASWFKDVMAKTESPRTSGVLSQPHLPF 389 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcC--cceeecchhhccHHHHHHHHHhcccccccCCcccCCCCcc
Confidence 9999999999999999999875 2222333334555677777776665566666555555554
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.21 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=204.8
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
+|.+.+.||+|+||.||++... ....+|+|.+..... .....+.+|++++..+ +|+||+++++++......+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 4677888899999999999853 236799999875432 2345688999999999 7999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~ 195 (359)
++|||+++|+|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeE
Confidence 999999999999998642 235689999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhh
Q 018244 196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (359)
Q Consensus 196 kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 268 (359)
||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-- 249 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-- 249 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc--
Confidence 999999988654322 1223567999999988889999999999999999998 8877765543332221111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
......+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 250 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 250 ---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1112234455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.89 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=190.9
Q ss_pred cCCCCCCcEEEEEEeC-------------------------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccc
Q 018244 64 EHGEKAPNVVYKGKLE-------------------------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 118 (359)
.||+|+||.||+|.+. ....||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5799999999999741 124689999876544445578889999999999999999
Q ss_pred cceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-----
Q 018244 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----- 193 (359)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----- 193 (359)
++++......++||||+++|+|..++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999988854 345789999999999999999999999 999999999999997643
Q ss_pred --CeEEeccCCcccCCCCCCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHH-hCCCCCCcchhHHHhhhhhhhhc
Q 018244 194 --NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLL-SGKHIPPSHALDLIRDRNIQTLT 269 (359)
Q Consensus 194 --~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~ 269 (359)
.++++|||++..........++..|+|||.+.+ ..++.++||||||+++|||+ +|..|+.......... ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~ 234 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-----FY 234 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-----HH
Confidence 389999999876554455567889999998875 45889999999999999985 6777765432221111 11
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
.. ....+.....++.+++.+||+.+|++|||+.++++.|
T Consensus 235 ~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 1112223346799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=326.60 Aligned_cols=247 Identities=18% Similarity=0.216 Sum_probs=195.9
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 130 (359)
+++++.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 56778889999999999995 578899999987532 223467889999999999999999999998776 7899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+.+ +|.+.+. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 82 v~e~~~~-~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQS-DLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeecccc-CHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999974 7888775 455799999999999999999999999 9999999999999999999999999998765432
Q ss_pred ----CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh------------------
Q 018244 210 ----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------ 266 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------ 266 (359)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||..............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 123567899999998874 478999999999999999999998865432111110000
Q ss_pred -hhccccccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 -TLTDSCLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 -~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+....... ......++++.+|+.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 1122346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=306.49 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=207.6
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|.+.+.||.|+||.||+|... ++..||+|.++... ....+.+.+|+++++.++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35778888899999999999965 78899999886432 222457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999988642 345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC-hHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l 285 (359)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+.......... ...+... .....+ ...+.++
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEKC-DYPPLPADHYSEEL 237 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH--HhhhhcC-CCCCCChhhcCHHH
Confidence 2457788999999998889999999999999999999999886543221110 0001111 111122 2556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.+++.+||..+|++|||+.++++.|+.+.
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=305.51 Aligned_cols=242 Identities=30% Similarity=0.430 Sum_probs=203.1
Q ss_pred cCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||.|+||.||+|.... +..+|+|.+....... .+.+.+|++.+..++|+||+++++++......++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 57999999999999543 7889999998765433 567899999999999999999999999999999999999999
Q ss_pred CHhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 139 TLAKHLFHWE-------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 139 sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
+|.+++.... ...+++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999997531 36789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....++..|+|||.+....++.++||||||+++|+|++ |..|+.............. ......+...+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPEYCPDE 235 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccCChH
Confidence 23456788999999988889999999999999999999 5777765533322222211 1122334556788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
+.+++.+||+.||++|||+.++++.|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=320.68 Aligned_cols=237 Identities=17% Similarity=0.232 Sum_probs=195.2
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEe
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 133 (359)
|++++.||+|+||+||+|.. .++..||+|++.... ....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45667789999999999984 468899999997532 223455778899998886 5778889999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999986 445699999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.............. . ....+...+.++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li 232 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----H--NVSYPKSLSKEAVSIC 232 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCccCCHHHHHHH
Confidence 234589999999999988899999999999999999999999876543332222211 1 1123445677899999
Q ss_pred HHhcccCCCCCCCHH
Q 018244 290 SRCLQYEPRERPNPR 304 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~ 304 (359)
.+||+.||.+|++..
T Consensus 233 ~~~l~~~p~~R~~~~ 247 (323)
T cd05615 233 KGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHcccCHhhCCCCC
Confidence 999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.59 Aligned_cols=257 Identities=17% Similarity=0.197 Sum_probs=207.0
Q ss_pred HHHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC
Q 018244 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (359)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 126 (359)
+++..-.....|++++.||.|+||.||+|.. .++..+|+|.+........+.+.+|+.+++.++|+||+++++.+....
T Consensus 3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 3444444556789999999999999999995 458899999998766555677889999999999999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++++|..++.+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred eEEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999888754 345689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCC----CCcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 207 RDG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+.............. ... .....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~--~~~~~ 237 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEP--PTLSQ 237 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCC--ccCCC
Confidence 322 23456789999999853 3478899999999999999999988765432211111110 000 01112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+...+.++.+++.+||..||++||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 34556789999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.11 Aligned_cols=254 Identities=19% Similarity=0.298 Sum_probs=205.6
Q ss_pred CcccccccCCCCCCcEEEEEEe--------CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
.+|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 3566778889999999999973 124579999987543 23356788999999999 7999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ |++|+||||+||+++++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~ 173 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTEN 173 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCC
Confidence 9999999999999999987532 23578889999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+.............
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999988654322 2234567999999998889999999999999999998 666665544333322211
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
. ......+...+..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 254 ~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 254 E-----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred c-----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 111122345677899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.25 Aligned_cols=242 Identities=20% Similarity=0.284 Sum_probs=196.6
Q ss_pred cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||+|.+. .+..||+|.+...... ..+.+.+|+.+++.++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3799999999999753 3557999999765432 2456889999999999999999999885 457899999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-------c
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------Y 212 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-------~ 212 (359)
|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999864 345789999999999999999999999 999999999999999999999999999875443221 1
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.++..|+|||.+.+..++.++||||||+++|++++ |..||.......... ..........+...+.++.+++.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-----FIEQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHHH
Confidence 22467999999988889999999999999999996 887776543222211 111112223345567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHh
Q 018244 292 CLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~ 313 (359)
||..||++||++.++.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.81 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=206.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
..|.+.+.||+|+||.||+|... +...+|+|.+.... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 36788899999999999999742 23469999998643 23345688899999999 7999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED 176 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCC
Confidence 9999999999999999996532 13588999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 999999999987654321 1123467999999998889999999999999999998 777766544332222111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.......+...+.++.+|+.+||+.+|++|||+.++++.|+.+...
T Consensus 257 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 257 -----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1112223445677899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.33 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=203.6
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
++.+.+.||+|+||.||+|.. ..+..||+|.+..... ...+.+.+|+++++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 466778889999999999973 1345799999876432 2345688999999999 7999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
++|||+++|+|.+++.......+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 999999999999999754444589999999999999999999999 9999999999999999999999999998765432
Q ss_pred C------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 R------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 ~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............ .........+...+
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 270 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGYRMAQPEHAP 270 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCCcCCCCCCCC
Confidence 2 1234578999999998889999999999999999998 88877654332211111 11111112223456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.++.+++.+||+.+|++|||+.++++.|+++
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 7899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.02 Aligned_cols=253 Identities=18% Similarity=0.309 Sum_probs=200.0
Q ss_pred ccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeC--CcceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (359)
|.+++.||+|+||.||.|.. .++..||+|.+.... ......+.+|+++++.++||||+++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 57788899999999999973 357789999987553 22345789999999999999999999998775 56899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999864 334689999999999999999999999 99999999999999999999999999988654322
Q ss_pred -------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh----------hhhhhhhccccc
Q 018244 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDSCL 273 (359)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~ 273 (359)
...++..|+|||.+.+..++.++||||||+++|+|+++..|.......... ............
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 234556799999998888999999999999999999987553221110000 000000011111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
....+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1122344678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=321.18 Aligned_cols=232 Identities=19% Similarity=0.234 Sum_probs=190.2
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHH-HHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|+. .++..||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999995 4688999999875321 12334555554 678899999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|...+. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9998886 445688999999999999999999999 999999999999999999999999999875322 123457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
|+.|+|||.+.+..++.++|||||||++|+|++|..||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998766443333222211 112344566789999999999
Q ss_pred cCCCCCCCHH
Q 018244 295 YEPRERPNPR 304 (359)
Q Consensus 295 ~dp~~Rps~~ 304 (359)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=325.95 Aligned_cols=256 Identities=17% Similarity=0.139 Sum_probs=203.0
Q ss_pred HHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeee
Q 018244 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCE 124 (359)
Q Consensus 49 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 124 (359)
+....-....|.+++.||+|+||.||+|.. .++..+|+|++.... ......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 333444557888999999999999999995 468899999986422 1223457789999999999999999999999
Q ss_pred CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
+...++||||+++|+|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999984 34588999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC-----CCcCCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 205 NSRDG-----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 205 ~~~~~-----~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
..... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||................. ....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~ 268 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTF 268 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--cccC
Confidence 65432 244689999999998753 278899999999999999999999876543322222111100 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRE--RPNPRSLVTAL 310 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~L 310 (359)
......+..+.+++.+||..++.+ |+++.+++++.
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 112356788999999999844433 67999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=303.20 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=199.6
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
.||+|+||.||+|...++..+|+|.+....... ...+.+|+++++.++||||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 469999999999998788899999987654332 3468899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----CcCCCcc
Q 018244 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SYSTNLA 217 (359)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~~~~t~~ 217 (359)
++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... ...++..
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 8864 345689999999999999999999999 99999999999999999999999999987543321 1233567
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
|+|||++.+..++.++||||||+++|++++ |..||.............. ......+...+.++.+++.+||+.+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-----GYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHHHHcccC
Confidence 999999998889999999999999999998 8878765433322221111 1122234456788999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 018244 297 PRERPNPRSLVTALV 311 (359)
Q Consensus 297 p~~Rps~~~il~~L~ 311 (359)
|++|||+.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=307.20 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred ccccccCCCCCCcEEEEEEeC-C---CcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCc-----
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----- 127 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 127 (359)
|.+.+.||+|+||.||+|... + +..||+|.+..... .....+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 356677899999999999853 2 36799999986432 234578999999999999999999998866544
Q ss_pred -ceEEEecCCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 128 -RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
.++++||+++|+|..++... ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988532 234689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 203 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
++...... ....+..|+|||.+.+..++.++||||||+++|||++ |..|+.............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~ 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-----GNRL 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCC
Confidence 88654332 1223568999999988889999999999999999999 7777655433222211111 1112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
..+...+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23455677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=315.42 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=209.3
Q ss_pred HHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 50 RTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 50 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
....+....|.+++.||.|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++......
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 33445557889999999999999999994 57889999999876655567788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999999984 35689999999999999999999999 999999999999999999999999999876543
Q ss_pred CC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
.. ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .............+...+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPELQNPERLSAV 244 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccCCCCCCCCccccCHH
Confidence 32 345678999999999888999999999999999999999888653221110 00000111111123445677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=312.42 Aligned_cols=254 Identities=17% Similarity=0.246 Sum_probs=209.0
Q ss_pred HHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 49 LRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 49 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
+......-..|.+++.||.|++|.||+|. ..++..||+|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 33344444668899999999999999998 45788999999987665556778999999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++|+||+++++|..++. ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999999999884 34689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 208 DGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 208 ~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
... ...++..|+|||.+.+..++.++||||||+++|+|++|..||............. .........+...+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 243 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSP 243 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCH
Confidence 332 3357789999999998889999999999999999999998886543211111100 000011112344667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.+++.+||..||++|||+.+++.+
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 89999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.27 Aligned_cols=250 Identities=15% Similarity=0.164 Sum_probs=193.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcC---CCcccccccceeee-----CC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----GD 126 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 126 (359)
.|++++.||+|+||+||+|.. .+++.||+|.+...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 367888899999999999985 46889999998754322 123456677777665 69999999998864 24
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 57999999975 898888654455689999999999999999999999 9999999999999999999999999998865
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc--------------
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-------------- 269 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 269 (359)
... ....+|..|+|||++.+..++.++|||||||++|+|++|.+||.................
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 433 234578899999999988899999999999999999999988755422211111100000
Q ss_pred ccccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... .......+.++.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00112356778999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=304.64 Aligned_cols=242 Identities=22% Similarity=0.297 Sum_probs=198.6
Q ss_pred cCCCCCCcEEEEEEeCC--C--cEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 56999999999998533 3 3699999987765 456678999999999999999999999988 8899999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-------C
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-------~ 211 (359)
+|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 999999754335789999999999999999999999 99999999999999999999999999988654321 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. .......+...+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHHHHHHHH
Confidence 345678999999998889999999999999999998 8888754322222111111 11111123345678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~ 311 (359)
+||+.+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.35 Aligned_cols=251 Identities=18% Similarity=0.267 Sum_probs=199.0
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
...|.+++.||+|+||+||+|.. .++..||+|.+...... ....+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 45688999999999999999985 46788999998754322 23457789999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++ +|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9976 78888754 345689999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------ccc
Q 018244 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------------TDS 271 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~~ 271 (359)
....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||................ ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 23456889999998875 458899999999999999999999887543321111110000 000
Q ss_pred cccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 CLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ......+.++.+|+.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0012346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=310.36 Aligned_cols=246 Identities=16% Similarity=0.202 Sum_probs=200.7
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
|++++.||.|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 577888999999999999954 5778999999766555567788999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~ 213 (359)
++|..++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999888754 345789999999999999999999999 9999999999999999999999999998654322 2345
Q ss_pred CCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 214 TNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 214 ~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
++..|+|||++. +..++.++|||||||++|+|++|+.||............... .. .....+...+.++.++
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~l 241 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EP--PTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-CC--CCCCCccccCHHHHHH
Confidence 788999999984 344778999999999999999999887654322111111110 00 0111233456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+.+++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.11 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=203.0
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CC---cEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+|++.+.||+|+||.||+|... ++ ..||+|.+.... ......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46778888999999999999854 33 369999987643 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~ 211 (359)
|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999864 345689999999999999999999999 999999999999999999999999999876433211
Q ss_pred -------cC--CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 212 -------YS--TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 212 -------~~--~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
.. .+..|+|||.+.+..++.++||||||+++||+++ |..||.............. ......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~ 236 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-----DYRLPPPMDC 236 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----CCcCCCcccC
Confidence 11 1347999999998889999999999999999886 8887765433222221111 1111223455
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+..+.+++.+||..+|++||++.+++..|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.08 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=205.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC-----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeee--CCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE--GDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 128 (359)
..+++++.||+|+||.||+|... ++..+|+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778888999999999999853 3678999999866543 45678999999999999999999999877 5578
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
+++|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+.....
T Consensus 84 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999964 233589999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh----------hhhhhhhccc
Q 018244 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDS 271 (359)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~----------~~~~~~~~~~ 271 (359)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..|+......... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 22 123345699999998888999999999999999999999887543222111 0111111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
......+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111122334557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.93 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=202.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
.+|.+.+.||.|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 35678888999999999999853 246899999875532 33456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999986422 23478899999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 202 ~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
+++..... ....++..|+|||.+.+..++.++||||||+++|+++| |..|+............. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~ 239 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-----DGGH 239 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-----cCCC
Confidence 98754332 22345678999999988889999999999999999998 887776543322222111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 2234445788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=310.26 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=203.6
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+++++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 567788899999999999842 235699998875442 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 132 AEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
+||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEE
Confidence 99999999999875321 23578999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhh
Q 018244 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD 262 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~ 262 (359)
++++.++|+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..........
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987643321 2234568999999988889999999999999999998 887776543332222
Q ss_pred hhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.. ........+...+.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 241 ~~-----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 LL-----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH-----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 1111222344566789999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.51 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=200.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|+..+.||.|+||+||+|.. .+++.+|+|.+...... ....+.+|+++|+.++|+||+.+.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 34556679999999999985 56889999998754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~ 211 (359)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999999888654455799999999999999999999999 9999999999999999999999999998764332 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..|+..|+|||.+.+..++.++|+||||+++|+|++|..||................... ...++...+.++.+|+..
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHH
Confidence 467899999999998889999999999999999999999887543222211111111111 112334566789999999
Q ss_pred hcccCCCCCCC-----HHHHHHH
Q 018244 292 CLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~ 309 (359)
||+.||++||| +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 5566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=308.69 Aligned_cols=248 Identities=15% Similarity=0.156 Sum_probs=201.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|.+.+.||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677888899999999999984 568899999998765555566888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9999999986 345789999999999999999999999 9999999999999999999999999998754322 33
Q ss_pred cCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh-hhhhccccccCCCChHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 212 ~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
..++..|+|||.+. ...++.++|+|||||++|+|++|..|+............ ......+... .....+..+.+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 243 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFHH 243 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHHH
Confidence 46789999999874 445888999999999999999999887543211111000 0000111000 11134567999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||+.+|++|||+++++++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=311.61 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=199.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCC---------------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN---------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLG 120 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~ 120 (359)
.+|++.+.||+|+||.||+|.... ...||+|.+...... ....+.+|+++++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 368888999999999999987532 235899999765322 3456889999999999999999999
Q ss_pred eeeeCCcceEEEecCCCCCHhhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC
Q 018244 121 CCCEGDERLLVAEYMPNDTLAKHLFHWE----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (359)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~ 190 (359)
++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~ 163 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVG 163 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEc
Confidence 9999999999999999999999985421 12468899999999999999999999 999999999999999
Q ss_pred CCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhC--CCCCCcchhHHHhh
Q 018244 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG--KHIPPSHALDLIRD 262 (359)
Q Consensus 191 ~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg--~~p~~~~~~~~~~~ 262 (359)
+++.+||+|||++....... ...++..|+|||.+.++.++.++||||||+++|+|+++ ..||..........
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 99999999999987643322 12335689999999988899999999999999999984 44554332222211
Q ss_pred hhhhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 263 RNIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 263 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
....... ........+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111000 000111123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=313.32 Aligned_cols=250 Identities=17% Similarity=0.238 Sum_probs=200.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++++.||+|+||.||++.. .++..+|+|.+...... ...++.+|++++..++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 577888899999999999984 46888999998765332 2456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--CCCcC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSYS 213 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--~~~~~ 213 (359)
++++|.+++.. ...+++..+..++.|++.||.|||+..+++|+||||+||++++++.++|+|||++..... .....
T Consensus 82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999999963 466899999999999999999999743899999999999999999999999999876433 23456
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh---hhhhcc--------------------
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTLTD-------------------- 270 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~---~~~~~~-------------------- 270 (359)
++..|+|||.+.+..++.++|+||||+++|+|++|..|+............ ......
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence 788999999998888999999999999999999999887643221111000 000000
Q ss_pred --------ccccCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 --------SCLEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 --------~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.......+ ...+.++.+++.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011 1246679999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=320.79 Aligned_cols=248 Identities=15% Similarity=0.189 Sum_probs=195.0
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCC------
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 126 (359)
...|.+++.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35788899999999999999985 468899999997542 233556889999999999999999999886543
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 5766663 2478899999999999999999999 9999999999999999999999999998764
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh------------------h
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------I 265 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~------------------~ 265 (359)
... ....+|..|+|||++.+..++.++||||||+++|+|++|+.||............ .
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 2346788999999999889999999999999999999999988654211100000 0
Q ss_pred hhhccc--ccc----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 266 QTLTDS--CLE----------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 266 ~~~~~~--~~~----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...... ... .......+.++.+|+.+||+.||++|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000 00011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.11 Aligned_cols=249 Identities=18% Similarity=0.145 Sum_probs=197.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|++++.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+.++..++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 578889999999999999994 468899999997421 1224457889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999864 345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred --CcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...||+.|+|||++.. ..++.++|||||||++|+|++|+.||..................... .......+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF-PPDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC-CCccCCCCH
Confidence 2358999999999873 35788999999999999999999998765432222111111000000 111123577
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
++.+++.+|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 8999999988654443 7899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.84 Aligned_cols=245 Identities=18% Similarity=0.211 Sum_probs=200.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-----hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.|.+.+.||.|++|.||+|.. .++..+|+|.+...... ....+.+|+++++.++||||+++++++...+..++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 355666779999999999984 56889999998754221 234678899999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
+||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999986 345689999999999999999999999 9999999999999999999999999998754332
Q ss_pred -----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||........... ..........+...+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHH
Confidence 223467889999999988899999999999999999999988755322111111 11111122344556778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++.+||..+|++|||+.+++++
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=306.39 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=195.8
Q ss_pred ccccCCCCCCcEEEEEEeCC-Cc--EEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC------Ccce
Q 018244 61 IVSEHGEKAPNVVYKGKLEN-QF--RIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERL 129 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 129 (359)
+.+.||+|+||.||+|...+ +. .+|+|.+.... ....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45678999999999998644 32 69999987643 23356788999999999999999999987432 2468
Q ss_pred EEEecCCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 130 LVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
++|||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+|||+++++.++|+|||+++.
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999999999887421 234589999999999999999999999 999999999999999999999999999887
Q ss_pred CCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 206 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~ 236 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-----QGNRLKQP 236 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cCCCCCCC
Confidence 54322 2234568999999998889999999999999999999 677776533222211111 11111223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45667899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.17 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=202.3
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCC-CcccccccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 129 (359)
.+.+.+.||+|+||.||+|++. .+..||+|++....... .+.+.+|+++|..+. ||||+++++++......+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 4567788899999999999853 24679999998653332 446889999999997 999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCC------------------------------------------------------------
Q 018244 130 LVAEYMPNDTLAKHLFHWET------------------------------------------------------------ 149 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 149 (359)
+||||+++|+|.+++.....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999864211
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 150 ------------------------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 150 ------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
..+++..+..++.|++.||.|||+. +++||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCC
Confidence 2467788899999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhh
Q 018244 194 NPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 266 (359)
.+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |..|+..........
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~---- 352 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY---- 352 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH----
Confidence 9999999998764321 12345678999999998889999999999999999998 777765432221111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.......+...+...+.++.+|+.+||..+|++||++.++++.|+.+
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111122223445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.71 Aligned_cols=249 Identities=17% Similarity=0.214 Sum_probs=207.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
-+.+++++.||.|+||.||+|..++ +...|.|++.-......+.|+-||++|..++||+||++++.|...+.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3457899999999999999999554 555678888877777788999999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC----CCCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGR 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~----~~~~ 210 (359)
|.||-+...+.. -++.+++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+-.. ....
T Consensus 111 C~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred cCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 999988887765 567899999999999999999999999 9999999999999999999999999987543 2345
Q ss_pred CcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
.+.||+.|||||++. ..+|+.++||||||++|.||..+.+|...-. .++.-.......+ .....|..++..+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRVllKiaKSeP-PTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEP-PTLLQPSHWSRSF 265 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHHHHHHhhcCC-CcccCcchhhhHH
Confidence 789999999999876 3569999999999999999999996543322 1211111111111 1122467889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+++..||.+||..||++.+++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=344.40 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=207.9
Q ss_pred ccccccCCCCCCcEEEEEEeCC--C----cEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLEN--Q----FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
-.+...||+|+||.||.|...+ + ..||||.+.+.. .....+|.+|..+|+.++|||||+++|++.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3455678999999999998543 3 349999998764 34467899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 132 AEYMPNDTLAKHLFHW-----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
+|||.+|+|..+|++. ....++....+.++.|||+|+.||+++ +.|||||.+.|+||+....|||+|||+|+..
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 9999999999999863 145789999999999999999999999 9999999999999999999999999999954
Q ss_pred CCCCCc------CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 207 RDGRSY------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 207 ~~~~~~------~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
.+..-+ .-...|||||.+..+.++.++|||||||++||++|.. .|++........ ....... +...|.
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~----~~~~~gg-RL~~P~ 927 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL----LDVLEGG-RLDPPS 927 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH----HHHHhCC-ccCCCC
Confidence 433211 1125799999999999999999999999999999955 444443222221 1111222 445677
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.++..+.+||.+||+.+|++||++..|++.+..+...
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 8899999999999999999999999999988887653
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=303.87 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=204.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+||+++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3577888899999999999997777789999887543 235678899999999999999999999877 77899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99999999764556788999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||++....++.++|+||||+++|++++ |..||............... .....+...+.++.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIMM 237 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----CCCCCcccCCHHHHHHHH
Confidence 223467999999998889999999999999999999 78777654332222211111 111123445678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+||+.+|++||++.+++..|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=305.53 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=203.0
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+|++.+.||+|+||.||+|... .+..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677888999999999999853 234799999876432 2345789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~ 211 (359)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999964 345689999999999999999999999 999999999999999999999999999886543321
Q ss_pred -------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 212 -------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 212 -------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
..++..|+|||.+.+..++.++|+||||+++|++++ |..|+............... .....+...+.
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 236 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCPA 236 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCCH
Confidence 112457999999998889999999999999999886 88877544322221111111 11122334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=320.38 Aligned_cols=236 Identities=19% Similarity=0.234 Sum_probs=191.5
Q ss_pred cCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.++..+ +|+||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 479999999999984 5678999999986432 2345578899999888 6999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~~ 214 (359)
+|..++. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9998886 345799999999999999999999999 999999999999999999999999999875321 223568
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH---HhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
|+.|+|||++.+..++.++||||||+++|+|++|..||....... ............ ....+...+..+.+++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 999999999998899999999999999999999999885321100 000011111111 122445567789999999
Q ss_pred hcccCCCCCCCHH
Q 018244 292 CLQYEPRERPNPR 304 (359)
Q Consensus 292 cl~~dp~~Rps~~ 304 (359)
||+.||++|+++.
T Consensus 237 ~L~~dP~~R~~~~ 249 (327)
T cd05617 237 FLNKDPKERLGCQ 249 (327)
T ss_pred HhccCHHHcCCCC
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=321.06 Aligned_cols=248 Identities=15% Similarity=0.205 Sum_probs=196.1
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC------C
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 126 (359)
...|.+++.||+|+||.||+|.. ..+..||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45788889999999999999984 468899999997543 22345678899999999999999999988654 3
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 46999999976 6777663 2488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh----------------
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT---------------- 267 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~---------------- 267 (359)
... ....+|..|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 443 2346789999999999888999999999999999999999988654321111100000
Q ss_pred --hccc----------cc--------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 --LTDS----------CL--------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 --~~~~----------~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... .. ........+.++.+|+.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00 000112235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.31 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=200.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|++.+.||+|+||+||++.. .+++.+|+|.+...... ....+.+|+.+++.++|+|++.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 34556679999999999984 46889999998754322 234577899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---~ 211 (359)
+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9999999988654455789999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ........ .....+...+.++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-hhhhcCccCCHHHHHHHHH
Confidence 467899999999998889999999999999999999999887532211110 11111111 1112334566789999999
Q ss_pred hcccCCCCCCC-----HHHHHHH
Q 018244 292 CLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~ 309 (359)
||+.||++||| +.+++++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcC
Confidence 99999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=303.62 Aligned_cols=246 Identities=18% Similarity=0.187 Sum_probs=205.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|+.++.||.|+||.||.+. ..++..+++|.+.... ......+.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 36778888999999999998 4568899999987543 23355688999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999999754456789999999999999999999999 99999999999999999999999999987654332
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. .. ....+...+.++.+++.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GN-YTPVVSVYSSELISLVH 234 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CC-CCCCccccCHHHHHHHH
Confidence 34578899999999888889999999999999999999988865433222211111 11 11122445678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||..+|++|||+.++++.
T Consensus 235 ~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHcccCcccCCCHHHHhhC
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.84 Aligned_cols=241 Identities=18% Similarity=0.301 Sum_probs=205.1
Q ss_pred cCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
.||+|.||+||-|+ ..++.++|||.+........+.+.+||.+.+.|+|.|||+++|.+..++++-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 46999999999999 56688999999998776777788999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEeccCCcccCCC----CCCcCCC
Q 018244 143 HLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD----GRSYSTN 215 (359)
Q Consensus 143 ~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DFg~a~~~~~----~~~~~~t 215 (359)
+++. +=+++ ++.++..+..||++||.|||.+ .|||||||-+|||++ -.|.+||+|||.++.... ..++.||
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 9965 44556 7889999999999999999999 999999999999997 478999999998876543 3467899
Q ss_pred ccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 216 LAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 216 ~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
..|||||++..+. |..++|||||||++.||.||++||..-.......-... .-..-+..|.+.+.+++.+|.+|+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG---myKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG---MYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---ceecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999998764 99999999999999999999998864322211111111 111234567889999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018244 294 QYEPRERPNPRSLVTA 309 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (359)
..||.+||+++++|..
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999864
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=304.73 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=190.1
Q ss_pred cCCCCCCcEEEEEEeCC---CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||+|...+ +..+|+|.+...... ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 57999999999998543 457999998765432 23468889999999999999999999999999999999999999
Q ss_pred HhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------
Q 018244 140 LAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------ 210 (359)
Q Consensus 140 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------ 210 (359)
|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999986422 23467788889999999999999999 99999999999999999999999999987543321
Q ss_pred CcCCCccccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 211 SYSTNLAFTPPEYLRTG-------RVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
...++..|+|||++.+. .++.++||||||+++|||++ |..||.............................+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 23456789999988642 35789999999999999996 88887654322221111111111111111122345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
..+.+++..|| .+|++|||+++|+..|.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 67899999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=307.39 Aligned_cols=248 Identities=20% Similarity=0.304 Sum_probs=200.5
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.|.+++.||+|++|.||+|... .+..||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 4667788899999999999864 3568999988754433 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---CeEEeccCC
Q 018244 131 VAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGL 202 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---~~kl~DFg~ 202 (359)
||||+++++|.+++.... ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++ .+||+|||+
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCcc
Confidence 999999999999986432 12589999999999999999999999 999999999999998654 599999999
Q ss_pred cccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 203 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
++...... ....+..|+|||++.+..++.++|||||||++|+|++ |..||........... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~~ 240 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----VTGGGRL 240 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCcC
Confidence 88653221 1222457999999998889999999999999999997 8877765433322211 1111122
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 234456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.82 Aligned_cols=245 Identities=18% Similarity=0.238 Sum_probs=197.8
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++++.||+|+||.||+|. ..++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 46778889999999999998 45788999999875532 23456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCcC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~~ 213 (359)
++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999986543 478889999999999999999999 9999999999999999999999999998765433 3456
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH---hhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI---RDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
++..|+|||++.+..++.++|+||||+++|+|++|..||........ .....................+.++.+++.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 78899999999988899999999999999999999988754211100 000111111111111112235678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++||++++++++
T Consensus 235 ~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 235 QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhhCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=314.05 Aligned_cols=244 Identities=17% Similarity=0.254 Sum_probs=209.8
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
-|.+-+.||+|-|++|-+|+ .-.|..||||++.+..... ...+++|++.|+.++|||||+++++......+|||.|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35666778999999999998 4578999999998765443 34689999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCCCCC---
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~~~--- 210 (359)
-++|+|.+||.. ....+.+....+++.||+.|+.|+|+. ++|||||||+||.+.+ -|-|||+|||++..+.++.
T Consensus 99 GD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 99 GDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred cCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 999999999986 345799999999999999999999999 9999999999998864 5889999999999887764
Q ss_pred CcCCCccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
..+|++.|.|||++.+..|+. ++||||||||||.|++|+.||+...-.. .+-.+++.. ...|...+.++++||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCK--YtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCK--YTVPSHVSKECRDLI 250 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhccc--ccCchhhhHHHHHHH
Confidence 567899999999999999875 7899999999999999999987543221 222233322 245788999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
..||..||.+|.|.++|...
T Consensus 251 ~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHhcCchhhccHHHHhcc
Confidence 99999999999999999864
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=301.58 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=199.1
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
.||.|+||.||+|...+++.||+|.+...... ....+.+|+++++.++|+||+++++++......++||||+.+++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 57999999999999766889999998865443 45678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC------cCCCc
Q 018244 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTNL 216 (359)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~------~~~t~ 216 (359)
++.. ....+++..+..++.+++.||.|||++ +++|+||||+||+++.++.++|+|||++........ ...+.
T Consensus 82 ~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 82 FLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9864 344688999999999999999999999 999999999999999999999999999876542221 12245
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (359)
.|+|||.+.++.++.++|+||||+++|+|+| |..|+............. .......+...+.++.+++.+||..
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-----SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-----cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 7999999988889999999999999999999 666665443222221111 1111223345667899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 018244 296 EPRERPNPRSLVTALV 311 (359)
Q Consensus 296 dp~~Rps~~~il~~L~ 311 (359)
+|++|||+.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=303.12 Aligned_cols=249 Identities=14% Similarity=0.162 Sum_probs=204.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+|.+.+.+|.|+||.||+|.. .++..+|+|.+........+.+.+|+++++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 3577888899999999999985 457889999998766556678899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
.+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 83 ~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999998864 235789999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cCCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
..++..|+|||.+.+. .++.++|+||||+++|+|++|..|+................... .........+.++.++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 239 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ccccchhhhhHHHHHH
Confidence 4567889999999876 78899999999999999999998876543221111111100000 0111234457789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~ 308 (359)
+.+||..+|.+|||+.+++.
T Consensus 240 i~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.06 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=202.7
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..++.+.+.||.|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 356778889999999999999977677899999875432 3457889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
.+++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 82 EHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999864 345689999999999999999999999 99999999999999999999999999987543321
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...++..|+|||.+.++.++.++||||||+++|+|++ |..||............... .....+...+..+.+|+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-----FRLYKPRLASQSVYELM 234 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-----CCCCCCCCCCHHHHHHH
Confidence 1223568999999998889999999999999999998 88777654332222211110 11111233467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L 310 (359)
.+||+.+|++|||+.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=305.26 Aligned_cols=244 Identities=17% Similarity=0.228 Sum_probs=210.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+.++++||+|+||.||+|. ...|..+|+|.+... .+.+++..|+.++++++.+++|+++|.|-....++||||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 4688899999999999998 457999999999864 4578899999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYS 213 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~ 213 (359)
|++.+.++. +..++++..+..+++..+.||+|||.. .-+|||||+.|||++-+|.+||+|||.|....+ .+...
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 999998865 567899999999999999999999998 889999999999999999999999999987654 35678
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
||+-|||||++..-.|+.++||||||++..||..|++|+.+-.. + ...+.....+.....-|..++.++.+++++||
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--M-RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--M-RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--c-ceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 99999999999999999999999999999999999987754321 1 11111122222222345678999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018244 294 QYEPRERPNPRSLVTA 309 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (359)
-+.|++|-|+.+++++
T Consensus 268 iK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEH 283 (502)
T ss_pred cCCHHHHHHHHHHhhh
Confidence 9999999999998874
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=309.96 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=200.6
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-----------------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~ 118 (359)
.+|++++.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467889999999999999987532 245899998865433 35678899999999999999999
Q ss_pred cceeeeCCcceEEEecCCCCCHhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
++++...+..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili 163 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLV 163 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchhceee
Confidence 999999999999999999999999986432 12689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCcchhHHHh
Q 018244 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIR 261 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--g~~p~~~~~~~~~~ 261 (359)
++++.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ +..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 999999999999987643221 2334678999999998889999999999999999998 44555432221111
Q ss_pred hhhhhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 262 DRNIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 262 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
........ ........+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111100 000111123345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=305.17 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=187.8
Q ss_pred cCCCCCCcEEEEEEeCC---CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
+||+|+||.||+|...+ ...+|+|.+...... ....+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 57999999999997433 346888887654322 24567899999999999999999999999999999999999999
Q ss_pred HhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC------C
Q 018244 140 LAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------R 210 (359)
Q Consensus 140 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~------~ 210 (359)
|.+++.... ....++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||++...... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 999986532 23356788899999999999999999 9999999999999999999999999998653222 2
Q ss_pred CcCCCccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 211 SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
...++..|+|||++.. ..++.++||||||+++|+|++ |..|+.........................+...+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2234567999998753 346789999999999999999 56565443221111111111111111122334566
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
..+.+++..|| .||++|||+++|++.|
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 77889999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=311.66 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=204.6
Q ss_pred cccccccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCc
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (359)
+|.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+++++.+ .||||+++++++.....
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 4567888999999999999741 245799999875432 2355688999999999 69999999999998889
Q ss_pred ceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ |++|+||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCC
Confidence 999999999999999996532 23588999999999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhh
Q 018244 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 266 (359)
.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 251 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997654321 1123457999999998889999999999999999999 7777765433222221111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
......+...+.++.+++.+||+.||++|||+.++++.|..+....
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 252 -----GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111233455678999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=315.68 Aligned_cols=248 Identities=15% Similarity=0.149 Sum_probs=193.6
Q ss_pred ccccCCCC--CCcEEEEEE-eCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 61 IVSEHGEK--APNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 61 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+++.||+| +|++||++. ..+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45677888 788999998 45789999999976532 22345778999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-------
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------- 208 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~------- 208 (359)
++|+|.+++.......+++..+..++.|++.||.|||++ +++||||||+|||++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999654455689999999999999999999999 999999999999999999999999986433211
Q ss_pred ----CCCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc-----------
Q 018244 209 ----GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS----------- 271 (359)
Q Consensus 209 ----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 271 (359)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 112245678999999976 358899999999999999999999886432211111100000000
Q ss_pred -----------------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 -----------------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 -----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..........++.+.+|+.+||+.||++|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000112346789999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.87 Aligned_cols=250 Identities=16% Similarity=0.222 Sum_probs=204.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....|.+++.||.|+||.||+|.. .++..+|+|.+........+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 445688999999999999999995 4688999999987655556678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999998864 345699999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 210 RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....++..|+|||.+. ...++.++|+||||+++|+|++|+.||.............. ... .....+...+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~ 237 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEP--PTLDQPSKWSSS 237 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCC--CCcCCcccCCHH
Confidence 2345788999999875 33477899999999999999999988765422211111110 000 011123446678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=316.17 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=199.7
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeC-Ccc
Q 018244 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~ 128 (359)
+|++.+.||.|+||.||+|.. .+++.||||.+...... ....+.+|+.++..+ +|+||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 678899999999999999973 34678999999764322 345688999999999 689999999988654 467
Q ss_pred eEEEecCCCCCHhhhhhcCC------------------------------------------------------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (359)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999986421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------CcCCCcc
Q 018244 149 -----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLA 217 (359)
Q Consensus 149 -----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------~~~~t~~ 217 (359)
...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....... ...++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 12367888999999999999999999 99999999999999999999999999987643221 1234567
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
|+|||.+.+..++.++||||||+++|+|++ |..|++.......... ..........+...+.++.+++.+||+.|
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH----HHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999988889999999999999999997 7777654322111111 11111111222334567999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhh
Q 018244 297 PRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 297 p~~Rps~~~il~~L~~~~~ 315 (359)
|++|||+.++++.|+.+.+
T Consensus 323 p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 323 PSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=304.58 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=201.0
Q ss_pred ccccccCCCCCCcEEEEEEeC-CC---cEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
|...+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|+++++.++|+||+++.+++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 445666799999999999854 33 379999987653 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC--
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-- 211 (359)
|+++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 87 YMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999864 345789999999999999999999999 999999999999999999999999999876543211
Q ss_pred -----cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 212 -----YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 212 -----~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...+..|+|||++.+..++.++||||||+++|+|++ |..|+.............. ......+...+.++
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~ 239 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-----GFRLPAPMDCPSAV 239 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-----CCCCCCCCCCCHHH
Confidence 112346999999988889999999999999999997 8888765432222211111 11112233456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+++.+||+.+|++||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=302.85 Aligned_cols=244 Identities=24% Similarity=0.318 Sum_probs=192.4
Q ss_pred cCCCCCCcEEEEEEeC----CCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeee-CCcceEEEecCCC
Q 018244 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEYMPN 137 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~ 137 (359)
.||+|+||.||+|... +...+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. +...+++|||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 4699999999999843 24579999986432 2345678899999999999999999997753 5568999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--------
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-------- 209 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-------- 209 (359)
|+|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 82 GDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999864 334567888899999999999999999 9999999999999999999999999998754321
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-CCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....++..|+|||.+.+..++.++||||||+++|||++|..| +............ . .......+...+..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL----L-QGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----h-cCCCCCCCCcCCHHHHHH
Confidence 122346689999999888899999999999999999996554 4332211111111 1 111111223346789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
+.+||+.+|++||++.++++.|+.+.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=306.18 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=204.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-----CcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeee-CCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~ 129 (359)
..|.+.+.||+|+||.||+|...+ +..||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 356677788999999999999654 68899999875432 235568899999999999999999998766 56789
Q ss_pred EEEecCCCCCHhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 130 LVAEYMPNDTLAKHLFHWET------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+++||+++++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 99999999999999864322 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCC
Q 018244 204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (359)
Q Consensus 204 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
+...... ...++..|+|||++.+..++.++||||||+++|++++ |+.||............. ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~ 239 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-----DGYRLA 239 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----cCCCCC
Confidence 8653321 2334668999999988889999999999999999999 888776543222221111 111112
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+..+++++.+++.+||..||++|||+.++++.|+.+.+
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 233456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=308.36 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=201.4
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
.+|++++.||.|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.+.||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 45778889999999999999853 4678999998765432 2456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
++|||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~ 163 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCLV 163 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheEe
Confidence 9999999999999996421 12478889999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhh
Q 018244 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD 262 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~ 262 (359)
++++.++|+|||++....... ....+..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987543221 2233567999999988889999999999999999998 766765433222211
Q ss_pred hhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
. +.... ....+...+.++.+|+.+||+.||++|||+.++++.|++
T Consensus 244 ~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 Y----VRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----HhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11111 111234456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=307.70 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=200.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
.+|.+++.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 46778889999999999999743 245799999875432 22345788999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCC
Confidence 9999999999999996422 13456778899999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 202 ~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |..|+............. .. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----~~-~~ 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM----DG-GY 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cC-CC
Confidence 98754322 12234567999999998889999999999999999998 566665433222221111 11 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 122334567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=305.06 Aligned_cols=245 Identities=14% Similarity=0.207 Sum_probs=196.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeC------Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG------DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~~ 129 (359)
.|.+.+.||.|+||.||+|.. .++..+|+|.+.... .....+.+|+.++..+ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 355667789999999999985 468899999997654 3345788899999998 699999999998753 4578
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
++|||+++++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 999999999999998764556789999999999999999999999 9999999999999999999999999998764322
Q ss_pred ----CCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 210 ----RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
....++..|+|||++. +..++.++||||||+++|+|++|..||........... .............
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 240 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKK 240 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCC
Confidence 2346788999999986 33588899999999999999999988754321111110 0111111112234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.+.++.+|+.+||..||.+|||+.+++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 5678999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.37 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=196.0
Q ss_pred cCCCCCCcEEEEEEeC-CCc--EEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||.||+|... ++. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..+++|||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 4699999999999864 343 57889887533 23345788999999999 7999999999999999999999999999
Q ss_pred CHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 139 TLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 139 sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999986422 13578999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
..... .....+..|+|||++....++.++||||||+++|+|++ |..||............ ........+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~ 235 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLEKPLN 235 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-----hCCCCCCCCCc
Confidence 43211 11223567999999988889999999999999999997 88887554332221111 11111122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.+.++.+++.+||+.||.+|||+.+++..|+.+.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=308.56 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=198.2
Q ss_pred cccccccCCCCCCcEEEEEEeC-----------------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCccccccc
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-----------------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL 119 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~ 119 (359)
+|.+.+.||+|+||.||++... ++..+|+|.+...... ....+.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4678888999999999998532 2446999999865322 346789999999999999999999
Q ss_pred ceeeeCCcceEEEecCCCCCHhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC
Q 018244 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (359)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~ 190 (359)
+++...+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~ 164 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVG 164 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEc
Confidence 99999999999999999999999986422 12477889999999999999999999 999999999999999
Q ss_pred CCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCcchhHHHhh
Q 018244 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRD 262 (359)
Q Consensus 191 ~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--g~~p~~~~~~~~~~~ 262 (359)
.++.++|+|||++....... ...++..|+|||...++.++.++||||||+++|||++ |..|+..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999987653322 1223568999999888889999999999999999998 555654332222111
Q ss_pred hhhhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 263 RNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
........ .......+..++..+.+|+.+||+.||++|||+.++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11000000 00011122345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=307.39 Aligned_cols=250 Identities=17% Similarity=0.254 Sum_probs=202.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++++.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788999999999999999964 68899999987542 223457889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCc
Q 018244 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~ 212 (359)
++++|.+++.... ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 9999998885421 2378999999999999999999996339999999999999999999999999998765332 234
Q ss_pred CCCccccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
.++..|+|||.+.+.. ++.++||||||+++|+|++|..||........... ...... ......+...+.++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~ 239 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVD-GDPPTLPSGYSDDAQ 239 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhh-cCCCCCCcccCHHHH
Confidence 5678999999986543 57899999999999999999998865433222111 111111 112234455788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+||..+|++||++.++++.
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhcC
Confidence 99999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=302.69 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+.+|.+.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 45678888999999999999975 56689999987543 245788999999999999999999998654 579999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-CcCC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYST 214 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-~~~~ 214 (359)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 999999999765555689999999999999999999999 99999999999999999999999999987654332 2233
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||.............. ......+...+..+.+++.+||
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----GYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----CCCCCCCCcCCHHHHHHHHHHc
Confidence 567999999988889999999999999999998 8877765543332222111 1111223445678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 018244 294 QYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~L~~ 312 (359)
+.+|++||++++++..|+.
T Consensus 235 ~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 235 ETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCChhhCcCHHHHHHHHcc
Confidence 9999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=338.93 Aligned_cols=255 Identities=19% Similarity=0.187 Sum_probs=203.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++++.||+|+||.||+|.. .++..||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4678889999999999999985 45889999999754322 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 133 EYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
||++||+|.+++.... ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.++|+|||++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999886311 23456778899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC----------------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh
Q 018244 204 KNSRDG----------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (359)
Q Consensus 204 ~~~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~ 261 (359)
...... ....||+.|+|||++.+..++.++|||||||++|||+||..||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 765110 1235899999999999989999999999999999999999988653322111
Q ss_pred hhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhh
Q 018244 262 DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP-NPRSLVTALVTLQK 315 (359)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~il~~L~~~~~ 315 (359)
.. .....+. ........+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 241 ~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 YR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111110 0001124567799999999999999996 66777777877654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=302.27 Aligned_cols=246 Identities=16% Similarity=0.181 Sum_probs=202.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC-CcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 133 (359)
.|++++.||.|++|.||++.. .+++.+|+|.+..... ...+.+.+|+++++.++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 367888999999999999994 4578899999875432 2345688899999999999999999887643 45789999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++.......+++.++..++.|++.||.+||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999999764456789999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||................ ....+...+..+.+++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li 234 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-----LPPMPKDYSPELGELI 234 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----CCCCccccCHHHHHHH
Confidence 23456789999999998889999999999999999999998886543332221111111 1123345677899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.+++.+
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHhccCcccCCCHHHHhcC
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=308.54 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=205.3
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..+|++++.||+|+||+||++.. .++..||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35688899999999999999984 4688999998875432 235678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--CCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRS 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--~~~ 211 (359)
|+++++|.+++. ....+++..+..++.+++.||.|||+..+++|+||+|+||++++++.++|+|||++..... ...
T Consensus 84 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred cCCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 999999999886 3456899999999999999999999743899999999999999999999999999865432 223
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH----h---hhhhhhhccccccCCCC-hHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----R---DRNIQTLTDSCLEGQFS-SDEGT 283 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~----~---~~~~~~~~~~~~~~~~~-~~~~~ 283 (359)
..++..|+|||++.+..++.++||||||+++|+|++|..||........ . ........... ....+ ...+.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCchhcCH
Confidence 4678999999999888899999999999999999999998875432100 0 00111111111 11111 23567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
++.+|+.+||+.||++|||+.+++++..-
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 89999999999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.40 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=196.9
Q ss_pred ccCCCCCCcEEEEEEeC-C---CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 63 SEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
++||+|+||.||+|... . +..+|+|.+...... ..+.+.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 35799999999999742 2 368999999866542 3557889999999999999999999875 4568999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc-----
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----- 212 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~----- 212 (359)
|+|.+++.. ...+++..+..++.|++.||.|||.. +++|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999974 34789999999999999999999999 9999999999999999999999999998865433221
Q ss_pred --CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 213 --STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 213 --~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+...+..+.+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-----ESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-----HcCCcCCCCCCCCHHHHHHH
Confidence 12357999999998889999999999999999998 88776543222211111 11111223445667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.+||..+|++|||+.++++.|+.+.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=319.27 Aligned_cols=248 Identities=15% Similarity=0.192 Sum_probs=195.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC------C
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 126 (359)
...|.+++.||+|+||.||+|.. ..+..||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 35788889999999999999984 468889999997542 23345688999999999999999999987543 3
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999976 6777764 2488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc-------------
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD------------- 270 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 270 (359)
... ....+|..|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 443 2346789999999999889999999999999999999999988654321111111100000
Q ss_pred -----cc--c----------------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 -----SC--L----------------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 -----~~--~----------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. . ........+.++.+|+.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0 000011134578999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=306.02 Aligned_cols=243 Identities=15% Similarity=0.227 Sum_probs=202.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|.+++.||.|++|.||+|.. .++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 567788889999999999995 468899999987653 334566889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++..... ..
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999853 3789999999999999999999999 9999999999999999999999999998776543 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH-HHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|+||..||............ ........+.. .+.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-----PKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-----hhcCCCCCcccccCHHHHHHHH
Confidence 45678899999999888999999999999999999999887543321111111 11111112222 5678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||..+|++|||+++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=305.07 Aligned_cols=253 Identities=17% Similarity=0.249 Sum_probs=202.4
Q ss_pred HHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 49 LRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 49 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
++.+++++.....+ |+|+||.||+|. ..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~~l---g~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 3 YEYEYDENGERVVL---GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccccccCCceEEE---ecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34456666665554 999999999998 44678899999987765666788999999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcc
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMK 204 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~ 204 (359)
.++|+||+++++|.+++... ...+ ++..+..++.|++.||+|||++ +++|+||||+||+++. ++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999998642 2344 8888999999999999999999 9999999999999986 6799999999987
Q ss_pred cCCCC----CCcCCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 205 NSRDG----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
..... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+............ ..........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIP 234 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCCC
Confidence 54322 2345788999999987643 788999999999999999999887543211111000 00001112334
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...++++.+++.+||+.+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 5567889999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.91 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=210.1
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchH-HHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
..+.++||+|-||.|..+....+..||||.++.....+. +.|.+|+++|.+|+|||||+++|+|..++.+++|+||+.+
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 456788999999999999988889999999998765554 7899999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc-----
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----- 212 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~----- 212 (359)
|+|.+++..+....+......+|+.||+.|++||.+. ++|||||.+.|+|+|.++++||+|||+++....+..+
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 9999999865444455566778999999999999999 9999999999999999999999999999976555432
Q ss_pred -CCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCcchhHHHhhhhhhhhccccc---cCCCChHHHHHHH
Q 018244 213 -STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTELV 286 (359)
Q Consensus 213 -~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 286 (359)
+-..+|||||.+..++++.++|+|+||+++||+++ ...|+.....+...+.. ..+.+... ....|.-++..+.
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~-~~~~~~~~~~~~l~~P~~cp~~ly 777 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA-GEFFRDQGRQVVLSRPPACPQGLY 777 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh-hhhcCCCCcceeccCCCcCcHHHH
Confidence 22479999999999999999999999999999854 55566544333333222 22222211 1223556788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
++|..||..|-++|||++++...|+..
T Consensus 778 elml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 778 ELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 999999999999999999999888754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=317.48 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=195.2
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC------C
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 126 (359)
...|.+++.||.|+||+||+|.. .++..||||.+..... .....+.+|+++|+.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 35688889999999999999984 5688999999975432 2345677899999999999999999987543 3
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++++|++ +++|.+++ ....+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 468999998 67898877 345699999999999999999999999 9999999999999999999999999999875
Q ss_pred CCC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh------------------
Q 018244 207 RDG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------ 266 (359)
Q Consensus 207 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------ 266 (359)
... ....+|..|+|||++.+ ..++.++||||||+++|+|++|..||+.............
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 543 34568899999999876 4688999999999999999999998875422111100000
Q ss_pred -hhccccccCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 -TLTDSCLEGQ-------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 -~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... +... .....++.+.+|+.+||..||++|||+.+++++
T Consensus 249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 249 RKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000 001134568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=308.63 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHH--HHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDAR--QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|++++.||+|+||+||++... ++..+|+|.+......... ...+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678889999999999999954 5678999999987544332 2456999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC----CCCCC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~----~~~~~ 211 (359)
++++|.+++. ....+++..+..++.|++.||.+||+. +++|+||||+||++++++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 456789999999999999999999999 9999999999999999999999999998752 22234
Q ss_pred cCCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh---hhhhhhhccccccCCCChHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 212 ~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
..++..|+|||++. +..++.++||||+|+++|+|++|..|+......... .......... ...........+.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--SSQQSREKSEELRD 235 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--HTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--cccccchhHHHHHH
Confidence 56788999999998 778999999999999999999999888765111111 1111111110 00111122478999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~ 308 (359)
++.+||+.||++|||+.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.29 Aligned_cols=236 Identities=25% Similarity=0.392 Sum_probs=190.3
Q ss_pred cCCCCCCcEEEEEEeCC-C----------cEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 64 EHGEKAPNVVYKGKLEN-Q----------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 57999999999999654 3 25888887655433 5678899999999999999999999988 7789999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-------CeEEeccCCccc
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-------NPRLSCFGLMKN 205 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-------~~kl~DFg~a~~ 205 (359)
||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++..
T Consensus 80 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 80 EYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999999999864 233789999999999999999999999 999999999999999887 799999999987
Q ss_pred CCCCCCcCCCccccCcccccCC--CCCCccchhhHHHHHHHHHhC-CCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 206 SRDGRSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 206 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
........++..|+|||++.+. .++.++||||||+++|+|++| ..|+.......... ... . ....+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~---~---~~~~~~~~~ 230 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQ---D---QHRLPMPDC 230 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHh---c---CCCCCCCCc
Confidence 6665556677889999999876 689999999999999999996 44443321111110 000 0 011112223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
..+.+++.+||..+|++|||+.++++.|
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.48 Aligned_cols=242 Identities=18% Similarity=0.278 Sum_probs=199.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch---------HHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
|.+.+.||.|++|.||+|.. .++..+|+|.+....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 44556789999999999985 467899999887543221 24578899999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999996 345689999999999999999999999 999999999999999999999999999876542
Q ss_pred C----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 209 G----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 209 ~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~ 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGE-NASPEIP 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhc-cCCCcCC
Confidence 1 12346788999999998889999999999999999999999886542211111 1111 1122334
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
...+..+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 456788999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.29 Aligned_cols=243 Identities=16% Similarity=0.273 Sum_probs=201.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|..++.||.|+||.||+|.. .++..||+|.+..... ...+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 456777889999999999985 4578899999875432 33456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
++++|.+++. ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999884 45789999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||++.+..++.++||||||+++|+|++|..|+.......... ..............+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCCCCCCCcccCHHHHHHHHH
Confidence 356788999999998889999999999999999999998875432211111 111111122233456789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.+|++|||+.+++.+
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 236 CLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HccCCcccCcCHHHHHHh
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=310.03 Aligned_cols=252 Identities=17% Similarity=0.254 Sum_probs=200.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+..|.+++.||.|+||.||+|.. .++..||+|.+...... ....+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 466789999999999999999985 46789999998754322 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 84 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99974 89888864 345689999999999999999999999 9999999999999999999999999998764322
Q ss_pred -CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-----------hhcc------
Q 018244 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------TLTD------ 270 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-----------~~~~------ 270 (359)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.............. ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223457899999998754 478899999999999999999998875433221110000 0000
Q ss_pred ---ccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 ---SCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ---~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.... ......+.++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0112356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.76 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=203.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.++.+.+.||.|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++|+||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346677788999999999998533 3469999887654 3345678999999999999999999998865 567899
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999964 344689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...++..|+|||.+....++.++||||||+++|++++ |..||.............. ......+...+..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 237 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPTL 237 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CCcCCCCCCCCHHH
Confidence 1223457999999988889999999999999999986 8888765533222111111 11112334566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.+++.+||..+|++|||+.++++.|+.+..+
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=303.04 Aligned_cols=251 Identities=18% Similarity=0.261 Sum_probs=205.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CC----cEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQ----FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||.||+|... +| ..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 35678888999999999999853 33 26899988765432 34678899999999999999999999877 78999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 86 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 86 ITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999864 344689999999999999999999998 99999999999999999999999999998655332
Q ss_pred C------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
. ..++..|+|||.+....++.++|+||||+++||+++ |..|+.............. ......+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 238 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-----GERLPQPPICTI 238 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-----CCCCCCCCCCCH
Confidence 2 112467999999988889999999999999999998 8888766543333221111 111122334557
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+.+++.+||..||++|||+.++++.|..+.+
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.23 Aligned_cols=235 Identities=17% Similarity=0.178 Sum_probs=188.7
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC---CCcccccccceeeeCCcceEEEecCCC
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL---RNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
||+|+||+||+|.. .++..||+|++..... ........|..++..+ .||||+++++++...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 59999999999985 4688999999875321 1223455667777665 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCcC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYS 213 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~~ 213 (359)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++..... .....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99999886 456789999999999999999999999 999999999999999999999999999875322 22456
Q ss_pred CCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC-hHHHHHHHHHHHH
Q 018244 214 TNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELVRLASR 291 (359)
Q Consensus 214 ~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~ 291 (359)
||..|+|||++.+. .++.++|||||||++|+|++|..||................ ..++ ...+.++.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK------VRFPKNVLSDEGRQFVKG 231 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC------CCCCCccCCHHHHHHHHH
Confidence 89999999998765 48899999999999999999999987654433322211110 0111 2356789999999
Q ss_pred hcccCCCCCC----CHHHHHH
Q 018244 292 CLQYEPRERP----NPRSLVT 308 (359)
Q Consensus 292 cl~~dp~~Rp----s~~~il~ 308 (359)
||+.||++|| ++.++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 9999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=324.14 Aligned_cols=243 Identities=18% Similarity=0.210 Sum_probs=191.1
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|.+.+.||.|+||.||+|... .+..||||.... ..+.+|+++|++++|+||+++++++......++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 4778889999999999999954 578899996432 335689999999999999999999999999999999995
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC------C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------R 210 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~------~ 210 (359)
++|.+++.. ....+++..+..|+.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++..... .
T Consensus 244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 588888854 344799999999999999999999999 9999999999999999999999999998765332 1
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch------------hHHHhhhhhh--hhcc------
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNIQ--TLTD------ 270 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~------------~~~~~~~~~~--~~~~------ 270 (359)
...||..|+|||++.+..++.++|||||||++|||++|..++.... ...+...... .+..
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2458999999999998899999999999999999999876543211 0011100000 0000
Q ss_pred ---------ccccCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 ---------SCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ---------~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
........ ...+.++.+|+.+||+.||.+|||+.|+|++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 0234578999999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=316.36 Aligned_cols=249 Identities=16% Similarity=0.128 Sum_probs=197.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||+|+||+||+++. .++..||+|.+.... ......+.+|+.++..++|+||+++++++...+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999999995 467889999987521 1223457889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 82 YYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999964 245789999999999999999999999 99999999999999999999999999987654332
Q ss_pred --CcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...||+.|+|||++.+ +.++.++||||||+++|+|++|+.||.................... .+......+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~~~ 238 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ-FPSHITDVSE 238 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc-CCCccccCCH
Confidence 2458999999999875 4578899999999999999999999876543222211111100000 0111133567
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
++.+++.+|+..++.+ |+++++++++
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 8999999999876544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.40 Aligned_cols=246 Identities=17% Similarity=0.191 Sum_probs=204.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|.+++.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367788899999999999984 568899999987532 22345788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+.+++|.+++.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999998654445689999999999999999999999 99999999999999999999999999987654432
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...++..|+|||++.+..++.++|+||||+++|+|++|..|+............... .....+...+.++.+++.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-----SYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-----CCCCCcccCCHHHHHHHH
Confidence 345778899999999888999999999999999999999888654333222111111 111233456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.+|++||++.+++.+
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.51 Aligned_cols=244 Identities=16% Similarity=0.258 Sum_probs=203.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|..++.||.|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.+.|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3566788899999999999985 4588999999875432 3356788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++++|.+++. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 84 LGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99999999884 35689999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......... ..............+..+.+++.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----hhhcCCCCCCchhhhHHHHHHHH
Confidence 2356788999999988889999999999999999999998876543221111 11111122334567788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.+|++||++.+++..
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=306.50 Aligned_cols=250 Identities=19% Similarity=0.225 Sum_probs=196.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+|.+++.||.|++|.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467788899999999999995 4688999999875432 2245688899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 135 MPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
+. ++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 97 58888886433 35789999999999999999999999 9999999999999999999999999998755432
Q ss_pred CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh--------------------
Q 018244 210 RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------------------- 268 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-------------------- 268 (359)
....+++.|+|||.+.+. .++.++||||||+++|+|+||+.||................
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 223457889999988754 47889999999999999999998886442211100000000
Q ss_pred cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 ~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...... .......+.++.+++.+||..||++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00112356788999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=311.88 Aligned_cols=243 Identities=13% Similarity=0.168 Sum_probs=190.3
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|.+++.||.|+||.||+|... ++..||+|..... ....|+.+++.++|+||+++++++......++|+||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 5888999999999999999954 5778999975532 23568999999999999999999999999999999995
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~ 213 (359)
++|.+++.. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 588888864 455789999999999999999999999 9999999999999999999999999998754322 2346
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh----HHHh--hhhhhhhc------ccccc-------
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIR--DRNIQTLT------DSCLE------- 274 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~----~~~~--~~~~~~~~------~~~~~------- 274 (359)
||..|+|||++.+..++.++|||||||++|||+++..++..... .... ...+.... .....
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 88999999999988999999999999999999987655432110 0000 00000000 00000
Q ss_pred ------------CC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 ------------GQ-------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 ------------~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. .....+.++.+||.+||+.||++|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 001234567789999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.21 Aligned_cols=244 Identities=17% Similarity=0.226 Sum_probs=199.7
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
|.+.+.||.|+||.||+|...++..+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 5566778999999999999878889999998754321 1345888999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---- 208 (359)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999998875421
Q ss_pred ------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 209 ------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 209 ------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||............ . .........+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 235 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-G--AHRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-h--hccCCCCCCCCCCC
Confidence 12345788999999999888999999999999999999999888643211111000 0 00011122344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.++.+++.+||+.+|++|||+.+++.
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 78999999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.14 Aligned_cols=245 Identities=16% Similarity=0.204 Sum_probs=202.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+|.+.+.||.|+||.||+|... ++..+|+|.+..... .+.+.+|+++++.++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 35677888899999999999965 478999999876432 567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
.+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999854 346789999999999999999999999 99999999999999999999999999988654332 3
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||++.+..++.++||||||+++|+|++|+.|+............. .........+...+.++.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHHH
Confidence 346789999999998889999999999999999999998876432211110000 00001111233456789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVT 308 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~ 308 (359)
||+.||++|||+.+++.
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.30 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=202.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++.+.+|.|+||+||+|.. .++..+|+|++..... .....+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 567888899999999999994 4688999999975432 24567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 136 PNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999975332 5689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC-CCChHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG-QFSSDEGTE 284 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 284 (359)
...++..|+|||.+... .++.++|+||||+++|+|++|+.|+............... ....... ......+..
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKS 239 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHH
Confidence 23578899999998876 6889999999999999999999887654322111111111 0111111 111245688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++.+||..||++|||+.+++.+
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=320.55 Aligned_cols=243 Identities=16% Similarity=0.199 Sum_probs=195.1
Q ss_pred cccccccCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|.+++.||.|+||.||+|... .+..||+|.+... ....+|+++|+.++||||+++++++......+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 5889999999999999999743 3578999988653 2346799999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+. ++|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++.......
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 96 57888884 456799999999999999999999999 99999999999999999999999999987654321
Q ss_pred --CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh---hhhhhh------------------
Q 018244 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQT------------------ 267 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~---~~~~~~------------------ 267 (359)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ......
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 346899999999999889999999999999999999999998654211000 000000
Q ss_pred -h--ccccccCCC--C-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 -L--TDSCLEGQF--S-----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 -~--~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+ ........+ + ...+.++.++|.+||..||++|||+.+++.+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000 0 1235678899999999999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.52 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=200.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCc----EEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
+++.++.||+|+||.||+|.+ .++. .+|+|.+....... ...+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 456777889999999999985 3443 57999887654322 34688999999999999999999998654 57799
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
+||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999999864 344689999999999999999999999 99999999999999999999999999998654322
Q ss_pred -----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+........... .........+...+.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEKGERLPQPPICTID 239 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCCCCCCCCCCCHH
Confidence 1234568999999998889999999999999999997 7777765432222211 1111111122345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+.+++.+||..+|++||++.++++.|+.+..+
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=310.60 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=204.8
Q ss_pred cccccccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCc
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (359)
.|.+.+.||+|+||.||+|... .+..+|+|.+..... ...+.+.+|+++++++ +|+||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 4678889999999999999732 123689998875432 2356788999999999 79999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
.++++||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~ 171 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDN 171 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC
Confidence 999999999999999986422 23578899999999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhh
Q 018244 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 266 (359)
.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 251 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999987654322 1223467999999998889999999999999999998 7777765543333222111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
......+...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 252 -----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111223345567899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=308.66 Aligned_cols=246 Identities=18% Similarity=0.174 Sum_probs=201.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|++.+.||.|++|.||+|... ++..+|+|.+...... ..+.+.+|+++++.++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5677888899999999999954 5889999999865433 34568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998754556799999999999999999999999 9999999999999999999999999987653221
Q ss_pred -----------------------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH
Q 018244 210 -----------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (359)
Q Consensus 210 -----------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~ 260 (359)
....|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 123567889999999988899999999999999999999999865543222
Q ss_pred hhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 018244 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSLVT 308 (359)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~il~ 308 (359)
.... .............+..+.+++.+||..||++||| ++++++
T Consensus 241 ~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 1111111111225788999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=299.80 Aligned_cols=246 Identities=18% Similarity=0.225 Sum_probs=186.4
Q ss_pred cCCCCCCcEEEEEEeCCC---cEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKLENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
+||+|+||.||+|...++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 579999999999974332 3566777665432 335678999999999999999999999999999999999999999
Q ss_pred HhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC------CCC
Q 018244 140 LAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS 211 (359)
Q Consensus 140 L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~------~~~ 211 (359)
|.+++.... ....++..+..++.||+.||+|||+. +++|+||||+|||++.++.++|+|||++..... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999986432 23467778899999999999999999 999999999999999999999999999764221 223
Q ss_pred cCCCccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCC-CCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 212 YSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
..++..|+|||++.. ..++.++||||||+++|||+++.. |+......................+......+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 456789999998753 235789999999999999998644 443322111111111111111111222334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.+.+++..|| .+|++|||++++++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 8899999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.71 Aligned_cols=246 Identities=18% Similarity=0.207 Sum_probs=203.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|++++.||.|++|.||+|.. .++..+|+|.+..... .....+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 367788889999999999984 5688999999876432 2355788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCCCCC---
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~~~~--- 210 (359)
+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 9999999999764455689999999999999999999999 99999999999999855 458999999988665432
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+............... .....+...+.++.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~ 234 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPISDRYSPDLRQLIL 234 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----CCCCCCCCcCHHHHHHHH
Confidence 345678999999999888899999999999999999999888655433222221111 111233446778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.+++++
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHccCChhhCCCHHHHhhC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=314.23 Aligned_cols=249 Identities=17% Similarity=0.137 Sum_probs=197.6
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||+|+||+||++... ++..+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5778889999999999999954 57789999986421 1223457889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++.+ ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999964 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred -CCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 210 -RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
....||+.|+|||++. ...++.++|||||||++|||++|+.||................... .........+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-QFPAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-cCCCccccCCH
Confidence 1346899999999986 3458889999999999999999999987654332222211110000 01111234578
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
++.+|+.+|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8999999999765544 6899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.07 Aligned_cols=241 Identities=17% Similarity=0.239 Sum_probs=198.3
Q ss_pred cccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
...||.|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 34579999999999985 46889999999766555566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCCc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t~ 216 (359)
.+++. ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++...... ....++.
T Consensus 107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCc
Confidence 99884 34689999999999999999999999 9999999999999999999999999998754322 2345788
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
.|+|||.+.+..++.++||||||+++|||++|..|+........... .......... .....+..+.+++.+||..|
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRVK--DSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCccc--cccccCHHHHHHHHHHccCC
Confidence 99999999888899999999999999999999998865432211111 1111111111 11235668999999999999
Q ss_pred CCCCCCHHHHHHH
Q 018244 297 PRERPNPRSLVTA 309 (359)
Q Consensus 297 p~~Rps~~~il~~ 309 (359)
|++|||++++++.
T Consensus 260 P~~Rpt~~~il~~ 272 (292)
T cd06658 260 PSQRATAQELLQH 272 (292)
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=301.26 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=201.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.++..||.|+||.||+|... +...+|+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45678888999999999999853 2467999998765433 3567899999999999999999999999989999
Q ss_pred EEEecCCCCCHhhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 130 LVAEYMPNDTLAKHLFHWET-------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++++|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999974331 2689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCC
Q 018244 203 MKNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (359)
Q Consensus 203 a~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
+...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~~~ 239 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLELP 239 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcCCC
Confidence 8654322 22344667999999988888999999999999999999 566664332221111111 1111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 23446678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.26 Aligned_cols=243 Identities=15% Similarity=0.221 Sum_probs=183.7
Q ss_pred ccCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee--CCcceEEEecCCC
Q 018244 63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN 137 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 137 (359)
.+||+|+||+||+|... ++..+|+|.+..... ...+.+|+++|+.++||||+++++++.. ....+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 46799999999999854 467899999975432 3457889999999999999999998854 3568899999865
Q ss_pred CCHhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee----CCCCCeEEeccCCcccC
Q 018244 138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 138 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll----~~~~~~kl~DFg~a~~~ 206 (359)
+|.+++... ....+++..+..++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||+++..
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 788877531 123589999999999999999999999 99999999999999 45678999999999765
Q ss_pred CCC-------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHH---------hhhhhhh--
Q 018244 207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI---------RDRNIQT-- 267 (359)
Q Consensus 207 ~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---------~~~~~~~-- 267 (359)
... ....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.....+.. .......
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 432 234678899999999864 588999999999999999999988853221100 0000000
Q ss_pred ------------------hccccccCC------------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 ------------------LTDSCLEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 ------------------~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......... .....+..+.+|+.+||+.||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 000123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=310.06 Aligned_cols=268 Identities=19% Similarity=0.226 Sum_probs=217.6
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
+.|..|+++ |+|+||.||-+. ..+|+.+|.|.+.+.... .....++|-++|.+++.+.||.+-..|.+++.++
T Consensus 185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 457777777 999999999998 457999999998754322 2334688999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
||+..|.||+|.-+|.+.....+++..+..++.+|+.||.+||+. +||+||+||+|||+|+.|+++|+|+|+|.....+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999999876677899999999999999999999999 9999999999999999999999999999987766
Q ss_pred C---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
. ..+||.+|||||++.++.|+.+.|+|||||++|||+.|+.||.......-.+...+.... ....++...+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 5 347899999999999999999999999999999999999998754322111111111111 12345677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCccccchhHHHHHHhh
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQFTYALLRL 335 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (359)
+|....|++||++|.....- ...++...+.+...+|..+..
T Consensus 419 slc~~LL~Kdp~~RLGcrg~--------ga~evk~HpfFk~lnw~rlea 459 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGE--------GAQEVKEHPFFKDLNWRRLEA 459 (591)
T ss_pred HHHHHHHccCHHHhccCCCc--------CcchhhhCcccccCCHhHHhc
Confidence 99999999999999865521 233444555555555555444
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.44 Aligned_cols=242 Identities=17% Similarity=0.221 Sum_probs=199.0
Q ss_pred ccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 61 IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
....||.|+||.||+|.. .++..||+|.+........+.+.+|+.++..+.||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 344679999999999985 4688999999976554556678899999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t 215 (359)
|.+++. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...... ....++
T Consensus 105 L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 105 LTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred HHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence 999873 35689999999999999999999999 9999999999999999999999999998754332 234578
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (359)
..|+|||++.+..++.++||||||+++|+|++|..||............ ...... ........+.++.+++.+||+.
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPP--KLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCC--CccccCCCCHHHHHHHHHHhcC
Confidence 8999999999888999999999999999999999887644221111111 000000 1111234567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 018244 296 EPRERPNPRSLVTA 309 (359)
Q Consensus 296 dp~~Rps~~~il~~ 309 (359)
+|++||++.+++++
T Consensus 258 ~P~~Rps~~~ll~~ 271 (297)
T cd06659 258 EPQERATAQELLDH 271 (297)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.18 Aligned_cols=248 Identities=19% Similarity=0.214 Sum_probs=201.7
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
...|.+++.||.|+||+||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 34577888899999999999985 4688999999865432 2235688999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~ 211 (359)
+||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 94 ~e~~~g-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 94 MEYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred HHhhCC-CHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 999974 77777653 345689999999999999999999999 999999999999999999999999999987776666
Q ss_pred cCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 212 ~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
..++..|+|||++. ...++.++||||||+++|+|+||..|+............ .............+..+.++
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH----hcCCCCCCCchhhCHHHHHH
Confidence 77888999999874 355888999999999999999999887654221111110 00001111123466789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L 310 (359)
+.+||..||++|||+.+++.+.
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcCh
Confidence 9999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.07 Aligned_cols=249 Identities=18% Similarity=0.158 Sum_probs=187.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC------cccccccceeeeC-Ccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEG-DER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~-~~~ 128 (359)
..|++++.||+|+||+||+|.. ..+..||||++.... ........|++++..++| .+++++++++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4588888999999999999985 467889999996432 123345567777776654 4588888888764 468
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--------------- 193 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~--------------- 193 (359)
++|||++ +++|.+++. ....+++..+..|+.||+.||.|||++.+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8999988 668988886 3467999999999999999999999733999999999999998765
Q ss_pred -CeEEeccCCcccCCC-CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-----
Q 018244 194 -NPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----- 266 (359)
Q Consensus 194 -~~kl~DFg~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~----- 266 (359)
.+||+|||.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 499999998765433 2355789999999999999999999999999999999999999865432111000000
Q ss_pred --------------hhccc--cccCCC---------------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 --------------TLTDS--CLEGQF---------------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 --------------~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+... .+.... .......+.+||.+||+.||++|||++|++++
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 00000 000000 00124568899999999999999999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.31 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=197.5
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|++++.||+|++|.||+|... +++.||+|++..... ...+.+.+|+++++.++|+|++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5778888999999999999964 688999999865432 2234578999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++++|..++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99988877764 344689999999999999999999999 99999999999999999999999999988765433
Q ss_pred CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh---hhhh-----------------c
Q 018244 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTL-----------------T 269 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~---~~~~-----------------~ 269 (359)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ .... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3456788999999876 45788999999999999999999888654321111000 0000 0
Q ss_pred cccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+...... ....+..+.+|+.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 01246789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=311.53 Aligned_cols=247 Identities=17% Similarity=0.192 Sum_probs=201.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (359)
-..|.++++||.||.+.||++...+...+|+|++..... ....-|.+|+..|.+|+ |.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 357899999999999999999987777899888765432 23566999999999996 999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||-+. +|...|.........| .+..+..||++|+.++|.. ||||.||||.|+|+- .|.+||+|||+|.....++
T Consensus 440 E~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 99755 8999997643333334 8889999999999999999 999999999999997 6799999999999877664
Q ss_pred ----CcCCCccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 211 ----SYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
..+||+.||+||.+... +.+.++||||||||||+|+.|+.||..-.. ....+..+.++...-
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNHEI 592 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCccc
Confidence 45799999999988632 266899999999999999999988764322 123445555554433
Q ss_pred CCChHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 QFSSDE-GTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++..- ..++.++++.||+.||++|||+.++|++
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 333322 2339999999999999999999999975
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=300.13 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=196.2
Q ss_pred cCCCCCCcEEEEEEeCC-------CcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 64 EHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.||+|+||.||+|+..+ +..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 46999999999998542 25799998865432 33567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-----CeEEeccCCccc
Q 018244 136 PNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKN 205 (359)
Q Consensus 136 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-----~~kl~DFg~a~~ 205 (359)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999996432 23478899999999999999999999 999999999999999877 899999999875
Q ss_pred CCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 206 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
..... ...++..|+|||.+.++.++.++||||||+++|+|++ |..||........... .........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~ 235 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-----VTAGGRLQKP 235 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-----HhcCCccCCc
Confidence 43221 2234578999999998899999999999999999998 8887765432221111 1111122234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 456788999999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=300.79 Aligned_cols=248 Identities=19% Similarity=0.213 Sum_probs=197.1
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc----------hHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP----------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
|.+.+.||.|++|.||+|.. .++..+|+|.+...... ..+.+.+|+.+++.++|+|++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 55667789999999999984 46889999988642111 12457789999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999864 35789999999999999999999999 99999999999999999999999999987654
Q ss_pred CC------CCcCCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 208 DG------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 208 ~~------~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
.. ....++..|+|||.+.... ++.++|+||||+++|++++|..|+...........................
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 32 1235678999999987654 788999999999999999999887543221111110000011111111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..+.++.+++.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=305.54 Aligned_cols=249 Identities=17% Similarity=0.134 Sum_probs=201.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+|.+++.||+|+||.||++.. ..+..||+|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 567788899999999999995 4578999999876532 224567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999963 35689999999999999999999999 9999999999999999999999999988642110
Q ss_pred ---------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 210 ---------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 210 ---------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---~ 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---W 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---C
Confidence 1234577899999998888999999999999999999999988765433322222111110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
.......+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11112456789999999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=296.06 Aligned_cols=245 Identities=28% Similarity=0.432 Sum_probs=199.9
Q ss_pred cccccCCCCCCcEEEEEEeCC-----CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 60 NIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.+.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|+..+..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356678999999999999643 378999999766543 46678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC--
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-- 211 (359)
|+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999653333389999999999999999999999 999999999999999999999999999876554321
Q ss_pred ---cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 212 ---~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
..++..|+|||.+.+..++.++||||+|+++|+|++ |..|+............... .....+...+.++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 235 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-----YRLPKPENCPPEIYK 235 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCCCcCCHHHHH
Confidence 225678999999988889999999999999999998 66666543322222111111 111223346778999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~L 310 (359)
++.+||..||++|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.64 Aligned_cols=249 Identities=17% Similarity=0.207 Sum_probs=196.8
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
.+..|.+++.||.|+||+||+|.. ..+..||+|.+..... .....+..|+.+|+.|+|||||+++++|... ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 346789999999999999999994 4577899999875432 2345688999999999999999999988653 5689
Q ss_pred EEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcC------CCcccccCCCCCeeeCC----------
Q 018244 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK------ERALYHDLNAYRIVFDD---------- 191 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~ivH~Dikp~NIll~~---------- 191 (359)
|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+. .+|+|+||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998642 235799999999999999999999984 15999999999999964
Q ss_pred -------CCCeEEeccCCcccCCCC---CCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH
Q 018244 192 -------DVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL 259 (359)
Q Consensus 192 -------~~~~kl~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~ 259 (359)
.+.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||+||+|+||..||.......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 345899999999865433 34468999999999864 348899999999999999999999986432111
Q ss_pred HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
......... + .......+.++.+||..||..+|++|||+.+++.
T Consensus 251 qli~~lk~~--p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 QLISELKRG--P---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHhcC--C---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 110111100 0 0111234678999999999999999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=302.20 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=198.7
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+|.+.+.||.|++|.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 367888899999999999995 4688999999986542 2345788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+ +++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 9999999864 346799999999999999999999999 99999999999999999999999999988665432
Q ss_pred -CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc-------------------
Q 018244 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------------- 269 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------------- 269 (359)
...++..|+|||.+.+.. ++.++||||+|+++|+|++|..++.................
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345788999999987544 68899999999999999999766654321111100000000
Q ss_pred -ccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 -DSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 -~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... .......+..+.+++.+||+.||++|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00112345889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.74 Aligned_cols=248 Identities=18% Similarity=0.203 Sum_probs=194.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+++.||.|+||.||+|.. .+|..+|+|.+...... ....+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 66778899999999999995 46889999998754221 2345778999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
.+ +|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 82 DQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 75 78887754 345689999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred cCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcch-hHHHhhhhhh--------------hhccccccC
Q 018244 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQ--------------TLTDSCLEG 275 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~-~~~~~~~~~~--------------~~~~~~~~~ 275 (359)
..++..|+|||.+.+.. ++.++||||||+++|+|+||+.|+.... .......... .........
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 34578999999987654 7889999999999999999998754321 1111000000 000000000
Q ss_pred ---------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 ---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+.++.+++.+||+.||.+|||+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0112356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=303.09 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=202.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|.+++.||.|++|.||++.. .+++.+|+|.+..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 577888899999999999985 4688999999875422 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~ 212 (359)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999999999863 46789999999999999999999999 9999999999999999999999999998876544 234
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.+++.|+|||.+.+...+.++||||||+++|+|++|..|+............. . .....+...+..+.+++.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~--~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----E--GKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----c--CCccCCccCCHHHHHHHHHH
Confidence 57889999999988888999999999999999999998886554222211111 1 11123444577899999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 018244 293 LQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 293 l~~dp~~Rp-----s~~~il~~ 309 (359)
|..||.+|+ ++++++++
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcC
Confidence 999999998 67776653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=313.43 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=216.5
Q ss_pred cccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 60 NIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.+..+||-|-||.||.|.|+. ...||||.++.+.. ..++|+.|..+|+.++|||+|+++|+|.....+|||+|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 345678999999999999764 66799999987653 4788999999999999999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC--cCC--
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--YST-- 214 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~-- 214 (359)
+|.+||++.....++.-.++.++.||..|+.||..+ ++|||||...|.|+.++..||++|||++++...+.- ..|
T Consensus 349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAK 427 (1157)
T KOG4278|consen 349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAK 427 (1157)
T ss_pred cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCcc
Confidence 999999988888889899999999999999999999 999999999999999999999999999998766542 233
Q ss_pred -CccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 215 -NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 215 -t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
.+.|+|||.+..+.++.++|||+|||+|||+.| |..|+++-.... ...++....+-..+..+++.+.+||.+|
T Consensus 428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 467999999999999999999999999999987 556666653332 3344444455556778889999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhh
Q 018244 293 LQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~~~ 315 (359)
|+..|.+||++.|+.+.++.+..
T Consensus 503 W~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred hcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999998754
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=301.63 Aligned_cols=246 Identities=14% Similarity=0.203 Sum_probs=196.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeee------CCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~ 128 (359)
..|.+.+.+|.|+||.||+|.. .++..+|+|.+.... .....+..|+.+++.+ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 3556777789999999999995 568899999986543 2345678899999998 69999999999853 4568
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
+++|||+++|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999999999765566789999999999999999999999 999999999999999999999999999875432
Q ss_pred ----CCCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 209 ----GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 209 ----~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
.....++..|+|||.+. ...++.++||||||+++|+|++|..||......... ..............
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~ 249 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKSK 249 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhCCCCCCccc
Confidence 22345788999999886 345888999999999999999999887543211111 11111111111123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..+.++.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 45678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.25 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=204.9
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|..++.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+++++.++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56777889999999999994 4688999999875432 2245688899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~ 214 (359)
+.+ +|.+.+.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..........+
T Consensus 107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 975 78777753 345689999999999999999999999 999999999999999999999999999887776666778
Q ss_pred CccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
+..|+|||.+. .+.++.++||||||+++|+|++|..||............ .............+..+.+++.+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHHHHHHHHH
Confidence 89999999974 356889999999999999999999887654222111111 11111111223456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 292 CLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
||+.+|.+||++.++++.+-.......
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhccCcc
Confidence 999999999999999987665544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=296.30 Aligned_cols=243 Identities=20% Similarity=0.216 Sum_probs=199.8
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-----chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
|...+.||+|++|.||+|... ++..||+|.+..... ...+.+.+|+++++.++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 445567899999999999965 788999999875432 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 99999999999863 34689999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||........... ..........+...+.++.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHH
Confidence 3445788899999988766 89999999999999999999988755431111111 111011122344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~ 308 (359)
+.+||+.+|++|||+.+++.
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHhhcCcccCcCHHHHhc
Confidence 99999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=298.68 Aligned_cols=247 Identities=18% Similarity=0.275 Sum_probs=199.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC------chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
|...+.||+|++|.||+|. ..++..+|+|.+..... ...+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 4455667999999999998 46788999999975331 1245688999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~~- 209 (359)
+||+++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+......
T Consensus 82 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999986 345689999999999999999999999 999999999999998775 5999999998765432
Q ss_pred -------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
....++..|+|||.+.+..++.++||||+|+++|+|++|..|+........... .............+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhC
Confidence 123567899999999888899999999999999999999988754322111111 111111111233445677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+++.+||..+|++|||+.++++.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 889999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=302.45 Aligned_cols=244 Identities=16% Similarity=0.223 Sum_probs=199.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+...+.||.|++|.||++.. .++..+|+|.+........+.+.+|+.+++.++|+|++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 33445669999999999984 56889999998765545556788999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~ 213 (359)
++|.+++.. ..+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999853 5689999999999999999999999 9999999999999999999999999987654332 2345
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
++..|+|||.+.+..++.++||||||+++|+|++|..||............... ..+. ...+...+..+.+++.+||
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK--LKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC--CcccccCCHHHHHHHHHHc
Confidence 788999999998888999999999999999999999887654322211111111 1111 1112235678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018244 294 QYEPRERPNPRSLVTA 309 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (359)
+.+|++|||+.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=296.70 Aligned_cols=246 Identities=18% Similarity=0.235 Sum_probs=203.1
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee--CCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 132 (359)
+|++++.||.|+||.||++. ..++..+|+|.+..... ...+.+.+|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 36788889999999999998 45678999999875432 234568889999999999999999998754 34679999
Q ss_pred ecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCT-----SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
||+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||+|+||++++++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998642 2467899999999999999999999 87 999999999999999999999999999887
Q ss_pred CCCCC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 206 SRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 206 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
..... ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+............ ........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~ 234 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRY 234 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-----hcCCCCCCcccc
Confidence 65433 345788999999999888999999999999999999999888765432222111 111122344566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.++.+++.+||+.+|++|||+.+|+++
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 7889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=299.11 Aligned_cols=249 Identities=18% Similarity=0.254 Sum_probs=202.1
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++++.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4667788899999999999954 688999999987543 33456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCc
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~ 212 (359)
++++|.+++... ...+++..+..++.|++.||.|||+ . +++|+||||+||++++++.++|+|||.+...... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 82 DGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred CCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 999999998642 2678999999999999999999999 7 9999999999999999999999999998754322 225
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH-hhhhhhhhccccccCCCChH-HHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-RDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 290 (359)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ............ ....+.. .+.++.++|.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChhhcCHHHHHHHH
Confidence 678899999999988899999999999999999999988765411000 000011111111 1112222 6778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||..||++|||+.+++.+
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 239 LCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHcCCCchhCcCHHHHhhC
Confidence 9999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=303.41 Aligned_cols=248 Identities=18% Similarity=0.234 Sum_probs=204.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....|.+++.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 345778889999999999999984 4678899999876555556678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++++|.+++. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 97 YLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred cCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999984 34688999999999999999999999 99999999999999999999999999876544332
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+++.|+|||.+....++.++|+||||+++|++++|..||........... ...........+...+..+.+++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCCCCCccccCHHHHHHH
Confidence 23567889999999888899999999999999999999998865432111000 00011111112234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||..+|++||++.+++.+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.21 Aligned_cols=243 Identities=18% Similarity=0.259 Sum_probs=199.9
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||.|+||.||+|.. .++..||+|.+...... ..+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 66778889999999999985 46889999999866543 5667899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHh--hcCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999986 344588999999999999999999999 99999999999999999999999999987654332
Q ss_pred ---CcCCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh--HHH
Q 018244 211 ---SYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS--DEG 282 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 282 (359)
...++..|+|||++.+.. ++.++||||||+++|++++|..||............... ......+. ..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 234 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GHKPPIPDSLQLS 234 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CCCCCCCcccccC
Confidence 234678999999998766 889999999999999999999988643211111101110 11112222 236
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 78999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.25 Aligned_cols=249 Identities=18% Similarity=0.246 Sum_probs=196.8
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|+.++.||.|++|.||+|.. .++..||||.+..... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 56788889999999999985 4688999999875432 22356889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
. ++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 6 5899988655566789999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred cCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc--------------------
Q 018244 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD-------------------- 270 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------------------- 270 (359)
..++..|+|||.+.+.. ++.++||||||+++|+|+||+.||..................
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34578899999887654 688899999999999999999988654321111110000000
Q ss_pred cccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... .......+.++.+++.+||+.||++|||+++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 00012245678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=297.65 Aligned_cols=244 Identities=18% Similarity=0.215 Sum_probs=194.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-----chHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
.|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 355667779999999999985 4688999999864321 2234688899999999999999999988653 5678
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+++||+++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999986 344689999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ............+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----FKIATQPTNPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----HHHhcCCCCCCCchhcC
Confidence 1234678999999999888999999999999999999999887644221111 11111111223344556
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+.+++ +||..+|++|||+++++++
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 7788888 7888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.86 Aligned_cols=248 Identities=14% Similarity=0.147 Sum_probs=195.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceee-----eCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCC-----EGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~ 129 (359)
.+|++++.||+|+||.||+|.. .++..+|+|.+.... .....+.+|+.+++.+ +|+||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 4567888899999999999985 467899999886533 2235678899999999 6999999999874 345689
Q ss_pred EEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999987532 345688999999999999999999999 99999999999999999999999999987654
Q ss_pred CC----CCcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
.. ....++..|+|||++.. ..++.++||||||+++|+|++|+.|+.............. .... ....+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~~ 252 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR-NPPP--TLHQP 252 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc-cCCC--cccCC
Confidence 32 23457889999998853 3478899999999999999999988765422111110000 0000 11112
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+.++.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 3345679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.74 Aligned_cols=244 Identities=16% Similarity=0.178 Sum_probs=196.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-----chHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
.|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+++++.++|+||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 456677789999999999985 5688999998864321 2245688899999999999999999988764 4678
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
++|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999863 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred ------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 209 ------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 209 ------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........... ..........+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 235 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhhC
Confidence 1234578899999999888899999999999999999999988764422211111 111111223445667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..+.+++.+||. +|++||+++++++.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 789999999995 89999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.45 Aligned_cols=249 Identities=17% Similarity=0.258 Sum_probs=200.3
Q ss_pred ccccccCCCCCCcEEEEEEeCC--CcEEEEEEeCCCC----------CchHHHHHHHHHHHhc-CCCcccccccceeeeC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSA----------WPDARQFLEEARAVGQ-LRNRRLANLLGCCCEG 125 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 125 (359)
|.+.+.||.|+||.||+|.... +..+|+|.+.... ......+.+|+.++.+ ++|+||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5677888999999999999654 7889999886432 1123457788888875 6899999999999999
Q ss_pred CcceEEEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 126 DERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999999998743 134568999999999999999999996338999999999999999999999999998
Q ss_pred ccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 204 KNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 204 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
...... ....++..|+|||.+.+..++.++||||||+++|+|++|..|+................. .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 237 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY----EPLPEGM 237 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC----CcCCccc
Confidence 865544 234578899999999988899999999999999999999988765433222221111111 1111123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.+..+.+++.+||+.||++|||+.++..+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 4678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.94 Aligned_cols=251 Identities=15% Similarity=0.146 Sum_probs=196.4
Q ss_pred HHHHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeee
Q 018244 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE 124 (359)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 124 (359)
.+.....++|..++.++ +|+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLK-LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhcccccee-ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 33333444444444443 59999999999984 5688899999875432221 22222222 69999999999999
Q ss_pred CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCc
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLM 203 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a 203 (359)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999999963 34899999999999999999999999 999999999999999888 9999999999
Q ss_pred ccCCCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 204 KNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
..........++..|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T PHA03390 158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSK 235 (267)
T ss_pred eecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCH
Confidence 8877666677899999999999888999999999999999999999988644322211111111111 11122345778
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPN-PRSLVT 308 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps-~~~il~ 308 (359)
.+.+++.+||+.||.+||+ ++++++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 8999999999999999996 588875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.86 Aligned_cols=244 Identities=19% Similarity=0.210 Sum_probs=202.3
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|++.+.||.|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 677888899999999999954 588999999975432 2356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~ 211 (359)
+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999999863 35789999999999999999999999 9999999999999999999999999998765543 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+......... ........ .....+...+.++.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-QIRAKQET--ADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-HHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence 45778899999998888999999999999999999999988765421000 00111110 1223445567899999999
Q ss_pred hcccCCCCCCCH--HHHHH
Q 018244 292 CLQYEPRERPNP--RSLVT 308 (359)
Q Consensus 292 cl~~dp~~Rps~--~~il~ 308 (359)
||+.||.+||++ +++++
T Consensus 236 ~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HccCChhHcCCccHHHHhc
Confidence 999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=309.12 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=212.4
Q ss_pred ccCCCCCCcEEEEEEeC---C--CcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 63 SEHGEKAPNVVYKGKLE---N--QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
+.||.|-||.||+|+.. . .-.||||..+.+. ..+.+.|+.|.-+|+.++|||||+++|+|.+ ...|||||.++
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~ 473 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP 473 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence 45799999999999842 2 3468999998754 3446789999999999999999999999965 46899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCC--
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-- 214 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~-- 214 (359)
-|.|..|+.. ++..++......+++||+.||+|||++ +.|||||...|||+.....|||+|||+++...+..-+..
T Consensus 474 ~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 474 LGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred chhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 9999999976 567899999999999999999999999 999999999999999999999999999998877654432
Q ss_pred ---CccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 215 ---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 215 ---t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...|||||.+.-.+++.++|||-|||.+||+++ |..||.+-.. ......+....+...|+.+++.+..|+.
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----sDVI~~iEnGeRlP~P~nCPp~LYslms 626 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----SDVIGHIENGERLPCPPNCPPALYSLMS 626 (974)
T ss_pred cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----cceEEEecCCCCCCCCCCCChHHHHHHH
Confidence 357999999999999999999999999999876 7778775422 2233334444556678889999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
+||++||.+||.+.++...|..+.......
T Consensus 627 kcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 627 KCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred HHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 999999999999999999999987754443
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.90 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=195.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
++..++.||+|+||.||++.. .++..+|+|.+..... .....+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 445667789999999999984 4688999999875432 23456889999999996 99999999999998899999999
Q ss_pred CCCCCHhhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 135 MPNDTLAKHL---FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 135 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
+.. ++.++. .......+++..+..++.|++.||+|||+..+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 865 555543 22234679999999999999999999997448999999999999999999999999998754332
Q ss_pred -CCcCCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..................+..........+.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 234578899999999876 5889999999999999999999887654211000000000011111112223467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+|+.+||+.||++|||+++++..
T Consensus 244 ~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 244 VNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.67 Aligned_cols=245 Identities=17% Similarity=0.250 Sum_probs=201.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||.|+||.||+|.. .++..+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 56677889999999999995 4578899999876422 23456789999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC-eEEeccCCcccCCCCC----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~-~kl~DFg~a~~~~~~~---- 210 (359)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. ++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999999764455689999999999999999999999 9999999999999998754 6999999987655432
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..|+................ ........+.++.+++.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-----FAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-----CCCCCCCCCHHHHHHHH
Confidence 2357888999999988889999999999999999999998886543322222111111 11223345678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||..+|++|||+.+++..
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 236 QLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=297.26 Aligned_cols=250 Identities=17% Similarity=0.233 Sum_probs=199.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeC--CcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 133 (359)
.|+.++.||.|++|.||+|.. .++..+|+|.+..... .....+.+|+++++.++||||+++++++... ..+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 456778889999999999995 4688999999986533 2356689999999999999999999988653 46899999
Q ss_pred cCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 134 YMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999999988653 2345689999999999999999999999 9999999999999999999999999998754432
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-----HHHhhhhhhhhccccccCCCC--hHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----DLIRDRNIQTLTDSCLEGQFS--SDEG 282 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~ 282 (359)
....++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... ......+....... ...+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGNGIKWS 239 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCCCCchH
Confidence 234567889999999988899999999999999999999988765411 001100 00001111111111 2356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+.+++.+||+.+|++|||+.+++..
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.73 Aligned_cols=243 Identities=16% Similarity=0.250 Sum_probs=201.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|.+++.||.|+||.||+|.. .++..+|+|.+..... .....+.+|+.++..++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 356777889999999999985 4688999999875432 23456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999999984 45689999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+........... .........+...+.++.+++.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCCCCCcccCHHHHHHHHH
Confidence 3567889999999888889999999999999999999988764332211111 11111222334456789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.+|++||++.+++.+
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=300.77 Aligned_cols=249 Identities=19% Similarity=0.265 Sum_probs=196.6
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|++++.||.|+||.||+|... +++.+|+|.+...... ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5678889999999999999964 5889999998754322 245678899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++++|..+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99988887764 334589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh---h-----------------hc
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ---T-----------------LT 269 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~---~-----------------~~ 269 (359)
...++..|+|||++.+. .++.++||||||+++|+|++|..||+............. . ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 23467889999998753 478899999999999999999987764322110000000 0 00
Q ss_pred cccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.... ......+..+.+|+.+||+.+|++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 0012346789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=296.30 Aligned_cols=247 Identities=15% Similarity=0.181 Sum_probs=198.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCC------cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD------ER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~ 128 (359)
..|.+++.||.|++|.||+|.. .++..+|+|.+..... ..+.+.+|+.+++.+ .|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 4677888899999999999996 4678899999876543 346788999999999 6999999999997644 48
Q ss_pred eEEEecCCCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 129 LLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999999886433 46789999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC----CCcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 207 RDG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
... ....++..|+|||.+.. ..++.++||||||+++|+|++|..||............... .......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~ 240 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPTLKS 240 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCCCCc
Confidence 332 23457889999998753 24778999999999999999999888643221111111111 0001111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
+...+.++.+++.+||..||++|||+.+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2335678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=297.19 Aligned_cols=250 Identities=17% Similarity=0.226 Sum_probs=203.9
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+....|.....+|.|++|.||+|... ++..+|+|++..... ..+.+.+|++.++.++|+|++++++++......++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 33445667778899999999999965 688999999986543 4567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999999999997522 4799999999999999999999998 9999999999999999999999999987654432
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+................. .........+..+.++
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l 249 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI---PPLKNPEKWSPEFKDF 249 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCcchhhCCHHHHHH
Confidence 233467889999999888899999999999999999999988765432211111111000 0111122356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.+|.+|||+.+++..
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHhccChhhCcCHHHHhhC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.42 Aligned_cols=242 Identities=15% Similarity=0.233 Sum_probs=182.8
Q ss_pred ccCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee--CCcceEEEecCCC
Q 018244 63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN 137 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 137 (359)
.+||+|+||+||+|... ++..||+|.+..... ...+.+|+++++.++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 35799999999999854 357899999875432 3457889999999999999999998854 4568999999875
Q ss_pred CCHhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee----CCCCCeEEeccCCcccC
Q 018244 138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 138 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll----~~~~~~kl~DFg~a~~~ 206 (359)
+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++..
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 787776421 123588999999999999999999999 99999999999999 46679999999999865
Q ss_pred CCC-------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh---------hhhh----
Q 018244 207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---------DRNI---- 265 (359)
Q Consensus 207 ~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~---------~~~~---- 265 (359)
... ....+|..|+|||++.+. .++.++||||||+++|||+||..||.....+... ....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 432 234568899999998764 4889999999999999999999887532211000 0000
Q ss_pred -------hh---------hccccccC------------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 266 -------QT---------LTDSCLEG------------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 266 -------~~---------~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.. ........ .........+.+|+.+||..||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 001112356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=299.12 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=194.5
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
...|.+++.||.|++|.||+|... ++..||+|.+...... ....+.+|+++++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 356888899999999999999954 6889999998754322 23456789999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9985 89998864 334789999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhhhh-----------hc-------
Q 018244 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQT-----------LT------- 269 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~~-----------~~------- 269 (359)
....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||..... .......... ..
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 12245778999999875 4588899999999999999999988854421 1000000000 00
Q ss_pred -------cccccCCCChHHH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 270 -------DSCLEGQFSSDEG--TELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 270 -------~~~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
....... ..... .++.+++.+||+.+|++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 00122 67889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.12 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=198.5
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
+...|.+++.||.|+||.||+|... +++.+|+|.++...... ...+.+|+.++..++||||+++++++... ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3457888889999999999999964 58899999997554322 23567899999999999999999998877 8899
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99999975 89888864 334689999999999999999999999 9999999999999999999999999998865443
Q ss_pred ----CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-----------------
Q 018244 210 ----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT----------------- 267 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~----------------- 267 (359)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...............
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 2334678899999987654 688999999999999999999887644221111110000
Q ss_pred --------hccccccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 --------LTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 --------~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.........++.. .++.+.+++.+||+.||++|||+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000011112222 46789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.40 Aligned_cols=243 Identities=18% Similarity=0.229 Sum_probs=208.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.++..++.||+|.||.|-.++ ...++.+|+|++++..... ...-..|-++|+..+||.+..+...|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 456678888999999999998 5679999999998764332 334577999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC----CC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RD 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~----~~ 208 (359)
||+.||.|.-.+. ..+.+++.....+..+|+.||.|||++ +||+||+|.+|.|+|.+|++||+|||+++.. ..
T Consensus 248 eyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 9999999998886 567799999999999999999999999 9999999999999999999999999998753 23
Q ss_pred CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....+||+.|+|||++....|..++|+|.+||++|||++|+-||+....+.+.+-+... .-.+|...+++++.|
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------d~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------DLKFPRTLSPEAKTL 398 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------hccCCccCCHHHHHH
Confidence 35788999999999999999999999999999999999999999876555444333221 124677888999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHH
Q 018244 289 ASRCLQYEPRERP-----NPRSLVT 308 (359)
Q Consensus 289 i~~cl~~dp~~Rp-----s~~~il~ 308 (359)
+..+|.+||.+|. .+.||.+
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHh
Confidence 9999999999995 4555543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=294.60 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=196.1
Q ss_pred ccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCC------
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 126 (359)
|.+.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345677899999999999843 36789999997643 233556889999999999999999999886532
Q ss_pred cceEEEecCCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
..++++||+.+|+|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999999998877421 223578999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 203 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
++...... ...++..|++||.+.+..++.++||||||+++|+|++ |..|+.............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~ 234 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-----GNRL 234 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----CCcC
Confidence 88654321 2234568999999988889999999999999999999 6766654432222111111 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 12234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.90 Aligned_cols=242 Identities=17% Similarity=0.161 Sum_probs=192.7
Q ss_pred ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch---HHHHHHHHHHH-hcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAV-GQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+.||.|+||.||+|.. .++..||+|.+....... ...+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4579999999999985 468899999987543211 22344454444 445899999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCcc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~ 217 (359)
++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..........++..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 99999986 345689999999999999999999999 999999999999999999999999999887665556678899
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (359)
|+|||.+.+..++.++||||||+++|+|++|..|+.................. .........+.++.+++.+||+.||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence 99999998888899999999999999999999988655433322211111110 1111223456889999999999999
Q ss_pred CCCCCHHHHHHH
Q 018244 298 RERPNPRSLVTA 309 (359)
Q Consensus 298 ~~Rps~~~il~~ 309 (359)
++|||+.++.+.
T Consensus 237 ~~R~~~~~~~~~ 248 (260)
T cd05611 237 AKRLGANGYQEI 248 (260)
T ss_pred HHccCCCcHHHH
Confidence 999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.34 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=197.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4778888999999999999954 58899999987542 22346788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
++++.+..+.. ....+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99876665553 345689999999999999999999999 99999999999999999999999999987755432
Q ss_pred -CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh----------------------
Q 018244 211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ---------------------- 266 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~---------------------- 266 (359)
...++..|+|||++.+. .++.++||||||+++|+|++|..|+..............
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999888 789999999999999999999988764321110000000
Q ss_pred hhccc----cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 267 TLTDS----CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 267 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..... .....++...+.++.+|+.+||..+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000122234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=299.65 Aligned_cols=248 Identities=21% Similarity=0.192 Sum_probs=195.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-----hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
|.+++.||.|++|.||+|.. .++..||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 56677889999999999995 46889999999765432 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||+ +++|.+++... ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 88999999642 23699999999999999999999999 99999999999999999999999999988654432
Q ss_pred --CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------cc
Q 018244 211 --SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------------TD 270 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~ 270 (359)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..+|................ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2345678999998865 457889999999999999999976665432111110000000 00
Q ss_pred ccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 SCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... ......+..+.+++.+||+.||++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0112346789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.63 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=204.2
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+|++.+.||.|++|.||+|... +++.||+|.+..... .....+.+|+..+..++|+|++++++++......++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 4667788899999999999965 589999999987654 33567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
++++|.+++.. ...+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 82 DGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999999963 3678999999999999999999999 8 99999999999999999999999999988654433
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch---hHHHhhhhhhhhccccccCCCChH-HHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSD-EGTELV 286 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 286 (359)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... ....... +.... ....+.. .+..+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~ 233 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGP-PPSLPAEEFSPEFR 233 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcCC-CCCCCcccCCHHHH
Confidence 2346789999999998889999999999999999999998875542 1111111 11111 1122333 678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+||..+|++|||+.++++.
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.77 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=194.3
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||+|+||+||+|.. .+|..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 59999999999984 4688999999875321 2234567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcCCCcc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~~t~~ 217 (359)
.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 9999754545789999999999999999999999 9999999999999999999999999998765432 23456788
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (359)
|+|||.+.+..++.++||||||+++|+|++|+.||.................. .....+...++.+.+++.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999888654321111111111111 1122334567889999999999999
Q ss_pred CCCC-----CHHHHHH
Q 018244 298 RERP-----NPRSLVT 308 (359)
Q Consensus 298 ~~Rp-----s~~~il~ 308 (359)
++|| ++.+++.
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 5665654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.74 Aligned_cols=243 Identities=18% Similarity=0.247 Sum_probs=198.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCC---CcccccccceeeeCCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 132 (359)
.|.+++.||.|+||.||+|.. .++..+|+|.+.... ....+.+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 356778889999999999994 578899999987643 233567888999999996 999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999999999984 34789999999999999999999999 99999999999999999999999999987654332
Q ss_pred --CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh-HHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELV 286 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 286 (359)
...++..|+|||.+.++ .++.++|+||||+++|+|++|..|+............ ........+. ..+.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-----PKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-----ccCCCCCCCcccCCHHHH
Confidence 34577889999998754 4788999999999999999999888654322111110 0001111112 2567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+||+.||++||++.+++..
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=297.01 Aligned_cols=248 Identities=15% Similarity=0.121 Sum_probs=195.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeC-----Ccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG-----DERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~ 129 (359)
..|.+++.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++..+ +|||++++++++... ...+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4567778889999999999995 568899999987543 2245677899999999 799999999998754 3589
Q ss_pred EEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999999987531 345689999999999999999999999 99999999999999999999999999987644
Q ss_pred CC----CCcCCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 208 DG----RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
.. ....++..|+|||.+... .++.++||||||+++|+|++|+.|+.............. ........+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 256 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHP 256 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcc
Confidence 32 234578899999998643 268899999999999999999988765422111111100 000011112
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+..+.+++.+||+.+|++|||+.+++++
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3455679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=289.00 Aligned_cols=247 Identities=18% Similarity=0.246 Sum_probs=204.6
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
+|...+.||+|++|.||++... ++..+++|++..........+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3567778899999999999964 688999999987665456788999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~ 213 (359)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 9999999864 225789999999999999999999998 9999999999999999999999999998876554 3456
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhc
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (359)
++..|+|||.+.+..++.++||||||+++|+|++|+.|+................. + ........+..+.+++.+||
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-P--GLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC-C--CcCcccccCHHHHHHHHHHc
Confidence 78899999999988899999999999999999999988765522211111111000 0 00111223678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018244 294 QYEPRERPNPRSLVTA 309 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (359)
+.||++|||+.+++..
T Consensus 236 ~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 236 QKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=296.24 Aligned_cols=246 Identities=18% Similarity=0.242 Sum_probs=193.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHH-HhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+|.+++.||+|+||.||+|.. .+|..||+|.+..... .....+..|+.. ++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 567888899999999999995 4689999999976532 223455566665 6667899999999999999999999999
Q ss_pred CCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
++ |+|.+++... ....+++..++.++.|++.||+|||++.+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 97 5888877542 335789999999999999999999985489999999999999999999999999987654322
Q ss_pred -CcCCCccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCcchh--HHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 -SYSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+..... .... ...............+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-----QVVEEPSPQLPAEKFSP 235 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-----HHHhcCCCCCCccccCH
Confidence 2457889999998865 3468899999999999999999988753211 1111 11111111111123567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+++.+||..+|++|||+.+++..
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=292.55 Aligned_cols=239 Identities=16% Similarity=0.189 Sum_probs=196.7
Q ss_pred CCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||.|++|.||+|+.. ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 599999999999954 588999999975432 2345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcCCCcc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~~t~~ 217 (359)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999963 34689999999999999999999998 9999999999999999999999999998876543 23457889
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (359)
|+|||.+.+..++.++|+||||+++|+|++|..|+.....+... .............++...+.++.+++.+||+.||
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME--IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH--HHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999988655311111 1111111112223444457889999999999999
Q ss_pred CCCCC-----HHHHHH
Q 018244 298 RERPN-----PRSLVT 308 (359)
Q Consensus 298 ~~Rps-----~~~il~ 308 (359)
++||+ ++++++
T Consensus 236 ~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 236 EERLGNLKGGIKDIKK 251 (262)
T ss_pred hhCcCCcccCHHHHhc
Confidence 99999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=297.26 Aligned_cols=241 Identities=17% Similarity=0.222 Sum_probs=197.8
Q ss_pred cccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
...||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 34569999999999985 57889999998765544566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCCc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t~ 216 (359)
.+++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 105 ~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 105 TDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 99873 34689999999999999999999999 9999999999999999999999999987654332 2345788
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
.|+|||.+.+..++.++|+||+|+++|+|++|..|+.............. ...... ......+..+.+++.+||+.|
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKL--KNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCccc--CCcccCCHHHHHHHHHHHhCC
Confidence 99999999888889999999999999999999998765432222111111 111110 012335667999999999999
Q ss_pred CCCCCCHHHHHHH
Q 018244 297 PRERPNPRSLVTA 309 (359)
Q Consensus 297 p~~Rps~~~il~~ 309 (359)
|.+||++.+++.+
T Consensus 258 P~~R~~~~~ll~~ 270 (292)
T cd06657 258 PAQRATAAELLKH 270 (292)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=285.52 Aligned_cols=259 Identities=17% Similarity=0.128 Sum_probs=205.1
Q ss_pred ccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccceeee----CCcceEEEecCC
Q 018244 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCE----GDERLLVAEYMP 136 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~----~~~~~lv~e~~~ 136 (359)
+.||-|-.|.|-.+. ..+|+.+|+|++... .+.++|+++.-... |||||.++++|.. ...+.+|||.++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 457999999999998 557899999998743 45678999887774 9999999998864 346789999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCCCC---
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~~~--- 210 (359)
||.|++.+.++....+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|||+|+......
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~ 221 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM 221 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence 99999999988888999999999999999999999999 9999999999999964 5679999999999876433
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc--ccCCCChHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l 288 (359)
+..-|+.|.|||++...+|+..+|+||+||++|-|++|.+||+...-..+..+-...+.... ......+..+++++++
T Consensus 222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL 301 (400)
T ss_pred CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence 34458999999999999999999999999999999999999976532222111111111111 1112235678999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhhcccCCccccchhH
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQF 328 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~ 328 (359)
|+.+|+.+|.+|.|+.+++++--- .....++..+...+.
T Consensus 302 IR~LLkt~PteRlTI~~~m~hpwi-~~~~~vp~tpl~t~~ 340 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMDHPWI-NQYEAVPQTPLSTSR 340 (400)
T ss_pred HHHHhcCCchhheeHHHhhcCchh-cccccCCCCCchhhh
Confidence 999999999999999999876322 223344444444333
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=297.55 Aligned_cols=248 Identities=19% Similarity=0.207 Sum_probs=200.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|..++.||.|+||.||+|.. .++..+|+|.+..... .....+.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466777889999999999995 4678899999864321 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~ 212 (359)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (308)
T cd06634 95 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171 (308)
T ss_pred EccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence 9996 578877653 345689999999999999999999999 9999999999999999999999999999877766667
Q ss_pred CCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 213 ~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
.++..|+|||.+. ...++.++||||||+++|+|++|..|+............... ..........+..+.+++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc----CCCCcCcccccHHHHHHH
Confidence 7889999999875 345788999999999999999999887654222111111111 011111234667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.+||+.+|++||++.+++....
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=300.56 Aligned_cols=243 Identities=17% Similarity=0.201 Sum_probs=190.1
Q ss_pred CCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 66 GEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 66 g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
|.|+||+||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+++|.+
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 4449999999985 57899999998754322 24568899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----------CC
Q 018244 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RS 211 (359)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----------~~ 211 (359)
++.......+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++||+.+...... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence 98764455689999999999999999999999 9999999999999999999999999754322110 11
Q ss_pred cCCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-----------------------
Q 018244 212 YSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------------- 266 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~----------------------- 266 (359)
..++..|+|||++.+. .++.++||||||+++|+|++|..||..............
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd08226 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247 (328)
T ss_pred ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccch
Confidence 2235679999999764 478899999999999999999998865432111100000
Q ss_pred ------------------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 ------------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...............+..+.+|+.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111123467789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=295.52 Aligned_cols=249 Identities=18% Similarity=0.204 Sum_probs=192.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||.||+|.. .++..||+|.+....... ...+.+|+++++.++|+||+++++++..+...++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 4577888999999999999984 568899999997543222 34577899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 96 577777653 334678888999999999999999999 9999999999999999999999999998754322 2
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh----------------------h
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------------T 267 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~----------------------~ 267 (359)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||.........-.... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 33467899999998754 478899999999999999999988754321100000000 0
Q ss_pred hccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 268 LTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 268 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.......... ....+..+.+++.+|+..||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0012467899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.22 Aligned_cols=252 Identities=16% Similarity=0.180 Sum_probs=184.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC--CcEEEEEEeC--------------C---CCCchHHHHHHHHHHHhcCCCcccc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFN--------------R---SAWPDARQFLEEARAVGQLRNRRLA 116 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~--------------~---~~~~~~~~~~~e~~~l~~l~h~niv 116 (359)
...|++++.||+|+||+||+|..+. +...++|.+. + ........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3578999999999999999987432 2222222111 0 1112234578999999999999999
Q ss_pred cccceeeeCCcceEEEecCCCCCHhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
++++++...+..++|+|++.+ +|.+++.... ........+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC
Confidence 999999999999999999854 7777764321 12234567788999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCCC-----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh----HHHhhhh
Q 018244 194 NPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRN 264 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~----~~~~~~~ 264 (359)
.+||+|||+++...... ...||..|+|||++.+..++.++|||||||++|||++|..++..... .......
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999998654332 34689999999999998999999999999999999999865432211 1110000
Q ss_pred ----------------hhhhcccc-c---cCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 ----------------IQTLTDSC-L---EGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 ----------------~~~~~~~~-~---~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+... . .... ....+.++.+++.+||+.||.+|||+.|++.+
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 0 0000 01134567888999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.97 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=214.3
Q ss_pred cccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 60 NIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+-+.||.|.||.|++|.++ ....||||.++....+ ...+|+.|..+|.+++||||+++.|+......+.||+||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 45566799999999999864 2467999999976543 356799999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-cC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YS 213 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-~~ 213 (359)
|++|+|..+|+.++ +.+++.++.-+++.|+.|+.||-+. +.|||||.+.|||++.+...|++|||+++...++.. ..
T Consensus 712 MENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 712 MENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999999998755 4599999999999999999999999 999999999999999999999999999998765541 11
Q ss_pred C------CccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 214 T------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 214 ~------t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
. ..+|+|||.+..++++.++||||||++|||.++ |..|+.+.......+. +....+...|.+++..|.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPPMDCPAALY 864 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCCCCCcHHHH
Confidence 1 268999999999999999999999999999876 6666655443333322 233344455788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+||..||++|-.+||.+.+|+..|.++.....
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 99999999999999999999999999877544
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=294.11 Aligned_cols=249 Identities=18% Similarity=0.228 Sum_probs=195.8
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|++++.||.|++|.||+|.. .+|..||+|++..... .....+.+|++.++.++|+|++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45677889999999999985 4789999999875432 22356788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
+ ++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 5899988654445789999999999999999999999 9999999999999999999999999998764322 12
Q ss_pred cCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-----------------hc---c
Q 018244 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------LT---D 270 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~-----------------~~---~ 270 (359)
..++..|+|||++.+. .++.++||||||+++|+|++|..||............... .. .
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3457889999988764 4788999999999999999999887644221110000000 00 0
Q ss_pred c---cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 S---CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ..........+..+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00001122345789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=311.63 Aligned_cols=240 Identities=16% Similarity=0.207 Sum_probs=195.4
Q ss_pred ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC----CCchHHHHHHHHHHHhcCCCcccccccceeeeCCc--ceEEEecC
Q 018244 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE--RLLVAEYM 135 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~ 135 (359)
..||+|+|-+||+|.. .+|..||.-.++.. .....+.|..|+.+|+.|+|+||++++.+|.+..+ ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 3479999999999985 45777875555432 22335789999999999999999999999988766 78899999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccCCCCCeeeCC-CCCeEEeccCCcccCCCC--CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG--RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~~--~~ 211 (359)
..|+|..|++ +.+.++...+..|++||+.||.|||++ +.|+|||||.+||+|+. .|.|||+|+|+|...... ..
T Consensus 126 TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 126 TSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999998 556788999999999999999999987 67999999999999985 589999999999876654 45
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..|||.|||||+.. ..|++.+|||||||.++||+|+..|+........... .+.....+..+..--.++++++|.+
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK---KV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK---KVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH---HHHcCCCHHHhhccCCHHHHHHHHH
Confidence 68999999999988 8899999999999999999999988876543322111 1111111111222234689999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||.. .++|||+.|+|..
T Consensus 280 Cl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKD 296 (632)
T ss_pred HhcC-chhccCHHHHhhC
Confidence 9999 9999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=294.25 Aligned_cols=239 Identities=18% Similarity=0.186 Sum_probs=187.3
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHH---HhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARA---VGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
||+|+||.||++.. .++..+|+|.+...... ....+.+|..+ +....|+||+.+.+++...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 69999999999995 46889999998754321 12223444433 3344799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCcCCC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~~~t 215 (359)
++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... ....++
T Consensus 82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999886 345699999999999999999999999 9999999999999999999999999998754332 234678
Q ss_pred ccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......... ..... .......+...+.++.+++.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence 99999999874 458899999999999999999999886432111110 00000 011122344567889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 018244 295 YEPRERP-----NPRSLVTA 309 (359)
Q Consensus 295 ~dp~~Rp-----s~~~il~~ 309 (359)
.||++|| |+++++++
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhC
Confidence 9999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=293.20 Aligned_cols=247 Identities=18% Similarity=0.210 Sum_probs=192.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCC-CcccccccceeeeC--CcceEEEe
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLLVAE 133 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 133 (359)
|++++.||+|+||.||+|.. .++..||+|.+..... .......+|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778899999999999984 5688999999875422 22234567899999985 99999999999887 88999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---C
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~ 210 (359)
|+.+ +|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++...... .
T Consensus 81 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9974 88888764 235789999999999999999999999 9999999999999999 99999999998765433 2
Q ss_pred CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh----------hccc--cccCCC
Q 018244 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT----------LTDS--CLEGQF 277 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~--~~~~~~ 277 (359)
...++..|+|||.+.. ..++.++|||||||++|+|++|..||............... .... .....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3456889999997654 45788999999999999999999888654321111000000 0000 000000
Q ss_pred -----------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 -----------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 -----------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+.++.+++.+||+.+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 12356889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=295.82 Aligned_cols=251 Identities=19% Similarity=0.219 Sum_probs=195.8
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|++.+.||.|++|.||+|... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999954 688999999875432 223567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~~--- 209 (359)
|+++ +|.+++.......+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9964 788887654444578899999999999999999999 9999999999999985 567999999998764322
Q ss_pred -CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------------
Q 018244 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---------------- 271 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 271 (359)
....+++.|+|||.+.+. .++.++||||||+++|+|+||..||..................+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233567899999988764 57889999999999999999998886442211111100000000
Q ss_pred ---cccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ---CLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ---~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ......+.++.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0112346779999999999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.69 Aligned_cols=247 Identities=15% Similarity=0.194 Sum_probs=194.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC------Cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (359)
..|.+++.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 5677888899999999999994 578899999987532 23345678899999999999999999988643 35
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 7999999965 88888742 289999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh------------------
Q 018244 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------ 266 (359)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------ 266 (359)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 432 34567899999999988899999999999999999999988865421110000000
Q ss_pred hhc---------------ccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 TLT---------------DSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ~~~---------------~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ..... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 00012346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.23 Aligned_cols=249 Identities=19% Similarity=0.280 Sum_probs=215.3
Q ss_pred HhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 52 ATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 52 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
..+.+..|.+++.||+|.|++|.+|+ ..++..||||.+.+..... ...+.+|+++|+.|.|||||+++.+......+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34566778999999999999999998 4568899999998875433 45689999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|+||||+.+|.+++++. +.+.+.+..+..++.|+..|++|||++ +|+|||||++||||+.+.++||+|||++..+..
T Consensus 131 ylV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999999997 555677789999999999999999999 999999999999999999999999999998775
Q ss_pred C---CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 G---RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~---~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
+ .+..|++.|.|||++.+..| .+.+|+||+|+++|-|+.|.-||.+..........+... -..+...+.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------~rIp~~ms~d 281 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------YRIPFYMSCD 281 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee------ecccceeech
Confidence 4 46789999999999998876 468999999999999999999998776554443332211 1234556788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.++|+++|-.+|.+|++++++...
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhh
Confidence 9999999999999999999998764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=295.07 Aligned_cols=244 Identities=19% Similarity=0.214 Sum_probs=197.4
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
|..+++||+|+||+||+|+. .++..||+|.+..... .....+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44556689999999999985 4688999999875432 2235678899999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~ 214 (359)
+.+ +|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++..........+
T Consensus 103 ~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~ 179 (313)
T cd06633 103 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG 179 (313)
T ss_pred CCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccc
Confidence 964 78777754 345689999999999999999999999 999999999999999999999999999877666666678
Q ss_pred CccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
+..|+|||++. ...++.++||||||+++|+|++|..|+................ .........+..+.+++.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCccccCHHHHHHHHH
Confidence 88999999985 3558889999999999999999998876543211111111110 1111123345679999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.+|++||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.60 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=205.7
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||.|++|.||++... ++..+|+|++..... .....+.+|+++++.++|+|++++.+.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 667788899999999999954 688999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 136 PNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999987532 46799999999999999999999999 99999999999999999999999999987655442
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+................ ....+...+.++.+++
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i 235 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----YPPIPSQYSSELRNLV 235 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----CCCCCCCCCHHHHHHH
Confidence 3356788999999988889999999999999999999998876553332222221111 1223345667899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||..+|++|||+.++++.
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.07 Aligned_cols=245 Identities=18% Similarity=0.225 Sum_probs=203.5
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC--CcceEEEe
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 133 (359)
|.+.+.||+|++|.||+|... ++..|++|++..... ...+.+.+|++.+++++|+||+++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 456677899999999999965 688999999976543 3356788999999999999999999999888 88999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999864 33899999999999999999999998 99999999999999999999999999988765443
Q ss_pred ---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...++..|+|||.+.+...+.++||||||+++|+|++|..|+........ ..............+...+..+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHH
Confidence 34567899999999988899999999999999999999988765431111 111111111222344556789999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||..||++||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=285.80 Aligned_cols=242 Identities=19% Similarity=0.257 Sum_probs=203.0
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||.|++|.||++... ++..+|+|.+..... .....+.+|++++..++|+|++++++++......+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 567788899999999999854 678999999987654 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---- 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~---- 211 (359)
++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 82 ENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 99999999863 36789999999999999999999999 999999999999999999999999999887654432
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||...+..++.++||||+|+++|+|++|..|+............. .......+...+..+.+++.+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCCCCCCCHHHHHHHHH
Confidence 457889999999987778899999999999999999998876433111111111 111223345567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVT 308 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~ 308 (359)
||..+|++|||+.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=335.25 Aligned_cols=240 Identities=17% Similarity=0.202 Sum_probs=202.5
Q ss_pred ccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
..+|.|.||.||.|. ..+|...|+|-+...... ....+.+|..+|..|+|||+|+++|+-.+.+.++|.||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 356999999999999 678999999988754332 34567889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--------CC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--------RS 211 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--------~~ 211 (359)
|.+++. .++..++.....+..|++.|++|||+. |||||||||+||+++.+|.+|++|||.|...... +.
T Consensus 1321 La~ll~--~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred HHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 999996 556788889999999999999999999 9999999999999999999999999999876543 24
Q ss_pred cCCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
..||+.|||||++.+.+ ...++||||+|||++||+||+.|+.....+....... .....+.+|...+.+-.++
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V----~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV----AAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH----hccCCCCCchhhhHhHHHH
Confidence 57899999999998643 5678999999999999999999875443322221111 2223345677799999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+..||..||++|.++.++++.
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHh
Confidence 999999999999999887764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.34 Aligned_cols=258 Identities=17% Similarity=0.251 Sum_probs=200.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 129 (359)
.|.+++.||.|+||+||+|.. .++..||||.+.... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 467788889999999999984 568899999987532 22345678899999999999999999988654 3479
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 58988886 345799999999999999999999999 9999999999999999999999999998865433
Q ss_pred ----CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-------------------hhh
Q 018244 210 ----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------RNI 265 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-------------------~~~ 265 (359)
....++..|+|||.+.. ..++.++||||||+++|+|++|+.||.......... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 23456789999998865 458899999999999999999998886532111000 000
Q ss_pred hhhcc---ccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhhcccC
Q 018244 266 QTLTD---SCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQKDTEV 319 (359)
Q Consensus 266 ~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~~~~~ 319 (359)
..... ..... ......+.++.+++.+||+.+|++|||+++++++ +..+......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00000 00000 0112456789999999999999999999999987 6665544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.63 Aligned_cols=248 Identities=19% Similarity=0.253 Sum_probs=198.7
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+++.||.|++|.||+|.. .+++.+|+|.+...... ....+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45677889999999999985 46889999998765433 3456888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
++ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 76 88888764 336789999999999999999999999 99999999999999999999999999987665432 3
Q ss_pred cCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc------------------
Q 018244 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC------------------ 272 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------------ 272 (359)
..++..|+|||.+.+. .++.++|+||||+++|+|+||+.||+.................+.
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4567789999998876 688999999999999999999988865432211111100000000
Q ss_pred ------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 ------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.........+.++.+++.+||+.||.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000112356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.48 Aligned_cols=245 Identities=16% Similarity=0.228 Sum_probs=204.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|++.+.+|.|++|.||++.. .++..+|+|.+..... .....+.+|+++++.++|+||+++.+++......++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 66778889999999999984 4688999999976432 23456788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CC
Q 018244 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~ 211 (359)
++++|.+++.+. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 999999988642 235689999999999999999999999 9999999999999999999999999998765443 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.............. ......+...+.++.+++.+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----GKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCchhhCHHHHHHHHH
Confidence 3567899999999988899999999999999999999998876543332222211 11122334567889999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||..+|++|||+.++++.
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=302.07 Aligned_cols=253 Identities=17% Similarity=0.255 Sum_probs=195.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cce
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 129 (359)
.+|.+.+.||+|+||.||+|. ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 357788889999999999998 4568899999987432 223456788999999999999999999876543 479
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+++||+.+ +|.+++ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999975 788877 445799999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-------CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh-----------hhh---
Q 018244 210 R-------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------IQT--- 267 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-----------~~~--- 267 (359)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 2356788999998765 45889999999999999999999888654221110000 000
Q ss_pred -----hcccc-ccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 018244 268 -----LTDSC-LEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (359)
Q Consensus 268 -----~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~ 314 (359)
..... .... .....+.++.+++.+||+.||++|||+.+++++ ++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 0000 011235679999999999999999999999986 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.14 Aligned_cols=252 Identities=21% Similarity=0.246 Sum_probs=196.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
+...|++++.||.|+||.||+|.. .+|..||+|.+....... ...+.+|+.+++.++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 456788999999999999999995 468899999987543221 23466899999999999999999998754 4689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 78888764 346789999999999999999999999 9999999999999999999999999998865433
Q ss_pred ----CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc--------------
Q 018244 210 ----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD-------------- 270 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 270 (359)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12234678999999875 45789999999999999999999888654322211111100000
Q ss_pred --c-ccc-CCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 --S-CLE-GQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 --~-~~~-~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ... ... ....++++.+++.+||+.||++|||+++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000 000 01246778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.52 Aligned_cols=248 Identities=21% Similarity=0.244 Sum_probs=196.1
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeC--CcceEEEe
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 133 (359)
|.+++.||.|++|.||+|+.. ++..+|+|.+.... ......+.+|+++++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 467788899999999999954 58899999998763 23345688899999999999999999999888 78999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 89888854 235789999999999999999999999 99999999999999999999999999988665432
Q ss_pred --CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------------
Q 018244 211 --SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---------------- 271 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 271 (359)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||..................+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23457789999987653 57899999999999999999998886543322111111000000
Q ss_pred ---------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ---------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.....+....+..+.+++.+||+.+|++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000011126789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=294.91 Aligned_cols=240 Identities=18% Similarity=0.210 Sum_probs=187.3
Q ss_pred CCcEEEEEE-eCCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhh
Q 018244 69 APNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145 (359)
Q Consensus 69 ~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 145 (359)
++|.||.++ ..+++.||||++... .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 444555555 336889999999765 23345678999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----------CCcCC
Q 018244 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RSYST 214 (359)
Q Consensus 146 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----------~~~~~ 214 (359)
......+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||.+...... ....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 55456789999999999999999999999 9999999999999999999999999987643211 22345
Q ss_pred CccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh----hhc-------------------
Q 018244 215 NLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----TLT------------------- 269 (359)
Q Consensus 215 t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~----~~~------------------- 269 (359)
+..|+|||.+.+. .++.++||||||+++|+|++|..||.............. ...
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998763 488899999999999999999998865322111100000 000
Q ss_pred -----cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
............+.++.+++.+||..||++|||+++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000011123456789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.15 Aligned_cols=250 Identities=16% Similarity=0.182 Sum_probs=193.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCC-CcccccccceeeeCCc-----c
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR-NRRLANLLGCCCEGDE-----R 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~ 128 (359)
.|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.+. |+||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 467778889999999999995 46889999998754322 2456788999999995 6999999999887665 8
Q ss_pred eEEEecCCCCCHhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcc
Q 018244 129 LLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMK 204 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~ 204 (359)
++||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++. ++.++|+|||++.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 999999986 7888876422 34689999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCCC----CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc--------
Q 018244 205 NSRDG----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS-------- 271 (359)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 271 (359)
..... ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...............+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 223457889999988754 47899999999999999999998886542211110000000000
Q ss_pred ----------ccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ----------CLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ----------~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... .......+..+.++|.+||..||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00012356789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.70 Aligned_cols=238 Identities=21% Similarity=0.218 Sum_probs=195.4
Q ss_pred CCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||.|+||.||+++.. ++..+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999965 488999999976543 3355688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----------
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------- 209 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----------- 209 (359)
.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999864 34789999999999999999999999 9999999999999999999999999998754332
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH--HHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EGTELV 286 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~ 286 (359)
....++..|+|||.+....++.++||||||+++|+|++|..|+............... . ...+.. .+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~ 231 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG----K--IEWPEDVEVSDEAI 231 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----C--cCCCccccCCHHHH
Confidence 1234677899999998888899999999999999999999988655433322221110 0 111222 367899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
+++.+||+.+|++|||+..+.+.|+
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.59 Aligned_cols=249 Identities=16% Similarity=0.238 Sum_probs=196.9
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|++++.||.|++|.||+|+.. +|..||+|.+...... ....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 3677888999999999999964 6889999999865432 2456788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
++ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 85 8888876432 34689999999999999999999999 9999999999999999999999999998754332 2
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc------------ccccCC-
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD------------SCLEGQ- 276 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~~~~- 276 (359)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||.................. +.....
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 33467889999988764 4788999999999999999999887654322211111100000 000000
Q ss_pred ----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 277 ----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 277 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.....+..+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11234577899999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.50 Aligned_cols=249 Identities=16% Similarity=0.220 Sum_probs=193.0
Q ss_pred ccccccCCCCCCcEEEEEEeC---CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeC--CcceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (359)
|.+++.||+|++|.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667888999999999999954 47899999998743 23345678899999999999999999999988 78999
Q ss_pred EEecCCCCCHhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC----CCCeEEeccCCc
Q 018244 131 VAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM 203 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~----~~~~kl~DFg~a 203 (359)
||||+++ +|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999975 677766432 223689999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCC-------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHH-----hhhhh-----
Q 018244 204 KNSRDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-----RDRNI----- 265 (359)
Q Consensus 204 ~~~~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-----~~~~~----- 265 (359)
...... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 865432 233567889999988764 578899999999999999999988764322110 00000
Q ss_pred -------------------hhhccccccCCCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 266 -------------------QTLTDSCLEGQFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 266 -------------------~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...........++ ...+.++.+++.+||+.||++|||+.+++.+
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000111 0344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=291.56 Aligned_cols=250 Identities=12% Similarity=0.056 Sum_probs=183.4
Q ss_pred CcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCchH-----------HHHHHHHHHHhcCCCcccccccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDA-----------RQFLEEARAVGQLRNRRLANLLGC 121 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~ 121 (359)
..|.+.+.||+|+||+||+|...+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 468888999999999999998543 45567776443322111 112234455667789999999987
Q ss_pred eeeCC----cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEE
Q 018244 122 CCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (359)
Q Consensus 122 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl 197 (359)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||.|||+. +++||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEE
Confidence 65543 34778888754 67666642 23467888999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCC-----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhh
Q 018244 198 SCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI 265 (359)
Q Consensus 198 ~DFg~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~ 265 (359)
+|||+++..... ....||+.|+|||+..+..++.++||||||+++|||++|..||..... ........
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999998764311 223588999999999988999999999999999999999998865421 11111111
Q ss_pred hhhccccccC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 266 QTLTDSCLEG-QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 266 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
.......... ......+..+.+++..||+.+|++||++.++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111110000 11233467899999999999999999999998865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=286.56 Aligned_cols=244 Identities=16% Similarity=0.186 Sum_probs=197.9
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-----CchHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
.|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+++++.++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 467778889999999999984 568899999875321 22345688999999999999999999998764 4578
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999863 34588999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ............+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVS 235 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccC
Confidence 1245788999999999888999999999999999999999888654222111 11111112233456677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+.+++.+||. +|..|||+.+++.+
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 889999999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.36 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=202.2
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 130 (359)
|.+.+.||.|++|.||+|... ++..||+|.+.... ....+.+.+|+.+++.++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 677788899999999999954 58899999997643 233567889999999999999999999998775 7899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
+|||+.+ +|.+++. ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~-~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELMET-DLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchhh-hHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999975 8988886 344899999999999999999999999 99999999999999999999999999988755432
Q ss_pred -------CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc----------
Q 018244 211 -------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC---------- 272 (359)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 272 (359)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..................+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 33567889999999887 789999999999999999999998876543221111111000000
Q ss_pred --------cc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhh
Q 018244 273 --------LE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (359)
Q Consensus 273 --------~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~ 315 (359)
.. .......+.++.+++.+||+.+|++|||+.+++.+ ++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00 00112246789999999999999999999999975 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=291.43 Aligned_cols=250 Identities=18% Similarity=0.264 Sum_probs=195.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (359)
.+..|.+++.||+|++|.||+|...+ +..+|||.+...... ....+.+|+.++.... |+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45667888999999999999999654 889999999765332 3445677887776765 99999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+.+ +|.+++.. ....+++..+..++.|++.||+|||+..+++|+||+|+||++++++.++|+|||++.......
T Consensus 93 ~e~~~~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 93 MELMST-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eeccCc-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999854 77777654 345789999999999999999999973399999999999999999999999999987654322
Q ss_pred --CcCCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc-cCCCChHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL-EGQFSSDEGT 283 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 283 (359)
...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......... ......... ........+.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV---LTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH---HHHHhcCCCCCCCCCCCCCH
Confidence 234677899999987553 788999999999999999999888653211100 001111110 0011123567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+|+.+||+.||++|||+.+++.+
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=288.19 Aligned_cols=238 Identities=19% Similarity=0.195 Sum_probs=187.9
Q ss_pred CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHH---HHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEA---RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 65 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
||+|+||.||+|.. .+++.||+|.+...... ....+..|. +.++...||||+.+.+++...+..++||||+.+
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 69999999999984 56889999998754322 112233343 345556799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--CCcCCC
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~~~~~t 215 (359)
|+|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....|+
T Consensus 82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99999886 345799999999999999999999999 9999999999999999999999999998754322 244678
Q ss_pred ccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
..|+|||.+.++ .++.++||||+|+++|+|++|..||............ ... .......+...+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--~~~-~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMT-LTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--HHh-hccCCCCCCcCCHHHHHHHHHHhh
Confidence 999999999754 5889999999999999999999988654211111000 000 001122334457889999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 018244 295 YEPRERP-----NPRSLVT 308 (359)
Q Consensus 295 ~dp~~Rp-----s~~~il~ 308 (359)
.+|.+|| ++.++++
T Consensus 236 ~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCHHhccCCCCCCHHHHHh
Confidence 9999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.09 Aligned_cols=249 Identities=18% Similarity=0.285 Sum_probs=195.0
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhc--CCCcccccccceeeeCC----cceEEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLVA 132 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~ 132 (359)
.++++.+|+|.||.||||.+.+ +.||||++... +.+.|.+|-++... ++|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3455566999999999999855 68999999853 34566666666554 58999999999887666 789999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
+|.+.|+|.+|| +...++|....+|+..|++||+|||.. ..|+|||||..||||.+|++..|+|||+|.
T Consensus 288 ~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999 567899999999999999999999973 579999999999999999999999999998
Q ss_pred cCCCCC------CcCCCccccCcccccCCC-CC-----CccchhhHHHHHHHHHhCCCCCC-------cc----------
Q 018244 205 NSRDGR------SYSTNLAFTPPEYLRTGR-VT-----PESVMYSFGTLLLDLLSGKHIPP-------SH---------- 255 (359)
Q Consensus 205 ~~~~~~------~~~~t~~y~aPE~~~~~~-~~-----~~~Di~slG~il~elltg~~p~~-------~~---------- 255 (359)
.+..+. ..+||.+|||||++.+.- +. ...||||+|.+||||++.-.-.. .-
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 776543 457899999999998642 22 36899999999999998653221 11
Q ss_pred hhHHHhhhhhhhhccccccCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 256 ALDLIRDRNIQTLTDSCLEGQFSS-----DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
..+.+... .+....++.++. ....-+++.+..||+.||+.|.|+.-+-+++..+.....
T Consensus 445 t~e~mq~~----VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 445 TLEEMQEL----VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CHHHHHHH----HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11111111 122223333333 245679999999999999999999999998888765443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=293.62 Aligned_cols=251 Identities=18% Similarity=0.218 Sum_probs=191.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCc----
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDE---- 127 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 127 (359)
....|.+++.||.|+||.||+|.. .++..||||.+...... ....+.+|+++++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345688899999999999999995 46889999998654322 23356789999999999999999998876543
Q ss_pred ----ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 128 ----RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 128 ----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
.++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4999999965 78887753 334689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC--------CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc---c
Q 018244 204 KNSRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD---S 271 (359)
Q Consensus 204 ~~~~~~~--------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~ 271 (359)
....... ...++..|+|||.+.+.. ++.++||||||+++|+|++|..|+............ ..+.. +
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI-SQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCCh
Confidence 7653321 224567899999887654 788999999999999999999887654322111000 00000 0
Q ss_pred c---------------ccCC---------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 C---------------LEGQ---------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ~---------------~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .... .+...+..+.+++.+||..||++|||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 0000 001124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.71 Aligned_cols=254 Identities=17% Similarity=0.137 Sum_probs=210.5
Q ss_pred HHHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC---CCchHHHHHHHHHHHhcCCCcccccccceee
Q 018244 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCC 123 (359)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 123 (359)
.+....-+-.+|.+++.||+|+||.|..++. .+++.+|+|++++- ...+..-|..|-.+|..-..+=|++++..|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3444445667888999999999999999994 56889999999862 2233456888999999999999999999999
Q ss_pred eCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+..++|+||||++||+|..++.+. ..+++..+..++..|..||.-||+. |.|||||||+|||||..|++||+|||.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999999743 3799999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCC-----CCcCCCccccCccccc----C-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc
Q 018244 204 KNSRDG-----RSYSTNLAFTPPEYLR----T-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 204 ~~~~~~-----~~~~~t~~y~aPE~~~----~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
-....+ ...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||+.+..-.....+... ..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h----k~ 298 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH----KE 298 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----hh
Confidence 766643 2457999999999986 2 56999999999999999999999999987654443333322 11
Q ss_pred cCCCC--hHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 018244 274 EGQFS--SDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (359)
Q Consensus 274 ~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (359)
...+| ...++++++||.+.+ -+|+.|.. ++++-.+
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 12233 457899999999988 46999987 7776553
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=306.43 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=204.1
Q ss_pred ccccCCCCCCcEEEEEEeCC--C--cEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 61 IVSEHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+.+.||+|.||.|++|.|.. | ..||||++...... ....|++|+.+|.+|+|+|+++++|+..+ ....+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 44566999999999999753 3 46999999876544 46789999999999999999999999987 6788999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--- 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~--- 212 (359)
+.|+|.+.|+......+-......++.|||.||.||.++ ++|||||-..|+|+...-.|||+|||+.+....+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999999876667888899999999999999999999 9999999999999999999999999999877655432
Q ss_pred ----CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 213 ----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 213 ----~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.....|+|||.+...+++.++|||+|||++|||+|+. .|+.+..- ..+...++...+...+..+++++.+
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----IQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----HHHHHhccccccCCCCCCChHHHHH
Confidence 2246799999999999999999999999999999855 45444321 1223334444445567889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++..||..+|++|||+..|.+.
T Consensus 347 imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHhccCCccccccHHHHHHh
Confidence 9999999999999999999743
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.05 Aligned_cols=242 Identities=21% Similarity=0.245 Sum_probs=200.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (359)
+|.+.+.||.|+||.||+|.. .++..||+|++..... .....+.+|+++++.+. |+||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577888899999999999995 4788999999876322 22456788999999998 999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999963 44799999999999999999999999 99999999999999999999999999987543322
Q ss_pred ----------------------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh
Q 018244 211 ----------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (359)
Q Consensus 211 ----------------------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 268 (359)
...++..|+|||.+.+..++.++||||||++++++++|..|+............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI---- 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----
Confidence 224578899999998888999999999999999999999887654322111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 018244 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP----RSLVT 308 (359)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~il~ 308 (359)
.. .....+...++.+.+++.+||+.+|++|||+ +++++
T Consensus 235 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 1123345557789999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=319.86 Aligned_cols=246 Identities=19% Similarity=0.214 Sum_probs=187.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeee--------
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE-------- 124 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 124 (359)
.+.+++.++.||+||||.||+++. -||..+|||++.... ......+.+|+.+|.+|+|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 445666777789999999999994 489999999998764 2224568899999999999999999876500
Q ss_pred ----------------------------------------------------------------------C---------
Q 018244 125 ----------------------------------------------------------------------G--------- 125 (359)
Q Consensus 125 ----------------------------------------------------------------------~--------- 125 (359)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 018244 126 --------------------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS 173 (359)
Q Consensus 126 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 173 (359)
..+||-||||+..+|.+++.++.. .-.....|+++++|+.||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHHHh
Confidence 124888999999777777743221 11467889999999999999999
Q ss_pred CCCcccccCCCCCeeeCCCCCeEEeccCCcccCC----------------------CCCCcCCCccccCcccccCCC---
Q 018244 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----------------------DGRSYSTNLAFTPPEYLRTGR--- 228 (359)
Q Consensus 174 ~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~----------------------~~~~~~~t~~y~aPE~~~~~~--- 228 (359)
. |+|||||||.||+++++..|||+|||+|+... ..+..+||.-|+|||++.+..
T Consensus 716 ~-giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 716 Q-GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred C-ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 99999999999999999999999999988611 112456889999999998654
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 018244 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306 (359)
Q Consensus 229 ~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 306 (359)
|+.|+||||||+|++||+. ||...... . ..+..+.+..++ ..+.....+.-.++|.+|++.||++||||.|+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a--~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMER-A--SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHH-H--HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 9999999999999999995 34433211 1 111122222211 22334455677899999999999999999999
Q ss_pred HH
Q 018244 307 VT 308 (359)
Q Consensus 307 l~ 308 (359)
|+
T Consensus 869 L~ 870 (1351)
T KOG1035|consen 869 LN 870 (1351)
T ss_pred hh
Confidence 86
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=280.64 Aligned_cols=242 Identities=19% Similarity=0.197 Sum_probs=197.1
Q ss_pred cCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCCCCCHh
Q 018244 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (359)
.||+|+|+.|-.++ ..+|..+|||++.+.......++.+|++++...+ |+||++++++|.++..+|||||-+.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 47999999999998 7889999999999887666788999999999996 999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcccCCCC---------
Q 018244 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG--------- 209 (359)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~~~~~~--------- 209 (359)
+.|. +...+++..+.+++.+|+.||.|||.+ ||.|||+||+|||...- .-+||+||.+.......
T Consensus 165 shI~--~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 165 SHIQ--KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9998 567799999999999999999999999 99999999999999754 34999999886543322
Q ss_pred --CCcCCCccccCccccc---C--CCCCCccchhhHHHHHHHHHhCCCCCCcc-----hhHH-----Hhhhhhhhhcccc
Q 018244 210 --RSYSTNLAFTPPEYLR---T--GRVTPESVMYSFGTLLLDLLSGKHIPPSH-----ALDL-----IRDRNIQTLTDSC 272 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~---~--~~~~~~~Di~slG~il~elltg~~p~~~~-----~~~~-----~~~~~~~~~~~~~ 272 (359)
.+.+|+..|||||+.. + ..|+.++|.||||||+|-|++|..||.+. .|+. .-+..+-.-+...
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 1235667899999764 2 34889999999999999999999999653 1111 0011111111111
Q ss_pred ccCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 LEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ..+| ...+.+..+++..++..|+.+|.++.+++++
T Consensus 322 k-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 322 K-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred C-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1 1122 3578899999999999999999999999983
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.33 Aligned_cols=248 Identities=17% Similarity=0.251 Sum_probs=193.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee----CCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 130 (359)
.|.+.+.||.|++|.||+|.. .++..||+|++..... .....+.+|+.+|+.++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 466777889999999999984 5688999999875432 234567889999999999999999998763 346899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+. ++|.+++. ....+++..+..++.||+.||.|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999996 58988885 345599999999999999999999999 99999999999999999999999999987643321
Q ss_pred --------CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-------------------
Q 018244 211 --------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------------------- 262 (359)
Q Consensus 211 --------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~------------------- 262 (359)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 2356788999999865 458899999999999999999999886542211100
Q ss_pred hhhhhhcccc-ccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 263 RNIQTLTDSC-LEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 263 ~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.......... ..... ....+.++.+++.+||+.+|++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00000 12346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.31 Aligned_cols=256 Identities=16% Similarity=0.204 Sum_probs=197.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-----CcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee-CCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 127 (359)
...|+.++.||+|.||.||+|...+ .+.+|+|.++.... .-....-+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3478899999999999999996322 34699999986521 123457889999999999999999999988 678
Q ss_pred ceEEEecCCCCCHhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC----CCeEEecc
Q 018244 128 RLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSCF 200 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~----~~~kl~DF 200 (359)
+++++||.+. +|...++.. +...++...+..|+.||+.|++|||++ =|+||||||.|||+..+ |.|||+||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999987 788888642 345788999999999999999999999 99999999999999876 99999999
Q ss_pred CCcccCCCC-------CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh---------h
Q 018244 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---------R 263 (359)
Q Consensus 201 g~a~~~~~~-------~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~---------~ 263 (359)
|+++.+... ...+.|.+|+|||.+.+.+ |+.+.||||.|||+.||+|-.+.|.....+.-.. .
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999976543 3456689999999999875 9999999999999999999887765432111000 0
Q ss_pred hhhhhcccc--------------------ccCCCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 264 NIQTLTDSC--------------------LEGQFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 264 ~~~~~~~~~--------------------~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
++..+-.+. ....+. ..-++...+|+.++|..||-+|.|+++++++.--
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 000000000 000000 0012348899999999999999999999987543
Q ss_pred h
Q 018244 313 L 313 (359)
Q Consensus 313 ~ 313 (359)
.
T Consensus 341 ~ 341 (438)
T KOG0666|consen 341 T 341 (438)
T ss_pred c
Confidence 3
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=287.99 Aligned_cols=249 Identities=16% Similarity=0.267 Sum_probs=195.2
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||.|++|+||+|... ++..||+|.+...... ......+|+..++.++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456778899999999999964 5788999998754322 2234567999999999 999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCc
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~ 212 (359)
+|+|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++...... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 77999988754445789999999999999999999999 9999999999999999999999999998866543 234
Q ss_pred CCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-----------------hcccccc
Q 018244 213 STNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------LTDSCLE 274 (359)
Q Consensus 213 ~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~ 274 (359)
.++..|+|||.+.+ ..++.++|+||||+++++|++|..||+.............. .......
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 56788999998864 45789999999999999999999888654221111000000 0000000
Q ss_pred -------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 -------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 -------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.......+.++.+++.+||+.||++|||+++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00011125789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=331.90 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=196.5
Q ss_pred ccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 61 IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
....||+|+||.||+|.. .++..||||.+...... ...|++.+++++|||||+++++|.+.+..++||||+++|+
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 334569999999999995 57889999998754322 2346889999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh---cCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCc
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCT---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL 216 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~ 216 (359)
|.+++. .++|..+..++.|++.||+||| +. +++||||||+||+++.++..++. ||.+..........+|.
T Consensus 770 L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~ 842 (968)
T PLN00113 770 LSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842 (968)
T ss_pred HHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccc
Confidence 999994 3899999999999999999999 55 99999999999999998888876 66665544444557789
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-----HHHh-----hhhhhhhccccccC--CCChHHHHH
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----DLIR-----DRNIQTLTDSCLEG--QFSSDEGTE 284 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-----~~~~-----~~~~~~~~~~~~~~--~~~~~~~~~ 284 (359)
.|+|||++.+..++.++|||||||++|||+||+.|+..... ..+. ........++.... ..+.....+
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 99999999988999999999999999999999998743210 0000 01111222222221 123345667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 889999999999999999999999999886533
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.29 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=202.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|...++||+|.||+||+|+ +.+++.||+|.+..+...+ .....+|+-+|+.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667788999999999999 6678999999998654222 34678999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
|+. .|..+... -.+.++.+....++.|++.||.++|++ ++.|||+||.|.||+.+|.+||+|||+++.++-.-
T Consensus 83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 976 78888854 567899999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccc--------------c
Q 018244 211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL--------------E 274 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~ 274 (359)
..+.|.+|.+|.++.+.+ |+.+.|+||.|||+.|+.. |++.|++...+.........+-.+.. .
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 335689999999999876 8889999999999999976 56667776555443333332221110 1
Q ss_pred CCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 GQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 ~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.++ +..+..-++|+.+.+.-+|.+|.++++++++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 2234456899999999999999999998864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=287.23 Aligned_cols=248 Identities=19% Similarity=0.218 Sum_probs=193.9
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch--HHHHHHHHHHHhcC---CCcccccccceeeeCCc-----
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQL---RNRRLANLLGCCCEGDE----- 127 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 127 (359)
|++++.||.|+||.||+|+.. ++..+|+|.+....... ...+.+|+.+++.+ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456778899999999999965 48899999997543221 33466777777666 59999999999988776
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 899888654445689999999999999999999999 99999999999999999999999999987754
Q ss_pred CCC---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc---------------
Q 018244 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT--------------- 269 (359)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 269 (359)
... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 332 23467889999999988899999999999999999999887765432221111111000
Q ss_pred ---ccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 270 ---DSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 270 ---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..... .......+..+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0011234678899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=289.63 Aligned_cols=246 Identities=17% Similarity=0.230 Sum_probs=195.1
Q ss_pred ccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCC----chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
|++.+.||.|+||.||.|.. .+|..||+|++..... ...+.+.+|++++..+ +|+||+.+++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56778889999999999985 3688999999875321 2245678899999999 5999999999999988999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999863 45688999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-----CcCCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 R-----SYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 ~-----~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
. ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+................... ...++...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCCCCccCC
Confidence 2 34578899999998753 46789999999999999999998875321111111111111111 112344567
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
..+.+++.+||+.||++|| ++.+++.+
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 7899999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=295.08 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=192.4
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCC--CCchHHHHHHHHHHHhcC-CCcccccccceeeeC--CcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRS--AWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~l 130 (359)
..|.+.+.||.|+||.||+|... ++..+|+|++... .......+.+|+.+++.+ +|+||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 35677788899999999999954 6889999988643 223345677899999999 999999999988653 36899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++ +|..++.. ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eeccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9999975 89998853 3789999999999999999999999 99999999999999999999999999987653322
Q ss_pred ---------CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh----------------
Q 018244 211 ---------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---------------- 264 (359)
Q Consensus 211 ---------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~---------------- 264 (359)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 2356788999998765 45788999999999999999999888643211110000
Q ss_pred ---hhhhcccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 ---IQTLTDSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 ---~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+...... .......+.++.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 00112246789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=295.30 Aligned_cols=279 Identities=14% Similarity=0.211 Sum_probs=206.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|.+++.||.|+||.||+|. ..++..||||.+...... ....+.+|+++|+.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 457788999999999999998 557889999998653222 2346789999999999999999999887654 3
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+ +++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 668988874 45789999999999999999999999 99999999999999999999999999988654
Q ss_pred CCC-CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-------------------
Q 018244 208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (359)
Q Consensus 208 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------- 266 (359)
... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..............
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 432 3456889999999876 3588899999999999999999988865422111000000
Q ss_pred hhcccc--c-c---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhhcccC-CccccchhHHHHHHhhcc
Q 018244 267 TLTDSC--L-E---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQKDTEV-SCFLFSSQFTYALLRLHI 337 (359)
Q Consensus 267 ~~~~~~--~-~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 337 (359)
...... . . .......+.++.+++.+|++.||++|||+.+++.+ ++........ ...+............++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEE 329 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHHhhccchHH
Confidence 000000 0 0 00112345679999999999999999999999953 5554332222 222233333334444455
Q ss_pred ccc
Q 018244 338 WSS 340 (359)
Q Consensus 338 ~~~ 340 (359)
|.+
T Consensus 330 ~~~ 332 (343)
T cd07880 330 WKR 332 (343)
T ss_pred HHH
Confidence 543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=297.46 Aligned_cols=248 Identities=16% Similarity=0.221 Sum_probs=192.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC----------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG---------- 125 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------- 125 (359)
..|.+.+.||.|+||.||+|.. .++..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4678888899999999999985 56889999999776655567788999999999999999999876543
Q ss_pred ----CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEecc
Q 018244 126 ----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF 200 (359)
Q Consensus 126 ----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DF 200 (359)
...++||||+.+ +|.+++. ...+++..+..++.|++.||.|||+. |++|+||||+||+++ +++.++|+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCc
Confidence 357899999974 8988873 45689999999999999999999999 999999999999997 4567899999
Q ss_pred CCcccCCCC-------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-----
Q 018244 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT----- 267 (359)
Q Consensus 201 g~a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~----- 267 (359)
|.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998764322 12346778999998764 45788999999999999999999988643211111000000
Q ss_pred --------------hccccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 --------------LTDSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 --------------~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......... .....+.++.+|+.+||+.||++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000 012345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=289.02 Aligned_cols=250 Identities=18% Similarity=0.212 Sum_probs=198.0
Q ss_pred ccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCC----chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
|.+.+.||.|++|.||++.. .++..||||.+..... ...+.+.+|++++..+ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56778889999999999974 3567899999875321 2234578899999999 5999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999986 345689999999999999999999999 9999999999999999999999999998764432
Q ss_pred C-----CcCCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 R-----SYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 ~-----~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
. ...++..|+|||.+.+.. .+.++||||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 2 234688999999987655 7889999999999999999998875322111111111111111 112234456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
..+.+++.+||+.||++|||+.++.+.|...
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 7899999999999999999988887766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.11 Aligned_cols=253 Identities=15% Similarity=0.221 Sum_probs=195.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|.+...||.|+||.||+|.. .++..||+|.+..... .....+.+|+++++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4677788889999999999994 5688999999875422 22346789999999999999999999986543 4
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5899999965 676654 23589999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-------------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~------------------- 266 (359)
.. ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 33 23456788999999876 4588899999999999999999999875432111110000
Q ss_pred hhc---cccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhh
Q 018244 267 TLT---DSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (359)
Q Consensus 267 ~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~ 315 (359)
... ....... ..+..+.++.+|+.+||+.||++|||+.+++.+ ++...+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 0000000 001245678999999999999999999999965 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.12 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=196.4
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
|.+.+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|+.+++.++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455677899999999999954 58899999998753 223456788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----~ 211 (359)
.+ +|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 74 899999642 24799999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred cCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh--------------------cc
Q 018244 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------------TD 270 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--------------------~~ 270 (359)
..++..|+|||.+.+. .++.++||||||+++|+|++|..||................ ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3346789999998776 78899999999999999999988876543221111100000 00
Q ss_pred ccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 SCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... ......+..+.+++.+||..||++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0011236789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.82 Aligned_cols=250 Identities=21% Similarity=0.235 Sum_probs=192.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCC-------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------- 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 126 (359)
..|.+.+.||.|+||.||+|... +++.||+|.+..... .....+.+|+++++.++|||++++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 45677788899999999999964 588999999975432 22345778999999999999999999987654
Q ss_pred ---cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 127 ---ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
..++|+||+++ ++.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 77777754 345789999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC-----CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc-----
Q 018244 204 KNSRDGR-----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC----- 272 (359)
Q Consensus 204 ~~~~~~~-----~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 272 (359)
....... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||..................+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 8654332 12346789999988654 478899999999999999999988764322111100000000000
Q ss_pred ------cc----------C---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 ------LE----------G---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ------~~----------~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. . ......+..+.+++.+||+.||++|||+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0011246789999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=279.04 Aligned_cols=232 Identities=22% Similarity=0.243 Sum_probs=194.0
Q ss_pred CCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCH
Q 018244 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
||.|+||.||++... ++..+|+|.+...... ....+.+|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 599999999999954 5889999998765432 345788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CCcCCCc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~~~~t~ 216 (359)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999963 34689999999999999999999998 9999999999999999999999999998765442 2445678
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
.|+|||...+...+.++|+||||+++|++++|..||.............. .....+...+..+.+++.+||..|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999888889999999999999999999988865433222211111 112234445778999999999999
Q ss_pred CCCCCCHHH
Q 018244 297 PRERPNPRS 305 (359)
Q Consensus 297 p~~Rps~~~ 305 (359)
|++|||+.+
T Consensus 232 p~~R~~~~~ 240 (250)
T cd05123 232 PTKRLGSGG 240 (250)
T ss_pred HhhCCCccc
Confidence 999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.80 Aligned_cols=245 Identities=16% Similarity=0.191 Sum_probs=195.5
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC-----CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.|.+.+.||+|+||.||++... .+..+++|.++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3667788999999999999854 34446666655321 12234567899999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 132 AEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
|||+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999999988863 2345789999999999999999999999 9999999999999975 57999999998765332
Q ss_pred ----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. ......+...+.++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 233 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-----GPTPSLPETYSRQL 233 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----CCCCCCcchhcHHH
Confidence 234567899999999888889999999999999999999998865432222211111 11222345667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+++.+||+.||++||++.++++.
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=291.99 Aligned_cols=249 Identities=18% Similarity=0.176 Sum_probs=192.8
Q ss_pred Cccccc-ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch--------------HHHHHHHHHHHhcCCCcccccccc
Q 018244 57 AMENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--------------ARQFLEEARAVGQLRNRRLANLLG 120 (359)
Q Consensus 57 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 120 (359)
..|..+ +.||.|+||+||+|.. .+++.||||.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 345544 4589999999999994 468899999987543221 124678999999999999999999
Q ss_pred eeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEecc
Q 018244 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (359)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DF 200 (359)
++...+..++||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 58999886 345689999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC------------------CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHh
Q 018244 201 GLMKNSRDG------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (359)
Q Consensus 201 g~a~~~~~~------------------~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~ 261 (359)
|++...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998755410 1123467899999987644 688999999999999999999888654322111
Q ss_pred hhhhhhhccccc---------------cC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 262 DRNIQTLTDSCL---------------EG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 262 ~~~~~~~~~~~~---------------~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.........+.. .. ......+.++.+++.+||+.+|++|||+.+++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111000000000 00 0012245779999999999999999999999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=299.91 Aligned_cols=240 Identities=19% Similarity=0.212 Sum_probs=200.0
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+..|.+...+|.|+|+.|-.+. ..+++..++|++.... ....+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888899999999999998 5567889999998762 2234577665555 6999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee-CCCCCeEEeccCCcccCCCCC-
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF-DDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll-~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|++.|+-+.+.+.. ..... ..+..|+.+|+.|+.|||.+ |+||||+||+|||+ ++.++++|+|||.++......
T Consensus 396 e~l~g~ell~ri~~--~~~~~-~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS--KPEFC-SEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred hhccccHHHHHHHh--cchhH-HHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 99999988887753 22233 77888999999999999998 99999999999999 589999999999998877662
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...-|..|.|||++....|++++||||||++||+|++|+.||.....+ ..+......+.+....+..+++|+.
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccccccCHHHHHHHH
Confidence 224578999999999889999999999999999999999998776554 1122222233445778899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||.+||++.++...
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HhccCChhhCcChhhhccC
Confidence 9999999999999999865
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=291.54 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=195.3
Q ss_pred HHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceee
Q 018244 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCC 123 (359)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 123 (359)
.++...+ ..|.+++.||+|+||.||+|. ..++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 10 ~~~~~~~---~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 10 KTIWEVP---ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHhhcc---CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3444444 445677788999999999998 45788999999975422 22456788999999999999999999886
Q ss_pred eC------CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEE
Q 018244 124 EG------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (359)
Q Consensus 124 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl 197 (359)
.. ...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEE
Confidence 43 3467888887 678988874 34689999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCCC-CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh---------
Q 018244 198 SCFGLMKNSRDGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------- 266 (359)
Q Consensus 198 ~DFg~a~~~~~~~-~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--------- 266 (359)
+|||++....... ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||+.............
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999988654433 3467889999998876 4688899999999999999999988864322111000000
Q ss_pred ----------hhc---cccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 ----------TLT---DSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ----------~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ....... .....+.++.+++.+||+.||++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0000000 001235678999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=295.22 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=196.2
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCc-----
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----- 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 127 (359)
...|.++..||.|++|.||+|.. .++..||+|++.... ....+.+.+|+.+++.++|+|++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 45678888899999999999995 467899999987532 2234567889999999999999999998876554
Q ss_pred -ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 569999884 35799999999999999999999999 9999999999999999999999999998865
Q ss_pred CCC-CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh----------------
Q 018244 207 RDG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---------------- 268 (359)
Q Consensus 207 ~~~-~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~---------------- 268 (359)
... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||................
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 433 344678889999998653 57889999999999999999999886543221111100000
Q ss_pred ---ccccc---cCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 ---TDSCL---EGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 ---~~~~~---~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... ... .....+.++.+++.+||+.||++|||+.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 000 011236789999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=288.24 Aligned_cols=250 Identities=18% Similarity=0.231 Sum_probs=190.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCC------
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 126 (359)
..+|.+++.||.|+||.||+|.. .++..+|+|.+....... ...+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 45788899999999999999995 468899999986543221 345678999999999999999999875543
Q ss_pred --cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 127 --ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 127 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
.+++|+||+.+ +|...+.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 46999999976 67776653 345799999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC---------------CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-
Q 018244 205 NSRDGR---------------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT- 267 (359)
Q Consensus 205 ~~~~~~---------------~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~- 267 (359)
...... ...++..|+|||.+.+. .++.++||||||+++|+|++|..||...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543221 12346789999988754 4889999999999999999999887643222111110000
Q ss_pred ----------------hccccccCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 268 ----------------LTDSCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 268 ----------------~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..........+ ......+.+++.+||..||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 123367899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=295.55 Aligned_cols=239 Identities=21% Similarity=0.235 Sum_probs=201.3
Q ss_pred ccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
+.||+|-||+||-|+ .++|+.||||++.+-... ...++++|+.+|+.+.||.||.+...|++++.+|.|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD- 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD- 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch-
Confidence 457999999999999 567999999999865432 3467899999999999999999999999999999999999764
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcccCCCC---CCcC
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG---RSYS 213 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~~~~~~---~~~~ 213 (359)
....+...+.+.+++.....++.||+.||.|||.+ +|+|+||||+|||+.+. ..+||||||+|+..... ...+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 55555555788999999999999999999999999 99999999999999643 57999999999998765 4678
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcc--hhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH--ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
||+.|+|||+++...|+.+-|+||.|||+|.-++|..||..+ ..+.+.+..+.. ......+.+..+.+||..
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy------Pp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY------PPNPWSEISPEAIDLINN 801 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc------CCCchhhcCHHHHHHHHH
Confidence 999999999999999999999999999999999999888654 222222222211 112235678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
+|+..-.+|.|.+..+.+
T Consensus 802 LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHhcchHhhccc
Confidence 999999999999887653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=288.21 Aligned_cols=247 Identities=17% Similarity=0.255 Sum_probs=193.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeee-CCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 133 (359)
.|.+++.||.|+||.||+|. ..++..||+|.+.... ....+.+.+|+++++.++||||+++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 46778888999999999998 4478899999886432 2234567889999999999999999999865 457899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~ 212 (359)
|+ +++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... ...
T Consensus 91 ~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 91 LL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred hh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 98 458988873 45688899999999999999999999 9999999999999999999999999998765433 234
Q ss_pred CCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-------------------hhhhhhcccc
Q 018244 213 STNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------RNIQTLTDSC 272 (359)
Q Consensus 213 ~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-------------------~~~~~~~~~~ 272 (359)
.++..|+|||.+.+ ..++.++||||||+++|+|++|..||+......... ..........
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 56788999998876 468999999999999999999998886542211000 0000000000
Q ss_pred -ccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 -LEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 -~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.....+ ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011 2245789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=299.35 Aligned_cols=254 Identities=19% Similarity=0.221 Sum_probs=196.1
Q ss_pred ccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCC------cceEEE
Q 018244 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ERLLVA 132 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~ 132 (359)
.-+.||+||||.||+|+ ..+|..||||.++... ....+.+.+|+++|++++|+|||+++++=.+.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34567999999999999 6689999999998743 344677899999999999999999998765543 468999
Q ss_pred ecCCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC--CCC--CeEEeccCCcccCC
Q 018244 133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDV--NPRLSCFGLMKNSR 207 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~--~~~--~~kl~DFg~a~~~~ 207 (359)
|||.+|+|...+.+.+ ...+++..++.++.++..||.|||.+ ||+||||||.||++- .+| ..||+|||.|+..+
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 9999999999997643 45799999999999999999999999 999999999999994 223 48999999999988
Q ss_pred CCC---CcCCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----Hhh----hhhhhhc--ccc
Q 018244 208 DGR---SYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRD----RNIQTLT--DSC 272 (359)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----~~~----~~~~~~~--~~~ 272 (359)
++. +..||..|.+||... .+.|+..+|.|||||++|++.||..||-...... +.. ......+ ...
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~ 255 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE 255 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence 775 567999999999998 4789999999999999999999999985432221 000 0000000 000
Q ss_pred cc------C--CCC----hHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhhh
Q 018244 273 LE------G--QFS----SDEGTELVRLASRCLQYEPRERP--NPRSLVTALVTLQK 315 (359)
Q Consensus 273 ~~------~--~~~----~~~~~~l~~li~~cl~~dp~~Rp--s~~~il~~L~~~~~ 315 (359)
.. . +++ ......+...+..+|..+|.+|- .+.+....+..+-.
T Consensus 256 eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 256 ENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred cCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 0 111 22334566778888999999998 66666655555443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=288.21 Aligned_cols=247 Identities=18% Similarity=0.231 Sum_probs=189.3
Q ss_pred ccccccCCCCCCcEEEEEEeC-C--CcEEEEEEeCCCC--CchHHHHHHHHHHHhcC-CCcccccccceeeeC----Ccc
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE-N--QFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEG----DER 128 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~ 128 (359)
|.+.+.||.|+||.||++... . +..||+|.+.... ....+.+.+|+.+++.+ .|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 567788899999999999953 4 7789999987532 12245678899999999 599999999875432 457
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++++||+. ++|.+++. ....+++..+..++.||+.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88899986 58998886 455789999999999999999999999 999999999999999999999999999875432
Q ss_pred C--------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh-----------h-
Q 018244 209 G--------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------T- 267 (359)
Q Consensus 209 ~--------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-----------~- 267 (359)
. ....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.............. .
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2 22357889999998765 4588999999999999999999988765322111110000 0
Q ss_pred -------h---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 -------L---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 -------~---~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ...... .......+..+.+++.+||+.||++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000 00111235689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=274.81 Aligned_cols=247 Identities=18% Similarity=0.214 Sum_probs=197.1
Q ss_pred cccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCC
Q 018244 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
+-++.||.|+||+|+|-. .+.|+..|||++..... ...++++.|.+...+- +.||||+++|.+-..+..||.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 345678999999999998 56799999999987654 3455688888766555 69999999999988899999999996
Q ss_pred CCCHhhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---C
Q 018244 137 NDTLAKHLF---HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (359)
Q Consensus 137 ~gsL~~~l~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~ 210 (359)
- ||..+-+ ......+++..+-+|....+.||.||.....|+|||+||+|||++..|.+||||||++....+. +
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 5 6655443 2356679999999999999999999998779999999999999999999999999998765432 3
Q ss_pred CcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC---hHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS---SDEGTEL 285 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 285 (359)
..+|-..|||||.+.. ..|+-++||||||++|||+.||..|+ ..|+...++..+...........+ .+.+..+
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy--r~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY--RKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc--chHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 4567789999999874 34899999999999999999999554 444444444433332221111222 3478899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..++.-||.+|-+.||...+++..
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcC
Confidence 999999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=272.14 Aligned_cols=252 Identities=17% Similarity=0.232 Sum_probs=195.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeC--------
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-------- 125 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 125 (359)
+.|..+.++|+|.||.||+|+ .+.|+.||+|++-..+.. -.....+|+++|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457778888999999999999 455778999877543321 234568899999999999999999988643
Q ss_pred CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
..+|+||.+|.. +|..++.+ ....++...+.+++.++..||.|+|++ .|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999987 79998854 456789999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCC--------CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh-------------
Q 018244 206 SRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR------------- 263 (359)
Q Consensus 206 ~~~~~--------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~------------- 263 (359)
+.... ..+.|.+|.+||.+.+.+ |+.+.|||+.|||+.||+|+.+.+++.........
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54322 234589999999998764 99999999999999999999988876532211110
Q ss_pred ------hhhhhc--cccccCCC--------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 264 ------NIQTLT--DSCLEGQF--------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 264 ------~~~~~~--~~~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.+...+ .+...+.+ +..-.++..+|+.+++..||.+|+++.+++++--
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 000000 00000000 0112347899999999999999999999998643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=282.19 Aligned_cols=238 Identities=19% Similarity=0.239 Sum_probs=204.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (359)
.+++++..||+|+||.|.+|. ..+.+.+|||+++++... +.+--+.|-++|... +-|.+++++..|++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 467788889999999999998 456789999999876322 233345677777766 578999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC----
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---- 207 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~---- 207 (359)
|||+.||+|--.++ .-+.+.+..+..++.+|+-||-+||++ ||++||||.+||++|.+|.+||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 99999999998887 456788999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 208 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...+..||+.|+|||++...+|..++|+|||||+||||+.|++||.++..+.+...+.... -.+|...+.++..
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------vsyPKslSkEAv~ 579 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------VSYPKSLSKEAVA 579 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc------CcCcccccHHHHH
Confidence 2346789999999999999999999999999999999999999999887776665554432 2467888999999
Q ss_pred HHHHhcccCCCCCCCH
Q 018244 288 LASRCLQYEPRERPNP 303 (359)
Q Consensus 288 li~~cl~~dp~~Rps~ 303 (359)
+....|.++|.+|...
T Consensus 580 ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHhhcCCccccCC
Confidence 9999999999999643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=281.01 Aligned_cols=250 Identities=16% Similarity=0.178 Sum_probs=199.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-C-c----ccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-N-R----RLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~~~ 129 (359)
..|.++..+|+|.||.|-.+.. ..+..||||+++.-. .-.+..+-|+++|+++. + | -+|.+.++|...++.|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 4688899999999999999984 457899999997533 22344667999999993 3 2 3788899999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC------------------
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD------------------ 191 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~------------------ 191 (359)
||+|.+ |-|+.+++..+.-.+++..++..|++|++.+++|||+. +++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 999998 55999999887778899999999999999999999999 9999999999999931
Q ss_pred --CCCeEEeccCCcccCCCCC-CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH---Hhhhhh
Q 018244 192 --DVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNI 265 (359)
Q Consensus 192 --~~~~kl~DFg~a~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~---~~~~~~ 265 (359)
+..++|+|||.|+...... ..+.|..|.|||++.+-+++..+||||+||||+||+||...|+.+...+ +.+...
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 3459999999999877665 4567999999999999999999999999999999999999887653111 111100
Q ss_pred hh---------------------------------hcccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 266 QT---------------------------------LTDSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 266 ~~---------------------------------~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.. ..+++.+ -...+.....+.+|+..||..||.+|+|+.|+++
T Consensus 326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 00 0000000 0012345567999999999999999999999987
Q ss_pred H
Q 018244 309 A 309 (359)
Q Consensus 309 ~ 309 (359)
+
T Consensus 406 H 406 (415)
T KOG0671|consen 406 H 406 (415)
T ss_pred C
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.88 Aligned_cols=146 Identities=21% Similarity=0.215 Sum_probs=130.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
+..|.+++.||.|+||+||+|... ++..||||++...... ....+.+|+.++..++|+||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 457888999999999999999954 6889999999754322 235688899999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
|||+.+++|.+++. ....+++..++.|+.||+.||.|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~--~~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986 345689999999999999999999999 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=273.85 Aligned_cols=219 Identities=19% Similarity=0.204 Sum_probs=178.4
Q ss_pred CCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhc
Q 018244 68 KAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (359)
Q Consensus 68 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (359)
|.+|.||++.. .+++.+|+|.+.... ...+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999994 578899999997643 233455555566799999999999999999999999999999999863
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCcCCCccccCccccc
Q 018244 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLR 225 (359)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~ 225 (359)
...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... ....++..|+|||.+.
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 34689999999999999999999999 9999999999999999999999999987655433 2334567899999998
Q ss_pred CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 018244 226 TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304 (359)
Q Consensus 226 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (359)
+..++.++|+||+|+++|+|++|..|+....... ........+...+..+.+++.+||+.||++|||+.
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 8889999999999999999999997654321110 00001123344567899999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=274.78 Aligned_cols=250 Identities=17% Similarity=0.229 Sum_probs=193.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC--CCcccccccceeeeCC----cceEEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEGD----ERLLVA 132 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~ 132 (359)
-.+++.+|+|.||.||+|.+. |+.||||+|.... ...+.+|.++.+.+ +|+||+.+++.-..++ .++||+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 356778899999999999994 5689999998543 46678888877764 9999999998654432 589999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-------~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
+|.+.|||.||| ....++.....+++..+|.||+|||. ++.|.|||||..|||+..++...|+|+|+|-.
T Consensus 289 dYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 289 DYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred ecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999999 55789999999999999999999996 36799999999999999999999999999865
Q ss_pred CCC--------CCCcCCCccccCcccccCCC----C-C-CccchhhHHHHHHHHHhCC----------CCCCcc-----h
Q 018244 206 SRD--------GRSYSTNLAFTPPEYLRTGR----V-T-PESVMYSFGTLLLDLLSGK----------HIPPSH-----A 256 (359)
Q Consensus 206 ~~~--------~~~~~~t~~y~aPE~~~~~~----~-~-~~~Di~slG~il~elltg~----------~p~~~~-----~ 256 (359)
... .+..+||.+|||||++...- + + ..+||||||+|+||+.... .||.+- .
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 433 24567999999999987431 2 2 3589999999999997532 233221 2
Q ss_pred hHHHhhhhhhhhccccccCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 257 LDLIRDRNIQTLTDSCLEGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+.+++-...+...+...+.+ ..+....+.++|+.||..||.-|.|+--+-..|.++.+
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222222222222222222 23567788999999999999999999999988888764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=293.72 Aligned_cols=249 Identities=14% Similarity=0.202 Sum_probs=207.4
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeee-----CCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE-----GDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~ 128 (359)
-..+.++..+|.|.+|.||+++ .++++..|+|+..... ...+++..|.++|+.. .|||++.++|+|.. ++.+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 3456777788999999999999 6678889999887654 3345678899999998 49999999999864 4689
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|||||||.+||..++++...+..+.|..+..|++.++.||.+||++ .++|||||-.|||++.++.|||+|||++...+.
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999999987888999999999999999999999999 999999999999999999999999999876553
Q ss_pred ----CCCcCCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 209 ----GRSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 209 ----~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
..+..||+.|||||++... .|+..+|+||||++..||.-|.+|+-+..-.. ..+.....+......+.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNPPPKLKRPK 252 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCCCccccchh
Confidence 3567899999999998743 47888999999999999999997764432111 11222223333333467
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.++.++|..||.+|-++||++.+++++
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 789999999999999999999999998864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.40 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=209.9
Q ss_pred cccccCCCCCCcEEEEEEe-CCC----cEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 60 NIVSEHGEKAPNVVYKGKL-ENQ----FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+..+.||+|+||+||+|.+ +.| -+||+|++..... +...++++|+-.|.+++|||+++++++|.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4567789999999999984 443 4799999876543 34668999999999999999999999998765 889999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~ 213 (359)
|++.|+|.++++. .+..+-....+.|.+||++||.|||.+ ++|||||-..|||+..-..+|+.|||+++....+....
T Consensus 778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999986 566788899999999999999999999 99999999999999999999999999999877654322
Q ss_pred ------CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 214 ------TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 214 ------~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
..+.|||=|.+....|+.++|||||||++||++| |..|+.....+.+ ..++....+...|+.++.++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-----~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-----PDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-----hHHHhccccCCCCCCccHHHH
Confidence 2357899999999999999999999999999988 6666665544443 333333344556778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.++.+||..|++.||+++++...+.++.++
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999988887654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.51 Aligned_cols=242 Identities=16% Similarity=0.177 Sum_probs=207.6
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCc-EEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLENQF-RIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
-.+++.+++..||-|+||.|=++...+.. .+|+|.+++.... ..+.+..|-++|...+.|.||+++..|.+...+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567788999999999999999865543 4999998865333 3456888999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
++||-|-||.|+..++ +.+.++......++..+++|+.|||++ |||+|||||+|.++|.+|-+||.|||+|+....+
T Consensus 497 mLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999997 677899999999999999999999999 9999999999999999999999999999987765
Q ss_pred C---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
. +++||+.|.|||++.+...+.++|.||||+++|||++|.+||..-......+.++..+-. -.+|......+.
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----IEFPRRITKTAT 649 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----hhcccccchhHH
Confidence 4 568999999999999999999999999999999999999999876433333333322221 235667778899
Q ss_pred HHHHHhcccCCCCCCC
Q 018244 287 RLASRCLQYEPRERPN 302 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps 302 (359)
+||+++.+.+|.+|..
T Consensus 650 ~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHhcCcHhhhc
Confidence 9999999999999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.03 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=203.0
Q ss_pred ccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEE
Q 018244 63 SEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+.||.|+||.|++|... ....||||.++.... .+.+.+..|+++|+.+ +|+||+.+.|+|...+..++|+
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 36799999999999732 145799999986543 3466789999999999 5999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCC------C--------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEe
Q 018244 133 EYMPNDTLAKHLFHWE------T--------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~ 198 (359)
||+..|+|..+++..+ . ..++....+.+++||+.|++||++. ++|||||-+.|||+..+..+||+
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIa 460 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIA 460 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEc
Confidence 9999999999997643 0 2388999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCCCCCCc-----CC--CccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCCcchhHHHhhhhhhhhcc
Q 018244 199 CFGLMKNSRDGRSY-----ST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 199 DFg~a~~~~~~~~~-----~~--t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~ 270 (359)
|||+++.......+ .+ ...|||||.+....|+.++||||||++||||+|... |+++-.. ...+...+.
T Consensus 461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~----~~~l~~~l~ 536 (609)
T KOG0200|consen 461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP----TEELLEFLK 536 (609)
T ss_pred cccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc----HHHHHHHHh
Confidence 99999965443322 22 235999999999899999999999999999999554 4443110 111122344
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
...+...|..++.++.++|..||+.+|++||++.++.+.+....
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 44455567778899999999999999999999999999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=282.37 Aligned_cols=246 Identities=17% Similarity=0.194 Sum_probs=194.5
Q ss_pred HHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceee
Q 018244 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCC 123 (359)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~ 123 (359)
.|..+--+-+.+..|+.||-|+||.|.++. .++...+|+|.+.+.+.- ....+..|-+||..-..+=||+++..|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 334444444567788899999999999998 556778999999865432 2344678999999999999999999999
Q ss_pred eCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+.+++|+||+|++||++-++|. +.+.+.+..+..++.++.+|+++.|.. |+|||||||+|||||.+|.+||+|||++
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999999997 567899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCC---------CC-------------------------------------CCcCCCccccCcccccCCCCCCccchhh
Q 018244 204 KNSR---------DG-------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYS 237 (359)
Q Consensus 204 ~~~~---------~~-------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~s 237 (359)
.-+. .+ ...+||..|+|||++....|+..+|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 5321 00 1236899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcchhHHHh--hhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 018244 238 FGTLLLDLLSGKHIPPSHALDLIR--DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (359)
Q Consensus 238 lG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 301 (359)
.|||||||+.|+.||-...-.... -.+....++- .+-.+.+.++.+||.+++. +++.|.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~----~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHI----PYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccc----ccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999999998654321111 1111111111 1224566778888877653 477775
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=292.61 Aligned_cols=250 Identities=18% Similarity=0.194 Sum_probs=167.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CC----CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccce------ee
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-EN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC------CC 123 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 123 (359)
...+|.+.+.||+|+||.||+|+. .+ +..||+|++..... .+....+ .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 456788889999999999999995 44 68999999865332 1111111 1222223333333222 23
Q ss_pred eCCcceEEEecCCCCCHhhhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCC
Q 018244 124 EGDERLLVAEYMPNDTLAKHLFHWETQ------------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (359)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~ 185 (359)
.....+||+||+.+++|.+++...... ......+..++.|++.||.|||++ +|+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHH
Confidence 456789999999999999988642110 112345678999999999999999 9999999999
Q ss_pred CeeeCC-CCCeEEeccCCcccCCCC-----CCcCCCccccCcccccCC----------------------CCCCccchhh
Q 018244 186 RIVFDD-DVNPRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTG----------------------RVTPESVMYS 237 (359)
Q Consensus 186 NIll~~-~~~~kl~DFg~a~~~~~~-----~~~~~t~~y~aPE~~~~~----------------------~~~~~~Di~s 237 (359)
|||++. ++.+||+|||+++..... ....+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 689999999999865432 345678999999965422 2345679999
Q ss_pred HHHHHHHHHhCCCCCCcchhHHHhhh-----hhhh---hccccccCC------CChHHHHHHHHHHHHhcccCCCCCCCH
Q 018244 238 FGTLLLDLLSGKHIPPSHALDLIRDR-----NIQT---LTDSCLEGQ------FSSDEGTELVRLASRCLQYEPRERPNP 303 (359)
Q Consensus 238 lG~il~elltg~~p~~~~~~~~~~~~-----~~~~---~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (359)
|||++|||+++..++..........- .... ......... ..........+|+.+||++||++|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99999999997754433221111100 0000 000000000 001112345689999999999999999
Q ss_pred HHHHHH
Q 018244 304 RSLVTA 309 (359)
Q Consensus 304 ~~il~~ 309 (359)
.+++++
T Consensus 445 ~e~L~H 450 (566)
T PLN03225 445 KAALAH 450 (566)
T ss_pred HHHhCC
Confidence 999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=271.74 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=197.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCC-CCch------HHHHHHHHHHHhcCCCcccccccceeee-CCcc
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS-AWPD------ARQFLEEARAVGQLRNRRLANLLGCCCE-GDER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 128 (359)
.|-++..||+|||+.||+|- +.....||||+-... ++.+ .+...+|.++.+.|.||.||++++||.- .+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 46677789999999999998 556778999987643 2222 2346789999999999999999999865 4678
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccCCCCCeeeC---CCCCeEEeccCCcc
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD---DDVNPRLSCFGLMK 204 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~ivH~Dikp~NIll~---~~~~~kl~DFg~a~ 204 (359)
|-|.|||+|.+|.-||+ ....+++..+..|+.||+.||.||... ..|||-||||.|||+. ..|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999999997 556789999999999999999999875 5799999999999995 45889999999999
Q ss_pred cCCCCC-----------CcCCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCcchhH--HHhhhhhhh
Q 018244 205 NSRDGR-----------SYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDRNIQT 267 (359)
Q Consensus 205 ~~~~~~-----------~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~--~~~~~~~~~ 267 (359)
..+++. ...||.+|++||.+.-+ +.+.++||||+|||+|.++.|+.||...... .+....+..
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 876542 34689999999988754 3789999999999999999999998654322 222222211
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ......+..+.++..+|.+||++.-++|....++...
T Consensus 702 AtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 702 ATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111 1112234577889999999999999999988877643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=255.84 Aligned_cols=233 Identities=21% Similarity=0.246 Sum_probs=192.9
Q ss_pred CCcEEEEEEeC-CCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhc
Q 018244 69 APNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (359)
Q Consensus 69 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (359)
+||.||+|... ++..+|+|++....... .+.+.+|++.++.++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57899999965 58899999998765444 67889999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcCCCccccCccc
Q 018244 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEY 223 (359)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~~t~~y~aPE~ 223 (359)
...+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+...... ....++..|+|||.
T Consensus 81 --~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 --RGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 22389999999999999999999999 9999999999999999999999999998876553 34557789999999
Q ss_pred ccCCCCCCccchhhHHHHHHHHHhCCCCCCc-chhHHHhhhhhhhhccccccCCCC-hHHHHHHHHHHHHhcccCCCCCC
Q 018244 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDSCLEGQFS-SDEGTELVRLASRCLQYEPRERP 301 (359)
Q Consensus 224 ~~~~~~~~~~Di~slG~il~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rp 301 (359)
+.+..++.++||||||+++++|++|..|+.. ............ ........ ...+.++.+++.+||..+|++||
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 9888889999999999999999999988765 222222111111 11100000 11567899999999999999999
Q ss_pred CHHHHHH
Q 018244 302 NPRSLVT 308 (359)
Q Consensus 302 s~~~il~ 308 (359)
++.++++
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 9999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=257.09 Aligned_cols=243 Identities=17% Similarity=0.250 Sum_probs=199.8
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...++.++..||+|+|+.|..++ .++.+.+|+|++++... ++..-...|-.+...- +||.+|.++.+|++...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 35677888899999999999998 55678999999986532 2344456676666666 6999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC---
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS--- 206 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~--- 206 (359)
+|.||++||+|.-.+. ..+.++++.+..+..+|+.||.|||+. ||++||+|.+|+|+|..|.+||+|+|+++..
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999987775 567899999999999999999999999 9999999999999999999999999998753
Q ss_pred -CCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH----HhhhhhhhhccccccCCCChHH
Q 018244 207 -RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
+...+..||+.|.|||++.+..|..++|+|+|||+++||+.|+.||.--..+. ..+...+.++.... ++|...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccccee
Confidence 23356789999999999999999999999999999999999999986332211 12222333333332 345666
Q ss_pred HHHHHHHHHHhcccCCCCCCC
Q 018244 282 GTELVRLASRCLQYEPRERPN 302 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps 302 (359)
+-.+..+++..|.+||.+|..
T Consensus 483 svkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcC
Confidence 777889999999999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.41 Aligned_cols=253 Identities=14% Similarity=0.134 Sum_probs=177.7
Q ss_pred CCcccccccCCCCCCcEEEEEEe-----------------CCCcEEEEEEeCCCCCchHHH--------------HHHHH
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-----------------ENQFRIAVKRFNRSAWPDARQ--------------FLEEA 104 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e~ 104 (359)
.++|.+.++||+|+||+||+|.. ..+..||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 34677788889999999999963 235679999987543322222 33467
Q ss_pred HHHhcCCCccc-----ccccceeee--------CCcceEEEecCCCCCHhhhhhcCC----------------------C
Q 018244 105 RAVGQLRNRRL-----ANLLGCCCE--------GDERLLVAEYMPNDTLAKHLFHWE----------------------T 149 (359)
Q Consensus 105 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------~ 149 (359)
..+.+++|.++ ++++++|.. ....+|||||+.+++|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 677777653 346899999999999999886321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----CcCCCccccCcccc
Q 018244 150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYL 224 (359)
Q Consensus 150 ~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~~~~t~~y~aPE~~ 224 (359)
..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....... ...+|+.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 2346778999999999999999999 99999999999999999999999999987543322 12337899999987
Q ss_pred cCCC--------------------C--CCccchhhHHHHHHHHHhCCC-CCCcch-h-HHHhh--hhhh---hhcccccc
Q 018244 225 RTGR--------------------V--TPESVMYSFGTLLLDLLSGKH-IPPSHA-L-DLIRD--RNIQ---TLTDSCLE 274 (359)
Q Consensus 225 ~~~~--------------------~--~~~~Di~slG~il~elltg~~-p~~~~~-~-~~~~~--~~~~---~~~~~~~~ 274 (359)
.... + ..+.||||+||++|+|+++.. |+.... . ..... .... ........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 6322 1 124799999999999999875 332210 0 00000 0000 00001111
Q ss_pred CCCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 018244 275 GQFSSDEGTELVRLASRCLQYEP---RERPNPRSLVTA 309 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~il~~ 309 (359)
-......++...+|+.+||..+| .+|+|++++|++
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11123456889999999999876 689999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=242.98 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=200.9
Q ss_pred HHHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccceee
Q 018244 46 IETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCC 123 (359)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 123 (359)
++.......+.++|++++++|+|-|+.||.|. ..+.+.++||.++... .+.+.+|+.+|..|. ||||+++++...
T Consensus 27 YE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 27 YESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred hhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 34444445677899999999999999999998 5678889999998633 467899999999997 999999999998
Q ss_pred eCC--cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEecc
Q 018244 124 EGD--ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCF 200 (359)
Q Consensus 124 ~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DF 200 (359)
++. ...||+||+.+.+...+. ..++.-.+..++.+++.||.|+|+. ||+|||+||.|++||. .-.++|+|+
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred CccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeec
Confidence 865 467999999997776655 3578888999999999999999999 9999999999999995 567999999
Q ss_pred CCcccCCCCCCc---CCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchh--HHHhh------------
Q 018244 201 GLMKNSRDGRSY---STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRD------------ 262 (359)
Q Consensus 201 g~a~~~~~~~~~---~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~--~~~~~------------ 262 (359)
|+|.+..++..+ +.+..|..||.+..- .|+.+-|+|||||++..|+..+.||..... +.+..
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 999998777544 446678999998864 488999999999999999999999864311 11100
Q ss_pred --hhhhhhccccccC-----------CC----C-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 263 --RNIQTLTDSCLEG-----------QF----S-SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 263 --~~~~~~~~~~~~~-----------~~----~-~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+++.... .+ . .-.++++.+|+.+.|..|-.+|+|++|++.+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0001111111110 00 0 1135889999999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.77 Aligned_cols=244 Identities=18% Similarity=0.259 Sum_probs=190.1
Q ss_pred ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCC-----cceEEEec
Q 018244 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLLVAEY 134 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~ 134 (359)
+-||.|+||.||.++. ++|+.||+|++... +....+.+.+|+++|..++|.|++..++...-.. .+|.++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4569999999999994 57999999998753 2334567899999999999999999988775542 57889999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC---
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~--- 211 (359)
+.. +|...+- ..+.++.+.+.-+++||++||.|||+. +|.||||||.|.|++.|..+||+|||+++..+.+..
T Consensus 139 mQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 866 7888775 667899999999999999999999999 999999999999999999999999999998765542
Q ss_pred --cCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchh----HH------------H---hhhhhhhhc
Q 018244 212 --YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL----DL------------I---RDRNIQTLT 269 (359)
Q Consensus 212 --~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~----~~------------~---~~~~~~~~~ 269 (359)
.+.|..|.|||++.+.+ |+.+.||||.|||+.||+..+..|....- +. + -++....++
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 23578899999999765 99999999999999999988876653310 00 0 011111111
Q ss_pred ccccc-CC--------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 270 DSCLE-GQ--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 270 ~~~~~-~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
..... +. .+.....+...++.+++..||++|.+..+++..+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111 11 1123445678899999999999999999988764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=235.34 Aligned_cols=197 Identities=17% Similarity=0.199 Sum_probs=165.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecC
Q 018244 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
...+.+||+|++|.|-+.+ ..+|...|+|.+...-. ...++.++|+++..+. .+|.+|.++|...+....+|.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3456678999999999988 56899999999986532 3345678888876665 6999999999998889999999999
Q ss_pred CCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 136 PNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 136 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
+. ||..+-.+ ..+..+++..+-+|+..++.||.|||++..++|||+||+|||++.+|.+|+||||++....+.-
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 65 77766543 2577899999999999999999999998899999999999999999999999999998765542
Q ss_pred CcCCCccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCcch
Q 018244 211 SYSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHA 256 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~elltg~~p~~~~~ 256 (359)
...|-..|||||.+.. ..|+-++||||||++++||.+++.|++...
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2456788999998863 358999999999999999999998876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.04 Aligned_cols=235 Identities=22% Similarity=0.239 Sum_probs=179.2
Q ss_pred CCCCCCcE-EEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 65 HGEKAPNV-VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 65 lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
+|.|+.|+ ||+|... |+.||||++-... ..-..+|++.|+.- .|||||++++.-.+..+.||..|.|.. +|.+
T Consensus 517 lG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d 591 (903)
T KOG1027|consen 517 LGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD 591 (903)
T ss_pred cccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence 38888766 7999984 4589999987533 34568999999998 599999999999999999999999976 9999
Q ss_pred hhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---C--CCeEEeccCCcccCCCCC-----
Q 018244 143 HLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---D--VNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 143 ~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~--~~~kl~DFg~a~~~~~~~----- 210 (359)
++... +.........+....|++.||++||+. +||||||||.||||+. + ..++|+|||+++....+.
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r 670 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR 670 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence 99642 111111133578899999999999998 9999999999999975 2 569999999998766543
Q ss_pred --CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...||.+|+|||++....-+.++||||+||++|+.++|...+.++..... .++..-......-....++ ++.+|
T Consensus 671 ~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~--eA~dL 746 (903)
T KOG1027|consen 671 LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC--EAKDL 746 (903)
T ss_pred ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH--HHHHH
Confidence 45689999999999998888899999999999999998544444332221 1111000000000001112 89999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
|.+|++.+|..||++.+|+.+
T Consensus 747 I~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=269.82 Aligned_cols=250 Identities=16% Similarity=0.183 Sum_probs=207.2
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+.-.+|+.+.++|.|.||.||||+ ...++..|+|+++.....+..-+.+|+-+++..+|||||-+++.+...+.++|.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 445688999999999999999999 5678999999999887777777889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC----C
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~----~ 208 (359)
|||.+|+|.+.-+ -.+.+++.++....+..++||+|||+. |-+|||||-.|||+++.|.+|++|||.+.... .
T Consensus 92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999998664 677899999999999999999999999 99999999999999999999999999876543 4
Q ss_pred CCCcCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcc-hhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
.....||+.|||||+.. .+.|...+|||++|+...|+---++|.... ......-......-.+.+ .-....++.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--kDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--KDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--cCCccchHH
Confidence 46789999999999764 456999999999999999997766554322 111111111111111111 123457888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
+-+|++.++.++|.+|||++.+|.
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 999999999999999999998775
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=259.47 Aligned_cols=250 Identities=15% Similarity=0.149 Sum_probs=196.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC------cccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~ 129 (359)
..|.+.+..|+|-|++|..|.. ..|..||||++.... .-.+.-+.|+++|++|.. -|+++++..|...+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 4678888899999999999984 347799999998643 224456789999999952 38999999999999999
Q ss_pred EEEecCCCCCHhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCC
Q 018244 130 LVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~ 207 (359)
||||-+. .+|.+.|+.. ..-.|....+..++.|+..||..|... ||+|.||||+|||+++. ..+||||||.|....
T Consensus 511 lVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred EEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccccccc
Confidence 9999885 4899999753 344678889999999999999999999 99999999999999864 669999999998766
Q ss_pred CCC--CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh----------------------
Q 018244 208 DGR--SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR---------------------- 263 (359)
Q Consensus 208 ~~~--~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~---------------------- 263 (359)
... .+..+.-|.|||++.|.+|+...|+||.||+||||.||+..|++...+.+..-
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH 668 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH 668 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence 553 34456789999999999999999999999999999999998887633322110
Q ss_pred ------------------h---hhhhcccc------cc--CCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 264 ------------------N---IQTLTDSC------LE--GQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 264 ------------------~---~~~~~~~~------~~--~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ....+.+. +. ..++ ......+.+|+.+||..||++|.|..++|.+
T Consensus 669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0 00000000 00 0011 1244678999999999999999999998864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=261.72 Aligned_cols=201 Identities=14% Similarity=0.149 Sum_probs=173.8
Q ss_pred HHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-----h---HHHHHHHHHHHhcCC---Cccccc
Q 018244 50 RTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----D---ARQFLEEARAVGQLR---NRRLAN 117 (359)
Q Consensus 50 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~---~~~~~~e~~~l~~l~---h~niv~ 117 (359)
+...++|++|..++.+|.|+||.|+.|+. .+...|+||.+.+...- . .-.+-.||++|..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 34557899999999999999999999995 45778999998764311 0 112456999999997 999999
Q ss_pred ccceeeeCCcceEEEecC-CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeE
Q 018244 118 LLGCCCEGDERLLVAEYM-PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (359)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~k 196 (359)
++++|++++++||+||-- ++-+|++++. .+..+++..+..|+.||+.|+++||+. ||||||||-+||+++.+|-+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEE
Confidence 999999999999999964 5569999996 567799999999999999999999999 999999999999999999999
Q ss_pred EeccCCcccCCC--CCCcCCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q 018244 197 LSCFGLMKNSRD--GRSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPP 253 (359)
Q Consensus 197 l~DFg~a~~~~~--~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~ 253 (359)
|+|||.+..... ...+.||..|.|||++.+.+|- ...|||++|++||-++....|++
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999876544 4578899999999999998875 46899999999999998887765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=231.39 Aligned_cols=206 Identities=25% Similarity=0.372 Sum_probs=182.7
Q ss_pred CCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhh
Q 018244 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (359)
||.|++|.||++... ++..+++|.+...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 589999999999965 4889999999876533 34678999999999999999999999999899999999999899999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCCCC----CCcCCCcc
Q 018244 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (359)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~~----~~~~~t~~ 217 (359)
++... ...+++..+..++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+...... ....+...
T Consensus 81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 98642 24689999999999999999999999 9999999999999999 899999999998876553 33456788
Q ss_pred ccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 018244 218 FTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (359)
Q Consensus 218 y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (359)
|++||.+... .++.++|+|++|+++++| ..+.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 9999999877 788999999999999999 46899999999999
Q ss_pred CCCCCCHHHHHHH
Q 018244 297 PRERPNPRSLVTA 309 (359)
Q Consensus 297 p~~Rps~~~il~~ 309 (359)
|++||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.44 Aligned_cols=245 Identities=18% Similarity=0.231 Sum_probs=189.8
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeC------Ccc
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DER 128 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 128 (359)
+|.-++-+|.|+- .|-.|- .-.+.+||+|++... .....+...+|..++..+.|+||++++.+|.-. ..+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555666688886 555554 235778999988654 344567789999999999999999999998654 357
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|+||||+.. +|...+. ..++-..+..+.+|++.|++|||+. ||+||||||+||++..++.+||.|||+|+....
T Consensus 97 y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCc
Confidence 999999966 8988875 3467788999999999999999999 999999999999999999999999999987665
Q ss_pred C---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhh--------------------hh
Q 018244 209 G---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRD--------------------RN 264 (359)
Q Consensus 209 ~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~--------------------~~ 264 (359)
. +.++.|..|.|||++.+..+.+.+||||+||++.||++|.-.|++... +.+.. ..
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 4 456778899999999998899999999999999999999987765310 00000 00
Q ss_pred ------------hhhh-ccccccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 ------------IQTL-TDSCLEG--QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 ------------~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... .+..... ..+.-....+++++.+||..||++|.|++++|.+
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0000000 0111234678999999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=246.39 Aligned_cols=131 Identities=16% Similarity=0.195 Sum_probs=113.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-----C---cccccccceeee---
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----N---RRLANLLGCCCE--- 124 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~--- 124 (359)
.+|.++++||=|-|++||+|. ..+...||+|+.+... .-.+..+.||++|++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 368899999999999999998 5567789999987432 22455788999999984 2 369999999965
Q ss_pred -CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
+.++|+|+|++ |.+|..+|....-+.++...+..|++||+.||.|||...||||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 45899999999 66999999887788899999999999999999999998899999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=226.60 Aligned_cols=251 Identities=19% Similarity=0.215 Sum_probs=189.4
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccce-eeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGC-CCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~~~~~lv~e~ 134 (359)
.|.+.+.||+|.||.+-++.+ .+...+++|-+.+... ...+|.+|..---.|. |.||+.-+++ |+..+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 577888899999999999994 5678899999987653 4678999988777774 8999987764 6777888899999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC--CCCCeEEeccCCcccCCCCCCc
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGRSY 212 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~--~~~~~kl~DFg~a~~~~~~~~~ 212 (359)
++.|+|.+-+ ....+.+....+++.|+++|+.|||++ ++||||||.+||||- +...+||||||+.+..+..-..
T Consensus 104 aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 104 APRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred Cccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999988 556789999999999999999999999 999999999999994 3457999999998765543322
Q ss_pred -CCCccccCcccccC---CC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh---ccccccCCCChHHHH
Q 018244 213 -STNLAFTPPEYLRT---GR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---TDSCLEGQFSSDEGT 283 (359)
Q Consensus 213 -~~t~~y~aPE~~~~---~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 283 (359)
.-+..|.|||.+.. ++ ..+.+|+|.||+++|.++||..|++....+.-........ ..+.++. .-...++
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~-~F~~fs~ 258 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK-KFNPFSE 258 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-hhcccCH
Confidence 23568999997653 22 5788999999999999999998876332111111111111 1111111 1134567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.+..+.++-|..+|++|=-..++-+.....+
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 8999999999999999955555544444333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=241.68 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=191.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (359)
..|..+.++|.|+|++||+|+.. .+..||+|.+...+.. ..+.+|+++|..+. +.||+++.+++..++...+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 45678888999999999999843 4678999999876543 56889999999995 99999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCC---
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSR--- 207 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~--- 207 (359)
+||++.....++.. .++...+..+++.++.||.++|.+ |||||||||+|+|.+. .+.-.|+|||+|...+
T Consensus 114 lp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999988874 377889999999999999999999 9999999999999984 5789999999986100
Q ss_pred --------------C--C-----------------------------CCcCCCccccCcccccCCC-CCCccchhhHHHH
Q 018244 208 --------------D--G-----------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTL 241 (359)
Q Consensus 208 --------------~--~-----------------------------~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i 241 (359)
. + -...||++|.|||++...+ .+.++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 0135799999999988654 7889999999999
Q ss_pred HHHHHhCCCCCCcchhH--------------HHhh-----hh------------------hhhh-cccccc--------C
Q 018244 242 LLDLLSGKHIPPSHALD--------------LIRD-----RN------------------IQTL-TDSCLE--------G 275 (359)
Q Consensus 242 l~elltg~~p~~~~~~~--------------~~~~-----~~------------------~~~~-~~~~~~--------~ 275 (359)
++.+++++.||.....+ .+.+ +. ...+ ...+.. .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999998533110 0000 00 0000 000000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+..+.+|+.+|+..||.+|.|++++|.+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1112234589999999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=233.19 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=199.5
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeC-CcceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~l 130 (359)
.+....+-+|.||.||.|.|. +.+.|-+|.++....+ ....++.|.-.|..+.|||+..+.+++.+. ...+.
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 344445688999999999653 3456777877655432 355688899999999999999999998764 56788
Q ss_pred EEecCCCCCHhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 131 VAEYMPNDTLAKHLFH------WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
++.+..-|+|..++.. ...+.++..++..++.|++.|++|||+. ++||.||...|.+||+...+||+|-.+++
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhcc
Confidence 8999999999999972 1345778889999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 205 NSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 205 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
..-+.. .......||+||.+....|+.++|+|||||+||||+|-...+..+. ..-.....+....+-..|
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----DPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----DPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc----CHHHHHHHHhccceecCC
Confidence 754432 2223468999999999999999999999999999998443333221 111223333344444567
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.++++++..+|.-||+.+|++||++++++.-|....
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 788999999999999999999999999999888753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=224.92 Aligned_cols=193 Identities=23% Similarity=0.259 Sum_probs=169.8
Q ss_pred cccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC
Q 018244 60 NIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
.+...+|.|++|.||++...+ +..+|+|.+...... ..+.+.+|++.++.++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 455677999999999999654 889999999876554 567889999999999999999999999988999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----CCc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RSY 212 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~~~ 212 (359)
++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 82 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 82 GDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 999999864221 289999999999999999999999 9999999999999999999999999998876554 345
Q ss_pred CCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 018244 213 STNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (359)
Q Consensus 213 ~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p~~~ 254 (359)
.++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 567889999998 556688899999999999999999999865
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=210.61 Aligned_cols=167 Identities=16% Similarity=0.109 Sum_probs=128.7
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCcc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~ 217 (359)
|+|.+++.. .+..+++..++.++.|++.||.|||+. + ||+|||++.++.+++ ||++....... ..||+.
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~ 69 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY 69 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence 689999864 355799999999999999999999998 6 999999999999999 99988765443 367899
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhH-HHhhhhhhhhcccccc-CCCChHHHH--HHHHHHHHhc
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLE-GQFSSDEGT--ELVRLASRCL 293 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li~~cl 293 (359)
|+|||++.+..++.++|||||||++|||+||+.||...... ................ ...+...+. ++.+++.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999887543211 1111111111111000 011223333 6999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 018244 294 QYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 294 ~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+.||++|||+.++++++..+..
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=260.58 Aligned_cols=190 Identities=16% Similarity=0.138 Sum_probs=139.3
Q ss_pred CCC-ccccccccee-------eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 018244 110 LRN-RRLANLLGCC-------CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (359)
Q Consensus 110 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~D 181 (359)
++| +||.+++++| .....+++++||+ +++|.+++.. ....+++..+..++.||+.||.|||++ ||+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence 345 5777888877 2334677888987 5599999964 345699999999999999999999999 999999
Q ss_pred CCCCCeeeCC-------------------CCCeEEeccCCcccCCCC--------------------CCcCCCccccCcc
Q 018244 182 LNAYRIVFDD-------------------DVNPRLSCFGLMKNSRDG--------------------RSYSTNLAFTPPE 222 (359)
Q Consensus 182 ikp~NIll~~-------------------~~~~kl~DFg~a~~~~~~--------------------~~~~~t~~y~aPE 222 (359)
|||+||||+. ++.+|++|||+++..... ....+|+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999954 455677777776532110 0134678899999
Q ss_pred cccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 018244 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (359)
Q Consensus 223 ~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 302 (359)
++.+..++.++|||||||+||||++|..|+..... ... ........+. ..........++.+||+.||.+|||
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMS-SLRHRVLPPQ-----ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHH-HHHHhhcChh-----hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 99999999999999999999999998866542211 111 1111111110 1112345678899999999999999
Q ss_pred HHHHHHH
Q 018244 303 PRSLVTA 309 (359)
Q Consensus 303 ~~~il~~ 309 (359)
+.+++++
T Consensus 259 ~~eil~h 265 (793)
T PLN00181 259 MSELLQS 265 (793)
T ss_pred hHHHhhc
Confidence 9999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=200.83 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=202.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.++..+++-+|.....|..|+|+++.+ .+++|++....... ...|..|.-.|+.+.||||+.+++.|..+.++.+|.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 455667777888899999999999765 46668877654433 346888999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc-cCCCCCeeeCCCCCeEEeccCCcccCCCCCC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~-Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~ 211 (359)
.|++.|+|...++....-..+..++.+++.+|+.|++|||+...++-| -+....+++|++.+.+|+ .+-+++.-....
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccc
Confidence 999999999999866566678889999999999999999998566666 799999999999888775 222333222222
Q ss_pred cCCCccccCcccccCCCC---CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRV---TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
..-.+.|++||.++..+- -.++|+|||++++|||.|..-||.+-........ +--..++..+|+..+..+.+|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----ialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----IALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----hhhccccccCCCCccHHHHHH
Confidence 333579999999986653 3479999999999999999988876533322211 122335556788889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
+.-|+..||.+||.+..|+-.|+++.
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=203.86 Aligned_cols=259 Identities=16% Similarity=0.142 Sum_probs=196.7
Q ss_pred cccccccCCCCCCcEEEEEEeCCC--cEEEEEEeCCCCCchHHHHHHHHHHHhcCCC----ccccccccee-eeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQ--FRIAVKRFNRSAWPDARQFLEEARAVGQLRN----RRLANLLGCC-CEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 130 (359)
.|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999995443 4799998876543333367778888888863 5888888888 47778899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-----CCeEEeccCCccc
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMKN 205 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-----~~~kl~DFg~a~~ 205 (359)
||+.+ |.+|.++......+.++..+...++.|++.+|.+||+. |++||||||+|+++... ..+.|.|||+++.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99998 66999988654567899999999999999999999999 99999999999999854 4699999999982
Q ss_pred CC---C-----------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc
Q 018244 206 SR---D-----------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 206 ~~---~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 271 (359)
.. . .....||..|+++....+...+.+.|+||++.++.+++.|.-|+.......... ........
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~-~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS-KFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH-HHHHHhhh
Confidence 11 1 112348999999999999999999999999999999999986654332111111 11111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
..........+..+.++...+-..+...+|....+...++........
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 111101223445677777777779999999999999998887665433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=209.23 Aligned_cols=155 Identities=15% Similarity=0.020 Sum_probs=122.2
Q ss_pred cccccccCCCCCCcEEEEEEeC--CCcEEEEEEeCCCC-----CchHHHHHHHHHHHhcCCCccccc-ccceeeeCCcce
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLAN-LLGCCCEGDERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~ 129 (359)
.|.+.+.||+|+||+||+|... ++..+|||++.... ......+.+|+++|+.++|+|++. +++ .+..+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcE
Confidence 5777888899999999999853 57778999875331 112456899999999999999985 433 24689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccC-CCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Di-kp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|||||++|++|.. +. .. . ...++.|++.||.|||+. ||+|||| ||+|||++.++.++|+|||+++....
T Consensus 95 LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 9999999999963 21 11 1 146789999999999999 9999999 99999999999999999999986543
Q ss_pred CC------------CcCCCccccCcccccC
Q 018244 209 GR------------SYSTNLAFTPPEYLRT 226 (359)
Q Consensus 209 ~~------------~~~~t~~y~aPE~~~~ 226 (359)
.. ...+++.|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32 2345778999998874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=197.42 Aligned_cols=247 Identities=22% Similarity=0.260 Sum_probs=193.9
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCc-ccccccceeeeCCcceEEEec
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNR-RLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 134 (359)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778899999999999976 67999999865433 256789999999999988 799999999777778999999
Q ss_pred CCCCCHhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCCC---
Q 018244 135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~~--- 209 (359)
+.++++.+++..... ..++......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999977753211 2689999999999999999999999 999999999999999988 7999999998754432
Q ss_pred -------CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchh----HHHhhhhhhhhccccccC
Q 018244 210 -------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 275 (359)
....++..|+|||.+.+ ..+....|+||+|++++++++|..|+..... ............. ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cccc
Confidence 45568899999999987 5788899999999999999999988655432 1111111111110 0000
Q ss_pred CCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 QFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ......+.+++..++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 1123578999999999999999998887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=178.47 Aligned_cols=267 Identities=15% Similarity=0.132 Sum_probs=208.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|+++++||+|+||.+|.|. ..+|..||||+-..... ..++..|..+...|+ -..|..+..++.+...-.+||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 368999999999999999998 78899999998764432 345677888888887 46888889899999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCC---
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRD--- 208 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~--- 208 (359)
. |-||.+++.- ..+.++..+++-++-|++.-++|+|.+ +.+||||||+|+|..- ...+.|+|||+|+...+
T Consensus 93 L-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 L-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred c-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 8 6699998743 567899999999999999999999999 9999999999999963 45699999999986543
Q ss_pred --------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC---CC
Q 018244 209 --------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QF 277 (359)
Q Consensus 209 --------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 277 (359)
+....||..|.+--...+...+...|+-|+|.+|.++..|.-|+++-....- .+..+.+....... ..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHHHHHHHHhhcCCCHHHH
Confidence 3456788889887666666677889999999999999999988876433211 11111111111110 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCccccchhHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQFT 329 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~ 329 (359)
-...+.++.-.+..|-..--++-|...-+-+.++-+.............+..
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~ 300 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM 300 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence 1335677889999999999999999998888888887777766666666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-26 Score=220.58 Aligned_cols=245 Identities=16% Similarity=0.080 Sum_probs=181.6
Q ss_pred ccccCCCCCCcEEEEEE-eCCCcEEEEEEeCC---CCCc--h-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNR---SAWP--D-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~--~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....+|.|++|.|+.+. ....+.++.|.+.. .... . ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34456999999888877 33445556565432 1111 1 1125668888888999999988887777666666699
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
||++ +|..++.+ ...++...+..++.|++.|+.|||.. |+.|||+|++|++++.+|.+||+|||.+..+.-.
T Consensus 402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 99999863 34688889999999999999999999 9999999999999999999999999998765432
Q ss_pred ----CCcCCCccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCCcchhHHHh--hhhh-hhhccccccCCCChHH
Q 018244 210 ----RSYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIR--DRNI-QTLTDSCLEGQFSSDE 281 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 281 (359)
....|+.+|+|||.+.+..|++ ..||||.|+++..|++|+.|+......... .... .......-........
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2346788999999999999987 589999999999999999766433221110 0000 0000000011122446
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+...+.+|.+||+.||.+|.|+++|++.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhC
Confidence 7788999999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=216.99 Aligned_cols=245 Identities=18% Similarity=0.205 Sum_probs=182.2
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCC-CchHH---HHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA-WPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
++...+.||.+.|=.|.+|+.+.|. |+||++-+.. .-... +-.+|++ ...++|||.+.+.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677788999999999999998886 9999987654 22233 3344555 556689999999888777888899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--C-
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~- 210 (359)
|+.. +|.|.+. .+.-+...+...|+.|++.||..+|.. ||+|+|||.+||||+....+.|+||...+...-. +
T Consensus 102 yvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9977 8999985 344567788899999999999999999 9999999999999999999999999876543211 1
Q ss_pred --------CcCCCccccCcccccCC----------C-CCCccchhhHHHHHHHHHhC-CCCCCcchhHHHhhhhhhhhcc
Q 018244 211 --------SYSTNLAFTPPEYLRTG----------R-VTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 211 --------~~~~t~~y~aPE~~~~~----------~-~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~ 270 (359)
+...-.+|.|||.+... . .+++.||||+||++.||++. +++|.-...-..+.+. .....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e 256 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPE 256 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHH
Confidence 11112479999987541 2 67899999999999999886 4444433222222221 11111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
..+. .+ ....+++|+..|++.||++|.|+++.|+.-+++
T Consensus 257 ~~Le-~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 257 QLLE-KI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHH-hC---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 11 123699999999999999999999999874443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=182.59 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=110.1
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--h------------------------HHHHHHHHHHHhcCCCccc
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--D------------------------ARQFLEEARAVGQLRNRRL 115 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 115 (359)
.+.||+|++|.||+|...+|+.||||+++..... . .....+|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4568999999999999778999999999754211 0 0122359999999988877
Q ss_pred ccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccccCCCCCeeeCCCCC
Q 018244 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~ivH~Dikp~NIll~~~~~ 194 (359)
.....+.. ...+|||||++++++..... ....++...+..++.|++.+|.++ |+. |++||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCc
Confidence 54433322 23489999999877765533 345789999999999999999999 688 999999999999998 578
Q ss_pred eEEeccCCcccCC
Q 018244 195 PRLSCFGLMKNSR 207 (359)
Q Consensus 195 ~kl~DFg~a~~~~ 207 (359)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=185.14 Aligned_cols=169 Identities=11% Similarity=0.035 Sum_probs=131.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHH---------HHHHHHHHHhcCCCcccccccceeeeC--
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR---------QFLEEARAVGQLRNRRLANLLGCCCEG-- 125 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~niv~~~~~~~~~-- 125 (359)
..|+.++.+|.|+||.||.+.. ++..+|+|.+......... .+.+|++.+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3578888899999999999766 4567999999755433222 267899999999999999999886643
Q ss_pred ------CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEec
Q 018244 126 ------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (359)
Q Consensus 126 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~D 199 (359)
...+|+|||++|.+|.++.. ++. ....+++.+|..+|+. |++|+|+||+||+++.+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988642 233 2456999999999999 999999999999999888 99999
Q ss_pred cCCcccCCCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHH
Q 018244 200 FGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (359)
Q Consensus 200 Fg~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 246 (359)
||........... ..++....|+.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987655322211 11334455778999999999887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=180.39 Aligned_cols=251 Identities=16% Similarity=0.196 Sum_probs=197.1
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|++-++||.|+||.++.|+ +-+++.||||.-...+ ...++..|.+..+.|. .++|...+.+..++-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 46788889999999999998 6688999999876543 3456777888888874 799999999888888899999998
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-----CCeEEeccCCcccCCCC-
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-----~~~kl~DFg~a~~~~~~- 209 (359)
|-||.|++ +..++.++..++..++.|++.-++|+|.+ .+|+|||||+|+||..- ..+.++|||+|+...+.
T Consensus 107 -GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 -GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred -CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 66999977 45788999999999999999999999999 99999999999999743 35999999999875443
Q ss_pred ----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCC---
Q 018244 210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--- 276 (359)
Q Consensus 210 ----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 276 (359)
++..||.+||+=-...+...+..-|+=|||-++++.|.|.-|+++-..+..++.- +.+-+. .+..
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-eKIGe~-Kr~T~i~ 261 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-EKIGET-KRSTPIE 261 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-HHhccc-cccCCHH
Confidence 3457899999988888888899999999999999999999888765444333211 111111 1111
Q ss_pred -CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 277 -FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 277 -~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.-...+.++..-+...-..+-++-|+.+-+...+..+.+
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 112356677778888888888888988877666555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-25 Score=205.07 Aligned_cols=224 Identities=16% Similarity=0.168 Sum_probs=189.0
Q ss_pred CCCCCCcEEEEEE----eCCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCCC
Q 018244 65 HGEKAPNVVYKGK----LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 65 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+|.|+||.|+.+. .+.|..+|+|+.++..... ......|..++..++ ||.+|+++..++.+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999875 2357889999987653221 113456888888887 99999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCcc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~ 217 (359)
|.|...+. +...+++.....+...++.|+.++|.. +++|+|+|++||+++.+|.+++.|||+++..-..+..+||..
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE 158 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence 99988875 556678888899999999999999999 999999999999999999999999999998777776799999
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (359)
|||||++. ....++|.||||+++++|+||..||..+....+ .. .....+...+..+.+++..++..+|
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~I--------l~--~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRI--------LK--AELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHH--------hh--hccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999998 668899999999999999999999887332222 11 1223567888999999999999999
Q ss_pred CCCCCH
Q 018244 298 RERPNP 303 (359)
Q Consensus 298 ~~Rps~ 303 (359)
..|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 999755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=174.84 Aligned_cols=141 Identities=15% Similarity=0.133 Sum_probs=112.2
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch--------------------------HHHHHHHHHHHhcCCCccc
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------------------------ARQFLEEARAVGQLRNRRL 115 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 115 (359)
.+.||+|++|.||+|...+|..||||++....... .....+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45689999999999997789999999988652110 1123578999999999988
Q ss_pred ccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCC
Q 018244 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~ 194 (359)
.....+... ..+|||||++++++..... ....++......++.|++.++.++|+ . |++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCC
Confidence 655544433 3489999999875544322 33467888999999999999999999 8 999999999999999 889
Q ss_pred eEEeccCCcccCCC
Q 018244 195 PRLSCFGLMKNSRD 208 (359)
Q Consensus 195 ~kl~DFg~a~~~~~ 208 (359)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=187.34 Aligned_cols=210 Identities=22% Similarity=0.335 Sum_probs=164.9
Q ss_pred HhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 107 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++++.||.|||+...-+|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678899999999999999999999999999999999965 577899999999999999999999998333999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCC------CCcCCCccccCcccccCCC-------CCCccchhhHHHHHHHHHhCCCCCC
Q 018244 187 IVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGR-------VTPESVMYSFGTLLLDLLSGKHIPP 253 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~elltg~~p~~ 253 (359)
.++|.+..+||+|||+....... .......-|.|||.+.... .+.+.||||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998776431 1112245799999988642 4667999999999999999999987
Q ss_pred cchhHHHhhhhhhhhcc---ccccCCCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 254 SHALDLIRDRNIQTLTD---SCLEGQFS--SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 254 ~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
..............+.+ ...++... .+..+++..++.+||..+|++||+++.+-..++.+....
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 64332221111111111 11111111 144557999999999999999999999999988887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-23 Score=178.73 Aligned_cols=228 Identities=19% Similarity=0.166 Sum_probs=146.9
Q ss_pred ccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCC---c-------cccccccee----
Q 018244 61 IVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRN---R-------RLANLLGCC---- 122 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h---~-------niv~~~~~~---- 122 (359)
..+.||.|+++.||.++.. +++.+|||++..... ...+++.+|.-....+.+ | .++.-++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3455799999999999964 589999999875442 235566666655555432 1 122222222
Q ss_pred -----eeCC--------cceEEEecCCCCCHhhhhhc---CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCC
Q 018244 123 -----CEGD--------ERLLVAEYMPNDTLAKHLFH---WET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184 (359)
Q Consensus 123 -----~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp 184 (359)
.... +.+++|+-+.+ +|.+++.. ... ..+....+..+..|+++.+++||+. |++|+||+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~ 173 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKP 173 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SG
T ss_pred CCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecccce
Confidence 1111 34778887744 78877642 111 1234556678889999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeccCCcccCCCCCC-cCCCccccCcccccCC--------CCCCccchhhHHHHHHHHHhCCCCCCcc
Q 018244 185 YRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRTG--------RVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (359)
Q Consensus 185 ~NIll~~~~~~kl~DFg~a~~~~~~~~-~~~t~~y~aPE~~~~~--------~~~~~~Di~slG~il~elltg~~p~~~~ 255 (359)
+|++++.+|.+.|+||+.....+.... ...+..|.|||..... .++.+.|.|+||+++|.|+++.-||...
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999987765544332 3445789999976432 4788999999999999999999887654
Q ss_pred hhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 018244 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (359)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 300 (359)
........ ...... +.++.++.||..+|+.||++|
T Consensus 254 ~~~~~~~~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 254 SPEADPEW---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGGSTSGG---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred Cccccccc---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 32211111 111223 778899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=174.47 Aligned_cols=192 Identities=16% Similarity=0.153 Sum_probs=146.2
Q ss_pred CCcccccccceeee---------------------------CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHH
Q 018244 111 RNRRLANLLGCCCE---------------------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALH 163 (359)
Q Consensus 111 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 163 (359)
+|||||+++++|.+ +..+|+||..++. +|..++ ..+..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl---~~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL---WTRHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH---hcCCCchHHHHHHHHH
Confidence 69999999998854 1346999998876 899999 5566778888899999
Q ss_pred HHHHHHHhhcCCCcccccCCCCCeeeC--CC--CCeEEeccCCcccCCCC----------CCcCCCccccCcccccCCC-
Q 018244 164 IAEALEYCTSKERALYHDLNAYRIVFD--DD--VNPRLSCFGLMKNSRDG----------RSYSTNLAFTPPEYLRTGR- 228 (359)
Q Consensus 164 i~~~L~~LH~~~~ivH~Dikp~NIll~--~~--~~~kl~DFg~a~~~~~~----------~~~~~t~~y~aPE~~~~~~- 228 (359)
+++|+.|||.+ ||.|||+|.+|||+. ++ ..+.|+|||.+--.+.. -...|.-.-||||+....+
T Consensus 350 lLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 999999999999993 33 45899999986533321 1223566789999987432
Q ss_pred -----CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 018244 229 -----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (359)
Q Consensus 229 -----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (359)
-..++|.|+.|.+-||+++...||+............++- ..+..+..+++.+++|+...|+.||.+|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~----qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES----QLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh----hCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 2358999999999999999999998743333322222211 1123456677889999999999999999988
Q ss_pred HHHHHHHH
Q 018244 304 RSLVTALV 311 (359)
Q Consensus 304 ~~il~~L~ 311 (359)
.-+-+.|.
T Consensus 505 ~iAANvl~ 512 (598)
T KOG4158|consen 505 NIAANVLN 512 (598)
T ss_pred cHHHhHHH
Confidence 76665544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=167.34 Aligned_cols=132 Identities=14% Similarity=0.120 Sum_probs=104.5
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-----CCcccccccceeeeCC---cce-EEEe
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-----RNRRLANLLGCCCEGD---ERL-LVAE 133 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~e 133 (359)
..||+|+||.||. ...++. .+||++........+.+.+|+.+++.+ .||||+++++++.++. .++ +|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4569999999996 323343 479998765545567799999999999 5799999999998864 333 7899
Q ss_pred c--CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCcccccCCCCCeeeCC----CCCeEEeccCC
Q 018244 134 Y--MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGL 202 (359)
Q Consensus 134 ~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~ivH~Dikp~NIll~~----~~~~kl~DFg~ 202 (359)
| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 557999999953 346655 35678888888 999999 9999999999999973 34799999543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=162.41 Aligned_cols=179 Identities=15% Similarity=0.098 Sum_probs=135.5
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch----HHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecC
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD----ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345679999999997776 56678878777654321 124788999999995 5889999886 3569999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccC-CCCCeeeCCCCCeEEeccCCcccCCCCCCc--
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-- 212 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Di-kp~NIll~~~~~~kl~DFg~a~~~~~~~~~-- 212 (359)
.|.+|.+.+. .. ...++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~---~~------~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP---RG------DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh---hh------hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9988875442 11 135778999999999999 9999999 799999999999999999999865543310
Q ss_pred ---------------CCCccccCcccccCC-CCC-CccchhhHHHHHHHHHhCCCCCCc
Q 018244 213 ---------------STNLAFTPPEYLRTG-RVT-PESVMYSFGTLLLDLLSGKHIPPS 254 (359)
Q Consensus 213 ---------------~~t~~y~aPE~~~~~-~~~-~~~Di~slG~il~elltg~~p~~~ 254 (359)
..++.|+.|+...-. ..+ ...+.++.|.-+|.++|++-+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 124567777643321 233 467899999999999999976543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=165.90 Aligned_cols=157 Identities=14% Similarity=0.037 Sum_probs=118.1
Q ss_pred CHHHHHHHhcCCCcccccccCCCCCCcEEEEEE--eCCCcEEEEEEeCCCCCc------------------------hHH
Q 018244 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWP------------------------DAR 98 (359)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~ 98 (359)
+..++.+..+.-..|.+.+.||.|++|.||+|. ..+|..||+|++...... ...
T Consensus 16 ~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (237)
T smart00090 16 TRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRL 95 (237)
T ss_pred HHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHH
Confidence 344555555555567888999999999999998 568999999998754311 012
Q ss_pred HHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-c
Q 018244 99 QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-A 177 (359)
Q Consensus 99 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-i 177 (359)
.+.+|+.++..+.+.+ +.+...+.. ...+|||||+++++|..... ....+.......++.|++.+|.+||+. | +
T Consensus 96 ~~~~E~~~L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~i 170 (237)
T smart00090 96 WAEKEFRNLQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE-GEL 170 (237)
T ss_pred HHHHHHHHHHHHHhcC-CCCCeeeEe-cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc-CCE
Confidence 3567999999997532 222222222 24589999999988876543 233456667789999999999999999 8 9
Q ss_pred ccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 178 vH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+|+||||+||+++ ++.++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=189.60 Aligned_cols=241 Identities=17% Similarity=0.130 Sum_probs=176.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC---CcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|.+-+.+|.|+||+||.|+..+|+.||+|+-+....-. |+=-.+++.+|+ -+.|..+...+...+.-+||+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 4567778899999999999998789999999887654221 122244455554 3456666666667778899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-------CCCCeEEeccCCccc-
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-------DDVNPRLSCFGLMKN- 205 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-------~~~~~kl~DFg~a~~- 205 (359)
|.+.|||.+++. ....++|.....++.|++..+.+||.. +|||+||||+|.||. +...++|+|||-+-.
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999999996 667899999999999999999999999 999999999999993 345699999998754
Q ss_pred --CCCCC---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 206 --SRDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 206 --~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
+.++. ...+|-.+-.+|+..|.+++..+|.|.|+.+++.||.|+..- ...+....... .++..
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~-----~~~Ry 919 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKT-----NFPRY 919 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceeccc-----cchhh
Confidence 33332 335678899999999999999999999999999999998321 11111111111 01122
Q ss_pred HHHH-HHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 281 EGTE-LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 281 ~~~~-l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
...+ ..+++..+|..|-..=|...++...|+....
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 2222 3355666666444444777777777777654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-21 Score=176.20 Aligned_cols=229 Identities=19% Similarity=0.247 Sum_probs=152.5
Q ss_pred cCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccc-------eeee-----CCc
Q 018244 64 EHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG-------CCCE-----GDE 127 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-------~~~~-----~~~ 127 (359)
..+.++++.++.....+ ...++.+..............+++-.+....|.+..-+.+ .+.. ...
T Consensus 251 ~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~ 330 (516)
T KOG1033|consen 251 SSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVY 330 (516)
T ss_pred cccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccc
Confidence 34555555555544222 2333444433333233344455666666655444333322 1111 235
Q ss_pred ceEEEecCCCCCHhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 128 RLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
+||.|++|...+|.+++.++ .....++.....++.|++.|+.| + +.+|+|+||.||++..+..+||+|||+....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheeec
Confidence 88999999999999999743 34467888999999999999999 6 9999999999999999999999999997765
Q ss_pred CCC----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 207 RDG----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 207 ~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
... ....||..||+||.+.+..|+.++||||||++|+||++ -...+. .......+.+..+.+
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGIIPP 479 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCCCCh
Confidence 433 24568999999999999999999999999999999997 121111 111111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPR 304 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (359)
.+ ..-.+.-..|+.+++...|.+||++.
T Consensus 480 ~~-~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 480 EF-LQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HH-hhcCcHHHHHHHHhcCCCcccCchHH
Confidence 11 01123456899999999999999443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.7e-20 Score=157.06 Aligned_cols=134 Identities=16% Similarity=0.164 Sum_probs=112.9
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch--------HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+.||+|++|.||+|.. .|..+++|+........ ...+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4679999999999987 55679999866432211 23577899999999999998888887778889999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|+|++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988531 12 7889999999999999999 999999999999999 78999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=183.59 Aligned_cols=202 Identities=18% Similarity=0.172 Sum_probs=145.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+++.|+.+..|+||.||.++++ ..+++|+| +++... +.+. +|.....| +.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~np---------------fvv---- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNP---------------FVV---- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCc---------------cee----
Confidence 35567777899999999999854 46789994 443221 1111 22222222 222
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-------
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------- 208 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~------- 208 (359)
|+-...++ .-+.++.. ++.+++|||+. +|+|||+||+|.+|+.-|.+|++|||+.+..-.
T Consensus 136 --gDc~tllk--~~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLK--NIGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcc--cCCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 33334443 22233322 27899999999 999999999999999999999999999764211
Q ss_pred ------------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCC
Q 018244 209 ------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (359)
Q Consensus 209 ------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
++...||+.|+|||++....|...+|+|++|+|+||.+-|..||.++.-+.+....+...+. ...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~---wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---WPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---ccc
Confidence 12357899999999999999999999999999999999999999988666555444333322 122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCC
Q 018244 277 FSSDEGTELVRLASRCLQYEPRERP 301 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rp 301 (359)
-......++++++.++|+.+|..|.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2445678899999999999999995
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=154.63 Aligned_cols=130 Identities=18% Similarity=0.212 Sum_probs=107.0
Q ss_pred CCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
||+|++|.||+|.+ ++..+++|........ ....+.+|++++..+.|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 69999999999985 5567999986543211 12456789999999998887666666667778899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
|++|.+++... .. .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~---~~------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG---ND------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc---HH------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887421 11 7899999999999999 999999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=151.07 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=108.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc----------------------hHHHHHHHHHHHhcCCCcc-
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNRR- 114 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n- 114 (359)
.|.+.+.||.|+||.||++...+|..||||++...... ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 36677888999999999999878999999987643210 0113567888999988774
Q ss_pred -cccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 115 -LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 115 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
++..++ ....++||||+++++|..... . .....++.+++.++.++|+. +++|+||||+||++++++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---~-----~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV---L-----EDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc---c-----ccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCC
Confidence 333333 245689999999998876542 0 34567889999999999998 999999999999999999
Q ss_pred CeEEeccCCcccCCC
Q 018244 194 NPRLSCFGLMKNSRD 208 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~ 208 (359)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=171.56 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=108.6
Q ss_pred cccccCCCCCCcEEEEEEeCCCcEEEEEEe-CCC-CCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRF-NRS-AWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
...+.||+|+||+||+|.+.... +++|+. ... ... ..+.+.+|++++..++|++++....++......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 34566799999999999875543 444432 211 111 124578899999999999999888887777788999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
|||+++++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999873 3567899999999999999 99999999999999 6789999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=138.23 Aligned_cols=135 Identities=15% Similarity=0.037 Sum_probs=113.0
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC--cccccccceeeeCCcceEEEecCCCC
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
+++.+|.|.++.||++...+ ..+++|.+..... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34667999999999999755 6799999876543 4568889999999976 58899988888778899999999887
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.+..+ +......++.+++.+|+++|.. .+++|+|++|+||+++..+.++++|||.+....
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 66543 5567788899999999999985 269999999999999998999999999876543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=140.21 Aligned_cols=138 Identities=15% Similarity=0.131 Sum_probs=97.0
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch--HHHH----------------------HHHHHHHhcCCCcc--c
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQF----------------------LEEARAVGQLRNRR--L 115 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~----------------------~~e~~~l~~l~h~n--i 115 (359)
.+.||+|+||.||+|...++..||||++....... ...+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35679999999999997788999999987543211 1111 24555555554332 2
Q ss_pred ccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCC
Q 018244 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~ 194 (359)
.+.++. ...++||||++++.+...... ..... ..+..++.+++.++.++|. . +++|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~--~~~~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK--DVRLL-EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhh--hhhhc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CCc
Confidence 333322 246899999998544321111 10111 6678899999999999999 7 999999999999999 899
Q ss_pred eEEeccCCcccCCC
Q 018244 195 PRLSCFGLMKNSRD 208 (359)
Q Consensus 195 ~kl~DFg~a~~~~~ 208 (359)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=143.79 Aligned_cols=133 Identities=17% Similarity=0.145 Sum_probs=102.3
Q ss_pred CC-CCCCcEEEEEEeCCCcEEEEEEeCCCCC-------------chHHHHHHHHHHHhcCCCccc--ccccceeeeCCc-
Q 018244 65 HG-EKAPNVVYKGKLENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRL--ANLLGCCCEGDE- 127 (359)
Q Consensus 65 lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~- 127 (359)
+| .|+.|+||.+... +..++||.+..... .....+.+|++++..|.|+++ +..+++......
T Consensus 39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 46 7888889999875 55799998864221 123457889999999998875 666665443222
Q ss_pred ---ceEEEecCCC-CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 128 ---RLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 128 ---~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
.++||||+++ .+|.+++. ...++... +.+++.+|.+||+. ||+|+||||+|||++.++.++|+|||.+
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~---~~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQ---EAPLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHh---cCCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2599999997 68988874 23455543 57899999999999 9999999999999999889999999987
Q ss_pred ccC
Q 018244 204 KNS 206 (359)
Q Consensus 204 ~~~ 206 (359)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-19 Score=172.61 Aligned_cols=248 Identities=13% Similarity=0.118 Sum_probs=188.5
Q ss_pred CcccccccCCCCCCcEEEEEEe--CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+++.+|+|+|+.|-.... .....+|+|.+.... .........|..+-+.+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566777789999999988874 335567777776553 222334455777777786 99999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD- 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~- 208 (359)
++|..++++.+-+........+......++.|+..++.|+| .. ++.|+||||+|.+++..+ .++++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998873223225677778899999999999999 77 999999999999999999 999999999987665
Q ss_pred CC------CcCC-CccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc--CCCC
Q 018244 209 GR------SYST-NLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFS 278 (359)
Q Consensus 209 ~~------~~~~-t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 278 (359)
.. ...| ++.|+|||...+. ......|+||.|+++.-+++|..|........ .....+...... ....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCcc
Confidence 21 3457 8999999999985 45668999999999999999997764332111 111111111101 1122
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
...+....+++.+++..+|+.|.+.+++-.
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccc
Confidence 345667889999999999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=145.00 Aligned_cols=241 Identities=19% Similarity=0.226 Sum_probs=183.6
Q ss_pred cccccCCC--CCCcEEEEEEe---CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEE
Q 018244 60 NIVSEHGE--KAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 60 ~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (359)
.+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .....-.+|+.....++ |+|.++.+..+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 45667799 99999999986 3577899998543322 22333466788777774 99999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE----ALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNS 206 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~ 206 (359)
+|++. .+|.++... ....++...++.+..+..+ ||.++|+. +++|-|+||.||+...+ ...+++|||+...+
T Consensus 197 tE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEc
Confidence 99996 588888753 3344778888899999999 99999999 99999999999999988 88999999998876
Q ss_pred CCCCC---------cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 207 RDGRS---------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 207 ~~~~~---------~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
..... ..+...|++||... +.++.+.|+||+|.++.+..++..++.......+.+.. .......+
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-----~~~ip~e~ 347 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-----QGYIPLEF 347 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-----cccCchhh
Confidence 65431 13556799999987 66788999999999999999888766544222221111 11112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
-...+.++...+.+|++.+|-.|++++.+.+.
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 33445567779999999999999999877653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=142.70 Aligned_cols=140 Identities=17% Similarity=0.130 Sum_probs=97.0
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHH----------------------------------------HHHH
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR----------------------------------------QFLE 102 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 102 (359)
+.||.|++|.||+|++.+|+.||||+.+........ .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 357999999999999999999999998654211100 1334
Q ss_pred HHHHHhcC----CCccccccccee-eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCC
Q 018244 103 EARAVGQL----RNRRLANLLGCC-CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE-ALEYCTSKER 176 (359)
Q Consensus 103 e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~~ 176 (359)
|.+.+.++ ++.+-+.+-.++ ......+|||||++|++|.++... .....+ ...++..++. .+..+|.. |
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~~---~~~ia~~~~~~~l~ql~~~-g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGLD---RKALAENLARSFLNQVLRD-G 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCCC---HHHHHHHHHHHHHHHHHhC-C
Confidence 55544444 222223322222 223457899999999999887642 111222 3445666665 46788998 9
Q ss_pred cccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 177 ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
++|+|+||.||+++.++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.2e-15 Score=128.44 Aligned_cols=199 Identities=18% Similarity=0.203 Sum_probs=141.5
Q ss_pred HHHHHhcCCCcccccccceeeeCC-----cceEEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcC-
Q 018244 103 EARAVGQLRNRRLANLLGCCCEGD-----ERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK- 174 (359)
Q Consensus 103 e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~- 174 (359)
-+..|-.+-|.|||+++.|+.+.. ...+++||+..|+|.++|++. ....+......+|+.||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345566667999999999997643 478999999999999999863 345677888899999999999999986
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCccc------C--CCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHH
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------S--RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~------~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 246 (359)
..|+|+++..+.|++..+|-+|++--..... . .......+.++|.+||.-.....+.++|||+||+..++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 5689999999999999888888764221110 0 0111234567899999988777888999999999999998
Q ss_pred hCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 247 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
-+..-..........+......+. .-....-+.++..|++..|..||+|.+++-+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~--------~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII--------GLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee--------eccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 776322111111111111111110 0011223568999999999999999998765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.1e-15 Score=140.25 Aligned_cols=144 Identities=15% Similarity=0.100 Sum_probs=93.1
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCch----------------------------------HHH-
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPD----------------------------------ARQ- 99 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~- 99 (359)
|..+.. +.+|+|++|.||+|++.+ |+.||||+....-... .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455555 567999999999999876 9999999997542110 011
Q ss_pred -----HHHHHHHHhcCC----Ccccccccceeee-CCcceEEEecCCCCCHhhhhhcCCCC----CCCHHHHHHHHHHHH
Q 018244 100 -----FLEEARAVGQLR----NRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQ----PMKWAMRLRVALHIA 165 (359)
Q Consensus 100 -----~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~ 165 (359)
+.+|...+.++. +.+.+.+-.++.+ ....+|||||++|+.+.+...-...+ .+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 233333333331 2333333333322 23567999999999998742111111 233444445555554
Q ss_pred HHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCcccCCC
Q 018244 166 EALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNSRD 208 (359)
Q Consensus 166 ~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~~~~ 208 (359)
.. |++|+|+||.||+++.++ .++++|||++...+.
T Consensus 278 -------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999887 999999999876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-13 Score=129.58 Aligned_cols=168 Identities=15% Similarity=0.156 Sum_probs=133.8
Q ss_pred EEE-EE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCC
Q 018244 73 VYK-GK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ 150 (359)
Q Consensus 73 Vy~-~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~ 150 (359)
+|. |. ..++..|.|...+...........+-++-|+.++||||++++..+......|||+|-+. -|..++.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----
Confidence 443 43 55788899998887765445667888999999999999999999999999999999874 47777753
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC----cCCCccccCcccccC
Q 018244 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFTPPEYLRT 226 (359)
Q Consensus 151 ~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~----~~~t~~y~aPE~~~~ 226 (359)
+........++||+.||.|||+..+++|++|.-+-|+++..|..||++|.++........ ...-..|..|+.+..
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 346777888999999999999776999999999999999999999999998765443331 112235677766543
Q ss_pred CCCCCccchhhHHHHHHHHHhCC
Q 018244 227 GRVTPESVMYSFGTLLLDLLSGK 249 (359)
Q Consensus 227 ~~~~~~~Di~slG~il~elltg~ 249 (359)
.. -..|.|.||+++++++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 32 4579999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.4e-14 Score=114.86 Aligned_cols=128 Identities=15% Similarity=0.073 Sum_probs=95.2
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccc-cccceeeeCCcceEEEecCCCCCH
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
++.++.|.++.||++... +..+++|....... ....+.+|+.++..+.+.+++ +++.+ .....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 345688999999999875 66899999865432 123457889999988655544 44433 23456899999999877
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-----ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
.... . ....++.+++.+|+.||+. + ++|+|++|+||+++ ++.++++|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5431 1 1134568999999999998 6 49999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.1e-14 Score=131.29 Aligned_cols=244 Identities=16% Similarity=0.101 Sum_probs=180.0
Q ss_pred CcccccccCCCCCCcEEEEEEe--CCCcEEEEEEeCCCCCchHHH--HHHHHHHHhcC-CCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (359)
.++..+..||.|.|+.|++... .++..+++|.+.........+ -..|+.+...+ .|.++++....|......+|=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 4566788889999999999874 367889999887664443333 35677777777 499999998888888888899
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCCCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~~~~ 210 (359)
-|||.++++...+. -...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+....-..
T Consensus 345 ~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceec
Confidence 99999988876653 456688889999999999999999999 99999999999999876 889999999986533222
Q ss_pred -CcCCCcccc--CcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 -SYSTNLAFT--PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 -~~~~t~~y~--aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....+-++. +++......+..++|++|||..+.+..++........ .. ..+ ........ ......+..
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~~------~~i-~~~~~p~~-~~~~~~~q~ 492 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-QS------LTI-RSGDTPNL-PGLKLQLQV 492 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-cc------eee-ecccccCC-CchHHhhhh
Confidence 222233344 4555555668889999999999999999885433211 10 001 11111111 222377888
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
+...+...++..||.+.++..+.+.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchh
Confidence 9999999999999999987765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.9e-12 Score=107.04 Aligned_cols=136 Identities=10% Similarity=0.115 Sum_probs=98.1
Q ss_pred ccCCCCCCcEEEEEEeCC-------CcEEEEEEeCCCCC----------------------chHHH----HHHHHHHHhc
Q 018244 63 SEHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW----------------------PDARQ----FLEEARAVGQ 109 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~----~~~e~~~l~~ 109 (359)
+.||.|--+.||.|...+ +..+|||+...... ...+. ..+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 457899999999998442 47899998752110 01112 2379999999
Q ss_pred CCC--cccccccceeeeCCcceEEEecCCCCCHhh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccccCCCC
Q 018244 110 LRN--RRLANLLGCCCEGDERLLVAEYMPNDTLAK-HLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAY 185 (359)
Q Consensus 110 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~ivH~Dikp~ 185 (359)
+.. -++.+.+++ ..-+|||||+.++.+.. .+ +...++......+..+++.+|..| |.. |++|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHH
Confidence 854 355555543 46789999997653422 23 223455566778889999999999 787 9999999999
Q ss_pred CeeeCCCCCeEEeccCCcccCC
Q 018244 186 RIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 186 NIll~~~~~~kl~DFg~a~~~~ 207 (359)
||+++ ++.+.|+|||.+-..+
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-13 Score=135.32 Aligned_cols=242 Identities=15% Similarity=0.118 Sum_probs=178.0
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
....+++-+-+|+++.++.+. -..|...+.|+..... ..+.+....+-.++-...+|.++....-+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 344556666889999999887 3345455555544322 112333444444554456677777776666677899999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC-----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----- 207 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~----- 207 (359)
+|..+++|...++ .....+.......+..+.++++|||.. .+.|+|++|.|++...++..+++|||......
T Consensus 884 ~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999886 444677777778888999999999998 79999999999999999999999998422110
Q ss_pred -------------------------C-----CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh
Q 018244 208 -------------------------D-----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257 (359)
Q Consensus 208 -------------------------~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~ 257 (359)
. .....+|+.|.+||...+......+|+|++|++++|.++|..||....-
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0123468899999999999999999999999999999999999877655
Q ss_pred HHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 018244 258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304 (359)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (359)
....+........ ...-+...+..+.+++...+..+|.+|..+.
T Consensus 1041 q~~f~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIFENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4444333322221 1223455678899999999999999998776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2e-11 Score=112.58 Aligned_cols=215 Identities=17% Similarity=0.166 Sum_probs=155.6
Q ss_pred CCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee----CCcceEEEecCCC-CCHhh
Q 018244 69 APNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMPN-DTLAK 142 (359)
Q Consensus 69 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~ 142 (359)
-..+.|++. .-+|..+++|+++............-++.++++.|.|+|++.++|.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346789998 56899999999954433333344556889999999999999998874 3468999999876 57766
Q ss_pred hhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 143 HLFHW-------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 143 ~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+-... .+...++..+|.++.|+..||.+||+. |+.-+-|.|.+||++.+.+++|+..|+......+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 54322 123467899999999999999999999 9988999999999999999999998887655444
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
.. |-+. -..+-|.=.||.+++-|.||..--. ..+....... .......+.++++++
T Consensus 447 ~~----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~--~~d~~~~s~~---------~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 447 PT----------EPLE---SQQQNDLRDLGLLLLALATGTENSN--RTDSTQSSHL---------TRITTTYSTDLRNVV 502 (655)
T ss_pred CC----------cchh---HHhhhhHHHHHHHHHHHhhcccccc--cccchHHHHH---------HHhhhhhhHHHHHHH
Confidence 31 1111 1234688899999999999963210 0010110000 112355677899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
......++++ -++.+++.+
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 9999999987 677777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-12 Score=108.49 Aligned_cols=140 Identities=17% Similarity=0.180 Sum_probs=107.9
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCc--ccccccceeeeC---CcceEEEecCC
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNR--RLANLLGCCCEG---DERLLVAEYMP 136 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 136 (359)
+.+|.|..+.||+++..+|..+++|....... .....+.+|+++++.+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 34689999999999987767899999865432 1345678899999999753 456677766553 25689999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 174 (359)
|.++.+.+. ...++......++.+++.+|..||+.
T Consensus 84 G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 988877652 13567777888888888888888841
Q ss_pred -------------CCcccccCCCCCeeeCC--CCCeEEeccCCccc
Q 018244 175 -------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKN 205 (359)
Q Consensus 175 -------------~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~ 205 (359)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24589999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-11 Score=99.22 Aligned_cols=144 Identities=16% Similarity=0.123 Sum_probs=108.3
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+..+-+|+-+.|+++.+. |+...||.-...... ...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3445578999999999985 445566654322111 1345678999999987667766666777888889999
Q ss_pred ecCCC-CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---CeEEeccCCcccC
Q 018244 133 EYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNS 206 (359)
Q Consensus 133 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---~~kl~DFg~a~~~ 206 (359)
||++| -++.+++...............++..|-..+.-||.+ +++|+||..+||++..++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 4788888764444444555578999999999999999 999999999999996544 3689999997643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-11 Score=99.48 Aligned_cols=131 Identities=18% Similarity=0.194 Sum_probs=100.4
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--ch------HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PD------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+++|+-+.+|.+.+-+. .+.+|.-..... +. ...-.+|+.++.+++--.|.-..=+..+++...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 358899999999976443 466665433221 11 234567999999987666666666777888999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
+|..|.+++... ...++..+-.-+.-||.. ||+|+||.++||++.++. +.++|||++...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999888888532 256777888888899999 999999999999998654 999999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-10 Score=101.44 Aligned_cols=132 Identities=11% Similarity=0.091 Sum_probs=97.9
Q ss_pred EEEEEEeCCCcEEEEEEeCCCCCch-H----------HHHHHHHHHHhcCCCccccc--ccceeee-----CCcceEEEe
Q 018244 72 VVYKGKLENQFRIAVKRFNRSAWPD-A----------RQFLEEARAVGQLRNRRLAN--LLGCCCE-----GDERLLVAE 133 (359)
Q Consensus 72 ~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~niv~--~~~~~~~-----~~~~~lv~e 133 (359)
.|++..+ +|+.+.||......... . ..+.+|...+..|..-+|.. .+++... ....+||||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3667766 56689999875444221 1 13778999998886544433 3455543 234689999
Q ss_pred cCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-------CCCeEEeccCCccc
Q 018244 134 YMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-------DVNPRLSCFGLMKN 205 (359)
Q Consensus 134 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-------~~~~kl~DFg~a~~ 205 (359)
++++. +|.+++........+......++.+++..+.-||.. |++|+|++++|||++. +..+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99875 799888543344566777889999999999999999 9999999999999975 46799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=96.20 Aligned_cols=126 Identities=19% Similarity=0.174 Sum_probs=82.4
Q ss_pred EEEEEEeCCCcEEEEEEeCCCCCc----------------------h----HHHHHHHHHHHhcCCCc--ccccccceee
Q 018244 72 VVYKGKLENQFRIAVKRFNRSAWP----------------------D----ARQFLEEARAVGQLRNR--RLANLLGCCC 123 (359)
Q Consensus 72 ~Vy~~~~~~~~~vavK~~~~~~~~----------------------~----~~~~~~e~~~l~~l~h~--niv~~~~~~~ 123 (359)
.||.|...+|..+|||........ . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999987532100 0 12356799999999765 455555442
Q ss_pred eCCcceEEEecCC--CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccccCCCCCeeeCCCCCeEEecc
Q 018244 124 EGDERLLVAEYMP--NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (359)
Q Consensus 124 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~ivH~Dikp~NIll~~~~~~kl~DF 200 (359)
.-.|||||++ |..+.. +.. ..++......++.+++..+..+ |.. |++|+|+.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~---~~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKD---VDLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHH---CGGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhh-HHh---ccccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 544433 322 1122344566777888866664 677 99999999999999977 9999999
Q ss_pred CCcccCC
Q 018244 201 GLMKNSR 207 (359)
Q Consensus 201 g~a~~~~ 207 (359)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9876554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-09 Score=96.76 Aligned_cols=247 Identities=17% Similarity=0.186 Sum_probs=154.9
Q ss_pred ccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccce------e-eeCCcceEEEe
Q 018244 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC------C-CEGDERLLVAE 133 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~-~~~~~~~lv~e 133 (359)
..||+|+-+.+|-.- ..+ .|| |++.........+ -+..|... .||-+-.-+.+ . ......-++|.
T Consensus 17 r~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred ccccCCccceeeecchhhc--hhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 357999999999654 322 244 7776554332222 23334443 35533221111 0 11122567777
Q ss_pred cCCCCC-Hhhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 134 YMPNDT-LAKHLF----HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 134 ~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
.+.+.. ...+.. +..-....|+...+.++.++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-.....-..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccC
Confidence 776642 222221 11223568999999999999999999999 999999999999999999999999665444333
Q ss_pred CC---CcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CCCCCcchh--------H-HHhhhhhhhhcc
Q 018244 209 GR---SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSG-KHIPPSHAL--------D-LIRDRNIQTLTD 270 (359)
Q Consensus 209 ~~---~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg-~~p~~~~~~--------~-~~~~~~~~~~~~ 270 (359)
+. ..+|...|++||.-. +-.-+...|.|.||+++++++.| ++||.+-.. + .+....+..-.+
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 33 346778999999755 33456789999999999999887 777653211 0 111111111111
Q ss_pred ccc-----cCCCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhc
Q 018244 271 SCL-----EGQFS-SDEGTELVRLASRCLQYE--PRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 271 ~~~-----~~~~~-~~~~~~l~~li~~cl~~d--p~~Rps~~~il~~L~~~~~~ 316 (359)
... ...++ .-.++++..|..+|+..- +.-|||++..+..|..+.+.
T Consensus 250 ~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 250 QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000 00111 225678899999999753 56899999998888777654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.1e-11 Score=114.21 Aligned_cols=144 Identities=21% Similarity=0.293 Sum_probs=104.6
Q ss_pred HHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCC-------------cCCCccccCcccccCCCC
Q 018244 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------------YSTNLAFTPPEYLRTGRV 229 (359)
Q Consensus 163 qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-------------~~~t~~y~aPE~~~~~~~ 229 (359)
+++.||.|+|+..++||++|.|++|.++.++.+||+.|+++-....... ......|.|||++.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 4449999999998999999999999999999999999998765443211 122467999999998888
Q ss_pred CCccchhhHHHHHHHHHhC-CCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 230 TPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 230 ~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
+.++|+||+|+++|.+..| +..+......... .............+....+.++++=+.+++..++..||++..+..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchh--hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 9999999999999999844 4333222111111 111111111122234667789999999999999999997777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-08 Score=87.02 Aligned_cols=147 Identities=15% Similarity=0.098 Sum_probs=101.5
Q ss_pred HHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc----------------------hHHHHHHHHH
Q 018244 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEAR 105 (359)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~ 105 (359)
.|....+.-.-+.+-..||-|--+.||.|..+.|..+|||.-...... ......+|.+
T Consensus 82 AL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 82 ALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 333333333344555678999999999999999999999975321100 1234678999
Q ss_pred HHhcCCCc--ccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCC
Q 018244 106 AVGQLRNR--RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183 (359)
Q Consensus 106 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dik 183 (359)
+|..|.-. .+.+.+++- .-.+||||++|-.|...- ++......++..|+.-+.-+-.. |+||+|+.
T Consensus 162 ~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~-GiVHGDlS 229 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR-GIVHGDLS 229 (304)
T ss_pred HHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc-CccccCCc
Confidence 99999755 677776643 568999999886554322 12333334444555555444455 99999999
Q ss_pred CCCeeeCCCCCeEEeccCCcccC
Q 018244 184 AYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 184 p~NIll~~~~~~kl~DFg~a~~~ 206 (359)
+=||+++++|.+.++||-.+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1e-08 Score=98.01 Aligned_cols=141 Identities=13% Similarity=0.061 Sum_probs=90.5
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchH------------------------------H----------HHHHH
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA------------------------------R----------QFLEE 103 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~e 103 (359)
-++.++-|.||+|++++|+.||||+....-.... + .+.+|
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 4588999999999999999999999864321100 0 13345
Q ss_pred HHHHhcCC----Cccccccccee-eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCc
Q 018244 104 ARAVGQLR----NRRLANLLGCC-CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERA 177 (359)
Q Consensus 104 ~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~i 177 (359)
...+.+++ ...-+++-.++ .......|+|||++|-.+.+...- +....+...+. ..++.+. ..+-.. |+
T Consensus 212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia---~~~~~~f~~q~~~d-gf 286 (517)
T COG0661 212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKELA---ELLVRAFLRQLLRD-GF 286 (517)
T ss_pred HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHHH---HHHHHHHHHHHHhc-Cc
Confidence 54444442 12222222222 234567899999999888887432 23445533332 2222222 222234 99
Q ss_pred ccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 178 vH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+|.|.+|.||+++.+|.+.+.|||+....++.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999998766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.8e-08 Score=82.06 Aligned_cols=137 Identities=13% Similarity=0.054 Sum_probs=101.3
Q ss_pred CCCCCcEEEEEEeCCCcEEEEEEeCCCC------CchHHHHHHHHHHHhcCCCcc--cccccceee-eC----CcceEEE
Q 018244 66 GEKAPNVVYKGKLENQFRIAVKRFNRSA------WPDARQFLEEARAVGQLRNRR--LANLLGCCC-EG----DERLLVA 132 (359)
Q Consensus 66 g~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~-~~----~~~~lv~ 132 (359)
|.||.+-|+.....+. .+=+|+-.... ......|.+|+..|..|..-+ +.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6788888999876544 57777664221 113457899999999996433 44444 332 11 2368999
Q ss_pred ecCCC-CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC--eEEeccCCccc
Q 018244 133 EYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKN 205 (359)
Q Consensus 133 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~--~kl~DFg~a~~ 205 (359)
|-+.+ -+|.+++.+..-...+......++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 5888888654444668888899999999999999999 9999999999999986667 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-08 Score=86.52 Aligned_cols=106 Identities=19% Similarity=0.202 Sum_probs=82.9
Q ss_pred HHHHHHHHHHhcCCCcc--cccccceeeeCC----cceEEEecCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 018244 98 RQFLEEARAVGQLRNRR--LANLLGCCCEGD----ERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170 (359)
Q Consensus 98 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~ 170 (359)
....+|...+..|..-+ .++.+++..... ..+||+|++++. +|.+++... ..++......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHHH
Confidence 35678888888875443 445555555432 348999999874 799988632 226777788999999999999
Q ss_pred hhcCCCcccccCCCCCeeeCCCC---CeEEeccCCcccC
Q 018244 171 CTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNS 206 (359)
Q Consensus 171 LH~~~~ivH~Dikp~NIll~~~~---~~kl~DFg~a~~~ 206 (359)
||.. |++|+|+++.|||++.++ .+.++||+-++..
T Consensus 134 lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999877 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.4e-08 Score=82.10 Aligned_cols=160 Identities=20% Similarity=0.202 Sum_probs=113.2
Q ss_pred cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch-------------------HH--
Q 018244 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-------------------AR-- 98 (359)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-- 98 (359)
.+...+...+....+......+.+.|+.|--+.||+|...++..+|+|++....... ..
T Consensus 31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 345566777777777777777778889999999999998888899999986432111 11
Q ss_pred ---HHHHHHHHHhcCC--CcccccccceeeeCCcceEEEecCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 018244 99 ---QFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172 (359)
Q Consensus 99 ---~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 172 (359)
-..+|+..|+++. +-.+.+-+++. .-.|||||+... .-.-.| +.-.+.......+..++++.+.-|-
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHH
Confidence 1345777777774 33444444443 457999998653 111122 2223344467778888888888887
Q ss_pred cCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 173 ~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
...++||+||..=|||+. ++.+.++|||.|-...
T Consensus 184 ~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 744999999999999999 8899999999876544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.1e-07 Score=76.20 Aligned_cols=134 Identities=13% Similarity=0.079 Sum_probs=84.0
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHH---------HHHHHHHHHhcCCCc---ccccccceeee--
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR---------QFLEEARAVGQLRNR---RLANLLGCCCE-- 124 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~---niv~~~~~~~~-- 124 (359)
|..++.+-......|.+-.. +|..+.+|..........+ .+.+.+..+..++.. ..+.++.+...
T Consensus 33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 33444445555555666655 4567999988754322111 123444444444332 22332222221
Q ss_pred ---CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 125 ---GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 125 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
....+++|||++|..|.+... +++ .+...+.+++.-||.. |++|+|.+|.|++++++ .++++||+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECc
Confidence 234568999999988876542 333 2446677889999999 99999999999999855 59999998
Q ss_pred Cccc
Q 018244 202 LMKN 205 (359)
Q Consensus 202 ~a~~ 205 (359)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.2e-07 Score=77.54 Aligned_cols=136 Identities=12% Similarity=0.101 Sum_probs=82.6
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--cccccceeeeCCcceEEEecCCCCC-H
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYMPNDT-L 140 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L 140 (359)
.+|.|..+.||+.. +..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 45999999999842 3357788876533 2345788999999986433 4667777777777889999998863 2
Q ss_pred hhhhh---------------------cCCCCCCCHHHH-HHHHH----------HHHHH-HHHhh---cCCCcccccCCC
Q 018244 141 AKHLF---------------------HWETQPMKWAMR-LRVAL----------HIAEA-LEYCT---SKERALYHDLNA 184 (359)
Q Consensus 141 ~~~l~---------------------~~~~~~l~~~~~-~~i~~----------qi~~~-L~~LH---~~~~ivH~Dikp 184 (359)
...+. ............ ..+.. .+... ..+|. ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 11110 000001111110 00100 01111 12222 123568999999
Q ss_pred CCeeeCCCCCeEEeccCCccc
Q 018244 185 YRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 185 ~NIll~~~~~~kl~DFg~a~~ 205 (359)
.||++++++ +.++||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.4e-07 Score=86.04 Aligned_cols=138 Identities=17% Similarity=0.102 Sum_probs=87.3
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch-------------------------------HH------HHHHHHHH
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-------------------------------AR------QFLEEARA 106 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~~ 106 (359)
.||..+.|.||+|++++|+.||||+-+..-... .+ .|.+|.+.
T Consensus 168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 468899999999999999999999866432111 00 12334433
Q ss_pred Hhc----CCCcc------cccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCC
Q 018244 107 VGQ----LRNRR------LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKE 175 (359)
Q Consensus 107 l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ 175 (359)
..+ ++|-+ |.+++-.+ .....|+|||++|..+.+.-.- ....++...+.. .+.++...+ =..
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~---~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILN---KLVEAYLEQIFKT- 320 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHH---HHHHHHHHHHHhc-
Confidence 322 23444 33333222 2357899999999877665322 444555554333 333332221 223
Q ss_pred CcccccCCCCCeeeC----CCCCeEEeccCCcccCCC
Q 018244 176 RALYHDLNAYRIVFD----DDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 176 ~ivH~Dikp~NIll~----~~~~~kl~DFg~a~~~~~ 208 (359)
|.+|+|-+|.||++. .++.+.+-|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999998 367899999999775543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=73.33 Aligned_cols=100 Identities=23% Similarity=0.281 Sum_probs=79.2
Q ss_pred HHHHHHHhcCCC-cccccccceeeeCCcceEEEecCCCCCHhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--
Q 018244 101 LEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYMPNDTLAKH---LFHWETQPMKWAMRLRVALHIAEALEYCTSK-- 174 (359)
Q Consensus 101 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-- 174 (359)
..|.-+|+.+++ +++++++|+| ..+++.||...+++... +. .-...+|..+.+|+.+++..+.++++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 347888888875 6999999999 45789999987765421 11 112468999999999999999999884
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..+.-.|++++|+-+++++++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 24555699999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.1e-08 Score=93.25 Aligned_cols=177 Identities=10% Similarity=-0.025 Sum_probs=131.6
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc-cccccceeeeCCcceEEEecCCCC-CH
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPND-TL 140 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL 140 (359)
...++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+...+..++.++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 344889999999998433334446665543 33455899999999999 777788888888899999999877 22
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---CCcCCCcc
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~~~~~t~~ 217 (359)
.... ......+..-+...+.+.-+.+++++|+. --+|+| ||+..+ +..+..||+......+. +...+|+.
T Consensus 323 ~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~ 395 (829)
T KOG0576|consen 323 ALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPE 395 (829)
T ss_pred cccC-ChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCC
Confidence 2211 11223344556667777888899999987 568888 777664 78899999988766554 45678899
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p 251 (359)
++|||+...+.+....|+|++|.--.++--|-+|
T Consensus 396 ~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 396 PLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 9999999999999999999999876666666544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.9e-06 Score=74.43 Aligned_cols=136 Identities=15% Similarity=0.098 Sum_probs=82.4
Q ss_pred CCCCC-cEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCCCCCHhhh
Q 018244 66 GEKAP-NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (359)
Q Consensus 66 g~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (359)
..|.. +.||+..... ..+.+|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 33444 7899998644 578888876543 335677888888884 44455677776666678999999999777644
Q ss_pred hh-------------------cCC--CCCCCHH--HHH-HH----------------------HHHHHHHHHHhh---cC
Q 018244 144 LF-------------------HWE--TQPMKWA--MRL-RV----------------------ALHIAEALEYCT---SK 174 (359)
Q Consensus 144 l~-------------------~~~--~~~l~~~--~~~-~i----------------------~~qi~~~L~~LH---~~ 174 (359)
.. ... ...+... ... .. ..++...|.... ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 000 0011100 000 00 111111111111 11
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 2589999999999999877788999997643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-06 Score=85.70 Aligned_cols=80 Identities=15% Similarity=0.258 Sum_probs=57.9
Q ss_pred ccccCCCCCCcEEEEEEeCCC---cEEEEEEeCCCCC-chHHHHHHHHHHHhcCC-Cccc--ccccceeeeC---CcceE
Q 018244 61 IVSEHGEKAPNVVYKGKLENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRL--ANLLGCCCEG---DERLL 130 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l 130 (359)
.+..++.|.++.+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 356679999999999886553 3677787654321 23456889999999995 6665 6777777654 45789
Q ss_pred EEecCCCCCH
Q 018244 131 VAEYMPNDTL 140 (359)
Q Consensus 131 v~e~~~~gsL 140 (359)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-06 Score=75.49 Aligned_cols=78 Identities=21% Similarity=0.285 Sum_probs=55.5
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc--ccccccceeee---CCcceEEEecCC
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGCCCE---GDERLLVAEYMP 136 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~ 136 (359)
++.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3456889999999999877 48999997754 3456678888888888533 34566654322 234689999999
Q ss_pred CCCHhh
Q 018244 137 NDTLAK 142 (359)
Q Consensus 137 ~gsL~~ 142 (359)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.3e-06 Score=68.60 Aligned_cols=126 Identities=17% Similarity=0.062 Sum_probs=88.4
Q ss_pred cCCCCCCcEEEEEEeCCCcEEEEEEeCCCC----------------CchHHHHHHHHHHHhcCC------Ccccccccce
Q 018244 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA----------------WPDARQFLEEARAVGQLR------NRRLANLLGC 121 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~~~ 121 (359)
.||+|+.-.||.--. .....||+..... .....+..+|+.-...+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~HP~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHPD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECCC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 359999999997643 3347888887655 122455666766555554 8899999999
Q ss_pred eeeCCcceEEEecCCC------CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC--C
Q 018244 122 CCEGDERLLVAEYMPN------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--V 193 (359)
Q Consensus 122 ~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~--~ 193 (359)
..+.-..-+|+|.+.+ -||.+++. ...++. .....+.+ -..||-.+ +|+.+|++|+||++..+ +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~~---f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALDE---FKRYLLDH-HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHHH---HHHHHHHc-CCeecCCCcccEEEEecCCC
Confidence 9999899999998643 27888883 344655 33333333 34566677 99999999999999632 2
Q ss_pred --CeEEec
Q 018244 194 --NPRLSC 199 (359)
Q Consensus 194 --~~kl~D 199 (359)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=66.77 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=94.4
Q ss_pred CCCcccccCHHHHHHHhcCCCcccccccCCCCCC-cEEEEEEeCCCcEEEEEEeCC---CCC------------------
Q 018244 37 NVPVFCEYSIETLRTATSGFAMENIVSEHGEKAP-NVVYKGKLENQFRIAVKRFNR---SAW------------------ 94 (359)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------ 94 (359)
..|....|+... .+.+.++.||.|.- |.||++... |..+|+|.+.. ...
T Consensus 25 ~gPKL~~F~~h~--------~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (207)
T PF13095_consen 25 PGPKLEPFTHHG--------DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPA 95 (207)
T ss_pred CCCCcCCcCCCC--------CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhh
Confidence 455666665511 56778888999999 999999984 55899999321 000
Q ss_pred chHHHHHHHHHHHhcCC---Cccc--ccccceeeeC------------------CcceEEEecCCCCCHhhhhhcCCCCC
Q 018244 95 PDARQFLEEARAVGQLR---NRRL--ANLLGCCCEG------------------DERLLVAEYMPNDTLAKHLFHWETQP 151 (359)
Q Consensus 95 ~~~~~~~~e~~~l~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~ 151 (359)
.-...|..|.++..+|+ +.++ |+.+||..-. ....||.||++... .
T Consensus 96 ~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~ 164 (207)
T PF13095_consen 96 HYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------P 164 (207)
T ss_pred hhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------c
Confidence 01124677888777775 4456 8888887432 12357777776542 2
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 152 MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 152 l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
++.. -+.+|.+-|..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 165 ~~~~----~~~~~~~dl~~~~k~-gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIR----DIPQMLRDLKILHKL-GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cchh----HHHHHHHHHHHHHHC-CeeeccCcccccc-----CCEEEecccC
Confidence 2333 345677778889999 9999999999987 5589999965
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.9e-05 Score=63.94 Aligned_cols=131 Identities=18% Similarity=0.185 Sum_probs=88.8
Q ss_pred cccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccc-ccceeeeCCcceEEEecCCCC
Q 018244 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN-LLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~g 138 (359)
+..+.||+|.+|.||++.+.++ .+|+|+-..++ ....+..|.++|..+.-.++.. ++.|. .-++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4556789999999999998655 78888776543 2466888999999988666544 33333 334569999998
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCC-CCCeeeCCCCCeEEeccCCcccCC
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dik-p~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.|.+.... .+..++. .++..-.-|... ||-|..|. |..+++.+++.+.|+||..|+.-.
T Consensus 98 ~L~~~~~~-----~~rk~l~----~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 98 PLGKLEIG-----GDRKHLL----RVLEKAYKLDRL-GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred chhhhhhc-----ccHHHHH----HHHHHHHHHHHh-ccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 88776531 1333333 344443334444 89998774 555555556699999999987443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=9.2e-06 Score=82.57 Aligned_cols=192 Identities=19% Similarity=0.150 Sum_probs=138.7
Q ss_pred HHHHHHHHhcCCCcccccccceeeeCCc----ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 018244 100 FLEEARAVGQLRNRRLANLLGCCCEGDE----RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175 (359)
Q Consensus 100 ~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 175 (359)
..-|+..+..+.|+|++.++.|...... ..+..+++...++.+.+. .-...+....+.+..+...||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3457778888899999999998765433 334567888888888886 456678889999999999999999998
Q ss_pred CcccccCCCC---CeeeCCCCCeEEe--ccCCcccCCCCCC---cCCCccccCcccccCCCCCC--ccchhhHHHHHHHH
Q 018244 176 RALYHDLNAY---RIVFDDDVNPRLS--CFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTP--ESVMYSFGTLLLDL 245 (359)
Q Consensus 176 ~ivH~Dikp~---NIll~~~~~~kl~--DFg~a~~~~~~~~---~~~t~~y~aPE~~~~~~~~~--~~Di~slG~il~el 245 (359)
...|.-+..+ +...+..+.+..+ ||+.......... ...+..+.|||......+.. ..|+|.+|.....+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6666655555 5555666777777 8888776654432 23345688888887666554 47999999999999
Q ss_pred HhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 246 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..|..+..... .....+. ........+...+|+..++++|+++.+++..
T Consensus 386 ~~~~~i~~~~~-----------~~~~~l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 386 SQGEDISEKSA-----------VPVSLLD----VLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hhcCccccccc-----------chhhhhc----cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 98875432211 0011111 1111157889999999999999999999976
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.5e-05 Score=67.18 Aligned_cols=72 Identities=15% Similarity=0.120 Sum_probs=43.3
Q ss_pred cCCCCCCc-EEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc---ccccccceeeeC---CcceEEEecCC
Q 018244 64 EHGEKAPN-VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEG---DERLLVAEYMP 136 (359)
Q Consensus 64 ~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~ 136 (359)
.++.|+.. .||+.. ..+.+|...... ....+.+|.++|..+... .+.+.++..... ...+++|++++
T Consensus 4 ~~~~gG~~n~vy~~~----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRLG----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEcC----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 34555554 588762 246778755422 244688899999888532 234444433322 23488999999
Q ss_pred CCCHh
Q 018244 137 NDTLA 141 (359)
Q Consensus 137 ~gsL~ 141 (359)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.2e-05 Score=67.53 Aligned_cols=77 Identities=12% Similarity=0.033 Sum_probs=55.6
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC---cccccccceeee---CCcceEEEec
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE---GDERLLVAEY 134 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~ 134 (359)
-++.||.|..+.||.....++ .+.+|..+.. .....+..|...|+.|.- -.+.++++++.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345679999999999987666 4666775431 123578889999988853 357777877654 3568999999
Q ss_pred CCCCCH
Q 018244 135 MPNDTL 140 (359)
Q Consensus 135 ~~~gsL 140 (359)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.7e-05 Score=66.29 Aligned_cols=136 Identities=14% Similarity=0.098 Sum_probs=77.3
Q ss_pred CCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecCCCCCHhhh
Q 018244 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (359)
+..|-.+.+|+... ++..+++|..........-...+|..+++.+...++ .+++... .-++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 45677889999874 455788887654332211134678888888864433 3333332 24789999998665421
Q ss_pred --------------hh---cCC--CCCCCH-HHHHHHHHHH---------HHHHHHhhc-------CCCcccccCCCCCe
Q 018244 144 --------------LF---HWE--TQPMKW-AMRLRVALHI---------AEALEYCTS-------KERALYHDLNAYRI 187 (359)
Q Consensus 144 --------------l~---~~~--~~~l~~-~~~~~i~~qi---------~~~L~~LH~-------~~~ivH~Dikp~NI 187 (359)
+. ... ...++. ..+..+..++ ...+..+-. ...++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11 000 111121 1111221111 111111211 12579999999999
Q ss_pred eeCCCCCeEEeccCCcccC
Q 018244 188 VFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 188 ll~~~~~~kl~DFg~a~~~ 206 (359)
++++++ +.|+||..+...
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999876 789999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=63.45 Aligned_cols=73 Identities=19% Similarity=0.149 Sum_probs=47.0
Q ss_pred ccCCCCCCcEEEEEEeCC--CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecCCCCC
Q 018244 63 SEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
+.|..|-.+.+|+....+ +..+.+|........ .....+|+.++..+...++ +++++.+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 345778888999998664 668999977643221 1223468888888854333 44443322 248999998866
Q ss_pred H
Q 018244 140 L 140 (359)
Q Consensus 140 L 140 (359)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00048 Score=62.55 Aligned_cols=158 Identities=13% Similarity=0.139 Sum_probs=87.8
Q ss_pred cCHHHHHHHhcCC--CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--ccccc
Q 018244 44 YSIETLRTATSGF--AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLL 119 (359)
Q Consensus 44 ~~~~~~~~~~~~~--~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~ 119 (359)
.+.++|...-..| ..-..+..++.|....+|+....+| .+.+|+...... ......|++++..|...+ +++++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3445554443333 2233456667787789999886655 577888755321 234556677776664222 33443
Q ss_pred cee------eeCCcceEEEecCCCCCHhh-----------hh---hcC-CC------C---CCCHHHHH-----------
Q 018244 120 GCC------CEGDERLLVAEYMPNDTLAK-----------HL---FHW-ET------Q---PMKWAMRL----------- 158 (359)
Q Consensus 120 ~~~------~~~~~~~lv~e~~~~gsL~~-----------~l---~~~-~~------~---~l~~~~~~----------- 158 (359)
... ...+..+++++|++|..+.. .+ +.. .. . .-.|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 321 12345689999998854321 01 100 00 0 01111110
Q ss_pred -HHHHHHHHHHHHhhc------CCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 159 -RVALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 159 -~i~~qi~~~L~~LH~------~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
.....+...++++.. ..+++|+|+++.||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334455532 2489999999999999988777899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00026 Score=63.90 Aligned_cols=139 Identities=14% Similarity=0.166 Sum_probs=82.3
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--cccccce------eeeCCcceEEEe
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGC------CCEGDERLLVAE 133 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 133 (359)
++.+..|....+|+....++ .+++|+.... .......|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45667788789999886555 6888987652 2345667788777774332 3444331 122345689999
Q ss_pred cCCCCCHhh----hh----------hcC----CC-----CCCCHHHHH----------HHHHHHHHHHHHhhc------C
Q 018244 134 YMPNDTLAK----HL----------FHW----ET-----QPMKWAMRL----------RVALHIAEALEYCTS------K 174 (359)
Q Consensus 134 ~~~~gsL~~----~l----------~~~----~~-----~~l~~~~~~----------~i~~qi~~~L~~LH~------~ 174 (359)
|++|..+.. .. +.. .. ....|.... .....+..++.++.. .
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865432 00 000 00 011111110 011112333444442 1
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0011 Score=61.99 Aligned_cols=76 Identities=16% Similarity=0.158 Sum_probs=53.5
Q ss_pred ccccCCCCCCcEEEEEEeCCC-cEEEEEEeCCC------CC-chHHHHHHHHHHHhcCC-C--cccccccceeeeCCcce
Q 018244 61 IVSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRS------AW-PDARQFLEEARAVGQLR-N--RRLANLLGCCCEGDERL 129 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~~-~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~ 129 (359)
..+.+|.|.++.||++...+| +.+.||.-... .+ -..+....|.+.|..+. + .++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 345779999999999998776 48999985421 11 13456677888888863 2 346666655 446688
Q ss_pred EEEecCCCC
Q 018244 130 LVAEYMPND 138 (359)
Q Consensus 130 lv~e~~~~g 138 (359)
+||||+++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999999764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00096 Score=60.92 Aligned_cols=159 Identities=13% Similarity=0.092 Sum_probs=83.8
Q ss_pred ccCHHHHHHHhcCCCc--ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--cccc
Q 018244 43 EYSIETLRTATSGFAM--ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANL 118 (359)
Q Consensus 43 ~~~~~~~~~~~~~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~ 118 (359)
..+.+++...-..|.. -.-++.++.|....+|.....+| .+++|++.... .+.+..|+.++..|...+ +.+.
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcc
Confidence 3455555544444432 12234556777789999987666 68889876212 233444555555553222 2233
Q ss_pred cc------eeeeCCcceEEEecCCCCCHh-----------hhhh---cC-CC--------CCCCH-HHHHH---------
Q 018244 119 LG------CCCEGDERLLVAEYMPNDTLA-----------KHLF---HW-ET--------QPMKW-AMRLR--------- 159 (359)
Q Consensus 119 ~~------~~~~~~~~~lv~e~~~~gsL~-----------~~l~---~~-~~--------~~l~~-~~~~~--------- 159 (359)
+. +....+..+++++|++|..+. ..+. .. .. ..+.| .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 22 112245578999999886431 1111 00 00 01111 11110
Q ss_pred ---HHHH-HHHHHHHhhc------CCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 160 ---VALH-IAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 160 ---i~~q-i~~~L~~LH~------~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
.+.+ +...+..+.. ..+++|+|++|.||+++++...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 1111222221 13799999999999999765568999998653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=59.12 Aligned_cols=31 Identities=23% Similarity=0.213 Sum_probs=25.8
Q ss_pred CcccccCCCCCeeeCCCCC-eEEeccCCcccC
Q 018244 176 RALYHDLNAYRIVFDDDVN-PRLSCFGLMKNS 206 (359)
Q Consensus 176 ~ivH~Dikp~NIll~~~~~-~kl~DFg~a~~~ 206 (359)
.++|+|++|.||++++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5799999999999997555 469999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00017 Score=64.20 Aligned_cols=147 Identities=14% Similarity=0.077 Sum_probs=100.2
Q ss_pred cCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--------------------h--HHHHH
Q 018244 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------------------D--ARQFL 101 (359)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~--~~~~~ 101 (359)
+.+-.|.+..+.-.-+.+-.+||-|--+.||.+...+|...++|.-...... - .-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 4455666666665566777788999999999999988999999964321100 0 11245
Q ss_pred HHHHHHhcCCC-c-ccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccc
Q 018244 102 EEARAVGQLRN-R-RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179 (359)
Q Consensus 102 ~e~~~l~~l~h-~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH 179 (359)
+|+..|+.|.. - -+.+.+++. .-++|||++.+-.|...-. ..+..++.. .+..-+--|-.+ |+||
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~---~lm~~Iv~la~~-GlIH 225 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH-----VEDPPTLYD---DLMGLIVRLANH-GLIH 225 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee-----cCChHHHHH---HHHHHHHHHHHc-Ccee
Confidence 68888888853 2 344555544 5689999998877765431 223333333 333333445566 9999
Q ss_pred ccCCCCCeeeCCCCCeEEeccCCc
Q 018244 180 HDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 180 ~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+|..-=||++++++.++++||-..
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred cccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0015 Score=59.23 Aligned_cols=146 Identities=15% Similarity=0.140 Sum_probs=101.9
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--c--------------------hHH----HHHHHHHHH
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--P--------------------DAR----QFLEEARAV 107 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~--------------------~~~----~~~~e~~~l 107 (359)
+.-..-++-+.|..|--+-||.|+..+|..+|||+++-+-. . ..+ -...|++.|
T Consensus 141 ~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 141 NRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred hcCeeeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence 33344456667788888899999988999999998752100 0 011 135688888
Q ss_pred hcCCCcccccccceeeeCCcceEEEecCCCCCHh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA-KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 108 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
++|....|.-.--.... .-.|||+++...... -.| +.-.++...+..+-.|++.-+.-|-+..++||.||.-=|
T Consensus 221 kRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 221 KRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred HHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 88876665443333322 347899998543221 122 445677778888889999988888776699999999999
Q ss_pred eeeCCCCCeEEeccCCccc
Q 018244 187 IVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~ 205 (359)
+|+- +|.+.++|-+.+-.
T Consensus 296 ~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred heEE-CCEEEEEEcccccc
Confidence 9987 67899999886543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00085 Score=60.75 Aligned_cols=73 Identities=22% Similarity=0.292 Sum_probs=46.9
Q ss_pred cCCCCCCcEEEEEEeCC-------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecC
Q 018244 64 EHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 135 (359)
.+..|-...+|+....+ +..+++|+..... .......+|.+++..+...++ .++++++. -.+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence 34567777899998654 4789999976543 222345678888888853333 34444442 23689999
Q ss_pred CCCCHh
Q 018244 136 PNDTLA 141 (359)
Q Consensus 136 ~~gsL~ 141 (359)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0052 Score=55.50 Aligned_cols=152 Identities=13% Similarity=0.086 Sum_probs=84.8
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCC--CCCchHHHHHHHHHHHhcCCC--cccccccceeeeCC--cce
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNR--SAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGD--ERL 129 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~ 129 (359)
+....+++....|....+|..... ++.+++. ... ..........+|..+++.+.- --....+++|.++. ..|
T Consensus 24 ~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 24 YAGLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred cCCCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 344445555444444455555543 6678888 331 222334455677777777642 23445566666655 679
Q ss_pred EEEecCCCCCHhhhhhcC------------------------------CCCCCCHHHHHHHHHHH--------------H
Q 018244 130 LVAEYMPNDTLAKHLFHW------------------------------ETQPMKWAMRLRVALHI--------------A 165 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~------------------------------~~~~l~~~~~~~i~~qi--------------~ 165 (359)
.||+|++|..+.+.+... ........++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 999999884332222100 00000111111222222 1
Q ss_pred HHHHHhhcC-------CCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 166 EALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 166 ~~L~~LH~~-------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
.-..+++.+ ..++|+|+++.||+++..+-+-|.||+++...++.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 112233322 35899999999999998888999999998776544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0039 Score=57.17 Aligned_cols=72 Identities=14% Similarity=0.063 Sum_probs=46.9
Q ss_pred cCCCCCCcEEEEEEeCCC-cEEEEEEeCC------CC-CchHHHHHHHHHHHhcCC--Ccc-cccccceeeeCCcceEEE
Q 018244 64 EHGEKAPNVVYKGKLENQ-FRIAVKRFNR------SA-WPDARQFLEEARAVGQLR--NRR-LANLLGCCCEGDERLLVA 132 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~------~~-~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 132 (359)
++|.|....||++..++| +.|+||.-.. .+ .-..++..-|...|+... -|. +++++ +.+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 569999999999997654 5899997531 11 122445566778887763 343 33433 23456677999
Q ss_pred ecCCC
Q 018244 133 EYMPN 137 (359)
Q Consensus 133 e~~~~ 137 (359)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0067 Score=56.67 Aligned_cols=81 Identities=19% Similarity=0.147 Sum_probs=53.2
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCC------C-chHHHHHHHHHHHhcCC---CcccccccceeeeCCcceE
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA------W-PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 130 (359)
..+.+|.|....||+.... +..+.||+-.... + -...+...|...|+.+. ..++++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4567799999999998864 4468899865211 1 12334455677776663 247777887775 45788
Q ss_pred EEecCCC--CCHhhhh
Q 018244 131 VAEYMPN--DTLAKHL 144 (359)
Q Consensus 131 v~e~~~~--gsL~~~l 144 (359)
+|||+++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999976 2344444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0026 Score=58.73 Aligned_cols=139 Identities=14% Similarity=0.106 Sum_probs=80.3
Q ss_pred cccCCCCCCcEEEEEEeCC-----CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecC
Q 018244 62 VSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 135 (359)
+..+..|-...+|++...+ +..|.+|........... -.+|+.+++.+..-++ .++++.+.. ..|++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC----ceEEEee
Confidence 3445557788999987532 367899988765422222 2668888888854444 345555422 2589999
Q ss_pred CCCCHhhh-----------------hhcCC--C-C-CCCHHHHHHHHHHHH-----------------HHHHH----hhc
Q 018244 136 PNDTLAKH-----------------LFHWE--T-Q-PMKWAMRLRVALHIA-----------------EALEY----CTS 173 (359)
Q Consensus 136 ~~gsL~~~-----------------l~~~~--~-~-~l~~~~~~~i~~qi~-----------------~~L~~----LH~ 173 (359)
++.+|... ++... . . ...+..+..+..++. ..+.. +..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665421 00000 0 0 112333434432221 11111 121
Q ss_pred ---CCCcccccCCCCCeeeCC-CCCeEEeccCCccc
Q 018244 174 ---KERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (359)
Q Consensus 174 ---~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~ 205 (359)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 125799999999999986 47899999988653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=7.5e-05 Score=78.15 Aligned_cols=153 Identities=11% Similarity=-0.064 Sum_probs=112.0
Q ss_pred HHHHHHHHhcCCCcccccccceeee--CCcceEEEecCCCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcC-
Q 018244 100 FLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSK- 174 (359)
Q Consensus 100 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~- 174 (359)
...|...++...|+++.....-... ....+..++|+.+|.+.+.+.+.. ...+....+.....+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4456666667789988876654433 235788999999999999887532 22333333444334436777777754
Q ss_pred ---CCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc----CCCccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 018244 175 ---ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247 (359)
Q Consensus 175 ---~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~----~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 247 (359)
.-.+|+++|+-|.+|+.+.+++++++|+.+...+.... .+++-|++|++...-.++.++|+|..|+-+|++.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 23589999999999999999999999999955544433 44567888998887788888999999999999988
Q ss_pred CCCCC
Q 018244 248 GKHIP 252 (359)
Q Consensus 248 g~~p~ 252 (359)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0064 Score=55.24 Aligned_cols=29 Identities=14% Similarity=0.072 Sum_probs=25.4
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 37899999999999987 678999999754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0038 Score=55.89 Aligned_cols=74 Identities=18% Similarity=0.166 Sum_probs=46.7
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC---CcccccccceeeeCCcceEEEecCCC
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
.+..++.|....+|+.. .++..+-||.-... ....+..|..-|+.|. --.+++.+++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34455889999999988 56678999987732 2345677888777773 34577888888777788999999876
Q ss_pred C
Q 018244 138 D 138 (359)
Q Consensus 138 g 138 (359)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0029 Score=58.28 Aligned_cols=60 Identities=17% Similarity=0.077 Sum_probs=43.9
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~ 190 (359)
..|+-+|..|-++..++. ....++....+++.-.+.|+--+---.+.+|.|++|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~---~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK---WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhh---cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 456667888989998884 444556666777777777765443323789999999999995
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0031 Score=59.63 Aligned_cols=161 Identities=20% Similarity=0.247 Sum_probs=90.0
Q ss_pred hHHHHHHHHHHHhcCCCcccccccceeeeC-CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 018244 96 DARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK 174 (359)
Q Consensus 96 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 174 (359)
...++...++.++.+.|+|...++++.... ....+|+|++ +.||.+.+..+. +-.... + .+
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~----------~----~~ 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESL----------L----AH 86 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhh----------c----cc
Confidence 345677789999999999999998877553 3478899998 559999885322 211110 0 11
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~ 254 (359)
++.|- ||+ +.+| -++. .. | ....+++||||+|.++.++.-|...+..
T Consensus 87 -~~~~~-----~~~-------~~td-~~~t---~~-----------~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 87 -GVLHL-----NII-------YITD-HFLT---KY-----------P-----SPIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -cccee-----hhh-------hccc-cccc---cC-----------C-----CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 22222 222 2222 0000 00 0 1112499999999999999988854332
Q ss_pred chhHHHhhhhhhhhccccc------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 018244 255 HALDLIRDRNIQTLTDSCL------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307 (359)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il 307 (359)
................+.. ...+...+....+++...|+-..|..||...++.
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 2111111111000000000 0011234566788899999999999988655443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0045 Score=52.37 Aligned_cols=151 Identities=13% Similarity=0.062 Sum_probs=90.6
Q ss_pred CCCcEEEEEEeCCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhc
Q 018244 68 KAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (359)
Q Consensus 68 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (359)
++.++.-+++.+-| ...+|++...... ...-|.++.+++.++. .|+++..- ..-..-+|.|+|..-..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 45556666654445 3445555433322 3445677888888875 66776632 33346688898854211
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCccccCccccc
Q 018244 147 WETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR 225 (359)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~ 225 (359)
.. ..++..=+.+|.-.|+ +.+.+|+|..|+||+-|..|.+||.|=+.-- ..+..|.--|
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------~~~V~~vN~~--- 201 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------ENQVNMVNIE--- 201 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--------hheeeEEeee---
Confidence 11 1222223467778884 4589999999999999999999999966321 1111222211
Q ss_pred CCCCCCccchhhHHHHHHHHHhCC
Q 018244 226 TGRVTPESVMYSFGTLLLDLLSGK 249 (359)
Q Consensus 226 ~~~~~~~~Di~slG~il~elltg~ 249 (359)
....+.++.+-+|=..+++++...
T Consensus 202 Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 202 YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ccccChHHHHHHHHHHHHHHHHHH
Confidence 133466777777777777776544
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.013 Score=53.35 Aligned_cols=106 Identities=14% Similarity=0.046 Sum_probs=71.4
Q ss_pred CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
...|++|++- |+++. .+ ..-.+.++..++.+.+..++-+..+...-|||+.-.||||+ +|++-|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3567777764 33332 22 13468889999999998888888776789999999999999 99999999999985
Q ss_pred CCCCCCcCCCccccCcccccCCCCCCccchhhHHHH
Q 018244 206 SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTL 241 (359)
Q Consensus 206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 241 (359)
...... ......--|-.+. +.-+..-+||-+--.
T Consensus 371 ~~~q~~-isy~rldhp~lF~-G~dd~QFeIYrlMr~ 404 (488)
T COG5072 371 SYSQGI-ISYNRLDHPDLFN-GVDDYQFEIYRLMRR 404 (488)
T ss_pred ccCCce-eeccccCchhhhc-CccceeeeHHHHHHH
Confidence 443322 1112233344444 333556677764433
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.025 Score=51.60 Aligned_cols=139 Identities=17% Similarity=0.244 Sum_probs=81.8
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccc------c----cceeeeCCcceEE
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN------L----LGCCCEGDERLLV 131 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------~----~~~~~~~~~~~lv 131 (359)
...|.+ .-..||+....+|.. ++|+.... ....++..|+..|..|.-.+|.- . +.....+...+-+
T Consensus 31 ~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 31 LRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred cccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 334444 456799999877765 88888765 33456677888888774322211 1 1111112367788
Q ss_pred EecCCCCCHhh-hh------------------hcCC------CCCCCHHH-------------HHHHHHHHHHHHHHhhc
Q 018244 132 AEYMPNDTLAK-HL------------------FHWE------TQPMKWAM-------------RLRVALHIAEALEYCTS 173 (359)
Q Consensus 132 ~e~~~~gsL~~-~l------------------~~~~------~~~l~~~~-------------~~~i~~qi~~~L~~LH~ 173 (359)
++|++|..+.. .- +... .....|.. -.....++...+..+..
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999877762 11 0000 01223320 01123334444444433
Q ss_pred C------C-C--cccccCCCCCeeeCCCCC-eEEeccCCcc
Q 018244 174 K------E-R--ALYHDLNAYRIVFDDDVN-PRLSCFGLMK 204 (359)
Q Consensus 174 ~------~-~--ivH~Dikp~NIll~~~~~-~kl~DFg~a~ 204 (359)
. . + +||+|+.|.||+++.+.. ..++||+.+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 2 3 899999999999998875 9999999764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.015 Score=54.02 Aligned_cols=74 Identities=14% Similarity=0.096 Sum_probs=48.8
Q ss_pred cccCCCCCCcEEEEEEeCC-CcEEEEEEeCC-----CC-CchHHHHHHHHHHHhcCC--Ccc-cccccceeeeCCcceEE
Q 018244 62 VSEHGEKAPNVVYKGKLEN-QFRIAVKRFNR-----SA-WPDARQFLEEARAVGQLR--NRR-LANLLGCCCEGDERLLV 131 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-----~~-~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv 131 (359)
+..||.|.-..||++...+ +..|+||.-.. .+ .-..++..-|.++|+... .|. +++++. .+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 6678999999999999743 56899997532 11 122456667888888763 343 444443 345567788
Q ss_pred EecCCC
Q 018244 132 AEYMPN 137 (359)
Q Consensus 132 ~e~~~~ 137 (359)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.016 Score=53.13 Aligned_cols=138 Identities=17% Similarity=0.179 Sum_probs=77.2
Q ss_pred ccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecCCC
Q 018244 63 SEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 137 (359)
+.+..|-...+|+....+ +..|.+|+....... .-.-.+|..+++.+..-++ .++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~---G-~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN---G-MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC---c-EeehhhcC
Confidence 334456667899887533 237889987654322 1123568888888865444 345555422 1 58999877
Q ss_pred CCHhhh--------------hh---cCC---CC-CCCHHHHHHHHHHH-------------------------HHHHHHh
Q 018244 138 DTLAKH--------------LF---HWE---TQ-PMKWAMRLRVALHI-------------------------AEALEYC 171 (359)
Q Consensus 138 gsL~~~--------------l~---~~~---~~-~l~~~~~~~i~~qi-------------------------~~~L~~L 171 (359)
.+|... +. ... .. .--+..+..+..++ +..+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 654221 10 000 00 11233333333222 1111112
Q ss_pred h-cC---CCcccccCCCCCeeeCC-CCCeEEeccCCccc
Q 018244 172 T-SK---ERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (359)
Q Consensus 172 H-~~---~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~ 205 (359)
. .. .-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 13699999999999974 57899999998754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.021 Score=51.94 Aligned_cols=31 Identities=10% Similarity=0.076 Sum_probs=27.9
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
.+++|+|+.++|||+++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.076 Score=48.65 Aligned_cols=70 Identities=20% Similarity=0.108 Sum_probs=43.6
Q ss_pred CCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--ccccc---c--eeeeCCcceEEEecCCCCC
Q 018244 69 APNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLL---G--CCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 69 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~gs 139 (359)
.-..||+....++..+++|+..... .....+..|++.+..|.... ++... | ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3467999998778889999876433 23456677888777763221 22211 1 1222456778899987753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.13 Score=54.53 Aligned_cols=149 Identities=17% Similarity=0.225 Sum_probs=81.7
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-------Cccccccc-cee---
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-------NRRLANLL-GCC--- 122 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~~~-~~~--- 122 (359)
..|.....+..|+. ..-.+|+....+|..+++|+..... .......|.++|..|. -|.++.-. |-.
T Consensus 22 ~~ygl~~~~~~L~s-~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~ 98 (1013)
T PRK06148 22 QHFGISATATPLDG-ERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS 98 (1013)
T ss_pred HHcCCceEEeecCC-cCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence 33433334456654 4688999988788889999998643 2233444555665442 23333321 111
Q ss_pred -ee-CC--cceEEEecCCCCCHhhhhh---------------------cCC----CCCCCHHH-----------------
Q 018244 123 -CE-GD--ERLLVAEYMPNDTLAKHLF---------------------HWE----TQPMKWAM----------------- 156 (359)
Q Consensus 123 -~~-~~--~~~lv~e~~~~gsL~~~l~---------------------~~~----~~~l~~~~----------------- 156 (359)
.. .+ ..+-+++|++|..+.+... ... ...+.|..
T Consensus 99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~ 178 (1013)
T PRK06148 99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE 178 (1013)
T ss_pred eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence 11 11 3567899999877654110 000 11122221
Q ss_pred HHHHHHHHHHHHH-----HhhcC-CCcccccCCCCCeeeCCCC--CeE-EeccCCccc
Q 018244 157 RLRVALHIAEALE-----YCTSK-ERALYHDLNAYRIVFDDDV--NPR-LSCFGLMKN 205 (359)
Q Consensus 157 ~~~i~~qi~~~L~-----~LH~~-~~ivH~Dikp~NIll~~~~--~~k-l~DFg~a~~ 205 (359)
...++.+++..+. .+... .++||.|+++.|||++.++ .+. |+|||.+..
T Consensus 179 ~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 179 DRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1222233333222 12111 3799999999999999775 555 999998654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.11 Score=44.56 Aligned_cols=73 Identities=21% Similarity=0.236 Sum_probs=48.6
Q ss_pred CCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC---CcccccccceeeeCCcceEEEecCCCCCHh
Q 018244 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (359)
Q Consensus 65 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (359)
+.-|..-..|.... +...+-||+-... ....|..|+.-|..|. .-++.+++.+....++.|+|+||++.+.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34454444455443 3456888876543 2456777887777774 345777788888889999999999875444
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.11 Score=48.57 Aligned_cols=76 Identities=12% Similarity=0.180 Sum_probs=44.8
Q ss_pred ccccCCCCCCcEEEEEEeCCC--c-----EEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEE
Q 018244 61 IVSEHGEKAPNVVYKGKLENQ--F-----RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVA 132 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 132 (359)
.++.+..|-.+.+|++...++ . .|.++...... ...-.-.+|+++++.+...++ .++++.+. -++|.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEE
Confidence 344555687889999975432 1 24444332211 111123568899999865544 44555553 36999
Q ss_pred ecCCCCCHh
Q 018244 133 EYMPNDTLA 141 (359)
Q Consensus 133 e~~~~gsL~ 141 (359)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987654
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.033 Score=50.12 Aligned_cols=40 Identities=20% Similarity=0.014 Sum_probs=29.5
Q ss_pred CHHHHHHHHHHHHHHHHHhhcC---CCcccccCCCCCeeeCCC
Q 018244 153 KWAMRLRVALHIAEALEYCTSK---ERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 153 ~~~~~~~i~~qi~~~L~~LH~~---~~ivH~Dikp~NIll~~~ 192 (359)
-.+-+..++.||+.-.-.+-.. .+.+|-||||+|||+-+.
T Consensus 277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 3466788999998766444332 367999999999999544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 359 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 359 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-61 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-60 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-59 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-26 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-25 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-23 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-21 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-20 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-20 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-19 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-18 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-18 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 6e-18 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-17 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-17 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-17 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-17 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-17 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-16 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-16 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 9e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-14 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-14 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-14 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-14 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-13 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-13 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-13 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-12 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-12 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-12 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-12 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-11 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-11 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-10 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-10 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-10 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-09 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-08 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-08 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-08 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-07 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-07 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-06 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-06 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-06 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-06 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-06 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 9e-06 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-05 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-05 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-05 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-05 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-05 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-05 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-05 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-05 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-05 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-05 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-04 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-04 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-04 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-04 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-04 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-04 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-04 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-04 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 5e-04 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-04 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-04 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-04 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-61
Identities = 87/310 (28%), Positives = 141/310 (45%), Gaps = 31/310 (10%)
Query: 26 DVENEEKPGVD--NVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFR 83
DV EE P V + F S+ L+ A+ F+ +NI+ G VYKG+L +
Sbjct: 3 DVPAEEDPEVHLGQLKRF---SLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGTL 56
Query: 84 IAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVKR QF E + +R L L G C ERLLV YM N ++A
Sbjct: 57 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116
Query: 143 HLF--HWETQPMKWAMRLRVALHIAEALEY--CTSKERALYHDLNAYRIVFDDDVNPRLS 198
L P+ W R R+AL A L Y + ++ D+ A I+ D++ +
Sbjct: 117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176
Query: 199 CFGLMKNSRDGRSY-STNLAFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK---- 249
FGL K ++ +T + T PEYL TG+ + ++ ++ +G +LL+L++G+
Sbjct: 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 250 -HIPP--------SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
L++++ ++ L D L+G + +E +L+++A C Q P ER
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296
Query: 301 PNPRSLVTAL 310
P +V L
Sbjct: 297 PKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-60
Identities = 81/318 (25%), Positives = 140/318 (44%), Gaps = 44/318 (13%)
Query: 28 ENEEKPGVD-NVPVFCEYSIETLRTATSGFAMENIVSEH---GEKAPNVVYKGKLENQFR 83
EN+ D F S L+ T+ F I GE VVYKG + N
Sbjct: 1 ENKSLEVSDTRFHSF---SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-T 56
Query: 84 IAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
+AVK+ +QF +E + + + ++ L LLG +GD+ LV YMPN +
Sbjct: 57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116
Query: 140 LAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR------IVFDDD 192
L L + T P+ W MR ++A A + + L+ + + +R I+ D+
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINF-------LHENHHIHRDIKSANILLDEA 169
Query: 193 VNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FGL + + + ++ ++ + T PE L G +TP+S +YSFG +LL+++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 247 SGK-----HIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+G H P LD ++ I+ D + S + +AS+CL +
Sbjct: 229 TGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK 287
Query: 297 PRERPNPRSLVTALVTLQ 314
+RP+ + + L +
Sbjct: 288 KNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-59
Identities = 78/317 (24%), Positives = 140/317 (44%), Gaps = 28/317 (8%)
Query: 14 GSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVV 73
GS+Y +A D + + L AT+ F + ++ G V
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRV---PLVDLEEATNNFDHKFLI---GHGVFGKV 55
Query: 74 YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
YKG L + ++A+KR + +F E + R+ L +L+G C E +E +L+ +
Sbjct: 56 YKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 134 YMPNDTLAKHLF--HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
YM N L +HL+ T M W RL + + A L Y RA+ H D+ + I+ D
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL--HTRAIIHRDVKSINILLD 173
Query: 191 DDVNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLD 244
++ P+++ FG+ K + +++ ST + T PEY GR+T +S +YSFG +L +
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 245 LLSGK----HIPPSH-------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
+L + P A++ + ++ + D L + + + A +CL
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 294 QYEPRERPNPRSLVTAL 310
+RP+ ++ L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 48/262 (18%), Positives = 95/262 (36%), Gaps = 34/262 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
++KG+ + I VK W R F EE + + + +LG C
Sbjct: 25 ELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 130 L--VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+ +MP +L L + + ++ AL +A + + + E + LN+
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSY-STNLAFTP----PEYLRTGRVTPESV---MYSF 238
++ D+D+ R+S + S+ S + P PE L+ M+SF
Sbjct: 144 VMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 239 GTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCL 293
LL +L++ + + + ++ T+ + +L C+
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP---------HVSKLMKICM 248
Query: 294 QYEPRERPNPRSLVTALVTLQK 315
+P +RP +V L +Q
Sbjct: 249 NEDPAKRPKFDMIVPILEKMQD 270
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 49/322 (15%), Positives = 105/322 (32%), Gaps = 57/322 (17%)
Query: 43 EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
+ E L + + + + G V+K +L N+ +AVK F D + +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGC-----VWKAQLLNE-YVAVKIFPIQ---DKQSW 63
Query: 101 LEEA--RAVGQLRNRRLANLLGCCCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKW 154
E ++ +++ + +G G + L+ + +L+ L + W
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSW 120
Query: 155 AMRLRVALHIAEALEY--------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN 205
+A +A L Y + A+ H D+ + ++ +++ ++ FGL
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 206 SRDGRSYSTNLAFT------PPEYLRTGRVTPESV-----MYSFGTLLLDLLSGK----- 249
G+S PE L MY+ G +L +L S
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 250 -----------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT-ELVRLASRCLQYEP 297
I +L+ +++ + L + G L C ++
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 298 RERPNPRSLVTALVTLQKDTEV 319
R + + + +Q+ T +
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 50/258 (19%), Positives = 106/258 (41%), Gaps = 23/258 (8%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V++ + +AVK + +FL E + +LR+ + +G +
Sbjct: 52 TVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 130 LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
+V EY+ +L + L + + RL +A +A+ + Y ++ + H +L + +
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
+ D ++ FGL + S + A TP PE LR +S +YSFG +L
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 244 DLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+L + + ++ P+ + + + + + + ++ + C EP
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---------QVAAIIEGCWTNEPW 281
Query: 299 ERPNPRSLVTALVTLQKD 316
+RP+ +++ L L K
Sbjct: 282 KRPSFATIMDLLRPLIKS 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 38/266 (14%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
VYKGK +AVK N +A + F E + + R+ + +G +L
Sbjct: 40 VYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 95
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
+V ++ +L HL H + + +A A ++Y +K + H DL + I
Sbjct: 96 IVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF 152
Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESV---MYSFG 239
+D ++ FGL K+ G L+ + PE +R P S +Y+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 240 TLLLDLLSGK-----HIPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+L +L++G+ ++++ ++ + +C + + RL +
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK---------RMKRLMA 263
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKD 316
CL+ + ERP+ ++ + L ++
Sbjct: 264 ECLKKKRDERPSFPRILAEIEELARE 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 48/259 (18%), Positives = 102/259 (39%), Gaps = 31/259 (11%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV K K + +A+K+ + + F+ E R + ++ + + L G C + LV
Sbjct: 23 VVCKAKWRAK-DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77
Query: 132 AEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAYRIV 188
EY +L L E P A + L ++ + Y + + +AL H DL ++
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 189 FDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
++ FG + D +++ TN + PE + + ++S+G +L
Sbjct: 138 LVAGGTVLKICDFGT---ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 244 DLLSGK------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
++++ + P + + + L + + + L +RC +P
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK---------PIESLMTRCWSKDP 245
Query: 298 RERPNPRSLVTALVTLQKD 316
+RP+ +V + L +
Sbjct: 246 SQRPSMEEIVKIMTHLMRY 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/266 (19%), Positives = 95/266 (35%), Gaps = 40/266 (15%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY+ +AVK D +EA+ L++ + L G C +
Sbjct: 22 KVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAY 185
LV E+ L + L + + + + A+ IA + Y + H DL +
Sbjct: 81 LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 186 RIVFDDDVNPRLSC--------FGLMKNSRD-GRSYSTNLAFTP----PEYLRTGRVTPE 232
I+ V FGL +R+ R+ + A PE +R +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194
Query: 233 SVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVR 287
S ++S+G LL +LL+G+ I + + + +C E +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAK 245
Query: 288 LASRCLQYEPRERPNPRSLVTALVTL 313
L C +P RP+ +++ L T+
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 55/266 (20%), Positives = 106/266 (39%), Gaps = 42/266 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA-------RQFLEEARAVGQLRNRRLANLLGCCC 123
+V+KG+ ++++ +A+K ++F E + L + + L G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93
Query: 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL 182
+V E++P L L + P+KW+++LR+ L IA +EY ++ + H DL
Sbjct: 94 NPP--RMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 183 NAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTNLAFTP----PEYL--RTGRVTP 231
+ I C FGL S+ + L PE + T
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGL---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 232 ESVMYSFGTLLLDLLSGK----HIPPSHA--LDLIRDRNIQ-TLTDSCLEGQFSSDEGTE 284
++ YSF +L +L+G+ +++IR+ ++ T+ + C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------R 258
Query: 285 LVRLASRCLQYEPRERPNPRSLVTAL 310
L + C +P++RP+ +V L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 56/332 (16%), Positives = 105/332 (31%), Gaps = 68/332 (20%)
Query: 43 EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
E + + ++ +G VYKG L+ + +AVK F+ + + + F
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGA-----VYKGSLDERP-VAVKVFS---FANRQNF 52
Query: 101 LEEAR--AVGQLRNRRLANLLGCCCEGD-----ERLLVAEYMPNDTLAKHLFHWETQPMK 153
+ E V + + +A + E LLV EY PN +L K+L
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109
Query: 154 WAMRLRVALHIAEALEY-------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGL--- 202
W R+A + L Y + A+ H DLN+ ++ +D +S FGL
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 203 -----MKNSRDGRSYSTNLAFTP----PEYLR-------TGRVTPESVMYSFGTLLLDLL 246
+ + + + + T PE L + MY+ G + ++
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 247 SGK------HIPPSHAL----DLIRDRNIQTLTDS-CLEGQ-------FSSDEGT--ELV 286
P + + ++ + + E Q + + L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
C + R + + L E
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 58/261 (22%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 72 VVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
+ E+M L +L Q + + L +A I+ A+EY K H DL A +
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + + A +T PE L + + +S +++FG LL +
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+ + P S +L+ + C E ++ L C Q+ P +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSD 255
Query: 300 RPNPRSLVTALVTLQKDTEVS 320
RP+ + A T+ +++ +S
Sbjct: 256 RPSFAEIHQAFETMFQESSIS 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 45/269 (16%), Positives = 87/269 (32%), Gaps = 39/269 (14%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY G+ + +A++ + + + F E A Q R+ + +G C
Sbjct: 48 QVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
++ TL + + ++A I + + Y +K + H DL + +
Sbjct: 106 IITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVF 162
Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP-------PEYLRTGRVTPESVM---- 235
+D+ ++ FGL + L PE +R E
Sbjct: 163 YDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 236 -----YSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286
++ GT+ +L + + P + + L+ G E+
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------IGMGKEIS 273
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQK 315
+ C +E ERP L+ L L K
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 48/272 (17%), Positives = 91/272 (33%), Gaps = 38/272 (13%)
Query: 73 VYKGKLENQFR-IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
K + +K R R FL+E + + L + + +G + +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EY+ TL + W+ R+ A IA + Y S + H DLN++ +
Sbjct: 86 TEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR 142
Query: 191 DDVNPRLSCFGL--------------MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPE 232
++ N ++ FGL + R + P PE + +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 233 SVMYSFGTLLLDLLSGKHIPP-----SHALDLIRDRNI-QTLTDSCLEGQFSSDEGTELV 286
++SFG +L +++ + P + L + + +C
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP---------SFF 253
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ RC +P +RP+ L L TL+
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 57/260 (21%), Positives = 110/260 (42%), Gaps = 24/260 (9%)
Query: 73 VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY+G + +AVK + +FL+EA + ++++ L LLG C ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
E+M L +L Q + + L +A I+ A+EY K H +L A +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG 352
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
++ +++ FGL + + A +T PE L + + +S +++FG LL ++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+ P S +L+ + C E ++ L C Q+ P +R
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSDR 463
Query: 301 PNPRSLVTALVTLQKDTEVS 320
P+ + A T+ +++ +S
Sbjct: 464 PSFAEIHQAFETMFQESSIS 483
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 64/259 (24%), Positives = 101/259 (38%), Gaps = 24/259 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y H DL A I+ +
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 315
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE GR T +S ++SFG LL +L
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ +P LD + C E L L +C + EP ERP
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 426
Query: 302 NPRSLVTALVTLQKDTEVS 320
L L TE
Sbjct: 427 TFEYLQAFLEDYFTSTEPQ 445
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 26/258 (10%)
Query: 73 VYKGKLENQ-FRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ G+L +AVK + PD + FL+EAR + Q + + L+G C + +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
V E + L E ++ L++ A +EY SK H DL A +
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF------TPPEYLRTGRVTPESVMYSFGTLLL 243
+ ++S FG+ + DG ++ T PE L GR + ES ++SFG LL
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 244 DLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+ S P + + + C + + RL +C YEP
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD---------AVFRLMEQCWAYEPG 357
Query: 299 ERPNPRSLVTALVTLQKD 316
+RP+ ++ L +++K
Sbjct: 358 QRPSFSTIYQELQSIRKR 375
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 28/250 (11%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
V G ++AVK A A+ FL EA + QLR+ L LLG E L +
Sbjct: 36 DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
V EYM +L +L + L+ +L + EA+EY H DL A ++
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDL 245
+D ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 151 SEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 246 LS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S G+ IP + + D C + + C + R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMR 258
Query: 301 PNPRSLVTAL 310
P+ L L
Sbjct: 259 PSFLQLREQL 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 28/255 (10%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LV 131
V G ++AVK A A+ FL EA + QLR+ L LLG E L +V
Sbjct: 209 VMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EYM +L +L + L+ +L + EA+EY H DL A ++
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS 323
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+D ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 324 EDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
S G+ IP + + D C + + C + RP
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATRP 431
Query: 302 NPRSLVTALVTLQKD 316
L L ++
Sbjct: 432 TFLQLREQLEHIRTH 446
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 64/259 (24%), Positives = 101/259 (38%), Gaps = 24/259 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y H DL A I+ +
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 398
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE GR T +S ++SFG LL +L
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ +P LD + C E L L +C + EP ERP
Sbjct: 459 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 509
Query: 302 NPRSLVTALVTLQKDTEVS 320
L L TE
Sbjct: 510 TFEYLQAFLEDYFTSTEPQ 528
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 38/264 (14%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ ++AVK + FL EA + L++ +L L + + ++
Sbjct: 204 VWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
E+M +L L E + + IAE + + + H DL A I+
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA 319
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ +++ FGL + D + A +T PE + G T +S ++SFG LL++++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 247 SGKHIP-PSHALDLIRDRNIQTLT-----------DSCLEGQFSSDEGTELVRLASRCLQ 294
+ IP P + N + + ++C E EL + RC +
Sbjct: 380 TYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWK 423
Query: 295 YEPRERPNPRSLVTALVTLQKDTE 318
P ERP + + L TE
Sbjct: 424 NRPEERPTFEYIQSVLDDFYTATE 447
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 50/256 (19%), Positives = 109/256 (42%), Gaps = 24/256 (9%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK + Q+ +AVK + +F +EA+ + +L + +L G C + +V
Sbjct: 23 VVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EY+ N L +L + ++ + L + + E + + S + H DL A + D
Sbjct: 82 TEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
D+ ++S FG+ + D + S+ ++ PE + + +S +++FG L+ ++
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S +P S + + + + + ++ C P +R
Sbjct: 199 FSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD---------TIYQIMYSCWHELPEKR 249
Query: 301 PNPRSLVTALVTLQKD 316
P + L++++ L++
Sbjct: 250 PTFQQLLSSIEPLREK 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 37/279 (13%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
++KG ++ + +K +++ + F E A + +L ++ L G C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
GDE +LV E++ +L +L + +L VA +A A+ + L H ++
Sbjct: 84 GDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVC 140
Query: 184 AYRI-VFDDDVNPR-------LSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESV 234
A I + ++ LS G+ + + PPE + + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATD 200
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
+SFGT L ++ SG P L DR Q + + EL L
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-----------HQLPAPKAAELANLI 249
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQF 328
+ C+ YEP RP+ R+++ L +L V
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHH 288
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 24/257 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G ++AVK + + FL EA + QL+++RL L + + ++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM N +L L + L +A IAE + + + H DL A I+ D
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD 144
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ IP + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 302 NPRSLVTALVTLQKDTE 318
L + L TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 32/259 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
+V+ G N+ ++A+K A F+EEA + +L + +L L G C E LV
Sbjct: 23 LVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
E+M + L+ +L + L + L + E + Y + H DL A +
Sbjct: 82 TEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC--VIHRDLAARNCL-- 136
Query: 191 DDVNPRLSC----FGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
V FG+ + D + S+ + PE R + +S ++SFG L
Sbjct: 137 --VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194
Query: 242 LLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++ S IP S ++ I + ++ + C +
Sbjct: 195 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST---------HVYQIMNHCWRER 245
Query: 297 PRERPNPRSLVTALVTLQK 315
P +RP L+ L + +
Sbjct: 246 PEDRPAFSRLLRQLAEIAE 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + +F+EEA+ + L + +L L G C + ++
Sbjct: 39 VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EYM N L +L + + L + + EA+EY SK+ H DL A + +
Sbjct: 98 TEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
D ++S FGL + D S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 246 LSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S +P S + I E ++ + C + ER
Sbjct: 215 YSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE---------KVYTIMYSCWHEKADER 265
Query: 301 PNPRSLVTALVTL 313
P + L++ ++ +
Sbjct: 266 PTFKILLSNILDV 278
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V++G +A+K R+ FL+EA + Q + + L+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENP 464
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
++ E L L + + A + A ++ AL Y SK H D+ A
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
++ + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 632
Query: 297 PRERPNPRSLVTALVTLQKDTEV 319
P RP L L T+ ++ ++
Sbjct: 633 PSRRPRFTELKAQLSTILEEEKL 655
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 32/266 (12%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G+ +N+ + A+K +R + FL E + L + + L+G +
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 128 RLL-VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ YM + L + + + P + + L +A +EY ++ H DL A
Sbjct: 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYLAEQK--FVHRDLAAR 153
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------TPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D YS T E L+T R T +S ++S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 238 FGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
FG LL +LL+ G HI P + + C + L ++ +C
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---------SLYQVMQQC 264
Query: 293 LQYEPRERPNPRSLVTALVTLQKDTE 318
+ +P RP R LV + +
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 51/263 (19%), Positives = 96/263 (36%), Gaps = 29/263 (11%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V++G +A+K R+ FL+EA + Q + + L+G +
Sbjct: 30 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITEN 88
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++ E L L + ++ + A ++ AL Y SK H D+ A
Sbjct: 89 PVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAYLESKR--FVHRDIAAR 145
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
++ + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ ++L P + + I + + +C L L ++C Y
Sbjct: 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAY 256
Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
+P RP L L T+ ++ +
Sbjct: 257 DPSRRPRFTELKAQLSTILEEEK 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 38/261 (14%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G L + AVK NR FL E + + + +LLG C +
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
L+V YM + L + + P + + L +A+ ++Y SK+ H DL A
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYLASKK--FVHRDLAAR 157
Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
+ D+ +++ FGL +RD ++ A E L+T + T +S
Sbjct: 158 NCMLDEKFTVKVADFGL---ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSD 214
Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG LL +L++ G + + + C + L +
Sbjct: 215 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 265
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C + RP+ LV+ +
Sbjct: 266 LKCWHPKAEMRPSFSELVSRI 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 57/282 (20%), Positives = 110/282 (39%), Gaps = 38/282 (13%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G + R+A+K N +A R FL EA + + + LLG +G
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100
Query: 126 DERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
L++ E M L +L + P + +++A IA+ + Y + +
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158
Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVT 230
H DL A + +D ++ FG+ ++ + Y PE L+ G T
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 231 PESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
S ++SFG +L ++ + + + L + + + D+C + L
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 269
Query: 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCFLFSSQ 327
L C QY P+ RP+ +++++ + + S+
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 52/278 (18%), Positives = 100/278 (35%), Gaps = 45/278 (16%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + +L + ++AVK D +FL EA + + + +A L+G
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 127 ER------LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
+ +++ +M + L + +R + IA +EY +S+
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157
Query: 177 ALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
H DL A + +D+ ++ FGL SR Y E L
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGL---SRKIYSGDYYRQGCASKLPVKWLALESLAD 213
Query: 227 GRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
T S +++FG + ++++ G+ I + + + N C+E
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME------- 266
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
E+ L +C +P++RP+ L L + V
Sbjct: 267 --EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 59/270 (21%), Positives = 103/270 (38%), Gaps = 39/270 (14%)
Query: 73 VYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKG L + + +A+K R FL EA +GQ + + L G +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+++ EYM N L K L + + + + + IA ++Y + H DL A
Sbjct: 120 PMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYLANM--NYVHRDLAAR 176
Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
I+ VN L C FGL +++ + ++ T PE + + T S
Sbjct: 177 NIL----VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 232
Query: 235 MYSFGTLLLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG ++ ++++ P + I D C + +L
Sbjct: 233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS---------AIYQLM 283
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+C Q E RP +V+ L L + +
Sbjct: 284 MQCWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 55/269 (20%), Positives = 96/269 (35%), Gaps = 38/269 (14%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V G+L + +A+K R FL EA +GQ + + L G G
Sbjct: 64 EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++V EYM N +L L + Q + + + + Y + H DL A
Sbjct: 124 LAMIVTEYMENGSLDTFLRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAAR 180
Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
++ V+ L C FGL +++ D +T T PE + + S
Sbjct: 181 NVL----VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236
Query: 235 MYSFGTLLLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG ++ ++L+ P + + + C L +L
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH---------ALHQLM 287
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
C + +RP +V+ L L + E
Sbjct: 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 40/269 (14%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V G+L + + +A+K R+ FL EA +GQ + + L G +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY-H-DLNAY 185
++V EYM N +L L + Q + + IA ++Y + Y H DL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQF-TVIQLVGMLRGIASGMKYLSDMG---YVHRDLAAR 176
Query: 186 RIVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESV 234
I+ +N L C FGL + D + T PE + + T S
Sbjct: 177 NIL----INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++S+G +L +++S P + + + C L +L
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA---------ALYQLM 283
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
C Q + RP +V+ L L ++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPG 312
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 59/278 (21%), Positives = 98/278 (35%), Gaps = 46/278 (16%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G++ ++AVK FL EA + + ++ + +G +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 126 DERLLVAEYMPNDTLAKHL---FHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH 180
R ++ E M L L +QP AM L VA IA +Y H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 204
Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
D+ A R P FG+ +RD Y PPE
Sbjct: 205 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
G T ++ +SFG LL ++ S G L+ + +C
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 313
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+ R+ ++C Q++P +RPN ++ + +D +V
Sbjct: 314 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 41/279 (14%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + +AVK+ S R F E + L++ + G C
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
R L+ EY+P +L +L + + + L+ I + +EY +K H DL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
I+ +++ ++ FGL K + Y PE L + + S ++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLA--- 289
SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 233 SFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPD 286
Query: 290 ----------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ C +RP+ R L + ++
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 46/278 (16%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G++ ++AVK FL EA + + ++ + +G +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105
Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
R ++ E M L L + + L VA IA +Y H
Sbjct: 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 163
Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
D+ A R P FG+ +RD SY PPE
Sbjct: 164 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRASYYRKGGCAMLPVKWMPPEAFME 219
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
G T ++ +SFG LL ++ S G L+ + +C
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 272
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+ R+ ++C Q++P +RPN ++ + +D +V
Sbjct: 273 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + +AVK+ S R F E + L++ + G C
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
R L+ EY+P D L KH + + L+ I + +EY +K H
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGTKR--YIH 137
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
DL I+ +++ ++ FGL K + + PE L + +
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RL 288
S ++SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRL 251
Query: 289 A-------------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ C +RP+ R L + ++ +
Sbjct: 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 60/278 (21%), Positives = 96/278 (34%), Gaps = 43/278 (15%)
Query: 73 VYKGKLEN-----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V + +AVK A P R + +E + L + + GCC +
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
LV EY+P D L +H L A I E + Y ++ H
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQL-------LLFAQQICEGMAYLHAQH--YIH 157
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
DL A ++ D+D ++ FGL K +G Y + PE L+ +
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA 217
Query: 233 SVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG-------- 282
S ++SFG L +LL+ P + +T L + G
Sbjct: 218 SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPRPDK 275
Query: 283 --TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E+ L C + E RP +L+ L T+ + +
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 44/276 (15%)
Query: 73 VYKGKL----ENQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V +G L ++AVK + + S+ + +FL EA + + + LLG C E
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 127 -----ERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
+ +++ +M L + + L+ + IA +EY +++
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167
Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRTG 227
H DL A + DD+ ++ FGL S+ Y E L
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGL---SKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 228 RVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
T +S +++FG + ++ + G + D + + + CL+
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD-------- 276
Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
EL + C + +P +RP L L L +
Sbjct: 277 -ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 30/264 (11%)
Query: 72 VVYKGKLEN---QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G Q +A+K + + + EA+ + QL N + L+G C+ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 409
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+LV E L K L + + + + ++ ++Y K H +L A
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARN 466
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
++ + ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526
Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
+ + LS P + I C EL L S C
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 577
Query: 295 YEPRERPNPRSLVTALVTLQKDTE 318
Y+ +RP+ ++ +
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLA 601
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 56/261 (21%), Positives = 100/261 (38%), Gaps = 38/261 (14%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G L + AVK NR FL E + + + +LLG C +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
L+V YM + L + + P + + L +A+ +++ SK+ H DL A
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFLASKK--FVHRDLAAR 221
Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
+ D+ +++ FGL +RD ++ A E L+T + T +S
Sbjct: 222 NCMLDEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG LL +L++ G + + + C + L +
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 329
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C + RP+ LV+ +
Sbjct: 330 LKCWHPKAEMRPSFSELVSRI 350
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 63/285 (22%), Positives = 101/285 (35%), Gaps = 56/285 (19%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V+ + N +AVK ++ + F EA + L+++ + G C EG
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 127 ERLLVAEYMPNDTLAKHL-------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
L+V EYM + L + L P+ L VA +A + Y
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176
Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----T 219
H DL R V L FG+ SRD Y
Sbjct: 177 LH--FVHRDLAT-RNCL---VGQGLVVKIGDFGM---SRDIYSTDYYRVGGRTMLPIRWM 227
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLE 274
PPE + + T ES ++SFG +L ++ + GK + + A+D I +C
Sbjct: 228 PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP 287
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
E+ + C Q EP++R + + + L L + V
Sbjct: 288 ---------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 31/265 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A + L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + MP L ++ + L + IA+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVTPESVMYSF 238
++ + +++ FGL K + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G IP S ++ C ++ + +C
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMRKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTE 318
+ RP R L+ + +D +
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 51/281 (18%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V+ + N + +AVK + F EA + L++ + G C +GD
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 127 ERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
++V EYM + L + + L +A IA + Y
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150
Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYS--TNLAF----TPP 221
S+ H DL R V L FG+ ++ Y + PP
Sbjct: 151 SQH--FVHRDLAT-RNCL---VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 204
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E + + T ES ++SFG +L ++ + GK + + ++ I + C +
Sbjct: 205 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK-- 262
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
E+ + C Q EP++R N + + L L K T
Sbjct: 263 -------EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 29/263 (11%)
Query: 72 VVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VY+G N + +AVK + D ++ F+ EA + L + + L+G E +
Sbjct: 27 EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEE 85
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++ E P L +L + + + +L I +A+ Y S H D+
Sbjct: 86 PTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYLESIN--CVHRDIAVR 142
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
I+ +L FGL + D Y ++ + PE + R T S ++ F
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ ++LS P + ++ + D C L L +RC Y
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP---------VLYTLMTRCWDY 253
Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
+P +RP LV +L + + +
Sbjct: 254 DPSDRPRFTELVCSLSDVYQMEK 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 54/264 (20%), Positives = 98/264 (37%), Gaps = 32/264 (12%)
Query: 72 VVYKGKLENQFR---IAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V KG + + +AVK + + + L EA + QL N + ++G CE +
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+LV E L K+L + + +K + + ++ ++Y H DL A
Sbjct: 91 SWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 146
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMYSF 238
++ ++S FGL K R +Y T+ + PE + + + +S ++SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 239 GTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G L+ + S P S ++ C E+ L + C
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCW 257
Query: 294 QYEPRERPNPRSLVTALVTLQKDT 317
Y+ RP ++ L D
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDV 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 50/265 (18%), Positives = 97/265 (36%), Gaps = 31/265 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A + L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + MP L ++ + L + IA+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
++ + +++ FGL K + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G IP S ++ C ++ + +C
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMVKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTE 318
+ RP R L+ + +D +
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQ 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 38/268 (14%)
Query: 72 VVYKGKL---ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G + Q +A+K + + + EA+ + QL N + L+G C+ +
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 83
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+LV E L K L + + + + ++ ++Y K H DL A
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140
Query: 187 IVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVM 235
++ + R FGL K SY + + PE + + + S +
Sbjct: 141 VL----LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 236 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+S+G + + LS P + I C EL L S
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMS 247
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTE 318
C Y+ +RP+ ++ +
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 44/265 (16%), Positives = 94/265 (35%), Gaps = 31/265 (11%)
Query: 72 VVYKGKLENQFR-----IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V+KG + + +K + + Q + A+G L + + LLG C G
Sbjct: 28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG 86
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
LV +Y+P +L H+ + + L + IA+ + Y + H +L A
Sbjct: 87 SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAA 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
++ +++ FG+ + + E + G+ T +S ++S+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G + + DL+ C ++ + +C
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI---------DVYMVMVKCW 254
Query: 294 QYEPRERPNPRSLVTALVTLQKDTE 318
+ RP + L + +D
Sbjct: 255 MIDENIRPTFKELANEFTRMARDPP 279
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 52/292 (17%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGDER- 128
V+ GK + ++AVK F + + E + Q R N+L +G
Sbjct: 53 VWMGKWRGE-KVAVKVFF---TTEEASWFRE-TEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 129 ---LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
L+ +Y N +L +L ++ + L++A L + T + A+
Sbjct: 108 TQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL + ++ + T PE L +
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLN 223
Query: 231 PESV-------MYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNIQTLTDSCLEG 275
MYSFG +L ++ P H L C++
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 276 Q-------FSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+SSDE ++ +L + C + P R + L + + ++
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 45/278 (16%)
Query: 73 VYKGKLENQF---RIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDE 127
V K +++ A+KR A D + F E + +L + + NLLG C
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 128 RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
L EY P+ L L + + L A +A ++Y +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRT 226
K+ H DL A I+ ++ +++ FGL SR Y T E L
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
T S ++S+G LL +++S G + + + + +C +
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------- 268
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
E+ L +C + +P ERP+ ++ +L + ++ +
Sbjct: 269 --EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 60/297 (20%), Positives = 106/297 (35%), Gaps = 50/297 (16%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCC 122
V + ++AVK A + E + + + + NLLG C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L H + + + A +A +
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
EY SK+ H DL A ++ +D +++ FGL ++ Y +TN P
Sbjct: 205 EYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG LL ++ + G +P L+++ + +C
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN-- 320
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL---VTLQKDTEVSCFLFSSQFTY 330
EL + C P +RP + LV L V L + E+ + Y
Sbjct: 321 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDY 370
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 54/275 (19%), Positives = 98/275 (35%), Gaps = 52/275 (18%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L +A+K A R+ F EA +L++ + LLG +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 126 DERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
++ Y + D + ++ + + IA +EY
Sbjct: 85 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 172 TSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYSTNLA------FTP 220
+S + H DL A R V V +L+ GL + Y +
Sbjct: 145 SSHH--VVHKDL-ATRNVL---VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198
Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHA----LDLIRDRNIQTLTDSCLEG 275
PE + G+ + +S ++S+G +L ++ S P ++ +++IR+R + D C
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA- 257
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+ L C P RP + + + L
Sbjct: 258 --------WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 50/275 (18%), Positives = 101/275 (36%), Gaps = 45/275 (16%)
Query: 73 VYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + ++AVK + + +E + L + + G C E
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96
Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
L+ E++P+ +L ++L + + + +L+ A+ I + ++Y S++ H DL
Sbjct: 97 GNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
A ++ + + ++ FGL K + Y + PE L + S ++
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 237 SFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLAS- 290
SFG L +LL+ AL L GQ + + RL
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTH--------GQMTVTRLVNTLKEGKRLPCP 265
Query: 291 ------------RCLQYEPRERPNPRSLVTALVTL 313
+C +++P R + ++L+ L
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 47/274 (17%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
V + + +AVK A + E + + +++ + NLLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L + M + + +A +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
EY S++ H DL A ++ ++ +++ FGL ++ + Y +TN P
Sbjct: 171 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 286
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL + C P +RP + LV L
Sbjct: 287 -------ELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 47/292 (16%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
V++GK + +AVK F+ + R + E + Q R N+L + +
Sbjct: 58 VWRGKWRGE-EVAVKIFS---SREERSWFRE-AEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
+ LV++Y + +L +L + +++AL A L + T + A+
Sbjct: 113 TQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL + + T PE L +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD-DSIN 228
Query: 231 PESV-------MYSFGTLLLDLLSGKHI---PPSHAL---DLI-RDRNIQTLTDS-CLEG 275
+ +Y+ G + ++ I + L DL+ D +++ + C +
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 276 Q--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
S + + ++ C R + L L + +
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 55/274 (20%), Positives = 101/274 (36%), Gaps = 34/274 (12%)
Query: 73 VYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + +AVK+ S R F E + + L + + G
Sbjct: 39 VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98
Query: 128 R--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
+ LV EY+P+ D L +H + + L + I + +EY S+ R ++ D
Sbjct: 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR-RCVHRD 152
Query: 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESV 234
L A I+ + + + +++ FGL K + Y PE L + +S
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG----------TE 284
++SFG +L +L + S + + +R + + +EG E
Sbjct: 213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ L C P++RP+ +L L L +
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 66/293 (22%), Positives = 105/293 (35%), Gaps = 60/293 (20%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V++ + +AVK A D + F EA + + N + LLG C G
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
L+ EYM L + L P+ A +L +A
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSY--STNL 216
+A + Y + ++ H DL A R V + FGL +N Y N
Sbjct: 183 VAAGMAYLSERK--FVHRDL-ATRNCL---VGENMVVKIADFGLSRNIYSADYYKADGND 236
Query: 217 AF----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQT 267
A PPE + R T ES ++++G +L ++ S G + + +RD NI
Sbjct: 237 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320
++C EL L C P +RP+ S+ L + + E +
Sbjct: 297 CPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 61/281 (21%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
V + + +AVK A + E + + +++ + NLLG C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L + M + + +A +
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
EY S++ H DL A R V V FGL +RD Y +TN
Sbjct: 217 EYLASQK--CIHRDL-AARNVL---VTENNVMKIADFGL---ARDINNIDYYKKTTNGRL 267
Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLT 269
PE L T +S ++SFG L+ ++ + G IP L+++ +
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 327
Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+C EL + C P +RP + LV L
Sbjct: 328 ANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 36/261 (13%)
Query: 72 VVYKGKL----ENQFRIAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCE 124
VV +G+ +AVK + + + P+A F+ E A+ L +R L L G
Sbjct: 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVL 91
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
+V E P +L L R A+ +AE + Y SK H DL
Sbjct: 92 TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 148
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
A ++ ++ FGLM+ + + PE L+T + S +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 237 SFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT--DSCLEGQFSSDEGTELVRLA 289
FG L ++ + P S L I D+ + L + C + ++ +
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDCPQ---------DIYNVM 258
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C ++P +RP +L L
Sbjct: 259 VQCWAHKPEDRPTFVALRDFL 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 36/199 (18%), Positives = 71/199 (35%), Gaps = 38/199 (19%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
V++G + + +AVK F+ D + + E + R N+L
Sbjct: 24 VWRGSWQGE-NVAVKIFS---SRDEKSWFRE-TELYNTVMLRHENILGFIASDMTSRHSS 78
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
+ L+ Y +L +L + + LR+ L IA L + T + A+
Sbjct: 79 TQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL +++ + T PE L +
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD-ETIQ 194
Query: 231 PESV-------MYSFGTLL 242
+ +++FG +L
Sbjct: 195 VDCFDSYKRVDIWAFGLVL 213
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 58/282 (20%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V K +AVK +A P + L E + Q+ + + L G C +
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98
Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
LL+ EY +L L H + + + + A
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLA 217
I++ ++Y + L H DL A I+ + ++S FGL SRD +
Sbjct: 159 ISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGR 213
Query: 218 F----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTL 268
E L T +S ++SFG LL ++++ G + IPP +L++ +
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER 273
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
D+C E E+ RL +C + EP +RP + L
Sbjct: 274 PDNCSE---------EMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 52/285 (18%), Positives = 92/285 (32%), Gaps = 58/285 (20%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
V + + ++AVK +A D ++ + E + + L + NLLG C
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 125 GDERLLVAEYMPN------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
G L++ EY F L + +A+ + +
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF---- 218
SK H D+ A R V + FGL +RD S N
Sbjct: 182 SKN--CIHRDVAA-RNVL---LTNGHVAKIGDFGL---ARDIMNDSNYIVKGNARLPVKW 232
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTLTDSC 272
PE + T +S ++S+G LL ++ S P ++ L++D
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 292
Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
+ + + C EP RP + + + L ++
Sbjct: 293 PK---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 56/290 (19%), Positives = 95/290 (32%), Gaps = 62/290 (21%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
V + + +AVK SA R+ + E + + L N + NLLG C
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98
Query: 125 GDERLLVAEYMPNDTLAKHL----------------FHWETQPMKWAMRLRVALHIAEAL 168
G L++ EY L L + + L + +A+ +
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
+ SK H DL A R + + FGL +RD S N
Sbjct: 159 AFLASKN--CIHRDL-AARNIL---LTHGRITKICDFGL---ARDIKNDSNYVVKGNARL 209
Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTL 268
PE + T ES ++S+G L +L S P P + +I++
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ E+ + C +P +RP + +V + ++
Sbjct: 270 PEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 39/280 (13%), Positives = 68/280 (24%), Gaps = 49/280 (17%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNR---RLANLLGCCCE 124
VV+ + +E A+K F A + + E A +L +
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 125 GD-----------------------ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMR 157
D LL+ D L L
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 158 LRVALHIAEALEYCTSKERALYH-DL---NAYRIVFDDDVNPRLSCFGL-MKNSRDGRSY 212
+ + SK L H N + D L K G +
Sbjct: 197 HILTAQLIRLAANLQSKG--LVHGHFTPDN---LFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 213 STNLAFTPPEYL--RTGRVTPESVMYSFGTLLLDLLSGK---HIPPSHALDLIRDRNIQT 267
S + + P E+L T T + G + + + + +++
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
L + + L R L ++ R R P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 44/249 (17%), Positives = 87/249 (34%), Gaps = 25/249 (10%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCC---CEGD 126
VYKG E +A + ++F EEA + L++ + +G
Sbjct: 42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101
Query: 127 ERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
+ + LV E M + TL +L + MK + I + L++ ++ + H DL
Sbjct: 102 KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 185 YRIVFD-DDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTL 241
I + ++ GL R + + F PE +Y+FG
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218
Query: 242 LLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
+L++ + ++ + + +T F E+ + C++
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 298 RERPNPRSL 306
ER + + L
Sbjct: 272 DERYSIKDL 280
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 48/282 (17%), Positives = 93/282 (32%), Gaps = 47/282 (16%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
V + +AVK A + + E + + + + + NLLG C +
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102
Query: 125 GDE-RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALE 169
+++ E+ L+ +L + + + +A+ +E
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162
Query: 170 YCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPE 222
+ S++ H DL A I+ + ++ FGL ++ Y + PE
Sbjct: 163 FLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQ 276
+ T +S ++SFG LL ++ S P +++ D
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 278
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E+ + C EP +RP LV L L +
Sbjct: 279 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 53/260 (20%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG--------CCC 123
+VY+G +N+ +AVKR + A + E + L C
Sbjct: 40 IVYRGMFDNR-DVAVKRILPECFSFADR---EVQL--------LRESDEHPNVIRYFCTE 87
Query: 124 EGDERL-LVAEYMP----NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
+ + + E K H +P+ ++ L + S +
Sbjct: 88 KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQ-----QTTSGLAHLHSLN--I 139
Query: 179 YH-DLNAYRIVF-----DDDVNPRLSCFGLMKNSRDGRSYSTNLAF---TP----PEYLR 225
H DL + I+ + +S FGL K GR + + T PE L
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 226 ---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG-QFSSDE 281
T ++S G + ++S P +L + + + CL +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 282 GTELVRLASRCLQYEPRERP 301
EL+ + + +P++RP
Sbjct: 260 ARELIE---KMIAMDPQKRP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 31/198 (15%), Positives = 56/198 (28%), Gaps = 36/198 (18%)
Query: 127 ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKERALYH-D 181
R + M ++ T + L + + RL++ L + L L H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 182 L---NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL-----------RTG 227
L + IV D L+ F + S + F PPE R
Sbjct: 232 LRPVD---IVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELV 286
+T ++ G ++ + P I ++ + L+
Sbjct: 289 LMTFSFDAWALGLVIYWIWCAD--LP------ITKDAALGGSEWIFRSCKNIPQPVRALL 340
Query: 287 RLASRCLQYEPRERPNPR 304
L+Y +R P
Sbjct: 341 E---GFLRYPKEDRLLPL 355
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 34/210 (16%), Positives = 56/210 (26%), Gaps = 35/210 (16%)
Query: 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL--- 182
L T + L + + RL++ L + L L H L
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPV 240
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL----------RTGRVTPE 232
+ IV D L+ F + F PPE +T
Sbjct: 241 D---IVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLAS 290
++ G + + P+ + E F S + + L
Sbjct: 298 FDTWTLGLAIYWIWCAD--LPNTDDAALGG----------SEWIFRSCKNIPQPVRALLE 345
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTEVS 320
L+Y +R P + Q TE+S
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 60/295 (20%), Positives = 97/295 (32%), Gaps = 67/295 (22%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
V ++AVK A R+ + E + + QL + + NLLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 125 GDERLLVAEYMPN---------------------DTLAKHLFHWETQPMKWAMRLRVALH 163
L+ EY + + + + + L A
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---S 213
+A+ +E+ K H DL A R V V FGL +RD S
Sbjct: 181 VAKGMEFLEFKS--CVHRDLAA-RNVL---VTHGKVVKICDFGL---ARDIMSDSNYVVR 231
Query: 214 TNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDR 263
N PE L G T +S ++S+G LL ++ S P ++ LI++
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E E+ + C ++ R+RP+ +L + L D E
Sbjct: 292 FKMDQPFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 44/244 (18%), Positives = 87/244 (35%), Gaps = 19/244 (7%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
K E+ + +K N S + E + +++ + E
Sbjct: 40 AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+V +Y L K + + + L + I AL++ + + L+ D+ + I
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFL 158
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
D +L FG+ + + TP PE +S +++ G +L +L
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPN 302
+ K A +++ L + G F S +L L S+ + PR+RP+
Sbjct: 219 CTLK--HAFEA------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 303 PRSL 306
S+
Sbjct: 271 VNSI 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 53/285 (18%), Positives = 92/285 (32%), Gaps = 82/285 (28%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL--LGCCCEGDERL 129
VV++G + + +AVKR A E + + + + N+ C D L
Sbjct: 31 VVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDDH--PNVIRYYCSETTDRFL 84
Query: 130 -LVAEYMPNDTL-----AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
+ E N L +K++ + K + + IA + + H L
Sbjct: 85 YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL--------HSLK 135
Query: 184 --------------------AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP--- 220
A + +++ +S FGL K G+S P
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 221 -----PEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
PE L R+T ++S G + +LS P R+ NI
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KYSRESNI--- 250
Query: 269 TDSCLEGQFS------------SDEGTELVRLASRCLQYEPRERP 301
+ G FS E T+L+ + + ++P +RP
Sbjct: 251 ----IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRP 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 27/265 (10%), Positives = 62/265 (23%), Gaps = 45/265 (16%)
Query: 72 VVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
VY+ +N+ + +K + + + +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139
Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERA--- 177
+ +LV E TL + + P + A+ + +E E
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF--AMRMLYMIEQVHDCEIIHGD 197
Query: 178 -------LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY--- 223
L + D L G S D + + FT +
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQCV 254
Query: 224 -LRTGRVTPESV-MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
+ + + + + + +L G ++ +++ + + D
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGECKPEGLFRRLPHLDM 307
Query: 282 GTELVRLASRCLQYEPRERPNPRSL 306
E L L
Sbjct: 308 WNEFFH---VMLNIPDCHHLPSLDL 329
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 39/256 (15%), Positives = 73/256 (28%), Gaps = 53/256 (20%)
Query: 61 IVSEHGEKAPNVVYKGKLENQFR-IAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
++ HG P ++ R +A+ D Q L + ++ +A
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
+L L+VAE++ +L + +T P +R +A A + +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAADA--AHRA 148
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKN---SRDGRSYSTNLAFTPPEYLRTGRVTPES 233
+ +P S DG A P P+
Sbjct: 149 GVAL-----S-----IDHPS--------RVRVSIDGDVVLAYPATMPD-------ANPQD 183
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--------GQFSSDEGTEL 285
+ G L LL + P L L + + D ++
Sbjct: 184 DIRGIGASLYALLVNR--WP-----LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 286 VRLASRCLQYEPRERP 301
+A+R +Q + R
Sbjct: 237 SAVAARSVQGDGGIRS 252
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 45/250 (18%), Positives = 92/250 (36%), Gaps = 20/250 (8%)
Query: 66 GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
GE + +V + + ++AVK + E + ++ + +
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
G+E ++ E++ L + + V + +AL Y ++ ++ D+ +
Sbjct: 114 GEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKS 169
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D +LS FG +L TP PE + E ++S G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
++++++ G+ P A+ +RD L +S + S L R L +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---HKVSP----VLRDFLERMLVRD 282
Query: 297 PRERPNPRSL 306
P+ER + L
Sbjct: 283 PQERATAQEL 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 38/197 (19%), Positives = 68/197 (34%), Gaps = 37/197 (18%)
Query: 133 EYMPNDTLAKHLFH-WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL---NAYRIV 188
+ + L + + + + L + + IAEA+E+ SK ++ DL N I
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSN---IF 196
Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP---------------E 232
F D ++ FGL+ T L P TG+V T +
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLA 289
++S G +L +LL ++ +TD +F + + + +
Sbjct: 257 VDIFSLGLILFELLYSF--STQMER-------VRIITDVR-NLKFPLLFTQKYPQEHMMV 306
Query: 290 SRCLQYEPRERPNPRSL 306
L P ERP +
Sbjct: 307 QDMLSPSPTERPEATDI 323
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 46/164 (28%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
+ E + H LN +R I+ DDD+N +L+ FG G
Sbjct: 132 ALLEVICAL--------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182
Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
+ TP PE + E M+S G ++ LL+G PP R
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFW------HRKQ 234
Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
+ + G + SD +LV R L +P++R
Sbjct: 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 66 GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + M V +ALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++++ G+ + P AL LI L + + S+ +RCL+ +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSA----IFRDFLNRCLEMD 257
Query: 297 PRERPNPRSL 306
+R + + L
Sbjct: 258 VEKRGSAKEL 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 86 VKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145
+KRF R E QL ++ + +++ E D LV EY+ TL++++
Sbjct: 55 LKRFER-----------EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103
Query: 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMK 204
P+ + I + +++ + + + H D+ I+ D + ++ FG+ K
Sbjct: 104 --SHGPLSVDTAINFTNQILDGIKH--AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 205 NSRDGRSYSTNLAF-TP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
+ TN T PE + + +YS G +L ++L G+ PP
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE--PP 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 60/273 (21%)
Query: 73 VYKG--KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
V K L++++ A+K+ + L E + L ++ + E +
Sbjct: 22 VVKARNALDSRYY-AIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 130 ------------LVAEYMPNDTLAKHLFHWETQPMKW--AMRLRVALHIAEALEYCTSKE 175
+ EY N TL + ++ + R+ I EAL Y S+
Sbjct: 80 PMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHSQG 136
Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------------TP 220
+ H DL I D+ N ++ FGL KN + T
Sbjct: 137 --IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 221 ----PEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLIRDRNIQTLT 269
E L TG + MYS G + +++ P S L +R +I+
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIE--- 247
Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
F ++ ++ + ++P +RP
Sbjct: 248 ---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 19/146 (13%)
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFT 219
I A++YC K + H DL A ++ D D+N +++ FG G +
Sbjct: 123 IVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 220 PPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
PE + G+ PE ++S G +L L+SG +P +N++ L + L G++
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG-SLP-------FDGQNLKELRERVLRGKY 231
Query: 278 S--SDEGTELVRLASRCLQYEPRERP 301
T+ L R L P +R
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRG 257
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 42/161 (26%)
Query: 164 IAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSYS 213
I EA+ Y H+ +R +++ D +++ FGL K
Sbjct: 157 ILEAVAYL--------HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT 269
T + TP PE LR PE M+S G + LL G P + +R Q +
Sbjct: 209 T-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG--FEPFYD-----ERGDQFMF 260
Query: 270 DSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
L ++ S +LVR + + +P++R
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAKDLVR---KLIVLDPKKRL 298
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 34/181 (18%), Positives = 69/181 (38%), Gaps = 16/181 (8%)
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+ E+ TL + + + + + L + I + ++Y SK + + DL I
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFL 155
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
D ++ FGL+ + ++ + + T PE + + E +Y+ G +L +L
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
L A + + L D + F + L + L +P +RPN
Sbjct: 215 LH----VCDTAFE--TSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSE 264
Query: 306 L 306
+
Sbjct: 265 I 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 45/269 (16%)
Query: 72 VVYKG--KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER 128
VV++ K+++ A+KR AR+ + E +A+ +L + + E +
Sbjct: 20 VVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 129 L------------LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKE 175
+ + + L + T + + ++ L + L IAEA+E+ SK
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP-- 231
L H DL I F D ++ FGL+ T L P TG+V T
Sbjct: 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196
Query: 232 -------------ESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQF 277
+ ++S G +L +LL P S ++ +R +++ L L Q
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVRTLTDVRNLKFPPLFTQK 252
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ L P ERP ++
Sbjct: 253 YP----CEYVMVQDMLSPSPMERPEAINI 277
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 39/164 (23%), Positives = 59/164 (35%), Gaps = 46/164 (28%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
+ EA+ + H N +R I+ DD++ RLS FG + G
Sbjct: 208 SLLEAVSFL--------HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258
Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
L TP PE L+ E +++ G +L LL+G PP R
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPP------FWHRRQ 310
Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
+ +EGQ+ S +L+ R LQ +P R
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEAR 351
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 21/190 (11%)
Query: 130 LVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH----DLN 183
+V EY LA + E Q + LRV + AL+ C + + DL
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
+ D N +L FGL + S++ TP PE + +S ++S G
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYE 296
LL +L + PP A + + L EG+F EL + +R L +
Sbjct: 204 CLLYELCALM--PPFTA------FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 297 PRERPNPRSL 306
RP+ +
Sbjct: 256 DYHRPSVEEI 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 42/259 (16%), Positives = 78/259 (30%), Gaps = 39/259 (15%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDE 127
V + L + A+KR D + EA + + L+ C E
Sbjct: 45 VDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + TL + + + L + L I LE +K H DL
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKP 162
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG----------------R 228
I+ D+ P L G M + S +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 229 VTPESVMYSFGTLLLDLLSGKH-----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
+ + ++S G +L ++ G+ ++ L + + SS
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP----RHSSA--- 275
Query: 284 ELVRLASRCLQYEPRERPN 302
L +L + + +P +RP+
Sbjct: 276 -LWQLLNSMMTVDPHQRPH 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 46/251 (18%), Positives = 100/251 (39%), Gaps = 27/251 (10%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VY+ L + +A+K+ DA+ ++E + QL + + E +E
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 129 LLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+V E L++ + F + + + + + + ALE+ S+ R ++ D+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPAN 166
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLL 242
+ +L GL + + + +L TP PE + +S ++S G LL
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-------SDEGTELVRLASRCLQY 295
++ + + P + N+ +L + + S+E +LV + C+
Sbjct: 227 YEMAALQ--SPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV---NMCINP 277
Query: 296 EPRERPNPRSL 306
+P +RP+ +
Sbjct: 278 DPEKRPDVTYV 288
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 25/161 (15%), Positives = 55/161 (34%), Gaps = 43/161 (26%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSY 212
+ AL Y H + ++ I+F ++ FGL + +
Sbjct: 132 QMMNALAYF--------HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
+ T PE + VT + ++S G ++ LL+G P +++ +
Sbjct: 184 TNAAG-TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC--LPFT------GTSLEEV 233
Query: 269 TDSCLEGQFS--------SDEGTELVRLASRCLQYEPRERP 301
+ + + + +L++ + L +P RP
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRP 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L D+
Sbjct: 43 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 101
Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ +V E D L L ++ ++ EA+ + H DL
Sbjct: 102 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGR 228
+ D +L FG+ + + + T PE ++ +
Sbjct: 157 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
++P+S ++S G +L + GK P ++ I + + D E +F +L
Sbjct: 216 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 288 LASRCLQYEPRERP 301
+ CL+ +P++R
Sbjct: 272 VLKCCLKRDPKQRI 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 34/246 (13%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V++ K + F+ AVK+ R EE A L + R+ L G EG +
Sbjct: 74 VHRMKDKQTGFQCAVKKVRL---EVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E + +L + + + L E LEY ++ R L+ D+ A ++
Sbjct: 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSS 185
Query: 192 D-VNPRLSCFGL---MKNSRDGRSYSTNLAF--TP----PEYLRTGRVTPESVMYSFGTL 241
D L FG ++ G+S T T PE + + ++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 242 LLDLLSGKH----IPPSHALDLIRDRN--IQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+L +L+G H I I+ + SC + + ++ L+
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC------APLTAQAIQ---EGLRK 296
Query: 296 EPRERP 301
EP R
Sbjct: 297 EPVHRA 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 28/241 (11%)
Query: 73 VYKG-KLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128
V+K E+ AVKR D + L E + ++ ++ L EG
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
L E L +H W + A AL + S+ ++ D+ I
Sbjct: 133 YLQTELCGPS-LQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIF 189
Query: 189 FDDDVNPRLSCFGLMK--------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
+L FGL+ ++G + PE L+ + ++S G
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----YMAPELLQGSY-GTAADVFSLGL 243
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++ P Q L L +F++ +EL + L+ +P+ R
Sbjct: 244 TILEVACNME-LPHGG------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
Query: 301 P 301
Sbjct: 297 A 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 44/166 (26%)
Query: 159 RVALHIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRD 208
R+ + + Y H N +R I+ + D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYM--------HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 209 GRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264
T PE LR G + ++S G +L LLSG PP + +N
Sbjct: 177 NTKMKD-RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT--PPFYG------KN 226
Query: 265 IQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
+ G+++ SD+ +L+R + L + P R
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 35/244 (14%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-----RRLA--NLLG--CC 122
VY + +++F +A+K ++ LE+A QLR L N+L
Sbjct: 25 VYLAREKQSKFILALKVLFKAQ-------LEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 123 CEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
R+ L+ EY P T+ + L + +A AL YC SK + H
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR--VIHR 133
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSF 238
D+ ++ +++ FG ++ R L + PPE + + ++S
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYE 296
G L + L GK PP Q +F+ L SR L++
Sbjct: 194 GVLCYEFLVGK--PP------FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 297 PRER 300
P +R
Sbjct: 246 PSQR 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 45/242 (18%), Positives = 78/242 (32%), Gaps = 51/242 (21%)
Query: 85 AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTL 140
A K D +E + + LR+ L NL + +E +++ E+M + +
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR------IVFDDDV 193
A MR + + L + H+ N + I+F
Sbjct: 246 ADEHNKMSEDEAVEYMR-----QVCKGLCHM--------HENNYVHLDLKPENIMFTTKR 292
Query: 194 NPRLSC--FGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ L FGL + +S T PE V + M+S G L LLS
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTG-TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 248 GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPR 298
G + P N + ++ S++G + +R + L +P
Sbjct: 352 G--LSP------FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPN 400
Query: 299 ER 300
R
Sbjct: 401 TR 402
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 39/183 (21%), Positives = 66/183 (36%), Gaps = 21/183 (11%)
Query: 83 RIAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLANL--LGCCCEGDERL-LVAEYMP 136
+A+K S+ P R EAR G+L+ + + G E D +L + +
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG---EIDGQLYVDMRLIN 117
Query: 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNP 195
LA L P+ + + I AL+ + H D+ I+ D
Sbjct: 118 GVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDA--AHAAGATHRDVKPENILVSADDFA 173
Query: 196 RLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH 250
L FG+ + D + L + PE T + +Y+ +L + L+G
Sbjct: 174 YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS- 232
Query: 251 IPP 253
PP
Sbjct: 233 -PP 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 24/193 (12%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
+ ++L + + M L HL + + AE LE+ ++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNR 311
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
+Y DL I+ D+ + R+S GL + + ++ T PE L+ G
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368
Query: 231 PESVMY-SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVR 287
S + S G +L LL G P ++ + L EL
Sbjct: 369 DSSADWFSLGCMLFKLLRGH--SPFRQHK---TKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 288 LASRCLQYEPRER 300
L LQ + R
Sbjct: 424 LLEGLLQRDVNRR 436
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 41/253 (16%), Positives = 86/253 (33%), Gaps = 33/253 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+V E D L L ++ ++ EA+ + H DL
Sbjct: 131 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 185
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGRV 229
+ D +L FG+ + + + PE ++ ++
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 230 TPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
+P+S ++S G +L + GK P ++ I + + D E +F +L +
Sbjct: 245 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 289 ASRCLQYEPRERP 301
CL+ +P++R
Sbjct: 301 LKCCLKRDPKQRI 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 35/198 (17%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
L + +RL V EY L HL E + R A I AL+Y S++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHSEKNV 270
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAF--TPPEYLRTGRVTPESV 234
+Y DL ++ D D + +++ FGL K +DG + T F T PEYL PE +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGT-PEYL-----APEVL 321
Query: 235 MY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG--QFSSDEG 282
G ++ +++ G+ P +++ + L + L +F G
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR--LP------FYNQDHEKLFELILMEEIRFPRTLG 373
Query: 283 TELVRLASRCLQYEPRER 300
E L S L+ +P++R
Sbjct: 374 PEAKSLLSGLLKKDPKQR 391
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 45/200 (22%), Positives = 72/200 (36%), Gaps = 35/200 (17%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
L E + L LV M L H++H A R + AE LE +
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE 305
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPE 232
R +Y DL I+ DD + R+S GL + +G++ T Y+ PE
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVGT-VGYM-----APE 355
Query: 233 SVMY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSD 280
V + G LL ++++G+ P + + + E +S
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK--KKIKREEVERLVKEVPEEYSER 411
Query: 281 EGTELVRLASRCLQYEPRER 300
+ L S+ L +P ER
Sbjct: 412 FSPQARSLCSQLLCKDPAER 431
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 42/237 (17%), Positives = 77/237 (32%), Gaps = 53/237 (22%)
Query: 85 AVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL-----LVAEYMPND 138
+K S +A+ + E + + ++ + + + D +V EY+
Sbjct: 110 VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169
Query: 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL---NAYRIVFDDDVN 194
+L + Q + A + L I AL Y L + DL N ++ ++ +
Sbjct: 170 SLKRSK----GQKLPVAEAIAYLLEILPALSY--LHSIGLVYNDLKPENI--MLTEEQL- 220
Query: 195 PRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG----- 248
+L G + + G Y T F PE +R T + +Y+ G L L
Sbjct: 221 -KLIDLGAVSRINSFGYLYGT-PGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRN 277
Query: 249 ----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+P + D RL R + +PR+R
Sbjct: 278 GRYVDGLPEDDPVLKTYD---------------------SYGRLLRRAIDPDPRQRF 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L D+
Sbjct: 24 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 82
Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ +V E D L L ++ ++ EA+ + H DL
Sbjct: 83 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH--GIVHSDLKPA 137
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TP----PEYLR-----------TGR 228
+ D +L FG+ + + + T PE ++ +
Sbjct: 138 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
++P+S ++S G +L + GK P ++ I + + D E +F +L
Sbjct: 197 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 252
Query: 288 LASRCLQYEPRERP 301
+ CL+ +P++R
Sbjct: 253 VLKCCLKRDPKQRI 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.2 bits (93), Expect = 9e-04
Identities = 61/407 (14%), Positives = 113/407 (27%), Gaps = 127/407 (31%)
Query: 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFL--EEARAVGQLRNR- 113
M+ EH + +++ E+ F V F+ D + L EE + ++
Sbjct: 7 MDFETGEHQYQYKDILSV--FEDAF---VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 114 -RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
L E + V +++ + L + + + P+K R Y
Sbjct: 62 SGTLRLFWTLLSKQEEM-VQKFV-EEVLRIN-YKFLMSPIKTEQRQPSM----MTRMYIE 114
Query: 173 SKERALYHD------LNAYRI---------VFDDDVNPRLSCFGLMKNSRDG-------- 209
++R LY+D N R+ + + + G + S G
Sbjct: 115 QRDR-LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG-VLGS--GKTWVALDV 170
Query: 210 -RSYSTNLAFTPPEY-LRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHA---------- 256
SY + L +PE+V+ LL + H+
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 257 -------------------LDLIRDRNI--------QTL--------TDS---------C 272
L +++ + L TD
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 273 LEGQ---FSSDEGTELVRLASRCLQYEPRERP------NPRSLVTALVTLQKDTEVSCFL 323
L+ + DE L+ + L P++ P NP +++ ++ +
Sbjct: 291 LDHHSMTLTPDEVKSLL---LKYLDCRPQDLPREVLTTNP--RRLSIIAESIRDGLATWD 345
Query: 324 FSSQFTYALLRLHIWSSSQIQQPA--RLCF---------VK-PPELL 358
L I SS + +PA R F P LL
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 359 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.9 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.36 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.18 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.24 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=427.77 Aligned_cols=255 Identities=18% Similarity=0.275 Sum_probs=207.5
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.++++.+.++||+|+||+||+|++.+ .||||+++.... ...+.|.+|+++|++++|||||++++++.. +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 35667788899999999999999754 499999975432 335679999999999999999999998854 5789999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
|||++|+|.+++.. ....+++..+..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 111 QWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp ECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999964 445799999999999999999999999 9999999999999999999999999999865432
Q ss_pred ---CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCCChHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
....||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... ...........+. ....+..++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-STTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-cccccccch
Confidence 24578999999999864 458999999999999999999999987543221 1111111111111 123345677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+++.+|+.+||+.||++|||+.+|++.|+.++.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 899999999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=432.85 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=215.4
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.++.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677888999999999999853 477899999987665566789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEec
Q 018244 131 VAEYMPNDTLAKHLFHW-----------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~D 199 (359)
|||||++|+|.+++... ....++|..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECC
Confidence 99999999999999642 235799999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccc
Q 018244 200 FGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (359)
Q Consensus 200 Fg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (359)
||+|+..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.............. .
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-----~ 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-----G 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH-----T
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----C
Confidence 9999865432 23457899999999999999999999999999999999 8988876544333222211 1
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.....+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22334566788999999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=433.86 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=211.8
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.++.+.++||+|+||+||+|++. ++..||||+++.......+.|.+|+++|++++|||||+++++|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45567788999999999999864 478899999987665667789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEE
Q 018244 131 VAEYMPNDTLAKHLFHWE-------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl 197 (359)
|||||++|+|.+++.... ...++|.++..|+.||+.||+|||++ +|+||||||+||||++++.+||
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEE
Confidence 999999999999997532 24689999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcc
Q 018244 198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 198 ~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 270 (359)
+|||+++..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.............
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 274 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT----- 274 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-----
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 999999865432 23568999999999999999999999999999999999 898887654333322221
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
...+...+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1123345567788999999999999999999999999999998664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-61 Score=438.40 Aligned_cols=247 Identities=17% Similarity=0.196 Sum_probs=209.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
++|++++.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|+.|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999995 5689999999976543 235678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
||+||+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.+|.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99999999999765666789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|||||++.+..|+.++|||||||++|||+||+.||................ ....+...+.++.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----CCCCCTTSCHHHHHHH
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----CCCCCccCCHHHHHHH
Confidence 24569999999999999999999999999999999999999998765444333322211 1223456778999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||++||++|||+.+++++
T Consensus 258 ~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=430.18 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=212.8
Q ss_pred CCcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
+++++++++||+|+||+||+|.+. +++.||||+++.... ...+.|.+|+.+|++++|||||+++|+|.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 456778899999999999999862 467899999976533 3356799999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~ 194 (359)
+||||||++|+|.++|.... ...++|..+..|+.||+.||+|||++ +||||||||+||||++++.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCC
Confidence 99999999999999996432 24689999999999999999999999 9999999999999999999
Q ss_pred eEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhh
Q 018244 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 267 (359)
+||+|||+++..... ....||+.|||||++.++.|+.++|||||||++|||+| |..||............
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i--- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI--- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 999999999864322 24568899999999999999999999999999999998 78888765443332222
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
........+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 261 --~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 --RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11222334667788999999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-61 Score=436.50 Aligned_cols=246 Identities=17% Similarity=0.224 Sum_probs=212.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|+++++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4588999999999999999995 568999999998665555667899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
++|+|.+++.+ ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999853 4699999999999999999999999 9999999999999999999999999999876433 35
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..||+.|||||++.+..|+.++|||||||++|||++|+.||................ . .........++++.+||.+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~--~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-P--PRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-C--CCCSCGGGSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-C--CCCCccccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999997764433322222111 1 1112234577899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.||++|||+.|++++
T Consensus 307 ~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHhcC
Confidence 999999999999998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=428.45 Aligned_cols=253 Identities=17% Similarity=0.139 Sum_probs=212.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....|.+.++||+|+||+||+|+. .+|..||||+++.... ..+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 345678888899999999999995 5689999999986432 2469999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~~--- 209 (359)
||+||+|.+++.. .+.+++..+..|+.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+|+.....
T Consensus 131 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999973 45799999999999999999999999 999999999999999887 5999999999875432
Q ss_pred ------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
....||+.|||||++.+..|+.++|||||||++|||+||+.||................. .....+..+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~s~ 284 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP---PIREIPPSCAP 284 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC---GGGGSCTTSCH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC---CchhcCccCCH
Confidence 234699999999999999999999999999999999999999876533222222111111 11124566788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
++.+||.+||++||++|||+.|++++|........
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 99999999999999999999999999888765444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=426.97 Aligned_cols=243 Identities=17% Similarity=0.179 Sum_probs=211.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+|++++.||+|+||+||+|.. .+++.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999994 578999999997532 233567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
|||+||+|.+++. +.+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999997 445799999999999999999999999 9999999999999999999999999999875432
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
...+||+.|||||++.+..|+.++||||+||++|+|+||+.||............... ...++...++++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 262 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------EYDFPEKFFPKAR 262 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCTTCCHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCcccCHHHH
Confidence 3457999999999999999999999999999999999999999876554443333221 1234566778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~ 308 (359)
+||.+||++||++|||++|++.
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHccCCHhHCcChHHHcC
Confidence 9999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=438.01 Aligned_cols=246 Identities=17% Similarity=0.228 Sum_probs=212.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|+++++||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4588999999999999999995 568999999998766666677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
+||+|.+++.. ..+++..+..|+.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99999999853 4699999999999999999999999 9999999999999999999999999999875433 35
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||................ .+ ........++++.+||.+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~--~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PP--RLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC--CCSCTTSSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CC--CCcccccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999997664433322222111 11 112234567899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||..||++|||+.|++++
T Consensus 384 ~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHhcC
Confidence 999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=413.11 Aligned_cols=244 Identities=19% Similarity=0.253 Sum_probs=197.7
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..+|++++.||+|+||+||+|.. .+|+.||||++.+... ...+.+.+|+++|+.++|||||++++++.+.+.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45789999999999999999994 5789999999976432 2345789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+ +|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 6799999874 45799999999999999999999999 9999999999999999999999999999876543
Q ss_pred -CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||............... ...++...++++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------VYTLPKFLSPGAAG 241 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCTTSCHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHH
Confidence 34679999999999998876 57999999999999999999999876554433322221 12345567789999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.|++++
T Consensus 242 li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhHCcCHHHHHcC
Confidence 9999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=413.55 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=199.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee----CCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 131 (359)
|++.++||+|+||+||+|.. .++..||+|++..... ...+.+.+|+++|+.++|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35666799999999999995 4688999999975432 235678999999999999999999999865 3458999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCC-CCCeEEeccCCcccCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~ 208 (359)
||||++|+|.+++. +...+++..+..|+.||+.||+|||++ + |+||||||+|||+++ ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999997 346799999999999999999999998 7 999999999999984 79999999999986544
Q ss_pred C--CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
. ....||+.|||||++. ++|+.++|||||||++|||+||+.||..... ..+......... ...++...++++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----CCCCCccCCHHH
Confidence 3 3457999999999987 4699999999999999999999999865422 212111111111 111233455789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+|+.+||+.||++|||+.+++++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=417.42 Aligned_cols=238 Identities=17% Similarity=0.184 Sum_probs=199.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
++|++++.||+|+||+||+|+.. .++.||||++..... .....+.+|+++|+.++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47899999999999999999852 467899999975432 223467889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~-- 208 (359)
|||||+||+|.+++. +...+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999997 345799999999999999999999999 999999999999999999999999999986432
Q ss_pred --CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 209 --GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 209 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||............... ...++...++++.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQ 254 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCcCCHHHH
Confidence 23567999999999999999999999999999999999999999876544443332221 1234566788999
Q ss_pred HHHHHhcccCCCCCCCH
Q 018244 287 RLASRCLQYEPRERPNP 303 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~ 303 (359)
+|+.+||+.||++|||+
T Consensus 255 ~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHHHTCSSGGGSTTC
T ss_pred HHHHHHcccCHHHCCCC
Confidence 99999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=417.77 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=213.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCC------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCC-cccccccceeeeC-
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRN-RRLANLLGCCCEG- 125 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~- 125 (359)
..++|++.+.||+|+||+||+|.+.. ++.||||.+...... ..+.+.+|+++|.++.| ||||+++++|...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 45678899999999999999998532 357999999865433 35678999999999965 8999999998764
Q ss_pred CcceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~ 191 (359)
+.++||||||++|+|.++|+... ...+++..+..|+.||+.||+|||++ +||||||||+|||+++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSE 220 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceeeCC
Confidence 56899999999999999997432 34589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhh
Q 018244 192 DVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~ 264 (359)
++.+||+|||+|+...... ...||+.|||||++.+..|+.++|||||||++|||+| |+.||.........
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~--- 297 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--- 297 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH---
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH---
Confidence 9999999999998764432 3357889999999999999999999999999999998 89888764322211
Q ss_pred hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
...+....+...+..+++++.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 298 -~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 298 -CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 11122222334566678899999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-57 Score=406.63 Aligned_cols=256 Identities=14% Similarity=0.160 Sum_probs=197.3
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC----cceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 133 (359)
++.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+..++|||||++++++...+ .++||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456667899999999999998 578999999975431 1222345667777899999999999998754 5799999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
|+++|+|.+++.. ..+++..+.+++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999953 4699999999999999999999964 38999999999999999999999999999865
Q ss_pred CCCC--------CcCCCccccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----------Hh
Q 018244 207 RDGR--------SYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------IR 261 (359)
Q Consensus 207 ~~~~--------~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----------~~ 261 (359)
.... ...||+.|+|||++.+. .++.++|||||||++|||+||..|+....... ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4322 34689999999999754 36789999999999999999986653211000 00
Q ss_pred hhhhhhhccccccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 262 DRNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 262 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
............++..+ .+.+..+.+|+.+||+.||++|||+.+|++.|+++.+...
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 00111111222222222 3466789999999999999999999999999999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=400.23 Aligned_cols=242 Identities=18% Similarity=0.251 Sum_probs=189.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCC--------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD-------- 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 126 (359)
.+|++++.||+|+||+||+|+. .+|..||||++...... ..+.+.+|+++|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3688999999999999999995 56899999999765433 3467899999999999999999999987654
Q ss_pred ----cceEEEecCCCCCHhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 127 ----ERLLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 127 ----~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
.+|||||||++|+|.+++..... ...++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCc
Confidence 36999999999999999974322 2346677899999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC----------------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhh
Q 018244 202 LMKNSRDG----------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 202 ~a~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~ 265 (359)
+|+..... ....||+.|||||++.+..|+.++|||||||++|||++ ||........ ..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~---~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR---TL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH---HH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH---HH
Confidence 99875432 12469999999999999999999999999999999996 5654321111 11
Q ss_pred hhhccccccCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 266 QTLTDSCLEGQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 266 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ...++ ...++.+.+|+.+||+.||++|||+.+++++
T Consensus 238 ~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 11122 2345677899999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=403.68 Aligned_cols=249 Identities=15% Similarity=0.243 Sum_probs=202.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee------CCc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------GDE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 127 (359)
++|++++.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4699999999999999999995 5799999999976532 234568899999999999999999998764 357
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+|||||||. |+|.+++. ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...
T Consensus 134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 57999986 456899999999999999999999999 99999999999999999999999999998653
Q ss_pred C--------CCCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc------
Q 018244 208 D--------GRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC------ 272 (359)
Q Consensus 208 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 272 (359)
. .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+................+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 2356899999999998875 468999999999999999999999987643332222111111000
Q ss_pred ------------ccCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 ------------LEGQF-------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ------------~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... ....++++.+||.+||..||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 12346789999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=390.33 Aligned_cols=245 Identities=18% Similarity=0.220 Sum_probs=196.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (359)
+.|++++.||+|+||+||+|+.+ .++.||+|.+.... ....+.+|+++|+.+ +|||||++++++.+.+.+|||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 35889999999999999999742 46789999987643 345688999999998 699999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~~~- 209 (359)
|||+++|+|.+++. .+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999983 489999999999999999999999 99999999999999876 79999999999754322
Q ss_pred -------------------------------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchh
Q 018244 210 -------------------------------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257 (359)
Q Consensus 210 -------------------------------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~ 257 (359)
...+||+.|+|||++.+. .|+.++||||+||++|||+||+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 124689999999999876 489999999999999999999999854321
Q ss_pred HHHhhhhhhh-------------------------------hc---------ccc---------ccCCCChHHHHHHHHH
Q 018244 258 DLIRDRNIQT-------------------------------LT---------DSC---------LEGQFSSDEGTELVRL 288 (359)
Q Consensus 258 ~~~~~~~~~~-------------------------------~~---------~~~---------~~~~~~~~~~~~l~~l 288 (359)
+...-..+.. .. .+. .........++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 1100000000 00 000 0000112356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||++|++++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=413.65 Aligned_cols=249 Identities=19% Similarity=0.153 Sum_probs=213.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+|++++.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||+++++|.+...++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4688999999999999999995 578999999998766566677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC--CCeEEeccCCcccCCCCC---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~--~~~kl~DFg~a~~~~~~~--- 210 (359)
+||+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999999864 445799999999999999999999999 99999999999999854 899999999999876553
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..|+.++|||||||++|+|++|..||.................. .........++++.+||.
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCSGGGTTSCHHHHHHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence 457999999999999999999999999999999999999999876544333222211110 111122346788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.|++++
T Consensus 393 ~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=409.52 Aligned_cols=248 Identities=17% Similarity=0.131 Sum_probs=204.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHH---HHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQF---LEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
.++|++++.||+|+||+||+|+. .+|+.||||++.+... .....+ .+++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999995 5699999999974321 112223 3456778888999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||||++||+|.+++. ..+.+++..+..|+.||+.||.|||++ |||||||||+||||+.+|.+||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999997 346799999999999999999999999 999999999999999999999999999987654
Q ss_pred C--CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 G--RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
. ...+||+.|||||++.. ..|+.++|||||||++|||++|..||.......... ....... ....++...++++
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~--~~~~~p~~~S~~a 421 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--MAVELPDSFSPEL 421 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH--CCCCCCTTSCHHH
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC--CCCCCCccCCHHH
Confidence 3 45689999999999975 579999999999999999999999997643221111 1111111 1223556778899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 018244 286 VRLASRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps-----~~~il~~ 309 (359)
.+||.+||+.||++|++ +++|+++
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 99999999999999998 6777754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=360.92 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=219.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|++.+.||+|+||+||+|...++..||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 45667778899999999999988899999999987766667889999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----
Q 018244 137 NDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (359)
Q Consensus 137 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----- 209 (359)
+|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999996432 23589999999999999999999999 9999999999999999999999999999764322
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----------HhhhhhhhhccccccCCC
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------IRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 277 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..........++......
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 22347899999999998899999999999999999999999886432111 111112223333334455
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 677889999999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=361.93 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=215.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+|.+.+.||+|+||+||+|.. .++..||+|.+........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5678888999999999999995 468899999997766566778999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 90 KGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999999975 356799999999999999999999999 99999999999999999999999999997654321
Q ss_pred -------------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-hhhhhhccccccCC
Q 018244 211 -------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQ 276 (359)
Q Consensus 211 -------------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 276 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..|+.......... ....... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~----~~~ 243 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----DRY 243 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH----HHT
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc----ccc
Confidence 3468999999999999999999999999999999999998876432211110 0011111 112
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.+..+++.+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 234455679999999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=358.43 Aligned_cols=259 Identities=19% Similarity=0.289 Sum_probs=208.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+.+|++.+.||+|+||+||+|.. ++..||||++...... ..+.+.+|+++++.++||||+++++++......++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456889999999999999999987 5778999999765432 3457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999996422 12389999999999999999999999 8 999999999999999999999999999764433
Q ss_pred ----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||............. ........+...+.++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKCKRLEIPRNLNPQV 268 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH----HSCCCCCCCTTSCHHH
T ss_pred ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcCCCCCCCccCCHHH
Confidence 34568999999999999999999999999999999999999987654332222111 1112233455677889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
.+|+.+||+.||++|||+.++++.|+.+.+....
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=360.68 Aligned_cols=248 Identities=17% Similarity=0.239 Sum_probs=210.8
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....|.+++.||+|+||+||+|. ..++..||||++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34568899999999999999998 46788999999987665567788999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+.+|+|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 9999999999953 4689999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.............. ........+...+..+.+|+
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHH
Confidence 245689999999999999999999999999999999999999876533222111111 11111223455678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.+++++
T Consensus 251 ~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 99999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=365.45 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=211.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
....|.+++.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++|+.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456789999999999999999995 6789999999976432 3356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp ECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 999999999999963 45699999999999999999999999 9999999999999999999999999999865543
Q ss_pred -CCcCCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..++ .++||||||+++|+|++|+.||............... ....+...+.++.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~ 243 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFYMSTDCEN 243 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence 345789999999999988765 7899999999999999999999876554443332221 11234556788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||..||.+|||+.+++++
T Consensus 244 li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=349.52 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=215.8
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..+|.+++.||+|+||+||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357889999999999999999988888999999986543 3567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~ 210 (359)
++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... .
T Consensus 88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999964 445689999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+|..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+.++.+++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIM 240 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCcCCHHHHHHH
Confidence 3445778999999998899999999999999999999 88887765443332222211 12223445577899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.+||+.||++|||+.++++.|+.+.+.
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=360.35 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=213.0
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+.+.||+|+||+||+|... .+..||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888999999999999999963 345699999986533 3356789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999964 445799999999999999999999999 99999999999999999999999999998765432
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............. ......+...+.
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 281 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-----GYRLPAPMGCPH 281 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCH
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-----CCCCCCCCCcCH
Confidence 2234678999999998889999999999999999999 8988866544333222211 122233456678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
++.+|+.+||+.||++|||+.++++.|+.+.+...
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 89999999999999999999999999999876544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=355.19 Aligned_cols=261 Identities=16% Similarity=0.201 Sum_probs=217.3
Q ss_pred cccCHHHHHHHhcCCCc-------ccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc
Q 018244 42 CEYSIETLRTATSGFAM-------ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR 113 (359)
Q Consensus 42 ~~~~~~~~~~~~~~~~~-------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 113 (359)
..++.+++..+++.... +...+.||+|+||.||+|... +|..||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34778888888765432 455667899999999999965 7899999999876666677899999999999999
Q ss_pred ccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC
Q 018244 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (359)
Q Consensus 114 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~ 193 (359)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999984 45799999999999999999999999 999999999999999999
Q ss_pred CeEEeccCCcccCCCC----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc
Q 018244 194 NPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT 269 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 269 (359)
.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... .
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~ 257 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-P 257 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-S
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-C
Confidence 9999999998765432 3457899999999999889999999999999999999999998765333222111111 1
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+ ........+..+.+++.+||+.||++|||+.+++++
T Consensus 258 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 258 PP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111223456789999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=363.77 Aligned_cols=254 Identities=19% Similarity=0.303 Sum_probs=212.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe--------CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 125 (359)
...|.+.+.||+|+||.||+|.. .++..||||++...... ..+.+.+|+++|+.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35688889999999999999984 23567999999865432 356789999999999 899999999999999
Q ss_pred CcceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~ 191 (359)
+..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECC
Confidence 99999999999999999997532 23589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhh
Q 018244 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~ 264 (359)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||............
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999999865432 22345778999999999999999999999999999999 88888765433322211
Q ss_pred hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
........+..++.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 319 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 319 -----KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112223455677889999999999999999999999999998865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=360.53 Aligned_cols=245 Identities=17% Similarity=0.223 Sum_probs=209.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..+|++++.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 45788999999999999999995 468999999997531 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC---
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--- 208 (359)
|||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999986 345789999999999999999999999 999999999999999999999999999986432
Q ss_pred -CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 209 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.....||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHH
Confidence 23456899999999999999999999999999999999999998766544333222211 12345567789999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 018244 288 LASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
|+.+||+.||++|| ++.+++++
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999 89999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=359.20 Aligned_cols=271 Identities=28% Similarity=0.472 Sum_probs=222.3
Q ss_pred cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccc
Q 018244 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (359)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~ 118 (359)
....++..++....++|. +.+.||+|+||.||+|...++..||||++...... ....+.+|+++++.++||||+++
T Consensus 16 ~~~~~~~~~~~~~~~~y~---~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFS---NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCEECCTHHHHTTTTSSC---STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccceecHHHHHHHhhccc---cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 356788888887776655 55666999999999999878899999999865422 23368899999999999999999
Q ss_pred cceeeeCCcceEEEecCCCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCC--CcccccCCCCCeeeCCCCC
Q 018244 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--~ivH~Dikp~NIll~~~~~ 194 (359)
++++......++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999997542 335999999999999999999999863 8999999999999999999
Q ss_pred eEEeccCCcccCCCC-----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH----------
Q 018244 195 PRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------- 259 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~---------- 259 (359)
+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999865432 23458999999999988889999999999999999999999885321110
Q ss_pred ---HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 260 ---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 260 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
..........+.......+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 011122223333344455677889999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=362.78 Aligned_cols=248 Identities=18% Similarity=0.195 Sum_probs=207.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.+.+.||+|+||+||+|.. .+|..||+|.+...... ..+.+.+|+.+|+.++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 3588899999999999999995 46889999999765322 2467899999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCccc
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKN 205 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~ 205 (359)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999996 456799999999999999999999999 999999999999998776 799999999987
Q ss_pred CCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s 246 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEFFSQTS 246 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSC
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchhccCCC
Confidence 6543 3456899999999999889999999999999999999999999776443332222111100 0000112356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+||.+||..||++|||+.+++++
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 789999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=353.92 Aligned_cols=258 Identities=19% Similarity=0.296 Sum_probs=211.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
..|++++.||+|+||+||+|.. .++..||||++........+.+.+|+++++.++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688999999999999999984 35889999999877656667899999999999999999999998553 5689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999999975 344699999999999999999999999 9999999999999999999999999999875433
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-----------hhhhhhccc
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNIQTLTDS 271 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~ 271 (359)
. ...++..|+|||.+.+..++.++||||||+++|+|+||..|+.......... .........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 2 2345677999999998999999999999999999999998876543322110 011111122
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
......+..++.++.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 222334556778999999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=347.73 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=212.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..+|.+++.||+|+||+||+|...++..||+|++..... ..+.+.+|++++..++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457889999999999999999988888999999986543 3567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~ 210 (359)
++++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 102 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999999964 245699999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||............... .....+...++.+.+++
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYTIM 254 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHH
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-----cCCCCCCcCCHHHHHHH
Confidence 3345778999999998889999999999999999998 88888765433332222211 12223344567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.+||+.||++|||+.++++.|+.+.++
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999988654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=347.67 Aligned_cols=252 Identities=20% Similarity=0.321 Sum_probs=213.2
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|.+++.||+|+||.||+|...++..||+|++..... ..+.+.+|++++..++||||+++++++......++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 56889999999999999999988888899999986553 35678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 87 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 87 NGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp TCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred CCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9999999964 344699999999999999999999999 99999999999999999999999999998665432 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...++.+.+++.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-----HRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHHH
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----CCCCCCCcChHHHHHHHH
Confidence 345677999999998889999999999999999999 88887655433322221111 112223445678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+||+.||++|||+.++++.|+.+.+.
T Consensus 240 ~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=350.75 Aligned_cols=260 Identities=17% Similarity=0.242 Sum_probs=211.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++++.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4688999999999999999994 4688999999865432 22457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999973 35799999999999999999999999 9999999999999999999999999999865433
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||................... .........+..+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHHH
Confidence 23468999999999999999999999999999999999999997664433222222111111 111123445678999
Q ss_pred HHHHhcccCCCCCC-CHHHHHHHHHHhhhcccCC
Q 018244 288 LASRCLQYEPRERP-NPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 288 li~~cl~~dp~~Rp-s~~~il~~L~~~~~~~~~~ 320 (359)
++.+||+.||++|| +++++.+.|+.+.......
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 99999999999998 8999999999876654443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=353.64 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=210.3
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..+|++++.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 46789999999999999999995 468999999997532 12356688999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-C
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~ 210 (359)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 999999999999973 45699999999999999999999999 9999999999999999999999999999876543 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...+.++.+++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----A--ELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----C--CCCCCTTSCHHHHHHHH
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCCCCHHHHHHHH
Confidence 56789999999999999999999999999999999999999876544333222221 1 12344566788999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 018244 291 RCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~il~~ 309 (359)
+||..||++|| ++++++++
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhccCHHHcCCCcCCCHHHHhcC
Confidence 99999999999 88988864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.79 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=213.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.+++.||+|+||+||+|.+. ++..||||++..... .....+.+|+.+++.++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788999999999999999843 466899999975433 33456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---CeEEeccC
Q 018244 130 LVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFG 201 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---~~kl~DFg 201 (359)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999999997532 24689999999999999999999999 999999999999999555 59999999
Q ss_pred CcccC------CCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 202 LMKNS------RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 202 ~a~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
+++.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.............. ...
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~-----~~~ 304 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----GGR 304 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----TCC
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCC
Confidence 98743 22234557889999999998899999999999999999998 8888876544333222211 112
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
...+...+..+.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 2234556778999999999999999999999999999987765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=365.82 Aligned_cols=248 Identities=17% Similarity=0.175 Sum_probs=207.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|.+++.||+|+||+||+|.. .+|..+|+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 4688899999999999999984 57889999999765432 34568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC---CCCCeEEeccCCcccCCCCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~---~~~~~kl~DFg~a~~~~~~~ 210 (359)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999874 45699999999999999999999999 999999999999998 46889999999998765432
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........++++.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--FPSPEWDTVTPEAK 245 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCccccccCCHHHH
Confidence 357899999999999889999999999999999999999998776544433322221111 11111235678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=365.90 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=212.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..+|.+.+.||+|+||.||+|... ++..||||.+...... ..+.+.+|+++|+.++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356788899999999999999965 7889999999865322 23468899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999964 344689999999999999999999999 99999999999999999999999999998654321
Q ss_pred ---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
...++..|+|||.+.+..++.++||||||+++|||+| |..|+........... .........+..++.++.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-----VEKGGRLPCPELCPDAVF 345 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-----HHTTCCCCCCTTCCHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHH
Confidence 1224667999999998889999999999999999998 8888776543322221 111122234455678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 287 RLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=356.21 Aligned_cols=257 Identities=15% Similarity=0.200 Sum_probs=204.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCc----ceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----RLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv 131 (359)
...|++++.||+|+||+||+|+.. +..||||++.... .......+|+.+++.++||||+++++++..... +++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357889999999999999999875 6789999997543 234456679999999999999999999987553 6999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK---------ERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999953 4599999999999999999999985 2899999999999999999999999999
Q ss_pred cccCCCC------CCcCCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCcchhHH------H-----
Q 018244 203 MKNSRDG------RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL------I----- 260 (359)
Q Consensus 203 a~~~~~~------~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~elltg~~p~~~~~~~~------~----- 260 (359)
++..... ....||+.|+|||++.+. .++.++||||||+++|+|+||+.||....... .
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9764432 235689999999999863 45678899999999999999998886431100 0
Q ss_pred -hhhhhhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 261 -RDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 261 -~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
................. ....+.++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000001111111111 2245677999999999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=341.87 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=213.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC--CcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (359)
.+..|.+++.||+|+||+||+|+.. +..||||++..... ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 4568899999999999999999985 77899999986543 2345789999999999999999999999887 78899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||+++|+|.+++.......+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999865455699999999999999999999998 8 99999999999999999999999988765333
Q ss_pred CCCcCCCccccCcccccCCCCCC---ccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTP---ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~---~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||............. ........+...+.++
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA----LEGLRPTIPPGISPHV 240 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH----HSCCCCCCCTTCCHHH
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH----hcCCCCCCCCCCCHHH
Confidence 3456789999999998765544 7999999999999999999987654333322221 1122233455677889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=362.61 Aligned_cols=246 Identities=18% Similarity=0.245 Sum_probs=205.8
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 356789999999999999999995 468899999997532 12345678899999988 6999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999973 45699999999999999999999999 999999999999999999999999999986432
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
.....||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~ 251 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLHEDA 251 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHH
Confidence 23456899999999999888999999999999999999999999876554443333221 123445567889
Q ss_pred HHHHHHhcccCCCCCCCH------HHHHHH
Q 018244 286 VRLASRCLQYEPRERPNP------RSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~------~~il~~ 309 (359)
.+|+.+||+.||++||++ .+++++
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999999998 677653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=355.24 Aligned_cols=249 Identities=16% Similarity=0.177 Sum_probs=209.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+..|.+.+.||+|+||+||+|... ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999954 68899999997543 3456688999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC--CCCeEEeccCCcccCCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~~~~~~-- 210 (359)
+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999953 345799999999999999999999999 9999999999999987 7899999999998765543
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||................... ........+.++.+|+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--ChhhhccCCHHHHHHH
Confidence 3458899999999998889999999999999999999999997765443332222111110 0000123567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||..||++|||+.+++++
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=369.98 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=214.4
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|.+.+.||+|+||+||+|...++..||||.+.... ...+.+.+|+++|+.++||||+++++++. .+..++||||+.
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4677888999999999999998888899999998654 34678999999999999999999999986 667999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----CC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~~ 211 (359)
+|+|.+++.......+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++..... ..
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 99999999754344689999999999999999999999 9999999999999999999999999999875432 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||++....++.++||||||+++|||+| |+.||.............. ......+..++.++.+|+.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GYRMPRPENCPEELYNIMM 419 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-----TCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHH
Confidence 345678999999998899999999999999999999 8988876543333222111 1222334567788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
+||+.||++|||+.++++.|+.+....
T Consensus 420 ~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 999999999999999999999886543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=352.73 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=209.8
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CC-------cEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQ-------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
.+|.+.+.||+|+||+||+|... ++ ..||+|.+........+.+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 46888899999999999999843 33 47999999876656677899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC--------eEEecc
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCF 200 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~--------~kl~DF 200 (359)
++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++. +||+||
T Consensus 88 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999975 344589999999999999999999999 9999999999999998877 999999
Q ss_pred CCcccCCCCCCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 201 GLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 201 g~a~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
|++..........+|..|+|||++.+ ..++.++||||||+++|+|++|..|+............... ....+.
T Consensus 166 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~------~~~~~~ 239 (289)
T 4fvq_A 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQLPA 239 (289)
T ss_dssp CSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCCC
T ss_pred cccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc------cCCCCC
Confidence 99987766666678899999999987 66899999999999999999976655443222111111110 112233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
..+.++.+|+.+||+.||++|||+.++++.|+.+......
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 3456799999999999999999999999999998764443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=344.44 Aligned_cols=271 Identities=28% Similarity=0.459 Sum_probs=222.2
Q ss_pred cccccCHHHHHHHhcCCCccc---ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCC----CchHHHHHHHHHHHhcCCC
Q 018244 40 VFCEYSIETLRTATSGFAMEN---IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRN 112 (359)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~---~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 112 (359)
....|+..++..++++|+... ..+.||+|+||.||+|.. ++..||+|++.... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999999997652 225679999999999987 56789999987532 2235678999999999999
Q ss_pred cccccccceeeeCCcceEEEecCCCCCHhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC
Q 018244 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (359)
Q Consensus 113 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~ 191 (359)
|||+++++++...+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDE 168 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECT
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999998643 245689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH----Hh
Q 018244 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IR 261 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~----~~ 261 (359)
++.+||+|||++...... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... +.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999998765432 23468999999998874 58899999999999999999998886532211 10
Q ss_pred hh------hhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 262 DR------NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 262 ~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.. ......+.. ....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 00 011111111 12345677889999999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=367.71 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=212.8
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC-cceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 133 (359)
+...|.+++.||+|+||.||+|... +..||||+++... ..+.+.+|+++|+.++||||+++++++.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567889999999999999999975 6689999998654 4567899999999999999999999987665 7899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~ 212 (359)
|+++|+|.+++.......+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 99999999999865455589999999999999999999999 9999999999999999999999999999865433 233
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.++..|+|||.+.+..++.++||||||+++|||+| |..||............ ........+..++.++.+||.+
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-----HTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHHHHHHHH
Confidence 56789999999999999999999999999999998 99888754332222111 1112233456677899999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 292 CLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
||+.||++|||+.++++.|+.+...
T Consensus 422 cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999988654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=358.21 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=215.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
..|.+.+.||+|+||+||+|... .+..||||++...... ....+.+|+++++.+ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 57888899999999999999842 2357999999865433 346789999999999 8999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED 227 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTT
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCC
Confidence 9999999999999999997543 24589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999865432 23345788999999999999999999999999999999 888887654443322221
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
. ......+...+.++.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 308 ~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 308 E-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp T-----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred c-----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 1 1222334556788999999999999999999999999999987654433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=359.55 Aligned_cols=251 Identities=17% Similarity=0.130 Sum_probs=197.8
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
....|.+++.||+|+||+||+|... +++.||||++..... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4567999999999999999999954 788999999976543 24568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC--eEEeccCCcccCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSRD--- 208 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~--~kl~DFg~a~~~~~--- 208 (359)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999863 45699999999999999999999999 9999999999999987765 99999999875332
Q ss_pred CCCcCCCccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPE-SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||...............+.............+.++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 234578999999999988877665 8999999999999999999875422111111111121111111112245678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHHhC
Confidence 9999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=354.30 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=214.9
Q ss_pred HhcCCCcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeee
Q 018244 52 ATSGFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE 124 (359)
Q Consensus 52 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 124 (359)
..-....|.+++.||+|+||.||+|... ++..||||++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3344567889999999999999999963 3478999999865433 34678999999999999999999999999
Q ss_pred CCcceEEEecCCCCCHhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccC
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Di 182 (359)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +++|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dl 200 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDL 200 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCC
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCC
Confidence 999999999999999999997532 25789999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeEEeccCCcccCCC------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q 018244 183 NAYRIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSH 255 (359)
Q Consensus 183 kp~NIll~~~~~~kl~DFg~a~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~ 255 (359)
||+||+++.++.+||+|||++..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999875432 223456889999999998889999999999999999999 88888765
Q ss_pred hhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
............ .....+...+.++.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 281 ~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 281 AHEEVIYYVRDG-----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CHHHHHHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ChHHHHHHHhCC-----CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 443332221111 112234556778999999999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=352.63 Aligned_cols=247 Identities=17% Similarity=0.165 Sum_probs=206.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.|.+.+.||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.+|+.++||||+++++++......++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 578888999999999999995 46889999999764322 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCcccC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~~ 206 (359)
||||+++++|.+++. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++ .+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999996 456799999999999999999999999 999999999999999877 8999999999876
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--EFEDEYFSNTSA 246 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC--CCCHHHHTTSCH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC--CcCccccccCCH
Confidence 433 345689999999999988999999999999999999999999876543332221111100 000001123467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.+|+.+||+.||++|||+.+++++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=349.58 Aligned_cols=252 Identities=19% Similarity=0.226 Sum_probs=202.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
-...|++++.||+|+||+||+|...++..||+|++...... ....+.+|+++++.++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34789999999999999999999888999999999754322 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++ +|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 99985 78888864 445699999999999999999999999 9999999999999999999999999999875432
Q ss_pred -CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc--------------
Q 018244 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL-------------- 273 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 273 (359)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................+..
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 33467999999999876 45899999999999999999999998754322221111110000000
Q ss_pred ---c--C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 274 ---E--G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 274 ---~--~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. . ......++++.+|+.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0 0012345789999999999999999999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=356.52 Aligned_cols=248 Identities=18% Similarity=0.210 Sum_probs=207.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|.+++.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3588889999999999999995 4688999999976543 234678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcccCCCCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~~~~~~~ 210 (359)
|+.+|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999986 445789999999999999999999999 99999999999999865 459999999998765443
Q ss_pred ---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.++.+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKS 263 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTGGGGSCHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHH
Confidence 357899999999999889999999999999999999999998765443332222111111 011111345788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 264 li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=359.37 Aligned_cols=248 Identities=17% Similarity=0.223 Sum_probs=206.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
++.+|.+++.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++|+.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467899999999999999999995 468899999987532 2235678899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+.+|+|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999997 456799999999999999999999999 9999999999999999999999999999876443
Q ss_pred --CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....+.. ....++...+.+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-~~~~~~~--~~~~~p~~~s~~ 246 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE-IVHTFET--TVVTYPSAWSQE 246 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-HHHHHHH--CCCCCCTTSCHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-HHHHHhh--cccCCCCcCCHH
Confidence 35678999999999974 458999999999999999999999986432211110 0111111 112345567789
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHH
Q 018244 285 LVRLASRCLQYEPRERPN-PRSLVT 308 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps-~~~il~ 308 (359)
+.+|+.+||+.||++||+ ++++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999998 666654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=348.59 Aligned_cols=249 Identities=17% Similarity=0.223 Sum_probs=197.7
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhc--CCCcccccccceeeeC----CcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEG----DERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~l 130 (359)
.+|.+++.||+|+||+||+|+. ++..||||++... ....+.+|.+++.. ++||||+++++++... ...++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4688899999999999999988 6788999999753 34455666666666 7899999999987553 45899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
||||+++|+|.+++ ....+++..++.++.|++.||.||| +. +++||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999 4557999999999999999999999 88 999999999999999999999999999
Q ss_pred cccCCCC--------CCcCCCccccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CCCCCcchh-
Q 018244 203 MKNSRDG--------RSYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSG----------KHIPPSHAL- 257 (359)
Q Consensus 203 a~~~~~~--------~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg----------~~p~~~~~~- 257 (359)
++..... ....||+.|+|||++.+. .++.++||||||+++|||+|| ..||.....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 8754332 233789999999999876 455789999999999999999 766643211
Q ss_pred ----HHHhhhhhhhhcccccc-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 258 ----DLIRDRNIQTLTDSCLE-GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 258 ----~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.............+... ...+...+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11111111000011000 112245778999999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=341.25 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=200.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc----hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
++..|.+.+.||+|+||.||+|... +..||||++...... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578889999999999999999974 778999998764322 24678899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---cccccCCCCCeeeCC--------CCCeEEec
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER---ALYHDLNAYRIVFDD--------DVNPRLSC 199 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~---ivH~Dikp~NIll~~--------~~~~kl~D 199 (359)
||||+++++|.+++ ....+++..++.++.|++.||.|||++ + ++|+||||+||+++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999998 456799999999999999999999999 8 899999999999986 77899999
Q ss_pred cCCcccCCCC--CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 200 FGLMKNSRDG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 200 Fg~a~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
||++...... ....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~ 235 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----MNKLALPI 235 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH----TSCCCCCC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh----cCCCCCCC
Confidence 9999865433 24568999999999998889999999999999999999999987654332222111 11122234
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 456678899999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=346.60 Aligned_cols=246 Identities=15% Similarity=0.181 Sum_probs=200.1
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--------------------------hHHHHHHHHHHHh
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--------------------------DARQFLEEARAVG 108 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~ 108 (359)
...|.+++.||+|+||.||+|.. .++..||||++...... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788999999999999999985 56889999999754311 1245889999999
Q ss_pred cCCCcccccccceeee--CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 109 QLRNRRLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 109 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
.++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.|++.||.|||++ +++||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHH
Confidence 9999999999999986 56789999999999998876 456799999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCC----CCcCCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCcchhHH
Q 018244 187 IVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL 259 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~~~~~----~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~ 259 (359)
||++.++.+||+|||++...... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999999876543 2456899999999998765 3778999999999999999999987654433
Q ss_pred HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......... .........+.++.+|+.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 248 LHSKIKSQA----LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHCC----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHhccc----CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 322221111 1111123456789999999999999999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=358.66 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=203.0
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+.+.||+|+||.||+|+.. ++..||||.+..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45778888999999999999854 567899999986533 2355789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999964 445799999999999999999999999 99999999999999999999999999998754432
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...++..|+|||++.+..++.++||||||+++|||++ |..||............. .......+...+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~ 277 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----EGYRLPPPMDCPA 277 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-----TTEECCCCTTCBH
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCccccH
Confidence 1123568999999998899999999999999999998 888886554333222211 1122233455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 8999999999999999999999999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=355.76 Aligned_cols=246 Identities=17% Similarity=0.173 Sum_probs=210.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...+|.+++.||+|+||.||+|.. .+|..||+|++.... ....+.+.+|+++|+.++||||+++++++.+....++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 456789999999999999999995 468899999997532 1235678899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999999974 35699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++.+|+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLL 269 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHH
Confidence 3557899999999999999999999999999999999999998766443332222211 1234456778899999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 018244 290 SRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps-----~~~il~~ 309 (359)
.+||+.||++||+ +.+++++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999998 8888764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=340.23 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=214.5
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
...|.+++.||+|+||.||+|...++..||+|.+..... ..+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467889999999999999999988888999999987553 3567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~ 210 (359)
++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...... .
T Consensus 86 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 86 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999965 345689999999999999999999999 9999999999999999999999999998865432 2
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+..+.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIM 238 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHH
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----CcCCCCccCcHHHHHHH
Confidence 3456778999999998889999999999999999999 78877655433322221111 11223345567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+||+.||++|||+.++++.|+.+.+
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=341.62 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=206.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch-------HHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
-..|++.+.||+|+||+||+|.. .++..||+|++....... .+.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788899999999999999995 578899999997543322 157889999999999999999999986544
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCCCCC-----eEEecc
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVN-----PRLSCF 200 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~~~~-----~kl~DF 200 (359)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. + ++|+||||+||+++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999998865 455799999999999999999999999 8 999999999999988776 999999
Q ss_pred CCcccCCCC-CCcCCCccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 201 GLMKNSRDG-RSYSTNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 201 g~a~~~~~~-~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
|+++..... ....+|+.|+|||++. ...++.++||||||+++|+|++|+.||.......... .............
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTI 251 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCC
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCC
Confidence 999865443 3456899999999984 4457899999999999999999999986543222211 1111122223344
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
+...++++.+++.+||+.||++|||+.++++.|+.+
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 566778899999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=345.06 Aligned_cols=250 Identities=17% Similarity=0.195 Sum_probs=201.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.+|++++.||+|+||+||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5788999999999999999995 46889999999765432 24678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++ +|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 66666654 456799999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcc-hhHHHhhhhhhhhcccc---------------
Q 018244 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSC--------------- 272 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~--------------- 272 (359)
....+|+.|+|||++.+.. ++.++||||||+++|+|++|..|+... ...............+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3456789999999998766 899999999999999999988875433 22111111111000000
Q ss_pred --------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 --------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 --------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.........+.++.+|+.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0001123456789999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=360.57 Aligned_cols=244 Identities=16% Similarity=0.225 Sum_probs=201.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|++++.||+|+||+||+|+.. +++.||+|++...... ..+.+.+|..+|..+ +||||+++++++.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567899999999999999999954 6889999999764322 234578899999887 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999873 45799999999999999999999999 999999999999999999999999999986322
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh-----hhhhhhhccccccCCCChH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-----DRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 280 (359)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ......+.. ....++..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~ 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCCc
Confidence 23557899999999999999999999999999999999999998532111100 001111111 12234566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH
Q 018244 281 EGTELVRLASRCLQYEPRERPNP 303 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~ 303 (359)
.+.++.+|+.+||+.||++||++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCC
Confidence 78899999999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=357.43 Aligned_cols=245 Identities=18% Similarity=0.219 Sum_probs=207.3
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|.+++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 456788999999999999999996 468899999997532 22355678899999877 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999963 35699999999999999999999999 999999999999999999999999999986432
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 245 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEA 245 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CCCCCcccCHHH
Confidence 23557899999999999999999999999999999999999999766544333222211 123445577889
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHH
Q 018244 286 VRLASRCLQYEPRERPNPR-SLVT 308 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~-~il~ 308 (359)
.+|+.+||..||++||++. ++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 9999999999999999997 6654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=371.42 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=215.8
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..+|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+|+.++||||+++++++......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567888999999999999999654 8899999998654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 9999999999865667799999999999999999999999 99999999999999999999999999998764332
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...++..|+|||++.+..++.++||||||+++|||+| |..||.......... .+........+..++.++.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCCCCTTCCHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCCCCHHHHHH
Confidence 2334678999999998889999999999999999999 888876654332221 112222233455677889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
|.+||+.||++|||+.++++.|+.+..
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=358.60 Aligned_cols=250 Identities=19% Similarity=0.157 Sum_probs=209.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
+..|.+++.||+|+||.||+|.. .++..||+|++..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35688999999999999999995 46889999999876555566789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC--CCCeEEeccCCcccCCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~~~~~~-- 210 (359)
+.+|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999864 345799999999999999999999999 9999999999999974 5779999999998765443
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..||................ ...........+.++.+|+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--CCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccccccCCHHHHHHH
Confidence 3468999999999998899999999999999999999999987654332222111110 0111122345678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.+++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=353.71 Aligned_cols=248 Identities=17% Similarity=0.137 Sum_probs=203.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+.+|++++.||+|+||+||+|... +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999954 7889999999754332 23568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999986 455699999999999999999999999 9999999999999999999999999999764322
Q ss_pred --CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........... ...............+..+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHH
Confidence 24578999999999987775 7789999999999999999999865432111100 01111111111244667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 99999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=344.51 Aligned_cols=250 Identities=17% Similarity=0.227 Sum_probs=202.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||+||+|...++..||+|++...... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578899999999999999999878899999999765422 246788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+++ +|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 976 89998864 346799999999999999999999999 9999999999999999999999999998765422 2
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------------cc
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS----------------CL 273 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------~~ 273 (359)
...+|+.|+|||++.+. .++.++||||||+++|+|++|..||..................+ ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 34679999999999764 58999999999999999999999987653322211111100000 00
Q ss_pred -------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 274 -------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 274 -------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
........+.++.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001123356789999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.27 Aligned_cols=250 Identities=16% Similarity=0.227 Sum_probs=205.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|.+++.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|..++..+ +||||+++++++.+....+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3467889999999999999999954 688999999986532 2345678899999988 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999963 35699999999999999999999999 999999999999999999999999999986322
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----HhhhhhhhhccccccCCCChH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 280 (359)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+... ...++..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCC
Confidence 234578999999999999899999999999999999999999986421100 000011111111 1234556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNP------RSLVTA 309 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~------~~il~~ 309 (359)
.+.++.+|+.+||+.||++||++ .+++++
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 77889999999999999999996 566543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=355.13 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=208.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|++++.||+|+||.||+|... +++.||||++.... ....+.+.+|..+|..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4567899999999999999999965 47899999997532 22356688899999988 7999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999973 35699999999999999999999999 999999999999999999999999999986322
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||............... ...++...+.++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 248 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA 248 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHH
Confidence 23557899999999999999999999999999999999999999876544333322221 123455677899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 018244 286 VRLASRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps-----~~~il~~ 309 (359)
.+|+.+||+.||++||+ +.+++++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 4677654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=346.70 Aligned_cols=256 Identities=14% Similarity=0.145 Sum_probs=207.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCC--cceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 132 (359)
..|.+.+.||+|+||+||+|... ++..||||++..... ...+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888999999999999999954 588999999985432 33567889999999999999999999988765 679999
Q ss_pred ecCCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee----CCCCCeEEeccCCcccCC
Q 018244 133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll----~~~~~~kl~DFg~a~~~~ 207 (359)
||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999997532 23499999999999999999999999 99999999999999 778889999999998765
Q ss_pred CCC---CcCCCccccCccccc--------CCCCCCccchhhHHHHHHHHHhCCCCCCcchh----HHHhhhhhhhhc---
Q 018244 208 DGR---SYSTNLAFTPPEYLR--------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLT--- 269 (359)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~elltg~~p~~~~~~----~~~~~~~~~~~~--- 269 (359)
... ...||+.|+|||++. +..++.++||||||+++|+|++|..||..... ............
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 443 446899999999886 46789999999999999999999998853211 111111111000
Q ss_pred ----------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 270 ----------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 270 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
............+..+.+++.+||+.||++|||+++++++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00011133467888999999999999999999999999987754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.94 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=212.2
Q ss_pred CcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+++++.++||||+++++++...+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 5688889999999999999985 2357899999986543 33567899999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHWET----------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NI 187 (359)
+||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +++|+||||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NI 181 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNI 181 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchheE
Confidence 99999999999999975322 3489999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHH
Q 018244 188 VFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLI 260 (359)
Q Consensus 188 ll~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~ 260 (359)
+++.++.+||+|||++....... ...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998654332 3345778999999998889999999999999999999 8888876543322
Q ss_pred hhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.... ........+...+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 262 ~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 FNLL-----KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHH-----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh-----hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2111 1111223445667889999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=366.50 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=210.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|.+.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+++|+.++||||+++++++.. +..+|||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4577888999999999999998887889999998654 335679999999999999999999999876 67899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+|+|.+++.......+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...... .
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 99999999643345689999999999999999999999 99999999999999999999999999998754322 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|||++ |..||............. .......+..++..+.+|+.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~ 415 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----RGYRMPCPPECPESLHDLMC 415 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence 345678999999998899999999999999999999 888887654333222211 11222344567788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+||+.||++|||+.++++.|+.+.....
T Consensus 416 ~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 416 QCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 9999999999999999999998865443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=353.34 Aligned_cols=260 Identities=21% Similarity=0.271 Sum_probs=213.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceee--eCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC--EGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 129 (359)
..|++++.||+|+||.||+|.. .++..||||++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688999999999999999984 358899999998776566677999999999999999999999886 445689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999964 234699999999999999999999999 9999999999999999999999999999865433
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh----------hhhhhhcccc
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD----------RNIQTLTDSC 272 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~----------~~~~~~~~~~ 272 (359)
. ...+|..|+|||++.+..++.++||||||+++|+|++|..||.......... ..........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2 3356778999999998889999999999999999999998876543322111 1111122222
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.....+...++++.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 2333456677899999999999999999999999999999876443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=354.64 Aligned_cols=248 Identities=19% Similarity=0.186 Sum_probs=203.7
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-----CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 588999999999999999985 468999999986421 12356789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC---eEEeccCCcccC
Q 018244 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNS 206 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~---~kl~DFg~a~~~ 206 (359)
|||+++++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999887642 234689999999999999999999999 9999999999999986654 999999999876
Q ss_pred CCCC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 207 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.... ...||+.|+|||++.+..++.++||||||+++|+|++|..||......... ......... ........+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~i~~~~~~~--~~~~~~~~s 260 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE-GIIKGKYKM--NPRQWSHIS 260 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH-HHHHTCCCC--CHHHHTTSC
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH-HHHcCCCCC--CccccccCC
Confidence 5432 346899999999999889999999999999999999999998765432211 111100000 000012346
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+|+.+||+.||++|||+.+++++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 789999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=355.54 Aligned_cols=245 Identities=19% Similarity=0.229 Sum_probs=206.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+..|.+++.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 456789999999999999999995 678899999987432 1223568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+ +|+|.+++.. ...+++..+..++.|++.||.|||+. |++||||||+|||+++++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 6799998863 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred --CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||............ .. .....+...++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~-~~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----NS-CVYVMPDFLSPGAQ 236 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----CS-SCCCCCTTSCHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----Hc-CCCCCcccCCHHHH
Confidence 34568999999999987775 68999999999999999999998764332221111 10 11223455678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||.+|||+.+++++
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=349.52 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=198.4
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-C---cEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcc--
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN-Q---FRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER-- 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-- 128 (359)
..|.+.+.||+|+||+||+|.... + ..||||++... .....+.+.+|+++++.++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 467888899999999999998543 3 27999999765 334467799999999999999999999999877655
Q ss_pred ----eEEEecCCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEecc
Q 018244 129 ----LLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (359)
Q Consensus 129 ----~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DF 200 (359)
++||||+.+|+|.+++... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeec
Confidence 9999999999999998642 122689999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccc
Q 018244 201 GLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 201 g~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
|+++...... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............. ..
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----~~ 256 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-----GN 256 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TC
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-----CC
Confidence 9998654332 2345678999999998899999999999999999999 8887765433322221111 11
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
....+...+.++.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 22334556788999999999999999999999999999997765543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=343.81 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=216.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..+|.+.+.||+|+||+||+|... ++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+....++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 356788899999999999999965 48889999998654 3467789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 9999999999876667799999999999999999999999 99999999999999999999999999998765433
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...++.+.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----KDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----TTCCCCCCTTCCHHHHHH
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----ccCCCCCCCCCCHHHHHH
Confidence 2235678999999998899999999999999999999 888876554333222211 112223345667889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+.+||+.||++|||+.++++.|+.+...
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999988664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=348.92 Aligned_cols=245 Identities=17% Similarity=0.209 Sum_probs=199.7
Q ss_pred CCcccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCC----chHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
...|++++.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+|+.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999986 4788999999986532 234557889999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999963 45689999999999999999999999 99999999999999999999999999987543
Q ss_pred CC----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~ 246 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------KLNLPPYLTQ 246 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------CCCCCTTSCH
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCH
Confidence 22 3456899999999999888999999999999999999999998765443332222211 1123455678
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
++.+|+.+||+.||++|| ++.+++++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 899999999999999999 77787764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=362.41 Aligned_cols=254 Identities=17% Similarity=0.135 Sum_probs=209.8
Q ss_pred HHHhcCCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeC
Q 018244 50 RTATSGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125 (359)
Q Consensus 50 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 125 (359)
....-...+|.+++.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 334445678899999999999999999954 68899999986421 11233478899999999999999999999999
Q ss_pred CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
..++|||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999999853 4689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCC-----CCcCCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCC
Q 018244 206 SRDG-----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (359)
Q Consensus 206 ~~~~-----~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
.... ....||+.|+|||++.+.. ++.++||||||+++|||++|+.||.................. ....
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~p 295 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--LTFP 295 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCC
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--ccCC
Confidence 6543 2567999999999998655 789999999999999999999999876544333332221111 1111
Q ss_pred CChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 277 FSSDEGTELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
.....+.++.+||.+||..+|.+ ||++++|+++
T Consensus 296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 12346788999999999999988 9999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=354.97 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=209.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
....|.+.+.||+|+||.||+|.+ .+++.||||++...... ..+.+.+|++++..+ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 345678888999999999999973 24578999999865433 345789999999999 7999999999988765
Q ss_pred c-ceEEEecCCCCCHhhhhhcCCC--------------------------------------------------------
Q 018244 127 E-RLLVAEYMPNDTLAKHLFHWET-------------------------------------------------------- 149 (359)
Q Consensus 127 ~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 149 (359)
. .++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 8999999999999999975321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------CcCCC
Q 018244 150 --------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTN 215 (359)
Q Consensus 150 --------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------~~~~t 215 (359)
..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ...+|
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 1289999999999999999999999 99999999999999999999999999998653322 34567
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcc
Q 018244 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (359)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (359)
+.|+|||++.+..++.++||||||+++|+|+| |..||.............. .......+...++++.+++.+||+
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----HTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 88999999998899999999999999999998 9988876432222111111 111223345567789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhh
Q 018244 295 YEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 295 ~dp~~Rps~~~il~~L~~~~~ 315 (359)
.||++|||+.+++++|+.+..
T Consensus 335 ~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 335 GEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=357.45 Aligned_cols=253 Identities=14% Similarity=0.139 Sum_probs=204.2
Q ss_pred CCcccccccCCCC--CCcEEEEEEeC-CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 56 FAMENIVSEHGEK--APNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...|++++.||+| +||+||+|... ++..||||++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578999999999 99999999954 689999999976532 234568889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~-- 208 (359)
||||+++|+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999999999865557799999999999999999999999 999999999999999999999999998754321
Q ss_pred ---------CCCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc------
Q 018244 209 ---------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS------ 271 (359)
Q Consensus 209 ---------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 271 (359)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 123467889999999987 579999999999999999999999986542221111111000000
Q ss_pred ----------------------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ----------------------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ----------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+...+.++.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00001223456789999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=342.23 Aligned_cols=258 Identities=15% Similarity=0.131 Sum_probs=210.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+.+.||+|+||.||+|.. .++..||||++.... ..+.+.+|+.+++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4688889999999999999994 678899999987543 234578899999999 799999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC-----eEEeccCCcccCCCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~-----~kl~DFg~a~~~~~~ 209 (359)
+ +++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++......
T Consensus 88 ~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9 8899999975 345699999999999999999999999 9999999999999987766 999999999865432
Q ss_pred -----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh---HHHhhhhhhhhccccccC
Q 018244 210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 210 -----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 275 (359)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .............. ...
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cHH
Confidence 234688999999999988999999999999999999999999876321 11111110000000 000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
......+.++.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 111245678999999999999999999999999999988765544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=355.63 Aligned_cols=248 Identities=19% Similarity=0.160 Sum_probs=201.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.+...+.||+|+||.||+|.. .+|..||+|++........+.+.+|+++|+.++||||+++++++...+..+|||||++
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 344456789999999999985 5688999999987665567789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee--CCCCCeEEeccCCcccCCCCC---C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF--DDDVNPRLSCFGLMKNSRDGR---S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll--~~~~~~kl~DFg~a~~~~~~~---~ 211 (359)
+++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 170 ~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 170 GGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp TCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999998864 345689999999999999999999999 99999999999999 567889999999998765432 3
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........++++.+|+.+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHHHHHT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHHHHHH
Confidence 46899999999999888999999999999999999999998765433322222111110 0011113456789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.||++|||+.+++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=340.57 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=211.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 5788899999999999999998888899999997654 34567899999999999999999999986 456899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~ 211 (359)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++....... .
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 99999999643233699999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...+.++.+++.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----GYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-----ccCCCCcccccHHHHHHHH
Confidence 345678999999998889999999999999999999 8888765443332221111 1122234556788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
+||+.||++|||+.++++.|+.+....
T Consensus 245 ~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=340.38 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..|++.+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 568889999999999999998532 457999998765433 3456899999999999999999999984 5678999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 94 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999965 345799999999999999999999999 99999999999999999999999999998764432
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-----NGERLPMPPNCPPTL 246 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----TTCCCCCCTTCCHHH
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-----cCCCCCCCCCCCHHH
Confidence 2345678999999998889999999999999999997 888876543322211111 111223445667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=345.87 Aligned_cols=256 Identities=15% Similarity=0.113 Sum_probs=208.1
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||+||+|.. .++..||||++..... .+.+.+|+++++.+ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4678889999999999999994 6788999999875432 24578899999999 899999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC-----eEEeccCCcccCCCC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~-----~kl~DFg~a~~~~~~ 209 (359)
+ +++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++. +||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 L-GPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred C-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9 8899999975 356799999999999999999999999 9999999999999998887 999999999865332
Q ss_pred -----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh---hhhhhhhccccccC
Q 018244 210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQTLTDSCLEG 275 (359)
Q Consensus 210 -----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 275 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......... .......... ...
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-PIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-CHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-CHH
Confidence 2456899999999999999999999999999999999999998763221111 1110000000 000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
......+ ++.+++..||+.||.+||++.++++.|+.+......
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0011233 899999999999999999999999999988765543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=340.93 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=197.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+.+.||+|+||+||+|.... .||+|++...... ..+.+.+|+++++.++||||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 467888899999999999998644 4999999765432 346789999999999999999999965 55678999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----- 209 (359)
+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 101 CEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred cCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999854 456799999999999999999999999 9999999999999999999999999998754421
Q ss_pred -CCcCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH-hhhhhhhhccccccCCCChHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-RDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....||+.|+|||.+. +..++.++||||||+++|+|++|+.||........ ..........+ ........++.+
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 257 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-DLSKVRSNCPKR 257 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-CTTSSCTTSCHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-chhhccccCCHH
Confidence 2346899999999987 56688899999999999999999999865432211 11111111111 111223456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=349.89 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=204.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCc----EEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||+||+|.. .++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 4688889999999999999985 3444 36888886443 23456789999999999999999999999875 4789
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 94 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999975 456799999999999999999999999 99999999999999999999999999998654332
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|..|+|||++.+..++.++||||||+++|+|+| |..||.......... ..........+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTI 246 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-----HHHTTCCCCCCTTBCH
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-----HHHcCCCCCCCccCCH
Confidence 2345778999999999999999999999999999999 898886544332221 1111222234456678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 899999999999999999999999999988653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=346.53 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=211.1
Q ss_pred ccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeC--CcceE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (359)
|++++.||+|+||+||++.. .++..||||++...... ..+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999998864 25789999999875432 356689999999999999999999999874 56899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999953 4599999999999999999999999 99999999999999999999999999998765432
Q ss_pred -------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH----------hhhhhhhhccccc
Q 018244 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----------RDRNIQTLTDSCL 273 (359)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~ 273 (359)
...+|..|+|||.+.+..++.++||||||+++|+|++|..|+........ .............
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 33467789999999988899999999999999999999988765432211 1111222222223
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
....+...+.++.+|+.+||+.||++|||+.++++.|+.+.+...
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 334456677899999999999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=340.89 Aligned_cols=255 Identities=18% Similarity=0.271 Sum_probs=202.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
++.+|++.+.||+|+||+||+|... +..||+|.+... ...+.+.+|+++++.++||||+++++++. +..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 4567889999999999999999975 678999999753 34567899999999999999999999886 458999999
Q ss_pred CCCCCHhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhc---CCCcccccCCCCCeeeCCCCC-eEEeccCCcccCCCC
Q 018244 135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTS---KERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDG 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~~ivH~Dikp~NIll~~~~~-~kl~DFg~a~~~~~~ 209 (359)
+++|+|.+++..... ..+++..++.++.|++.||.|||+ + +++||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999974322 247899999999999999999999 6 9999999999999998887 799999998765432
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... . ..............+..+.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--W-AVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--H-HHHTTCCCCCBTTCCHHHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--H-HHhcCCCCCcccccCHHHHHH
Confidence 345689999999999988999999999999999999999998864321111100 0 001111122334566789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+.+||+.||++|||+.++++.|+.+.+...
T Consensus 237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999876443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=349.44 Aligned_cols=247 Identities=19% Similarity=0.211 Sum_probs=207.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|.+++.||+|+||+||+|.. .++..||||++...... ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 477888899999999999994 67889999999765332 23568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~ 213 (359)
|+. |+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..........
T Consensus 135 ~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 211 (348)
T 1u5q_A 135 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211 (348)
T ss_dssp CCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred cCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence 997 588888754 346799999999999999999999999 99999999999999999999999999999887777788
Q ss_pred CCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 214 TNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 214 ~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
||+.|+|||++. +..++.++||||||+++|+|++|+.||.............. .......+...+..+.+|+.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCCCTTSCHHHHHHHH
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCCCCCCHHHHHHHH
Confidence 999999999985 46789999999999999999999998865433222111111 11111223456678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~ 311 (359)
+||+.||++|||+.+++++.-
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHH
T ss_pred HHcccChhhCcCHHHHhhChh
Confidence 999999999999999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=345.03 Aligned_cols=251 Identities=16% Similarity=0.239 Sum_probs=190.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|++++.||+|+||+||+|.. .++..||+|.+..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 4688899999999999999984 4688999999975432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 135 MPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
++ |+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 98 5899988642 224689999999999999999999999 9999999999999999999999999999875432
Q ss_pred ---CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc--------------
Q 018244 210 ---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS-------------- 271 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------- 271 (359)
....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||..................+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 345679999999999864 58999999999999999999999987654332221111100000
Q ss_pred --c------------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 --C------------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 --~------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .........+.++.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000112346789999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=354.69 Aligned_cols=243 Identities=19% Similarity=0.203 Sum_probs=197.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHH-HhcCCCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
...+|++++.||+|+||.||+|+.. ++..||||++..... .....+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467899999999999999999954 588999999976432 223456677776 57789999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC--
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-- 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~-- 207 (359)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999973 45689999999999999999999999 99999999999999999999999999998632
Q ss_pred --CCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 208 --DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 208 --~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
......||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSA 266 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------CCCCCSSSCHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------ccCCCCCCCHHH
Confidence 223567899999999999999999999999999999999999999776544433332221 112345567889
Q ss_pred HHHHHHhcccCCCCCCCHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSL 306 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~i 306 (359)
.+|+.+||+.||.+||++.+.
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTT
T ss_pred HHHHHHHcccCHHhCCCCCCC
Confidence 999999999999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.66 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=200.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC---CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..+|++++.||+|+||.||+|.. .++..||||++... .......+.+|+.+++.++||||+++++++...+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788999999999999999994 56889999999753 223345678899999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999999863 4579999999999999999999998 7 9999999999999999999999999999864322
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ...++...++++.
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~ 377 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLGPEAK 377 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHHH
Confidence 3457899999999999999999999999999999999999999776544333322221 1224456678899
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 018244 287 RLASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
+|+.+||+.||++|| |+.+++++
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 999999999999999 99998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=337.16 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=207.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCC---cEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcc-eEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER-LLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 131 (359)
.|.+.+.||+|+||+||+|.. .++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 344557889999999999984 332 3799999986543 2356789999999999999999999999876665 999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC---
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--- 208 (359)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999965 456789999999999999999999999 999999999999999999999999999975432
Q ss_pred -----CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 209 -----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
.....++..|+|||.+.+..++.++||||||+++|+|++|..|+......... ............+...+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL----THFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH----HHHHHTTCCCCCCTTCCH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH----HHHhhcCCCCCCCccchH
Confidence 22345678999999999989999999999999999999977665433221111 111111112223455677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
.+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 899999999999999999999999999998775443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=345.92 Aligned_cols=245 Identities=17% Similarity=0.228 Sum_probs=196.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCC--------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD-------- 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 126 (359)
.+|++++.||+|+||.||+|... ++..||||++..... ...+.+.+|+++|+.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999965 789999999975443 34567899999999999999999999986543
Q ss_pred -------------------------------------------------cceEEEecCCCCCHhhhhhcCCC-CCCCHHH
Q 018244 127 -------------------------------------------------ERLLVAEYMPNDTLAKHLFHWET-QPMKWAM 156 (359)
Q Consensus 127 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~ 156 (359)
..++||||+++++|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27999999999999999975322 3456778
Q ss_pred HHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----------------CCcCCCccccC
Q 018244 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------------RSYSTNLAFTP 220 (359)
Q Consensus 157 ~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----------------~~~~~t~~y~a 220 (359)
++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++..... ....||+.|+|
T Consensus 166 ~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 999999999999999999 9999999999999999999999999999876543 23458999999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 018244 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (359)
Q Consensus 221 PE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 300 (359)
||++.+..++.++||||||+++|+|++|..|+.... ...... ... .........++++.+|+.+||+.||++|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDV----RNL-KFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHH----HTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHh----hcc-CCCcccccCChhHHHHHHHHccCCCCcC
Confidence 999999899999999999999999999875432211 111000 000 0001113455778999999999999999
Q ss_pred CCHHHHHHH
Q 018244 301 PNPRSLVTA 309 (359)
Q Consensus 301 ps~~~il~~ 309 (359)
||+.+++++
T Consensus 318 ps~~~~l~~ 326 (332)
T 3qd2_B 318 PEATDIIEN 326 (332)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhhc
Confidence 999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=342.97 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=212.5
Q ss_pred CcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 128 (359)
..|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4688889999999999999984 3467899999986543 2356789999999999 899999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWET----------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCC
Confidence 999999999999999975432 2589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||++....... ...+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.............
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 999999999998765443 2335678999999998899999999999999999999 888876543222111111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
........+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 262 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 262 ----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11122223455678899999999999999999999999999988664
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=345.88 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=211.8
Q ss_pred CcccccccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
..|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.+ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 57888999999999999999852 467899999986543 2356788999999999 8999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.+
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTEN 193 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTT
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCC
Confidence 99999999999999999975321 2489999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 99999999999865543 23345778999999988889999999999999999999 888887654433322211
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
. ......+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 274 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 274 E-----GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 112233455677899999999999999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=343.80 Aligned_cols=255 Identities=18% Similarity=0.298 Sum_probs=206.8
Q ss_pred cccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeC--Ccce
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (359)
.|++++.||+|+||.||+|.+ .++..||+|++.... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 478889999999999999983 368899999998543 23356789999999999999999999999876 6689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 102 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999999954 345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHH----------hhhhhhhhcccc
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----------RDRNIQTLTDSC 272 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~ 272 (359)
. ...+|..|+|||.+.+..++.++||||||+++|+|++|..|+........ ............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 34567789999999988899999999999999999999976533211110 001111111222
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
.....+...++++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 223345567789999999999999999999999999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=349.78 Aligned_cols=246 Identities=20% Similarity=0.225 Sum_probs=190.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|.+.+.||+|+||.||+|... ++..||||++.... ..+.+.+|+++++.++||||+++++++......++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4788889999999999999965 57899999998643 34567889999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCCC---C
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG---R 210 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~~---~ 210 (359)
+|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+++..... .
T Consensus 132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999986 445689999999999999999999999 9999999999999975 889999999999865543 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++||||||+++|+|++|..||................. ...........+.++.+|+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-YYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-CCCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-CccCCchhhhCCHHHHHHHH
Confidence 45689999999999988999999999999999999999999876543321111111000 00111222456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.+++++
T Consensus 288 ~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 288 KLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=343.74 Aligned_cols=264 Identities=17% Similarity=0.201 Sum_probs=205.0
Q ss_pred cCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..+..|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456789999999999999999995 578899999997533 223556889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998642 356789999999999999999999999 99999999999999999999999999987654
Q ss_pred CC----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
.. ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... ...+.............+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH--HHHHHTTCSCCCCTTTSCH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH--HHHhhcccCCCCcccccCH
Confidence 33 23467899999999998899999999999999999999999886543221110 0011111111112244667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
++.+|+.+||+.||++|||+.++++.|+++......+
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 8999999999999999999999999999997765544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=350.88 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=208.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (359)
...|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 35788889999999999999985 245689999998543 23356789999999999 89999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~N 202 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARN 202 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhh
Confidence 9999999999999999975322 2479999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHH
Q 018244 187 IVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDL 259 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~ 259 (359)
|+++.++.+||+|||++....... ...+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 999999999999999998654332 2345678999999998899999999999999999998 888886653222
Q ss_pred HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
..... .........+...+.++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 283 ~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 283 NFYKL----IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHH----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHH----HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111 111122233455678899999999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.81 Aligned_cols=259 Identities=16% Similarity=0.188 Sum_probs=204.9
Q ss_pred HhcCCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 52 ATSGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 52 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
....+..|.+++.||+|+||.||+|... ++..||+|++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3445788999999999999999999954 68899999997653222 3668899999999999999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999999973 35699999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 208 DG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 208 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.. ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................. ....+...+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 262 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR---PSTVRPGIP 262 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC---GGGTSTTCC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC---ccccCCCCC
Confidence 33 2346789999999999888999999999999999999999998876544332221111111 112234556
Q ss_pred HHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhc
Q 018244 283 TELVRLASRCLQYEPRERP-NPRSLVTALVTLQKD 316 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-s~~~il~~L~~~~~~ 316 (359)
.++.+++.+||+.||++|| |++++++.|+.....
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 7899999999999999999 999999999987553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=349.04 Aligned_cols=252 Identities=17% Similarity=0.256 Sum_probs=205.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcE----EEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||+||+|.. .++.. ||+|.+.... ......+.+|+.+++.++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5688999999999999999985 34443 8888876443 222345778999999999999999999886 567899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+.+|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999964 345789999999999999999999999 99999999999999999999999999998764332
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|..|+|||++.+..++.++||||||+++|+|+| |..||............. .......+...+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 244 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-----KGERLAQPQICTI 244 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-----TTCBCCCCTTBCT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-----cCCCCCCCCcCcH
Confidence 3346779999999998899999999999999999999 998887654333222111 1112223344566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 799999999999999999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=360.30 Aligned_cols=244 Identities=19% Similarity=0.270 Sum_probs=208.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56889999999999999999954 78999999997532 123457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999999999996 456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||................ ...+...+.++.+|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~L 246 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------FYTPQYLNPSVISL 246 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------CCCCTTCCHHHHHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------cCCCccCCHHHHHH
Confidence 34568999999999998775 679999999999999999999987664433332222111 12234566789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+.+++++
T Consensus 247 i~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHcCCCchhCcCHHHHHhC
Confidence 999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=352.80 Aligned_cols=259 Identities=15% Similarity=0.166 Sum_probs=206.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCC------CcEEEEEEeCCCCCchH-----------HHHHHHHHHHhcCCCccccccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDA-----------RQFLEEARAVGQLRNRRLANLL 119 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~ 119 (359)
..|.+.+.||+|+||+||+|.... +..||||++........ ..+.+|+..+..++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 478899999999999999998654 47899999876542211 1234566778888999999999
Q ss_pred ceeeeC----CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC--CCC
Q 018244 120 GCCCEG----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDV 193 (359)
Q Consensus 120 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~--~~~ 193 (359)
+++... ...+|||||+ +++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCC
Confidence 998775 4589999999 9999999975 446799999999999999999999999 999999999999999 889
Q ss_pred CeEEeccCCcccCCCC-----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh
Q 018244 194 NPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD 262 (359)
Q Consensus 194 ~~kl~DFg~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~ 262 (359)
.+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|+|+||+.||.....+....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999764322 23348999999999999899999999999999999999999987532211110
Q ss_pred --------hhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCc
Q 018244 263 --------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSC 321 (359)
Q Consensus 263 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~ 321 (359)
.....+.+.++. ....+.++.+++..||+.||++|||+.++++.|+.+........
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 111122222221 13346789999999999999999999999999999887655543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=360.86 Aligned_cols=253 Identities=17% Similarity=0.125 Sum_probs=207.7
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
-...+|++++.||+|+||+||+|+.. +++.||+|++..... .....+.+|+.++..++||||++++++|.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34567888999999999999999965 578999999974221 11233788999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
|||||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 151 lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999964 356799999999999999999999999 9999999999999999999999999999765443
Q ss_pred C-----CcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 210 R-----SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 210 ~-----~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
. ...||+.|+|||++. ...++.++|||||||++|||++|+.||.................... .+....
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~ 307 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-FPTQVT 307 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-CCSSCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-CCcccc
Confidence 2 357899999999987 45689999999999999999999999987654433332222111111 111123
Q ss_pred HHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRE--RPNPRSLVTA 309 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (359)
..++++.+||.+||..+|++ ||++++++++
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 46788999999999988888 9999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=339.91 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=204.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC-CcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 133 (359)
+...|++++.||+|+||+||+|... +..||||.+.... ..+.+.+|+++++.++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3567899999999999999999874 7789999997543 456789999999999999999999987554 47899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCc
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~ 212 (359)
|+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...... ...
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 99999999999753333489999999999999999999999 9999999999999999999999999998765443 234
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...++.+.+++.+
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----KGYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----TTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----cCCCCCCcccCCHHHHHHHHH
Confidence 56789999999998889999999999999999998 888876554332222111 111223345667889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 292 CLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
||+.||++|||+.++++.|+.+...
T Consensus 250 ~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=340.19 Aligned_cols=251 Identities=15% Similarity=0.150 Sum_probs=200.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-----chHHHHHHHHHHHhcCC---CcccccccceeeeCC-
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLR---NRRLANLLGCCCEGD- 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~- 126 (359)
..|++++.||+|+||+||+|.. .+++.||||++..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4688899999999999999994 5788999999874321 11345677887777764 999999999998765
Q ss_pred ----cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 127 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
..++||||+. ++|.+++.......+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4799999997 5999999765555699999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc-------
Q 018244 203 MKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC------- 272 (359)
Q Consensus 203 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 272 (359)
++..... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||..................+.
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9866543 235679999999999989999999999999999999999999876544333222211110000
Q ss_pred -------ccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 -------LEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 -------~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ......+.++.+|+.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 0012356789999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=337.79 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=206.3
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+.+|.+++.||+|+||+||+|.. .++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 356788999999999999999985 4577999999865321 124568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999863 35689999999999999999999999 9999999999999999999999999998665433
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.............. .....+...+.++.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDL 237 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTSCHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------CCCCCCCcCCHHHHHH
Confidence 345689999999999988899999999999999999999999876654433222211 1122345567789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=337.67 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=213.4
Q ss_pred Ccccccc-cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+++ .||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566776 7999999999999853 577899999987543 3456789999999999999999999999 55679999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999864 455699999999999999999999999 99999999999999999999999999998764332
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..||............. .......+...+.
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~~ 240 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----QGKRMECPPECPP 240 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-----TTCCCCCCTTCCH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-----cCCcCCCCCCcCH
Confidence 2345788999999988889999999999999999998 998886654332222111 1122334556778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSC 321 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~ 321 (359)
++.+++.+||+.||++|||+.++++.|+.+........
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999999999977655543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=337.86 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=205.9
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceee-eCCcce
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERL 129 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 129 (359)
...|++.+.||+|+||+||+|...+ ...+|+|.+..... ...+.+.+|+.+++.++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998532 33689999986443 33567899999999999999999999854 456789
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999964 456789999999999999999999999 9999999999999999999999999999865432
Q ss_pred --------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCC-cchhHHHhhhhhhhhccccccCCCChH
Q 018244 210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 210 --------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+. ............. ......+..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 256 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----GRRLLQPEY 256 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-----TCCCCCCTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-----CCCCCCCcc
Confidence 23345778999999998899999999999999999999655443 3221111111111 111222344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 56789999999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=345.23 Aligned_cols=258 Identities=19% Similarity=0.295 Sum_probs=212.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-----CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCC--cce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 129 (359)
..|++++.||+|+||.||+|.. .++..||||++........+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4578899999999999999983 368899999998876666778999999999999999999999886654 789
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 121 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999999975 345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh-----------hhhhhhccc
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNIQTLTDS 271 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~ 271 (359)
. ...++..|+|||.+.+..++.++||||||+++|+|+||..|+.......... .........
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2 2345678999999998889999999999999999999997765432211110 011111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
......+...+.++.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus 279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 122233456778899999999999999999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.35 Aligned_cols=249 Identities=19% Similarity=0.177 Sum_probs=201.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-----CcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----NRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~l 130 (359)
..|.+++.||+|+||+||+|.. .++..||||++.... .....+..|+.+++.+. ||||+++++++...+..++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 4678888999999999999995 568899999997532 33456788999999996 9999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-------------------
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD------------------- 191 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~------------------- 191 (359)
||||+ +++|.+++.......+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 99999 88999999876556799999999999999999999999 9999999999999975
Q ss_pred ------CCCeEEeccCCcccCCC-CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh
Q 018244 192 ------DVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (359)
Q Consensus 192 ------~~~~kl~DFg~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~ 264 (359)
++.+||+|||++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 78999999999986544 34567899999999999999999999999999999999999998754322111110
Q ss_pred hhhh-------------------c-cccccCCCC--------------------hHHHHHHHHHHHHhcccCCCCCCCHH
Q 018244 265 IQTL-------------------T-DSCLEGQFS--------------------SDEGTELVRLASRCLQYEPRERPNPR 304 (359)
Q Consensus 265 ~~~~-------------------~-~~~~~~~~~--------------------~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (359)
.... . .......++ ...++.+.+|+.+||+.||++|||+.
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 351 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPA 351 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHH
Confidence 0000 0 000000000 00126788999999999999999999
Q ss_pred HHHH
Q 018244 305 SLVT 308 (359)
Q Consensus 305 ~il~ 308 (359)
++++
T Consensus 352 elL~ 355 (360)
T 3llt_A 352 ELLK 355 (360)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=356.84 Aligned_cols=249 Identities=16% Similarity=0.133 Sum_probs=194.1
Q ss_pred CCccccc-ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhc-CCCcccccccceeee----CCcc
Q 018244 56 FAMENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQ-LRNRRLANLLGCCCE----GDER 128 (359)
Q Consensus 56 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 128 (359)
+.+|.++ +.||.|+||+||+|.. .++..||||++.. ...+.+|+.++.+ .+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456666 5789999999999995 4688999999963 2456788888744 589999999999875 5678
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCccc
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKN 205 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~ 205 (359)
+|||||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999999764455799999999999999999999999 9999999999999997 78999999999987
Q ss_pred CCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc--ccCCCChH
Q 018244 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSD 280 (359)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 280 (359)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...............+.... ........
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 6543 345679999999999989999999999999999999999999865432111000001111100 11111234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
.+.++.+||.+||+.||++|||+.+++++.
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 678899999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=344.60 Aligned_cols=247 Identities=18% Similarity=0.203 Sum_probs=206.5
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 5788899999999999999954 6889999999764322 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCcccC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~~ 206 (359)
||||+++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999996 456789999999999999999999999 999999999999999887 7999999999876
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 247 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFFSHTSE 247 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhhcccCH
Confidence 543 3456899999999999889999999999999999999999998765443332221111000 00001123457
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.+|+.+||+.||++|||+.+++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 89999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=341.66 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=207.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-----CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
...|.+.+.||+|+||+||+|.... +..||||.+...... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3557778889999999999998532 245999999865432 3456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 123 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999965 446799999999999999999999999 9999999999999999999999999999875432
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
. ...+|..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~ 275 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-----GFRLPTPMDC 275 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----TCCCCCCTTC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-----CCcCCCcccC
Confidence 2 2234678999999998899999999999999999999 9988865543322221111 1122234556
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 7889999999999999999999999999999876443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=368.26 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=213.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
..|.+.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+++|+.++|+||+++++++.. +..+|||||+.
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 4577888999999999999998887889999998654 335679999999999999999999999876 67899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----CC
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS 211 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~~ 211 (359)
+|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 99999999643345689999999999999999999999 9999999999999999999999999999876432 23
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..++..|+|||++.+..++.++||||||+++|||++ |..||............. .......+..++..+.+||.
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----RGYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence 345778999999998899999999999999999999 888887654333222211 11222334566788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+||+.||++|||+.+|++.|+.+.....
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 9999999999999999999998865443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=344.66 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=200.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcc----
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDER---- 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 128 (359)
..|.+++.||+|+||.||+|.. .++..||||++....... ...+.+|+++++.++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5688999999999999999995 678899999998653322 45688999999999999999999998776544
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999963 45699999999999999999999999 999999999999999999999999999976543
Q ss_pred C-------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 209 ~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+ ........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCC
Confidence 2 23457999999999999899999999999999999999999987654433322221111100 00011235
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhhh
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLV-TALVTLQK 315 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il-~~L~~~~~ 315 (359)
+.++.+++.+||+.||++||++.+++ ..+.....
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 67899999999999999999766655 44555443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=335.55 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=208.0
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
...|++++.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35688999999999999999995 4688999999975432 23466889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC---eEEeccCCcccCCCC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~---~kl~DFg~a~~~~~~ 209 (359)
||+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999998863 45699999999999999999999999 9999999999999986655 999999999766544
Q ss_pred C---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
. ...+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................. .........++++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--CCchhhcccCHHHH
Confidence 3 356899999999999999999999999999999999999998766544333322221111 11111234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.11 Aligned_cols=240 Identities=18% Similarity=0.172 Sum_probs=194.7
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|++++.||+|+||+||+|... ++..||||++...... .......|+..+..+ +||||+++++++.+.+..++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 5788889999999999999965 7899999998764332 233455666666555 89999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---C
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---~ 210 (359)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 138 ~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 138 LC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp CC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 99 6699998865 345799999999999999999999999 9999999999999999999999999998776543 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...||+.|+|||++.+ .++.++||||||+++|||++|..++..... ...... ...+ ..+...+.++.+|+
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~l~~li 285 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG----YLPP----EFTAGLSSELRSVL 285 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTT----CCCH----HHHTTSCHHHHHHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhcc----CCCc----ccccCCCHHHHHHH
Confidence 4468999999999885 789999999999999999999876654321 111111 1111 11233567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.+++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcCCChhhCcCHHHHHhC
Confidence 99999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.06 Aligned_cols=247 Identities=16% Similarity=0.200 Sum_probs=194.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC--CCchHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|++++.||+|+||+||+|.. .++..||||++... .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 5688999999999999999984 46889999999764 2233567889999999999999999999997653 4
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.+|||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 142 ~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 6999999976 5777663 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred CC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc-------------
Q 018244 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS------------- 271 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 271 (359)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...............+..+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 43 34578999999999999999999999999999999999999997653322111111100000
Q ss_pred -----ccc-C------CCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 -----CLE-G------QFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 -----~~~-~------~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... . .++ ...+.++.+|+.+||+.||++|||+.+++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0 000 1126789999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=343.58 Aligned_cols=252 Identities=18% Similarity=0.270 Sum_probs=204.1
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcE----EEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||+||+|.. .++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence 5688999999999999999985 34443 5778776433 33467799999999999999999999999865 4889
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
|+||+.+|+|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 94 v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999975 455799999999999999999999999 99999999999999999999999999998654322
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........... .........+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEKGERLPQPPICTI 246 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCCCCCTTBCH
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCCccCCH
Confidence 2345778999999999999999999999999999999 8988876543332221 111122233455677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=347.04 Aligned_cols=246 Identities=18% Similarity=0.234 Sum_probs=200.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCC--cccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 132 (359)
..|.+++.||+|+||.||+|...++..||||++...... ..+.+.+|+.+|..++| +||+++++++......++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468899999999999999999888999999999765332 34678899999999986 99999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC--
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
|+ .+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 89 e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 EC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred eC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 95 57799999974 45799999999999999999999999 999999999999997 6789999999998764332
Q ss_pred ----CcCCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 211 ----SYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
...||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ............
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~ 240 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 240 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCccc
Confidence 4468999999999864 5688999999999999999999999865322111 112222222333
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L 310 (359)
.++...+.++.+|+.+||+.||++|||+.+++++.
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 44455567899999999999999999999999763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=353.76 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=191.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCC-CcccccccceeeeCC--cceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGD--ERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l 130 (359)
..|.+++.||+|+||+||+|.. .++..||||++.... ......+.+|+.+|..+. ||||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 5788999999999999999984 568899999996542 234566889999999997 999999999997654 6899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~-- 208 (359)
||||+. ++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 589998853 5799999999999999999999999 999999999999999999999999999976432
Q ss_pred -----------------------CCCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh
Q 018244 209 -----------------------GRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (359)
Q Consensus 209 -----------------------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~ 264 (359)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 123468999999999986 56899999999999999999999999765433222211
Q ss_pred hhhhcccc-----------------------------ccC------------CCChHHHHHHHHHHHHhcccCCCCCCCH
Q 018244 265 IQTLTDSC-----------------------------LEG------------QFSSDEGTELVRLASRCLQYEPRERPNP 303 (359)
Q Consensus 265 ~~~~~~~~-----------------------------~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (359)
...+..+. ... ......++++.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 11100000 000 0011346789999999999999999999
Q ss_pred HHHHHH
Q 018244 304 RSLVTA 309 (359)
Q Consensus 304 ~~il~~ 309 (359)
.+++++
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=356.60 Aligned_cols=255 Identities=18% Similarity=0.121 Sum_probs=206.9
Q ss_pred HHhcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCC
Q 018244 51 TATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (359)
Q Consensus 51 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 126 (359)
...-...+|++++.||+|+||.||+|.. .+++.||||++.+... ...+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3344557788999999999999999996 4689999999975321 12234788999999999999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
.+||||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheec
Confidence 99999999999999999964 234799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-----CcCCCccccCccccc-------CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 207 RDGR-----SYSTNLAFTPPEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 207 ~~~~-----~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
.... ...||+.|+|||++. +..++.++|||||||++|||++|+.||................... ..
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-~~ 291 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL-SL 291 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-CC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc-CC
Confidence 5432 357899999999987 3568999999999999999999999998765443332222111000 01
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRER---PNPRSLVTA 309 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~il~~ 309 (359)
+..+...+.++.+||.+||. +|.+| |++++++++
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11224567889999999999 99998 589998865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=367.78 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=209.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...+|.+++.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 345688889999999999999995 478999999996532 1234568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++|+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999999765555699999999999999999999999 9999999999999999999999999999876544
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..++.++|||||||++|||++|..||...............+.. ....++...+.++.+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~~d 418 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARS 418 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHHHH
Confidence 2457899999999999888999999999999999999999998764211111111111111 122345667789999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 018244 288 LASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
|+.+||+.||++|| ++.+++++
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 99999999999999 78888764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=343.24 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=209.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcE--EEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFR--IAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
++.+|.+.+.||+|+||.||+|.. .++.. +|+|.+.... ....+.+.+|+++++.+ +||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 346788899999999999999984 45554 4999987532 23345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~ 195 (359)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeE
Confidence 9999999999999997432 24789999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccCCC---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccc
Q 018244 196 RLSCFGLMKNSRD---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 196 kl~DFg~a~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (359)
||+|||+++.... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~----- 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 256 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-----
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-----
Confidence 9999999875432 223456788999999988889999999999999999998 9988876544333222211
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
......+...+.++.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1122334556788999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=338.74 Aligned_cols=248 Identities=15% Similarity=0.162 Sum_probs=205.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|.+++.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 4678889999999999999995 468899999998765445567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCCC--
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~~-- 210 (359)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++ ++++.++|+|||++.......
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999999863 35689999999999999999999999 99999999999999 788999999999987654432
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................. .........+.++.+++.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--FESPFWDDISESAKDFIC 243 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--CCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCccccccCCHHHHHHHH
Confidence 335789999999999889999999999999999999999998765443332222111111 111223456788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.+++++
T Consensus 244 ~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHCSSTTTSCCHHHHHTS
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=357.59 Aligned_cols=249 Identities=15% Similarity=0.158 Sum_probs=184.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 128 (359)
..|.+++.||+|+||+||+|.. .++..||||++..... ...+.+.+|+++|+.++||||+++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5689999999999999999984 4688999999976432 2356789999999999999999999998543 568
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 68999986 456799999999999999999999999 999999999999999999999999999986542
Q ss_pred C-------------------------------CCcCCCccccCccccc-CCCCCCccchhhHHHHHHHHHh---------
Q 018244 209 G-------------------------------RSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS--------- 247 (359)
Q Consensus 209 ~-------------------------------~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt--------- 247 (359)
. ....||+.|+|||++. +..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 1 2345789999999864 5669999999999999999999
Q ss_pred --CCCCCCcchhH--------------------HHhhhhhh-------------------hhc---ccccc---CCCChH
Q 018244 248 --GKHIPPSHALD--------------------LIRDRNIQ-------------------TLT---DSCLE---GQFSSD 280 (359)
Q Consensus 248 --g~~p~~~~~~~--------------------~~~~~~~~-------------------~~~---~~~~~---~~~~~~ 280 (359)
|+++|++.... ........ ... ..... ......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 55555443210 00000000 000 00000 001123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.++.+|+.+||..||++|||+++++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 46789999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=332.72 Aligned_cols=243 Identities=18% Similarity=0.223 Sum_probs=205.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 35788889999999999999954 57789999998765566788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCC---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~--- 209 (359)
++++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||++ +.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 89 TGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999998863 45689999999999999999999999 99999999999999 78899999999999865543
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh----HHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS----DEGTEL 285 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l 285 (359)
....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||................ ...+. ..++.+
T Consensus 166 ~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT------FTFPEKDWLNVSPQA 238 (277)
T ss_dssp CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCHHHHTTSCHHH
T ss_pred hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CCCCchhhhcCCHHH
Confidence 34568999999999875 48999999999999999999999987654333222221111 01111 356789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=346.05 Aligned_cols=248 Identities=16% Similarity=0.223 Sum_probs=196.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|.+++.||+|+||.||+|.. .+|..||||++...... ..+.+.+|+++|+.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4688999999999999999995 56899999999654322 3456889999999999999999999997653 4
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 7799999853 5699999999999999999999999 99999999999999999999999999998765
Q ss_pred CC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc----------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT---------------- 269 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---------------- 269 (359)
.. ....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.................
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 43 34578999999999887 6799999999999999999999999876533221111110000
Q ss_pred ------ccc---ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 ------DSC---LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ------~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... .........++++.+|+.+||..||++|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0001123456789999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=335.26 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=206.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
..+|.+.+.||+|+||+||+|...+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3578888899999999999998532 34699999986533 345678999999999999999999999865 46799
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999965 345689999999999999999999999 99999999999999999999999999988654432
Q ss_pred -----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+...++.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV 242 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-----HTCCCCCCTTCCHH
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-----cCCCCCCCCCCCHH
Confidence 3345778999999998889999999999999999998 998886543222211111 11112234456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998755
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=337.80 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=205.9
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee------------
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE------------ 124 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------------ 124 (359)
.|.+++.||+|+||.||+|... +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 5788888999999999999965 78999999997643 346789999999999999999998854
Q ss_pred ----CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEecc
Q 018244 125 ----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (359)
Q Consensus 125 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DF 200 (359)
....++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcc
Confidence 34589999999999999999765556799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 201 GLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 201 g~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
|++...... ....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... .. ..+.. ...
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~----~~~~~----~~~ 236 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FF----TDLRD----GII 236 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HH----HHHHT----TCC
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HH----HHhhc----ccc
Confidence 998876543 345688999999999988899999999999999999999976543211 11 11111 122
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
+...+..+.+++.+||+.||++|||+.++++.|..+.+....
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 344567799999999999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=340.46 Aligned_cols=247 Identities=17% Similarity=0.176 Sum_probs=197.3
Q ss_pred ccccc-ccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEec
Q 018244 58 MENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|.++ +.||+|+||+||+|. ..++..||||++..........+.+|++++.++ +||||+++++++...+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 46665 568999999999999 457889999999876655577899999999985 799999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC---eEEeccCCcccCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~---~kl~DFg~a~~~~~~-- 209 (359)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++. +||+|||++......
T Consensus 93 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999974 35689999999999999999999999 9999999999999998766 999999998754321
Q ss_pred ---------CCcCCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-----------Hhhhh
Q 018244 210 ---------RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------IRDRN 264 (359)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----------~~~~~ 264 (359)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 13358999999999875 458899999999999999999999986542100 00000
Q ss_pred hhhhccccccCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 IQTLTDSCLEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+.... ..++ ...+.++.+|+.+||+.||++|||+.+++++
T Consensus 250 ~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 250 FESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111110 1112 1346789999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=348.83 Aligned_cols=256 Identities=17% Similarity=0.160 Sum_probs=205.6
Q ss_pred CcccccccCCCCCCcEEEEEEeC---------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccc----------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE---------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN---------- 117 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------- 117 (359)
..|.+.+.||+|+||.||+|... ++..||+|.+... +.+.+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57889999999999999999965 3789999999754 35788999999999999998
Q ss_pred -----ccceeee-CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC
Q 018244 118 -----LLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (359)
Q Consensus 118 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~ 191 (359)
+++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||.|||++ +++||||||+|||++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcC
Confidence 4566655 67889999999 89999999764457899999999999999999999999 9999999999999999
Q ss_pred CC--CeEEeccCCcccCCCC-----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch--
Q 018244 192 DV--NPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-- 256 (359)
Q Consensus 192 ~~--~~kl~DFg~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~-- 256 (359)
++ .+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 88 9999999999765422 23468899999999998899999999999999999999999887642
Q ss_pred hHHHhhhhhhhhcccc--ccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 257 LDLIRDRNIQTLTDSC--LEG--QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 257 ~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
....... ........ ... ......+.++.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 275 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 275 TEDIMKQ-KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHH-HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHH-HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1111111 11111000 000 001234678999999999999999999999999999988765544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=336.41 Aligned_cols=244 Identities=16% Similarity=0.182 Sum_probs=204.4
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+|++++.||+|+||+||+|... ++..||+|.+.... ......+.+|+..+..+ +||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 36788899999999999999964 78999999998643 23456788999999999 8999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-------------------
Q 018244 133 EYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD------------------- 191 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~------------------- 191 (359)
||+++++|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999996432 25689999999999999999999999 9999999999999984
Q ss_pred CCCeEEeccCCcccCCCCCCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc
Q 018244 192 DVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD 270 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 270 (359)
...+||+|||.+..........+|+.|+|||.+.+. .++.++||||||+++|+|++|..++........ +..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~ 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE-------IRQ 242 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH-------HHT
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH-------HHc
Confidence 447999999999988877777899999999999866 566899999999999999999976644321111 111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+...+.++.+|+.+||+.||++|||+.+++++
T Consensus 243 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 243 -GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11122344567789999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=348.06 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=198.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC--C--CcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeee-CCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE--N--QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 130 (359)
..|.+.+.||+|+||+||+|... + +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677788999999999999853 2 2468999987543 3346679999999999999999999998654 567899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999964 455789999999999999999999999 9999999999999999999999999999865332
Q ss_pred -------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
....+|+.|+|||.+.+..++.++||||||+++|||+|| ..||............ ........+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-----~~~~~~~~p~~~ 321 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQGRRLLQPEYC 321 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-----HTTCCCCCCTTC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-----HcCCCCCCCCCC
Confidence 223456789999999989999999999999999999995 5555433211111111 111112234456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 7789999999999999999999999999999876443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=342.53 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=209.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
..|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 46788889999999999999853 3678999999865432 3456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999986421 24679999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 202 ~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
++...... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||............... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~ 258 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-----GL 258 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-----CC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-----Cc
Confidence 98765432 22345788999999998889999999999999999999 77777654333322221111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 22345567789999999999999999999999999988644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=338.29 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=200.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCc--
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDE-- 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 127 (359)
...|.+.+.||+|+||.||+|... .+..||+|.+...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 356888889999999999999843 3457999999865332 34668999999999999999999999987553
Q ss_pred ---ceEEEecCCCCCHhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEecc
Q 018244 128 ---RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (359)
Q Consensus 128 ---~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DF 200 (359)
.++||||+.+|+|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeec
Confidence 49999999999999998531 345799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccc
Q 018244 201 GLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 201 g~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
|++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............... .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~ 266 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-----H 266 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----C
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-----C
Confidence 999765432 23345788999999998899999999999999999999 77777654333222221111 1
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
....+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2233455677899999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=334.25 Aligned_cols=246 Identities=18% Similarity=0.257 Sum_probs=208.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
...+|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 4567899999999999999999954 67889999986432 1224578899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999974 34689999999999999999999999 9999999999999999999999999998765432
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. ....++...+.++.++
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPPFLSDGSKDL 242 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------cccCCCCcCCHHHHHH
Confidence 345689999999999988999999999999999999999999876543322221111 1122345567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+.+++++
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHhhcCHhhCCCHHHHhhC
Confidence 999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=339.77 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=206.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee----CCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 130 (359)
...|.+++.||+|+||.||+|.. .++..||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788999999999999999995 6789999999976655566788999999999999999999999873 347899
Q ss_pred EEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 131 VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||+.+|+|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999998642 356799999999999999999999999 999999999999999999999999999876532
Q ss_pred C-------------CCcCCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc
Q 018244 209 G-------------RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC 272 (359)
Q Consensus 209 ~-------------~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 272 (359)
. ....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ..........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~ 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALAVQNQ 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHHHHCC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHHhhcc
Confidence 1 1224688999999987654 6889999999999999999998875321100 0001111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.........+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1122234567789999999999999999999999999998854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=349.72 Aligned_cols=255 Identities=16% Similarity=0.119 Sum_probs=198.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCch-----------HHHHHHHHHHHhcCCCcccccccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-----------ARQFLEEARAVGQLRNRRLANLLGC 121 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~ 121 (359)
..|.+.+.||+|+||.||+|... ++..+|+|++....... ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57889999999999999999964 57789999998654321 1235678899999999999999999
Q ss_pred eee----CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC--Ce
Q 018244 122 CCE----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--NP 195 (359)
Q Consensus 122 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~--~~ 195 (359)
+.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+. +++||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcE
Confidence 988 67899999999 8999999964 33799999999999999999999999 999999999999998877 99
Q ss_pred EEeccCCcccCCCC-----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh
Q 018244 196 RLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (359)
Q Consensus 196 kl~DFg~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~ 264 (359)
||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....+......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999765322 2346899999999999888999999999999999999999998543211111100
Q ss_pred ----hhhhcccccc-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 265 ----IQTLTDSCLE-GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 265 ----~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.......... .......+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0000000000 00011456689999999999999999999999999988654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=340.23 Aligned_cols=255 Identities=16% Similarity=0.221 Sum_probs=199.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC--CCcccccccceeeeC----CcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEG----DERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~l 130 (359)
..|++++.||+|+||.||+|+.. +..||||++.... ...+.+|.+++..+ +||||+++++++... ...++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 36788999999999999999975 7899999986432 34455566666555 899999999999887 67899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE-------RALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++
T Consensus 113 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 9999999999999953 46999999999999999999999752 8999999999999999999999999999
Q ss_pred ccCCCCC--------CcCCCccccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CCCCCcchhHH
Q 018244 204 KNSRDGR--------SYSTNLAFTPPEYLRTGRVTPE------SVMYSFGTLLLDLLSG----------KHIPPSHALDL 259 (359)
Q Consensus 204 ~~~~~~~--------~~~~t~~y~aPE~~~~~~~~~~------~Di~slG~il~elltg----------~~p~~~~~~~~ 259 (359)
....... ...||+.|+|||++.+...+.. +||||||+++|||+|| ..|+.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7654322 3468999999999987766665 9999999999999999 54443221100
Q ss_pred Hh-hhhhhhhccccccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 260 IR-DRNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 260 ~~-~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.. ................+ ..++.++.+|+.+||+.||++|||+.++++.|+.+.+..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 00 00000011111112222 3678899999999999999999999999999999977654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=335.89 Aligned_cols=249 Identities=17% Similarity=0.214 Sum_probs=189.0
Q ss_pred hcCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
...+.+|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 44567899999999999999999995 5788999999974321 2246788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999864 346789999999999999999999999 999999999999999999999999999987543
Q ss_pred C----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
. ....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. .. ....+...+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~--~~~~~~~~~~~ 238 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----LA--DYEMPSFLSIE 238 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----SS--CCCCCTTSCHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----hc--ccCCccccCHH
Confidence 2 23567899999999998889999999999999999999999887543222111111 00 11234456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=349.39 Aligned_cols=245 Identities=18% Similarity=0.237 Sum_probs=200.1
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCC--CcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|.+++.||+|+||+||+|...++..||||++..... ...+.+.+|+.+|..++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 35889999999999999999987789999999976532 23567899999999996 599999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 467899999974 45789999999999999999999999 999999999999996 589999999999876433
Q ss_pred ---CCcCCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 210 ---RSYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....+.......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHHHHhCccccC
Confidence 24568999999999875 3688999999999999999999999865321111 111222222222
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++...+.++.+|+.+||+.||++|||+.+++++
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 3344456789999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=366.36 Aligned_cols=247 Identities=19% Similarity=0.264 Sum_probs=205.3
Q ss_pred cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCCC
Q 018244 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
.||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+++|+.++||||+++++++.. +..+|||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6899999999999853 466799999986532 346789999999999999999999999976 56999999999999
Q ss_pred HhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-------Cc
Q 018244 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------SY 212 (359)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-------~~ 212 (359)
|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 9999964 455799999999999999999999999 99999999999999999999999999998764332 12
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
.+++.|+|||++.+..++.++||||||+++|||++ |+.||............ ........+..++.++.+||.+
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li~~ 574 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-----EQGKRMECPPECPPELYALMSD 574 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-----HTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHHHHHHHH
Confidence 34578999999998899999999999999999998 99888765433322211 1122233456677899999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 292 CLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
||+.||++|||+.++++.|+.+.....
T Consensus 575 cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 575 CWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp TTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 999999999999999999998865443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=346.13 Aligned_cols=257 Identities=18% Similarity=0.287 Sum_probs=210.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCC------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
....|.+.+.||+|+||.||+|.... ...||+|.+...... ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34678888999999999999998532 247999999865432 356689999999999 8999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~ 194 (359)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+|||++.++.
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCe
Confidence 9999999999999999986421 34689999999999999999999999 9999999999999999999
Q ss_pred eEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhh
Q 018244 195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 267 (359)
+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|+|+| |..||...........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 278 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK---- 278 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH----
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH----
Confidence 9999999998653322 2345678999999998889999999999999999999 8877765432221111
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
..........+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111112223344567899999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=340.10 Aligned_cols=250 Identities=20% Similarity=0.218 Sum_probs=199.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|.+++.||+|+||+||+|... ++..||+|++....... .+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56889999999999999999964 58899999987654332 4567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999999988876 456699999999999999999999999 9999999999999999999999999999875532
Q ss_pred CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc-------------------
Q 018244 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------------- 269 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------------- 269 (359)
....+|..|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 23467899999999976 5689999999999999999999999876533222111100000
Q ss_pred -cccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 -DSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 -~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+...... ....+.++.+|+.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 02356779999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=343.30 Aligned_cols=238 Identities=19% Similarity=0.189 Sum_probs=202.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--------hHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
..|.+++.||+|+||+||+|.. .++..||||++...... ....+.+|+.+|+.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4688999999999999999984 56889999999765321 22356789999999999999999999999999
Q ss_pred ceEEEecCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 128 RLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 128 ~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
.++||||+.+| +|.+++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999998776 9999986 455799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC---CcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 207 RDGR---SYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 207 ~~~~---~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... . ... ....+...+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~----~~~--~~~~~~~~~ 248 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T----VEA--AIHPPYLVS 248 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G----TTT--CCCCSSCCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H----Hhh--ccCCCcccC
Confidence 5443 3468999999999998876 7899999999999999999998865211 0 000 011233456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+|+.+||+.||++|||+.+++++
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 789999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.45 Aligned_cols=250 Identities=19% Similarity=0.143 Sum_probs=199.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC-----CCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS-----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
..|++++.||+|+||+||+|.. .++..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3678888999999999999995 56889999998643 23345678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 018244 131 VAEYMPNDTLAKHLFHW--------------------------------------ETQPMKWAMRLRVALHIAEALEYCT 172 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH 172 (359)
||||+++|+|.+++... ....+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988421 0112367788999999999999999
Q ss_pred cCCCcccccCCCCCeeeCCCC--CeEEeccCCcccCCC--------CCCcCCCccccCcccccC--CCCCCccchhhHHH
Q 018244 173 SKERALYHDLNAYRIVFDDDV--NPRLSCFGLMKNSRD--------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGT 240 (359)
Q Consensus 173 ~~~~ivH~Dikp~NIll~~~~--~~kl~DFg~a~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~ 240 (359)
++ +++|+||||+||+++.++ .+||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+
T Consensus 186 ~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 186 NQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 99 999999999999998766 899999999975432 134568999999999975 56899999999999
Q ss_pred HHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 241 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++|+|++|+.||.................. .........+.++.+|+.+||+.||++|||+.+++++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccc--cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999998765443322222111110 0111112356789999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=341.57 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=209.1
Q ss_pred CCcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
...|.+++.||+|+||.||+|.. .++..||||.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999983 2467899999975432 3355788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEecc
Q 018244 129 LLVAEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCF 200 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DF 200 (359)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+|||++. +..+||+||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999975432 4589999999999999999999999 9999999999999984 456999999
Q ss_pred CCcccCCC------CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccc
Q 018244 201 GLMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 201 g~a~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
|++..... .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.............. ..
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~~ 262 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----GG 262 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----TC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc-----CC
Confidence 99875322 223456889999999998889999999999999999998 8888766543332221111 11
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccC
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~ 319 (359)
....+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 2223455677899999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=344.90 Aligned_cols=250 Identities=18% Similarity=0.254 Sum_probs=197.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||+||+|... ++..||+|++....... ...+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999954 68899999997543221 12345799999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 975 89998865 455799999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred CcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc---------------
Q 018244 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--------------- 274 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 274 (359)
...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................+...
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 3467899999999886 568999999999999999999999987754433222211111100000
Q ss_pred --C-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 --G-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 --~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ......+.++.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0012346789999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=335.57 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=207.8
Q ss_pred CCcccccc-cCCCCCCcEEEEEEe---CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 56 FAMENIVS-EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 56 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
...|.+.+ .||+|+||+||+|.. .++..||||++...... ..+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 899999999999953 34678999999865322 256789999999999999999999999 667889
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 99999999999999974 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+...
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~ 245 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----KGERMGCPAGC 245 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCC
Confidence 2 2234678999999988889999999999999999999 998887654333222111 11122344566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 788999999999999999999999999999986543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=344.16 Aligned_cols=241 Identities=16% Similarity=0.191 Sum_probs=180.0
Q ss_pred ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCCCCCH
Q 018244 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (359)
+.||+|+||+||+|.. .++..||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 6789999999999995 46889999999753 3456788999999997 99999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---CeEEeccCCcccCCCC----CCcC
Q 018244 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNSRDG----RSYS 213 (359)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---~~kl~DFg~a~~~~~~----~~~~ 213 (359)
.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 999974 46799999999999999999999999 999999999999997665 7999999999865443 2445
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh---hhhhhhccccccCC--CChHHHHHHHHH
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNIQTLTDSCLEGQ--FSSDEGTELVRL 288 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~l~~l 288 (359)
+|+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....+........ .....++++.+|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 7899999999998899999999999999999999999987543211000 00111111110000 012357789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+.+++++
T Consensus 251 i~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHCCCChhHCCCHHHHhcC
Confidence 999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=333.70 Aligned_cols=247 Identities=15% Similarity=0.187 Sum_probs=201.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|.+.+.||+|+||+||+|.. .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 678889999999999999995 568899999997653 234677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCC-
Q 018244 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~- 209 (359)
++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.+||+|||++......
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999988642 246799999999999999999999999 99999999999999 45688999999999765433
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....+|+.|+|||.+. ..++.++||||||+++|+|++|..||................... .......++++.+
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 257 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY---AVECRPLTPQAVD 257 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---CC--CCCCHHHHH
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---ccccCcCCHHHHH
Confidence 3456899999999986 568999999999999999999999987765444332222111110 0111224678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=343.42 Aligned_cols=252 Identities=17% Similarity=0.220 Sum_probs=195.7
Q ss_pred cCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
..+..|.+++.||+|+||+||+|.. .++..||||++....... .+.+.+|+++++.++||||+++++++......++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999984 578899999997654322 3457899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-----CCCCeEEeccCCccc
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-----DDVNPRLSCFGLMKN 205 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-----~~~~~kl~DFg~a~~ 205 (359)
||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 111 v~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999975 99999973 45699999999999999999999999 999999999999994 455699999999976
Q ss_pred CCCC----CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc--------
Q 018244 206 SRDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-------- 272 (359)
Q Consensus 206 ~~~~----~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 272 (359)
.... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||..................+.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 5422 3346789999999998754 89999999999999999999999876543322221111110000
Q ss_pred ----ccCC------------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 ----LEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ----~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 011245789999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=370.86 Aligned_cols=245 Identities=19% Similarity=0.234 Sum_probs=209.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
...+|++++.||+|+||.||+|.. .+++.||||++.... ....+.+..|..+|..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457789999999999999999995 468899999997531 23356678899999988 6999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC-
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~- 208 (359)
|||||+++|+|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999974 35699999999999999999999999 999999999999999999999999999986322
Q ss_pred ---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
.....||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 569 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA 569 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------CCCCCTTSCHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHH
Confidence 23457899999999999999999999999999999999999999876554443333221 123456678899
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHH
Q 018244 286 VRLASRCLQYEPRERPNP-----RSLVT 308 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~-----~~il~ 308 (359)
.+||.+||+.||++||++ ++|++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999999997 66665
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.08 Aligned_cols=256 Identities=15% Similarity=0.149 Sum_probs=207.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccccccee-eeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 134 (359)
..|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.++|++++..+.++ ......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4688889999999999999995 6789999999876543 24588999999999988877666655 556778999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~-- 209 (359)
+ +++|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 8899999964 345799999999999999999999999 99999999999999 47899999999999865433
Q ss_pred ---------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchh-------HHHhhhhhhhhccccc
Q 018244 210 ---------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNIQTLTDSCL 273 (359)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 273 (359)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............ .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-- 240 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E-- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H--
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-H--
Confidence 344688999999999998999999999999999999999999865321 111111111000 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCcc
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSCF 322 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~~ 322 (359)
......++++.+++.+||+.||++|||+.++++.|+.+......+..
T Consensus 241 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 241 --VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp --HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred --HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 01133457899999999999999999999999999999877665543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=361.96 Aligned_cols=251 Identities=17% Similarity=0.220 Sum_probs=207.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
....|.+++.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++|+.++||||+++++++.+...+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 446788888999999999999996 4689999999975321 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 131 VAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999986533 45799999999999999999999999 999999999999999999999999999987654
Q ss_pred CC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
.. ...||+.|+|||++.+..++.++|||||||++|||++|..||...............+... ...++...+.+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~ 419 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCHH
Confidence 32 3478999999999999899999999999999999999999987642110011111111111 12345667789
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHH
Q 018244 285 LVRLASRCLQYEPRERPNP-----RSLVT 308 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~-----~~il~ 308 (359)
+.+|+.+||+.||++||++ .++++
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999975 55654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=341.15 Aligned_cols=254 Identities=17% Similarity=0.181 Sum_probs=192.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccceee--------eCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCC--------EGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~~ 126 (359)
..|++.+.||+|+||.||+|.. .++..||||++........+.+.+|+.++..+. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 3688899999999999999995 478899999997665555677899999999996 999999999984 334
Q ss_pred cceEEEecCCCCCHhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 127 ERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
..++||||+. |+|.+++... ....+++..++.++.||+.||.|||+. + ++|+||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5799999996 6899988642 345699999999999999999999999 8 999999999999999999999999999
Q ss_pred ccCCCCC----------------CcCCCccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh
Q 018244 204 KNSRDGR----------------SYSTNLAFTPPEYL---RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (359)
Q Consensus 204 ~~~~~~~----------------~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~ 264 (359)
....... ...+|+.|+|||++ .+..++.++||||||+++|+|++|..||............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 8754322 23478999999998 4566889999999999999999999988654322211111
Q ss_pred hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
.........+..+.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 266 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 266 --------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred --------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 111112333456899999999999999999999999999987755443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.38 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=199.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||.||+|.. .++..||||++...... ..+|++++.++ +||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4588999999999999999995 46889999999765432 34688888887 799999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC----CCeEEeccCCcccCCCC-
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~----~~~kl~DFg~a~~~~~~- 209 (359)
+++|+|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+|||+.++ +.+||+|||+++.....
T Consensus 98 ~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999997 456799999999999999999999999 99999999999998543 34999999999865443
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch---hHHHhhhhhhhhccccccCCCChHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
....+|+.|+|||++.+..++.++||||||+++|+|++|..||.... ............ ...........+.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--FSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC--CCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC--cccCccccccCCH
Confidence 24567899999999988779999999999999999999999987531 111111111100 0111122345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+|+.+||+.||++|||+.+++++
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 89999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.11 Aligned_cols=247 Identities=19% Similarity=0.189 Sum_probs=204.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|++++.||+|+||+||+|.. .++..||||++.... ......+.+|+++|+.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 3688999999999999999995 478899999986432 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC---CCCCeEEeccCCcccCCCC-
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~---~~~~~kl~DFg~a~~~~~~- 209 (359)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 102 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999998864 35699999999999999999999999 999999999999995 4567999999999865543
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||................... ........+.++.+
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--CSGGGGGSCHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCcccCCCCHHHHH
Confidence 34568999999999875 59999999999999999999999987764433322221111100 00112345788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 256 li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=337.42 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=209.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
....|.+.+.||+|+||+||+|.. .++..||||++...... ..+.+.+|+.++..+ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 345788999999999999999973 34678999999865433 345688999999999 6999999999987754
Q ss_pred -cceEEEecCCCCCHhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC
Q 018244 127 -ERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (359)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~ 191 (359)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSE 183 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECC
Confidence 48999999999999999975322 1288999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhh
Q 018244 192 DVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~ 264 (359)
++.+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|+|+| |..||............
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999998654332 2345788999999998899999999999999999998 88887654322111111
Q ss_pred hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.. .......+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 264 ~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 264 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hc----cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11 1111223445677899999999999999999999999999988653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=339.59 Aligned_cols=251 Identities=16% Similarity=0.197 Sum_probs=200.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeC------
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG------ 125 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 125 (359)
....|.+++.||+|+||+||+|.. .++..||||++...... ....+.+|+++++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 356899999999999999999996 57899999998754322 245678999999999999999999999873
Q ss_pred --CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 126 --DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 126 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
+..++||||+.+ +|.+.+.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999976 78887754 445699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC--------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 204 KNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 204 ~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||................... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI-TP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Ch
Confidence 765421 234578999999998764 58999999999999999999999887654332221111100000 00
Q ss_pred CCCC----------------------h-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 GQFS----------------------S-----DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 ~~~~----------------------~-----~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..++ . ..++.+.+|+.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0 014678999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.66 Aligned_cols=259 Identities=15% Similarity=0.148 Sum_probs=204.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccccccee-eeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 134 (359)
..|.+.+.||+|+||+||+|.. .++..||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4578888899999999999995 6788999998765432 23478899999999988877776655 567788999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~-- 209 (359)
+ +++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9 8899999864 345799999999999999999999999 99999999999999 78899999999999865432
Q ss_pred ---------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC---CC
Q 018244 210 ---------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QF 277 (359)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 277 (359)
....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ............ ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccccchhhhh
Confidence 23468899999999999899999999999999999999999986532110000 000000000000 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCCc
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSC 321 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~~ 321 (359)
....+.++.+++.+||+.||++|||+.++++.|+.+......+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 12345789999999999999999999999999999987665543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=344.75 Aligned_cols=252 Identities=17% Similarity=0.224 Sum_probs=205.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
...|.+++.||+|+||+||+|... ++..||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356889999999999999999954 6889999999865433 34678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC--CCCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRS 211 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~--~~~~ 211 (359)
|+++++|.+++.. ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++.... ....
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 9999999999974 34689999999999999999999984389999999999999999999999999986532 2345
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhh---------------------------
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN--------------------------- 264 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~--------------------------- 264 (359)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 57899999999999989999999999999999999999998754332221100
Q ss_pred -----------hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 -----------IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.................+.++.+|+.+||+.||++|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000001111122356789999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.74 Aligned_cols=245 Identities=16% Similarity=0.249 Sum_probs=207.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|.+++.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 478888999999999999985 568899999997654 234677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
++++|.+++ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... ..
T Consensus 103 ~~~~L~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 103 GGGSALDLL---EPGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TTEEHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCCcHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 999999998 446799999999999999999999999 9999999999999999999999999999765443 34
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..+|+.|+|||.+.+..++.++||||||+++|+|++|..||............ ........+...+..+.+|+.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-----PKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSCCCCCCSSCCHHHHHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-----hcCCCCCCccccCHHHHHHHHH
Confidence 56789999999999889999999999999999999999988654332221111 1111222344566789999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~ 311 (359)
||+.||++|||+.+++++.-
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHH
T ss_pred HcCCChhhCcCHHHHhhChh
Confidence 99999999999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=341.65 Aligned_cols=252 Identities=17% Similarity=0.263 Sum_probs=201.3
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+..|++++.||+|+||.||+|... ++..||||++....... .+.+.+|+.+++.++||||+++++++......++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4567999999999999999999964 58899999986554332 44578999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998888765 455699999999999999999999999 9999999999999999999999999999765432
Q ss_pred --CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-------------------
Q 018244 210 --RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------- 267 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~------------------- 267 (359)
....+|..|+|||.+.+. .++.++||||||+++|+|++|+.||...............
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 345688999999999875 6899999999999999999999998765332211111000
Q ss_pred -hccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 -LTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 -~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+...... ....+.++.+|+.+||+.||++|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 12356789999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.72 Aligned_cols=252 Identities=16% Similarity=0.210 Sum_probs=206.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee--CCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 129 (359)
....|++++.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 456789999999999999999995 4688999999976543 234568899999999999999999998854 56789
Q ss_pred EEEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccccCCCCCeeeCCCCCeEEeccCC
Q 018244 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-----ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999642 234599999999999999999999998 8 99999999999999999999999999
Q ss_pred cccCCCCC----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 203 MKNSRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 203 a~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
+....... ...+|..|+|||.+.+..++.++||||||+++|+|++|..||............... .....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~ 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIP 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----ccccCC
Confidence 88765443 235789999999999888999999999999999999999988765433222221111 112334
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
...+.++.+++.+||+.||++|||+.++++.+..
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 5567889999999999999999999999986543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=335.46 Aligned_cols=248 Identities=18% Similarity=0.221 Sum_probs=200.8
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|++++.||+|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 46889999999999999999964 58899999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC----CCCCC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~----~~~~~ 211 (359)
++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++... .....
T Consensus 99 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 99 PGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999998864 345699999999999999999999999 9999999999999999999999999987532 12334
Q ss_pred cCCCccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 212 YSTNLAFTPPEYL-----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 212 ~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
..+|..|+|||++ .+..++.++||||||+++|+|++|..|+............... .......+...+.++.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---DPPTLLTPSKWSVEFR 253 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---CCcccCCccccCHHHH
Confidence 5689999999998 3567899999999999999999999988754332221111111 0011112345677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+||+.||++|||+.+++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999998863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=356.88 Aligned_cols=246 Identities=15% Similarity=0.183 Sum_probs=200.7
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.|++++.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 5889999999999999999954 68899999997643 22356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcccCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~~~~~~-- 209 (359)
+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||++......
T Consensus 118 ~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 118 YKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 999999998863 45699999999999999999999999 99999999999999764 55999999999876543
Q ss_pred -CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
....||+.|+|||++. ..++.++||||||+++|+|++|..||................... ........+..+.+|
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGTTSCHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CchhcccCCHHHHHH
Confidence 3456899999999986 579999999999999999999999998765443332222111110 001113456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||.+|||+.+++++
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999965
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=357.49 Aligned_cols=247 Identities=18% Similarity=0.162 Sum_probs=206.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++.+.||+|+||+||+|... ++..||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 35888999999999999999954 78899999996543 234677899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~ 209 (359)
||+.+|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999987 456799999999999999999999999 99999999999999 46789999999999876544
Q ss_pred C---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
. ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.................. .........++++.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAK 259 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCSGGGGGSCHHHH
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCCcccccCCHHHH
Confidence 3 3468999999999875 6999999999999999999999999765443332222111111 00111234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=341.58 Aligned_cols=252 Identities=19% Similarity=0.204 Sum_probs=197.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch-----HHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
....|.+++.||+|+||.||+|.. .+|..||||++....... ...+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 345788889999999999999995 468899999997543221 23578999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 89888854 445689999999999999999999999 999999999999999999999999999987543
Q ss_pred C----CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc---c------
Q 018244 209 G----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---E------ 274 (359)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~------ 274 (359)
. ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..................+.. .
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 245679999999999764 4889999999999999999999888765433222221111100000 0
Q ss_pred --------CCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 --------GQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 --------~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... ....+.++.+|+.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 13345789999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=351.79 Aligned_cols=249 Identities=16% Similarity=0.184 Sum_probs=194.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 128 (359)
..|.+++.||+|+||+||+|.. .++..||||++..... ...+.+.+|+.+|+.++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 4688999999999999999995 4688999999976432 3356789999999999999999999999776 568
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
|+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999986 59999996 456799999999999999999999999 999999999999999999999999999986543
Q ss_pred C--------------------------CCcCCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCC----------
Q 018244 209 G--------------------------RSYSTNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHI---------- 251 (359)
Q Consensus 209 ~--------------------------~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p---------- 251 (359)
. ....||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2 345689999999986 455699999999999999999985433
Q ss_pred -CCcch------------------hHHHh------------------hhhhhhhcccc-ccCCC-----ChHHHHHHHHH
Q 018244 252 -PPSHA------------------LDLIR------------------DRNIQTLTDSC-LEGQF-----SSDEGTELVRL 288 (359)
Q Consensus 252 -~~~~~------------------~~~~~------------------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~l 288 (359)
|++.. .+.+. ........... ..... ....++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 32211 00000 00000000000 00000 12356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||+.||++|||+++++++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.98 Aligned_cols=249 Identities=17% Similarity=0.214 Sum_probs=201.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..+.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3444455679999999999995 568899999998766555678999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCcccCCCC----
Q 018244 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~~~~~---- 209 (359)
++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++. ++.+||+|||++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9999999997532 33567999999999999999999999 9999999999999987 899999999999865432
Q ss_pred CCcCCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||............ ..........+...+.++.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHCCCCCCCTTSCHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hccccccccccccCCHHHHH
Confidence 3456889999999987653 788999999999999999999888643221111000 00011122345566788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.00 Aligned_cols=247 Identities=18% Similarity=0.212 Sum_probs=199.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeee----CCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 128 (359)
-..|.+.+.||+|+||+||+|.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34577888899999999999985 568899999987543 2335668899999999999999999998865 3458
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeC-CCCCeEEeccCCccc
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKN 205 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~-~~~~~kl~DFg~a~~ 205 (359)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. + ++|+||||+||+++ .++.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999963 35689999999999999999999999 8 99999999999998 789999999999976
Q ss_pred CCCCC--CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 206 SRDGR--SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 206 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
..... ...+|+.|+|||.+. +.++.++||||||+++|+|++|+.||................. .....+...++
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 257 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---KPASFDKVAIP 257 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---CCGGGGGCCCH
T ss_pred ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC---CccccCCCCCH
Confidence 55432 456899999999887 5689999999999999999999999875322211111111111 11112233446
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+|+.+||+.||++|||+.+++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 79999999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.19 Aligned_cols=245 Identities=16% Similarity=0.150 Sum_probs=207.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
...|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999964 578999999875432 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999998863 45789999999999999999999999 9999999999999999999999999999865422
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.............. . ....+...+..+.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----N--EYSIPKHINPVAAS 244 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----T--CCCCCTTSCHHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----c--cCCCccccCHHHHH
Confidence 234678999999999988899999999999999999999999876543322211111 1 11234456678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||+.||++|||+.+++++
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHcccChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.34 Aligned_cols=249 Identities=16% Similarity=0.219 Sum_probs=202.8
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhc--CCCcccccccceeeeCC----cceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv 131 (359)
.|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++.... ..++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 577888889999999999998 4789999999753 34567888888887 78999999999998876 78999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
|||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 119 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999953 46899999999999999999999 77 9999999999999999999999999998
Q ss_pred ccCCCC--------CCcCCCccccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCCCcch---
Q 018244 204 KNSRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSG----------KHIPPSHA--- 256 (359)
Q Consensus 204 ~~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~il~elltg----------~~p~~~~~--- 256 (359)
...... ....+|+.|+|||++.+.. ++.++||||||+++|+|+|| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 765432 3346899999999998652 33689999999999999999 55664321
Q ss_pred --hHHHhhhhhhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 257 --LDLIRDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 257 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
....... +......... ....+..+.+|+.+||+.||++|||+.++++.|+.+.+...
T Consensus 275 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 275 PSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CCHHHHHHH----HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ccHHHHHHH----HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 1111111 1111112222 23567889999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=339.95 Aligned_cols=246 Identities=16% Similarity=0.149 Sum_probs=208.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC---chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
....|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3457889999999999999999954 578999999875422 235668899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999998863 45799999999999999999999999 9999999999999999999999999999865422
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....+|..|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+..+.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 269 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAA 269 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------CCCCCccCCHHHH
Confidence 3456889999999999888999999999999999999999998765433222111111 1123445667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=331.49 Aligned_cols=253 Identities=17% Similarity=0.203 Sum_probs=205.9
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.|.+++.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 5788899999999999999965 6889999998754321 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCcccC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~~ 206 (359)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999963 45689999999999999999999999 999999999999998877 8999999999876
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--FDEEYFSNTSE 240 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--CcchhcccCCH
Confidence 443 2346889999999999889999999999999999999999998765433222211111000 00001123457
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhh
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~--L~~~~~ 315 (359)
.+.+++.+||+.||++|||+.+++++ ++.+..
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 79999999999999999999999974 555433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=327.09 Aligned_cols=247 Identities=17% Similarity=0.136 Sum_probs=203.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+|.+++.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46888999999999999999964 68899999997543 23356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC------
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------ 208 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~------ 208 (359)
+++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999986 445799999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.....+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||............ ..............+..+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHH
Confidence 234568899999999987765 67899999999999999999988654321111000 01110111112345678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCCchhCCCHHHHhcC
Confidence 9999999999999999998863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.75 Aligned_cols=249 Identities=16% Similarity=0.132 Sum_probs=204.2
Q ss_pred ccccc-ccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEE
Q 018244 58 MENIV-SEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 58 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (359)
.|.+. +.||+|+||+||+|... ++..||+|++.... ......+.+|+.++..+. ||||+++++++......++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 35555 67899999999999954 68899999997543 223567899999999995 699999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCCC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~~ 209 (359)
||+.+|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999999999998655567899999999999999999999999 9999999999999997 789999999999876543
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+..+.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--DYSEETFSSVSQLAT 265 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTTTTTSCHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc--ccCchhhcccCHHHH
Confidence 345689999999999999999999999999999999999999876544333222211111 111222345677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+|+.+||+.||++|||+.+++++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=349.65 Aligned_cols=259 Identities=13% Similarity=0.136 Sum_probs=208.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCC--cceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 132 (359)
..|.+.+.||+|+||+||+|... ++..||||++..... ...+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46889999999999999999954 588999999985432 23567889999999999999999999998765 679999
Q ss_pred ecCCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee----CCCCCeEEeccCCcccCC
Q 018244 133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll----~~~~~~kl~DFg~a~~~~ 207 (359)
||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999996432 23499999999999999999999999 99999999999999 777889999999998765
Q ss_pred CCC---CcCCCccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCCCcchh----HHHhhhhhhhhcc--
Q 018244 208 DGR---SYSTNLAFTPPEYLRT--------GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTD-- 270 (359)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~elltg~~p~~~~~~----~~~~~~~~~~~~~-- 270 (359)
... ...||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... .............
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 432 4568999999999864 4578899999999999999999998753211 1111111100000
Q ss_pred -----------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 271 -----------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 271 -----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
...........+..+.+++.+||+.||++|||+.++++.++.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0011123466888999999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=350.95 Aligned_cols=247 Identities=15% Similarity=0.176 Sum_probs=190.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--------chHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
..|.+.+.||+|+||+||+|.. .++..||||++..... .....+.+|+++|+.++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 4678888999999999999985 5688999999875321 11224789999999999999999999985 456
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcc
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK 204 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~ 204 (359)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 899999999999999886 456799999999999999999999999 99999999999999754 459999999998
Q ss_pred cCCCC---CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCC
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 277 (359)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ........... .....
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~--~~~~~ 368 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN--FIPEV 368 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC--CCHHH
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC--CCchh
Confidence 76544 34568999999999864 568889999999999999999999986542211 11000000000 00000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+..+.+|+.+||+.||++|||+.+++++
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 12346789999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.86 Aligned_cols=247 Identities=15% Similarity=0.143 Sum_probs=202.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-------------chHHHHHHHHHHHhcCCCccccccccee
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRLANLLGCC 122 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~~ 122 (359)
..|.+++.||+|+||+||+|.. .++..||+|++..... ...+.+.+|+.+|+.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 5688999999999999999995 4688999999975432 2246788999999999999999999999
Q ss_pred eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC---CeEEec
Q 018244 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSC 199 (359)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---~~kl~D 199 (359)
.+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999863 45699999999999999999999999 999999999999998775 699999
Q ss_pred cCCcccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCC
Q 018244 200 FGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (359)
Q Consensus 200 Fg~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
||++...... ....||+.|+|||++. +.++.++||||||+++|+|++|..||.................... ..
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~ 269 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD--FN 269 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--HH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--cc
Confidence 9999876544 3456899999999987 5699999999999999999999999987654433322221111000 00
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.....+.++.+|+.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012356789999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=344.37 Aligned_cols=248 Identities=18% Similarity=0.235 Sum_probs=184.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC------Cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (359)
..|.+++.||+|+||.||+|.. .+|..||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4688999999999999999984 5688999999976432 2356788999999999999999999998654 56
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++|+||+ +++|.+++. ...+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 679999884 36799999999999999999999999 99999999999999999999999999998754
Q ss_pred CC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------- 268 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~----------------- 268 (359)
.. ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||................
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 43 34578999999999987 578999999999999999999999987653322111111100
Q ss_pred --cccccc-CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 --TDSCLE-GQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 --~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...... .. .....++.+.+|+.+||+.||++|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 00 011245789999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=335.30 Aligned_cols=255 Identities=19% Similarity=0.248 Sum_probs=202.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
.+..|.+.+.||+|+||.||+|.... .+|+|.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45778999999999999999999754 499999875432 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~---- 208 (359)
||+++++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred ecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999964 345689999999999999999999999 999999999999998 68999999999765421
Q ss_pred -----CCCcCCCccccCcccccC---------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 209 -----GRSYSTNLAFTPPEYLRT---------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 209 -----~~~~~~t~~y~aPE~~~~---------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
.....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..................
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 261 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP---- 261 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC----
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC----
Confidence 123357899999999874 34788999999999999999999998765544333222111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
.......+.++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11122345679999999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=341.14 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=196.7
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHH--HHhcCCCcccccccceeee-----CC
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEAR--AVGQLRNRRLANLLGCCCE-----GD 126 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~niv~~~~~~~~-----~~ 126 (359)
-++..|.+++.||+|+||+||+|+. ++..||||++.... ...+..|.+ .+..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3567899999999999999999987 67899999997543 333444444 4556899999999975533 23
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CcccccCCCCCeeeCCCCCeEEe
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--------RALYHDLNAYRIVFDDDVNPRLS 198 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------~ivH~Dikp~NIll~~~~~~kl~ 198 (359)
..++||||+++|+|.+++.. ...++..+..++.||+.||.|||+.. +|+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 57899999999999999953 34589999999999999999999852 89999999999999999999999
Q ss_pred ccCCcccCCCC------------CCcCCCccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCCCCCcchh-H
Q 018244 199 CFGLMKNSRDG------------RSYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-D 258 (359)
Q Consensus 199 DFg~a~~~~~~------------~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~elltg~~p~~~~~~-~ 258 (359)
|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..... .
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99999765432 13458999999999986 3466789999999999999999766533211 0
Q ss_pred HHh-------------hhhhhhhccccccCCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 259 LIR-------------DRNIQTLTDSCLEGQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 259 ~~~-------------~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
... ...............+ ....+.++.+|+.+||+.||++|||+.++++.|+.+...-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 000 0000000011111111 23467789999999999999999999999999999865433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=353.00 Aligned_cols=240 Identities=15% Similarity=0.099 Sum_probs=189.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCC---CCchHHHHHHHH---HHHhcCCCccccccc-------cee
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS---AWPDARQFLEEA---RAVGQLRNRRLANLL-------GCC 122 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~ 122 (359)
..|.+.+.||+|+||+||+|.. .+|..||||++... .....+.+.+|+ +.|+.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5688889999999999999994 57899999999743 333457788999 555566899999998 554
Q ss_pred eeCC-----------------cceEEEecCCCCCHhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 018244 123 CEGD-----------------ERLLVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYH 180 (359)
Q Consensus 123 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~ 180 (359)
...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence 4432 378999999 679999997421 12234588899999999999999999 99999
Q ss_pred cCCCCCeeeCCCCCeEEeccCCcccCCCC-CCcCCCccccCcccccCC-----------CCCCccchhhHHHHHHHHHhC
Q 018244 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSG 248 (359)
Q Consensus 181 Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~il~elltg 248 (359)
||||+|||++.++.+||+|||+++..... ....| +.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999875543 24456 999999999877 799999999999999999999
Q ss_pred CCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 249 KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 249 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.||......... ..+.. .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 310 ~~Pf~~~~~~~~~----~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 310 DLPITKDAALGGS----EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp SCCC------CCS----GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred CCCCcccccccch----hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9988654322111 11111 113446789999999999999999999999963
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=327.36 Aligned_cols=245 Identities=18% Similarity=0.246 Sum_probs=200.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
...|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999965 68899999997532 12345788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999974 35689999999999999999999999 99999999999999999999999999998765432
Q ss_pred --CcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||............... ....+...+..+.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchhcCHHHHH
Confidence 3467899999999987765 57999999999999999999998765443332221111 11233455678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||+.||++|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=331.21 Aligned_cols=247 Identities=15% Similarity=0.182 Sum_probs=201.8
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
...|.+++.||.|+||.||+|... +|..||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 356888999999999999999964 58899999997643 346789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... .
T Consensus 106 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 999999999863 356799999999999999999999999 9999999999999999999999999999765433 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...+|+.|+|||.+.+..++.++||||||+++|+|++|..||.............. ........+...+..+.+|+.
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT---NPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCCcccCCcccCCHHHHHHHH
Confidence 45678999999999988999999999999999999999998865432211111000 000111123445778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.+++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=347.10 Aligned_cols=250 Identities=18% Similarity=0.195 Sum_probs=201.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC------CCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL------RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~ 129 (359)
..|++++.||+|+||+||+|.. .++..||||++.... .....+.+|+.+++.+ .|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 3588999999999999999985 458899999997542 2345677788888777 5779999999999999999
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC--eEEeccCCcccCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSR 207 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~--~kl~DFg~a~~~~ 207 (359)
+||||+. ++|.+++.......+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9999996 5899999876666799999999999999999999999 9999999999999999887 9999999997655
Q ss_pred CC-CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------c
Q 018244 208 DG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------------T 269 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------------~ 269 (359)
.. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 43 35578999999999999999999999999999999999999887653322211111000 0
Q ss_pred cccc---------------------------c-CC--------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 DSCL---------------------------E-GQ--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ~~~~---------------------------~-~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... . .. .....++++.+|+.+||+.||++|||+.+++++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 0000 0 00 011125679999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=365.48 Aligned_cols=243 Identities=21% Similarity=0.246 Sum_probs=202.6
Q ss_pred cCCCCCCcEEEEEEe---CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
.||+|+||+||+|.+ ..+..||||+++.... ...+.+.+|+++|+.++|||||++++++. .+..+|||||+.+|
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCC
Confidence 689999999999964 3467899999986432 23577999999999999999999999996 45689999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-------C
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-------~ 211 (359)
+|.+++. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 455 ~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9999996 445799999999999999999999999 99999999999999999999999999998664332 2
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..+|..|+|||++.+..++.++||||||+++|||++ |+.||............. .......+..++.++.+||.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----KGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence 235678999999998899999999999999999998 998887654433322221 11223345567789999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+||+.||++|||+.++++.|+.+..
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.30 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=200.1
Q ss_pred CCcccccccCCCCCCcEEEEEEeC--CCc--EEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE--NQF--RIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
...|++++.||+|+||+||+|.+. ++. .||+|++.... ....+.+.+|+++++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999842 233 69999997642 234567899999999999999999999997754 8
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 96 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999964 335689999999999999999999999 999999999999999999999999999887644
Q ss_pred CC-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
.. ...+|..|+|||.+.+..++.++||||||+++|+|++ |..||.............. .......+..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 249 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGERLPRPED 249 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCCCCCCCTT
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc----cCCCCCCCcC
Confidence 32 2346778999999988889999999999999999999 8988876543332222111 1112223445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 67889999999999999999999999999998765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.46 Aligned_cols=249 Identities=16% Similarity=0.202 Sum_probs=202.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCC----chHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
...|.+++.||+|+||+||+|.. .++..||||++..... ...+.+.+|+++|..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46788999999999999999986 3688999999975321 2234567899999999 6999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999974 35699999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC-----CCcCCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 207 RDG-----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 207 ~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.................. ....++.
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc
Confidence 322 234689999999999863 4788999999999999999999998643211111111111111 1123455
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (359)
..+..+.+|+.+||+.||++|| |+.+++++
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 6778899999999999999999 88988875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=329.47 Aligned_cols=246 Identities=18% Similarity=0.177 Sum_probs=201.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC----CchHHHHHHHHHHHhcCCCcccccccceee--eCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCC--EGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 128 (359)
...|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35788999999999999999995 568899999997542 233567899999999999999999999984 45678
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+.++ |.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999876 77877765667899999999999999999999999 999999999999999999999999999986543
Q ss_pred C------CCcCCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 209 G------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 209 ~------~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
. ....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||............... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~~~~~ 235 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAIPGD 235 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCCCCSS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCCCCCc
Confidence 2 2345789999999998644 477999999999999999999998765443332221111 1123445
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+..+.+|+.+||+.||++|||+.+++++
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 66789999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=339.99 Aligned_cols=248 Identities=12% Similarity=0.110 Sum_probs=203.7
Q ss_pred CCcccccccCCCCCCcEEEEEE------eCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC---CcccccccceeeeCC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGD 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 126 (359)
-..|.+.+.||+|+||+||+|. ..+++.||||++.... ...+.+|++++..++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3568888899999999999993 4568899999998643 456778888888886 999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-----------C
Q 018244 127 ERLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----------D 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-----------~ 192 (359)
..+|||||+++|+|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------C
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999642 345799999999999999999999999 9999999999999998 8
Q ss_pred CCeEEeccCCcccCC---C---CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh
Q 018244 193 VNPRLSCFGLMKNSR---D---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~---~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~ 266 (359)
+.+||+|||+++... . .....||+.|+|||++.+..++.++||||||+++|||+||+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 999999999996532 1 13456899999999999999999999999999999999999887544221100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhcc
Q 018244 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER-PNPRSLVTALVTLQKDT 317 (359)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~il~~L~~~~~~~ 317 (359)
...... . ...++.+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 295 --~~~~~~-~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 --PEGLFR-R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --ECSCCT-T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --echhcc-c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 011111 1 1235678899999999999999 68888888888876643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=348.26 Aligned_cols=248 Identities=12% Similarity=0.028 Sum_probs=183.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHH---HHHhcCCCccccccc-------ceee
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEA---RAVGQLRNRRLANLL-------GCCC 123 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~ 123 (359)
.|.+++.||+|+||+||+|.. .++..||||++...... ..+.+.+|+ +.|+. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 478889999999999999995 47889999999876532 244567774 45555 799988855 3333
Q ss_pred eC-----------------CcceEEEecCCCCCHhhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCcccc
Q 018244 124 EG-----------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMR------LRVALHIAEALEYCTSKERALYH 180 (359)
Q Consensus 124 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~ivH~ 180 (359)
.. ...+|||||++ |+|.+++... ...+++..+ ..++.||+.||+|||++ +|+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccC
Confidence 22 33799999998 7999999752 233455555 77889999999999999 99999
Q ss_pred cCCCCCeeeCCCCCeEEeccCCcccCCCCC-CcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCcchh
Q 018244 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257 (359)
Q Consensus 181 Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~ 257 (359)
||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776554 5567799999999987 6799999999999999999999999876532
Q ss_pred HHHhhhhh---hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 258 DLIRDRNI---QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 258 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
........ ................+..+.+|+.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 21110000 00001111111123567889999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=334.03 Aligned_cols=254 Identities=18% Similarity=0.260 Sum_probs=187.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
+...|.+.+.||+|+||.||+|.. .++..||||.+..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 346788999999999999999984 5688999999875432 33556889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 133 EYMPNDTLAKHLFH------WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 133 e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
||+++++|.+++.. .....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999999863 1345689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCC---------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc----ccc
Q 018244 207 RDG---------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----DSC 272 (359)
Q Consensus 207 ~~~---------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~~~ 272 (359)
... ....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||................. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 332 23467899999999875 4689999999999999999999998865432221111111100 000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.........+.++.+|+.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0111223456789999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=338.95 Aligned_cols=247 Identities=15% Similarity=0.183 Sum_probs=192.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|.+++.||+|+||.||+|.. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5788999999999999999985 4688999999976432 23456889999999999999999999997665 6
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 7888874 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc--------------
Q 018244 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD-------------- 270 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 270 (359)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 43 3456899999999999989999999999999999999999998765332211111110000
Q ss_pred -------------------ccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 271 -------------------SCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 271 -------------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+. .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 011236789999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=335.20 Aligned_cols=245 Identities=17% Similarity=0.198 Sum_probs=198.6
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccccccccceeee--CCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCE--GDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 131 (359)
-..|++++.||+|+||+||+|.. .++..||||++.... .+.+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 35789999999999999999984 578899999997533 567899999999997 9999999999987 5678999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~~- 209 (359)
|||+.+++|.+++. .+++..+..++.|++.||.|||++ +++||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999884 389999999999999999999999 999999999999999776 8999999999865433
Q ss_pred --CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH--Hhh-------hhhhhhc--------
Q 018244 210 --RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL--IRD-------RNIQTLT-------- 269 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~--~~~-------~~~~~~~-------- 269 (359)
....+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... .......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 34567899999999987 568999999999999999999999885331110 000 0000000
Q ss_pred ---------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 ---------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
............+.++.+|+.+||+.||++|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000111122357889999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=332.72 Aligned_cols=248 Identities=14% Similarity=0.194 Sum_probs=199.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeee------CCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~ 127 (359)
...|++++.||.|+||.||+|.. .++..||||++.... ...+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 45678889999999999999995 578899999997544 3356788999999999 79999999999987 467
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+++|+|.+++.......+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 89999999999999999765556799999999999999999999999 99999999999999999999999999987654
Q ss_pred CC----CCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC
Q 018244 208 DG----RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (359)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (359)
.. ....+|+.|+|||++. +..++.++||||||+++|+|++|..||............ ..........
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 256 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPAPRLKS 256 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----hcCccccCCc
Confidence 32 3456899999999987 456899999999999999999999988654322211111 1111111123
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+..+.+|+.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 3456789999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=341.12 Aligned_cols=248 Identities=18% Similarity=0.244 Sum_probs=199.1
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 129 (359)
..|.+++.||+|+||.||+|.. .++..||||++...... ..+.+.+|+++|+.++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 3688999999999999999985 46889999999854433 346788999999999999999999998765 3689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 107 iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999975 89998853 4699999999999999999999999 9999999999999999999999999999865432
Q ss_pred -------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------
Q 018244 210 -------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---------- 271 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 271 (359)
....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..................+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 234789999999987654 48999999999999999999999987653322211111100000
Q ss_pred ---------c-ccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 ---------C-LEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ---------~-~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .... .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 112346789999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=332.48 Aligned_cols=250 Identities=17% Similarity=0.167 Sum_probs=204.4
Q ss_pred CcccccccCCCCCCcEEEEEEe--CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc------cccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 128 (359)
..|++++.||+|+||+||+|.. .++..||||++.... ...+.+.+|+++++.++|++ ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4788999999999999999985 368899999997542 33566888999999987765 99999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-----------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----------------- 191 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~----------------- 191 (359)
++||||+ +++|.+++.......+++..+..++.|++.||+|||++ +++||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999 78999999865556789999999999999999999999 9999999999999987
Q ss_pred --CCCeEEeccCCcccCCCC-CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh
Q 018244 192 --DVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (359)
Q Consensus 192 --~~~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 268 (359)
++.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 678999999999875543 45578999999999998899999999999999999999999987653322111100000
Q ss_pred c-------------------------------------cc-cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 T-------------------------------------DS-CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 ~-------------------------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .+ ..........++++.+|+.+||+.||++|||+.+++++
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0 00 00011234567889999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=343.21 Aligned_cols=247 Identities=18% Similarity=0.194 Sum_probs=196.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC----------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG---------- 125 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------- 125 (359)
..|.+++.||+|+||+||+|.. .+|+.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4688889999999999999984 5789999999875432 224699999999999999999998543
Q ss_pred ----------------------------CcceEEEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 018244 126 ----------------------------DERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKE 175 (359)
Q Consensus 126 ----------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 175 (359)
...++||||+++ +|.+.+.. .....+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 348899999985 77777653 2456799999999999999999999999
Q ss_pred CcccccCCCCCeeeC-CCCCeEEeccCCcccCCCC---CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCC
Q 018244 176 RALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKH 250 (359)
Q Consensus 176 ~ivH~Dikp~NIll~-~~~~~kl~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~ 250 (359)
||+||||||+|||++ .++.+||+|||+++..... ....+|+.|+|||.+.+.. ++.++||||+|+++|+|++|+.
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999998 6889999999999865433 3456789999999988754 8999999999999999999999
Q ss_pred CCCcchhHHHhhhhhhhhcc-----------------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 018244 251 IPPSHALDLIRDRNIQTLTD-----------------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307 (359)
Q Consensus 251 p~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il 307 (359)
||.................. ......++...+.++.+|+.+||+.||++|||+.+++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 98765332222111110000 0001112344667899999999999999999999998
Q ss_pred HH
Q 018244 308 TA 309 (359)
Q Consensus 308 ~~ 309 (359)
++
T Consensus 321 ~h 322 (383)
T 3eb0_A 321 AH 322 (383)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=337.10 Aligned_cols=252 Identities=16% Similarity=0.160 Sum_probs=205.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCch-----------------HHHHHHHHHHHhcCCCcccccc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-----------------ARQFLEEARAVGQLRNRRLANL 118 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~ 118 (359)
..+|.+++.||+|+||.||+|.. ++..||||.+....... .+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999999 88999999987432111 1788999999999999999999
Q ss_pred cceeeeCCcceEEEecCCCCCHhhh------hhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCC
Q 018244 119 LGCCCEGDERLLVAEYMPNDTLAKH------LFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDD 191 (359)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~ 191 (359)
++++...+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ . +++|+||||+||+++.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcC
Confidence 9999999999999999999999998 654336789999999999999999999999 8 9999999999999999
Q ss_pred CCCeEEeccCCcccCCCC--CCcCCCccccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhhh
Q 018244 192 DVNPRLSCFGLMKNSRDG--RSYSTNLAFTPPEYLRTG-RVTP-ESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQ 266 (359)
Q Consensus 192 ~~~~kl~DFg~a~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~-~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~ 266 (359)
++.+||+|||++...... ....+|..|+|||.+.+. .++. ++||||||+++|+|++|..||..... .........
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 999999999999875443 345688999999999877 5666 99999999999999999999875432 111111111
Q ss_pred hhcc-cccc------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 TLTD-SCLE------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ~~~~-~~~~------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... +... .......+.++.+|+.+||+.||++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000 00013466789999999999999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=338.24 Aligned_cols=248 Identities=19% Similarity=0.197 Sum_probs=202.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc--------hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP--------DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
..|.+.+.||.|+||.||+|... +|..||||++...... ..+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45788888999999999999964 7899999998754321 134578899999999 7999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. |++|+||||+||+++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999973 45699999999999999999999999 9999999999999999999999999998876
Q ss_pred CCC---CCcCCCccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCC
Q 018244 207 RDG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................... ..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS--PE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH--HH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--cc
Confidence 543 34568999999998863 35889999999999999999999998764332222111111000000 00
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+..+.+|+.+||+.||++|||+.+++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01345679999999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=349.20 Aligned_cols=251 Identities=14% Similarity=0.162 Sum_probs=200.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC--------Ccccccccceee----
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--------NRRLANLLGCCC---- 123 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~---- 123 (359)
..|.+++.||+|+||+||+|.. .++..||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 5688999999999999999984 568899999997542 33567889999999985 788999999987
Q ss_pred eCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----------
Q 018244 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---------- 193 (359)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~---------- 193 (359)
.....++||||+ +++|.+++.......+++..++.++.||+.||.|||++.+|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456799999999 557777776555567999999999999999999999854899999999999999775
Q ss_pred ---------------------------------------CeEEeccCCcccCCCC-CCcCCCccccCcccccCCCCCCcc
Q 018244 194 ---------------------------------------NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPES 233 (359)
Q Consensus 194 ---------------------------------------~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~ 233 (359)
.+||+|||++...... ....||+.|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 8999999999865443 345789999999999998999999
Q ss_pred chhhHHHHHHHHHhCCCCCCcchhHHH-----hhhhhhhhccc-------------------------------------
Q 018244 234 VMYSFGTLLLDLLSGKHIPPSHALDLI-----RDRNIQTLTDS------------------------------------- 271 (359)
Q Consensus 234 Di~slG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~------------------------------------- 271 (359)
|||||||++|+|++|+.||........ ...........
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999864321100 00000000000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00012345678899999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=328.14 Aligned_cols=250 Identities=18% Similarity=0.153 Sum_probs=205.5
Q ss_pred cCCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---------chHHHHHHHHHHHhcCC-Cccccccccee
Q 018244 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---------PDARQFLEEARAVGQLR-NRRLANLLGCC 122 (359)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 122 (359)
..+..|.+++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3467889999999999999999996 4688999999975431 11345788999999996 99999999999
Q ss_pred eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
......++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999999973 45799999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---CCcCCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc
Q 018244 203 MKNSRDG---RSYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (359)
Q Consensus 203 a~~~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
+...... ....+|+.|+|||++. ...++.++||||||+++|+|++|..||.................. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~ 248 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--F 248 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--C
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc--c
Confidence 9875543 2446789999999885 456889999999999999999999988765433322211111110 1
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
........+..+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11112356778999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=338.42 Aligned_cols=257 Identities=15% Similarity=0.195 Sum_probs=196.5
Q ss_pred HHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc-----------hHHHHHHHHHHHhcCCCccc
Q 018244 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-----------DARQFLEEARAVGQLRNRRL 115 (359)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni 115 (359)
.++.... ..|.+++.||+|+||.||+|...++..||||++...... ..+.+.+|+++++.++||||
T Consensus 15 ~~~~~~~---~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 15 AELHAMQ---SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHTT---CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHhc---cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4444444 456677888999999999999878999999999653221 13678999999999999999
Q ss_pred ccccceeeeC-----CcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC
Q 018244 116 ANLLGCCCEG-----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (359)
Q Consensus 116 v~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~ 190 (359)
+++++++... ...++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++ +++|+||||+||+++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEc
Confidence 9999998543 35799999997 588888864 455799999999999999999999999 999999999999999
Q ss_pred CCCCeEEeccCCcccCCCC---CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh
Q 018244 191 DDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ 266 (359)
Q Consensus 191 ~~~~~kl~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~ 266 (359)
.++.+||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754433 34567899999999887 6689999999999999999999999876543222211111
Q ss_pred hhcc-------------------ccccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 267 TLTD-------------------SCLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 267 ~~~~-------------------~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ..... ......++.+.+|+.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 00000 0112345779999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.26 Aligned_cols=254 Identities=17% Similarity=0.182 Sum_probs=206.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC-cccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 134 (359)
..|.+++.||+|+||.||+|.. .++..||||++..... ...+.+|+++++.++| +++..+..++...+..+|||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4688999999999999999995 5788999998875443 2357889999999986 5566666677778889999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee---CCCCCeEEeccCCcccCCCCC-
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll---~~~~~~kl~DFg~a~~~~~~~- 210 (359)
+ +++|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++......
T Consensus 85 ~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9 8899999964 356799999999999999999999999 99999999999999 588999999999998654432
Q ss_pred ----------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhH-------HHhhhhhhhhccccc
Q 018244 211 ----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-------LIRDRNIQTLTDSCL 273 (359)
Q Consensus 211 ----------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 273 (359)
...||..|+|||++.+..++.++||||||+++|+|++|+.||...... .+...........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-- 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-- 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH--
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH--
Confidence 456899999999999999999999999999999999999998753211 1111111111110
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
....++.++.+|+..||+.||++||++.+|++.|+.+.......
T Consensus 240 ---l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp ---HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ---HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 01234568999999999999999999999999999987655433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=327.06 Aligned_cols=250 Identities=18% Similarity=0.185 Sum_probs=189.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch--HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..+|++++.||+|+||+||+|.. .+++.||+|++....... .+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35788999999999999999995 578899999998653322 223445556688889999999999999999999999
Q ss_pred ecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 133 EYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||+++ +|.+++.. .....+++..++.++.|++.||.|||++.+++|+||||+||+++.++.+||+|||++.......
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 99975 88877753 1456799999999999999999999984489999999999999999999999999997654432
Q ss_pred ---CcCCCccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ---SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...+|+.|+|||++ .+..++.++||||||+++|+|++|+.||.......... ................+.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 241 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPADKFSA 241 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTTTSCH
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccccCCH
Confidence 34688999999996 45568999999999999999999999886432211111 111111111122345677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 242 EFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 89999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.78 Aligned_cols=246 Identities=19% Similarity=0.253 Sum_probs=194.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee-----------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----------- 124 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------- 124 (359)
.+|++++.||+|+||.||+|.. .++..||||.+.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3578888999999999999995 478899999996432 335678899999999999999999998865
Q ss_pred --CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 125 --GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 125 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
....++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3467999999999999999975 345678899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC------------------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh
Q 018244 203 MKNSRDG------------------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263 (359)
Q Consensus 203 a~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~ 263 (359)
+...... ....+|+.|+|||.+.+. .++.++||||||+++|+|++ |+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 8765421 234578899999999865 68999999999999999998 3433211111111
Q ss_pred hhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ........++...+..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 240 KLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 11112233445567789999999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=332.12 Aligned_cols=248 Identities=17% Similarity=0.229 Sum_probs=193.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceee------------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC------------ 123 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------------ 123 (359)
..|.+++.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56889999999999999999965 58899999998766555678899999999999999999998873
Q ss_pred --eCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEecc
Q 018244 124 --EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF 200 (359)
Q Consensus 124 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DF 200 (359)
.....++||||+. |+|.+++ ....+++..++.++.|++.||+|||++ +++|+||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVL---EQGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHh---hcCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 5999998 446799999999999999999999999 999999999999997 5679999999
Q ss_pred CCcccCCCC-------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc---
Q 018244 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT--- 269 (359)
Q Consensus 201 g~a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~--- 269 (359)
|++...... ....+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999865432 23346889999998875 6689999999999999999999999876533222111111000
Q ss_pred ---------------ccccc-CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 ---------------DSCLE-GQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ---------------~~~~~-~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... .. .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 00 112356789999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=330.82 Aligned_cols=251 Identities=18% Similarity=0.203 Sum_probs=200.4
Q ss_pred CcccccccCCCCCCcEEEEEEe--CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcC---CCcccccccceee-----e
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCC-----E 124 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 124 (359)
..|.+++.||+|+||.||+|.. .++..||+|++...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4688999999999999999996 46788999998743221 123456677776666 8999999999987 4
Q ss_pred CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
....++||||+. |+|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 567899999997 5999999765566799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---------- 271 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 271 (359)
..... ....+|..|+|||++.+..++.++||||||+++|+|++|+.||..................+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 65432 34567899999999998899999999999999999999999987654322221111100000
Q ss_pred -----------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 -----------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 -----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..........+..+.+|+.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00011223466789999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=357.11 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=207.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC----CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
..|.+.+.||+|+||.||+|... .+..||+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 56788889999999999999863 2467999998765433 2467899999999999999999999985 4678999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 469 MELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999999975 345689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...+|+.|+|||++.+..++.++||||||+++|||++ |..||.............. ......+...+..+
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPTL 621 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-----TCCCCCCTTCCHHH
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccccHHH
Confidence 2345678999999998899999999999999999997 8888776543322221111 11223445667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.15 Aligned_cols=247 Identities=15% Similarity=0.199 Sum_probs=196.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcc-----
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDER----- 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----- 128 (359)
..|.+.+.||+|+||+||+|.. .+|..||||++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4678888899999999999985 46889999999865433 246788999999999999999999999877655
Q ss_pred -eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 129 -LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 129 -~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888773 3499999999999999999999999 99999999999999999999999999998665
Q ss_pred CC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------- 268 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~----------------- 268 (359)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||................
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 43 34578999999999987 678999999999999999999999987653322211111100
Q ss_pred --ccccccC------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 --TDSCLEG------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 --~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....... ......++++.+|+.+||+.||++|||+.+++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 0012346789999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=343.69 Aligned_cols=246 Identities=22% Similarity=0.230 Sum_probs=193.3
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC------CcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 130 (359)
.|.+++.||+|+||+||+|... ++..||||++..... ...+|+++|+.++||||+++++++... ..+++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5888899999999999999964 689999999875432 234699999999999999999988542 23679
Q ss_pred EEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-CCeEEeccCCcccCC
Q 018244 131 VAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-~~~kl~DFg~a~~~~ 207 (359)
||||+++ +|.+.+.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 9999986 67666542 2456799999999999999999999999 99999999999999955 568999999998654
Q ss_pred CC---CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc----------ccc-
Q 018244 208 DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----------DSC- 272 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~- 272 (359)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...............+. .+.
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 33 345789999999999765 689999999999999999999999976532221111111000 000
Q ss_pred ----c--------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 ----L--------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ----~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ...++...+.++.+|+.+||+.||++|||+.+++++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000223456789999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.48 Aligned_cols=247 Identities=19% Similarity=0.220 Sum_probs=194.1
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCc------ceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------RLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~l 130 (359)
..|.+++.||+|+||+||+|....+..+|+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468899999999999999999876667999988654321 2369999999999999999999965443 789
Q ss_pred EEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEeccCCcccCC
Q 018244 131 VAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DFg~a~~~~ 207 (359)
||||++++ +.+.+.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99999875 4443321 1356799999999999999999999999 999999999999999 79999999999998754
Q ss_pred CC---CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh---------------
Q 018244 208 DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------- 268 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--------------- 268 (359)
.. ....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||................
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 33 355789999999998765 48999999999999999999999998654322211111100
Q ss_pred cccc--------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 TDSC--------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 ~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ....++...++++.+|+.+||+.||++|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 0001223356789999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=333.45 Aligned_cols=247 Identities=15% Similarity=0.169 Sum_probs=194.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--------chHHHHHHHHHHHhcCCCcccccccceeeeCCc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (359)
..|.+++.||+|+||.||+|.. .++..||||++..... .....+.+|+++|+.++||||+++++++... .
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-c
Confidence 3688899999999999999995 4688999999975421 1123478999999999999999999998665 4
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC---eEEeccCCcc
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMK 204 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~---~kl~DFg~a~ 204 (359)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||++ +++|+||||+||+++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999886 456799999999999999999999999 9999999999999987654 9999999998
Q ss_pred cCCCCC---CcCCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCC
Q 018244 205 NSRDGR---SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF 277 (359)
Q Consensus 205 ~~~~~~---~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 277 (359)
...... ...||+.|+|||++. ...++.++||||||+++|+|++|..||....... ........... .....
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 243 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN--FIPEV 243 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC--CCHHH
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc--cCchh
Confidence 765542 345789999999974 4568999999999999999999999886542211 11000000000 00000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....+.++.+|+.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 12346789999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.46 Aligned_cols=248 Identities=15% Similarity=0.193 Sum_probs=198.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 129 (359)
..|.+.+.||+|+||.||+|... +|..||||++...... ....+.+|+++++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 46888899999999999999954 6889999999754332 345678999999999999999999988654 6789
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 589998853 5699999999999999999999999 9999999999999999999999999999865422
Q ss_pred --------------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh-------
Q 018244 210 --------------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------- 267 (359)
Q Consensus 210 --------------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~------- 267 (359)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 12357899999998765 67899999999999999999999998765432211111000
Q ss_pred -------------hcccccc-C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 -------------LTDSCLE-G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 -------------~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
....... . ......+.++.+|+.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0 0012456789999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=332.45 Aligned_cols=251 Identities=17% Similarity=0.200 Sum_probs=187.7
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCc-------
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------- 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 127 (359)
+..|.+.+.||+|+||+||+|.. .++..||||++..... ......++++.+..++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 45778888999999999999996 4688999999865432 23456778888899999999999999976443
Q ss_pred ceEEEecCCCCCHhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCcccccCCCCCeeeCC-CCCeEEeccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCT--SKERALYHDLNAYRIVFDD-DVNPRLSCFGL 202 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~ 202 (359)
.++||||+.+ +|...+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 7899999987 55554432 25567899999999999999999999 88 9999999999999996 89999999999
Q ss_pred cccCCCCC---CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc-------
Q 018244 203 MKNSRDGR---SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS------- 271 (359)
Q Consensus 203 a~~~~~~~---~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 271 (359)
+....... ...+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||..................+
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98765433 456799999999987654 8999999999999999999999987654332222211100000
Q ss_pred -------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 -------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 -------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..........+.++.+|+.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00011122357889999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=332.98 Aligned_cols=252 Identities=17% Similarity=0.153 Sum_probs=199.8
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Cc-----ccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NR-----RLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 128 (359)
...|.+++.||+|+||+||+|.. .++..||||++.... .....+.+|+.++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 35788899999999999999985 468899999997532 23456778888888875 44 499999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeC--CCCCeEEeccCCccc
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFD--DDVNPRLSCFGLMKN 205 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~--~~~~~kl~DFg~a~~ 205 (359)
+|||||+.+ +|.+++.......+++..+..++.|++.||.|||+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999999965 99999986555679999999999999999999995 23999999999999995 478899999999987
Q ss_pred CCCC-CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh----------------
Q 018244 206 SRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---------------- 268 (359)
Q Consensus 206 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~---------------- 268 (359)
.... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence 6543 45678999999999999999999999999999999999999987653322211111100
Q ss_pred -cccccc-----------------------------------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 018244 269 -TDSCLE-----------------------------------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306 (359)
Q Consensus 269 -~~~~~~-----------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 306 (359)
...... .........++.+|+.+||+.||++|||+.++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~ 370 (382)
T 2vx3_A 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA 370 (382)
T ss_dssp HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHH
Confidence 000000 00011234589999999999999999999999
Q ss_pred HHH
Q 018244 307 VTA 309 (359)
Q Consensus 307 l~~ 309 (359)
+++
T Consensus 371 L~h 373 (382)
T 2vx3_A 371 LQH 373 (382)
T ss_dssp TTS
T ss_pred hcC
Confidence 863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.35 Aligned_cols=247 Identities=15% Similarity=0.150 Sum_probs=174.7
Q ss_pred ccccccc-CCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee----CCcceEE
Q 018244 58 MENIVSE-HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV 131 (359)
Q Consensus 58 ~~~~~~~-lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 131 (359)
+|.++++ ||+|+||+||+|... +++.||||++.... ....+....++.+.||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 6777654 899999999999964 68899999996532 222223344666799999999999976 4458999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~~~ 208 (359)
|||+++|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++.....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 9999999999999865556799999999999999999999999 9999999999999986 45599999999986554
Q ss_pred C--CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc--cccCCCChHHHHH
Q 018244 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--CLEGQFSSDEGTE 284 (359)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 284 (359)
. ....+|+.|+|||++.+..++.++||||||+++|+|++|..||................... ..........+.+
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence 3 34567899999999988889999999999999999999999986554332211111111111 1111122356788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+|+.+||+.||++|||+.+++++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.90 Aligned_cols=247 Identities=15% Similarity=0.214 Sum_probs=181.0
Q ss_pred ccccc-cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee--CCcceEEE
Q 018244 59 ENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVA 132 (359)
Q Consensus 59 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 132 (359)
|.+.+ +||+|+||+||+|... ++..||||++..... ...+.+|+.+|+.++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 55544 6899999999999964 578899999986543 3467899999999999999999999954 66899999
Q ss_pred ecCCCCCHhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee----CCCCCeEEeccC
Q 018244 133 EYMPNDTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFG 201 (359)
Q Consensus 133 e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll----~~~~~~kl~DFg 201 (359)
||+.+ +|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 99975 788877521 223589999999999999999999999 99999999999999 678999999999
Q ss_pred CcccCCCC-------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHH---------hhhh
Q 018244 202 LMKNSRDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI---------RDRN 264 (359)
Q Consensus 202 ~a~~~~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---------~~~~ 264 (359)
+++..... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....+.. ....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99865432 245679999999999874 489999999999999999999999864322100 0000
Q ss_pred hhhh------------------------ccccccC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 265 IQTL------------------------TDSCLEG--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 265 ~~~~------------------------~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
...+ ....... ......+.++.+|+.+||+.||++|||+.+++++
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000000 0001115678999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=328.59 Aligned_cols=247 Identities=15% Similarity=0.192 Sum_probs=196.4
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCc------
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDE------ 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 127 (359)
..|.+.+.||+|+||.||+|.. .+|..||||++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4678888899999999999995 46889999999765322 24568899999999999999999999987654
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 58888773 2499999999999999999999999 99999999999999999999999999998755
Q ss_pred CC-CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhh------------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------ 267 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~------------------ 267 (359)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 43 34567999999999887 57899999999999999999999998764322211111100
Q ss_pred -h---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 -L---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 -~---~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. ...... .......+.++.+|+.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 11223567889999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=327.98 Aligned_cols=250 Identities=16% Similarity=0.140 Sum_probs=201.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CC-cEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc------cccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 128 (359)
..|++++.||+|+||+||+|... ++ ..||+|++.... ...+.+.+|+.+++.++|++ ++.+.+++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 46889999999999999999853 34 689999997532 33566888999999998776 88999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee-------------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF------------------- 189 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll------------------- 189 (359)
++||||+ +++|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999 56788888765556799999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC-CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh
Q 018244 190 DDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 268 (359)
+.++.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 56789999999999865443 45578999999999998999999999999999999999999987653322111100000
Q ss_pred c-------------------------------------cc-cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 269 T-------------------------------------DS-CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 269 ~-------------------------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .+ ..........+.++.+|+.+||+.||++|||+.+++++
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00 00001123456789999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=325.34 Aligned_cols=246 Identities=18% Similarity=0.230 Sum_probs=198.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCC--CcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 131 (359)
-..|.+++.||+|+||.||+|...++..||||++..... ...+.+.+|++++..++ |+||+++++++......++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 356889999999999999999988889999999975432 23567899999999997 59999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|| +.+++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||++++ +.+||+|||++.......
T Consensus 107 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred Ee-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99 457799999974 45789999999999999999999999 9999999999999964 899999999998654332
Q ss_pred -----CcCCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc
Q 018244 211 -----SYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 211 -----~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
...||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccc
Confidence 3457999999999875 4688899999999999999999998865422111 11112222222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..++...+.++.+++.+||+.||++|||+.++++.
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 23344456789999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=328.19 Aligned_cols=253 Identities=16% Similarity=0.181 Sum_probs=182.0
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHH-HHhcCCCcccccccceeeeCCcceEEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..+|.+++.||+|+||.||+|.. .+++.||||++...... ....+.+|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46788899999999999999996 46889999999765432 2345566665 777889999999999999999999999
Q ss_pred ecCCCCCHhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC
Q 018244 133 EYMPNDTLAKHLFH---WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~ 209 (359)
||+.+ +|.+++.. .....+++..+..++.|++.||.|||++.+++|+||||+||+++.++.+||+|||++......
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99986 78877752 235679999999999999999999998548999999999999999999999999999765443
Q ss_pred C---CcCCCccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 210 R---SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 210 ~---~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
. ...||+.|+|||++ .+..++.++||||||+++|+|++|..||..................+..........+
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCC
Confidence 2 33688999999998 4566899999999999999999999988653211110000000001111111223467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..+.+|+.+||+.||++|||+.++++.
T Consensus 260 ~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 260 PSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 789999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=319.46 Aligned_cols=247 Identities=18% Similarity=0.184 Sum_probs=202.3
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
..|++++.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46889999999999999999964 68899999986542 2346778999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC---CCeEEeccCCcccCCCCC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~---~~~kl~DFg~a~~~~~~~ 210 (359)
|+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999998863 34689999999999999999999999 99999999999999754 469999999988665433
Q ss_pred ---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
...+|+.|+|||.+.+ .++.++||||||+++|+|++|..||................... ........+.++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGTTSCHHHHH
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CchhhhhcCHHHHH
Confidence 2346889999999875 58999999999999999999999987654333222111111000 00011245678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||+.||++|||+.++++.
T Consensus 256 li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHcccChhhCcCHHHHhcC
Confidence 9999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=333.42 Aligned_cols=251 Identities=16% Similarity=0.211 Sum_probs=200.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-----------Ccccccccceeee
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCCE 124 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 124 (359)
..|.+++.||+|+||+||+|.. .++..||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788999999999999999995 578899999997532 33556888999999886 8899999999986
Q ss_pred CC----cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC------CCCC
Q 018244 125 GD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD------DDVN 194 (359)
Q Consensus 125 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~------~~~~ 194 (359)
.+ ..++||||+ +++|.+++.......+++..+..++.||+.||.|||++.+|+||||||+|||++ ..+.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 54 789999999 889999998766667999999999999999999999954899999999999994 4457
Q ss_pred eEEeccCCcccCCCC-CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHh------hhhhhh
Q 018244 195 PRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR------DRNIQT 267 (359)
Q Consensus 195 ~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~------~~~~~~ 267 (359)
+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||......... ......
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999999999866543 4557899999999999989999999999999999999999988754211000 000000
Q ss_pred h-----------------cc-------------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 268 L-----------------TD-------------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 268 ~-----------------~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .. ......++...+.++.+|+.+||+.||++|||+.+++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 00 000112456778899999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.71 Aligned_cols=242 Identities=18% Similarity=0.132 Sum_probs=185.7
Q ss_pred cccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCCCC
Q 018244 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
...+.||+|+||+||.+...+|..||||++... ..+.+.+|+++|..+ +||||+++++++.+....+|||||+. |
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 344668999999998777778899999998753 245678899999876 89999999999999999999999996 5
Q ss_pred CHhhhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC-------------CCeEEecc
Q 018244 139 TLAKHLFHWETQP-----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-------------VNPRLSCF 200 (359)
Q Consensus 139 sL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~-------------~~~kl~DF 200 (359)
+|.+++....... .++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999997432111 12334578999999999999999 99999999999999754 47999999
Q ss_pred CCcccCCCCC--------CcCCCccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhh
Q 018244 201 GLMKNSRDGR--------SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (359)
Q Consensus 201 g~a~~~~~~~--------~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~ 264 (359)
|+++...... ...||+.|+|||++.+ ..++.++|||||||++|||+| |..||........ ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HH
Confidence 9998765432 3468999999999975 568999999999999999999 8887765432211 11
Q ss_pred hhhhc-cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 265 IQTLT-DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 265 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
..... .+..........+.++.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111 111111223567889999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=326.44 Aligned_cols=240 Identities=18% Similarity=0.259 Sum_probs=200.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCC--CcccccccceeeeC
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEG 125 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~ 125 (359)
-...|.+.+.||+|+||.||+|.. .++..||||.+...... ....+.+|+.+++.++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 345688999999999999999984 57889999999754322 1234677999999996 59999999999999
Q ss_pred CcceEEEecCCC-CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEeccCCc
Q 018244 126 DERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLM 203 (359)
Q Consensus 126 ~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DFg~a 203 (359)
+..++||||+.+ ++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+|||++ +++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999976 899999873 45789999999999999999999999 999999999999999 7899999999999
Q ss_pred ccCCCC--CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 204 KNSRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 204 ~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
...... ....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||..... .... ....+..
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~----------~~~~~~~ 265 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRG----------QVFFRQR 265 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHC----------CCCCSSC
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hhcc----------ccccccc
Confidence 876543 34568999999999987765 6789999999999999999988865421 1100 0112344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.++.+|+.+||+.||++|||+.++++.
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 56789999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=323.66 Aligned_cols=238 Identities=19% Similarity=0.287 Sum_probs=193.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcC----CCcccccccceeeeC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQL----RNRRLANLLGCCCEG 125 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~~~~~ 125 (359)
..|++.+.||+|+||.||+|.. .++..||||++...... ....+.+|+.++..+ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 4678888999999999999984 56889999999765432 122356789999888 899999999999999
Q ss_pred CcceEEEec-CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC-CCCCeEEeccCCc
Q 018244 126 DERLLVAEY-MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLM 203 (359)
Q Consensus 126 ~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~-~~~~~kl~DFg~a 203 (359)
+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++ .++.+||+|||++
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999 788999999974 45699999999999999999999999 999999999999999 8899999999998
Q ss_pred ccCCCC--CCcCCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 204 KNSRDG--RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 204 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
...... ....+|..|+|||++.+..+. .++||||||+++|+|++|+.||..... .... ...++..
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----------~~~~~~~ 255 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILEA----------ELHFPAH 255 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHT----------CCCCCTT
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhhh----------ccCCccc
Confidence 876543 345688999999999877664 489999999999999999988865421 1110 1123455
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+.++.+++.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67789999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=319.43 Aligned_cols=249 Identities=17% Similarity=0.230 Sum_probs=183.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch-H-HHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD-A-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.+.+|.+++.||+|+||.||+|... ++..||||++....... . +.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3567889999999999999999964 68899999997654332 2 2344555678888999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
|||+ ++.+..+... ....+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 4455555432 35679999999999999999999998 5 8999999999999999999999999998765433
Q ss_pred --CCcCCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCCChHH
Q 018244 210 --RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
....+|+.|+|||++. ...++.++||||||+++|+|++|..||....... ........ ..+. .......
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~--~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPL--LPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCC--CCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCC--CCccCCC
Confidence 2346889999999985 4568899999999999999999998886532211 11111111 0110 0111235
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+.++.+|+.+||+.||.+|||+.+++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 6789999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=331.36 Aligned_cols=242 Identities=14% Similarity=0.118 Sum_probs=187.2
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|.+.+.||+|+||+||.....++..||||++...... .+.+|+++|+.+ +||||+++++++.+....+|||||+.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 57777888999999976555667889999999764432 346799999999 79999999999999999999999996
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-----CCCeEEeccCCcccCCCC--
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-----~~~~kl~DFg~a~~~~~~-- 209 (359)
|+|.+++.. ......+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 102 -g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 -ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp -EEHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred -CCHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 599999975 333455556779999999999999999 9999999999999953 346889999999875432
Q ss_pred -----CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 210 -----RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......... ....... ........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~--~~~~~~~~ 255 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSL--DCLHPEKH 255 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCC--TTSCTTCH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCc--cccCcccc
Confidence 23568999999999983 567889999999999999999 777764433222111 1110000 01112345
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.+..+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 6778999999999999999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=342.77 Aligned_cols=260 Identities=18% Similarity=0.181 Sum_probs=201.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeee------CC
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE------GD 126 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 126 (359)
.+..|.+.+.||.|+||+||+|.. .+|..||||++..... ...+.+.+|+++++.++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 346789999999999999999985 5688999999876532 335668999999999999999999998765 66
Q ss_pred cceEEEecCCCCCHhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC---eEEeccCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGL 202 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~---~kl~DFg~ 202 (359)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++. +||+|||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999999999999997532 23689999999999999999999999 9999999999999997665 99999999
Q ss_pred cccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhh----------hhhhhc
Q 018244 203 MKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR----------NIQTLT 269 (359)
Q Consensus 203 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~----------~~~~~~ 269 (359)
+...... ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||........... ......
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 9876543 345689999999999999999999999999999999999999865321110000 000000
Q ss_pred c--------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHHhhh
Q 018244 270 D--------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS-----LVTALVTLQK 315 (359)
Q Consensus 270 ~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~-----il~~L~~~~~ 315 (359)
. ...........+..+.+++.+||+.||++|||+.+ .++.++.+..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0 00011234567899999999999999999999988 4455555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=308.90 Aligned_cols=232 Identities=13% Similarity=0.109 Sum_probs=185.1
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
..|++++.||+|+||.||+|... ++..||||++....... .+.+.+|+.++..++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 35888999999999999999964 58899999998654332 367899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCc
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~ 212 (359)
||+++++|.+++.. + .....+..++.|++.||.|||++ ||+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999842 2 45667889999999999999999 99999999999999999999998554
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc-ccccCCCChHHHHHHHHHHHH
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD-SCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 291 (359)
|++ .++.++||||||+++|+|+||+.||.................. ...........+.++.+|+.+
T Consensus 175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 333 3688999999999999999999998764321100000000000 000001123456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 292 CLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
||+.||++| |+.++++.|+.+....
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999 9999999999986543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=308.86 Aligned_cols=227 Identities=16% Similarity=0.149 Sum_probs=182.1
Q ss_pred Cccccc-ccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHH-hcCCCcccccccceeee----CCcce
Q 018244 57 AMENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAV-GQLRNRRLANLLGCCCE----GDERL 129 (359)
Q Consensus 57 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~ 129 (359)
..|.++ +.||+|+||.||+|.. .++..||+|++.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456777 5689999999999995 5688999999964 24567888888 55689999999999977 66789
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS 206 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~ 206 (359)
+||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 999999999999999875566799999999999999999999999 9999999999999997 788999999998643
Q ss_pred CCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCC----hHHH
Q 018244 207 RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS----SDEG 282 (359)
Q Consensus 207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 282 (359)
. +..++.++||||||+++|+|++|..||.................... ...+ ...+
T Consensus 171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFPNPEWSEVS 230 (299)
T ss_dssp T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC--CSSCHHHHTTSC
T ss_pred c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc--ccCCchhcccCC
Confidence 2 24578899999999999999999999865533222111111111110 1111 2356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.++.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 789999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=345.52 Aligned_cols=239 Identities=18% Similarity=0.210 Sum_probs=195.6
Q ss_pred CcccccccCCCCCCcEEEEEEeC--CCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCc-----c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE-----R 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~ 128 (359)
..|++++.||+|+||+||+|... ++..||||++..... .....+.+|+++++.++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57889999999999999999964 588999999875443 234568899999999999999999999988765 6
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||||+++++|.+++. . .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~---~-~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG---Q-KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC-------C-CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHh---C-CCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 99999999999998763 2 699999999999999999999999 99999999999999975 999999999998877
Q ss_pred CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
.....||+.|+|||++.+. ++.++||||||+++|+|++|..|+........ . ........+..+.+|
T Consensus 234 ~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~----~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------P----EDDPVLKTYDSYGRL 300 (681)
T ss_dssp CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------C----TTCHHHHHCHHHHHH
T ss_pred CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc--------c----ccccccccCHHHHHH
Confidence 7777899999999998765 48899999999999999999876654211100 0 000112245689999
Q ss_pred HHHhcccCCCCCCC-HHHHHHHHHHhh
Q 018244 289 ASRCLQYEPRERPN-PRSLVTALVTLQ 314 (359)
Q Consensus 289 i~~cl~~dp~~Rps-~~~il~~L~~~~ 314 (359)
+.+||+.||++||+ ++++...|..+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999995 555666666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=319.83 Aligned_cols=240 Identities=12% Similarity=0.067 Sum_probs=187.1
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC--------chHHHHHHHHHHHhcCC----------------
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLR---------------- 111 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------------- 111 (359)
..+|.+++.||+|+||+||+|+. +|..||||++..... ...+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 678999999986532 22467889999988886
Q ss_pred ----------Ccccccccceeee-------------CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 018244 112 ----------NRRLANLLGCCCE-------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL 168 (359)
Q Consensus 112 ----------h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L 168 (359)
||||+++++++.. ....+|||||+++|++.+.+. ...+++..+..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHH
Confidence 6666666666665 678999999999998777773 35689999999999999999
Q ss_pred HHhh-cCCCcccccCCCCCeeeCCCC--------------------CeEEeccCCcccCCCCCCcCCCccccCcccccCC
Q 018244 169 EYCT-SKERALYHDLNAYRIVFDDDV--------------------NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG 227 (359)
Q Consensus 169 ~~LH-~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~~ 227 (359)
.||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.+.
T Consensus 175 ~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 175 AVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred HHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence 9999 88 999999999999999887 8999999999876543 45789999999999866
Q ss_pred CCCCccchhhHHHH-HHHHHhCCCCCCcchhHH-Hhhhhhhhhc-cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 018244 228 RVTPESVMYSFGTL-LLDLLSGKHIPPSHALDL-IRDRNIQTLT-DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304 (359)
Q Consensus 228 ~~~~~~Di~slG~i-l~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (359)
. +.++||||+|++ .+++++|..||....+.. .......... ............++++.+|+.+||+.| |+.
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 6 889999998776 778888988775432211 1111110100 111111122457899999999999977 899
Q ss_pred HHH
Q 018244 305 SLV 307 (359)
Q Consensus 305 ~il 307 (359)
+++
T Consensus 327 e~l 329 (336)
T 2vuw_A 327 DLL 329 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 888
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=323.61 Aligned_cols=239 Identities=15% Similarity=0.093 Sum_probs=182.1
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCC-cccccccce-----------
Q 018244 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRN-RRLANLLGC----------- 121 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-~niv~~~~~----------- 121 (359)
.+...+.||+|+||+||+|. ..+|+.||||++...... ..+.+.+|+.+++.++| +|......+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 35666778999999999999 457899999999844322 25678999999999987 322211111
Q ss_pred ----------eee-----CCcceEEEecCCCCCHhhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 018244 122 ----------CCE-----GDERLLVAEYMPNDTLAKHLF-----HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (359)
Q Consensus 122 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~D 181 (359)
+.. ....+++|+++ +++|.+++. ......+++..+..++.||+.||.|||++ +|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrD 236 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTY 236 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence 111 12456777776 569999884 22345678889999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCeEEeccCCcccCCCC-CCcCCCccccCcccc----------cCCCCCCccchhhHHHHHHHHHhCCC
Q 018244 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYL----------RTGRVTPESVMYSFGTLLLDLLSGKH 250 (359)
Q Consensus 182 ikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~~~t~~y~aPE~~----------~~~~~~~~~Di~slG~il~elltg~~ 250 (359)
|||+|||++.++.+||+|||+++..... ....| +.|+|||++ .+..++.++|||||||++|+|++|+.
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999998865543 33456 999999999 55568899999999999999999999
Q ss_pred CCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 251 IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 251 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
||........... .... ....++++.+|+.+||+.||++|||+.++++.
T Consensus 316 Pf~~~~~~~~~~~----~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 316 PNTDDAALGGSEW----IFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CCCTTGGGSCSGG----GGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcchhhhHHH----HHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9876532221111 1110 12345789999999999999999999888653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=282.83 Aligned_cols=179 Identities=12% Similarity=0.063 Sum_probs=128.1
Q ss_pred cCCCCCCcEEEEEE-eCCCcEEEEEEeCCCCC----------chHHHHHHHHHHHhcC-CCcccccccceeeeCCcceEE
Q 018244 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW----------PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (359)
..+.|++|.+..+. .--|+.+|+|++..... ...+++.+|+++|+++ .|+||+++++++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777777665 33477899999976421 1235689999999999 699999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~- 210 (359)
|||++|++|.++|. ..+.++.. .|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 45567764 4789999999999999 99999999999999999999999999998765433
Q ss_pred ---CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 018244 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249 (359)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~ 249 (359)
...||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 3468999999999974 5677899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=247.34 Aligned_cols=177 Identities=14% Similarity=0.120 Sum_probs=144.0
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--------hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.+.||+|+||+||+|.. .+..+|+|........ ..+.+.+|+++|+.++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 34579999999999964 4567999987543221 12347899999999999999987777778888999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999853 568999999999999999 9999999999999998 9999999999987653
Q ss_pred -------CCcCCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCC
Q 018244 210 -------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIP 252 (359)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~ 252 (359)
....||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.++
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24568999999999986 56888899999999888887766443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=208.95 Aligned_cols=154 Identities=16% Similarity=0.055 Sum_probs=123.7
Q ss_pred HHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCC------------------chHHHHHHHHHHHhc
Q 018244 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW------------------PDARQFLEEARAVGQ 109 (359)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~ 109 (359)
.+....+.-..|.+.+.||.|+||.||+|...+|..||||.+..... .....+.+|+++|+.
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34444455556666689999999999999997789999999975321 124568899999999
Q ss_pred CCCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 110 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
++ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. |++||||||+|||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl 226 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLV 226 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEE
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEE
Confidence 99 5 777776644 56799999999999988 521 12457999999999999999 99999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCCCcCCCccccCccccc
Q 018244 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR 225 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~ 225 (359)
+ ++.+||+|||++.. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------CCCCCHHHHHH
Confidence 9 99999999999863 34578899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-23 Score=179.33 Aligned_cols=153 Identities=13% Similarity=0.051 Sum_probs=115.1
Q ss_pred cCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCcE--EEEEEeCCCCCch------------------------
Q 018244 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFR--IAVKRFNRSAWPD------------------------ 96 (359)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------ 96 (359)
++...+....+.-..|.+.+.||+|+||.||+|.. .+|.. ||||++.......
T Consensus 34 ~~~~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 113 (258)
T 1zth_A 34 RTLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKV 113 (258)
T ss_dssp HHHHHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHH
T ss_pred HHHHHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHH
Confidence 33444555555556678889999999999999996 68888 9999876432110
Q ss_pred HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCC-C----CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 018244 97 ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN-D----TLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171 (359)
Q Consensus 97 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L 171 (359)
...+.+|+.+|..+.|+++.....+.. ...+|||||+.+ | +|.+.... .++..+..++.|++.||.||
T Consensus 114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 114 FIWTEKEFRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHH
Confidence 125788999999998886532222221 367999999942 3 67665532 23456788999999999999
Q ss_pred h-cCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 172 T-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 172 H-~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
| +. |++||||||+|||++. .++|+|||++...
T Consensus 187 H~~~-givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTS-CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHC-CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 88 9999999999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-20 Score=169.41 Aligned_cols=150 Identities=10% Similarity=0.054 Sum_probs=106.2
Q ss_pred HHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--------------hHHHH--------HHH
Q 018244 46 IETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------------DARQF--------LEE 103 (359)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~e 103 (359)
+-.|....+.-..|.+.+.||.|++|.||+|...+|..||||+++..... ..... .+|
T Consensus 84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE 163 (397)
T 4gyi_A 84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE 163 (397)
T ss_dssp HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH
Confidence 34556666666678999999999999999999888999999987632100 01112 235
Q ss_pred HHHHhcCCCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCC
Q 018244 104 ARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183 (359)
Q Consensus 104 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dik 183 (359)
...|.++.+.++.....+.. ...+|||||++|++|.++.. . .....++.|++.+|.+||+. ||||||||
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~-gIVHrDLK 232 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH-GLIHGDFN 232 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred HHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC-CCcCCCCC
Confidence 55555553333322111111 23479999999988876542 1 12356789999999999999 99999999
Q ss_pred CCCeeeCCCCC----------eEEeccCCcccC
Q 018244 184 AYRIVFDDDVN----------PRLSCFGLMKNS 206 (359)
Q Consensus 184 p~NIll~~~~~----------~kl~DFg~a~~~ 206 (359)
|.|||+++++. +.|+||+.+-..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999987763 899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=6.7e-14 Score=122.93 Aligned_cols=139 Identities=14% Similarity=-0.021 Sum_probs=108.8
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|.+...+|.|+.+.||++... +..+++|............+.+|+.+++.+. +.++.++++++...+..|+||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 4667777788888999999864 5689999987532122345788999999885 6778889999988889999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 174 (359)
|.+|.+.+. +......++.+++.+|..||+.
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999987642 1122347788999999999981
Q ss_pred ----------------CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 175 ----------------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 175 ----------------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 148999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=113.42 Aligned_cols=133 Identities=14% Similarity=0.081 Sum_probs=98.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--cccccceeeeCCcceEEEecCC
Q 018244 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~ 136 (359)
+.+....+.|..+.||++...+|..+++|...... ...+.+|+.+++.+.+.+ +.+++++....+..++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 33333334566799999987777789999976542 245678999998885444 5668888877778899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE----------------------------------------- 175 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------- 175 (359)
|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 99 G~~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 99 GQDLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SEETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CcccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 98884 21 1 12 2356778888888888741
Q ss_pred ----------------CcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 176 ----------------RALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 176 ----------------~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
.++|+|++|.||++++++.+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 18999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.6e-11 Score=112.74 Aligned_cols=145 Identities=14% Similarity=0.123 Sum_probs=108.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeC--CCCC-chHHHHHHHHHHHhcCC--CcccccccceeeeC---Ccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN--RSAW-PDARQFLEEARAVGQLR--NRRLANLLGCCCEG---DER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~ 128 (359)
.....++.++.|.++.||+....+ ..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +..
T Consensus 38 ~~~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 38 AGPLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCCCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CCCceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 334456678999999999998765 478888876 3321 22346788999999987 44578888887765 348
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK---------------------------------- 174 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------- 174 (359)
|+||||++|..+.+.. -..++......++.+++.+|..||+.
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999997775422 23477888899999999999999971
Q ss_pred -----------------------CCcccccCCCCCeeeCCCCC--eEEeccCCcccC
Q 018244 175 -----------------------ERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNS 206 (359)
Q Consensus 175 -----------------------~~ivH~Dikp~NIll~~~~~--~kl~DFg~a~~~ 206 (359)
..++|+|++|.||+++.++. +.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997653 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-11 Score=109.55 Aligned_cols=181 Identities=13% Similarity=0.104 Sum_probs=120.0
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-Ccc--cccccceeeeCC---cceEEEecC
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRR--LANLLGCCCEGD---ERLLVAEYM 135 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~ 135 (359)
++.++.|..+.||+.. ..+++|..... .....+.+|..+|+.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4456889999999864 35888986532 23567889999998884 333 334444433332 358999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK----------------------------------------- 174 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------------- 174 (359)
+|.+|.+... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988865432 2467777888888888888888851
Q ss_pred ----------------CCcccccCCCCCeeeCC--CCCeEEeccCCcccCCCCCCcCCCccc---cCcccccC-----C-
Q 018244 175 ----------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGRSYSTNLAF---TPPEYLRT-----G- 227 (359)
Q Consensus 175 ----------------~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~~~~~~~~~~t~~y---~aPE~~~~-----~- 227 (359)
..++|+|++|.||++++ ...+.|+||+.+...+..........+ ..|+.... +
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 14699999999999997 456889999998765432211111111 12221110 0
Q ss_pred --------CCCCccchhhHHHHHHHHHhCCCCC
Q 018244 228 --------RVTPESVMYSFGTLLLDLLSGKHIP 252 (359)
Q Consensus 228 --------~~~~~~Di~slG~il~elltg~~p~ 252 (359)
....-.+.|++|.++|.+.+|..++
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0112257999999999999998544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=9.5e-08 Score=85.52 Aligned_cols=135 Identities=14% Similarity=0.050 Sum_probs=92.6
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc---ccccccceee-eCCcceEEEecCCC
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCC-EGDERLLVAEYMPN 137 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 137 (359)
+..++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345678888899988 45688888532 12345788999999999753 3555565553 34457899999999
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------- 174 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------- 174 (359)
.+|.+... ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88766321 1234555555666666666655542
Q ss_pred ----------------CCcccccCCCCCeeeCC---CCCe-EEeccCCcccC
Q 018244 175 ----------------ERALYHDLNAYRIVFDD---DVNP-RLSCFGLMKNS 206 (359)
Q Consensus 175 ----------------~~ivH~Dikp~NIll~~---~~~~-kl~DFg~a~~~ 206 (359)
..++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 13589999999999987 4554 89999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=4.1e-07 Score=79.64 Aligned_cols=126 Identities=16% Similarity=0.051 Sum_probs=91.0
Q ss_pred cEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCCCCCHhhhhhcCC
Q 018244 71 NVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE 148 (359)
Q Consensus 71 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 148 (359)
+.||+.... ++..+.+|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++.+....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-- 113 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-- 113 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--
T ss_pred CeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--
Confidence 469988743 5667889986542 3456788999998884 33467788888888899999999999887765532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 018244 149 TQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------------------ 174 (359)
Q Consensus 149 ~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------------------ 174 (359)
.......+..+++..|.-||..
T Consensus 114 ----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 114 ----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp ----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred ----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 1122334555666666666641
Q ss_pred ---CCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 175 ---ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 175 ---~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
..++|+|+.+.||++++++.+-|+||+.+..
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0268999999999999877778999998653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-07 Score=86.82 Aligned_cols=81 Identities=5% Similarity=-0.050 Sum_probs=54.6
Q ss_pred cccC-CCCCCcEEEEEEeC-------CCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCC-C--cccccccceeeeC--
Q 018244 62 VSEH-GEKAPNVVYKGKLE-------NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-N--RRLANLLGCCCEG-- 125 (359)
Q Consensus 62 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~-- 125 (359)
++.| +.|..+.+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4556 78888999998754 25678888865432 111234677888888885 3 2466777776554
Q ss_pred -CcceEEEecCCCCCHhh
Q 018244 126 -DERLLVAEYMPNDTLAK 142 (359)
Q Consensus 126 -~~~~lv~e~~~~gsL~~ 142 (359)
+..++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.8e-06 Score=80.05 Aligned_cols=76 Identities=13% Similarity=0.056 Sum_probs=49.6
Q ss_pred ccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCC-------chHHHHHHHHHHHhcCCC--cc-cccccceeeeCCcce
Q 018244 61 IVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-------PDARQFLEEARAVGQLRN--RR-LANLLGCCCEGDERL 129 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~ 129 (359)
.++.+|.|..+.||++... ++..++||....... .....+..|.++|+.+.. +. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567899999999999743 467899998653211 123456778888887732 33 3445433 455678
Q ss_pred EEEecCCCC
Q 018244 130 LVAEYMPND 138 (359)
Q Consensus 130 lv~e~~~~g 138 (359)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.37 E-value=2.7e-06 Score=76.91 Aligned_cols=138 Identities=9% Similarity=0.104 Sum_probs=78.4
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc--ccccccc------eeeeCCcceEEEe
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLG------CCCEGDERLLVAE 133 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e 133 (359)
+..++.|..+.||+....+| .+++|+.... ...+..|..++..|... .+++++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34456677899999987665 5899998752 23344455555555311 2333332 1234567889999
Q ss_pred cCCCCCHh--------------hhhhc--CC---C-------CCCCHHH-------------------------------
Q 018244 134 YMPNDTLA--------------KHLFH--WE---T-------QPMKWAM------------------------------- 156 (359)
Q Consensus 134 ~~~~gsL~--------------~~l~~--~~---~-------~~l~~~~------------------------------- 156 (359)
|++|.++. ..++. .. . ....|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 01111 00 0 0112221
Q ss_pred HHHHHHHHHHHHHHhhc------------CCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 157 RLRVALHIAEALEYCTS------------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 157 ~~~i~~qi~~~L~~LH~------------~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
+..+...+..++.+|+. ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11111223345556642 2489999999999999888899999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.10 E-value=1.8e-05 Score=65.73 Aligned_cols=141 Identities=12% Similarity=0.022 Sum_probs=93.0
Q ss_pred CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcCCCcc
Q 018244 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (359)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~t~~ 217 (359)
-||.+.|.. .+.+++++++|.+++|.+.+|.-+-....-..+=+-|..|++..+|.|.+.+ +.+. .....
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~~~~~ 102 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------AGEPP 102 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------ccccC
Confidence 378888865 6779999999999999999997762210112233457889999999988874 2111 12335
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHhccc--
Q 018244 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY-- 295 (359)
Q Consensus 218 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-- 295 (359)
+.|||... ...+.+.=|||||+++|.-+--..+. ......++.|.+||..|...
T Consensus 103 ~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~Mt~~~~ 158 (229)
T 2yle_A 103 PVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHMANTVE 158 (229)
T ss_dssp ----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHHTTCCC
T ss_pred CCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHHHhccc
Confidence 67888764 34567888999999999888544221 11244567788899888766
Q ss_pred -----------------------CCCCCCCHHHHHHHHHH
Q 018244 296 -----------------------EPRERPNPRSLVTALVT 312 (359)
Q Consensus 296 -----------------------dp~~Rps~~~il~~L~~ 312 (359)
.+..|+|.++|++.=..
T Consensus 159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp --------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 24678899998876554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.09 E-value=8.9e-06 Score=71.84 Aligned_cols=75 Identities=23% Similarity=0.275 Sum_probs=54.5
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCc---ccccccceeeeCCcceEEEecCCC
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEGDERLLVAEYMPN 137 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~ 137 (359)
-++.+|.|..+.||+.+..+|+.|.+|+...........+..|...|+.|.-. .+++++++ +.-++||||+++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 45667999999999999999999999987655433345678899998888422 23444433 235889999987
Q ss_pred CC
Q 018244 138 DT 139 (359)
Q Consensus 138 gs 139 (359)
+.
T Consensus 95 ~~ 96 (288)
T 3f7w_A 95 RP 96 (288)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=69.52 Aligned_cols=75 Identities=17% Similarity=0.081 Sum_probs=58.5
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC---CcccccccceeeeCCcceEEEecCCCC
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
+..++.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+++++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 455689999999999864 557888987643 2556788998888884 356788888887778899999999987
Q ss_pred CH
Q 018244 139 TL 140 (359)
Q Consensus 139 sL 140 (359)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.90 E-value=8.3e-05 Score=69.33 Aligned_cols=76 Identities=13% Similarity=0.053 Sum_probs=46.6
Q ss_pred hcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcC---C--CccccCcccccCC---CCCCccchhhHHHHHH
Q 018244 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS---T--NLAFTPPEYLRTG---RVTPESVMYSFGTLLL 243 (359)
Q Consensus 172 H~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~---~--t~~y~aPE~~~~~---~~~~~~Di~slG~il~ 243 (359)
+.. .++|+|++|.||+++.++ +.|+||+.+......-... . ...|.+|+..... .-....++.+....+|
T Consensus 230 ~~~-~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQ-ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCC-EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCC-eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 344 899999999999998776 9999999887544321110 0 1245555544311 1112234556777777
Q ss_pred HHHhCC
Q 018244 244 DLLSGK 249 (359)
Q Consensus 244 elltg~ 249 (359)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00011 Score=65.84 Aligned_cols=160 Identities=11% Similarity=0.122 Sum_probs=86.6
Q ss_pred cccCHHHHHHHhcCCCcc--cccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--ccc
Q 018244 42 CEYSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LAN 117 (359)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 117 (359)
..++.+++...-..|... .-++.++.|....+|+....+| .+++|...... ....+..|+.++..+...+ +.+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 345566666655555432 2345567788899999987666 58899887531 1234456777776663222 233
Q ss_pred ccce------eeeCCcceEEEecCCCCCHhh--------------hhhc----CCCC---CC---CHHHHHH--------
Q 018244 118 LLGC------CCEGDERLLVAEYMPNDTLAK--------------HLFH----WETQ---PM---KWAMRLR-------- 159 (359)
Q Consensus 118 ~~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~---~l---~~~~~~~-------- 159 (359)
++.. ....+..+++++|++|..+.. .++. .... .. .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 122355789999998854311 0110 0000 01 1221100
Q ss_pred ----HHHHHHHHHHHhhc------CCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 160 ----VALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 160 ----i~~qi~~~L~~LH~------~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
+...+...+..+.. ..+++|+|+++.||++++++.+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444432 1368999999999999977656899999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=6.4e-05 Score=66.72 Aligned_cols=71 Identities=14% Similarity=0.159 Sum_probs=43.4
Q ss_pred cccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecC-CCCC
Q 018244 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYM-PNDT 139 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gs 139 (359)
++.++.|..+.+|+. ..+.+|+....... .....+|+.+++.+...++ .+++++ +.+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 556688888999999 35888988653211 1122457777777643333 344443 344568999999 6544
Q ss_pred H
Q 018244 140 L 140 (359)
Q Consensus 140 L 140 (359)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00019 Score=64.62 Aligned_cols=32 Identities=13% Similarity=0.084 Sum_probs=27.4
Q ss_pred CcccccCCCCCeeeCCC----CCeEEeccCCcccCC
Q 018244 176 RALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSR 207 (359)
Q Consensus 176 ~ivH~Dikp~NIll~~~----~~~kl~DFg~a~~~~ 207 (359)
.++|+|+++.||+++.+ +.+.|+||+.+....
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 78999999999999874 679999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00094 Score=59.73 Aligned_cols=139 Identities=19% Similarity=0.153 Sum_probs=79.8
Q ss_pred ccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc--cccccce-----eeeCCcceEEEecC
Q 018244 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGC-----CCEGDERLLVAEYM 135 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~ 135 (359)
..++ |....||+....+|..+++|....... ....+..|..++..+.... +++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 778899998877777799999874322 2455667888877774222 3444432 12234567899999
Q ss_pred CCCCHhh-----------h---hhc----CC---CCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 018244 136 PNDTLAK-----------H---LFH----WE---TQPMKWAMR----------------------LRVALHIAEALEYCT 172 (359)
Q Consensus 136 ~~gsL~~-----------~---l~~----~~---~~~l~~~~~----------------------~~i~~qi~~~L~~LH 172 (359)
+|.++.. . ++. .. ....++... ...+..++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754320 0 000 00 011222111 111122222222221
Q ss_pred ---cCCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 173 ---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 173 ---~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 112679999999999999 4 899999998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00019 Score=67.13 Aligned_cols=73 Identities=18% Similarity=0.315 Sum_probs=49.0
Q ss_pred cccCCCCCCcEEEEEEeCC--------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEE
Q 018244 62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVA 132 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 132 (359)
+..++.|....||++...+ +..+.+|+...... ...+.+|..+++.+...++ +++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4456788889999998653 46899998843221 2455679998888853333 55665543 2 3899
Q ss_pred ecCCCCCH
Q 018244 133 EYMPNDTL 140 (359)
Q Consensus 133 e~~~~gsL 140 (359)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00022 Score=65.41 Aligned_cols=139 Identities=14% Similarity=0.132 Sum_probs=82.5
Q ss_pred cccCCCCCCcEEEEEEeC--------CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEE
Q 018244 62 VSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (359)
++.+..|-...+|++... ++..+.+|+.... ........+|..+++.|. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345667888899999864 2468999986432 223556678999998885 3223556655532 3999
Q ss_pred ecCCCCCHhhh--------------h---hcC---CCCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 018244 133 EYMPNDTLAKH--------------L---FHW---ETQPMK--WAMRLRVALHIAE-------------------ALEYC 171 (359)
Q Consensus 133 e~~~~gsL~~~--------------l---~~~---~~~~l~--~~~~~~i~~qi~~-------------------~L~~L 171 (359)
||++|.+|... | +.. -..... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99988654321 0 000 011222 4566666655432 12222
Q ss_pred ----hc---CCCcccccCCCCCeeeCCC----CCeEEeccCCccc
Q 018244 172 ----TS---KERALYHDLNAYRIVFDDD----VNPRLSCFGLMKN 205 (359)
Q Consensus 172 ----H~---~~~ivH~Dikp~NIll~~~----~~~kl~DFg~a~~ 205 (359)
.. ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 1358999999999999876 7899999998653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00028 Score=64.44 Aligned_cols=74 Identities=14% Similarity=0.215 Sum_probs=43.7
Q ss_pred cccCCCCCCcEEEEEEeCC---------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc-cccccceeeeCCcceEE
Q 018244 62 VSEHGEKAPNVVYKGKLEN---------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLV 131 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 131 (359)
+..++.|....+|+....+ +..+++|+..... ........|..+++.+...+ ..++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4566888889999998654 2578888875432 11112356788887775333 34555443 24789
Q ss_pred EecCCCCCH
Q 018244 132 AEYMPNDTL 140 (359)
Q Consensus 132 ~e~~~~gsL 140 (359)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.004 Score=56.08 Aligned_cols=32 Identities=6% Similarity=-0.047 Sum_probs=27.9
Q ss_pred CCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36899999999999998888999999876643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00077 Score=63.38 Aligned_cols=74 Identities=14% Similarity=0.086 Sum_probs=46.3
Q ss_pred cccCCCCCCcEEEEEEeCC-CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-ccccceeeeCCcceEEEecCCCCC
Q 018244 62 VSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDT 139 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 139 (359)
+..|+.|-...+|+....+ +..+.+|+....... .-.-.+|..++..|...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3456778889999998765 467889987543211 1112578888888864444 45666552 2 35999998754
Q ss_pred H
Q 018244 140 L 140 (359)
Q Consensus 140 L 140 (359)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0062 Score=56.52 Aligned_cols=139 Identities=13% Similarity=0.084 Sum_probs=82.8
Q ss_pred ccccCCCCCCcEEEEEEeCC--------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcc-cccccceeeeCCcceEE
Q 018244 61 IVSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLV 131 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 131 (359)
-++.+..|-...+|+....+ +..+.+++..... ...-...+|..+++.+.-.+ ..++++.+ .-++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEE
Confidence 34566778889999998753 5679999865432 11112356888887774223 34455433 24789
Q ss_pred EecCCCCCHhhh-h-------------h---c--C---------CCCCCCHHHHHHHHHHHHH-----------------
Q 018244 132 AEYMPNDTLAKH-L-------------F---H--W---------ETQPMKWAMRLRVALHIAE----------------- 166 (359)
Q Consensus 132 ~e~~~~gsL~~~-l-------------~---~--~---------~~~~l~~~~~~~i~~qi~~----------------- 166 (359)
+||++|.+|... + . . . ...+.-+.++..+..++-.
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 999998654210 0 0 0 0 1111124555555433321
Q ss_pred --HHHHhh--------------------c---CCCcccccCCCCCeeeCCCCCeEEeccCCccc
Q 018244 167 --ALEYCT--------------------S---KERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (359)
Q Consensus 167 --~L~~LH--------------------~---~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~ 205 (359)
.+..|. . ...++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222221 1 125799999999999 7788999999998753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.18 E-value=0.035 Score=51.10 Aligned_cols=29 Identities=14% Similarity=0.056 Sum_probs=24.6
Q ss_pred cccccCCCCCeee------CCCCCeEEeccCCccc
Q 018244 177 ALYHDLNAYRIVF------DDDVNPRLSCFGLMKN 205 (359)
Q Consensus 177 ivH~Dikp~NIll------~~~~~~kl~DFg~a~~ 205 (359)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.97 E-value=0.31 Score=40.32 Aligned_cols=114 Identities=15% Similarity=0.142 Sum_probs=75.3
Q ss_pred CCcccccccceeeeCCcceEEEecCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeee
Q 018244 111 RNRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 111 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll 189 (359)
.||+.+.. .+-...+.+.|.++.-+.+ ++.. + ..++...+++++.+|+....+++.. +|--++|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~r---~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRTR---YTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGSS---EECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcCc---eEEEEecceEEE
Confidence 57777765 4445556666666654322 2222 3 2478889999999999888666544 788999999999
Q ss_pred CCCCCeEEeccCCcccCCCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 018244 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~ 252 (359)
+.++.+++.-.|+... ++|. ..+...=.-.+=+++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~-------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTT-------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccC-------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999998876432 2222 1122222335677888899887443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.62 E-value=0.46 Score=39.38 Aligned_cols=112 Identities=15% Similarity=0.215 Sum_probs=73.8
Q ss_pred CCcccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCcccccCCCCCeee
Q 018244 111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE-YCTSKERALYHDLNAYRIVF 189 (359)
Q Consensus 111 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~ivH~Dikp~NIll 189 (359)
.||++ -..+-.+.+.+.|.++.-+++.=...++ .++...+++++.+|+.... +++.. +|--++|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~r---~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSARR---LIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSSS---EECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhCc---eeEEEeCceEEE
Confidence 56776 3334455667777777654433333342 4788999999999988776 55544 788899999999
Q ss_pred CCCCCeEEeccCCcccCCCCCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCC
Q 018244 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH 250 (359)
Q Consensus 190 ~~~~~~kl~DFg~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~ 250 (359)
+.++.+++.-.|+-.. ++|..+ +..-=.-++=+++..++.++.
T Consensus 118 ~~~~~p~i~hRGi~~~-------------lpP~e~-----~ee~fl~qyKali~all~~K~ 160 (219)
T 4ano_A 118 NRALEPFFLHVGVKES-------------LPPDEW-----DDERLLREVKATVLALTEGEY 160 (219)
T ss_dssp CTTCCEEESCCEETTT-------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSS
T ss_pred eCCCcEEEEEcCCccc-------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCC
Confidence 9999999998886332 333221 111122346678888888764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.24 E-value=0.099 Score=49.06 Aligned_cols=61 Identities=5% Similarity=0.011 Sum_probs=17.9
Q ss_pred cccccCCCCCCcEEEEEEeCC-CcEEEE------EEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceee
Q 018244 60 NIVSEHGEKAPNVVYKGKLEN-QFRIAV------KRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCC 123 (359)
Q Consensus 60 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 123 (359)
.+.+.+| ||.||+|.+.. ...||+ |....... .....+.+|..+++.++|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4455666 99999999654 357888 66654221 22345788889999999999999987664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 359 | ||||
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-06 |
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-42
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 12/245 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + + +F+EEA+ + L + +L L G C + ++
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N L +L + L + + EA+EY SK + L+ DL A + +D
Sbjct: 78 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVND 135
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FGL + D S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
S +P + L ++ + C + ERP + L
Sbjct: 196 SLGKMPYER----FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 307 VTALV 311
++ ++
Sbjct: 252 LSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-42
Identities = 52/249 (20%), Positives = 105/249 (42%), Gaps = 12/249 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
+V+ G N+ ++A+K A + F+EEA + +L + +L L G C E LV
Sbjct: 20 LVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M + L+ + + L + L + E + Y ++ DL A + +
Sbjct: 79 FEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGE 136
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ ++S FG+ + D + S+ + + PE R + +S ++SFG L+ ++
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
S IP + + +I + T + ++ + C + P +RP L
Sbjct: 197 SEGKIPYENRSNSEVVEDIS----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 307 VTALVTLQK 315
+ L + +
Sbjct: 253 LRQLAEIAE 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-41
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 20/251 (7%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
V G ++AVK A A+ FL EA + QLR+ L LLG E L +
Sbjct: 22 DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V EYM +L +L + L+ +L + EA+EY ++ DL A ++
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVS 137
Query: 191 DDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249
+D ++S FGL K S + + +T PE LR + + +S ++SFG LL ++ S
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 250 HIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
+P + + D C + + C + RP+
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFL 248
Query: 305 SLVTALVTLQK 315
L L ++
Sbjct: 249 QLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 1e-39
Identities = 55/255 (21%), Positives = 111/255 (43%), Gaps = 12/255 (4%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 32 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E+M L +L Q + + L +A I+ A+EY K ++ DL A +
Sbjct: 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVG 149
Query: 191 DDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
++ +++ FGL + + + +T PE L + + +S +++FG LL ++
Sbjct: 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
+ P +DL + L + + ++ L C Q+ P +RP+
Sbjct: 210 ATYGM-SPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265
Query: 306 LVTALVTLQKDTEVS 320
+ A T+ +++ +S
Sbjct: 266 IHQAFETMFQESSIS 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 22/249 (8%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++AVK + + FL EA + QL+++RL L + + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N +L L + L +A IAE + + + ++ DL A I+ D
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-IHRDLRAANILVSD 144
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + + +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ IP + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 302 NPRSLVTAL 310
L + L
Sbjct: 256 TFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 1e-38
Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 26/293 (8%)
Query: 44 YSIETLRTATSGFAMENIVSEH------GEKAPNVVYKGKL----ENQFRIAVKRFNRSA 93
++ E A FA E +S G V G L + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 94 WPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPM 152
R FL EA +GQ + + +L G + +++ E+M N +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
+ + IA ++Y ++ DL A I+ + ++ ++S FGL + D S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 213 STN---------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263
T + +T PE ++ + T S ++S+G ++ +++S P + ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MTNQ 240
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
++ + D + L +L C Q + RP +V L + ++
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-38
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 12/244 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 32 EVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y ++ DL A I+ +
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGE 148
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + + +T PE GR T +S ++SFG LL +L
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ +P + +R + + + L L +C + EP ERP L
Sbjct: 209 TKGRVPYPG----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
Query: 307 VTAL 310
L
Sbjct: 265 QAFL 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-38
Identities = 50/257 (19%), Positives = 105/257 (40%), Gaps = 20/257 (7%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VYKGK + + + F E + + R+ + +G + +V
Sbjct: 23 TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
++ +L HL ET + + +A A+ ++Y +K ++ DL + I +
Sbjct: 82 TQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHE 139
Query: 192 DVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRT---GRVTPESVMYSFGTLL 242
D+ ++ FGL +K+ G L+ + PE +R + +S +Y+FG +L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 243 LDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+L++G+ +I + + R + S + + RL + CL+ +
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK----AMKRLMAECLKKKRD 255
Query: 299 ERPNPRSLVTALVTLQK 315
ERP ++ ++ L +
Sbjct: 256 ERPLFPQILASIELLAR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-36
Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 17/260 (6%)
Query: 56 FAMEN--IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQ 109
+A+E+ I G+ VY + +++F +A+K ++ A Q E
Sbjct: 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
LR+ + L G + L+ EY P T+ + L +A AL
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALS 120
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTG 227
YC SK R ++ D+ ++ +++ FG ++ R + L + PPE +
Sbjct: 121 YCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
+ ++S G L + L GK ++ R + +E F
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARD 233
Query: 288 LASRCLQYEPRERPNPRSLV 307
L SR L++ P +RP R ++
Sbjct: 234 LISRLLKHNPSQRPMLREVL 253
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 44/277 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VV+K + +A K + P R Q + E + + + + + G E
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+ E+M +L + L + + + +V++ + + L Y K + ++ D+ I+
Sbjct: 81 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ +L FG+ D + S ++ PE L+ + +S ++S G L+++
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 248 GKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT----------------------- 283
G++ IPP A +L Q D+ G
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 284 --------------ELVRLASRCLQYEPRERPNPRSL 306
E ++CL P ER + + L
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 72 VVYKGKL------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
+VY+G E + R+A+K N +A R +FL EA + + + LLG +
Sbjct: 35 MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94
Query: 125 GDERLLVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKER 176
G L++ E M L +L P + +++A IA+ + Y + +
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-K 153
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVT 230
++ DL A + +D ++ FG+ ++ + Y + + PE L+ G T
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213
Query: 231 PESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
S ++SFG +L ++ + P L + + + D+C + L
Sbjct: 214 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 264
Query: 286 VRLASRCLQYEPRERPNPRSLVTAL 310
L C QY P+ RP+ +++++
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-35
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 30/256 (11%)
Query: 72 VVYKGKLENQ---FRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V KG + + +AVK A A + L EA + QL N + ++G C E +
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+LV E L K+L + + +K + + ++ ++Y ++ DL A
Sbjct: 81 SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARN 137
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
++ ++S FGL K R +Y + + PE + + + +S ++SFG
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
L+ + S P S ++ C E+ L + C
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 248
Query: 295 YEPRERPNPRSLVTAL 310
Y+ RP ++ L
Sbjct: 249 YDVENRPGFAAVELRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 4e-35
Identities = 52/255 (20%), Positives = 97/255 (38%), Gaps = 28/255 (10%)
Query: 72 VVYKGKL---ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G + Q +A+K + D + + EA+ + QL N + L+G C + +
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 82
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
+LV E L K L + + + + ++ ++Y K ++ DL A +
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNV 140
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGT 240
+ + ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ + LS P + I C EL L S C Y
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 251
Query: 296 EPRERPNPRSLVTAL 310
+ +RP+ ++ +
Sbjct: 252 KWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-35
Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 72 VVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
VY G L + + AVK NR + QFL E + + + +LLG C +
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 127 ER-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V YM + L ++ ET + L +A+ +++ SK + ++ DL A
Sbjct: 102 GSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAAR 159
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D S + + + E L+T + T +S ++S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ---FSSDEGTELVRLASRCLQ 294
FG LL +L++ P D N +T L+G+ L + +C
Sbjct: 220 FGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272
Query: 295 YEPRERPNPRSLVTALVTLQKD 316
+ RP+ LV+ + +
Sbjct: 273 PKAEMRPSFSELVSRISAIFST 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 7e-35
Identities = 46/243 (18%), Positives = 84/243 (34%), Gaps = 14/243 (5%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY + + N +A+K+ + S + ++E R + +LR+ GC
Sbjct: 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
LV EY H +P++ V + L Y S ++ D+ A I
Sbjct: 90 AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNI 146
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLD 244
+ + +L FG S+ + PE + G+ + ++S G ++
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
L K + Q + + G +S CLQ P++RP
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSE 262
Query: 305 SLV 307
L+
Sbjct: 263 VLL 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 2e-34
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 50/279 (17%)
Query: 72 VVYKGKLENQFR------IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
V++ + +AVK A D + F EA + + N + LLG C
Sbjct: 28 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHW----------------------ETQPMKWAMRLRVAL 162
G L+ EYM L + L P+ A +L +A
Sbjct: 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147
Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
+A + Y + + + ++ DL + +++ +++ FGL +N Y + +
Sbjct: 148 QVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206
Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDS 271
+ PPE + R T ES ++++G +L ++ S P + +RD NI ++
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266
Query: 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
C EL L C P +RP+ S+ L
Sbjct: 267 CPL---------ELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-34
Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 28/255 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
K + + + K + + +A + + E + +L++ + +
Sbjct: 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 129 LL--VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH---- 180
L V EY LA + E Q + LRV + AL+ C + +
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMY 236
DL + D N +L FGL + S++ TP PE + +S ++
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198
Query: 237 SFGTLLLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
S G LL +L + IR+ + + + EL + +R
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD---------ELNEIITRM 249
Query: 293 LQYEPRERPNPRSLV 307
L + RP+ ++
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-33
Identities = 58/286 (20%), Positives = 110/286 (38%), Gaps = 34/286 (11%)
Query: 72 VVYKGKLEN---QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRR-LANLLGCCCEGD 126
V K +++ + A+KR A D R F E + +L + + NLLG C
Sbjct: 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 127 ERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCT 172
L EY P+ L L + + L A +A ++Y +
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRV 229
K + ++ DL A I+ ++ +++ FGL + + + + E L
Sbjct: 145 QK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFSSDEGTELV 286
T S ++S+G LL +++S P L + +G + + E+
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAELYEKLPQGYRLEKPLNCDDEVY 256
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTEVSC-FLFSSQFTYA 331
L +C + +P ERP+ ++ +L + ++ + +FTYA
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-33
Identities = 44/256 (17%), Positives = 90/256 (35%), Gaps = 15/256 (5%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
I+ E G+ A VYK + E A K + + + ++ E + + + LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
+ ++ E+ + + E +P+ + V +AL Y + ++
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN-KIIH 133
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLRT-----GRVT 230
DL A I+F D + +L+ FG+ + + PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
++ ++S G L+++ + PP H L+ +R + S +
Sbjct: 194 YKADVWSLGITLIEMAEIE--PPHHELNPMRVLL-KIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 291 RCLQYEPRERPNPRSL 306
+CL+ R L
Sbjct: 251 KCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-33
Identities = 48/259 (18%), Positives = 101/259 (38%), Gaps = 19/259 (7%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A ++ L+EA + + N + LLG C
Sbjct: 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
+L+ + MP L + + L + IA+ + Y + R ++ DL A
Sbjct: 84 TVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAAR 140
Query: 186 RIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
++ + +++ FGL K + + ++ E + T +S ++S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+ +L++ P D I I ++ + ++ + +C +
Sbjct: 201 VTVWELMTFGSKPY----DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 300 RPNPRSLVTALVTLQKDTE 318
RP R L+ + +D +
Sbjct: 257 RPKFRELIIEFSKMARDPQ 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-32
Identities = 54/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)
Query: 72 VVYKG------KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
V K ++AVK A R+ + E + + QL + + NLLG C
Sbjct: 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111
Query: 124 EGDERLLVAEYMPNDTLAKHLF---------------------HWETQPMKWAMRLRVAL 162
L+ EY L +L + + + L A
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
+A+ +E+ K ++ DL A ++ ++ FGL ++ +Y +
Sbjct: 172 QVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276
+ PE L G T +S ++S+G LL ++ S P + D N L + +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GIPVDANFYKLIQNGFKMD 287
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
E+ + C ++ R+RP+ +L + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 20/244 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY + +A+++ N P + E + + +N + N L GDE +
Sbjct: 35 TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V EY+ +L + M V +ALE+ S + ++ D+ + I+
Sbjct: 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG 150
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
D + +L+ FG +S + + TP PE + P+ ++S G + ++++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 247 SGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
G+ P AL LI L Q +RCL + +R +
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 303 PRSL 306
+ L
Sbjct: 264 AKEL 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-32
Identities = 53/278 (19%), Positives = 107/278 (38%), Gaps = 22/278 (7%)
Query: 54 SGFAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDAR-QFLEEARAV 107
S + ++ G VYKG L+ + +A+K R FL EA +
Sbjct: 7 SCVTRQKVI---GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
GQ + + L G + +++ EYM N + + + IA
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTP 220
++Y + ++ DL A I+ + ++ ++S FGL + D + + +T
Sbjct: 123 MKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
PE + + T S ++SFG ++ ++++ P + + + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMD 237
Query: 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ + +L +C Q E RP +V+ L L + +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-32
Identities = 51/269 (18%), Positives = 94/269 (34%), Gaps = 34/269 (12%)
Query: 72 VVYKGKLENQFR------IAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
V + + +AVK SA R+ + E + + L N + NLLG C
Sbjct: 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 124 EGDERLLVAEYMPNDTLAKHLFHW----------------ETQPMKWAMRLRVALHIAEA 167
G L++ EY L L + + L + +A+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
+ + SK ++ DL A I+ ++ FGL ++ ++ +Y + + P
Sbjct: 158 MAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
E + T ES ++S+G L +L S P + D +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSKFYKMIKEGFRMLSPEHA 273
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
E+ + C +P +RP + +V +
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 42/288 (14%), Positives = 91/288 (31%), Gaps = 50/288 (17%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEA--RAVGQLRNRRLANLLGCCCEGD--- 126
V++GK + +AVK F+ + R + EA LR+ + + + +
Sbjct: 18 EVWRGKWRGE-EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-------TSKERAL 178
+ LV++Y + +L +L + +++AL A L + K
Sbjct: 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----STNLAFTP----PEYLRT---- 226
+ DL + I+ + ++ GL + T PE L
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 227 --GRVTPESVMYSFGTLLLDLLSGKHIPPSH---------------ALDLIRDRNIQTLT 269
+ +Y+ G + ++ I H +++ +R +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 270 DSCLEGQFSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
+ ++ S E + ++ C R + L L +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (298), Expect = 3e-31
Identities = 45/241 (18%), Positives = 77/241 (31%), Gaps = 10/241 (4%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VV++ A K D +E + + LR+ L NL + +E ++
Sbjct: 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E+M L + + E M + + + L + ++ DL I+F
Sbjct: 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFT 158
Query: 191 DDVNPR--LSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ L FGL + +S F PE V + M+S G L L
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
LSG P + D ++ S + + L +P R
Sbjct: 219 LSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 306 L 306
Sbjct: 277 A 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 40/240 (16%), Positives = 73/240 (30%), Gaps = 15/240 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V + +AVK + D + +E L + + G EG+ +
Sbjct: 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
L EY L + M R + + Y + D+ ++
Sbjct: 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLL 136
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV-MYSFGTLL 242
D+ N ++S FGL R L + PE L+ E V ++S G +L
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+L+G+ + + + + L+ + L P R
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARIT 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-31
Identities = 51/263 (19%), Positives = 98/263 (37%), Gaps = 27/263 (10%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V++G +A+K R+ FL+EA + Q + + L+G E +
Sbjct: 22 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
++ E L + + A + A ++ AL Y SK R ++ D+ A
Sbjct: 81 PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARN 138
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY-----LRTGRVTPESVMYSFGTL 241
++ + +L FGL + D Y + P ++ + R T S ++ FG
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 249
Query: 297 PRERPNPRSLVTALVTLQKDTEV 319
P RP L L T+ ++ +
Sbjct: 250 PSRRPRFTELKAQLSTILEEEKA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 8e-31
Identities = 45/247 (18%), Positives = 90/247 (36%), Gaps = 17/247 (6%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VYKG E +A + ++F EEA + L++ + +
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 129 ----LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
+LV E M + TL +L + MK + I + L++ ++ + H DL
Sbjct: 84 KKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141
Query: 184 AYRIVFDD-DVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGT 240
I + ++ GL R + + F PE + +Y+FG
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 200
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++ + ++ P S + + + +T F E+ + C++ ER
Sbjct: 201 CMLEMATSEY-PYSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 301 PNPRSLV 307
+ + L+
Sbjct: 258 YSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 20/257 (7%)
Query: 72 VVYKGKLE----NQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE 124
VV +G+ + +AVK F+ E A+ L +R L L G
Sbjct: 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+ +V E P +L R A+ +AE + Y SK ++ DL A
Sbjct: 83 PPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-IHRDLAA 139
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYS 237
++ ++ FGLM+ + A+ PE L+T + S +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
FG L ++ + P L + + + D ++ + +C ++P
Sbjct: 200 FGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 256
Query: 298 RERPNPRSLVTALVTLQ 314
+RP +L L+ Q
Sbjct: 257 EDRPTFVALRDFLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 113 bits (283), Expect = 4e-29
Identities = 49/244 (20%), Positives = 83/244 (34%), Gaps = 16/244 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VV++ K N D E + QL + +L NL + E +L
Sbjct: 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E++ L + E M A + E L++ ++ D+ I+ +
Sbjct: 104 ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCE 161
Query: 191 DDVNPR--LSCFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ FGL + F PE + V + M++ G L L
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 246 LSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRERPN 302
LSG L+ + +N++ E FS S E + ++ LQ EPR+R
Sbjct: 222 LSGLSPFAGEDDLETL--QNVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLT 276
Query: 303 PRSL 306
Sbjct: 277 VHDA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 40/255 (15%), Positives = 80/255 (31%), Gaps = 23/255 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + L A+K + E + +L + L + ++
Sbjct: 23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
Y N L K++ I ALEY K ++ DL I
Sbjct: 83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENI 139
Query: 188 VFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTL 241
+ ++D++ +++ FG K S+ + PE L S +++ G +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199
Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRE 299
+ L++G PP R N + ++ ++ E + L + L + +
Sbjct: 200 IYQLVAGL--PP------FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 251
Query: 300 RPNPRSLVTALVTLQ 314
R +
Sbjct: 252 RLGCEEMEGYGPLKA 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 2e-28
Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 11/242 (4%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V + Q +A+K + A E + ++++ + L G
Sbjct: 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA--LYHDLNAYRI 187
L+ + + L + E R+ + +A++Y N
Sbjct: 84 LIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
D+D +S FGL K G ST + PE L + +S G +
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
LL G PP + + + + + + D ++ +P +R
Sbjct: 202 LLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
Query: 305 SL 306
Sbjct: 260 QA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 108 bits (271), Expect = 5e-28
Identities = 45/245 (18%), Positives = 79/245 (32%), Gaps = 20/245 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE--- 124
V+ + L +AVK D +F EA+ L + + +
Sbjct: 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81
Query: 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
G +V EY+ TL + PM + V +AL + ++ D+
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVK 138
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL-------AFTPPEYLRTGRVTPESVMY 236
I+ ++ FG+ + D + T + PE R V S +Y
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198
Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
S G +L ++L+G+ PP + D +L + + L
Sbjct: 199 SLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 297 PRERP 301
P R
Sbjct: 257 PENRY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 40/258 (15%), Positives = 92/258 (35%), Gaps = 23/258 (8%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
I + G +V++ ++ K D +E + R+R + +L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLH 67
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
+E +++ E++ + + + + + + + EAL++ S +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSH-NIGH 125
Query: 180 HDLNAYRIVFDDDVNPR--LSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESV 234
D+ I++ + + FG + + G ++ + PE + V+ +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE------GTELVRL 288
M+S GTL+ LLSG + Q + ++ + +++ DE E +
Sbjct: 186 MWSLGTLVYVLLSGIN--------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 289 ASRCLQYEPRERPNPRSL 306
R L E + R
Sbjct: 238 VDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 48/271 (17%), Positives = 91/271 (33%), Gaps = 33/271 (12%)
Query: 72 VVYKG------KLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCC- 123
V + K +AVK A + R + E + + + + L C
Sbjct: 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87
Query: 124 -EGDERLLVAEYMPNDTLAKHLFH--------------WETQPMKWAMRLRVALHIAEAL 168
G +++ E+ L+ +L + + + +A+ +
Sbjct: 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPE 222
E+ S+ + ++ DL A I+ + ++ FGL ++ Y L + PE
Sbjct: 148 EFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
+ T +S ++SFG LL ++ S P + D +
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
E+ + C EP +RP LV L L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 52/269 (19%), Positives = 97/269 (36%), Gaps = 35/269 (13%)
Query: 72 VVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGC 121
V + ++AVK A D + E + + +++ + NLLG
Sbjct: 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEA 167
C + ++ EY L ++L + + + A +A
Sbjct: 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
+EY SK + ++ DL A ++ +D +++ FGL ++ Y + + P
Sbjct: 148 MEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
E L T +S ++SFG LL ++ + P + + L S+
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPSNC 262
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL + C P +RP + LV L
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (260), Expect = 4e-26
Identities = 44/258 (17%), Positives = 94/258 (36%), Gaps = 20/258 (7%)
Query: 56 FAMEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQ 109
+++++ I+ G + V+ + N A+K + +Q +E +
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
+ + + + G + + ++ +Y+ L ++Q + A + ALE
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGR 228
Y SK +Y DL I+ D + + +++ FG K D + + PE + T
Sbjct: 119 YLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELV 286
+SFG L+ ++L+G D N + L + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPPFFNEDVK 229
Query: 287 RLASRCLQYEPRERPNPR 304
L SR + + +R
Sbjct: 230 DLLSRLITRDLSQRLGNL 247
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (259), Expect = 1e-25
Identities = 45/240 (18%), Positives = 78/240 (32%), Gaps = 16/240 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPD------ARQFLEEARAVGQLRNRRLANLLGCCCE 124
VY + + A+K ++ A V + +
Sbjct: 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
D+ + + M L HL A A I LE+ ++ +Y DL
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKP 135
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGR-VTPESVMYSFGTL 241
I+ D+ + R+S GL + + +++ + PE L+ G + +S G +
Sbjct: 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L LL G H + + TLT + S E L+ LQ + R
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRL 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 22/242 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVG-QLRNRRLANLLGCCCEGD 126
V+ + + A+K + D + E R + + L ++ +
Sbjct: 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
V EY+ L H+ + A I L++ SK +Y DL
Sbjct: 77 NLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDN 133
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSFGTLL 242
I+ D D + +++ FG+ K + G + + T PE L + +SFG LL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEPRER 300
++L G+ ++ + L S E L + EP +R
Sbjct: 194 YEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 301 PN 302
Sbjct: 246 LG 247
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 44/253 (17%), Positives = 82/253 (32%), Gaps = 27/253 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ------FLEEARAVGQLRNRRLANLLGCCCE 124
VV K + + A K + +R+ E + ++++ + L
Sbjct: 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+ +L+ E + L E + + I + Y S + A + DL
Sbjct: 85 KTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIA-HFDLKP 141
Query: 185 YRIVFDDDVNPR----LSCFGLMKNSRDGRSYSTNL---AFTPPEYLRTGRVTPESVMYS 237
I+ D P+ + FGL G + F PE + + E+ M+S
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 238 FGTLLLDLLSGKHIPPSH----ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + LLSG L + N + E ++ S+ R L
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYE------FEDEYFSNTSALAKDFIRRLL 255
Query: 294 QYEPRERPNPRSL 306
+P++R +
Sbjct: 256 VKDPKKRMTIQDS 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (249), Expect = 5e-25
Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 25/255 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---------RQFLEEARAVGQLRN-RRLANLLG 120
VV + AVK + + L+E + ++ + L
Sbjct: 18 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
LV + M L +L E + ++ + E + ++
Sbjct: 78 TYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL-NIVHR 134
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRV------TP 231
DL I+ DDD+N +L+ FG G ++ PE +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
E M+S G ++ LL+G PP + + + D + L SR
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 292 CLQYEPRERPNPRSL 306
L +P++R
Sbjct: 253 FLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 1e-23
Identities = 38/257 (14%), Positives = 76/257 (29%), Gaps = 23/257 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERL 129
+Y G + +A+K Q E++ ++ + C EGD +
Sbjct: 22 DIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+V E + LF++ ++ L +A + +EY SK ++ D+ +
Sbjct: 80 MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLM 136
Query: 190 ---DDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVM 235
+ FGL K RD R++ + + +
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCL 293
S G +L+ G R + + S +E + C
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256
Query: 294 QYEPRERPNPRSLVTAL 310
++P+ L
Sbjct: 257 SLRFDDKPDYSYLRQLF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 1e-23
Identities = 48/248 (19%), Positives = 90/248 (36%), Gaps = 27/248 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS------AWPDARQFLEEARAVGQLRN--RRLANLLGCC 122
VY G + + +A+K + P+ + E + ++ + + LL
Sbjct: 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78
Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
D +L+ E E ++ + + EA+ +C + L+ D+
Sbjct: 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGV-LHRDI 136
Query: 183 NAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGRVTPESV-MYSF 238
I+ D + +L FG +D + ++PPE++R R S ++S
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
G LL D++ G P H ++IR + F +E L CL P
Sbjct: 197 GILLYDMVCGDI-PFEHDEEIIRGQVF-----------FRQRVSSECQHLIRWCLALRPS 244
Query: 299 ERPNPRSL 306
+RP +
Sbjct: 245 DRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 3e-23
Identities = 47/268 (17%), Positives = 82/268 (30%), Gaps = 36/268 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA-----RQFLEEARAVGQLRNRRLANLLGCCCEG 125
VYK + +A+K+ +A R L E + + +L + + LL
Sbjct: 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
LV ++M D + + + + L + LEY + DL
Sbjct: 73 SNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL-HRDLKPN 129
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTGRVTPESVMYSFGT 240
++ D++ +L+ FGL K+ T+ T P M++ G
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE----------------------GQFS 278
+L +LL P + R +TL E
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSL 306
S G +L+ L + P R
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 95.3 bits (236), Expect = 5e-23
Identities = 42/284 (14%), Positives = 83/284 (29%), Gaps = 32/284 (11%)
Query: 60 NIVSEH-------GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR 111
N+V H GE + V+++G L N ++A+K R + DA Q +E R L
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA 58
Query: 112 NRR-LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170
+ N+ EG +LV + + L + A + ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 171 CTSKERALYHDLNAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTN---------- 215
K +Y D+ + + + FG++K RD +
Sbjct: 117 IHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 216 -LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP--SHALDLIRDRNIQTLTDSC 272
+ + + + G + + L G A + + I S
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
+ + E + P+ L + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 94.6 bits (234), Expect = 7e-23
Identities = 42/281 (14%), Positives = 95/281 (33%), Gaps = 35/281 (12%)
Query: 58 MEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNR 113
ME + + GE VVYK + A+K+ + + E + +L++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS 173
+ L +LV E++ D L ++ L + + YC
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGR 228
+ R L+ DL ++ + + +++ FGL + T+ T + + +
Sbjct: 119 R-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPS-----------------------HALDLIRDRNI 265
+ ++S G + ++++G + P + +L +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
T+ + F + L S+ L+ +P +R +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 2e-22
Identities = 50/271 (18%), Positives = 85/271 (31%), Gaps = 41/271 (15%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER-- 128
VVY+ KL ++ +A+K+ + D R E + + +L + + L E+
Sbjct: 35 VVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90
Query: 129 ----LLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
LV +Y+P + Q + + +L Y S + D+
Sbjct: 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIK 149
Query: 184 AYRIVFDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSF 238
++ D D +L FG K G + + P T ++S
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 239 GTLLLDLLSGKHI----PPSHALDLI-------------------RDRNIQTLTDSCLEG 275
G +L +LL G+ I L I + +
Sbjct: 210 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
F E + L SR L+Y P R P
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 4e-22
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 35/282 (12%)
Query: 58 MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRN 112
MEN V + GE VVYK + +A+K+ + + E + +L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
+ LL ++ LV E++ D L K + + + + + L +C
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
S R L+ DL ++ + + +L+ FGL + T+ T P L
Sbjct: 120 SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 228 RVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRD--RNIQTLTDSCLEGQFSSDE--- 281
+ ++S G + ++++ + + P +D + R + T + G S +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 282 -----------------GTELVRLASRCLQYEPRERPNPRSL 306
+ L S+ L Y+P +R + ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 9e-22
Identities = 38/271 (14%), Positives = 91/271 (33%), Gaps = 37/271 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
+V N+ R+A+K+ + ++ L E + + + R+ + +
Sbjct: 23 MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82
Query: 130 LVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
+ Y+ + L+ +TQ + I L+Y S L+ DL ++
Sbjct: 83 MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 141
Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESV-MYSFGT 240
+ + ++ FGL + + ++ + PE + + +S+ ++S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------------------G 275
+L ++LS + I P + + L E
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + ++ + L + L + P +R
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 4e-21
Identities = 45/242 (18%), Positives = 82/242 (33%), Gaps = 17/242 (7%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + A+K + A + + E+R + R+ L L D
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
V EY L HL + A I ALEY S+ +Y D+ +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHSR-DVVYRDIKLENL 136
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
+ D D + +++ FGL K + TP PE L + G ++
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 244 DLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+++ G+ + + + + + E +F E L + L+ +P++R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
Query: 304 RS 305
Sbjct: 251 GP 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 6e-21
Identities = 42/249 (16%), Positives = 77/249 (30%), Gaps = 20/249 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCC----CEG 125
V + Q + A+K D + E + + + ++
Sbjct: 27 KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V E + L + Q + I EA++Y S + D+
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPE 140
Query: 186 RIVFDDDVNP---RLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
+++ +L+ FG K + S +T + PE L + M+S G
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEP 297
++ LL G S+ I + E S+ E+ L L+ EP
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260
Query: 298 RERPNPRSL 306
+R
Sbjct: 261 TQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 3e-20
Identities = 37/271 (13%), Positives = 88/271 (32%), Gaps = 41/271 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-- 126
V ++A+K+ R + A++ E R + +R+ + LL +
Sbjct: 33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
+ LV +M D + + + + + + L Y + ++ DL
Sbjct: 93 DDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDL 147
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPESVMYSFGT 240
+ ++D ++ FGL + + + + P L R T ++S G
Sbjct: 148 KPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207
Query: 241 LLLDLLSGKHI-------------------PPSHALDLIRDRNIQTLTDSCLE------G 275
++ ++++GK + PP+ + ++ + E
Sbjct: 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 267
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
++ V L + L + +R
Sbjct: 268 SILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 2e-19
Identities = 41/281 (14%), Positives = 85/281 (30%), Gaps = 36/281 (12%)
Query: 61 IVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNR 113
V+E GE A V+K + +A+KR + + + R + +
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLA----KHLFHWETQPMKWAMRLRVALHIAEALE 169
+ L C + + + +L + + + L+
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRT 226
+ S R ++ DL I+ +L+ FGL + + ++ L + PE L
Sbjct: 131 FLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 227 GRVTPESVMYSFGTLLLDLLSGKHI---------------------PPSHALDLIRDRNI 265
++S G + ++ K + D+ R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ +F +D L +CL + P +R + S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 5e-19
Identities = 40/283 (14%), Positives = 80/283 (28%), Gaps = 37/283 (13%)
Query: 58 MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRN 112
M+ + + GE V+K K E +A+KR + L E + +L++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
+ + L + LV E+ D F + + + + L +C
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
S+ L+ DL ++ + + +L+ FGL + + T P
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIP------------------------PSHALDLIRDR 263
+ M+S G + +L + L +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ L L+ P +R +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.5 bits (203), Expect = 3e-18
Identities = 45/236 (19%), Positives = 76/236 (32%), Gaps = 14/236 (5%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V K E+ A+K ++ +Q L E R + + L L +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
+V EY+ + HL A I EY S +Y DL +
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENL 172
Query: 188 VFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ D +++ FG K + + PE + + ++ G L+ ++
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+G PP A I+ FSS +L L LQ + +R
Sbjct: 233 AGY--PPFFADQPIQIYEKIVSGKVRFPSHFSS----DLKDLLRNLLQVDLTKRFG 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 49/292 (16%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
+++ G+ V+K + + ++A+K+ + L E + + L++ + N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 118 LLGCCCEGDER--------LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
L+ C LV ++ +D L + RV + L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPP 221
Y + L+ D+ A ++ D +L+ FGL + ++ N L + PP
Sbjct: 132 YIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 222 EYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPS----HALDLIRD-------------- 262
E L R P ++ G ++ ++ + I H L LI
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 263 --------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
++ + + + L + L +P +R +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 4e-16
Identities = 46/262 (17%), Positives = 84/262 (32%), Gaps = 23/262 (8%)
Query: 58 MEN--IVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWPD----ARQFLEEARAV 107
+EN ++ G A V+ + + A+K ++ E + +
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 108 GQLRNRRLANLLGCCCEGDERLLVA-EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
+R L + + +L + +Y+ L HL E I
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--YVGEIVL 140
Query: 167 ALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY--- 223
ALE+ +Y D+ I+ D + + L+ FGL K + EY
Sbjct: 141 ALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 224 --LRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
+R G +S G L+ +LL+G P + + E +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 280 DEGTELVRLASRCLQYEPRERP 301
+ L R L +P++R
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 1e-14
Identities = 42/278 (15%), Positives = 84/278 (30%), Gaps = 33/278 (11%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLAN 117
+S G A V + R+AVK+ +R + A++ E R + +++ +
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKE 175
LL + L + + Q + + I L+Y S
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTPPEYLRTGRVTPES 233
++ DL + ++D ++ FGL + +T P L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 234 VMYSFGTLLLDLLSGKH-------------------IPPSHALDLIRDRNIQTLTDSCLE 274
++S G ++ +LL+G+ P + L I + + S +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 275 ------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
V L + L + +R
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 69.5 bits (169), Expect = 7e-14
Identities = 42/276 (15%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129
V++ + N ++ VK ++ E + + LR + L + R
Sbjct: 50 EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 130 --LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
LV E++ N + Q + I +AL+YC S ++ D+ + +
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNV 160
Query: 188 VFD-DDVNPRLSCFGLMKNSRDGRSYS----TNLAFTPPEYLRTGRVTPESVMYSFGTLL 242
+ D + RL +GL + G+ Y+ + P + M+S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 243 LDLLSGKH--------------------------------IPPSHALDLIRDRNIQTLTD 270
++ K I + I R+ + +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + E + + L+Y+ + R R
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.9 bits (167), Expect = 1e-13
Identities = 42/299 (14%), Positives = 91/299 (30%), Gaps = 65/299 (21%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ K + N +A+K +E + + ++ + +LL
Sbjct: 28 TVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKER 176
+ +E + + +++ + L+Y +
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146
Query: 177 ALYHDLNAYRIVFDDD------VNPRLSCFGLMKNSRDGRSYS-TNLAFTPPEYLRTGRV 229
++ D+ ++ + + +++ G + + S + PE L
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206
Query: 230 TPESVMYSFGTLLLDLLSGKHI-------------------------PPSHALDLIRD-- 262
+ ++S L+ +L++G + PS+ L +
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266
Query: 263 ---------RNIQTLTDSCLEG------QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
RNI L LE +FS DE E+ S LQ +PR+R + L
Sbjct: 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 2e-13
Identities = 39/294 (13%), Positives = 90/294 (30%), Gaps = 54/294 (18%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLAN 117
+ G A +V +A+K+ +R A++ E + + ++ + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 118 LLGCCC------EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
LL E + LV E M + + + + +++
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHL 135
Query: 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGR 228
S ++ DL IV D ++ FGL + + + + PE +
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------- 274
++S G ++ +++ K + P ++ I+ L C E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 275 ----------------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + + ++ L S+ L +P +R +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 46.3 bits (109), Expect = 1e-06
Identities = 20/147 (13%), Positives = 35/147 (23%), Gaps = 25/147 (17%)
Query: 72 VVYKGKLENQFRIAVKRFNRSA----------WPDARQFLEEARAVGQLRNRRLANLLGC 121
V+ E VK F A + R L L G
Sbjct: 15 AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74
Query: 122 CC----EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
+ ++ E + E ++ V I E + +
Sbjct: 75 AVPKVYAWEGNAVLMELI---------DAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK 204
++ DL+ Y V + + F
Sbjct: 125 VHGDLSQY-NVLVSEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 359 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.1 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-59 Score=409.97 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=207.0
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.++|++++.||+|+||+||+|.+.++..||||++.... ...+++.+|++++++++|||||++++++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35788999999999999999998888899999998654 34567999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999864 456789999999999999999999999 99999999999999999999999999998654332
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCc-chhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...||+.|+|||++.+..++.++|||||||++|||+|+..|+.. ......... +........+...++++.+|+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-----ISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-----HHHTCCCCCCTTSCHHHHHHH
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHhcCCCCCccccCHHHHHHH
Confidence 34578999999999999999999999999999999996555443 322222211 111222334556678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+||+.||++|||++++++.|+++.+
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-59 Score=413.68 Aligned_cols=246 Identities=17% Similarity=0.239 Sum_probs=211.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
..|.++++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 3689999999999999999994 578999999998766556778999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----CC
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~~ 211 (359)
++|+|.+++.+ ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99999998853 4699999999999999999999999 9999999999999999999999999999876433 34
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..||+.|+|||++.+..++.++|||||||++|+|+||+.||.............. ........+...++++.+|+.+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHH
Confidence 5689999999999999999999999999999999999999876543222211111 1111122345677899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018244 292 CLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (359)
||+.||++|||+.|++++
T Consensus 253 ~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HTCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-59 Score=414.80 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=217.5
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.++|++.+.||+|+||+||+|.+. ++..||||+++... ...+++.+|+++|+.++|||||+++++|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 357788899999999999999964 58899999997654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~---- 210 (359)
+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 9999999999876677899999999999999999999999 99999999999999999999999999998765443
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcc-hhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...||+.|+|||++.+..++.++|||||||++|||++|..|+... ...... ..+........+...++++.+|
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-----~~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----HHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-----HHHhcCCCCCCCccchHHHHHH
Confidence 224678899999999999999999999999999999987766433 222221 1222223344556678899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+.+||+.||++|||+.++++.|+.+.++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-59 Score=409.12 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=211.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
++|++++.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+++|+.++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5788999999999999999996 468899999987432 223567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--C
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R 210 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--~ 210 (359)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 9999999999997 345699999999999999999999999 9999999999999999999999999999876544 3
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ....++...++++.+|+.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHHHHHHH
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCccCCHHHHHHHH
Confidence 45789999999999999999999999999999999999999977654433322211 112345567789999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||++|++++
T Consensus 237 ~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTC
T ss_pred HHccCCHhHCcCHHHHHcC
Confidence 9999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=408.64 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=206.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCC--CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+.+|.+.+.||+|+||+||+|+++. .||||+++... ....+.+.+|+++|++++|||||++++++.. +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4567888899999999999998653 59999997543 3346779999999999999999999998754 56899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999964 445799999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCcCCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCCChHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||....... ...........+. ....+..+++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~ 240 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-LSKVRSNCPK 240 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-GGGSCTTCCH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-chhccccchH
Confidence 24568999999999864 358999999999999999999999987543221 1111111111111 1123455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
++.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 899999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-58 Score=414.34 Aligned_cols=266 Identities=20% Similarity=0.288 Sum_probs=210.4
Q ss_pred cCHHHHHHHhcCC------CcccccccCCCCCCcEEEEEEeC-CC---cEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCC
Q 018244 44 YSIETLRTATSGF------AMENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSAWP-DARQFLEEARAVGQLRN 112 (359)
Q Consensus 44 ~~~~~~~~~~~~~------~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h 112 (359)
++++++..++++| +.|++.+.||+|+||+||+|... ++ ..||||.+...... ..+.+.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 3444444444433 56778888999999999999864 22 36899998765433 35679999999999999
Q ss_pred cccccccceeeeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 113 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
||||++++++...+..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSN 164 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCC
Confidence 9999999999999999999999999999998864 455799999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCCC---------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhh
Q 018244 193 VNPRLSCFGLMKNSRDGR---------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD 262 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~~---------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~ 262 (359)
+.+||+|||+++...... ...+|+.|+|||.+.++.++.++|||||||++|||+| |+.||..........
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~ 244 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999998754332 1346789999999999999999999999999999998 788877654433322
Q ss_pred hhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
... ...+...+..++.++.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 245 ~i~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 AIE-----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHH-----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH-----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 221 1222334566778899999999999999999999999999988664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=408.90 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=212.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+.+|++++.||+|+||+||+|.++++..||||++.... ...+.+.+|+++|++++|||||++++++.+ +..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788899999999999999999888899999998654 345679999999999999999999998754 5689999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----C
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-----~ 210 (359)
++|+|.+++.......+++..+..|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 999999988654445699999999999999999999999 9999999999999999999999999999876543 2
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcch-hHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...||+.|+|||++.++.++.++|||||||++|||+||..|+.... ....... +....+...+...++++.+|+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----LERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHhcCCCCCcccChHHHHHHH
Confidence 3467889999999998899999999999999999999766654432 2211111 111223334566778899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+||+.||++|||++++++.|+.+..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=407.90 Aligned_cols=246 Identities=17% Similarity=0.138 Sum_probs=203.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.+|++++.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4689999999999999999995 56899999999765432 345689999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-----
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----- 209 (359)
+++|+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999996 456799999999999999999999999 9999999999999999999999999999865322
Q ss_pred -CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||............ ..............++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence 34578999999999988776 57899999999999999999998654321111111 11111111122456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~ 308 (359)
|+.+||+.||++|||++++++
T Consensus 239 li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=409.86 Aligned_cols=247 Identities=16% Similarity=0.203 Sum_probs=209.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.|++++.||+|+||+||+|.. .++..||||++........+.+.+|+++|+.++|||||++++++.+.+..+|||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 578999999999999999995 5688999999987766667789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC----CCCc
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSY 212 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~----~~~~ 212 (359)
+|+|.+++.+ ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9999998764 345799999999999999999999999 999999999999999999999999999976543 2356
Q ss_pred CCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 213 STNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 213 ~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
.||+.|+|||++. +..|+.++|||||||++|+|+||+.||............... .......+...++++.+
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHHHH
Confidence 7899999999984 345899999999999999999999998765333222211111 11111234567789999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018244 288 LASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (359)
|+.+||+.||++|||+.|++++
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=396.28 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=214.5
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.++|++++.||+|+||+||+|+.+++..||||.++.... ..+++.+|+.++++++||||+++++++.+.+.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 356788999999999999999998888999999987654 3567999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
.+|+|..++.. ....+++..+.+++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999998764 455789999999999999999999999 99999999999999999999999999998654332
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+|+.|+|||.+.+..++.++||||||+++|||+| |+.||............. ...+...+...++++.+|+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-----QGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-----hCCCCCCcccccHHHHHHH
Confidence 3457889999999999999999999999999999998 787777655443332222 1223344566778999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTALVT 312 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~ 312 (359)
.+||+.||++|||+++++++|..
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=404.64 Aligned_cols=248 Identities=17% Similarity=0.220 Sum_probs=199.6
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeee--CCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 130 (359)
.++|++++.||+|+||+||+|+. .+|+.||||.+...... ..+.+.+|+++|+.++|||||++++++.+ .+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 35789999999999999999985 56899999999876433 24568899999999999999999999865 456899
Q ss_pred EEecCCCCCHhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCC----CcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 131 VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKE----RALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~----~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 3567999999999999999999999861 39999999999999999999999999998
Q ss_pred cCCCC----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 205 NSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||............... .....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~ 237 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIPYR 237 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----CCCCCCTT
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----CCCCCCcc
Confidence 76543 3457899999999999999999999999999999999999999776544333222111 11234456
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
.++++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 7788999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-57 Score=407.14 Aligned_cols=245 Identities=19% Similarity=0.209 Sum_probs=209.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch---HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.|..+++||+|+||+||+|.. .++..||||++....... .+.+.+|+++|+.++|||||++++++.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 378899999999999999984 578899999997654332 3568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCCCcC
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~ 213 (359)
||.+|+|..++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.........
T Consensus 96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172 (309)
T ss_dssp CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence 999998877665 446799999999999999999999999 99999999999999999999999999999888888889
Q ss_pred CCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 214 TNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 214 ~t~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
||+.|+|||++.+ +.|+.++|||||||++|||++|..||.............. .......+...++++.+|+.
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSCTTSCHHHHHHHH
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCCCHHHHHHHH
Confidence 9999999999864 4589999999999999999999999876543322221111 11111223456788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.+++++
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=405.20 Aligned_cols=244 Identities=17% Similarity=0.173 Sum_probs=209.6
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
++|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5789999999999999999995 578999999997432 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC---
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~--- 209 (359)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999886 446799999999999999999999999 9999999999999999999999999999876432
Q ss_pred ---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHH
Q 018244 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (359)
....||+.|+|||++.+..++.++|||||||++|+|++|..||............... ...++...++++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------EYDFPEKFFPKAR 238 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCCCCTTCCHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC------CCCCCccCCHHHH
Confidence 2456899999999999999999999999999999999999999876444333222211 1234556778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018244 287 RLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+||.+||+.||++|||++|+++.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHccCCHhHCcCHHHHcCC
Confidence 99999999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-57 Score=404.99 Aligned_cols=247 Identities=15% Similarity=0.173 Sum_probs=195.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|++++.||+|+||+||+|.. .+++.||||++...... ....+.+|+.+|+.++|||||++++++.+++.+||||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 488999999999999999995 46889999999765432 2346789999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC---CCCCeEEeccCCcccCCCC---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~---~~~~~kl~DFg~a~~~~~~--- 209 (359)
++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999997 456799999999999999999999999 999999999999995 5789999999999876544
Q ss_pred CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
....||+.|+|||++.+..|+.++|||||||++|+|++|..||................. ..........++++.+|+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--EFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCCCccccCCCHHHHHHH
Confidence 345689999999999999999999999999999999999999987654443332222111 111223356778999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.|++++
T Consensus 245 ~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHS
T ss_pred HHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=410.15 Aligned_cols=254 Identities=17% Similarity=0.213 Sum_probs=206.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
++|++++.||+|+||+||+|.. .+|..||+|+++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.++|||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4688999999999999999995 5789999999976533 3356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC--CCCc
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY 212 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~--~~~~ 212 (359)
+++|+|.+++.+ ...+++..+..++.|++.||.|||++.+|+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 86 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 86 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999999999973 456999999999999999999999732899999999999999999999999999986532 3456
Q ss_pred CCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh--------------------------
Q 018244 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------------------- 266 (359)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-------------------------- 266 (359)
.||+.|+|||++.+..|+.++||||+||++|||++|+.||..............
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 899999999999999999999999999999999999999865432211100000
Q ss_pred ------------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHH
Q 018244 267 ------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVT 312 (359)
Q Consensus 267 ------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~ 312 (359)
...............+.++.+|+.+||..||++|||++|++++ +++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000000112246789999999999999999999999985 544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=395.45 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=198.8
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee----CCcceEE
Q 018244 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV 131 (359)
Q Consensus 59 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 131 (359)
|++.++||+|+||+||+|.. .++..||+|.+..... ...+.+.+|+++|+.++|||||++++++.+ ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 45666799999999999995 4688999999875432 335578999999999999999999999865 3458999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccCCCCCeeeC-CCCCeEEeccCCcccCCC
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--ivH~Dikp~NIll~-~~~~~kl~DFg~a~~~~~ 208 (359)
|||+++|+|.+++. +...+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999997 345799999999999999999999998 7 99999999999996 578999999999987554
Q ss_pred C--CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhH-HHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
. ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ........... ...++...++++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV 242 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC----CcccCccCCHHH
Confidence 3 34579999999999874 6999999999999999999999998654222 12111111111 111233456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCCHhHCcCHHHHhCC
Confidence 999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=396.02 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=206.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCCC-----cEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQ-----FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
+.|.+.+.||+|+||+||+|.+... ..||||++...... ....+.+|+++|+.++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3466677789999999999985432 46999999765433 34568999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
||||+.+|++.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999999998765 456799999999999999999999999 99999999999999999999999999998754321
Q ss_pred -------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...||+.|+|||++.++.++.++|||||||++|||+++..|+........ ....+....+...+...+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~----~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTTCCCCCCTTCBH
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH----HHHHHhccCCCCCchhhHH
Confidence 23578899999999999999999999999999999997766654322211 1112222233445566778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
++.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 9999999999999999999999999999887643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-56 Score=409.92 Aligned_cols=250 Identities=19% Similarity=0.158 Sum_probs=213.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
++.|++++.||+|+||+||+|.. .+|..||||++........+.+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999995 57999999999876655566788999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC--CCCCeEEeccCCcccCCCCC--
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR-- 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~--~~~~~kl~DFg~a~~~~~~~-- 210 (359)
|++|+|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999999998753 445799999999999999999999999 999999999999998 67899999999999876553
Q ss_pred -CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...||+.|+|||++.+..++.++|||||||++|+|+||+.||................. ..........++++.+||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHH
Confidence 35789999999999999999999999999999999999999987544333222221111 111223345778899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 018244 290 SRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (359)
.+||+.||++|||+.|++++
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-56 Score=408.30 Aligned_cols=249 Identities=19% Similarity=0.153 Sum_probs=212.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.+|++++.||+|+||+||+|.. .+|..||||++........+.+.+|+++|+.++|||||++++++.+.+.++|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688999999999999999995 578999999998776666677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC--CCCCeEEeccCCcccCCCCC---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~--~~~~~kl~DFg~a~~~~~~~--- 210 (359)
++|+|.+++.+ ....+++..+..|+.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999854 445799999999999999999999999 999999999999996 46889999999998766543
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .........++++.+||.
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SCCGGGGGCCHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence 457899999999999999999999999999999999999999765443332222211110 111122346788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018244 291 RCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (359)
+||+.||++|||+.|++++
T Consensus 262 ~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=397.95 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=210.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
+.+|++.+.||+|+||+||+|+++++..||||++.... ...+.+.+|+.+|++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788999999999999999998888889999997654 345779999999999999999999999854 5689999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-----
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~----- 210 (359)
++|+|..++.......+++.++..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999999998754556799999999999999999999999 99999999999999999999999999998654332
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHH-HhhhhhhhhccccccCCCChHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (359)
...+|+.|+|||++.++.++.++||||||+++|||+||..|+....... ..... ........+..+++++.+|+
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTCCCCCCTTSCHHHHHHH
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-----HhcCCCCCCcccCHHHHHHH
Confidence 3457899999999999999999999999999999999776665433221 21111 11222334566778999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 290 SRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
.+||+.||++|||+++|++.|+......
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999998865543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=395.13 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=207.6
Q ss_pred ccccc-cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 59 ENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 59 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
+.+.. +||+|+||+||+|.+. ++..||||+++..... ..+.+.+|+++|++++|||||++++++.. +..+||||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 34444 4899999999999753 3557999999865433 35679999999999999999999999864 56899999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 89 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred eCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999998754 456799999999999999999999999 99999999999999999999999999998764432
Q ss_pred ----CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
...||+.|+|||++.++.++.++|||||||++|||+| |+.||........... +....+...+..+++++
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQGKRMECPPECPPEL 241 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HHTTCCCCCCTTCCHHH
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCcCCHHH
Confidence 3457889999999998999999999999999999998 8888876543322221 12222334566778899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+|+.+||+.||++|||+.+|++.|+....
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=401.30 Aligned_cols=245 Identities=17% Similarity=0.225 Sum_probs=212.6
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.++|++++.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35789999999999999999995 578999999997532 23356789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++|+|.+++. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999987 456789999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||............... ...++...++++.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHH
Confidence 2457899999999999999999999999999999999999999877655443332221 12345667889999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHHH
Q 018244 288 LASRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 288 li~~cl~~dp~~Rps-----~~~il~~ 309 (359)
||.+||++||++||+ +.+++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999995 7888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=392.53 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=201.5
Q ss_pred cCCCCCCcEEEEEEeC---CCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEecCCCC
Q 018244 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 64 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (359)
+||+|+||+||+|.+. .++.||||+++.... ...+.+.+|+++|++++|||||+++++|.. +..+|||||+++|
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g 92 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 92 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence 5899999999999853 346799999975432 235679999999999999999999999864 5678999999999
Q ss_pred CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC-------C
Q 018244 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (359)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~-------~ 211 (359)
+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 93 ~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 9999987 456799999999999999999999999 99999999999999999999999999998654332 3
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||........... +....+...+..++.++.+|+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-----i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCcccCHHHHHHHH
Confidence 457899999999998999999999999999999998 7888876543322221 1122233455667889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 291 RCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
+||+.||++|||+.+|++.|+....
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998887643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=403.93 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=206.7
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC-C-----cEEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN-Q-----FRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (359)
.++|++.+.||+|+||+||+|+... + ..||+|.+.... ......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998532 2 369999987543 23355789999999998 89999999999999999
Q ss_pred ceEEEecCCCCCHhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
.+|||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~N 194 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARN 194 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCchhc
Confidence 9999999999999999975321 3589999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHH
Q 018244 187 IVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDL 259 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~ 259 (359)
||++.++.+||+|||+|+...... ...||+.|+|||++.++.++.++|||||||++|||+| |..||.......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654432 2346899999999999999999999999999999998 788886543322
Q ss_pred HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018244 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~ 311 (359)
.. ...+....+...+...++++.+||.+||+.||++|||+++|+++|.
T Consensus 275 ~~----~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 NF----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1122222333455667889999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=389.09 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeee-CCcceEEEec
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEY 134 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 134 (359)
.++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|++++++++||||+++++++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356788899999999999999984 6789999997543 35679999999999999999999999865 4568999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CCcC
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYS 213 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~~~ 213 (359)
+++|+|.+++.......+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~ 161 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 161 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCCCcccc
Confidence 9999999999754444689999999999999999999999 9999999999999999999999999999875443 3456
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHHh
Q 018244 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (359)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (359)
+|..|+|||++.+..++.++||||||+++|||+| |+.|+............ ........+...++++.+|+.+|
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-----TTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----HcCCCCCCCccCCHHHHHHHHHH
Confidence 7889999999998999999999999999999998 56555544333222221 22233445666778999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhhc
Q 018244 293 LQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 293 l~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
|+.||++|||+.++++.|++++..
T Consensus 237 l~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999988653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-55 Score=395.75 Aligned_cols=244 Identities=18% Similarity=0.211 Sum_probs=211.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (359)
++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5789999999999999999995 568999999997432 233567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-CC
Q 018244 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RS 211 (359)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~~ 211 (359)
||+.||+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 9999999999887 456789999999999999999999999 9999999999999999999999999999886544 45
Q ss_pred cCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHHH
Q 018244 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (359)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (359)
..||+.|+|||++.+..|+.++|||||||++|+|+||+.||............... ...++...++++.+++.+
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------ELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHH
Confidence 67999999999999999999999999999999999999999876544433332221 123455677889999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 018244 292 CLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 292 cl~~dp~~Rp-----s~~~il~~ 309 (359)
||..||.+|+ |+++++++
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhhCHHhccccchhhHHHHHcC
Confidence 9999999996 89999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=395.34 Aligned_cols=247 Identities=17% Similarity=0.167 Sum_probs=207.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC------chHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.|++++.||+|+||+||+|.. .+|..||||++..... ...+.+.+|+++|+.++|||||++++++.+.+..+|
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 489999999999999999995 5789999999965422 235678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC----CeEEeccCCcccC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~----~~kl~DFg~a~~~ 206 (359)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++...
T Consensus 91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999974 45799999999999999999999999 999999999999998776 5999999999876
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .....+...+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA 245 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCchhcCCCCH
Confidence 543 3456899999999999989999999999999999999999999866444332222111100 00111234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++.+||.+||+.||++|||+++++++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=385.72 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=202.6
Q ss_pred CCcccccccCCCCCCcEEEEEEeCC----CcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.++|++.+.||+|+||+||+|+... +..||||.+....... .+.+.+|+++|++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578899999999999999998532 4579999987654333 456899999999999999999999995 467899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998764 456799999999999999999999999 9999999999999999999999999999875433
Q ss_pred ----CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHH
Q 018244 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (359)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (359)
....||+.|+|||++.+..++.++|||||||++|||+| |..|+............. .......+..++++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-----NGERLPMPPNCPPT 237 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----TTCCCCCCTTCCHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHH
Confidence 23456889999999999999999999999999999998 777776544332222111 11223455677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+.+||.+||+.||++|||+.+|++.|+.+.++
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-54 Score=396.43 Aligned_cols=245 Identities=17% Similarity=0.175 Sum_probs=211.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEE
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (359)
.++|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46799999999999999999995 578999999987432 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-C
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-~ 210 (359)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 120 ~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999999873 45799999999999999999999999 9999999999999999999999999999876543 4
Q ss_pred CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHHHH
Q 018244 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (359)
...||+.|+|||++.+..++.++|||||||++|+|+||+.||............... ....+...++++.+|+.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHHHHH
Confidence 567899999999999999999999999999999999999999876544333322221 12334567789999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 018244 291 RCLQYEPRERP-----NPRSLVTA 309 (359)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~il~~ 309 (359)
+||+.||.+|+ |+++++++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89998863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-54 Score=384.08 Aligned_cols=253 Identities=16% Similarity=0.185 Sum_probs=205.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc---hHHHHHHHHHHHhcCCCcccccccceeeeCCc----c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDE----R 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~ 128 (359)
++|++++.||+|+||+||+|.. .+|+.||||++...... ....+.+|+++|+.++||||+++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4589999999999999999994 57899999999865433 24568999999999999999999999977543 7
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||||+++|+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.++|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999886 445799999999999999999999999 999999999999999999999999999875432
Q ss_pred C-------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHH
Q 018244 209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (359)
Q Consensus 209 ~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (359)
. ....||+.|+|||++.+..++.++|||||||++|+|+||+.||................. ..........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC--CCCchhccCC
Confidence 2 245689999999999998999999999999999999999999976644333222221111 1111223456
Q ss_pred HHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhh
Q 018244 282 GTELVRLASRCLQYEPRERP-NPRSLVTALVTLQ 314 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rp-s~~~il~~L~~~~ 314 (359)
++++.+|+.+||+.||++|| |++++++.|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 78899999999999999999 8999999988874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-54 Score=383.68 Aligned_cols=249 Identities=18% Similarity=0.158 Sum_probs=209.3
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch---------HHHHHHHHHHHhcCC-Ccccccccceeee
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLR-NRRLANLLGCCCE 124 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 124 (359)
+.+|++++.||+|+||+||+|+. .+++.||||++....... .+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 56789999999999999999995 578999999997653221 235789999999997 9999999999999
Q ss_pred CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
++..||||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999973 45799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC---CCcCCCccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccC
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
..... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||................. ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY--QFGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 76543 34568999999998863 3478899999999999999999999987654433322222111 1122
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
......++++.+|+.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2234678899999999999999999999998763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-54 Score=388.22 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=210.3
Q ss_pred CCcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCch-HHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
.++|++++.||+|+||+||+|+.. ++..||||+++...... .+++.+|+++|+.++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 346788999999999999999853 35789999998655443 45799999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~N 186 (359)
+++|||+.+|+|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~N 170 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRN 170 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeEEcccc
Confidence 99999999999999986421 23588999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCCcchhHH
Q 018244 187 IVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDL 259 (359)
Q Consensus 187 Ill~~~~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~ 259 (359)
||++.++.+||+|||+++..... ....+|+.|+|||.+.+..++.++|||||||++|||++|.. ||.......
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 99999999999999998754322 23457889999999999999999999999999999999975 454443332
Q ss_pred HhhhhhhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
..... ........+...++++.+|+.+||+.||++||||.+|++.|+++.
T Consensus 251 ~~~~v-----~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYV-----RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHH-----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHH-----HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22211 111223345567789999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=392.92 Aligned_cols=250 Identities=16% Similarity=0.177 Sum_probs=210.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
-|++|.+++.||+|+||+||+|.. .++..||||.+.... .+...+.+|+++|+.++|||||++++++.+.+.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367899999999999999999995 468899999998754 334568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC--CCCeEEeccCCcccCCCCC-
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~--~~~~kl~DFg~a~~~~~~~- 210 (359)
||++|+|.+++.. ....+++..+..|+.||+.||.|||++ ||+||||||+|||++. ...+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999999999964 344799999999999999999999999 9999999999999985 4589999999998765543
Q ss_pred --CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...+|+.|+|||.+.+..++.++|||||||++|+|++|..||.................. .........++++.+|
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTSCHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhhccCCCHHHHHH
Confidence 346789999999999999999999999999999999999999876544333222221110 0000112356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018244 289 ASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (359)
+.+||..||++|||+.|++++
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=390.08 Aligned_cols=252 Identities=18% Similarity=0.269 Sum_probs=206.2
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CCc----EEEEEEeCCCC-CchHHHHHHHHHHHhcCCCcccccccceeeeCCcceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE-NQF----RIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (359)
.+|++++.||+|+||+||+|.+. +|+ .||+|.+.... ....+.+.+|+++|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999853 443 58999887543 33467799999999999999999999999764 5778
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~ 210 (359)
++||+.+|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999999999998865 566799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChHHHH
Q 018244 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (359)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (359)
...||+.|+|||++.++.++.++|||||||++|||+| |..||.......... .+....+...+..+++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-----~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTI 240 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-----HHHHTCCCCCCTTBCH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCCCcccCH
Confidence 2357899999999999999999999999999999999 566665443322221 1222223344566788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
++.+|+.+||+.||++|||+.++++.|..+.+.
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999887543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=384.53 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=201.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeC--C--CcEEEEEEeCCCC---CchHHHHHHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE--N--QFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
..+|++++.||+|+||+||+|+.. + ...||||++.... ....+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467899999999999999999843 2 2368999997643 2335678999999999999999999999976 467
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred heeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 899999999999998864 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CC-------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhhhhhccccccCCCChH
Q 018244 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (359)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (359)
.. ...++..|+|||.+.+..++.++||||||+++|||+| |..||............. ........+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~ 239 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEGERLPRPED 239 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----TSCCCCCCCTT
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH----hCCCCCCCccc
Confidence 32 2346789999999999999999999999999999998 788887664444332222 22223334556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 018244 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (359)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~ 313 (359)
.+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 778899999999999999999999999998875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=388.28 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=210.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCc--EEEEEEeCCCC-CchHHHHHHHHHHHhcC-CCcccccccceeeeCCcce
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (359)
+|++|++.+.||+|+||+||+|++. ++. .||||.+.... ....+.+.+|+++|+++ +|||||++++++.+.+..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 4677888889999999999999854 443 57888886443 23455789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCe
Q 018244 130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~ 195 (359)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCce
Confidence 999999999999999642 236799999999999999999999999 99999999999999999999
Q ss_pred EEeccCCcccCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-CCcchhHHHhhhhhhhhccc
Q 018244 196 RLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDS 271 (359)
Q Consensus 196 kl~DFg~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~ 271 (359)
||+|||+++..... ....||..|+|||.+.++.++.++|||||||++|||++|..| +.......+.... ..
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i-----~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQ 241 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-----GG
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH-----Hh
Confidence 99999999765432 244678999999999999999999999999999999998754 4443333322221 11
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcc
Q 018244 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (359)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~ 317 (359)
..+...+...++++.+||.+||+.||++|||+.+|++.|+++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 2233455667889999999999999999999999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=391.88 Aligned_cols=247 Identities=17% Similarity=0.148 Sum_probs=200.0
Q ss_pred Cccccccc-CCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcC-CCcccccccceeee----CCcce
Q 018244 57 AMENIVSE-HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE----GDERL 129 (359)
Q Consensus 57 ~~~~~~~~-lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~ 129 (359)
.+|.++++ ||+|+||+||+|.. .+++.||||++.. ...+.+|+.++.++ +|||||+++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46788865 89999999999995 6789999999864 34678899987654 89999999999875 35689
Q ss_pred EEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC---CCCeEEeccCCcccC
Q 018244 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS 206 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~---~~~~kl~DFg~a~~~ 206 (359)
||||||+||+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+++..
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence 999999999999999765556799999999999999999999999 9999999999999985 567999999999875
Q ss_pred CCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccccc--CCCChHH
Q 018244 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDE 281 (359)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 281 (359)
... ....||+.|+|||++.+..|+.++|||||||++|+|+||+.||...............+...... .......
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 543 34578999999999998899999999999999999999999987653222211111111111111 1111346
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
++++.+|+.+||+.||++|||+.+++++
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 7889999999999999999999999885
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-53 Score=392.53 Aligned_cols=248 Identities=17% Similarity=0.131 Sum_probs=202.9
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC---chHHHH---HHHHHHHhcCCCcccccccceeeeCCcc
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQF---LEEARAVGQLRNRRLANLLGCCCEGDER 128 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (359)
.++|++++.||+|+||+||+|+. .+|+.||||++..... .....+ .+++++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 35788999999999999999995 4689999999864321 112223 3457788888999999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
||||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999997 346789999999999999999999999 999999999999999999999999999987654
Q ss_pred C--CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHH
Q 018244 209 G--RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (359)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (359)
. ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||........... ..... ......+...++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSS--SCCCCCCSSSCHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcc--cCCCCCCCCCCHHH
Confidence 3 35679999999999975 4689999999999999999999999876432211110 01111 11223445677899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 018244 286 VRLASRCLQYEPRERPN-----PRSLVTA 309 (359)
Q Consensus 286 ~~li~~cl~~dp~~Rps-----~~~il~~ 309 (359)
.+||.+||+.||++||| +++++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 6888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=388.28 Aligned_cols=243 Identities=18% Similarity=0.234 Sum_probs=206.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCC---CchHHHHHHHHHHHh-cCCCcccccccceeeeCCcceEE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVG-QLRNRRLANLLGCCCEGDERLLV 131 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 131 (359)
++|.+++.||+|+||+||+|+. .+++.||||++.+.. ....+.+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4788999999999999999995 568999999997532 223456677777665 68999999999999999999999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC--
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~-- 209 (359)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 445689999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHH
Q 018244 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (359)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (359)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+............. ...++...++++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 232 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEAKD 232 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHH
Confidence 3457899999999999999999999999999999999999999876554433332211 22345567889999
Q ss_pred HHHHhcccCCCCCCCHH-HHHH
Q 018244 288 LASRCLQYEPRERPNPR-SLVT 308 (359)
Q Consensus 288 li~~cl~~dp~~Rps~~-~il~ 308 (359)
|+.+||+.||++|||+. ++++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHhcccCCCCCcCHHHHHHh
Confidence 99999999999999996 6764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=380.62 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=207.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCC--------CcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCC
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 126 (359)
++|++.+.||+|+||.||+|+... +..||||++...... ...++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578899999999999999998422 347999999876543 346788899999888 7999999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +++||||||+|||++.+
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED 171 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTT
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCC
Confidence 9999999999999999997532 24689999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||+++..... ....+|+.|+|||.+.++.|+.++||||||+++|||++ |..||..........
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~--- 248 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--- 248 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH---
Confidence 99999999998865432 23467889999999999999999999999999999998 566666554433322
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
.+........+...++++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 249 --~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 --LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222223344556677899999999999999999999999999998743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-54 Score=383.95 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=198.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeC-C
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-D 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 126 (359)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|...+.++ +|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357889999999999999999842 2468999999765433 345678888888877 689999999987664 4
Q ss_pred cceEEEecCCCCCHhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
.+++||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEK 170 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCC
Confidence 6899999999999999996432 23589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCCcchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~ 265 (359)
+.+||+|||+|+..... ....||+.|+|||++.+..++.++|||||||++|||+||.. ||..........
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~--- 247 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--- 247 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH---
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 99999999999865432 23468899999999999999999999999999999999765 454432221111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~ 315 (359)
..+........+...++++.+|+.+||+.||++|||+.+++++|+.+.+
T Consensus 248 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 -RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111222334456677889999999999999999999999999998743
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=380.25 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=203.8
Q ss_pred ccCCCCCCcEEEEEEeCC----CcEEEEEEeCCC-CCchHHHHHHHHHHHhcCCCcccccccceeeeC-CcceEEEecCC
Q 018244 63 SEHGEKAPNVVYKGKLEN----QFRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEYMP 136 (359)
Q Consensus 63 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~ 136 (359)
+.||+|+||+||+|++.+ ...||||+++.. .....+.+.+|+++|++++||||++++|++... ...++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 467999999999998643 236999999754 333457799999999999999999999998764 57899999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC------
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------ 210 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~------ 210 (359)
+|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 113 ~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 113 HGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp TCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred cCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 9999998864 556788999999999999999999999 99999999999999999999999999998654332
Q ss_pred --CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHHHHHHHH
Q 018244 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (359)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (359)
...||..|+|||.+.+..++.++||||||+++|||+||+.||........ ....+....+...+...++++.+|
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCCCCcccCcHHHHHH
Confidence 24578899999999999999999999999999999998888765432211 111111112233455667889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
+.+||+.||++|||+.||++.|+.+...
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=382.11 Aligned_cols=246 Identities=20% Similarity=0.200 Sum_probs=195.2
Q ss_pred ccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCch-----HHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 61 IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
.++.||+|+||+||+|.. .+|+.||||++....... .+.+.+|+++|+.++|||||++++++...+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 456789999999999995 568999999997543222 23588999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+.++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99887766653 456799999999999999999999999 9999999999999999999999999999876543 2
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccc----------------
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---------------- 273 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 273 (359)
...||+.|+|||++.+. .++.++|||||||++|||+||..||..................+..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45689999999998755 5799999999999999999999888765332222111111000000
Q ss_pred -cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 274 -EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 274 -~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
... .....++++.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 012346789999999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=375.86 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=200.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
++|++++.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788999999999999999995 67899999999754322 25678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~---- 209 (359)
|+.+ ++.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 9976 555666554667899999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc------------ccccCC
Q 018244 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD------------SCLEGQ 276 (359)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~~~~ 276 (359)
....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.................. ......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 3447899999999887665 578999999999999999999998765322211111100000 000000
Q ss_pred -----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 277 -----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 277 -----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.....+.++.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 012345789999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=378.63 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=211.3
Q ss_pred CcccccccCCCCCCcEEEEEEe------CCCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcC-CCcccccccceeeeCCcc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 128 (359)
.+|++.+.||+|+||.||+|++ .+++.||||+++..... ....+.+|+.+++.+ +|||||++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4778888999999999999985 24678999999865433 345689999999999 699999999999999999
Q ss_pred eEEEecCCCCCHhhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWE----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~ 192 (359)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +++||||||+||+++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccccccccc
Confidence 99999999999999987532 23689999999999999999999999 99999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------CcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCC-cchhHHHhhhhh
Q 018244 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNI 265 (359)
Q Consensus 193 ~~~kl~DFg~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~-~~~~~~~~~~~~ 265 (359)
+.+|++|||+++...... ...||+.|+|||.+.++.++.++||||||+++|||+|++.|+. ....... .
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~----~ 257 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----F 257 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----H
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH----H
Confidence 999999999998765432 3456899999999999999999999999999999999555543 3322111 1
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhc
Q 018244 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (359)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~ 316 (359)
..++....+...+...+.++.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 122222333444556778999999999999999999999999999876543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=375.78 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=208.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCcEEEEEEeCCCCCc-hHHHHHHHHHHHhcCCCcccccccceeeeCCcce
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (359)
+++.+.+.||+|+||+||+|.+. ++..||||+++..... ....+.+|++++++++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56788889999999999999853 2568999999765432 3456899999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccC
Q 018244 130 LVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (359)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg 201 (359)
+||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++++||+|||
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecc
Confidence 999999999999988642 224579999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCcchhHHHhhhhhhhhcccccc
Q 018244 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLE 274 (359)
Q Consensus 202 ~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (359)
+++..... ....+|+.|+|||.+.++.++.++||||||+++|||+||. .|+............ .+ ...
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i----~~-~~~ 253 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----ME-GGL 253 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----HT-TCC
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hh-CCC
Confidence 99865432 2335789999999999999999999999999999999996 444443332222211 11 122
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 018244 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (359)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~ 314 (359)
...+..+++.+.+|+.+||+.||++|||+.+|++.|++..
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3345567788999999999999999999999999987763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-52 Score=370.97 Aligned_cols=249 Identities=16% Similarity=0.211 Sum_probs=201.7
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEec
Q 018244 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (359)
++|+++++||+|+||+||+|+.++|+.||||++...... ..+.+.+|+.+|++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 478899999999999999999889999999999765322 256789999999999999999999999999999999999
Q ss_pred CCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC----C
Q 018244 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (359)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~----~ 210 (359)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+...... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 98876665554 457799999999999999999999999 9999999999999999999999999998765433 3
Q ss_pred CcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcc-------------------
Q 018244 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD------------------- 270 (359)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------------- 270 (359)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||..................
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 44678999999998765 4789999999999999999999998754322221111100000
Q ss_pred ----ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018244 271 ----SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (359)
Q Consensus 271 ----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (359)
...........++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001112345678999999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=373.85 Aligned_cols=254 Identities=15% Similarity=0.186 Sum_probs=196.7
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHH--HHHHHHHhcCCCcccccccceeeeCC----cceEE
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF--LEEARAVGQLRNRRLANLLGCCCEGD----ERLLV 131 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 131 (359)
+|.+.+.||+|+||+||+|+. +|..||||++.... ...+ ..|+..+..++|||||++++++.+.+ .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455667789999999999997 57799999997543 2333 34555666789999999999998754 57999
Q ss_pred EecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
|||+++|+|.+++.+ ..++|..+..++.|++.||+|||+. .+|+||||||+||||+.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999964 4699999999999999999999962 399999999999999999999999999988
Q ss_pred cCCCC--------CCcCCCccccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCcchhHH-----------
Q 018244 205 NSRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDL----------- 259 (359)
Q Consensus 205 ~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~----------- 259 (359)
..... ....||+.|+|||++.+.. ++.++|||||||++|||+||..|+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 65432 2456899999999987542 6778999999999999999987653221100
Q ss_pred HhhhhhhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhccc
Q 018244 260 IRDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (359)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~ 318 (359)
..............++.. +......+.+|+.+||+.||++|||+.||++.|+++.+...
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 000011111111122222 23456779999999999999999999999999999877654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=373.68 Aligned_cols=238 Identities=19% Similarity=0.268 Sum_probs=198.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc------hHHHHHHHHHHHhcCC--CcccccccceeeeCCc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 127 (359)
++|++.+.||+|+||+||+|+. .+|..||||++...... ...++.+|+.+|+.++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3688889999999999999995 57899999998754221 1233678999999986 8999999999999999
Q ss_pred ceEEEecCCC-CCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-CCCeEEeccCCccc
Q 018244 128 RLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (359)
Q Consensus 128 ~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-~~~~kl~DFg~a~~ 205 (359)
.++||||+.+ +++.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 57888776 345799999999999999999999999 9999999999999985 57899999999986
Q ss_pred CCCC--CCcCCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCChHHH
Q 018244 206 SRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (359)
Q Consensus 206 ~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
.... ....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||..... .... ...++...+
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--i~~~----------~~~~~~~~s 228 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRG----------QVFFRQRVS 228 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHC----------CCCCSSCCC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--Hhhc----------ccCCCCCCC
Confidence 5543 45678999999999987765 5679999999999999999998875421 1111 112334567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
+++.+|+.+||+.||++|||++|++++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 889999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=371.89 Aligned_cols=251 Identities=18% Similarity=0.193 Sum_probs=197.8
Q ss_pred CcccccccCCCCCCcEEEEEEe-CC-CcEEEEEEeCCCCC--chHHHHHHHHHHHhcC---CCcccccccceeee-----
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAW--PDARQFLEEARAVGQL---RNRRLANLLGCCCE----- 124 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 124 (359)
.+|++++.||+|+||+||+|.. .+ ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5789999999999999999985 34 66799999865322 1223456777776665 79999999999853
Q ss_pred CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
....+++|||+.++.+.... ......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 34689999999887655443 33667799999999999999999999999 99999999999999999999999999988
Q ss_pred cCCCC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc----------
Q 018244 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---------- 271 (359)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 271 (359)
..... ....||+.|+|||++.+..|+.++||||+||++|||++|+.||..................+
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 65433 35678999999999999999999999999999999999999997654322221111110000
Q ss_pred -----------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 -----------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 -----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.....+....++.+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011233457789999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=368.10 Aligned_cols=252 Identities=16% Similarity=0.216 Sum_probs=196.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeCC------c
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (359)
..|++++.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|+.++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4688999999999999999995 56999999999865332 2457889999999999999999999997654 4
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
+++||||+ +++|..++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccC
Confidence 69999999 557877774 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred CC-CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------------
Q 018244 208 DG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------- 268 (359)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~----------------- 268 (359)
.. ....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||................
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 44 456789999999998764 47899999999999999999999987643221111000000
Q ss_pred -----ccc---cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 018244 269 -----TDS---CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTL 313 (359)
Q Consensus 269 -----~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~ 313 (359)
... ..........++++.+|+.+||..||++|||+.|++++ ++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000 00001123456789999999999999999999999985 5444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=368.42 Aligned_cols=249 Identities=17% Similarity=0.222 Sum_probs=194.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC-chHHHHHHHHHHHhcCCCcccccccceeeeCCc----ceE
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----RLL 130 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~l 130 (359)
+.|++++.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|+.++||||+++++++..... .++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 3589999999999999999984 5799999999976543 235678999999999999999999999876532 345
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCC-
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~- 209 (359)
+++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.....
T Consensus 88 l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5566778999999953 4699999999999999999999999 9999999999999999999999999999764332
Q ss_pred ------CCcCCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccc-----------
Q 018244 210 ------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS----------- 271 (359)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 271 (359)
....||+.|+|||++.. ..++.++||||+||++|+|++|+.||..................+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 34568899999999854 457889999999999999999999987653221111111000000
Q ss_pred --------c-ccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 272 --------C-LEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 272 --------~-~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
. .... .....+.++.+|+.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 012345689999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=362.79 Aligned_cols=252 Identities=16% Similarity=0.178 Sum_probs=196.2
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeee-------
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------- 124 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 124 (359)
..+.|+++++||+|+||+||+|+. .+|+.||||++..... .....+.+|+++|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 457899999999999999999995 5789999999865432 235678899999999999999999998855
Q ss_pred -CCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCc
Q 018244 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (359)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a 203 (359)
....++||||+.++.+..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeeccee
Confidence 346899999998876654443 556789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC--------CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc--
Q 018244 204 KNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-- 272 (359)
Q Consensus 204 ~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 272 (359)
+..... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 765422 234689999999998865 589999999999999999999999875433222211111110000
Q ss_pred cc----------------C-CCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 LE----------------G-QFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 ~~----------------~-~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. . ... ...++++.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0 000 0124578899999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=365.52 Aligned_cols=251 Identities=21% Similarity=0.217 Sum_probs=195.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccccccceeeeC------CcceE
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL 130 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 130 (359)
+|+.++.||+|+||+||+|+. .+|+.||||++..... ...+|+++|+.++||||++++++|... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578888899999999999995 5689999999976532 234699999999999999999998543 34789
Q ss_pred EEecCCCCCHhhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCC
Q 018244 131 VAEYMPNDTLAKHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD 208 (359)
Q Consensus 131 v~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~ 208 (359)
||||++++.+..+.. ......+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999998764333321 12456799999999999999999999999 999999999999999765 899999999987654
Q ss_pred C---CCcCCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhh-----------c----
Q 018244 209 G---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------T---- 269 (359)
Q Consensus 209 ~---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------~---- 269 (359)
. ....||..|+|||.+.+. .++.++||||+||++|||++|+.||................ .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 345789999999988754 68999999999999999999999987653322211111000 0
Q ss_pred cc--------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 018244 270 DS--------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTL 313 (359)
Q Consensus 270 ~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--L~~~ 313 (359)
.. ..........++++.+|+.+||+.||++|||+.|++++ ++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00 00011123457789999999999999999999999975 4444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=353.73 Aligned_cols=250 Identities=17% Similarity=0.171 Sum_probs=203.0
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeCCcceEEEe
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (359)
.+|+++++||+|+||+||+|+. .++..||||+++.... .....+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4789999999999999999995 5788999999975432 335678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCCCC---
Q 018244 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (359)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~~~--- 210 (359)
++.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999998888775 566789999999999999999999999 99999999999999999999999999998765432
Q ss_pred -CcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchh-HHHhhhhhhhhc------------------
Q 018244 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLT------------------ 269 (359)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~------------------ 269 (359)
...++..|+|||.+.+.. ++.++|||||||++|||++|+.||..... ............
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 335678899999988665 68999999999999999999988643321 111110000000
Q ss_pred -----cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
............++.+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011223456789999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-49 Score=359.48 Aligned_cols=246 Identities=17% Similarity=0.195 Sum_probs=197.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeC--CcceE
Q 018244 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLL 130 (359)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l 130 (359)
+.++|++++.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|+.++ ||||+++++++... ...++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 446799999999999999999995 578999999997543 567889999999995 99999999998754 46899
Q ss_pred EEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCC-CeEEeccCCcccCCCC
Q 018244 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG 209 (359)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~-~~kl~DFg~a~~~~~~ 209 (359)
||||+.+++|..+. +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999987764 3599999999999999999999999 999999999999998655 5999999999876543
Q ss_pred ---CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhh--------------------
Q 018244 210 ---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------- 265 (359)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~-------------------- 265 (359)
....+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||.............
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3556899999999988654 7999999999999999999999886432111000000
Q ss_pred ----hhhc--------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 266 ----QTLT--------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 266 ----~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.... ............++++.+||.+||..||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0000011123356789999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-49 Score=350.47 Aligned_cols=258 Identities=15% Similarity=0.127 Sum_probs=205.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC-cccccccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 135 (359)
.|++++.||+|+||+||+|+. .+|+.||||++..... ...+.+|++.++.++| +|++.+++++......++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 578899999999999999995 4688999999865432 3456789999999975 89999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCC-----CCCeEEeccCCcccCCCC-
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRDG- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~-----~~~~kl~DFg~a~~~~~~- 209 (359)
+++|.+++.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 -~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 -GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred -CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 6799998865 456799999999999999999999999 9999999999999974 578999999999865322
Q ss_pred ----------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh--hhhhhhccccccCCC
Q 018244 210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--RNIQTLTDSCLEGQF 277 (359)
Q Consensus 210 ----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~ 277 (359)
....||+.|+|||++.+..++.++||||||+++|||+||..||.......... ...............
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 23468999999999999999999999999999999999999986432211100 000000000000011
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
....++++.+++..|++.+|++||+++.+.+.|+.+.+.....
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 1234567999999999999999999999999888876554443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=353.98 Aligned_cols=258 Identities=15% Similarity=0.119 Sum_probs=200.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccccc-ccceeeeCCcceEEEecC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN-LLGCCCEGDERLLVAEYM 135 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~ 135 (359)
.|++++.||+|+||+||+|.. .+|+.||||++..... .+++.+|+++++.++|+|++. +.+++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 588999999999999999985 5688999999876432 235788999999998776555 455567778899999999
Q ss_pred CCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeC---CCCCeEEeccCCcccCCCC---
Q 018244 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG--- 209 (359)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~---~~~~~kl~DFg~a~~~~~~--- 209 (359)
. ++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..++|+|||+|+.....
T Consensus 86 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 G-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp C-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred C-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 5 467776654 556799999999999999999999999 999999999999985 4567999999999875432
Q ss_pred --------CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhh--hhccccccCCCCh
Q 018244 210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--TLTDSCLEGQFSS 279 (359)
Q Consensus 210 --------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 279 (359)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||.............. .............
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 234689999999999998999999999999999999999999865432221111000 0000000001123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhcccCC
Q 018244 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVS 320 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~L~~~~~~~~~~ 320 (359)
.+++++.+++..||+.||++||++.++.+.|+.+.......
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 45678999999999999999999999999998876544433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=362.66 Aligned_cols=248 Identities=17% Similarity=0.206 Sum_probs=202.3
Q ss_pred CCcccccccCCCCCCcEEEEEEe----CCCcEEEEEEeCCCCC----chHHHHHHHHHHHhcCCC-cccccccceeeeCC
Q 018244 56 FAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQLRN-RRLANLLGCCCEGD 126 (359)
Q Consensus 56 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~ 126 (359)
.++|++++.||+|+||+||+|.. .+|+.||||.++.... ...+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 46799999999999999999984 2478999999975421 224567889999999976 89999999999999
Q ss_pred cceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccC
Q 018244 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (359)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~ 206 (359)
..+++|||+.+|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999987 445678999999999999999999999 9999999999999999999999999999765
Q ss_pred CCC-----CCcCCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhccccccCCCCh
Q 018244 207 RDG-----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (359)
Q Consensus 207 ~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (359)
... ....|++.|+|||.+.+. .++.++|||||||+||+|++|..||.................. ....++.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~~ 257 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ 257 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--CCCCCcc
Confidence 432 345678999999999765 3678999999999999999999998765332222111111111 1223455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 018244 280 DEGTELVRLASRCLQYEPRERPN-----PRSLVT 308 (359)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps-----~~~il~ 308 (359)
..++++.+|+.+||++||++||| ++|+++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 67889999999999999999994 777765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=359.63 Aligned_cols=249 Identities=16% Similarity=0.213 Sum_probs=196.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCc--hHHHHHHHHHHHhcCCCcccccccceeeeC-----Ccc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 128 (359)
.+|++++.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|+.++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 3689999999999999999994 57999999999865432 345688999999999999999999998643 334
Q ss_pred eEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCCC
Q 018244 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (359)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~~ 208 (359)
+++++|+.+|+|.+++ ..+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~---~~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhc---ccccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc
Confidence 6777888899999998 445799999999999999999999999 999999999999999999999999999876543
Q ss_pred C-CCcCCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhcccc--------------
Q 018244 209 G-RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-------------- 272 (359)
Q Consensus 209 ~-~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 272 (359)
. ....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....................
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 3 4556889999999877654 68899999999999999999999876533222211111100000
Q ss_pred -----cc-CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 273 -----LE-GQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 273 -----~~-~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. .. .....++++.+||.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 00 012346789999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=356.34 Aligned_cols=247 Identities=16% Similarity=0.199 Sum_probs=190.1
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCC--chHHHHHHHHHHHhcCCCcccccccceeeeC------Cc
Q 018244 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (359)
Q Consensus 57 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (359)
..|++++.||+|+||+||+|.. .+|..||||++..... .....+.+|+.+|+.++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4689999999999999999995 4699999999976543 2345688999999999999999999999643 57
Q ss_pred ceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCCcccCC
Q 018244 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (359)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~a~~~~ 207 (359)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccc
Confidence 89999999775 444442 3589999999999999999999999 99999999999999999999999999987655
Q ss_pred CC---CCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhhhhhhhhc---------------
Q 018244 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT--------------- 269 (359)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 269 (359)
.. ....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.................
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 43 345689999999999999999999999999999999999999875432221111100000
Q ss_pred ---cc---------------cccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 270 ---DS---------------CLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 270 ---~~---------------~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
.. ..... .....+.++.+|+.+||+.||++|||++|+|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 012357889999999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-42 Score=319.28 Aligned_cols=251 Identities=16% Similarity=0.178 Sum_probs=190.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-----------CcccccccceeeeC
Q 018244 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCCEG 125 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~ 125 (359)
+|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.+. |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 489999999999999999995 579999999998643 22456788999888875 47899999887643
Q ss_pred --CcceEEEecCCCC-CHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCC------eE
Q 018244 126 --DERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN------PR 196 (359)
Q Consensus 126 --~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~------~k 196 (359)
...+++++++..+ .............+++..+..++.||+.||.|||+..||+||||||+|||++.++. ++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 4556666665443 34444444466788999999999999999999998339999999999999986553 99
Q ss_pred EeccCCcccCCC-CCCcCCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCcchhHHHhh------hhh----
Q 018244 197 LSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------RNI---- 265 (359)
Q Consensus 197 l~DFg~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~------~~~---- 265 (359)
++|||.+..... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......... ...
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 999999886543 345678999999999999999999999999999999999999875431110000 000
Q ss_pred -------------hhhcc---------c----------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018244 266 -------------QTLTD---------S----------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (359)
Q Consensus 266 -------------~~~~~---------~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (359)
..... . ..........++++.+|+.+||+.||.+|||++|+|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 00112345678899999999999999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.6e-26 Score=188.46 Aligned_cols=162 Identities=15% Similarity=0.099 Sum_probs=118.9
Q ss_pred ccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCc------------------hHHHHHHHHHHHhcCCCccccccccee
Q 018244 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------------------DARQFLEEARAVGQLRNRRLANLLGCC 122 (359)
Q Consensus 61 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~~ 122 (359)
+-+.||+|+||+||+|+..+|+.||||++...... ......+|...+..+.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 44568999999999999888999999987632110 012345688999999999998877653
Q ss_pred eeCCcceEEEecCCCCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccCCCCCeeeCCCCCeEEeccCC
Q 018244 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (359)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ivH~Dikp~NIll~~~~~~kl~DFg~ 202 (359)
..+++|||++++.+.+ ++......++.|++.||.|||++ |++||||||+|||++++ .++|+|||+
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECCC
Confidence 3479999998865543 23344567899999999999999 99999999999999965 489999999
Q ss_pred cccCCCCCCcCCCccccCc------ccccCCCCCCccchhhHHHHH
Q 018244 203 MKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLL 242 (359)
Q Consensus 203 a~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Di~slG~il 242 (359)
|......... .|... +.+ ...|+.++|+||..--+
T Consensus 149 a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 8765433211 11111 111 25688899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=2.4e-08 Score=85.01 Aligned_cols=139 Identities=14% Similarity=-0.002 Sum_probs=93.1
Q ss_pred cccccccCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEEecCC
Q 018244 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP 136 (359)
Q Consensus 58 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 136 (359)
.++.++..+.++.+.||+...++ ..+.+|+...........+.+|...+..+. +--+.+++.+...++..++||++++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEeCC-CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 33455544445567899987544 467788887554333445677888887774 4346777888888888999999999
Q ss_pred CCCHhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 018244 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (359)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 174 (359)
|.++.+.... . .. ...++.+++..++.||+.
T Consensus 94 G~~~~~~~~~--~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 94 GVLCSEEYED--E--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHTTT--C--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccc--c--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 9887665421 0 11 222344444445555421
Q ss_pred ----------------CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 175 ----------------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 175 ----------------~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999977667799999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=8.2e-06 Score=73.26 Aligned_cols=76 Identities=13% Similarity=0.135 Sum_probs=48.5
Q ss_pred cccCCCCCCcEEEEEEeC-CCcEEEEEEeCC------CCC-chHHHHHHHHHHHhcCC-C--cccccccceeeeCCcceE
Q 018244 62 VSEHGEKAPNVVYKGKLE-NQFRIAVKRFNR------SAW-PDARQFLEEARAVGQLR-N--RRLANLLGCCCEGDERLL 130 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~------~~~-~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 130 (359)
.+.+|.|....||+.... ++..+.||.-.. ... ....+...|...|+.+. + ..+++++. .+++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 457899999999999854 467899997542 111 12334566888887662 2 23445543 35667889
Q ss_pred EEecCCCCC
Q 018244 131 VAEYMPNDT 139 (359)
Q Consensus 131 v~e~~~~gs 139 (359)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=1.3e-05 Score=67.02 Aligned_cols=69 Identities=19% Similarity=0.181 Sum_probs=50.3
Q ss_pred CcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCC--cccccccceeeeCCcceEEEecCCCCCHh
Q 018244 70 PNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (359)
Q Consensus 70 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (359)
.+.||+...+++..+.+|........ .+..|...|+.+.. -.+.+++.+..+++..++||++++|.++.
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 36799999888888899987654432 35667777776632 33566777777888899999999886553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.69 E-value=8.1e-05 Score=64.73 Aligned_cols=68 Identities=25% Similarity=0.234 Sum_probs=46.1
Q ss_pred CcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCcccc-----cc--cceeeeCCcceEEEecCCCC
Q 018244 70 PNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-----NL--LGCCCEGDERLLVAEYMPND 138 (359)
Q Consensus 70 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-----~~--~~~~~~~~~~~lv~e~~~~g 138 (359)
-..||+++..+|..+++|+...... ..+++..|...+..|...++. .. -..+......+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3689999998999999999875543 356677888888887533221 11 11223455678889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.00061 Score=60.67 Aligned_cols=73 Identities=15% Similarity=0.251 Sum_probs=48.9
Q ss_pred cccCCCCCCcEEEEEEeCC--------CcEEEEEEeCCCCCchHHHHHHHHHHHhcCC-CcccccccceeeeCCcceEEE
Q 018244 62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (359)
Q Consensus 62 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (359)
++.|+.|-...+|++...+ ...|.+++.-. . .......+|..+++.+. +.-..++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 4567888889999998654 34577776653 2 22334567888888885 433446676663 36899
Q ss_pred ecCCCCCH
Q 018244 133 EYMPNDTL 140 (359)
Q Consensus 133 e~~~~gsL 140 (359)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.10 E-value=0.00048 Score=59.26 Aligned_cols=158 Identities=12% Similarity=0.057 Sum_probs=81.4
Q ss_pred cCHHHHHHHhcCCCcccccc--cCCCCCCcEEEEEEeCCCcEEEEEEeCCCCCchHHHHHHHHHHHhcCCCccc-----c
Q 018244 44 YSIETLRTATSGFAMENIVS--EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-----A 116 (359)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~--~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v 116 (359)
.+.+++...-..|.--.+.+ .+..|--.+.|+.+..+| .+++|++.... ..+.+..|++++..|...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 45677777777665433333 345676788999998776 48999986532 12344556666666643222 1
Q ss_pred ccc-c--eeeeCCcceEEEecCCCCCHhh--------------hhhc----CC---CCCCC------------------H
Q 018244 117 NLL-G--CCCEGDERLLVAEYMPNDTLAK--------------HLFH----WE---TQPMK------------------W 154 (359)
Q Consensus 117 ~~~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~---~~~l~------------------~ 154 (359)
... | +.........++.++.+..... .++. .. ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 1 1112334455666665532111 0000 00 00000 0
Q ss_pred HHHHHHHHHHHHHHHHhhcC---CCcccccCCCCCeeeCCCCCeEEeccCCcc
Q 018244 155 AMRLRVALHIAEALEYCTSK---ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (359)
Q Consensus 155 ~~~~~i~~qi~~~L~~LH~~---~~ivH~Dikp~NIll~~~~~~kl~DFg~a~ 204 (359)
......+......+.-.+.. .|+||+|+.++||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222333332221 379999999999999988777899999864
|